Psyllid ID: psy763
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | 2.2.26 [Sep-21-2011] | |||||||
| Q3TZA2 | 342 | Cyclin-dependent kinase-l | yes | N/A | 0.521 | 0.461 | 0.579 | 7e-56 | |
| Q8CEQ0 | 352 | Cyclin-dependent kinase-l | no | N/A | 0.435 | 0.375 | 0.714 | 2e-55 | |
| Q5MAI5 | 315 | Cyclin-dependent kinase-l | yes | N/A | 0.613 | 0.590 | 0.505 | 4e-55 | |
| Q00532 | 357 | Cyclin-dependent kinase-l | no | N/A | 0.435 | 0.369 | 0.714 | 4e-55 | |
| Q66HE7 | 352 | Cyclin-dependent kinase-l | no | N/A | 0.435 | 0.375 | 0.706 | 3e-54 | |
| Q6AXJ9 | 350 | Cyclin-dependent kinase-l | yes | N/A | 0.435 | 0.377 | 0.691 | 4e-54 | |
| Q4R7T5 | 570 | Cyclin-dependent kinase-l | N/A | N/A | 0.435 | 0.231 | 0.646 | 2e-47 | |
| Q92772 | 493 | Cyclin-dependent kinase-l | no | N/A | 0.435 | 0.267 | 0.646 | 2e-47 | |
| Q5R754 | 493 | Cyclin-dependent kinase-l | no | N/A | 0.435 | 0.267 | 0.646 | 2e-47 | |
| Q9TTK0 | 566 | Cyclin-dependent kinase-l | no | N/A | 0.435 | 0.233 | 0.646 | 6e-47 |
| >sp|Q3TZA2|CDKL4_MOUSE Cyclin-dependent kinase-like 4 OS=Mus musculus GN=Cdkl4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 217 bits (553), Expect = 7e-56, Method: Compositional matrix adjust.
Identities = 98/169 (57%), Positives = 129/169 (76%), Gaps = 11/169 (6%)
Query: 3 FNKKKKSSYYKEAIRQATEATNKKEKR-----------SLKHPNLVNLLEVFRRKKKLHL 51
F + KSS AI++ E+ + + R LKHPNLVNL+EVFRRK+K+HL
Sbjct: 19 FKCRNKSSGQVVAIKKFVESEDDRVVRKIALREIRMLKQLKHPNLVNLIEVFRRKRKMHL 78
Query: 52 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 111
VFE+CDHT+LNELE +P+G+ +IK + WQ L+ +++CH+H CIHRD+KPENIL+T G
Sbjct: 79 VFEYCDHTLLNELERNPNGVSDGVIKSVLWQTLQALNFCHKHNCIHRDVKPENILITKQG 138
Query: 112 VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
++K+CDFGFAR++ PG+ YTDYVATRWYRAPELLVGDT YG +VDVWA+
Sbjct: 139 MIKICDFGFARILIPGDAYTDYVATRWYRAPELLVGDTKYGSSVDVWAV 187
|
Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q8CEQ0|CDKL1_MOUSE Cyclin-dependent kinase-like 1 OS=Mus musculus GN=Cdkl1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 95/133 (71%), Positives = 114/133 (85%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V+
Sbjct: 56 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEPLVKNITWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T +KLCDFGFARL+ PG+ YTDYVATRWYR+PELLVG
Sbjct: 116 FCHKHNCIHRDVKPENILITKQSAIKLCDFGFARLLTGPGDYYTDYVATRWYRSPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 176 DTQYGPPVDVWAI 188
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q5MAI5|CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 101/200 (50%), Positives = 139/200 (69%), Gaps = 14/200 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P+G+ +IK + WQ L+ ++
Sbjct: 56 KQLKHPNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPNGVADGVIKSVLWQTLQALN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
+CH H CIHRDIKPENIL+T G++K+CDFGFA+++ PG+ YTDYVATRWYRAPELLVGD
Sbjct: 116 FCHIHNCIHRDIKPENILITKQGIIKICDFGFAQILIPGDAYTDYVATRWYRAPELLVGD 175
Query: 149 TLYGPAVDVWAIE------------WTSHSYSQIGFIGLGNMGSHMAR--NLLKNNGRVT 194
T YG +VD+WAI W S ++ + +G + R ++ K+NG
Sbjct: 176 TQYGSSVDIWAIGCVFAELLTGQPLWPGKSDVDQLYLIIRTLGKLIPRHQSIFKSNGFFH 235
Query: 195 VILKSDSLDSETWDLTWQEI 214
I + D ET + + ++
Sbjct: 236 GISIPEPEDMETLEEKFSDV 255
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q00532|CDKL1_HUMAN Cyclin-dependent kinase-like 1 OS=Homo sapiens GN=CDKL1 PE=1 SV=5 | Back alignment and function description |
|---|
Score = 214 bits (546), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 95/133 (71%), Positives = 115/133 (86%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V+
Sbjct: 56 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFARL+ P + YTDYVATRWYR+PELLVG
Sbjct: 116 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLAGPSDYYTDYVATRWYRSPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 176 DTQYGPPVDVWAI 188
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q66HE7|CDKL1_RAT Cyclin-dependent kinase-like 1 OS=Rattus norvegicus GN=Cdkl1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 94/133 (70%), Positives = 115/133 (86%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLV+LLEVFRRK++LHLVFE+C HTVL+EL+ + G+P L+K ITWQ L+ V+
Sbjct: 56 KQLKHPNLVSLLEVFRRKRRLHLVFEYCHHTVLHELDRYQRGVPEPLVKNITWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFARL+ PG+ YTDYVATRWYR+PELLVG
Sbjct: 116 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPGDYYTDYVATRWYRSPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 176 DTQYGPPVDVWAI 188
|
Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q6AXJ9|CDKL1_DANRE Cyclin-dependent kinase-like 1 OS=Danio rerio GN=cdkl1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 92/133 (69%), Positives = 113/133 (84%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNL+EVFRRK+KLHLVFE+CDHTVLNEL+ +P G+P ++K I WQ L+ V+
Sbjct: 56 KQLKHPNLVNLMEVFRRKRKLHLVFEYCDHTVLNELDRYPRGVPEHMVKSIIWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+ CIHRD+KPENIL+T + V+KLCDFGFAR++ P + YTD VATRWYRAPELLVG
Sbjct: 116 FCHKQNCIHRDVKPENILITKHQVIKLCDFGFARILTGPCDYYTDCVATRWYRAPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWA+
Sbjct: 176 DTQYGPPVDVWAV 188
|
Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q4R7T5|CDKL2_MACFA Cyclin-dependent kinase-like 2 OS=Macaca fascicularis GN=CDKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 86/133 (64%), Positives = 109/133 (81%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+H NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL + ++++ +Q++ G+
Sbjct: 56 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYRAPELLVG 147
+CH H IHRDIKPENIL++ +GVVKLCDFGFAR L PGE YTDYVATRWYRAPELLVG
Sbjct: 116 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
D YG AVDVWAI
Sbjct: 176 DVKYGKAVDVWAI 188
|
Macaca fascicularis (taxid: 9541) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q92772|CDKL2_HUMAN Cyclin-dependent kinase-like 2 OS=Homo sapiens GN=CDKL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 86/133 (64%), Positives = 109/133 (81%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+H NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL + ++++ +Q++ G+
Sbjct: 56 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYRAPELLVG 147
+CH H IHRDIKPENIL++ +GVVKLCDFGFAR L PGE YTDYVATRWYRAPELLVG
Sbjct: 116 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
D YG AVDVWAI
Sbjct: 176 DVKYGKAVDVWAI 188
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q5R754|CDKL2_PONAB Cyclin-dependent kinase-like 2 OS=Pongo abelii GN=CDKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (480), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 86/133 (64%), Positives = 109/133 (81%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+H NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL + ++++ +Q++ G+
Sbjct: 56 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYRAPELLVG 147
+CH H IHRDIKPENIL++ +GVVKLCDFGFAR L PGE YTDYVATRWYRAPELLVG
Sbjct: 116 FCHSHNIIHRDIKPENILVSKSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
D YG AVDVWAI
Sbjct: 176 DVKYGKAVDVWAI 188
|
Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9TTK0|CDKL2_RABIT Cyclin-dependent kinase-like 2 OS=Oryctolagus cuniculus GN=CDKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (476), Expect = 6e-47, Method: Compositional matrix adjust.
Identities = 86/133 (64%), Positives = 108/133 (81%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+H NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL ++++ +Q++ G+
Sbjct: 56 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDDQVVQKYLFQIINGIG 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYRAPELLVG 147
+CH H IHRDIKPENIL++ +GVVKLCDFGFAR L PGE YTDYVATRWYRAPELLVG
Sbjct: 116 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
D YG AVDVWAI
Sbjct: 176 DVKYGKAVDVWAI 188
|
Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | ||||||
| 328714070 | 388 | PREDICTED: cyclin-dependent kinase-like | 0.435 | 0.340 | 0.825 | 7e-62 | |
| 242017241 | 351 | mitogen-activated protein kinase ERK-A, | 0.435 | 0.376 | 0.787 | 4e-60 | |
| 357630311 | 369 | putative cdkl1/4 [Danaus plexippus] | 0.435 | 0.357 | 0.795 | 7e-60 | |
| 321475433 | 329 | hypothetical protein DAPPUDRAFT_44967 [D | 0.435 | 0.401 | 0.810 | 1e-59 | |
| 156542367 | 388 | PREDICTED: cyclin-dependent kinase-like | 0.435 | 0.340 | 0.765 | 3e-59 | |
| 345492622 | 394 | PREDICTED: cyclin-dependent kinase-like | 0.435 | 0.335 | 0.765 | 3e-59 | |
| 312385893 | 458 | hypothetical protein AND_00226 [Anophele | 0.435 | 0.288 | 0.772 | 4e-58 | |
| 391333303 | 360 | PREDICTED: cyclin-dependent kinase-like | 0.429 | 0.361 | 0.792 | 5e-58 | |
| 383849185 | 392 | PREDICTED: cyclin-dependent kinase-like | 0.435 | 0.336 | 0.757 | 5e-58 | |
| 347969416 | 431 | AGAP003180-PA [Anopheles gambiae str. PE | 0.435 | 0.306 | 0.772 | 5e-58 |
| >gi|328714070|ref|XP_001949199.2| PREDICTED: cyclin-dependent kinase-like 1-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 243 bits (620), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 109/132 (82%), Positives = 121/132 (91%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLVNLLEVFRRK+KLHLVFEFC+HTVL+ELE HP+G P KQI WQ L+ V+
Sbjct: 88 KTLKHPNLVNLLEVFRRKRKLHLVFEFCEHTVLHELERHPYGCPEIFTKQIIWQTLQAVA 147
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCHRH CIHRDIKPENILLT+ GVVKLCDFGFARL+NPGENYTDYVATRWYR+PELLVGD
Sbjct: 148 YCHRHNCIHRDIKPENILLTSQGVVKLCDFGFARLMNPGENYTDYVATRWYRSPELLVGD 207
Query: 149 TLYGPAVDVWAI 160
TLYGP+VDVWAI
Sbjct: 208 TLYGPSVDVWAI 219
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242017241|ref|XP_002429100.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212513964|gb|EEB16362.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 238 bits (606), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 104/132 (78%), Positives = 121/132 (91%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLVNLLEVFRRKKK+HLVFE+CDHTVL+ELE +P G P L + ITWQ+L+G++
Sbjct: 56 KNLKHPNLVNLLEVFRRKKKIHLVFEYCDHTVLHELEKYPKGCPEQLTQYITWQILQGIA 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCH+H+CIHRDIKPENILLT+ G+VKLCDFGFAR++NPGENYTDYVATRWYRAPELLVGD
Sbjct: 116 YCHQHSCIHRDIKPENILLTSQGIVKLCDFGFARMLNPGENYTDYVATRWYRAPELLVGD 175
Query: 149 TLYGPAVDVWAI 160
T YG VDVWAI
Sbjct: 176 TNYGTPVDVWAI 187
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357630311|gb|EHJ78519.1| putative cdkl1/4 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 236 bits (603), Expect = 7e-60, Method: Compositional matrix adjust.
Identities = 105/132 (79%), Positives = 120/132 (90%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLVNL+EVFRRK+KLHLVFE+CDHTVL+ELE +P G P L KQI WQ L+GV+
Sbjct: 81 KNLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLHELEKYPAGCPELLSKQIIWQTLQGVA 140
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCHRH CIHRD+KPENILLT++GVVKLCDFGFAR+I+PGE+YTDYVATRWYRAPELLVGD
Sbjct: 141 YCHRHNCIHRDVKPENILLTSDGVVKLCDFGFARMISPGESYTDYVATRWYRAPELLVGD 200
Query: 149 TLYGPAVDVWAI 160
TLY VDVWAI
Sbjct: 201 TLYSTPVDVWAI 212
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|321475433|gb|EFX86396.1| hypothetical protein DAPPUDRAFT_44967 [Daphnia pulex] | Back alignment and taxonomy information |
|---|
Score = 236 bits (602), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 107/132 (81%), Positives = 115/132 (87%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNL+EVFRRKKKLHLVFE+CD TVLNELE HP G+P L K+I WQ L+ V
Sbjct: 56 KQLKHPNLVNLIEVFRRKKKLHLVFEYCDLTVLNELEKHPRGVPEVLTKRIIWQTLQAVG 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCH H CIHRD+KPENILLT GVVKLCDFGFARL+NPGENYTDYVATRWYRAPELLVGD
Sbjct: 116 YCHAHNCIHRDVKPENILLTKEGVVKLCDFGFARLLNPGENYTDYVATRWYRAPELLVGD 175
Query: 149 TLYGPAVDVWAI 160
T YGP VDVWAI
Sbjct: 176 TQYGPGVDVWAI 187
|
Source: Daphnia pulex Species: Daphnia pulex Genus: Daphnia Family: Daphniidae Order: Diplostraca Class: Branchiopoda Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156542367|ref|XP_001600503.1| PREDICTED: cyclin-dependent kinase-like 1-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 234 bits (598), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 101/132 (76%), Positives = 122/132 (92%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLVNLLEVFRRK+KLHLVFE+C+HT+L+E+E +PHG P + KQ+TWQ+L+GV+
Sbjct: 80 KNLKHPNLVNLLEVFRRKRKLHLVFEYCEHTLLHEMEKYPHGCPELMTKQLTWQILQGVA 139
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCHR C+HRD+KPENILLTA+GVVKLCDFGFAR+++PGENYT+YVATRWYRAPELLVGD
Sbjct: 140 YCHRLGCVHRDVKPENILLTADGVVKLCDFGFARMLSPGENYTEYVATRWYRAPELLVGD 199
Query: 149 TLYGPAVDVWAI 160
T YG VDVWAI
Sbjct: 200 TQYGTPVDVWAI 211
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345492622|ref|XP_003426895.1| PREDICTED: cyclin-dependent kinase-like 1-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 234 bits (597), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 101/132 (76%), Positives = 122/132 (92%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLVNLLEVFRRK+KLHLVFE+C+HT+L+E+E +PHG P + KQ+TWQ+L+GV+
Sbjct: 86 KNLKHPNLVNLLEVFRRKRKLHLVFEYCEHTLLHEMEKYPHGCPELMTKQLTWQILQGVA 145
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCHR C+HRD+KPENILLTA+GVVKLCDFGFAR+++PGENYT+YVATRWYRAPELLVGD
Sbjct: 146 YCHRLGCVHRDVKPENILLTADGVVKLCDFGFARMLSPGENYTEYVATRWYRAPELLVGD 205
Query: 149 TLYGPAVDVWAI 160
T YG VDVWAI
Sbjct: 206 TQYGTPVDVWAI 217
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|312385893|gb|EFR30285.1| hypothetical protein AND_00226 [Anopheles darlingi] | Back alignment and taxonomy information |
|---|
Score = 231 bits (588), Expect = 4e-58, Method: Compositional matrix adjust.
Identities = 102/132 (77%), Positives = 118/132 (89%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLV LLEVFRRK++LHLVFEFC+HTVL+ELE HP G P +L KQIT+Q ++GV+
Sbjct: 195 KNLKHPNLVCLLEVFRRKRRLHLVFEFCEHTVLHELERHPEGCPDNLTKQITYQTIQGVA 254
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCH+ C+HRDIKPENILLTA G VKLCDFGFAR+++PGENYTDYVATRWYRAPELLVGD
Sbjct: 255 YCHKQGCLHRDIKPENILLTAQGQVKLCDFGFARMLSPGENYTDYVATRWYRAPELLVGD 314
Query: 149 TLYGPAVDVWAI 160
T YG VDVWAI
Sbjct: 315 TQYGTPVDVWAI 326
|
Source: Anopheles darlingi Species: Anopheles darlingi Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|391333303|ref|XP_003741058.1| PREDICTED: cyclin-dependent kinase-like 1-like [Metaseiulus occidentalis] | Back alignment and taxonomy information |
|---|
Score = 230 bits (587), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 103/130 (79%), Positives = 115/130 (88%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90
LKHPNLVNLLEVFRRK+KLHLVFEFCD TVL+ LE HP G+P L K+ITWQV++ V++C
Sbjct: 58 LKHPNLVNLLEVFRRKRKLHLVFEFCDATVLDILEKHPKGVPEQLTKRITWQVIQAVNFC 117
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTL 150
H H IHRD+KPENILLT GVVKLCDFGFAR ++PGENYTDYVATRWYRAPELLVGDT
Sbjct: 118 HSHNAIHRDVKPENILLTKEGVVKLCDFGFARTLSPGENYTDYVATRWYRAPELLVGDTQ 177
Query: 151 YGPAVDVWAI 160
YGP+VDVWAI
Sbjct: 178 YGPSVDVWAI 187
|
Source: Metaseiulus occidentalis Species: Metaseiulus occidentalis Genus: Metaseiulus Family: Phytoseiidae Order: Mesostigmata Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383849185|ref|XP_003700226.1| PREDICTED: cyclin-dependent kinase-like 4-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 230 bits (587), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 100/132 (75%), Positives = 120/132 (90%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLVNLLEVFRRK+KLHLVFE+C++T+LNE+E +PHG P KQ+TWQ+L+GV+
Sbjct: 86 KNLKHPNLVNLLEVFRRKRKLHLVFEYCEYTLLNEMERYPHGCPEITTKQLTWQILQGVA 145
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCHR C+HRD+KPENIL+TA GVVKLCDFGFAR+++PGENYT+YVATRWYRAPELLVGD
Sbjct: 146 YCHRLCCVHRDVKPENILITAEGVVKLCDFGFARILSPGENYTEYVATRWYRAPELLVGD 205
Query: 149 TLYGPAVDVWAI 160
T YG VDVWAI
Sbjct: 206 TQYGTPVDVWAI 217
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347969416|ref|XP_312877.4| AGAP003180-PA [Anopheles gambiae str. PEST] gi|333468514|gb|EAA08474.4| AGAP003180-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 230 bits (587), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 102/132 (77%), Positives = 118/132 (89%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLV LLEVFRRK++LHLVFEFC+HTVL+ELE HP G P +L KQIT+Q ++GV+
Sbjct: 136 KNLKHPNLVCLLEVFRRKRRLHLVFEFCEHTVLHELERHPEGCPDNLTKQITYQTIQGVA 195
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCH+ C+HRDIKPENILLTA G VKLCDFGFAR+++PGENYTDYVATRWYRAPELLVGD
Sbjct: 196 YCHKQGCLHRDIKPENILLTAQGQVKLCDFGFARMLSPGENYTDYVATRWYRAPELLVGD 255
Query: 149 TLYGPAVDVWAI 160
T YG VDVWAI
Sbjct: 256 TQYGTPVDVWAI 267
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | ||||||
| UNIPROTKB|E1C5K5 | 352 | CDKL1 "Uncharacterized protein | 0.435 | 0.375 | 0.729 | 4.8e-55 | |
| FB|FBgn0031730 | 501 | CG7236 [Drosophila melanogaste | 0.435 | 0.263 | 0.765 | 2.6e-54 | |
| UNIPROTKB|E2RRC1 | 358 | CDKL1 "Uncharacterized protein | 0.435 | 0.368 | 0.729 | 5.5e-54 | |
| UNIPROTKB|J9NTE6 | 281 | CDKL1 "Uncharacterized protein | 0.435 | 0.469 | 0.729 | 5.5e-54 | |
| UNIPROTKB|A6QLF0 | 352 | CDKL1 "Uncharacterized protein | 0.435 | 0.375 | 0.714 | 1.5e-53 | |
| MGI|MGI:1918341 | 352 | Cdkl1 "cyclin-dependent kinase | 0.435 | 0.375 | 0.714 | 3.8e-53 | |
| UNIPROTKB|J3KMW1 | 276 | CDKL1 "Cyclin-dependent kinase | 0.435 | 0.478 | 0.714 | 4.9e-53 | |
| UNIPROTKB|Q00532 | 357 | CDKL1 "Cyclin-dependent kinase | 0.435 | 0.369 | 0.714 | 4.9e-53 | |
| UNIPROTKB|E2QUJ9 | 336 | CDKL4 "Uncharacterized protein | 0.435 | 0.392 | 0.681 | 1e-52 | |
| UNIPROTKB|E2R1T0 | 342 | CDKL4 "Uncharacterized protein | 0.435 | 0.385 | 0.681 | 1e-52 |
| UNIPROTKB|E1C5K5 CDKL1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
Identities = 97/133 (72%), Positives = 117/133 (87%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK+KLHLVFE+CDHTVL+EL+ HP G+P L++ ITWQ L+ V+
Sbjct: 56 KQLKHPNLVNLLEVFRRKRKLHLVFEYCDHTVLHELDKHPRGVPEQLVRSITWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFAR++ PG+ YTDYVATRWYR+PELLVG
Sbjct: 116 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARMLTGPGDYYTDYVATRWYRSPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 176 DTQYGPPVDVWAI 188
|
|
| FB|FBgn0031730 CG7236 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 561 (202.5 bits), Expect = 2.6e-54, P = 2.6e-54
Identities = 101/132 (76%), Positives = 115/132 (87%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKHPNLV+LLEVFRRK++LHLVFEFC+ TVL+ELE HP G P L KQI +Q L GV+
Sbjct: 165 KNLKHPNLVSLLEVFRRKRRLHLVFEFCELTVLHELERHPQGCPEHLTKQICYQTLLGVA 224
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCH+ C+HRDIKPENILLTA G VKLCDFGFAR+++PGENYTDYVATRWYRAPELLVGD
Sbjct: 225 YCHKQGCLHRDIKPENILLTAQGQVKLCDFGFARMLSPGENYTDYVATRWYRAPELLVGD 284
Query: 149 TLYGPAVDVWAI 160
T YG VDVWAI
Sbjct: 285 TQYGTPVDVWAI 296
|
|
| UNIPROTKB|E2RRC1 CDKL1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 5.5e-54, P = 5.5e-54
Identities = 97/133 (72%), Positives = 115/133 (86%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK+KLHLVFE+CDHTVL+EL+ H G+P L+K ITWQ L+ V+
Sbjct: 57 KQLKHPNLVNLLEVFRRKRKLHLVFEYCDHTVLHELDRHQRGVPEHLVKNITWQTLQAVN 116
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFARL+ P + YTDYVATRWYR+PELLVG
Sbjct: 117 FCHKHDCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYTDYVATRWYRSPELLVG 176
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 177 DTQYGPPVDVWAI 189
|
|
| UNIPROTKB|J9NTE6 CDKL1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 5.5e-54, P = 5.5e-54
Identities = 97/133 (72%), Positives = 115/133 (86%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK+KLHLVFE+CDHTVL+EL+ H G+P L+K ITWQ L+ V+
Sbjct: 57 KQLKHPNLVNLLEVFRRKRKLHLVFEYCDHTVLHELDRHQRGVPEHLVKNITWQTLQAVN 116
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFARL+ P + YTDYVATRWYR+PELLVG
Sbjct: 117 FCHKHDCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYTDYVATRWYRSPELLVG 176
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 177 DTQYGPPVDVWAI 189
|
|
| UNIPROTKB|A6QLF0 CDKL1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 554 (200.1 bits), Expect = 1.5e-53, P = 1.5e-53
Identities = 95/133 (71%), Positives = 115/133 (86%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNL+EVFRRK++LHLVFE+CDHTVL+EL+ H G+P L+K ITWQ L+ V+
Sbjct: 56 KQLKHPNLVNLIEVFRRKRRLHLVFEYCDHTVLHELDRHQRGVPEHLVKSITWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H+CIHRD+KPENIL+T V+KLCDFGFARL+ P + YTDYVATRWYR+PELLVG
Sbjct: 116 FCHKHSCIHRDVKPENILVTKQSVIKLCDFGFARLLTGPSDYYTDYVATRWYRSPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 176 DTQYGPPVDVWAI 188
|
|
| MGI|MGI:1918341 Cdkl1 "cyclin-dependent kinase-like 1 (CDC2-related kinase)" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 3.8e-53, P = 3.8e-53
Identities = 95/133 (71%), Positives = 114/133 (85%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V+
Sbjct: 56 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEPLVKNITWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T +KLCDFGFARL+ PG+ YTDYVATRWYR+PELLVG
Sbjct: 116 FCHKHNCIHRDVKPENILITKQSAIKLCDFGFARLLTGPGDYYTDYVATRWYRSPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 176 DTQYGPPVDVWAI 188
|
|
| UNIPROTKB|J3KMW1 CDKL1 "Cyclin-dependent kinase-like 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 4.9e-53, P = 4.9e-53
Identities = 95/133 (71%), Positives = 115/133 (86%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V+
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFARL+ P + YTDYVATRWYR+PELLVG
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYTDYVATRWYRSPELLVG 176
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 177 DTQYGPPVDVWAI 189
|
|
| UNIPROTKB|Q00532 CDKL1 "Cyclin-dependent kinase-like 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 4.9e-53, P = 4.9e-53
Identities = 95/133 (71%), Positives = 115/133 (86%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V+
Sbjct: 56 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFARL+ P + YTDYVATRWYR+PELLVG
Sbjct: 116 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLAGPSDYYTDYVATRWYRSPELLVG 175
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 176 DTQYGPPVDVWAI 188
|
|
| UNIPROTKB|E2QUJ9 CDKL4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 546 (197.3 bits), Expect = 1.0e-52, P = 1.0e-52
Identities = 90/132 (68%), Positives = 115/132 (87%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P G+ +IK + WQ L+ ++
Sbjct: 56 KQLKHPNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPKGVADGVIKSVLWQTLQALN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
+CH+H CIHRD+KPENIL+T G++K+CDFGFAR++ PG+ YTDYVATRWYRAPELLVGD
Sbjct: 116 FCHKHNCIHRDVKPENILITKQGIIKICDFGFARILIPGDAYTDYVATRWYRAPELLVGD 175
Query: 149 TLYGPAVDVWAI 160
T YG +VD+WAI
Sbjct: 176 TQYGSSVDIWAI 187
|
|
| UNIPROTKB|E2R1T0 CDKL4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 546 (197.3 bits), Expect = 1.0e-52, P = 1.0e-52
Identities = 90/132 (68%), Positives = 115/132 (87%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P G+ +IK + WQ L+ ++
Sbjct: 56 KQLKHPNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPKGVADGVIKSVLWQTLQALN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
+CH+H CIHRD+KPENIL+T G++K+CDFGFAR++ PG+ YTDYVATRWYRAPELLVGD
Sbjct: 116 FCHKHNCIHRDVKPENILITKQGIIKICDFGFARILIPGDAYTDYVATRWYRAPELLVGD 175
Query: 149 TLYGPAVDVWAI 160
T YG +VD+WAI
Sbjct: 176 TQYGSSVDIWAI 187
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5MAI5 | CDKL4_HUMAN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.505 | 0.6138 | 0.5904 | yes | N/A |
| Q6AXJ9 | CDKL1_DANRE | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6917 | 0.4356 | 0.3771 | yes | N/A |
| Q3TZA2 | CDKL4_MOUSE | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5798 | 0.5214 | 0.4619 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 303 | |||
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-92 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-80 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-79 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-63 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-61 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-54 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-48 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-47 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-43 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-42 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-41 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-40 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-40 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-40 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-39 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-38 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-38 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-37 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-37 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-36 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-36 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-35 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-35 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-34 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-33 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-31 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-31 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-31 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-30 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-30 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-29 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-29 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-28 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-28 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-27 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-27 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-27 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-26 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-22 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-09 | |
| pfam03446 | 163 | pfam03446, NAD_binding_2, NAD binding domain of 6- | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-08 | |
| COG2084 | 286 | COG2084, MmsB, 3-hydroxyisobutyrate dehydrogenase | 9e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-05 | |
| PRK09599 | 301 | PRK09599, PRK09599, 6-phosphogluconate dehydrogena | 3e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-05 | |
| PRK11559 | 296 | PRK11559, garR, tartronate semialdehyde reductase; | 6e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| TIGR01692 | 288 | TIGR01692, HIBADH, 3-hydroxyisobutyrate dehydrogen | 2e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| PRK15461 | 296 | PRK15461, PRK15461, NADH-dependent gamma-hydroxybu | 3e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-04 | |
| pfam03807 | 93 | pfam03807, F420_oxidored, NADP oxidoreductase coen | 0.002 | |
| PLN02858 | 1378 | PLN02858, PLN02858, fructose-bisphosphate aldolase | 0.003 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 1e-92
Identities = 97/133 (72%), Positives = 114/133 (85%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNL+EVFRRK+KLHLVFE+CDHTVLNELE +P G+P LIK+I WQ L+ V+
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T G +KLCDFGFAR++ +YTDYVATRWYRAPELLVG
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 175 DTQYGPPVDVWAI 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 2e-80
Identities = 90/158 (56%), Positives = 111/158 (70%), Gaps = 3/158 (1%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL 64
KK K S E +++ T K R L+H N+VNL E FRRK +L+LVFE+ + T+L L
Sbjct: 32 KKFKESEDDEDVKK-TALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL 90
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
E P GLP D ++ WQ+L+ ++YCH H IHRDIKPENIL++ +GV+KLCDFGFAR +
Sbjct: 91 EASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150
Query: 125 --NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
P TDYVATRWYRAPELLVGDT YG VDVWAI
Sbjct: 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 9e-79
Identities = 90/133 (67%), Positives = 112/133 (84%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+H NLVNL+EVFRRKK+L+LVFEF DHTVL++LE +P+GL +++ +Q+LRG+
Sbjct: 55 KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH H IHRDIKPENIL++ +GVVKLCDFGFAR + PGE YTDYVATRWYRAPELLVG
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 148 DTLYGPAVDVWAI 160
DT YG AVD+WA+
Sbjct: 175 DTKYGRAVDIWAV 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-63
Identities = 75/160 (46%), Positives = 102/160 (63%), Gaps = 8/160 (5%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61
KK K + E I + T +E + LK HPN++ LL+VFR K L+LVFEF D +
Sbjct: 30 KKIKLRFESEGIPK----TALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLY 85
Query: 62 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 121
+++ GLP LIK +Q+L+G+++CH H +HRD+KPEN+L+ GV+KL DFG A
Sbjct: 86 KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLA 145
Query: 122 RLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
R P YT YV TRWYRAPELL+GD Y VD+W++
Sbjct: 146 RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 9e-61
Identities = 67/133 (50%), Positives = 92/133 (69%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPN+V LL+V ++KL+LVFE+CD + L+ P L +LIK I +Q+LRG++
Sbjct: 53 KELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
YCH H +HRD+KP+NIL+ +GV+KL DFG AR P YT V T WYRAPE+L+G
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG 172
Query: 148 DTLYGPAVDVWAI 160
Y AVD+W++
Sbjct: 173 SKHYSTAVDIWSV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 2e-54
Identities = 65/162 (40%), Positives = 89/162 (54%), Gaps = 13/162 (8%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEK---RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 58
KKK + +R E + LKHPN+V L +VF + KL+LV E+C+
Sbjct: 31 VIKKKKIKKDRERILR---------EIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEG 81
Query: 59 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDF 118
L +L L D + Q+L + Y H +HRD+KPENILL +G VKL DF
Sbjct: 82 GDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADF 141
Query: 119 GFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
G AR ++PGE T +V T Y APE+L+G YG AVD+W++
Sbjct: 142 GLARQLDPGEKLTTFVGTPEYMAPEVLLGKG-YGKAVDIWSL 182
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 7e-54
Identities = 66/161 (40%), Positives = 98/161 (60%), Gaps = 10/161 (6%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLK----HPNLVNLLEVFRRKKKLHLVFEFCDHTV 60
KK K +Y E N +E +SL+ HPN+V L EVFR +L+ VFE+ + +
Sbjct: 30 KKMKKKFYSWE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNL 84
Query: 61 LNELENHPHG-LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 119
+++ +I+ I +Q+L+G+++ H+H HRD+KPEN+L++ VVK+ DFG
Sbjct: 85 YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG 144
Query: 120 FARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
AR I YTDYV+TRWYRAPE+L+ T Y VD+WA+
Sbjct: 145 LAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWAL 185
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-51
Identities = 63/134 (47%), Positives = 84/134 (62%), Gaps = 3/134 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
R L HPN+V L++ F K L+LV E+C+ L + L L D K+I Q+LRG+
Sbjct: 53 RRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGL 111
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLV 146
Y H + IHRD+KPENILL NGVVK+ DFG A+ + + T +V T WY APE+L+
Sbjct: 112 EYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 147 GDTLYGPAVDVWAI 160
G YGP VDVW++
Sbjct: 172 GGNGYGPKVDVWSL 185
|
Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-48
Identities = 75/158 (47%), Positives = 111/158 (70%), Gaps = 4/158 (2%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL 64
KK K S E +++ T K R+LK N+V L E FRR+ KL+LVFE+ + +L L
Sbjct: 32 KKFKDSEENEEVKETT-LRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELL 90
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
E P+G+P + ++ +Q+++ + +CH++ +HRDIKPEN+L++ N V+KLCDFGFAR +
Sbjct: 91 EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
Query: 125 NPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ G NYT+YVATRWYR+PELL+G YG AVD+W++
Sbjct: 151 SEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSV 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-47
Identities = 59/148 (39%), Positives = 79/148 (53%), Gaps = 31/148 (20%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDL------------- 75
+ LKHPN++ LL+VF K ++LVFEF + DL
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFME---------------TDLEKVIKDKSIVLTP 101
Query: 76 --IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTD 132
IK LRG+ Y H + +HRD+KP N+L+ ++GV+KL DFG AR +P T
Sbjct: 102 ADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161
Query: 133 YVATRWYRAPELLVGDTLYGPAVDVWAI 160
V TRWYRAPELL G YG VD+W++
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSV 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 57/134 (42%), Positives = 82/134 (61%), Gaps = 2/134 (1%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++ +HP +V LL+VF LV E+ + L + LP +K +L+GV+
Sbjct: 54 QACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLV 146
Y H + +HRD+KP N+L++A+GV+K+ DFG ARL + E Y+ VATRWYRAPELL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 147 GDTLYGPAVDVWAI 160
G Y P VD+WA+
Sbjct: 174 GARKYDPGVDLWAV 187
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 58/136 (42%), Positives = 82/136 (60%), Gaps = 4/136 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKK--LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
+ L+HPN+V L E+ K K +++VFE+ DH + L++ IK Q+L G
Sbjct: 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEG 112
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP--GENYTDYVATRWYRAPEL 144
+ Y H + +HRDIK NIL+ +GV+KL DFG AR +YT+ V T WYR PEL
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 145 LVGDTLYGPAVDVWAI 160
L+G T YGP VD+W++
Sbjct: 173 LLGATRYGPEVDMWSV 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 8e-43
Identities = 62/134 (46%), Positives = 86/134 (64%), Gaps = 2/134 (1%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGV 87
+ L HPN+V LL+V + KL+LVFEF D + +++ P GL LIK +Q+L+G+
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLV 146
+YCH H +HRD+KP+N+L+ G +KL DFG AR P YT V T WYRAPE+L+
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 172
Query: 147 GDTLYGPAVDVWAI 160
G Y VD+W+I
Sbjct: 173 GSRQYSTPVDIWSI 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 6e-42
Identities = 54/135 (40%), Positives = 81/135 (60%), Gaps = 3/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
+ L HPN+V L VF + L+LV E+C+ ++ + L+ + L D I +I Q+L G+
Sbjct: 46 KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGL 105
Query: 88 SYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLINPGENY-TDYVATRWYRAPELL 145
Y H + IHRD+KPENILL + NG VKL DFG ++L+ ++ V T Y APE+L
Sbjct: 106 EYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL 165
Query: 146 VGDTLYGPAVDVWAI 160
+G Y D+W++
Sbjct: 166 LGKGYYSEKSDIWSL 180
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-41
Identities = 60/134 (44%), Positives = 86/134 (64%), Gaps = 2/134 (1%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGV 87
+ L HPN+V LL+V + KL+LVFEF + ++ P G+P LIK +Q+L+G+
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLV 146
++CH H +HRD+KP+N+L+ G +KL DFG AR P YT V T WYRAPE+L+
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 147 GDTLYGPAVDVWAI 160
G Y AVD+W++
Sbjct: 174 GCKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 57/141 (40%), Positives = 88/141 (62%), Gaps = 10/141 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83
R L+H N++ LL++ R +++V E + T L+++ P L D I+ +Q+
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWY 139
LRG+ Y H IHRD+KP NIL+ +N +K+CDFG AR ++P E+ T+YV TRWY
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
RAPELL+ + Y A+D+W++
Sbjct: 173 RAPELLLSSSRYTKAIDIWSV 193
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 61/137 (44%), Positives = 85/137 (62%), Gaps = 7/137 (5%)
Query: 30 SLKHPNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQV 83
S +HPN+V LL+V R+ KL LVFE D + L P GLP + IK + Q+
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPE 143
LRGV + H H +HRD+KP+NIL+T++G VK+ DFG AR+ + T V T WYRAPE
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 144 LLVGDTLYGPAVDVWAI 160
+L+ + Y VD+W++
Sbjct: 177 VLLQSS-YATPVDMWSV 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-40
Identities = 57/134 (42%), Positives = 81/134 (60%), Gaps = 3/134 (2%)
Query: 30 SLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 87
+L+HPN+V L EV + + LV E+C+ + + L+N P +K + Q+LRG+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLV 146
Y H + IHRD+K N+LLT G +K+ DFG AR P + T V T WYRAPELL+
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 147 GDTLYGPAVDVWAI 160
G T Y A+D+WA+
Sbjct: 182 GCTTYTTAIDMWAV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 60/141 (42%), Positives = 85/141 (60%), Gaps = 18/141 (12%)
Query: 32 KHPNLVNLLEVFRRK--KKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQ-ITWQVLR 85
HPN+V LL V + + K ++LVFE+ + H V+ + D+ K+ I +Q+L+
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR------ANILEDVHKRYIMYQLLK 118
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY------TDYVATRWY 139
+ Y H IHRD+KP NILL ++ VKL DFG AR ++ E TDYVATRWY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
RAPE+L+G T Y VD+W++
Sbjct: 179 RAPEILLGSTRYTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 9e-38
Identities = 60/145 (41%), Positives = 85/145 (58%), Gaps = 13/145 (8%)
Query: 29 RSLKHPNLVNLLEVFRRKKK--------LHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 80
+ LKH N+VNL+E+ R K +LVFEFC+H + L N IK++
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVA 135
+L G+ Y HR+ +HRD+K NIL+T +G++KL DFG AR + +N YT+ V
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T WYR PELL+G+ YGP +D+W
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGA 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 9e-38
Identities = 59/148 (39%), Positives = 85/148 (57%), Gaps = 18/148 (12%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHG----LPWDLIKQITWQ 82
R LKH N+V+L+EVF K ++L+F++ +H + ++ H +P ++K + WQ
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTAN----GVVKLCDFGFARLINP------GENYTD 132
+L GV Y H + +HRD+KP NIL+ GVVK+ D G ARL N +
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--P 174
Query: 133 YVATRWYRAPELLVGDTLYGPAVDVWAI 160
V T WYRAPELL+G Y A+D+WAI
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAI 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 62/154 (40%), Positives = 94/154 (61%), Gaps = 7/154 (4%)
Query: 13 KEAIRQATEATNKKEKRSLK----HPNLVNLLEV-FRRK-KKLHLVFEFCDHTVLNELEN 66
K+ + + N +E ++L+ HPN++ L+EV F RK +L LVFE D + ++
Sbjct: 33 KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG 92
Query: 67 HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP 126
LP +K +Q+L+ + + HR+ HRDIKPENIL+ + ++KL DFG R I
Sbjct: 93 RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS 151
Query: 127 GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
YT+Y++TRWYRAPE L+ D YGP +D+WA+
Sbjct: 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAV 185
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 56/135 (41%), Positives = 86/135 (63%), Gaps = 3/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRG 86
+ L+HPN+V L +V ++ +L+L+FEF + L++ P G + +L+K +Q+L+G
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELL 145
+ +CH +HRD+KP+N+L+ GV+KL DFG AR P YT V T WYRAPE+L
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 146 VGDTLYGPAVDVWAI 160
+G Y VD+W+I
Sbjct: 174 LGSPRYSTPVDIWSI 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 51/135 (37%), Positives = 85/135 (62%), Gaps = 3/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRG 86
+ LKH N+V L +V + KL LVFE+ D + ++ H L + +K T+Q+L+G
Sbjct: 53 KELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKG 112
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELL 145
+++CH + +HRD+KP+N+L+ G +KL DFG AR P +++ V T WYRAP++L
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 146 VGDTLYGPAVDVWAI 160
+G Y ++D+W++
Sbjct: 173 LGSRTYSTSIDIWSV 187
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-36
Identities = 53/132 (40%), Positives = 83/132 (62%), Gaps = 1/132 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L +V KKL LVFE+CD + ++ + +++K +Q+L+G++
Sbjct: 54 KELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH H +HRD+KP+N+L+ NG +KL DFG AR P Y+ V T WYR P++L G
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 148 DTLYGPAVDVWA 159
LY ++D+W+
Sbjct: 174 AKLYSTSIDMWS 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 65/143 (45%), Positives = 85/143 (59%), Gaps = 12/143 (8%)
Query: 29 RSLKHPNLVNLLEVF----------RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQ 78
R L H N+VNL E+ + K +LVFE+ DH ++ LE+ D IK
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVAT 136
Q+L G++YCH+ +HRDIK NILL G +KL DFG ARL N E+ YT+ V T
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 137 RWYRAPELLVGDTLYGPAVDVWA 159
WYR PELL+G+ YGPA+DVW+
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 51/134 (38%), Positives = 81/134 (60%), Gaps = 3/134 (2%)
Query: 30 SLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 87
L+HPN+V + EV K+++V E+ +H + + +E +K + Q+L GV
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLV 146
++ H + +HRD+K N+LL G++K+CDFG AR +P + YT V T WYRAPELL+
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL 179
Query: 147 GDTLYGPAVDVWAI 160
G Y A+D+W++
Sbjct: 180 GAKEYSTAIDMWSV 193
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 9e-34
Identities = 56/147 (38%), Positives = 92/147 (62%), Gaps = 7/147 (4%)
Query: 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWD 74
AIR+A+ + LKH N+V L ++ KK L LVFE+ D + +++ GL
Sbjct: 50 AIREASLL------KDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH 103
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDY 133
++ +Q+LRG++YCH+ +HRD+KP+N+L++ G +KL DFG AR + P + Y++
Sbjct: 104 NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163
Query: 134 VATRWYRAPELLVGDTLYGPAVDVWAI 160
V T WYR P++L+G T Y ++D+W +
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGV 190
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 57/158 (36%), Positives = 82/158 (51%), Gaps = 32/158 (20%)
Query: 29 RSLKHPNLVNLLEVF--------RRKKKLHLVFEFCDHTVLNELEN------HPHGLPWD 74
+ LKHPN+V L+++ R++ +++V + DH + LEN
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ----- 116
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-----NPG-- 127
IK Q+L G++Y H + +HRDIK NIL+ G++K+ DFG AR NP
Sbjct: 117 -IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 128 -----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
YT+ V TRWYR PELL+G+ Y AVD+W I
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 54/135 (40%), Positives = 83/135 (61%), Gaps = 3/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGV 87
+ ++H N+V L +V +K+L+LVFE+ D + +++ P LIK +Q+LRG+
Sbjct: 56 KEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 88 SYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELL 145
+YCH H +HRD+KP+N+L+ +KL DFG AR P +T V T WYRAPE+L
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 146 VGDTLYGPAVDVWAI 160
+G Y VD+W++
Sbjct: 176 LGSRHYSTPVDIWSV 190
|
Length = 294 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-31
Identities = 57/141 (40%), Positives = 87/141 (61%), Gaps = 7/141 (4%)
Query: 26 KEKRSLKHPNLVNLLEVFR-----RKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQI 79
+ + +HPN+V L +V R+ KL LVFE D + L+ P G+P + IK +
Sbjct: 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 115
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWY 139
+Q+LRG+ + H H +HRD+KP+NIL+T++G +KL DFG AR+ + T V T WY
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
RAPE+L+ + Y VD+W++
Sbjct: 176 RAPEVLLQSS-YATPVDLWSV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 61/146 (41%), Positives = 85/146 (58%), Gaps = 7/146 (4%)
Query: 21 EATNKKEKRSLKHPNLVNLLEV-----FRRKKKLHLVFEFCDHTVLNELENHPH-GLPWD 74
E K + HPN+V L++V R+ K+ LVFE D + L+ P GLP +
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE 108
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
IK + Q LRG+ + H + +HRD+KPENIL+T+ G VKL DFG AR+ + T V
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVV 168
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
T WYRAPE+L+ T Y VD+W++
Sbjct: 169 VTLWYRAPEVLLQST-YATPVDMWSV 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 9e-31
Identities = 57/147 (38%), Positives = 90/147 (61%), Gaps = 7/147 (4%)
Query: 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWD 74
AIR+A+ + LKH N+V L ++ K+ L LVFE+ + ++ HP GL +
Sbjct: 50 AIREASLL------KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE 103
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDY 133
+K +Q+LRG+SY H+ +HRD+KP+N+L++ G +KL DFG AR + P Y++
Sbjct: 104 NVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163
Query: 134 VATRWYRAPELLVGDTLYGPAVDVWAI 160
V T WYR P++L+G T Y +D+W +
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGV 190
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 56/139 (40%), Positives = 76/139 (54%), Gaps = 11/139 (7%)
Query: 31 LKHPNLVNL--LEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
LKHPNLV +EV R +K+++ E+C L EL H L +I+ T Q+L G++
Sbjct: 56 LKHPNLVKYYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA 113
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP-----GENYTDYVATRWYRAPE 143
Y H H +HRDIKP NI L NGV+KL DFG A + GE T Y APE
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 144 LLVGDTL--YGPAVDVWAI 160
++ G +G A D+W++
Sbjct: 174 VITGGKGKGHGRAADIWSL 192
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-30
Identities = 52/133 (39%), Positives = 85/133 (63%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++LKH N+V L ++ ++ L LVFE+ D + L+N + + +K +Q+LRG+S
Sbjct: 58 KNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLS 117
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
YCH+ +HRD+KP+N+L+ G +KL DFG AR + P + Y++ V T WYR P++L+G
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 148 DTLYGPAVDVWAI 160
T Y +D+W +
Sbjct: 178 STEYSTPIDMWGV 190
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 52/133 (39%), Positives = 84/133 (63%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L ++ +K L LVFE+ D + L++ + + +K +Q+LRG++
Sbjct: 59 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
YCHR +HRD+KP+N+L+ G +KL DFG AR + P + Y++ V T WYR P++L+G
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 148 DTLYGPAVDVWAI 160
T Y +D+W +
Sbjct: 179 STDYSTQIDMWGV 191
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 55/146 (37%), Positives = 86/146 (58%), Gaps = 7/146 (4%)
Query: 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWD 74
AIR+A+ + LKH N+V L ++ K+ L VFE+ + + HP GL
Sbjct: 50 AIREASLL------KGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY 103
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDY 133
++ +Q+LRG++Y H +HRD+KP+N+L++ G +KL DFG AR + P + Y+
Sbjct: 104 NVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163
Query: 134 VATRWYRAPELLVGDTLYGPAVDVWA 159
V T WYR P++L+G T Y A+D+W
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWG 189
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 50/133 (37%), Positives = 83/133 (62%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L ++ K L LVFE+ D + +++ + + +K +Q+LRG++
Sbjct: 59 KDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
YCHR +HRD+KP+N+L+ G +KL DFG AR + P + Y++ V T WYR P++L+G
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 148 DTLYGPAVDVWAI 160
+ Y +D+W +
Sbjct: 179 SSEYSTQIDMWGV 191
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 51/138 (36%), Positives = 85/138 (61%), Gaps = 11/138 (7%)
Query: 34 PNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVL 84
+V LL+V ++K L+LVFE+ D + ++++ LP IK +Q+L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 85 RGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAP 142
+GV++CH+H +HRD+KP+N+L+ G++K+ D G R + P ++YT + T WYRAP
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+L+G T Y VD+W++
Sbjct: 181 EVLLGSTHYSTPVDIWSV 198
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 51/146 (34%), Positives = 84/146 (57%), Gaps = 21/146 (14%)
Query: 29 RSLKHPNLVNLLEVFRRK-----KKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQ 78
R KH N++ +L++ R +++V E + + ++ L N D I+
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN-------DHIQY 110
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYV 134
+Q+LRG+ Y H +HRD+KP N+LL N +K+CDFG AR+ +P ++ T+YV
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
ATRWYRAPE+++ Y A+D+W++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSV 196
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 7/136 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHGLPWDLIKQITWQVLRG 86
R L HPN+V LL V ++ L +V E+ L + +N P L + Q+ RG
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA---TRWYRAPE 143
+ Y IHRD+ N L+ N VVK+ DFG +R + + Y RW APE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APE 174
Query: 144 LLVGDTLYGPAVDVWA 159
L + + DVW+
Sbjct: 175 SLK-EGKFTSKSDVWS 189
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 7/136 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
+ L HPN+V LL V + + L++V E+ L + L H L + Q+ Q+ +G+
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPE 143
Y +HRD+ N L+T N VVK+ DFG +R I + Y +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 144 LLVGDTLYGPAVDVWA 159
L D + DVW+
Sbjct: 175 SLK-DGKFTSKSDVWS 189
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 43/135 (31%), Positives = 63/135 (46%), Gaps = 6/135 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
R L HPN+V LL V ++ L++V E+ + L L + L + Q+ RG+
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA---TRWYRAPEL 144
Y IHRD+ N L+ N VVK+ DFG +R + + Y RW APE
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APES 174
Query: 145 LVGDTLYGPAVDVWA 159
L + + DVW+
Sbjct: 175 LK-EGKFTSKSDVWS 188
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 53/138 (38%), Positives = 82/138 (59%), Gaps = 7/138 (5%)
Query: 29 RSLKHPNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83
R L H N++ + ++ +++V+E D T L+++ L D + +Q+
Sbjct: 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQL 117
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAP 142
LRG+ Y H +HRD+KP N+LL AN +K+CDFG AR + G+ T+YV TRWYRAP
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 143 ELLVGDTLYGPAVDVWAI 160
ELL+ + Y A+DVW++
Sbjct: 178 ELLLNCSEYTTAIDVWSV 195
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 10/161 (6%)
Query: 8 KSSYYKEAIRQATEATNKKEK--RSLKHPNLVNLL--EVFRRKKKLHLVFEFCDH-TVLN 62
KS + EA ++ + SL+HPN+V E K L++ E+ ++ +
Sbjct: 31 KSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS 90
Query: 63 ELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
L+ LP +I++ T Q+L G++Y H + +HRDIK NIL+ ++GVVKL DFG A+
Sbjct: 91 LLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK 149
Query: 123 LINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ E T ++ APE++ G+ YG A D+W++
Sbjct: 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSL 189
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 54/141 (38%), Positives = 83/141 (58%), Gaps = 14/141 (9%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---ENH-----PHGLPWDLIKQITW 81
KH N+++ L++ + H+ F + V+ EL + H P L D +K +
Sbjct: 55 FFKHDNVLSALDIL---QPPHIDP-FEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWY 139
Q+LRG+ Y H +HRDIKP N+L+ +N V+K+CDFG AR+ P E + T V T++Y
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
RAPE+L+G Y AVD+W++
Sbjct: 171 RAPEILMGSRHYTSAVDIWSV 191
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 59/150 (39%), Positives = 87/150 (58%), Gaps = 18/150 (12%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENH--------PHGLPWDLIKQ 78
R LKHPN++ L +VF +K+ L+F++ +H + + ++ H P LP ++K
Sbjct: 53 RELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS 112
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGV----VKLCDFGFARLIN----PGENY 130
+ +Q+L G+ Y H + +HRD+KP NIL+ G VK+ D GFARL N P +
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 131 TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
V T WYRAPELL+G Y A+D+WAI
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAI 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 45/131 (34%), Positives = 74/131 (56%), Gaps = 2/131 (1%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSY 89
KHPN+V + +K +L +V EFC ++ + L++ L I + ++L+G+ Y
Sbjct: 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDT 149
H + IHRDIK NILLT++G VKL DFG + ++ + V T ++ APE++ G
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 150 LYGPAVDVWAI 160
Y D+W++
Sbjct: 174 -YDYKADIWSL 183
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 59/150 (39%), Positives = 88/150 (58%), Gaps = 18/150 (12%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENH--------PHGLPWDLIKQ 78
R LKHPN+++L +VF +K+ L+F++ +H + + ++ H P LP ++K
Sbjct: 53 RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGV----VKLCDFGFARLIN----PGENY 130
+ +Q+L G+ Y H + +HRD+KP NIL+ G VK+ D GFARL N P +
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 131 TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
V T WYRAPELL+G Y A+D+WAI
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAI 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 61/169 (36%), Positives = 91/169 (53%), Gaps = 26/169 (15%)
Query: 15 AIRQATEATNKK--EKRSLK----------HPNLVNLLE---VFRRK-KKLHLVFEF--C 56
AI++ T +KK KR+L+ H N+ L + VF +L+L E
Sbjct: 31 AIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA 90
Query: 57 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 116
D L+++ L + +Q+L G+ Y H +HRD+KP N+L+ A+ +K+C
Sbjct: 91 D---LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147
Query: 117 DFGFARLI--NPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
DFG AR NPGEN T+YVATRWYRAPE+++ Y A+DVW++
Sbjct: 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV 196
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 15 AIRQATEATNKKEK--------RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LE 65
AI++ KE + KHPN+V+ + + +L +V E+ D L + +
Sbjct: 48 AIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT 107
Query: 66 NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLI 124
+ + I + +VL+G+ Y H IHRDIK +NILL+ +G VKL DFGF A+L
Sbjct: 108 QNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167
Query: 125 NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVW 158
V T ++ APE ++ YGP VD+W
Sbjct: 168 KEKSKRNSVVGTPYWMAPE-VIKRKDYGPKVDIW 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 51/144 (35%), Positives = 85/144 (59%), Gaps = 16/144 (11%)
Query: 29 RSLKHPNLVNLLEVFRRK----KKLHLVFEF--CD-HTVLNELENHPHGLPWDLIKQITW 81
R KH N++ + ++ R K +++V + D H +++ + P L + I+ +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS--DQP--LTEEHIRYFLY 114
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI--NPGEN---YTDYVAT 136
Q+LRG+ Y H IHRD+KP N+L+ + +++ DFG AR + +P E+ T+YVAT
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 137 RWYRAPELLVGDTLYGPAVDVWAI 160
RWYRAPELL+ Y A+D+W++
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSV 198
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 56/146 (38%), Positives = 84/146 (57%), Gaps = 19/146 (13%)
Query: 29 RSLKHPNLVNLLEVF-----RRKKKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQIT 80
R L+HP++V + + R K +++VFE + H V+ ++ L + +
Sbjct: 54 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD----LTPEHHQFFL 109
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPGEN---YTDYVAT 136
+Q+LR + Y H HRD+KP+NIL A+ +K+CDFG AR+ N +TDYVAT
Sbjct: 110 YQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 137 RWYRAPELLVGD--TLYGPAVDVWAI 160
RWYRAPE L G + Y PA+D+W+I
Sbjct: 170 RWYRAPE-LCGSFFSKYTPAIDIWSI 194
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 15/144 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQIT------- 80
+ L HPN+V LL V ++ L+LV E+ + L + L P ++
Sbjct: 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 81 -WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD----YVA 135
Q+ +G+ Y +HRD+ N L+ + VVK+ DFG +R + + Y +
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP 170
Query: 136 TRWYRAPELLVGDTLYGPAVDVWA 159
RW APE L D ++ DVW+
Sbjct: 171 IRWM-APESLK-DGIFTSKSDVWS 192
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 17/145 (11%)
Query: 29 RSLKHPNLVNLL--EVFRRKKKLHLVFEFCDHTVLNEL------ENHPHGLPWDLIKQIT 80
R LKHPN+V + R + L++V E+C+ L +L E + + I +I
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRIL 111
Query: 81 WQVLRGVSYCHR-----HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YV 134
Q+L + CH + +HRD+KP NI L AN VKL DFG A+++ ++ YV
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWA 159
T +Y +PE L + Y D+W+
Sbjct: 172 GTPYYMSPEQLNHMS-YDEKSDIWS 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 16/150 (10%)
Query: 26 KEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLR 85
K +KH N++ L++V+ ++LV + L ++ + L +K I Q+L
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVVDRKIRLTESQVKCILLQILN 130
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR---------------LINPGENY 130
G++ H+ +HRD+ P NI + + G+ K+ DFG AR + E
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 131 TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T V T WYRAPELL+G Y AVD+W++
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
|
Length = 335 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 13 KEAIRQATEATNKKEKR---SLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELE 65
K+ I++ E+ + HP +V L F+ ++KL+LV E+ + L++
Sbjct: 29 KKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE- 87
Query: 66 NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LI 124
+ + +++ + Y H I+RD+KPENILL A+G +KL DFG A+ L
Sbjct: 88 ---GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELS 144
Query: 125 NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ G + T Y APE+L+G YG AVD W+
Sbjct: 145 SEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWS 178
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 6/137 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHG---LPWDLIKQITWQVL 84
+ L HPN++ E F K KL +V E+ D L++ ++ P + I Q+
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYRAPE 143
+ Y H +HRDIKP+NI LT+NG+VKL DFG ++ L + + V T +Y +PE
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 144 LLVGDTLYGPAVDVWAI 160
L Y D+W++
Sbjct: 174 LCQNKP-YNYKSDIWSL 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 8e-25
Identities = 58/169 (34%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL 64
KK S KE R E + PN+V L + F+ + L+LV E+ D L +L
Sbjct: 31 AKKLESKSKEVERFLREI--QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDL 88
Query: 65 ENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGF 120
L I Q+L + Y H IHRDIKPENILL +G VVKL DFG
Sbjct: 89 LKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL 148
Query: 121 ARLINPGEN-------YTDYVATRWYRAPELLVGDTL--YGPAVDVWAI 160
A+L+ + + V T Y APE+L+G +L + D+W++
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197
|
Length = 384 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 48/132 (36%), Positives = 78/132 (59%), Gaps = 5/132 (3%)
Query: 29 RSLKHPNLVNLLEVF-RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 87
+ L+H N+++L ++F + ++ V E + L + P L I+ +Q+LRG+
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP--LEKQFIQYFLYQILRGL 121
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG 147
Y H +HRD+KP NIL+ N +K+CDFG AR+ +P T YV+TR+YRAPE+++
Sbjct: 122 KYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLT 179
Query: 148 DTLYGPAVDVWA 159
Y VD+W+
Sbjct: 180 WQKYDVEVDIWS 191
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 61/161 (37%), Positives = 84/161 (52%), Gaps = 13/161 (8%)
Query: 7 KKSSYYKEAIRQATEATNK--KEKR---SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61
KK SY + +Q+ E KE R L+HPN + + R+ LV E+C +
Sbjct: 46 KKMSY---SGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSAS 102
Query: 62 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 121
+ LE H L I I L+G++Y H H IHRDIK NILLT G VKL DFG A
Sbjct: 103 DILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162
Query: 122 RLINPGENYTDYVATRWYRAPE--LLVGDTLYGPAVDVWAI 160
L++P + +V T ++ APE L + + Y VDVW++
Sbjct: 163 SLVSPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 8e-24
Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 6/133 (4%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90
LKHPN+V + L+++ E+ ++ L ++ P L+ +QVL+G++Y
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLVGDT 149
H IHRDIK NIL T +GVVKL DFG A +L + ++ V T ++ APE++
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS- 174
Query: 150 LYGP--AVDVWAI 160
G A D+W++
Sbjct: 175 --GASTASDIWSL 185
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-23
Identities = 42/132 (31%), Positives = 73/132 (55%), Gaps = 3/132 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
RS + P +V F ++ ++ +V E+ D L +L +P ++ I Q+L+G+
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD 113
Query: 89 YCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVATRWYRAPELLV 146
Y H IHRDIKP N+L+ + G VK+ DFG ++++ + + +V T Y +PE +
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 147 GDTLYGPAVDVW 158
G++ Y A D+W
Sbjct: 174 GES-YSYAADIW 184
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-23
Identities = 49/139 (35%), Positives = 77/139 (55%), Gaps = 12/139 (8%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLR 85
KHPN+V L E + + KL ++ EFCD +++ ELE GL I+ + Q+L
Sbjct: 58 ECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLE 114
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPEL 144
+++ H H IHRD+K NILLT +G VKL DFG A+ + + ++ T ++ APE+
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 145 LVGDTL----YGPAVDVWA 159
+ +T Y D+W+
Sbjct: 175 VACETFKDNPYDYKADIWS 193
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 57/167 (34%), Positives = 88/167 (52%), Gaps = 12/167 (7%)
Query: 1 LRFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCD--- 57
LR KK S ++ I + + +KH N++ LL+VF + L EF D
Sbjct: 43 LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE---EFNDVYL 99
Query: 58 --HTVLNELEN--HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 113
H + +L N L D ++ + +Q+LRG+ Y H IHRD+KP N+ + + +
Sbjct: 100 VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 159
Query: 114 KLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
K+ DFG AR + + T YVATRWYRAPE+++ Y VD+W++
Sbjct: 160 KILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 49/138 (35%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ + H N++ LL+VF L +LV + N ++ L D I+ + +Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLVYQ 126
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+LRG+ Y H IHRD+KP NI + + +K+ DFG AR + + T YVATRWYRAP
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 184
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++ Y VD+W++
Sbjct: 185 EIMLNWMHYNQTVDIWSV 202
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 47/138 (34%), Positives = 74/138 (53%), Gaps = 16/138 (11%)
Query: 32 KHPNLVNLLEVFRRKKKL------HLVFEFCDHT---VLNELENHPHGLPWDLIKQITWQ 82
H N++ LL VF +K L +LV E D V+ +H + + + +Q
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH------ERMSYLLYQ 126
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L G+ + H IHRD+KP NI++ ++ +K+ DFG AR T YV TR+YRAP
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++G Y VD+W++
Sbjct: 187 EVILG-MGYKENVDIWSV 203
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 51/144 (35%), Positives = 87/144 (60%), Gaps = 12/144 (8%)
Query: 29 RSLKHPNLVNL-----LEVFRRKKK---LHLVFEFCDHTVLNELENHP---HGLPWDLIK 77
++L H N++ L E F++ +K L++V EF TV ++++ H LP L+K
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLINPGENYTDYVAT 136
++Q+ R ++Y H HRD+KP+N+L+ N +KLCDFG A+ + G+ Y+ +
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233
Query: 137 RWYRAPELLVGDTLYGPAVDVWAI 160
R+YRAPEL++G T Y +D+W++
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSL 257
|
Length = 440 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 57/158 (36%), Positives = 83/158 (52%), Gaps = 7/158 (4%)
Query: 7 KKSSYYKEAIRQATEATNKKEK--RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL 64
KK SY + + + K+ K + LKHPN + + ++ LV E+C + + L
Sbjct: 52 KKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLL 111
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
E H L I IT L+G++Y H H IHRDIK NILLT G VKL DFG A
Sbjct: 112 EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171
Query: 125 NPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAI 160
+P + +V T ++ APE+++ + Y VDVW++
Sbjct: 172 SPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 16 IRQATEATNKKEKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGL 71
I++ K EK L HP ++ L F+ ++ L+ V E+ + L + L
Sbjct: 40 IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL 99
Query: 72 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--- 128
+ ++L + Y H IHRD+KPENILL + +K+ DFG A++++P
Sbjct: 100 DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159
Query: 129 ------------------NYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ +V T Y +PELL + G + D+WA
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWA 207
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 6e-21
Identities = 45/138 (32%), Positives = 72/138 (52%), Gaps = 10/138 (7%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90
+ P +V L F+ KK L+LV E+ L L + L D+ + +++ + Y
Sbjct: 50 AQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYL 109
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFGFA------RLINPGENYTD---YVATRWYRA 141
H + IHRD+KP+NIL+ +NG +KL DFG + R IN ++ + V T Y A
Sbjct: 110 HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 142 PELLVGDTLYGPAVDVWA 159
PE+++G + VD W+
Sbjct: 170 PEVILGQG-HSKTVDWWS 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-21
Identities = 54/162 (33%), Positives = 85/162 (52%), Gaps = 7/162 (4%)
Query: 7 KKSSYYKEAIRQATEATNKKEK--RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL 64
KK SY + + + K+ + + L+HPN + + R+ LV E+C + + L
Sbjct: 46 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL 105
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
E H L I +T L+G++Y H H IHRD+K NILL+ G+VKL DFG A ++
Sbjct: 106 EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 125 NPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTS 164
P +V T ++ APE+++ + Y VDVW++ T
Sbjct: 166 APANX---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-21
Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 6/133 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
P +V F + + E+ D L++ L+ +P ++ +I VL+G+
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGL 113
Query: 88 SYCHR-HACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELL 145
+Y H H IHRD+KP NIL+ + G +KLCDFG + +L+N +V T Y APE +
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERI 171
Query: 146 VGDTLYGPAVDVW 158
G+ Y D+W
Sbjct: 172 QGND-YSVKSDIW 183
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-20
Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLP 72
+EA++Q + K L+HPN+V L R + L++ E L +L P
Sbjct: 43 QEAVKQLEQEIALLSK--LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP 100
Query: 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD 132
+I+ T Q+L G+ Y H +HRDIK NIL+ NGVVKL DFG A+ +
Sbjct: 101 EPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160
Query: 133 YVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ + ++ APE++ YG A D+W++
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSL 188
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 27/166 (16%)
Query: 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRK--------------KKLHLVFEFCDH 58
K A+R+ K R L H N+V + EV +++V E+ +
Sbjct: 47 KHALREI------KIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET 100
Query: 59 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL-TANGVVKLCD 117
+ N LE P L + + +Q+LRG+ Y H +HRD+KP N+ + T + V+K+ D
Sbjct: 101 DLANVLEQGP--LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158
Query: 118 FGFARLINPGENYTDY----VATRWYRAPELLVGDTLYGPAVDVWA 159
FG AR+++P ++ Y + T+WYR+P LL+ Y A+D+WA
Sbjct: 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-20
Identities = 54/162 (33%), Positives = 87/162 (53%), Gaps = 11/162 (6%)
Query: 1 LRFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTV 60
+ ++ K+ + +++ I++ K + +KHPN + + R+ LV E+C +
Sbjct: 58 MSYSGKQSNEKWQDIIKEV------KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA 111
Query: 61 LNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 120
+ LE H L I IT L+G++Y H H IHRDIK NILLT G VKL DFG
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 171
Query: 121 ARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAI 160
A + +P + +V T ++ APE+++ + Y VDVW++
Sbjct: 172 ASIASPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 210
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 47/144 (32%), Positives = 68/144 (47%), Gaps = 15/144 (10%)
Query: 32 KHPNLVNLLEVFRRKK------KLHLVFEFCDH----TVLNELENHPHGLPWDLIKQITW 81
HPN+ F +K +L LV E C ++ L L + I I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYR 140
+ LRG++Y H + IHRDIK +NILLT N VKL DFG + L + ++ T ++
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 141 APELLVG----DTLYGPAVDVWAI 160
APE++ D Y DVW++
Sbjct: 181 APEVIACDEQPDASYDARSDVWSL 204
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-20
Identities = 51/138 (36%), Positives = 77/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ +KH N++ LL+VF L +LV F T L +L H L D I+ + +Q
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMG-TDLGKLMKHEK-LSEDRIQFLVYQ 126
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L+G+ Y H IHRD+KP N+ + + +K+ DFG AR + T YV TRWYRAP
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD--SEMTGYVVTRWYRAP 184
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++ Y VD+W++
Sbjct: 185 EVILNWMHYTQTVDIWSV 202
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 7e-20
Identities = 47/136 (34%), Positives = 76/136 (55%), Gaps = 6/136 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL--NELEN--HPHGLPWDLIKQITWQVL 84
+ +KH N++ LL+VF + E T L +L N L + ++ + +Q+L
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPEL 144
RG+ Y H IHRD+KP N+ + + +++ DFG AR + + T YVATRWYRAPE+
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPEI 186
Query: 145 LVGDTLYGPAVDVWAI 160
++ Y VD+W++
Sbjct: 187 MLNWMHYNQTVDIWSV 202
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-20
Identities = 53/133 (39%), Positives = 71/133 (53%), Gaps = 4/133 (3%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVS 88
+KHPN+V E F L++V E+CD L + G P D I Q Q+ GV
Sbjct: 55 MKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVG 147
+ H +HRDIK +NI LT NG VKL DFG ARL+ +PG YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-E 173
Query: 148 DTLYGPAVDVWAI 160
+ Y D+W++
Sbjct: 174 NMPYNNKSDIWSL 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 13/145 (8%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH---PHGLPWDLIKQITWQVLRG 86
HPN+V F +L LV + L ++ GL +I + +VL+G
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENY----TDYVATRWYRA 141
+ Y H + IHRDIK NILL +G VK+ DFG A L + G+ +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 142 PELLVGDTLYGPAVDVW-----AIE 161
PE++ Y D+W AIE
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R +HPN+V + + +L +V EF + L ++ H + + I + VL+ +S
Sbjct: 71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALS 129
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELLVG 147
+ H IHRDIK ++ILLT++G VKL DFGF A++ V T ++ APE ++
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-VIS 188
Query: 148 DTLYGPAVDVWAI 160
YG VD+W++
Sbjct: 189 RLPYGTEVDIWSL 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 12/143 (8%)
Query: 25 KKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIK 77
EK L+ HP +V L F+ KK ++++ E+C T+L + +
Sbjct: 41 FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTAR 96
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR 137
V+ Y H I+RD+KPEN+LL +NG VKL DFGFA+ + G+ + T
Sbjct: 97 FYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156
Query: 138 WYRAPELLVGDTLYGPAVDVWAI 160
Y APE+++ Y +VD W++
Sbjct: 157 EYVAPEIILNKG-YDFSVDYWSL 178
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 47/138 (34%), Positives = 75/138 (54%), Gaps = 11/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH------LVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ ++H N++ LL+VF LV + T L ++ HP L D ++ + +Q
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHP--LSEDKVQYLVYQ 125
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L G+ Y H IHRD+KP N+ + + +K+ DFG AR + T YV TRWYRAP
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAP 183
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++ Y VD+W++
Sbjct: 184 EVILNWMHYNQTVDIWSV 201
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-19
Identities = 47/133 (35%), Positives = 73/133 (54%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R KHPN+VN L+ + +L +V E+ L ++ + I + + L+ +
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALE 129
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVG 147
+ H + IHRDIK +NILL +G VKL DFGF I P ++ + V T ++ APE +V
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVT 188
Query: 148 DTLYGPAVDVWAI 160
YGP VD+W++
Sbjct: 189 RKAYGPKVDIWSL 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGV 87
+ +HPN+V + R+ KL +V E+C L ++ G L I + + L+G+
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGL 114
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELL- 145
+Y H IHRDIK NILLT +G VKL DFG A+L ++ T ++ APE+
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 146 ---VGDTLYGPAVDVWAI 160
G Y D+WA+
Sbjct: 175 VERKGG--YDGKCDIWAL 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 52/145 (35%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 23 TNKKEKRSLKH-----PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIK 77
TN K +R++ P + L F+ K L+LV E+ + L GLP D K
Sbjct: 41 TNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK 100
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR 137
Q +V+ GV H+ IHRDIKPEN+L+ G +KL DFG +R G +V T
Sbjct: 101 QYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENKKFVGTP 157
Query: 138 WYRAPELL--VGDTLYGPAVDVWAI 160
Y APE + VGD D W++
Sbjct: 158 DYLAPETILGVGDD---KMSDWWSL 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 4/134 (2%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGV 87
L ++ E F K KL++V E+ ++ L++L G LP D + + Q+L G+
Sbjct: 55 KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVATRWYRAPELLV 146
++ H +HRDIK N+ L A VK+ D G A+L++ N+ + V T +Y +PE L
Sbjct: 115 AHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LC 173
Query: 147 GDTLYGPAVDVWAI 160
D Y DVWA+
Sbjct: 174 EDKPYNEKSDVWAL 187
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 2e-18
Identities = 46/138 (33%), Positives = 77/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ + H N+++LL VF +K L +LV E D + ++ L + + + +Q
Sbjct: 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQ 127
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L G+ + H IHRD+KP NI++ ++ +K+ DFG AR T YV TR+YRAP
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++G Y VD+W++
Sbjct: 188 EVILG-MGYKENVDIWSV 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 46/138 (33%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ + H N+++LL VF +K L +LV E D + + L + + + +Q
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQ 131
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L G+ + H IHRD+KP NI++ ++ +K+ DFG AR T YV TR+YRAP
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++G Y VD+W++
Sbjct: 192 EVILG-MGYKENVDIWSV 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 30/151 (19%)
Query: 26 KEKR---SLKHPNLVNLLEVFRRKKKLHLVFEFC---DHTVLNELENHPHGLPWDLIKQI 79
E+R L HP LVNL F+ ++ ++LV + D L + L +++
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD-------------LRYHLSQKV 95
Query: 80 TWQ----------VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN 129
+ ++ + Y H IHRDIKP+NILL G V + DF A + P
Sbjct: 96 KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155
Query: 130 YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T T Y APE+L Y AVD W++
Sbjct: 156 TTSTSGTPGYMAPEVLCR-QGYSVAVDWWSL 185
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-18
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHG------LPWDLIKQI 79
K KH N++NLL V ++ L++V E+ H L + P G P + +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 80 T--------WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT 131
T +QV RG+ + CIHRD+ N+L+T + V+K+ DFG AR I ++
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI----HHI 185
Query: 132 DY--------VATRWYRAPELLVGDTLYGPAVDVWA 159
DY + +W APE L D +Y DVW+
Sbjct: 186 DYYRKTTNGRLPVKWM-APEALF-DRVYTHQSDVWS 219
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 41/91 (45%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRA 141
VL+G+SY H IHRDIKP NILLT G VKLCDFG + L+N + T +Y A
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMA 171
Query: 142 PELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172
PE + G Y DVW++ T +Q F
Sbjct: 172 PERIQGKP-YSITSDVWSLGLTLLEVAQNRF 201
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 45/138 (32%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ + H N++ LL VF +K L ++V E D + ++ L + + + +Q
Sbjct: 78 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQ 134
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L G+ + H IHRD+KP NI++ ++ +K+ DFG AR T YV TR+YRAP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++G Y VD+W++
Sbjct: 195 EVILG-MGYKENVDIWSV 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 43/129 (33%), Positives = 73/129 (56%), Gaps = 5/129 (3%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC-HR 92
P +V F ++ + E D L+++ +P +++ +++ VLRG++Y +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLVGDTLY 151
H +HRD+KP NIL+ + G +KLCDFG + +LI+ N +V TR Y +PE L G T Y
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQG-THY 179
Query: 152 GPAVDVWAI 160
D+W++
Sbjct: 180 SVQSDIWSM 188
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 5/134 (3%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVS 88
+KHPN+V F+ +L +V E+CD L + N G+ + + ++W Q+ G+
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 89 YCHRHACIHRDIKPENILLTANGVV-KLCDFGFARLINPGENYTDY-VATRWYRAPELLV 146
+ H +HRDIK +NI L+ NG+V KL DFG AR +N V T +Y +PE +
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE-IC 174
Query: 147 GDTLYGPAVDVWAI 160
+ Y D+W++
Sbjct: 175 QNRPYNNKTDIWSL 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 51/136 (37%), Positives = 73/136 (53%), Gaps = 6/136 (4%)
Query: 27 EKR---SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83
EKR S++HP LVNL F+ L+LV E+ L P + + QV
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPE 143
+ + Y H ++RD+KPEN+LL ++G +K+ DFGFA+ + G YT T Y APE
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYT-LCGTPEYLAPE 168
Query: 144 LLVGDTLYGPAVDVWA 159
+++ YG AVD WA
Sbjct: 169 IILS-KGYGKAVDWWA 183
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+SLKH N+V L + + EF ++ + N LP + + T Q+L GV+
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-------NPGENYTDYVATRWYRA 141
Y H + +HRDIK N++L NG++KL DFG AR + T ++ A
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 142 PELLVGDTLYGPAVDVWAIEWT 163
PE ++ ++ YG D+W+I T
Sbjct: 177 PE-VINESGYGRKSDIWSIGCT 197
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 43/133 (32%), Positives = 71/133 (53%), Gaps = 4/133 (3%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVS 88
+KHPN+V E F L++V ++C+ L + N G+ + + + W Q+ +
Sbjct: 56 MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG 147
+ H +HRDIK +NI LT +G +KL DFG AR++N E + T +Y +PE +
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-ICE 174
Query: 148 DTLYGPAVDVWAI 160
+ Y D+WA+
Sbjct: 175 NRPYNNKSDIWAL 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-17
Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE----LENHPHGLPWDLIKQITWQV 83
K L+HPN+V + F +L++V + + L E L+ + I I Q+
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 84 LRGVSYCHRHACI-HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+ + Y H+ I HRD+ P NI+L + V + DFG A+ P T V T Y P
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182
Query: 143 ELLVGDTLYGPAVDVWAI 160
E++ + YG DVWA
Sbjct: 183 EIVKNEP-YGEKADVWAF 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-17
Identities = 46/133 (34%), Positives = 74/133 (55%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LK+PN+VN L+ F +L +V E+ L ++ + I + + L+ +
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALE 129
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVG 147
+ H + IHRDIK +N+LL +G VKL DFGF I P ++ + V T ++ APE +V
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVT 188
Query: 148 DTLYGPAVDVWAI 160
YGP VD+W++
Sbjct: 189 RKAYGPKVDIWSL 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-17
Identities = 53/156 (33%), Positives = 81/156 (51%), Gaps = 12/156 (7%)
Query: 15 AIRQAT-EATNKKE--------KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE 65
AIRQ + KKE R K+PN+VN L+ + +L +V E+ L ++
Sbjct: 49 AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108
Query: 66 NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN 125
+ I + + L+ + + H + IHRDIK +NILL +G VKL DFGF I
Sbjct: 109 TET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 126 PGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
P ++ + V T ++ APE +V YGP VD+W++
Sbjct: 168 PEQSKRSTMVGTPYWMAPE-VVTRKAYGPKVDIWSL 202
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 45/133 (33%), Positives = 72/133 (54%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R H N+V++ + +L +V EF + L ++ H + + I + VLR +S
Sbjct: 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALS 132
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELLVG 147
Y H IHRDIK ++ILLT++G +KL DFGF A++ V T ++ APE ++
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VIS 191
Query: 148 DTLYGPAVDVWAI 160
YG VD+W++
Sbjct: 192 RLPYGTEVDIWSL 204
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 45/133 (33%), Positives = 70/133 (52%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R +H N+V + + +L +V EF + L ++ H + + I + VL+ +S
Sbjct: 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALS 130
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG 147
H IHRDIK ++ILLT +G VKL DFGF ++ V T ++ APE L+
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LIS 189
Query: 148 DTLYGPAVDVWAI 160
YGP VD+W++
Sbjct: 190 RLPYGPEVDIWSL 202
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-16
Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R K+PN+VN L+ + +L +V E+ L ++ + I + + L+ +
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALD 129
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVG 147
+ H + IHRDIK +NILL +G VKL DFGF I P ++ + V T ++ APE +V
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVT 188
Query: 148 DTLYGPAVDVWAI 160
YGP VD+W++
Sbjct: 189 RKAYGPKVDIWSL 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 38/92 (41%), Positives = 60/92 (65%), Gaps = 5/92 (5%)
Query: 71 LPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGE 128
+P +++ +I+ VLRG++Y +H +HRD+KP NIL+ + G +KLCDFG + +LI+
Sbjct: 96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
N +V TR Y +PE L G T Y D+W++
Sbjct: 156 N--SFVGTRSYMSPERLQG-THYTVQSDIWSL 184
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 46/139 (33%), Positives = 68/139 (48%), Gaps = 10/139 (7%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ P + F + KL ++ E+C + L+ L+ P L I I +VL G+
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLE 112
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLVG 147
Y H IHRDIK NILL+ G VKL DFG + +L + +V T ++ APE++
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 148 DTLYGPAVDVW-----AIE 161
+ Y D+W AIE
Sbjct: 173 -SGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 7/140 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
++L+H +V R + L + E+ +V ++L+ + L + ++ T Q+L GV
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGV 117
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP----GENYTDYVATRWYRAPE 143
Y H + +HRDIK NIL + G VKL DFG ++ + G T ++ +PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 144 LLVGDTLYGPAVDVWAIEWT 163
++ G+ YG DVW++ T
Sbjct: 178 VISGEG-YGRKADVWSVGCT 196
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 45/139 (32%), Positives = 69/139 (49%), Gaps = 3/139 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ KH N+V + R+ KL + EFC L ++ + L I ++ + L+G+
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG 147
Y H +HRDIK NILLT NG VKL DFG + I ++ T ++ APE+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 148 DTL--YGPAVDVWAIEWTS 164
+ Y D+WA+ T+
Sbjct: 181 ERKGGYNQLCDIWAVGITA 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 8/133 (6%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGL--PWDLIKQITWQVLRGVSY 89
H N+VNLL + ++ E+C + +LN L DL+ ++QV +G+++
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLL-SFSYQVAKGMAF 156
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPELLV 146
CIHRD+ N+LLT +VK+CDFG AR I NY R + APE +
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 147 GDTLYGPAVDVWA 159
+ +Y DVW+
Sbjct: 217 -NCVYTFESDVWS 228
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 50/151 (33%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFC-----DHTVLNELENHPHGLPWDLIKQITWQVL 84
+ HP +V LL F KL ++ EFC D +L EL+ GL I+ I Q+L
Sbjct: 65 TCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIML-ELD---RGLTEPQIQVICRQML 120
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPE 143
+ Y H IHRD+K N+LLT +G +KL DFG A+ + + ++ T ++ APE
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 144 LLVGDTL----YGPAVDVWAIEWTSHSYSQI 170
+++ +T+ Y D+W++ T +QI
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQI 211
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-16
Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 7/136 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRG 86
+ +KHPNLV LL V R+ +++ EF + L + E + + ++ + Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
+ Y + IHRD+ N L+ N +VK+ DFG +RL+ G+ YT + ++ + APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 175
Query: 144 LLVGDTLYGPAVDVWA 159
L + + DVWA
Sbjct: 176 SLAYNK-FSIKSDVWA 190
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 12/150 (8%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLR 85
S HPN+V LL+ F + L ++ EFC V+ ELE L I+ + Q L
Sbjct: 58 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLE 114
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPEL 144
++Y H + IHRD+K NIL T +G +KL DFG A+ + ++ T ++ APE+
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174
Query: 145 LVGDTL----YGPAVDVWAIEWTSHSYSQI 170
++ +T Y DVW++ T +QI
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQI 204
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 41/129 (31%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC-HR 92
P +V F ++ + E D L+++ +P ++ +++ V++G++Y +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLVGDTLY 151
H +HRD+KP NIL+ + G +KLCDFG + +LI+ N +V TR Y +PE L G T Y
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQG-THY 179
Query: 152 GPAVDVWAI 160
D+W++
Sbjct: 180 SVQSDIWSM 188
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 6/133 (4%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSY 89
L HPNLV L V +++ + +V E+ + +LN L L + + + V + Y
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPELLV 146
+ IHRD+ N L+ + VVK+ DFG AR + + YT T++ + PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFD 174
Query: 147 GDTLYGPAVDVWA 159
+ + DVW+
Sbjct: 175 -YSRFSSKSDVWS 186
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 28 KRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHG--LPWDLIKQI 79
K+ H N+ F +K +L LV EFC + +L + G L D I I
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRW 138
++LRG+++ H H IHRDIK +N+LLT N VKL DFG A+L ++ T +
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 139 YRAPELLV----GDTLYGPAVDVWAIEWTS 164
+ APE++ D Y D+W++ T+
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITA 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 17/150 (11%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH---TVLNELENH-PHGLPWDLIKQITWQVL 84
R L+HPN++ + F +L++V + L L+ H P GLP I I VL
Sbjct: 54 RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVL 111
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYV-----ATR- 137
+ Y H IHR +K +ILL+ +G V L ++ +I G+ + +
Sbjct: 112 NALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 138 --WYRAPELLVGDTL-YGPAVDVWAIEWTS 164
W +PE+L + Y D++++ T+
Sbjct: 172 LPWL-SPEVLQQNLQGYNEKSDIYSVGITA 200
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-15
Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVS 88
L+HPN++ F L + E+ + L + G +++ +Q++ VS
Sbjct: 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY------VATRWYRAP 142
Y H+ +HRDIK NI LT G++KL DFG ++++ ++Y V T +Y +P
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-----SEYSMAETVVGTPYYMSP 170
Query: 143 ELLVGDTLYGPAVDVWAI 160
EL G Y D+WA+
Sbjct: 171 ELCQGVK-YNFKSDIWAL 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 46/133 (34%), Positives = 70/133 (52%), Gaps = 9/133 (6%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGV 87
L HP +VN++ F+ + +++ + EF V EL H P D+ K +++
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEF---VVGGELFTHLRKAGRFPNDVAKFYHAELVLAF 131
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG 147
Y H I+RD+KPEN+LL G VK+ DFGFA+ + P +T T Y APE++
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT-LCGTPEYLAPEVIQS 189
Query: 148 DTLYGPAVDVWAI 160
+G AVD W +
Sbjct: 190 KG-HGKAVDWWTM 201
|
Length = 329 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 44/133 (33%), Positives = 72/133 (54%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R +H N+V + + + ++L ++ EF L ++ + L + I + VL+ +
Sbjct: 73 RDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALC 131
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELLVG 147
Y H IHRDIK ++ILLT +G VKL DFGF A++ V T ++ APE ++
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE-VIS 190
Query: 148 DTLYGPAVDVWAI 160
T YG VD+W++
Sbjct: 191 RTPYGTEVDIWSL 203
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-15
Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 13/150 (8%)
Query: 28 KRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHG--LPWDLIKQI 79
K+ H N+ F +K +L LV EFC + +L + G L + I I
Sbjct: 57 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRW 138
++LRG+S+ H+H IHRDIK +N+LLT N VKL DFG A+L ++ T +
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176
Query: 139 YRAPELLV----GDTLYGPAVDVWAIEWTS 164
+ APE++ D Y D+W++ T+
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITA 206
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--------PHGLPWDLIKQIT 80
+ L HPN++ L F +L++V E D L+ + H P W Q+
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG--ENYTDYVATRW 138
+ + H +HRDIKP N+ +TA GVVKL D G R + ++ V T +
Sbjct: 117 ----SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 171
Query: 139 YRAPELLVGDTLYGPAVDVWAI 160
Y +PE + + Y D+W++
Sbjct: 172 YMSPERIHENG-YNFKSDIWSL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 34/83 (40%), Positives = 49/83 (59%), Gaps = 1/83 (1%)
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATR 137
I +VL + Y H+ IHRDIK NIL+T G VKLCDFG A L+N + + +V T
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP 165
Query: 138 WYRAPELLVGDTLYGPAVDVWAI 160
++ APE++ Y D+W++
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSL 188
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 9/137 (6%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R + HPN+V ++F ++ ++ EF D LE H + + Q+L G++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDG---GSLEGT-HIADEQFLADVARQILSGIA 182
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELL-- 145
Y HR +HRDIKP N+L+ + VK+ DFG +R++ + V T Y +PE +
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 146 -VGDTLY-GPAVDVWAI 160
+ Y G A D+W++
Sbjct: 243 DLNHGAYDGYAGDIWSL 259
|
Length = 353 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 46/147 (31%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 25 KKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQIT 80
KE LK P +V + + L +V E+C +V + ++ L + I I
Sbjct: 46 IKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAIL 105
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWY 139
+Q L+G+ Y H + IHRDIK NILL G KL DFG + +L + + T ++
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165
Query: 140 RAPELLVGDTLYGPAVDVW-----AIE 161
APE++ + Y D+W AIE
Sbjct: 166 MAPEVI-QEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 6/139 (4%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
EKR L KHP L L F+ K +L V E+ + L + +
Sbjct: 45 EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE 104
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPGENYTDYVATRWYRA 141
++ G+ + H I+RD+K +N+LL + G +K+ DFG + I G + + T Y A
Sbjct: 105 IVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIA 164
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE+L YGPAVD WA+
Sbjct: 165 PEILSYQ-PYGPAVDWWAL 182
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 6/135 (4%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLR 85
S+ HPN+++ E F KL +V E+ +++ + +P I +I Q+LR
Sbjct: 55 SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
G+ H +HRD+K NILL AN +VK+ D G ++++ T + T Y APE+
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVW 173
Query: 146 VGDTLYGPAVDVWAI 160
G Y D+W++
Sbjct: 174 KG-RPYSYKSDIWSL 187
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 53/153 (34%), Positives = 70/153 (45%), Gaps = 34/153 (22%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--- 79
EKR L KHP L L F+ K +L V E+ + DL+ QI
Sbjct: 45 EKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG--------------DLMFQIQRS 90
Query: 80 -----------TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPG 127
+V + + HRH I+RD+K +NILL A G KL DFG + I G
Sbjct: 91 RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG 150
Query: 128 ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T + T Y APE+L + YGP+VD WA+
Sbjct: 151 VTTTTFCGTPDYIAPEIL-QELEYGPSVDWWAL 182
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 54/158 (34%), Positives = 71/158 (44%), Gaps = 5/158 (3%)
Query: 4 NKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
NK + K R T AT R++ HP+++ L F K L+ +
Sbjct: 114 NKTCEHVVIKAGQRGGT-ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY 172
Query: 64 LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 123
L + I I VLR + Y H + IHRDIK ENI + G V L DFG A
Sbjct: 173 LAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231
Query: 124 -INPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
++ N Y + T APELL D YGPAVD+W+
Sbjct: 232 PVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWS 268
|
Length = 391 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 44/126 (34%), Positives = 64/126 (50%), Gaps = 15/126 (11%)
Query: 71 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGEN 129
+P ++ +I V++G++Y +HRD+KP N+L+ G VKLCDFG + L+N
Sbjct: 92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--SI 149
Query: 130 YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT-------SHSYSQIGFIGLGNMGSHM 182
YV T Y APE + G+ YG DVW++ + Y QI N GS M
Sbjct: 150 AKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQI----QKNQGSLM 204
Query: 183 ARNLLK 188
LL+
Sbjct: 205 PLQLLQ 210
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 6e-14
Identities = 41/134 (30%), Positives = 72/134 (53%), Gaps = 2/134 (1%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 87
+++ HP LV L F+ + +L V E+ + L LP + + + ++ +
Sbjct: 50 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 109
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLV 146
+Y H I+RD+K +N+LL + G +KL D+G + + PG+ + + T Y APE+L
Sbjct: 110 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169
Query: 147 GDTLYGPAVDVWAI 160
G+ YG +VD WA+
Sbjct: 170 GED-YGFSVDWWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-14
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 22/169 (13%)
Query: 13 KEAIRQATEATNKKEKRS--------------LKHPNLVNLLEVFRRKKKLHLVFEFCDH 58
K+ + A++K KRS L+H N+V L L++ E+
Sbjct: 31 KQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPG 90
Query: 59 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDF 118
+ L N+ L++ Q+L+G++Y H IHRDIK NIL+ G +K+ DF
Sbjct: 91 GSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDF 150
Query: 119 GFARLINP-------GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
G ++ + + ++ APE +V T Y D+W++
Sbjct: 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPE-VVKQTSYTRKADIWSL 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 6 KKKSSYY------KEAI--RQATEATNKKEKR------SLKHPNLVNLLEVFRRKKKLHL 51
KK Y K I R E+ EKR S +HP LVNL F+ + +
Sbjct: 21 KKTGELYAIKALKKGDIIARDEVESL-MCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79
Query: 52 VFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYCHRHACIHRDIKPENILLTA 109
V E+ +L H H + + + + V+ G+ Y H + ++RD+K +N+LL
Sbjct: 80 VMEY---AAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136
Query: 110 NGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
G VK+ DFG + + G+ + + T + APE+L +T Y AVD W
Sbjct: 137 EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT-ETSYTRAVDWWG 186
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-14
Identities = 45/156 (28%), Positives = 63/156 (40%), Gaps = 13/156 (8%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGV 87
SL H NL+ L V L +V E L + ++ + Q+ G+
Sbjct: 52 SLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDY----VATRWYRAP 142
Y IHRD+ NILL ++ VK+ DFG R L ++Y V W AP
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC-AP 169
Query: 143 ELLVGDTLYGPAVDVWAIE---WTSHSYSQIGFIGL 175
E L T + A DVW W +Y + + GL
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGL 204
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 6 KKKSSYYKEAIRQ-ATEATNKKEKRS----------LKHPNLVNLLEVFRRKKKLHLVFE 54
++K+ I+Q E K E+ + L HPN++ E F K L +V E
Sbjct: 20 RRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79
Query: 55 FCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG- 111
+ L E L D I Q+L + + H +HRD+K +NILL +
Sbjct: 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM 139
Query: 112 VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
VVK+ DFG +++++ V T Y +PEL G Y D+WA+
Sbjct: 140 VVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWAL 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 3/139 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ KH N+V + ++KL + E+C L ++ + L I + + L+G++
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPEL--L 145
Y H +HRDIK NILLT NG VKL DFG A I ++ T ++ APE+ +
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 146 VGDTLYGPAVDVWAIEWTS 164
+ Y D+WA+ T+
Sbjct: 181 EKNGGYNQLCDIWAVGITA 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 22/148 (14%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW---------------D 74
KH N++NLL + L+++ E+ L E P G+ + D
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ T+QV RG+ Y CIHRD+ N+L+T N V+K+ DFG AR +N + Y
Sbjct: 139 LV-SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 135 ATRW---YRAPELLVGDTLYGPAVDVWA 159
R + APE L D +Y DVW+
Sbjct: 198 NGRLPVKWMAPEALF-DRVYTHQSDVWS 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 7/136 (5%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90
L HP+++ +L +L E+ ++ L + +I T Q+LRG+SY
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 91 HRHACIHRDIKPENILLTANG-VVKLCDFGFA-----RLINPGENYTDYVATRWYRAPEL 144
H + IHRD+K N+L+ + G +++ DFG A + GE + T + APE+
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 145 LVGDTLYGPAVDVWAI 160
L G+ YG + DVW++
Sbjct: 180 LRGEQ-YGRSCDVWSV 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 44/141 (31%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 29 RSLKHPNLVNLLEVFR--RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
++L+H +V R +KKL + E+ + + L ++ ++ T Q+L+G
Sbjct: 59 KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG 118
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN----PGENYTDYVATRWYRAP 142
VSY H + +HRDIK NIL + G VKL DFG ++ I G T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 143 ELLVGDTLYGPAVDVWAIEWT 163
E++ G+ YG DVW++ T
Sbjct: 179 EVISGEG-YGRKADVWSVACT 198
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 42/129 (32%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-R 92
P +V+ F + + + EF D L+ + +P +++ +I V+ G++Y +
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLVGDTLY 151
H +HRDIKP NIL+ + G +KLCDFG + LIN + +V T Y +PE + G Y
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGK-Y 179
Query: 152 GPAVDVWAI 160
DVW++
Sbjct: 180 TVKSDVWSL 188
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 17 RQATEATNKKEKRSLKH----PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--- 69
+ T + E+ L+H P LV L F+ + KLHL+ D+ E+ H +
Sbjct: 44 KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL---DYVSGGEMFTHLYQRD 100
Query: 70 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR--LINPG 127
D ++ + +++ + + H+ ++RDIK ENILL + G V L DFG ++ L
Sbjct: 101 NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160
Query: 128 ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
E + T Y APE++ G +G AVD W++
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL 193
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHG-LPWDLIKQITWQVLRG 86
+L HP L L F+ + L LV ++C L L+ P L ++ + +VL
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN--------------------- 125
+ Y H ++RD+KPENILL +G + L DF ++ +
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 126 ---------PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
P +V T Y APE++ GD +G AVD W
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWT 217
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 36/199 (18%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE- 63
K+ ++ RQ E + L+HPN+V LL V +++ ++FE+ H L+E
Sbjct: 44 KENAEPKVQQEFRQEAELMSD-----LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF 98
Query: 64 -LENHPHG--------------LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
+ N PH L I Q+ G+ Y H +HRD+ N L+
Sbjct: 99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158
Query: 109 ANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYG---PAVDVWA-- 159
VK+ DFG +R I + Y + RW PE + LYG D+W+
Sbjct: 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM-PPEAI----LYGKFTTESDIWSFG 213
Query: 160 -IEWTSHSYSQIGFIGLGN 177
+ W SY + G N
Sbjct: 214 VVLWEIFSYGLQPYYGFSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 6/137 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW----QVL 84
+ L HPN++ L+ F +L++V E D L+++ + + ++ W Q+
Sbjct: 57 KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-DYVATRWYRAPE 143
V + H +HRDIKP N+ +TA GVVKL D G R + V T +Y +PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 144 LLVGDTLYGPAVDVWAI 160
+ + Y D+W++
Sbjct: 177 -RIHENGYNFKSDIWSL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 30/154 (19%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL----------------ENHPHGLPWDL 75
KH N++NLL V ++ L+++ E+ L E + L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 76 IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY-- 133
+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR G + DY
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYK 191
Query: 134 ------VATRWYRAPELLVGDTLYGPAVDVWAIE 161
+ +W APE L D +Y DVW+
Sbjct: 192 KTSNGRLPVKWM-APEALF-DRVYTHQSDVWSFG 223
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 33 HPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQV 83
HPN+V ++ +K +L LV E C+ + +L + +I I +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAP 142
L G+ + H + IHRD+K NILLT G VKL DFG A+L + V T ++ AP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 143 ELLVG----DTLYGPAVDVWAIEWTS 164
E++ D+ Y DVW++ T+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITA 219
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 41/129 (31%), Positives = 69/129 (53%), Gaps = 2/129 (1%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92
+P LV L F+ +L LV E+ + L LP + + ++ +++ H
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLY 151
I+RD+K +N+LL A+G +KL D+G + + PG+ + + T Y APE+L G+ Y
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-Y 173
Query: 152 GPAVDVWAI 160
G +VD WA+
Sbjct: 174 GFSVDWWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 7/151 (4%)
Query: 17 RQATEATNKKEKRSLKH----PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLP 72
+ T + E++ L+ P LV L F+ KLHL+ ++ + L
Sbjct: 44 KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT 103
Query: 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT- 131
++ +++ + + H+ I+RDIK ENILL + G V L DFG ++ E
Sbjct: 104 ESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 132 -DYVATRWYRAPELL-VGDTLYGPAVDVWAI 160
+ T Y APE++ G + AVD W++
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 46/145 (31%), Positives = 69/145 (47%), Gaps = 21/145 (14%)
Query: 31 LKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
L HPN+V LL+ + L VFE+ L E+ LP ++ QVL
Sbjct: 35 LYHPNIVALLD---SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDA 91
Query: 87 VSYCHRHACIHRDIKPENILLTANGV---VKLCDFGFARLINPGEN---------YTDYV 134
++ H +HRD+KP+NI+++ GV K+ DFG L+ PG T+ +
Sbjct: 92 LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVL 150
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWA 159
T Y APE L G+ + P D++A
Sbjct: 151 GTPTYCAPEQLRGEPV-TPNSDLYA 174
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-13
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 7 KKSSYYKEAIRQATEATNKKEK--------RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 58
K + K AI+ E +E L HP LV L V ++K L++V EF ++
Sbjct: 24 KWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83
Query: 59 -TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCD 117
+LN L L D++ + V G+ Y R++ IHRD+ N L+++ GVVK+ D
Sbjct: 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSD 143
Query: 118 FGFARLINPGENYTDYVATRW---YRAPELLVGDTLYGPAVDVWA 159
FG R + E YT ++ + PE+ Y DVW+
Sbjct: 144 FGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWS 186
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 38/128 (29%), Positives = 63/128 (49%), Gaps = 1/128 (0%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93
P +V L F+ L+LV ++ L D K +++ + + H++
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVATRWYRAPELLVGDTLYG 152
++RD+KPENILL A G + LCDFG ++ T+ + T Y APE+L+ + Y
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 153 PAVDVWAI 160
VD W++
Sbjct: 176 KHVDFWSL 183
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 8/151 (5%)
Query: 16 IRQATEATNKKEKR----SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL-NELENHPHG 70
+R + + K +R ++KHP +V+L+ F+ KL+L+ E+ L LE
Sbjct: 38 VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF 97
Query: 71 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGEN 129
+ D ++ + + H+ I+RD+KPENILL A G VKL DFG + I+ G
Sbjct: 98 ME-DTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156
Query: 130 YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ T Y APE+L+ + +G AVD W++
Sbjct: 157 THTFCGTIEYMAPEILM-RSGHGKAVDWWSL 186
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 8e-13
Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 1/131 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+++ HP+++ + + +V + L LP D I Q+L G+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLR 171
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
Y H IHRD+K ENI + V + D G A+ + T APE+L D
Sbjct: 172 YLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231
Query: 149 TLYGPAVDVWA 159
Y D+W+
Sbjct: 232 K-YNSKADIWS 241
|
Length = 357 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 45/170 (26%)
Query: 29 RSLKHPNLVNLLEVFRRK--KKLHLVFEFCD-----------HTVLNELENHPHGLPWDL 75
R LKH N+V ++ F K +KL+++ EFCD + + ++E H
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA------- 119
Query: 76 IKQITWQVLRGVSYCHR-------HACIHRDIKPENILLTA---------------NG-- 111
I IT Q+L ++YCH +HRD+KP+NI L+ NG
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 112 VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDT-LYGPAVDVWAI 160
+ K+ DFG ++ I V T +Y +PELL+ +T Y D+WA+
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
|
Length = 1021 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 49/146 (33%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 33 HPNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQV 83
HPN+V +F + K L LV E C+ + EL L +I I +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAP 142
L G+ + H + IHRD+K NILLT G VKL DFG A+L + V T ++ AP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
Query: 143 ELLVG----DTLYGPAVDVWAIEWTS 164
E++ D Y DVW++ T+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITA 223
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 6/137 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW----QVL 84
+ L HPN++ F +L++V E D L+ + H + ++ W Q+
Sbjct: 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-DYVATRWYRAPE 143
+ + H +HRDIKP N+ +TA GVVKL D G R + V T +Y +PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 144 LLVGDTLYGPAVDVWAI 160
+ + Y D+W++
Sbjct: 177 -RIHENGYNFKSDIWSL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 55/170 (32%), Positives = 85/170 (50%), Gaps = 22/170 (12%)
Query: 2 RFNKK--KKSSYYKEAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEFC 56
+ NKK KK Y+ A+ EKR L + +V+L F+ K L LV
Sbjct: 25 KLNKKRLKKRKGYEGAM---------VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75
Query: 57 D-----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 111
+ + + N E +P G P T Q++ G+ + H+ I+RD+KPEN+LL +G
Sbjct: 76 NGGDLRYHIYNVDEENP-GFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG 134
Query: 112 VVKLCDFGFARLINPGENYTD-YVATRWYRAPELLVGDTLYGPAVDVWAI 160
V++ D G A + G++ T Y T + APELL G+ Y +VD +A+
Sbjct: 135 NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFSVDYFAL 183
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW---------------D 74
KH N++NLL + L+++ E+ L E P G+ + D
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR I+ + Y
Sbjct: 142 LV-SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 135 ATRW---YRAPELLVGDTLYGPAVDVWA 159
R + APE L D +Y DVW+
Sbjct: 201 NGRLPVKWMAPEALF-DRIYTHQSDVWS 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 2/129 (1%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92
HP LV L F+ + +L V EF L LP + + + ++ +++ H
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLY 151
I+RD+K +N+LL A G +KL D+G + I PG+ + + T Y APE+L G+ Y
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED-Y 173
Query: 152 GPAVDVWAI 160
G +VD WA+
Sbjct: 174 GFSVDWWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 4/134 (2%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90
L H N+V L ++ L + E+ + L++ T QVL G++Y
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARL---INPGENYTDYVATRWYRAPELLVG 147
H +HRD+K +N+L+ A+G+ K+ DFG ++ I + + ++ APE++
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 148 DTL-YGPAVDVWAI 160
+ Y VD+W++
Sbjct: 185 YSQGYSAKVDIWSL 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 51/174 (29%), Positives = 76/174 (43%), Gaps = 25/174 (14%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEK-----------RSLKHPNLVNLLEVFRRKKKLHLVF 53
+K S+Y + Q KKE+ ++LKHP LV L F+ +KL+ V
Sbjct: 16 RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75
Query: 54 EFCD------HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 107
++ + H P + +V + Y H I+RD+KPENILL
Sbjct: 76 DYVNGGELFFHLQRERCFLEPRA------RFYAAEVASAIGYLHSLNIIYRDLKPENILL 129
Query: 108 TANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ G V L DFG + + P E + + T Y APE+L + Y VD W +
Sbjct: 130 DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCL 182
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 34/83 (40%), Positives = 47/83 (56%), Gaps = 4/83 (4%)
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW- 138
++QV RG+ + CIHRD+ NILL+ N VVK+CDFG AR I +Y + R
Sbjct: 180 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 139 --YRAPELLVGDTLYGPAVDVWA 159
+ APE + D +Y DVW+
Sbjct: 240 LKWMAPESIF-DKVYTTQSDVWS 261
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW---------------D 74
KH N++NLL + L+++ E+ L E P G+ + D
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR ++ + Y
Sbjct: 136 LV-SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 135 ATRW---YRAPELLVGDTLYGPAVDVWA 159
R + APE L D +Y DVW+
Sbjct: 195 NGRLPVKWMAPEALF-DRVYTHQSDVWS 221
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
++ GL + T+QV RG+ + C+HRD+ N+LL +VK+CDFG AR I
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 125 NPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
NY + ++ +W APE + D LY DVW+
Sbjct: 288 MHDSNYVSKGSTFLPVKWM-APESIF-DNLYTTLSDVWS 324
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKK-KLHLVFEFCDHTV 60
+ N + S ++A Q + ++ LKHPN+V E + + L++V FC+
Sbjct: 32 KLNLRNASRRERKAAEQEAQLLSQ-----LKHPNIVAYRESWEGEDGLLYIVMGFCEGGD 86
Query: 61 LNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDF 118
L G LP + + + Q+ + Y H +HRD+K +N+ LT ++K+ D
Sbjct: 87 LYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDL 146
Query: 119 GFARLINPGENYTDY----VATRWYRAPELLVGDTLYGPAVDVWAI 160
G AR++ EN D + T +Y +PEL + Y DVWA+
Sbjct: 147 GIARVL---ENQCDMASTLIGTPYYMSPELF-SNKPYNYKSDVWAL 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 10/163 (6%)
Query: 6 KKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFC-DHTVLNEL 64
KK +E + E + + P + L F+ K L+LV E+ +L+ L
Sbjct: 35 KKSVLLAQETVSFFEEERDILSISN--SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL 92
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG-FARL 123
+ D+ + +++ + H+ +HRDIKPEN+L+ G +KL DFG ARL
Sbjct: 93 NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152
Query: 124 -INPGENYTDYVATRWYRAPELLV-----GDTLYGPAVDVWAI 160
N N V T Y APE+L G YG D W++
Sbjct: 153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-12
Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 6/133 (4%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEF-CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 89
L H LV L V +++ +++V E+ + +LN L H + ++ V G++Y
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPELLV 146
IHRD+ N L+ G VK+ DFG +R + E YT V +++ + PE+L+
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLL 174
Query: 147 GDTLYGPAVDVWA 159
+ DVWA
Sbjct: 175 YSK-FSSKSDVWA 186
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 40/95 (42%), Positives = 52/95 (54%), Gaps = 17/95 (17%)
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI--NPGENYT 131
DLI ++QV RG+ + CIHRD+ NILL+ N VVK+CDFG AR I +P
Sbjct: 174 DLI-SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP----- 227
Query: 132 DYVAT-------RWYRAPELLVGDTLYGPAVDVWA 159
DYV +W APE + D +Y DVW+
Sbjct: 228 DYVRKGDARLPLKWM-APESIF-DKVYTTQSDVWS 260
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 7 KKSSYYKEAIRQATEATNKKEKRSLKH----PNLVNLLEVFRRKKKLHLVFEFCDHTVLN 62
KK++ ++A + TE T + E++ L+H P LV L F+ KLHL+ ++ + L
Sbjct: 37 KKATIVQKA--KTTEHT-RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELF 93
Query: 63 ELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
+ ++ + +++ + + H+ I+RDIK ENILL +NG V L DFG ++
Sbjct: 94 THLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153
Query: 123 --LINPGENYTDYVATRWYRAPELLV-GDTLYGPAVDVWAI 160
+ E + T Y AP+++ GD + AVD W++
Sbjct: 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 45/119 (37%), Positives = 65/119 (54%), Gaps = 11/119 (9%)
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFA-RL--INP-GE 128
I T Q+L G+ Y H + +HRDIK +N+L+ T +GVVK+ DFG + RL INP E
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167
Query: 129 NYTDYVATRWYRAPELL-VGDTLYGPAVDVWAIEWT--SHSYSQIGFIGLGNMGSHMAR 184
+T T Y APE++ G YG D+W++ T + + FI LG + M +
Sbjct: 168 TFT---GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK 223
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 13 KEAIRQATEATNKKEKRS-----LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH 67
K+AI + E + +R+ +KHP LV L F+ KL+ V D+ EL H
Sbjct: 30 KKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL---DYVNGGELFFH 86
Query: 68 ---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL- 123
P + ++ + Y H I+RD+KPENILL + G V L DFG +
Sbjct: 87 LQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146
Query: 124 INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVW 158
I + + + T Y APE+L Y VD W
Sbjct: 147 IEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWW 180
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 22 ATNKKEKRSLKH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-------GLPW 73
A N+K+ +V+L F K L LV T++N + H G P
Sbjct: 40 ALNEKKILEKVSSRFIVSLAYAFETKDDLCLVM-----TLMNGGDLKYHIYNVGEPGFPE 94
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY 133
Q++ G+ + H+ ++RD+KPEN+LL +G V++ D G A + G+
Sbjct: 95 ARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154
Query: 134 VATRWYRAPELLVGDTLYGPAVDVWAI 160
T Y APE+L G+ Y +VD +A+
Sbjct: 155 AGTPGYMAPEVLQGEV-YDFSVDWFAL 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 52/190 (27%), Positives = 83/190 (43%), Gaps = 29/190 (15%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLR 85
+SL+H N+V V ++ L LV E+ + L + L+ H L + Q+ +
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR-------W 138
G+ Y +HRD+ NIL+ + VK+ DFG +++ + Y Y W
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY--YKVREPGESPIFW 177
Query: 139 YRAPELLVGDTLYGPAVDVWAI-----EWTSHS----------YSQIGFIGLGNMGSHMA 183
Y APE L ++ + A DVW+ E ++S +G G M +
Sbjct: 178 Y-APESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 184 RNLLKNNGRV 193
LLKNNGR+
Sbjct: 236 IELLKNNGRL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 69 HGLPWDLIKQITWQVLRGVSYC-HRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINP 126
+P D++ ++T +++ + Y +H IHRD+KP NILL A+G VKLCDFG + RL++
Sbjct: 109 GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 127 GENYTDYVATRWYRAPELLVGDTL---YGPAVDVWAI 160
T Y APE + Y DVW++
Sbjct: 169 KAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-12
Identities = 50/172 (29%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 16 IRQATEATNKKE-------KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENH 67
++Q A KKE L HP +V L+ V + + L LV E L + L+
Sbjct: 31 LKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKR 89
Query: 68 PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG 127
+P +K++ QV G++Y +HRD+ N+LL K+ DFG +R + G
Sbjct: 90 RE-IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148
Query: 128 ENYTDYVAT-------RWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQ 169
+Y Y AT +WY APE + + DVW+ W + SY
Sbjct: 149 SDY--YRATTAGRWPLKWY-APECINYGK-FSSKSDVWSYGVTLWEAFSYGA 196
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 56/171 (32%), Positives = 88/171 (51%), Gaps = 19/171 (11%)
Query: 5 KKKKSS--YYKEAIRQA-----TEATNKKEKRSL----KHPNLVNLLEVFRRKKKLHLVF 53
+K+ + Y + IR+A +E T+ +R++ P +V L F+ +KL+LV
Sbjct: 13 RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVL 72
Query: 54 EFCDHTVLNELENHPHGL-PWDLIKQ--ITWQVLRGVSYCHRHACIHRDIKPENILLTAN 110
F + EL +H +DL + T ++L + H+ I+RD+KPENILL
Sbjct: 73 AFING---GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ 129
Query: 111 GVVKLCDFGFARLINPGENYTD-YVATRWYRAPELLVGDTLYGPAVDVWAI 160
G + LCDFG +L ++ T+ + T Y APELL+G Y AVD W +
Sbjct: 130 GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTL 179
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-12
Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSY 89
L HP LV L V + + LVFEF +H L++ G + + + V G++Y
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPELLV 146
IHRD+ N L+ N VVK+ DFG R + + YT T++ + +PE +
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPE-VF 173
Query: 147 GDTLYGPAVDVWA 159
+ Y DVW+
Sbjct: 174 SFSKYSSKSDVWS 186
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 17/144 (11%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92
+P +V++ F K+ L +V E+ + L + LP D+ + + + + Y H
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 119
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFAR--LINPGEN-YTDYVA-------------T 136
+ +HRD+KP+N+L+T+ G +KL DFG ++ L++ N Y ++ T
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 137 RWYRAPELLVGDTLYGPAVDVWAI 160
Y APE+++ YG VD WA+
Sbjct: 180 PEYIAPEVILRQG-YGKPVDWWAM 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 42/156 (26%), Positives = 61/156 (39%), Gaps = 31/156 (19%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93
P +V L F+ ++ L+LV E+ L L P + + +++ + H+
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 94 ACIHRDIKPENILLTANGVVKLCDFGFA--------------RLINPGENYTDYVATRW- 138
IHRDIKP+NIL+ A+G +KL DFG N V R
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 139 ---------------YRAPELLVGDTLYGPAVDVWA 159
Y APE+L G YG D W+
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWS 215
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 42/138 (30%), Positives = 62/138 (44%), Gaps = 13/138 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--TWQVLRG 86
+ L+H LV L V ++ +++V E+ L + G L + + Q+ G
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
++Y IHRD+ NIL+ N V K+ DFG ARLI E YT ++ + APE
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPE 174
Query: 144 LLVGDTLYGP---AVDVW 158
YG DVW
Sbjct: 175 AA----NYGRFTIKSDVW 188
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 13/168 (7%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKR-----------SLKHPNLVNLLEVFRRKKKLHLVF 53
+K Y + Q N+KE++ ++KHP LV L F+ +KL+ V
Sbjct: 16 RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75
Query: 54 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 113
+F + L P + ++ + Y H ++RD+KPENILL + G V
Sbjct: 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHV 135
Query: 114 KLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
L DFG + I + T + T Y APE++ Y VD W +
Sbjct: 136 VLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCL 182
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 7/152 (4%)
Query: 13 KEAIRQATEATNKKEKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP 68
K + + E + +R + K LV LL F+ + L+L E+ L N+
Sbjct: 36 KSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL 95
Query: 69 HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE 128
L D + ++ V H IHRD+KPEN L+ A+G +KL DFG ++ I
Sbjct: 96 GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA 155
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
N V + Y APE+L G Y VD W++
Sbjct: 156 N--SVVGSPDYMAPEVLRG-KGYDFTVDYWSL 184
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD 132
DL+ + + QV +G+ + CIHRD+ N+LLT V K+CDFG AR I N ++
Sbjct: 212 DDLL-RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI---MNDSN 267
Query: 133 YVA-------TRWYRAPELLVGDTLYGPAVDVWA 159
YV +W APE + D +Y DVW+
Sbjct: 268 YVVKGNARLPVKWM-APESIF-DCVYTVQSDVWS 299
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 51/205 (24%), Positives = 79/205 (38%), Gaps = 31/205 (15%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLR 85
R+L H N+V V + L L+ E+ L + L+ H + + + Q+ +
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA-------TRW 138
G+ Y IHRD+ NIL+ + +VK+ DFG A+++ ++Y Y W
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY--YYVKEPGESPIFW 178
Query: 139 YRAPELLVGDTLYGPAVDVWAIEWT--------SHSYSQIGFIGLGNMGSHMAR------ 184
Y APE L A DVW+ T S S +
Sbjct: 179 Y-APECLRTSKFSS-ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 185 NLLKNNGRVTVILKSDSLDSETWDL 209
LLK R+ + S E +DL
Sbjct: 237 ELLKEGERLP---RPPSCPDEVYDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 49/139 (35%), Positives = 65/139 (46%), Gaps = 14/139 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFE--FCD-HTVLNELENHPHGLPWDLIKQITWQVLR 85
R L HP ++ LL+V LV D +T L P GL + + Q+L
Sbjct: 215 RRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLR-PLGLAQ--VTAVARQLLS 271
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLC--DFG---FARLINPGENYTDYVATRWYR 140
+ Y H IHRDIK EN+L+ NG +C DFG FAR + T
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLV--NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 141 APELLVGDTLYGPAVDVWA 159
APE+L GD Y P+VD+W+
Sbjct: 330 APEVLAGDP-YTPSVDIWS 347
|
Length = 461 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 41/124 (33%), Positives = 67/124 (54%), Gaps = 5/124 (4%)
Query: 43 FRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 101
+ + KL ++ E+ + L+ LE P L I I ++L+G+ Y H IHRDIK
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 102 PENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
N+LL+ +G VKL DFG A +L + +V T ++ APE ++ + Y D+W++
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSL 187
Query: 161 EWTS 164
T+
Sbjct: 188 GITA 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 33/83 (39%), Positives = 46/83 (55%), Gaps = 4/83 (4%)
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW- 138
++QV +G+ + CIHRD+ NILL+ N VVK+CDFG AR I +Y R
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 139 --YRAPELLVGDTLYGPAVDVWA 159
+ APE + D +Y DVW+
Sbjct: 245 LKWMAPETIF-DRVYTIQSDVWS 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 42/130 (32%), Positives = 65/130 (50%), Gaps = 3/130 (2%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90
+ HP VNL F+ + L+LV EF P D+ Q++ Y
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTL 150
++RD+KPEN+LL +G +K+ DFGFA++++ YT T Y APE+L+ +
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT-LCGTPEYIAPEILL-NVG 204
Query: 151 YGPAVDVWAI 160
+G A D W +
Sbjct: 205 HGKAADWWTL 214
|
Length = 340 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 67 HPHGLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLTANGVVKLCDFGFA-RLI 124
+P D++ +I +++ + Y H + + IHRD+KP N+L+ NG VKLCDFG + L+
Sbjct: 96 KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155
Query: 125 NPGENYTDYVATRWYRAPELLVGDT---LYGPAVDVWAI 160
+ D + Y APE + + Y DVW++
Sbjct: 156 DSVAKTID-AGCKPYMAPERINPELNQKGYDVKSDVWSL 193
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN----PGEN 129
++ ++ T Q+L GVSY H + +HRDIK NIL + G VKL DFG ++ + G
Sbjct: 106 NVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165
Query: 130 YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163
T ++ +PE++ G+ YG D+W++ T
Sbjct: 166 MKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCT 198
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 41/136 (30%), Positives = 71/136 (52%), Gaps = 10/136 (7%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYC 90
P +V+ F + +++ E+ D L++L G+P D++++IT+ V++G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 91 -HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDT 149
H IHRD+KP N+L+ NG VKLCDFG + + T+ + + Y APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERIKSGG 177
Query: 150 L-----YGPAVDVWAI 160
Y DVW++
Sbjct: 178 PNQNPTYTVQSDVWSL 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 14 EAIRQATEATNKKEKR---SLKHPNLVNLLEVFRRKKKLHLVFEF-CDHTVLNELEN--- 66
E IR E EKR + HP ++ L ++ L+++ E+ + + L N
Sbjct: 38 EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR 97
Query: 67 --HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
+ GL + +++ + Y H ++RD+KPENILL G +KL DFGFA+ +
Sbjct: 98 FSNSTGLFY------ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 125 NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+T T Y APE++ + AVD WA+
Sbjct: 152 R-DRTWT-LCGTPEYLAPEVI-QSKGHNKAVDWWAL 184
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-11
Identities = 43/142 (30%), Positives = 74/142 (52%), Gaps = 9/142 (6%)
Query: 29 RSLKHPNLVNLLEVFRRK--KKLHLVFEFC-DHTVLNELENHPHGLPWDLIKQITWQVLR 85
++L+H +V R + K L + E+ +V ++L+ + L + ++ T Q+L
Sbjct: 59 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILE 117
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN----PGENYTDYVATRWYRA 141
G+SY H + +HRDIK NIL + G VKL DFG ++ + G T ++ +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 142 PELLVGDTLYGPAVDVWAIEWT 163
PE++ G+ YG DVW++ T
Sbjct: 178 PEVISGEG-YGRKADVWSLGCT 198
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 7/163 (4%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61
+ +++ YK + Q + + + P + ++ K++ + D V
Sbjct: 141 KHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVT 200
Query: 62 NE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 120
+E LE L + + ++QV +G+S+ CIHRD+ NILLT + K+CDFG
Sbjct: 201 SEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL 260
Query: 121 ARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
AR I NY + +W APE + + +Y DVW+
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWM-APESIF-NCVYTFESDVWS 301
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-11
Identities = 52/177 (29%), Positives = 72/177 (40%), Gaps = 31/177 (17%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGL---------------- 71
HPN+V LL V K + L+FE+ + LNE H P
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 72 PWDLIK----QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG 127
P L I QV G++Y +HRD+ N L+ N VVK+ DFG +R I
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 128 ENY----TDYVATRWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
+ Y D + RW PE + + Y DVWA + W SY + G+ +
Sbjct: 184 DYYKASENDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENHPH-----GLPWDLIKQITWQVLRG 86
P +VNL F K L LV +++N +L+ H + GL + + + Q+ G
Sbjct: 53 PFIVNLAYAFESKTHLCLVM-----SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCG 107
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV 146
+ + H ++RD+KPEN+LL G +L D G A + G+ T T Y APE+L
Sbjct: 108 ILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK 167
Query: 147 GDTLYGPAVDVWAI 160
+ Y VD +A+
Sbjct: 168 EEP-YSYPVDWFAM 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 16/160 (10%)
Query: 14 EAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEFCDH----TVLNELEN 66
E +++A A ++E+ L + + + NL F+ + L+LV ++ T+L++ E+
Sbjct: 38 EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED 97
Query: 67 HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP 126
LP D+ + +++ + H+ +HRDIKP+N+LL NG ++L DFG +
Sbjct: 98 R---LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154
Query: 127 GENYTDYVA--TRWYRAPELLV----GDTLYGPAVDVWAI 160
VA T Y +PE+L G YGP D W++
Sbjct: 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 45/156 (28%), Positives = 64/156 (41%), Gaps = 27/156 (17%)
Query: 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--------ELENHPHGLP 72
EA+ KE ++V LL V + +V E L E EN+P P
Sbjct: 59 EASVMKE---FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 73 WDLIKQITW--QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY 130
L K I ++ G++Y +HRD+ N ++ + VK+ DFG R I
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI----YE 171
Query: 131 TDY--------VATRWYRAPELLVGDTLYGPAVDVW 158
TDY + RW APE L D ++ DVW
Sbjct: 172 TDYYRKGGKGLLPVRWM-APESL-KDGVFTTKSDVW 205
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 44/139 (31%), Positives = 64/139 (46%), Gaps = 6/139 (4%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
EKR L HP L L F+ +L V EF + L + +
Sbjct: 45 EKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 104
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPGENYTDYVATRWYRA 141
+ + + H I+RD+K +N+LL G KL DFG + I G+ + + T Y A
Sbjct: 105 ITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIA 164
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE+L + LYGP+VD WA+
Sbjct: 165 PEIL-QEMLYGPSVDWWAM 182
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 71 LPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGE 128
+P +++ +I ++ ++Y IHRD+KP NILL NG +KLCDFG + +L++
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAV--DVWAI 160
D R Y APE + G V DVW++
Sbjct: 164 KTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSL 196
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 18/194 (9%)
Query: 5 KKKKSSYYKEAIRQATEATNK-KEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
++ + K R A + N+ L H N++ + E+ R + +++ + D + +
Sbjct: 193 ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 64 LENHPHGLPWD---LIKQ---ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCD 117
+ + W L+KQ I Q+L V Y H IHRDIK ENI L +G + L D
Sbjct: 253 M--YDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGD 310
Query: 118 FGFARLINPGENYTDY--VATRWYRAPELLVGDTLYGPAVDVWA-----IEWTSHSYSQI 170
FG A DY V T +PE+L GD Y D+W+ ++ SH + I
Sbjct: 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPI 369
Query: 171 GFIGLGNMGSHMAR 184
G G G G + +
Sbjct: 370 GD-GGGKPGKQLLK 382
|
Length = 501 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 6/120 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--TWQVLRG 86
+ L+HP L+ L V ++ +++V E + L E G L + I QV G
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASG 115
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
++Y IHRD+ N+L+ N + K+ DFG AR+I Y ++ + APE
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 31/84 (36%), Positives = 49/84 (58%), Gaps = 2/84 (2%)
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYR 140
++L+G+ Y H IHRDIK N+LL+ G VKL DFG A +L + +V T ++
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 141 APELLVGDTLYGPAVDVWAIEWTS 164
APE ++ + Y D+W++ T+
Sbjct: 169 APE-VIQQSAYDSKADIWSLGITA 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 13 KEAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH 67
K ++ EA EK+ L+ N +V+L + K L LV T++N +L+ H
Sbjct: 36 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL-----TLMNGGDLKFH 90
Query: 68 PH-----GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
+ G + ++ G+ HR ++RD+KPENILL G +++ D G A
Sbjct: 91 IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV 150
Query: 123 LINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
I GE V T Y APE +V + Y + D W +
Sbjct: 151 EIPEGETIRGRVGTVGYMAPE-VVKNERYTFSPDWWGL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 5/133 (3%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92
P + + + KL ++ E+ + L+ L+ P L I I ++L+G+ Y H
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHS 119
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLVGDTLY 151
IHRDIK N+LL+ G VKL DFG A +L + +V T ++ APE ++ + Y
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAY 178
Query: 152 GPAVDVWAIEWTS 164
D+W++ T+
Sbjct: 179 DFKADIWSLGITA 191
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 40/135 (29%), Positives = 69/135 (51%), Gaps = 7/135 (5%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN----ELENHPHGLPWDLIKQITWQVLRG 86
L HP +V F + ++ E+C+ L+ EL++ L + + + Q+L G
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYRAPELL 145
V Y H+ +HRD+K +NI L N ++K+ DFG +R L+ + T + T +Y +PE L
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 146 VGDTLYGPAVDVWAI 160
Y D+W++
Sbjct: 178 KHQG-YDSKSDIWSL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 6/153 (3%)
Query: 13 KEAIRQATE-ATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP 68
KE I E A E R L+ HP L L F+ +L V E+ + L +
Sbjct: 30 KEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE 89
Query: 69 HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPG 127
D + +++ + Y H ++RD+K EN++L +G +K+ DFG + I+ G
Sbjct: 90 RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149
Query: 128 ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ T Y APE+L D YG AVD W +
Sbjct: 150 ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGL 181
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 14 EAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEF-CDHTVLNELENHPH 69
E +++A A ++E+ L + + + L F+ + L+LV ++ +L L
Sbjct: 38 EMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED 97
Query: 70 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN 129
LP D+ + +++ + H+ +HRDIKP+N+LL NG ++L DFG +N
Sbjct: 98 RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157
Query: 130 YTDYVA--TRWYRAPELLV----GDTLYGPAVDVWAI 160
VA T Y +PE+L G YGP D W++
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 194
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 16/181 (8%)
Query: 26 KEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITW 81
+E R LK HPN+V L+ V +K+ +++V E L L L + Q+
Sbjct: 42 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVE 101
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD----YVATR 137
G+ Y CIHRD+ N L+T V+K+ DFG +R G + + +
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK 161
Query: 138 WYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVT 194
W APE L Y DVW+ + W + S +G + N+ + R ++ R+
Sbjct: 162 W-TAPEAL-NYGRYSSESDVWSFGILLWEAFS---LGAVPYANLSNQQTREAIEQGVRLP 216
Query: 195 V 195
Sbjct: 217 C 217
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 16/143 (11%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH-PHGLPWDLIKQI 79
E+R L +HP L +L F+ K+ L V E+ LN +L H +D +
Sbjct: 45 ERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY-----LNGGDLMFHIQSSGRFDEARAR 99
Query: 80 TW--QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVAT 136
+ +++ G+ + H+ I+RD+K +N+LL +G +K+ DFG + GE + T
Sbjct: 100 FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159
Query: 137 RWYRAPELLVGDTLYGPAVDVWA 159
Y APE+L G Y +VD W+
Sbjct: 160 PDYIAPEILKGQ-KYNESVDWWS 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRG 86
+ L+H +L++L V + ++++ E + L P G LP + + QV G
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD--YVATRWYRAPEL 144
++Y IHRD+ NIL+ + V K+ DFG ARLI + + +W APE
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPEA 175
Query: 145 LVGDTLYGPAVDVWAIEWTSH---SYSQIGFIGLGN 177
T + DVW+ + +Y Q+ + G+ N
Sbjct: 176 ASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 14 EAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEF-CDHTVLNELENHPH 69
E +++A A ++E+ L + + + L F+ + L+LV ++ +L L
Sbjct: 38 EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED 97
Query: 70 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGE 128
LP D+ + +++ + H+ +HRDIKP+NIL+ NG ++L DFG +L+ G
Sbjct: 98 RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157
Query: 129 NYTDY-VATRWYRAPELLV----GDTLYGPAVDVWAI 160
+ V T Y +PE+L G YGP D W++
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL 194
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 10/140 (7%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW- 81
EKR L +HP L +L F+ K+ L V E+ + L H +DL + +
Sbjct: 45 EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYA 102
Query: 82 -QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVATRWY 139
+++ G+ + H ++RD+K +NILL +G +K+ DFG + G+ T + T Y
Sbjct: 103 AEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDY 162
Query: 140 RAPELLVGDTLYGPAVDVWA 159
APE+L+G Y +VD W+
Sbjct: 163 IAPEILLGQK-YNTSVDWWS 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 12/167 (7%)
Query: 5 KKKKSSYY------KEAIRQATE-ATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFE 54
+K YY KE I E A E R LK HP L +L F+ K +L V E
Sbjct: 16 EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75
Query: 55 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 114
+ + L + D + +++ + Y H ++RD+K EN++L +G +K
Sbjct: 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIK 135
Query: 115 LCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ DFG + I + T Y APE+L D YG AVD W +
Sbjct: 136 ITDFGLCKEGITDAATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGL 181
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 26 KEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFC-DHTVLNELENHPHGLPWDLIKQITW 81
+E LK HPN+V L+ V +K+ +++V E ++L L + L + Q++
Sbjct: 41 QEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL 100
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-----DYVAT 136
G+ Y CIHRD+ N L+ N V+K+ DFG +R G YT +
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI-YTVSDGLKQIPI 159
Query: 137 RWYRAPELL-VGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGR 192
+W APE L G Y DVW+ + W + S + G+ N R +++ R
Sbjct: 160 KW-TAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERIESGYR 213
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 44/132 (33%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93
P +V L F+ K L++V E+ L L ++ + +P K T +V+ + H
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSM 161
Query: 94 ACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDY-VATRWYRAPELLV---GD 148
IHRD+KP+N+LL +G +KL DFG ++ G D V T Y +PE+L GD
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 149 TLYGPAVDVWAI 160
YG D W++
Sbjct: 222 GYYGRECDWWSV 233
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 29/66 (43%), Positives = 39/66 (59%), Gaps = 3/66 (4%)
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN---PGENYTDYVATRW 138
QVL V + H IHRDIK NILL +NG+VKL DFGF+++ + + T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 139 YRAPEL 144
Y APE+
Sbjct: 211 YVAPEI 216
|
Length = 496 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 2/143 (1%)
Query: 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQ 78
A T + ++ +HP L L F+ +L V E+ + L + + +
Sbjct: 40 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 99
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPGENYTDYVATR 137
+++ + Y H ++RDIK EN++L +G +K+ DFG + I+ G + T
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 138 WYRAPELLVGDTLYGPAVDVWAI 160
Y APE+L D YG AVD W +
Sbjct: 160 EYLAPEVL-EDNDYGRAVDWWGL 181
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 13 KEAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH 67
K ++ E+ EK+ L+ N +VNL + K L LV T++N +L+ H
Sbjct: 36 KRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL-----TIMNGGDLKFH 90
Query: 68 PH-----GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
+ G + ++L G+ HR ++RD+KPENILL G +++ D G A
Sbjct: 91 IYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV 150
Query: 123 LINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
I GE+ V T Y APE+L + Y + D W +
Sbjct: 151 KIPEGESIRGRVGTVGYMAPEVL-NNQRYTLSPDYWGL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 14 EAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEFC-DHTVLNELENHPH 69
E I+++ A +E+ + H N +V L F+ K L++V E+ ++N + N+
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 70 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGE 128
+P + T +V+ + H IHRD+KP+N+LL +G +KL DFG ++ G
Sbjct: 139 -IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197
Query: 129 NYTDY-VATRWYRAPELLV---GDTLYGPAVDVWAI 160
D V T Y +PE+L GD YG D W++
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 32/75 (42%), Positives = 43/75 (57%), Gaps = 2/75 (2%)
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY 133
++IK + QVL G+ HR +HRDIKPEN+L+T +G VK+ DFG A + G N+
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPL 368
Query: 134 VAT--RWYRAPELLV 146
Y PE LV
Sbjct: 369 YGMLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 71 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY 130
L + + ++QV G+ + C+HRD+ N+L+ +VK+CDFG AR I NY
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295
Query: 131 ----TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ ++ +W APE + + LY DVW+
Sbjct: 296 ISKGSTFLPLKWM-APESIF-NNLYTTLSDVWS 326
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 8/136 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--TWQVLRG 86
+ L+HP LV L V ++ ++++ E+ ++ L + P G+ + K I Q+ G
Sbjct: 56 KQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEG 114
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
+++ R IHRD++ NIL++ K+ DFG ARLI E YT ++ + APE
Sbjct: 115 MAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 173
Query: 144 LLVGDTLYGPAVDVWA 159
+ T + DVW+
Sbjct: 174 AINYGT-FTIKSDVWS 188
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVS 88
+HPN++ VF L ++ F + N L P G+ LI I + LRG++
Sbjct: 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLN 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFG-FARLINPGENYT---DY----VATRWYR 140
Y H++ IHR+IK +IL++ +G+V L L+ G+ D+ + +
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175
Query: 141 APELLVGDTLYGPAV--DVWAIEWTS 164
+PELL D LYG V D++++ T+
Sbjct: 176 SPELLRQD-LYGYNVKSDIYSVGITA 200
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 19/161 (11%)
Query: 7 KKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN 66
K + EA Q + K L+H LV L V ++ +++V E+ L +
Sbjct: 39 KPGTMSPEAFLQEAQVMKK-----LRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK 92
Query: 67 HPHGLPWDLIKQITW--QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
G L + + Q+ G++Y R +HRD++ NIL+ N V K+ DFG ARLI
Sbjct: 93 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152
Query: 125 NPGENYTDYVATRW---YRAPELLVGDTLYGPAV---DVWA 159
E YT ++ + APE LYG DVW+
Sbjct: 153 EDNE-YTARQGAKFPIKWTAPEA----ALYGRFTIKSDVWS 188
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCH 91
HPN++ L V + + + ++ E+ ++ L++ L + + + + G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDY---VATRWYRAPELLVG 147
+HRD+ NIL+ +N V K+ DFG +R + E YT + RW APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPE-AIA 181
Query: 148 DTLYGPAVDVWA---IEWTSHSYSQ 169
+ A DVW+ + W SY +
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|217563 pfam03446, NAD_binding_2, NAD binding domain of 6-phosphogluconate dehydrogenase | Back alignment and domain information |
|---|
Score = 54.4 bits (132), Expect = 4e-09
Identities = 19/28 (67%), Positives = 21/28 (75%)
Query: 168 SQIGFIGLGNMGSHMARNLLKNNGRVTV 195
++IGFIGLG MGS MA NLLK VTV
Sbjct: 1 AKIGFIGLGVMGSPMALNLLKAGYTVTV 28
|
The NAD binding domain of 6-phosphogluconate dehydrogenase adopts a Rossmann fold. Length = 163 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 44/167 (26%), Positives = 70/167 (41%), Gaps = 13/167 (7%)
Query: 6 KKKSSYYKEAIRQATEATNKKEKR-----------SLKHPNLVNLLEVFRRKKKLHLVFE 54
K + +Y + Q KKE++ ++KHP LV L F+ KL+ V +
Sbjct: 17 KAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 76
Query: 55 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 114
+ + L + ++ + Y H ++RD+KPENILL + G +
Sbjct: 77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 136
Query: 115 LCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
L DFG + I + + T Y APE+L Y VD W +
Sbjct: 137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCL 182
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 28/180 (15%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHG---------------LPW 73
L+HPN+V LL V +++ L ++F +C H+ L+E + PH P
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--- 130
D + +T Q+ G+ + H +H+D+ N+L+ VK+ D G R + + Y
Sbjct: 125 DFVHIVT-QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 131 -TDYVATRWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGNMGS-HMARN 185
+ RW ++ G + D+W+ + W SY + G N M RN
Sbjct: 184 GNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 14 EAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG 70
E I+++ A +E+ + N +V L F+ + L++V E+ L L ++ +
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YD 138
Query: 71 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP-GEN 129
+P + T +V+ + H IHRD+KP+N+LL +G +KL DFG +N G
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 130 YTDY-VATRWYRAPELLV---GDTLYGPAVDVWAI 160
D V T Y +PE+L GD YG D W++
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 17/149 (11%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS---- 88
HPN+++L V + K + +V E+ ++ L+ H + +I+ + +LRG++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVG--MLRGIASGMK 120
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI--NPGENYTDY---VATRWYRAPE 143
Y +HRD+ NIL+ +N V K+ DFG +R++ +P YT + RW APE
Sbjct: 121 YLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPE 179
Query: 144 LLVGDTLYGPAVDVWA---IEWTSHSYSQ 169
+ + A DVW+ + W SY +
Sbjct: 180 -AIAYRKFTSASDVWSYGIVMWEVMSYGE 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRG 86
++L+H LV L V ++ ++++ EF L + G L K I + Q+ G
Sbjct: 56 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
+++ + IHRD++ NIL++A+ V K+ DFG AR+I E YT ++ + APE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 173
Query: 144 LLVGDTLYGPAV---DVWA--IEWTS-HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVIL 197
+ +G DVW+ I +Y +I + G+ N +++ R +
Sbjct: 174 AIN----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYRMP 223
Query: 198 KSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227
+ ++ E +++ + ++ F+Y+
Sbjct: 224 RPENCPEELYNIMMRCWKNRPEERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 44/139 (31%), Positives = 64/139 (46%), Gaps = 14/139 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDL--IKQITWQVLRG 86
+ L+H LV L V + +++V E+ L + G L + + QV G
Sbjct: 56 KKLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 114
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
++Y R IHRD++ NIL+ V K+ DFG ARLI E YT ++ + APE
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPE 173
Query: 144 LLVGDTLYGPAV---DVWA 159
LYG DVW+
Sbjct: 174 A----ALYGRFTIKSDVWS 188
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 18/35 (51%), Positives = 27/35 (77%)
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 123
Y HRH IHRD+KP+N+L++ G +KL DFG +++
Sbjct: 119 YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 34/152 (22%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--- 79
EKR L K P L L F+ +L+ V E+ + DL+ I
Sbjct: 50 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG--------------DLMYHIQQV 95
Query: 80 -----------TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPG 127
++ G+ + H I+RD+K +N++L A G +K+ DFG + I G
Sbjct: 96 GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155
Query: 128 ENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ + T Y APE ++ YG +VD WA
Sbjct: 156 KTTRTFCGTPDYIAPE-IIAYQPYGKSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 42/157 (26%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRG 86
++L+H LV L V +++ ++++ E+ L + G L K I + Q+ G
Sbjct: 56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 115
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
++Y R IHRD++ N+L++ + + K+ DFG AR+I E YT ++ + APE
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 174
Query: 144 LLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
+ + + DVW+ + + +Y +I + G+ N
Sbjct: 175 AINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 43/144 (29%), Positives = 63/144 (43%), Gaps = 9/144 (6%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGL-PWDLIKQITWQVLRGVS 88
L H NLV LL V L++V E ++N L L + Q + V G+
Sbjct: 56 LHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
Y +HRD+ NIL++ +GV K+ DFG AR + + +W APE L
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKW-TAPEALKHK 172
Query: 149 TLYGPAVDVWA---IEWTSHSYSQ 169
+ DVW+ + W SY +
Sbjct: 173 K-FSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 12/175 (6%)
Query: 13 KEAIRQATEATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHP 68
KE + Q + E R LK HPN+V L+ V +++ +++V E L+ L
Sbjct: 28 KEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK 87
Query: 69 HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG- 127
L + + G++Y CIHRD+ N L+ N V+K+ DFG +R + G
Sbjct: 88 DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147
Query: 128 --ENYTDYVATRWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
+ + +W APE L Y DVW+ + W + S + G+ N
Sbjct: 148 YSSSGLKQIPIKW-TAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 50/188 (26%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 9 SSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEV-FRRKKKLHL-----VFEFCDH---- 58
SS +E +R EA KE HPN++ L+ V R + K L + F H
Sbjct: 42 SSDIEEFLR---EAACMKE---FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLH 95
Query: 59 --TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 116
+++ + P LP + + + G+ Y IHRD+ N +L N V +
Sbjct: 96 TFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155
Query: 117 DFGFARLINPGENYTDYVAT----RWYRAPELLVGDTLYGPAVDVWAIE---WTSHSYSQ 169
DFG ++ I G+ Y A+ +W L D +Y DVWA W + Q
Sbjct: 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQ 213
Query: 170 IGFIGLGN 177
+ G+ N
Sbjct: 214 TPYAGVEN 221
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 40/195 (20%)
Query: 3 FNKKKKSSYYKEAIRQATEATNKKEKRSL----------KHPNLVNLLEVFRRKKKLHLV 52
F K ++ Y A++ E + E R L HP+++ L + L L+
Sbjct: 22 FRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81
Query: 53 FEFCDHTVL----------------------NELENHPHGLPWDLIKQIT--WQVLRGVS 88
E+ + L + ++P + I+ WQ+ RG+
Sbjct: 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQ 141
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT----DYVATRWYRAPEL 144
Y +HRD+ N+L+ +K+ DFG +R + ++Y + +W A E
Sbjct: 142 YLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWM-AIES 200
Query: 145 LVGDTLYGPAVDVWA 159
L D +Y DVW+
Sbjct: 201 LF-DHIYTTQSDVWS 214
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 14/139 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRG 86
+ L+H LV L V ++ +++V EF L + G L + + Q+ G
Sbjct: 56 KKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW---YRAPE 143
++Y R IHRD++ NIL+ N V K+ DFG ARLI E YT ++ + APE
Sbjct: 115 MAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPE 173
Query: 144 LLVGDTLYGPAV---DVWA 159
LYG DVW+
Sbjct: 174 A----ALYGRFTIKSDVWS 188
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 31/163 (19%)
Query: 17 RQATEATNKKEKRSL---KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-----LENHP 68
RQA A + E L H +V + F+ KL L+ E+ LN+ L+ H
Sbjct: 107 RQAAYA--RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEH- 163
Query: 69 HGLPWDL--IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP 126
LP+ + + +Q++ + H +HRD+K NI L G++KL DFGF++
Sbjct: 164 --LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---- 217
Query: 127 GENYTDYVA---------TRWYRAPELLVGDTLYGPAVDVWAI 160
Y+D V+ T +Y APEL Y D+W++
Sbjct: 218 --QYSDSVSLDVASSFCGTPYYLAPELW-ERKRYSKKADMWSL 257
|
Length = 478 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 14/169 (8%)
Query: 5 KKKKSSYY-------KEAIRQATE-ATNKKEKRSL---KHPNLVNLLEVFRRKKKLHLVF 53
K+K + Y KE I E A E R L +HP L L F+ +L V
Sbjct: 15 KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 74
Query: 54 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLTANGV 112
E+ + L + D + +++ + Y H ++RD+K EN++L +G
Sbjct: 75 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH 134
Query: 113 VKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+K+ DFG + I G + T Y APE+L D YG AVD W +
Sbjct: 135 IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGL 182
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 18/29 (62%), Positives = 22/29 (75%)
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFG 119
H+ IHRDIKP+N+LL A G +KL DFG
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 41/130 (31%), Positives = 61/130 (46%), Gaps = 18/130 (13%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-------HPHGLPW-DLIKQIT 80
R L HPN++ L LV EFC L +L+N + D+++++
Sbjct: 50 RELNHPNVLQCLGQCIESIPYLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRMA 106
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TD---YVA 135
+V G+ + H+ IH D+ N LTA+ VK+ D+G A P E+Y T V
Sbjct: 107 CEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP-EDYYITKDCHAVP 165
Query: 136 TRWYRAPELL 145
RW APEL+
Sbjct: 166 LRWL-APELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 18/130 (13%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH------PHGLPWDL--IKQIT 80
RSL+H NL+ L LV EFC L +L+ + + D ++++
Sbjct: 50 RSLQHSNLLQCLGQCTEVTPYLLVMEFCP---LGDLKGYLRSCRKAELMTPDPTTLQRMA 106
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-----TDYVA 135
++ G+ + H++ IH D+ N LLTA+ VK+ D+G + E+Y +V
Sbjct: 107 CEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVP 165
Query: 136 TRWYRAPELL 145
RW APEL+
Sbjct: 166 LRWI-APELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 7/134 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
R HP++V L+ V + + +V E L L+ + + L + ++Q+ +
Sbjct: 62 RQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA---TRWYRAPEL 144
+Y +HRDI N+L+++ VKL DFG +R + Y +W APE
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-APE- 178
Query: 145 LVGDTLYGPAVDVW 158
+ + A DVW
Sbjct: 179 SINFRRFTSASDVW 192
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 1/75 (1%)
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
G+ H+ ++RD+KPENILL +G +++ D G A + G+ V T Y APE +
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE-V 172
Query: 146 VGDTLYGPAVDVWAI 160
V + Y + D WA+
Sbjct: 173 VKNERYTFSPDWWAL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVS 88
S+ HP++V LL + ++ L+ + +L+ + NH + + Q+ +G+S
Sbjct: 65 SVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYRAP 142
Y +HRD+ N+L+ VK+ DFG A+L++ E +Y A +W A
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK--EYHAEGGKVPIKWM-AL 180
Query: 143 ELLVGDTLYGPAVDVWA 159
E ++ +Y DVW+
Sbjct: 181 ESIL-HRIYTHKSDVWS 196
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 43/141 (30%), Positives = 73/141 (51%), Gaps = 12/141 (8%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGL-PWDLIKQITW 81
EKR L ++P L +L F+ K+ L V EF + +L H +DL + +
Sbjct: 45 EKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG---GDLMFHIQDKGRFDLYRATFY 101
Query: 82 --QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-TDYVATRW 138
+++ G+ + H I+RD+K +N++L +G +K+ DFG + G+N + + T
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPD 161
Query: 139 YRAPELLVGDTLYGPAVDVWA 159
Y APE+L G Y +VD W+
Sbjct: 162 YIAPEILQGLK-YTFSVDWWS 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 13 KEAIRQATEATNKKEKRSLKHPN---LVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH 67
K ++ EA EKR L+ N +V+L + K L LV T++N +L+ H
Sbjct: 36 KRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL-----TIMNGGDLKFH 90
Query: 68 PHGLP---WDLIKQITW--QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
+ + +D + I + ++ G+ R ++RD+KPENILL G +++ D G A
Sbjct: 91 IYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV 150
Query: 123 LINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
I GE V T Y APE++ + Y + D W +
Sbjct: 151 QIPEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|224995 COG2084, MmsB, 3-hydroxyisobutyrate dehydrogenase and related beta-hydroxyacid dehydrogenases [Lipid metabolism] | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 19/45 (42%), Positives = 23/45 (51%), Gaps = 11/45 (24%)
Query: 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQ 212
+I FIGLG MGS MA NLLK VTV ++ T +
Sbjct: 1 MKIAFIGLGIMGSPMAANLLKAGHEVTV-----------YNRTPE 34
|
Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-08
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 26/171 (15%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPH---GLPWD---LIK----- 77
L HPN+V LL V +++ + ++FE+ + L+E + PH G D +K
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 78 ----QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--- 130
I Q+ G+ Y H +H+D+ NIL+ VK+ D G +R I + Y
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 131 -TDYVATRWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
+ RW ++ G + D+W+ + W S+ + G N
Sbjct: 184 PKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 2/94 (2%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVS 88
L+HPNLV LL V + L++V E+ L + + V G+
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
Y +HRD+ N+L++ + V K+ DFG A+
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 17/129 (13%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVL 84
R L+HPN++ L LVFE+C+ + L++ + H L++++ ++
Sbjct: 50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------- 136
GV++ H+H +H D+ N LT++ VK+ D+G I P DY+ T
Sbjct: 110 AGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG----IGPSRYKEDYIETEDDKCVPL 165
Query: 137 RWYRAPELL 145
RW APEL+
Sbjct: 166 RWL-APELV 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 10/108 (9%)
Query: 76 IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA 135
I ++ QV G+ Y +HRD+ N+LL K+ DFG ++ + ENY
Sbjct: 97 ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156
Query: 136 T-----RWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGL 175
+WY APE + + DVW+ + W + SY Q + G+
Sbjct: 157 HGKWPVKWY-APECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 28/149 (18%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELEN-----HPHGLPWDLI 76
EKR L K P L L F+ +L+ V E+ + ++ +++ PH + +
Sbjct: 50 EKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--- 106
Query: 77 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT 136
++ G+ + H I+RD+K +N++L + G +K+ DFG + EN D V T
Sbjct: 107 ---AAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTT 158
Query: 137 RW------YRAPELLVGDTLYGPAVDVWA 159
+ Y APE++ YG +VD WA
Sbjct: 159 KTFCGTPDYIAPEIIAYQP-YGKSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 38/154 (24%)
Query: 27 EKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--- 79
EKR L K P L L F+ +L+ V E+ + +L H I+Q+
Sbjct: 50 EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG---GDLMYH--------IQQVGKF 98
Query: 80 --------TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT 131
++ G+ + HR I+RD+K +N++L + G +K+ DFG + E+
Sbjct: 99 KEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMV 153
Query: 132 DYVATRW------YRAPELLVGDTLYGPAVDVWA 159
D V TR Y APE++ YG +VD WA
Sbjct: 154 DGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 18/145 (12%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN------ELEN---HPHGLPWDLIKQITW 81
LK+PN++ LL V L ++ E+ ++ LN E+E+ H + +P I + +
Sbjct: 74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLY 133
Query: 82 ---QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYV 134
Q+ G+ Y +HRD+ N L+ + +K+ DFG +R + G+ Y +
Sbjct: 134 MAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVL 193
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWA 159
RW +L+G + A DVWA
Sbjct: 194 PIRWMAWESILLGK--FTTASDVWA 216
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 16/141 (11%)
Query: 29 RSLKHPNLVNLLEVFRRK--KKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQITWQVLR 85
++L H N+V + K L L+ E+ ++ + L H L L+ Q+
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQICE 118
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR-------W 138
G++Y H IHRD+ N+LL + +VK+ DFG A+ + G Y Y W
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGDSPVFW 176
Query: 139 YRAPELLVGDTLYGPAVDVWA 159
Y A E L + A DVW+
Sbjct: 177 Y-AVECLKENKFSY-ASDVWS 195
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 47/176 (26%), Positives = 71/176 (40%), Gaps = 39/176 (22%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-------------ENHPHG-LPWDLI 76
+H N+V V +VFE+ +H LN+ + P G L +
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 77 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-TDY-- 133
QI Q+ G+ Y +HRD+ N L+ + VVK+ DFG +R + Y TDY
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-----YTTDYYR 179
Query: 134 ------VATRWYRAPELLVGDTLYGPAV---DVWA---IEWTSHSYSQIGFIGLGN 177
+ RW PE +Y DVW+ + W +Y + + GL N
Sbjct: 180 VGGHTMLPIRWM-PPE----SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 34/106 (32%), Positives = 47/106 (44%), Gaps = 16/106 (15%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-------LENHP-----HGLPWDLIKQ-- 78
HPN++NLL + L+L E+ H L + LE P + L Q
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 79 --ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
V RG+ Y + IHRD+ NIL+ N V K+ DFG +R
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 5/134 (3%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+++ H ++NL+ +R K + +V + ++ LP + I ++L ++
Sbjct: 141 KTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS-GPLPLEQAITIQRRLLEALA 199
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDY--VATRWYRAPELL 145
Y H IHRD+K ENI L L DFG A +L + Y T +PELL
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259
Query: 146 VGDTLYGPAVDVWA 159
D Y D+W+
Sbjct: 260 ALDP-YCAKTDIWS 272
|
Length = 392 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 1/114 (0%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92
HP +V L F+ + KL+L+ +F L + + +K ++ + + H
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-DYVATRWYRAPELL 145
I+RD+KPENILL G +KL DFG ++ E + T Y APE++
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-07
Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 2/100 (2%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
S+ HP+LV LL V + LV + H L + + H + L+ Q+ +G+
Sbjct: 65 SMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE 128
Y +HRD+ N+L+ + VK+ DFG ARL+ E
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 8/135 (5%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVS 88
SL H +V LL + L LV + ++L+ + H L + Q+ +G+
Sbjct: 65 SLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY----VATRWYRAPEL 144
Y H +HR++ NILL ++ +V++ DFG A L+ P + Y +W +
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 145 LVGDTLYGPAVDVWA 159
L G Y DVW+
Sbjct: 184 LFGR--YTHQSDVWS 196
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS---- 88
HPN+++L V + + + ++ EF ++ L+ G + +I+ + +LRG++
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVG--MLRGIAAGMK 120
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RWYRA 141
Y +HRD+ NIL+ +N V K+ DFG +R + + Y ++ RW A
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TA 179
Query: 142 PELLVGDTLYGPAVDVWA---IEWTSHSYSQ 169
PE + + A DVW+ + W SY +
Sbjct: 180 PE-AIAYRKFTSASDVWSYGIVMWEVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-07
Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 21/166 (12%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELEN------HPHGLPWDLIKQITWQVL 84
HPN+V LL V + +++ E + +L+ L + P L + I V
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 85 RGVSYCHRHACIHRDIKPENILLTANG-----VVKLCDFGFARLINPGENYTD----YVA 135
+G Y + IHRD+ N L++ G VVK+ DFG AR I + Y +
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 136 TRWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGNM 178
RW APE L+ D + DVW+ + W + Q + L N
Sbjct: 177 VRWM-APESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 38/148 (25%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 31 LKHPNLVNLLEVF-RRKKKLHLVFEF-CDHTVLNELENHPHG-LPWDLIKQITWQVLRGV 87
L+H NLV LL V K L++V E+ ++++ L + L D + + + V +
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG 147
Y + +HRD+ N+L++ + V K+ DFG + + ++ T + +W APE L
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEAL-R 172
Query: 148 DTLYGPAVDVWA---IEWTSHSYSQIGF 172
+ + DVW+ + W +S+ ++ +
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 4 NKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
NK ++ + KE I+ + LK PN++ LL V L ++ E+ ++ LN+
Sbjct: 59 NKNARNDFLKE-IKIMSR---------LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 64 -LENH-PHGLPWDL---------IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV 112
L H P + + Q+ G+ Y +HRD+ N L+ N
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168
Query: 113 VKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+K+ DFG +R + G+ Y + RW +L+G + A DVWA
Sbjct: 169 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWA 217
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 30/211 (14%)
Query: 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKLH------LVFEFCDHTVLN------ELENHP 68
EA K+ HPN++ L+ V L ++ F H L+ L P
Sbjct: 51 EAACMKD---FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP 107
Query: 69 HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE 128
LP + + + G+ Y IHRD+ N +L + V + DFG ++ I G+
Sbjct: 108 EKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
Query: 129 NYTD----YVATRWYRAPELLVGDTLYGPAVDVWAI---EWTSHSYSQIGFIGLGNMGSH 181
Y + +W A E L D +Y DVWA W + Q + G+ N H
Sbjct: 168 YYRQGRIAKMPVKWI-AIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---H 222
Query: 182 MARNLLKNNGRVTVILKSDSLDSETWDLTWQ 212
+ L++ R+ + + E +DL +
Sbjct: 223 EIYDYLRHGNRLK---QPEDCLDELYDLMYS 250
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 25/79 (31%), Positives = 44/79 (55%), Gaps = 1/79 (1%)
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRA 141
+++ G+ + H ++RD+KP NILL +G V++ D G A + + + V T Y A
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMA 163
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE+L T Y + D +++
Sbjct: 164 PEVLQKGTAYDSSADWFSL 182
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 28/85 (32%), Positives = 43/85 (50%)
Query: 36 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95
+V + F+ K+ L+L+ EF + L L + + + + + H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 96 IHRDIKPENILLTANGVVKLCDFGF 120
IHRDIKP+N+LL A G VKL DFG
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYC 90
H N++ L V + K ++ E+ ++ L++ ++ + L+ + + G+ Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GIAAGMKYL 123
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLI--NPGENYTDY---VATRWYRAPELL 145
+HRD+ NIL+ +N K+ DFG +R++ +P YT + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPE-A 181
Query: 146 VGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
+ + A DVW+ + W S+ + + + N
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRA 141
+++ G+ + H ++RD+KP NILL +G V++ D G A + + + V T Y A
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMA 163
Query: 142 PELLVGDTLYGPAVD 156
PE+L Y + D
Sbjct: 164 PEVLQKGVAYDSSAD 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 10/84 (11%)
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP------GENYTDYVA 135
Q+ G+SY H+ IH+DI N ++ VK+ D +R + P G+N +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN--ENRP 182
Query: 136 TRWYRAPELLVGDTLYGPAVDVWA 159
+W A E LV + Y A DVW+
Sbjct: 183 VKWM-ALESLV-NKEYSSASDVWS 204
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 34/150 (22%)
Query: 14 EAIRQATEATNKKEKRS------LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LEN 66
+A+++A+E+ + +R L+H ++V V + L +VFE+ H LN L +
Sbjct: 41 KALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRS 100
Query: 67 H----------------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 110
H L L I Q+ G+ Y +HRD+ N L+
Sbjct: 101 HGPDAKILAGGEDVAPGQLTLGQML--AIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158
Query: 111 GVVKLCDFGFARLINPGENYTDYVATRWYR 140
VVK+ DFG +R D +T +YR
Sbjct: 159 LVVKIGDFGMSR---------DIYSTDYYR 179
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR---- 137
Q+ +G+ Y +HRD+ N+L+ + VK+ DFG + I + Y
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 138 -WYRAPELLVGDTLYGPAVDVWAIEWTSH 165
WY APE L+ Y A DVW+ T +
Sbjct: 177 FWY-APECLIQSKFY-IASDVWSFGVTLY 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 35 NLVNLLEVFRRKKKLHLVFEFCDHTVLN--------ELENHPHGLPWDL--IKQITWQVL 84
++V LL V + + +V E H L E EN+P P L + Q+ ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD----YVATRWYR 140
G++Y + +HRD+ N ++ + VK+ DFG R I + Y + RW
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 188
Query: 141 APELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
APE L D ++ + D+W+ + W S ++ + GL N
Sbjct: 189 APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 17/31 (54%), Positives = 22/31 (70%)
Query: 91 HRHACIHRDIKPENILLTANGVVKLCDFGFA 121
H+ IHRDIKP+NIL+ G +KL DFG +
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 6e-06
Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91
+PN + L K L+ ++ L +L L +K+I Q++ ++ H
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 92 RHACIHRDIKPENILLT-ANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDT 149
+H IH DIK EN+L A + LCD+G ++I P Y T Y +PE + G
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPEKIKGH- 181
Query: 150 LYGPAVDVWAI 160
Y + D WA+
Sbjct: 182 NYDVSFDWWAV 192
|
Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 24/177 (13%)
Query: 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLH------LVFEFCDHTVL------NELENH 67
+EA KE HPN++ L+ V + + ++ F H L + L +
Sbjct: 49 SEAVCMKE---FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105
Query: 68 PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG 127
P LP ++ + + G+ Y + IHRD+ N +L N V + DFG ++ I G
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
Query: 128 ENYTD----YVATRWYRAPELLVGDTLYGPAVDVWAI---EWTSHSYSQIGFIGLGN 177
+ Y + +W L D +Y DVW+ W + Q + G+ N
Sbjct: 166 DYYRQGRIAKMPVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 17/33 (51%), Positives = 23/33 (69%)
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFG 119
+ H+ IHRDIKP+NIL+ +G +KL DFG
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 35/179 (19%)
Query: 4 NKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
NK ++ + KE K LK PN++ LL V + L ++ E+ ++ LN+
Sbjct: 59 NKNARNDFLKEV----------KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 64 LENHPH-------GLPWD------------LIKQITWQVLRGVSYCHRHACIHRDIKPEN 104
+ H G + + Q+ G+ Y +HRD+ N
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168
Query: 105 ILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
L+ N +K+ DFG +R + G+ Y + RW +L+G + A DVWA
Sbjct: 169 CLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWA 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 35/109 (32%), Positives = 44/109 (40%), Gaps = 12/109 (11%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPH-GLPW-----DLIKQITWQVL 84
H N+V L+ V + ++ E L EN P P DL+ V
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF-CARDVA 126
Query: 85 RGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLINPGENY 130
+G Y + IHRDI N LLT G V K+ DFG AR I Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 28/85 (32%), Positives = 42/85 (49%)
Query: 36 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95
+V L F+ K L+ V ++ + L P DL + ++ V H+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 96 IHRDIKPENILLTANGVVKLCDFGF 120
IHRDIKP+NIL+ +G +KL DFG
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 4/106 (3%)
Query: 29 RSLKHPNLVNLLEVFRRKKKL-HLVFEFCDHTVLNELENHPHGLPW--DLIKQITWQVLR 85
+ HPN+++LL + + +V + H L P DLI QV +
Sbjct: 51 KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAK 109
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT 131
G+ Y +HRD+ N +L + VK+ DFG AR I E Y+
Sbjct: 110 GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 28/185 (15%)
Query: 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-------- 64
K+ R+A TN L+H ++V V L +VFE+ H LN+
Sbjct: 52 KDFHREAELLTN------LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 65 -----ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 119
N P L + I Q+ G+ Y +HRD+ N L+ N +VK+ DFG
Sbjct: 106 VLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFG 165
Query: 120 FARLINPGENYT----DYVATRWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGF 172
+R + + Y + RW PE ++ + DVW+ + W +Y + +
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPW 223
Query: 173 IGLGN 177
L N
Sbjct: 224 YQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 49/191 (25%), Positives = 72/191 (37%), Gaps = 48/191 (25%)
Query: 6 KKKSSYYKEAIRQATEATNKKEKRSL-----------KHPNLVNLLEVFRRKKKLHLVFE 54
KK AI+ E ++ + R HPN++NLL + L++ E
Sbjct: 24 KKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83
Query: 55 FCDHTVLNE-------LENHP-----HGLPWDLIKQITWQVLR-------GVSYCHRHAC 95
+ + L + LE P HG L Q Q+L+ G+ Y
Sbjct: 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ---QLLQFASDVATGMQYLSEKQF 140
Query: 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA-------TRWYRAPELLVGD 148
IHRD+ N+L+ N K+ DFG +R GE YV RW L
Sbjct: 141 IHRDLAARNVLVGENLASKIADFGLSR----GEEV--YVKKTMGRLPVRWMAIESL--NY 192
Query: 149 TLYGPAVDVWA 159
++Y DVW+
Sbjct: 193 SVYTTKSDVWS 203
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 8/89 (8%)
Query: 36 LVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91
+V L F+ K L+ V ++ ++L +E P L I ++T + H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL----AIESVH 118
Query: 92 RHACIHRDIKPENILLTANGVVKLCDFGF 120
+ IHRDIKP+NIL+ +G +KL DFG
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 27/85 (31%), Positives = 42/85 (49%)
Query: 36 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95
+V + F+ K L+L+ EF + L L + + + + + H+
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 96 IHRDIKPENILLTANGVVKLCDFGF 120
IHRDIKP+N+LL + G VKL DFG
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---------ENHPHGLPWDLIKQI 79
R L H N+V LL + R + +++ E+ D L + + P L +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVAT 136
Q+ G+ + +HRD+ N L+++ VK+ ++ + E Y +
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 137 RWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
RW APE + D + DVW+ + W + ++ F GL +
Sbjct: 183 RWL-APEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|236582 PRK09599, PRK09599, 6-phosphogluconate dehydrogenase-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 44.7 bits (107), Expect = 3e-05
Identities = 14/27 (51%), Positives = 17/27 (62%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
Q+G IGLG MG +MAR LL+ V
Sbjct: 2 QLGMIGLGRMGGNMARRLLRGGHEVVG 28
|
Length = 301 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 31/188 (16%)
Query: 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE--------- 63
K+ R+A TN L+H ++V V L +VFE+ H LN+
Sbjct: 52 KDFQREAELLTN------LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 64 ---LENHPHGLPWDL----IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 116
++ P +L + I Q+ G+ Y +HRD+ N L+ AN +VK+
Sbjct: 106 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 165
Query: 117 DFGFARLINPGENYT----DYVATRWYRAPELLVGDTLYGPAVDVWA---IEWTSHSYSQ 169
DFG +R + + Y + RW PE ++ + DVW+ I W +Y +
Sbjct: 166 DFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGK 223
Query: 170 IGFIGLGN 177
+ L N
Sbjct: 224 QPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 23/183 (12%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEK-------RSLKHPNLVNLLEVFRRKKKLHLVFEFCD 57
+KK+ + ++ E + + E L +P +V ++ V + L LV E
Sbjct: 19 RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS 77
Query: 58 HTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 116
LN+ L + + ++ QV G+ Y +HRD+ N+LL K+
Sbjct: 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKIS 137
Query: 117 DFGFARLINPGENYTDYVAT-------RWYRAPELLVGDTLYGPAVDVWA---IEWTSHS 166
DFG ++ + ++Y Y A +WY APE + + DVW+ W + S
Sbjct: 138 DFGLSKALGADDSY--YKARSAGKWPLKWY-APECINFRK-FSSRSDVWSYGITMWEAFS 193
Query: 167 YSQ 169
Y Q
Sbjct: 194 YGQ 196
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIK--QITWQVLRGV 87
S P LV + + R K +L ++ E+EN+P P L K Q+ ++ G+
Sbjct: 79 SQGQPTLVIMELMTRGDLKSYL------RSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD----YVATRWYRAPE 143
+Y + + +HRD+ N ++ + VK+ DFG R I + Y + RW +PE
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPE 191
Query: 144 LLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
L D ++ DVW+ + W + ++ + G+ N
Sbjct: 192 SL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 29/151 (19%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENH---PHGLPWDLIKQITWQVL- 84
L PN+ LL V L ++ E+ ++ LN+ L+ H GL + K +++ L
Sbjct: 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN-SKSLSFSTLL 133
Query: 85 -------RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-DY--- 133
G+ Y +HRD+ N L+ N +K+ DFG +R Y+ DY
Sbjct: 134 YMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYSSDYYRV 188
Query: 134 -----VATRWYRAPELLVGDTLYGPAVDVWA 159
+ RW +L+G + DVWA
Sbjct: 189 QGRAPLPIRWMAWESVLLGK--FTTKSDVWA 217
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 33/151 (21%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-------LENHP-----HGLPWDLIKQIT 80
HPN++NLL + L+L E+ H L + LE P + L Q
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ-- 112
Query: 81 WQVLR-------GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--- 130
Q+L G+ Y + IHRD+ NIL+ N V K+ DFG +R G+
Sbjct: 113 -QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 167
Query: 131 --TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ RW L ++Y DVW+
Sbjct: 168 KTMGRLPVRWMAIESL--NYSVYTTNSDVWS 196
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 3/72 (4%)
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLINPGENYT-- 131
+I+ I Q+L + H +HRD+KP+NI+ + +G K+ D G A + G NY
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 132 DYVATRWYRAPE 143
+++ Y APE
Sbjct: 316 EFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|183197 PRK11559, garR, tartronate semialdehyde reductase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 14/27 (51%), Positives = 19/27 (70%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
++GFIGLG MG M++NLLK + V
Sbjct: 4 KVGFIGLGIMGKPMSKNLLKAGYSLVV 30
|
Length = 296 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 62 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 121
E+ LIK I +L + Y H H H DIKPENI++ N + D+G A
Sbjct: 114 KEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 22/77 (28%), Positives = 31/77 (40%), Gaps = 13/77 (16%)
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRA 141
Q L + HR A K NILLT +G++KL G E + A
Sbjct: 25 QCLGALRELHRQA------KSGNILLTWDGLLKL--DGSV-AFKTPEQ--SRPDPYF-MA 72
Query: 142 PELLVGDTLYGPAVDVW 158
PE++ G Y D++
Sbjct: 73 PEVIQG-QSYTEKADIY 88
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|130753 TIGR01692, HIBADH, 3-hydroxyisobutyrate dehydrogenase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 16/24 (66%), Positives = 16/24 (66%)
Query: 172 FIGLGNMGSHMARNLLKNNGRVTV 195
FIGLGNMG MA NLLK V V
Sbjct: 1 FIGLGNMGGPMAANLLKAGHPVRV 24
|
3-hydroxyisobutyrate dehydrogenase is an enzyme that catalyzes the NAD+-dependent oxidation of 3-hydroxyisobutyrate to methylmalonate semialdehyde of the valine catabolism pathway. In Pseudomonas aeruginosa, 3-hydroxyisobutyrate dehydrogenase (mmsB) is co-induced with methylmalonate-semialdehyde dehydrogenase (mmsA) when grown on medium containing valine as the sole carbon source. The positive transcriptional regulator of this operon (mmsR) is located upstream of these genes and has been identified as a member of the XylS/AraC family of transcriptional regulators. 3-hydroxyisobutyrate dehydrogenase shares high sequence homology to the characterized 3-hydroxyisobutyrate dehydrogenase from rat liver with conservation of proposed NAD+ binding residues at the N-terminus (G-8,10,13,24 and D-31). This enzyme belongs to the 3-hydroxyacid dehydrogenase family, sharing a common evolutionary origin and enzymatic mechanism with 6-phosphogluconate. HIBADH exhibits sequence similarity to the NAD binding domain of 6-phosphogluconate dehydrogenase above trusted (pfam03446) [Energy metabolism, Amino acids and amines]. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 22/59 (37%), Positives = 35/59 (59%), Gaps = 4/59 (6%)
Query: 79 ITW--QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA 135
+ W Q+ +G+SY +HRD+ N+L+ + VK+ DFG ARL++ E T+Y A
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE--TEYHA 168
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 16/40 (40%), Positives = 22/40 (55%)
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN 125
+ Y H +HRD+KP+NILL G V + D+G A
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
|
Length = 932 |
| >gnl|CDD|185358 PRK15461, PRK15461, NADH-dependent gamma-hydroxybutyrate dehydrogenase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 16/28 (57%), Positives = 19/28 (67%)
Query: 168 SQIGFIGLGNMGSHMARNLLKNNGRVTV 195
+ I FIGLG MGS MA NLLK ++ V
Sbjct: 2 AAIAFIGLGQMGSPMASNLLKQGHQLQV 29
|
Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 36/137 (26%)
Query: 15 AIRQATEATNKKEKR----------SLKHPNLVNLLEVFRRKKKLHLVFEFC-DHTVLNE 63
AI++ EAT+ K + S+ +P++ LL + C TV
Sbjct: 40 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI-------------CLTSTVQLI 86
Query: 64 LENHPHGLPWDLIKQ----------ITW--QVLRGVSYCHRHACIHRDIKPENILLTANG 111
+ P G D +++ + W Q+ +G++Y +HRD+ N+L+
Sbjct: 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ 146
Query: 112 VVKLCDFGFARLINPGE 128
VK+ DFG A+L+ E
Sbjct: 147 HVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 28/113 (24%)
Query: 66 NHPHGLPWDLIKQITWQVLRGVSYCHRHA-CIHRDIKPENILLTANGV------------ 112
+H H + QI +Q + Y H +H D+KPENIL+ +
Sbjct: 229 SHRH------LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282
Query: 113 ----VKLCDFGFARLINPGENYTDYVATRWYRAPELLVG-DTLYGPAVDVWAI 160
V++CD G + + T V+TR YR+PE+++G +Y + D+W++
Sbjct: 283 DPCRVRICDLGGC--CDERHSRTAIVSTRHYRSPEVVLGLGWMY--STDMWSM 331
|
Length = 467 |
| >gnl|CDD|202773 pfam03807, F420_oxidored, NADP oxidoreductase coenzyme F420-dependent | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 12/27 (44%), Positives = 14/27 (51%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTVI 196
IG IG GNMG +AR L V +
Sbjct: 2 IGIIGAGNMGEALARGLAAAGHEVVIA 28
|
Length = 93 |
| >gnl|CDD|215463 PLN02858, PLN02858, fructose-bisphosphate aldolase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 19/43 (44%), Positives = 23/43 (53%)
Query: 148 DTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNN 190
LY P I + +IGFIGLG MG MA +LLK+N
Sbjct: 305 RELYKPEDLAKQITMQAKPVKRIGFIGLGAMGFGMASHLLKSN 347
|
Length = 1378 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 21/93 (22%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 27 EKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
+ L+HPN+V L+ + R +K +L+ E+ + L+E+ L W+ ++I + +
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKA 792
Query: 87 VSYCHRH---ACIHRDIKPENILLTANGVVKLC 116
+ + H A + ++ PE I++ L
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 25/112 (22%), Positives = 50/112 (44%), Gaps = 4/112 (3%)
Query: 34 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92
PN+V L + + + LV + + + + + + +P + +K+ +++ + HR
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKRWAAEMVVALDALHR 103
Query: 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPEL 144
+ RD+ P NILL G ++L F R ++ Y APE+
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEV 153
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0608|consensus | 1034 | 99.98 | ||
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG4236|consensus | 888 | 99.98 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| KOG0577|consensus | 948 | 99.97 | ||
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0603|consensus | 612 | 99.97 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4645|consensus | 1509 | 99.97 | ||
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0596|consensus | 677 | 99.97 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| KOG4250|consensus | 732 | 99.97 | ||
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0983|consensus | 391 | 99.97 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0670|consensus | 752 | 99.97 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0200|consensus | 609 | 99.97 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG1025|consensus | 1177 | 99.97 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG0696|consensus | 683 | 99.97 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1151|consensus | 775 | 99.97 | ||
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG1027|consensus | 903 | 99.97 | ||
| KOG2345|consensus | 302 | 99.97 | ||
| KOG0574|consensus | 502 | 99.96 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| KOG1989|consensus | 738 | 99.96 | ||
| KOG0695|consensus | 593 | 99.96 | ||
| KOG0984|consensus | 282 | 99.96 | ||
| KOG0587|consensus | 953 | 99.95 | ||
| KOG1035|consensus | 1351 | 99.95 | ||
| KOG1167|consensus | 418 | 99.95 | ||
| KOG1006|consensus | 361 | 99.95 | ||
| KOG1024|consensus | 563 | 99.95 | ||
| KOG1152|consensus | 772 | 99.94 | ||
| KOG1290|consensus | 590 | 99.94 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG2052|consensus | 513 | 99.93 | ||
| KOG3653|consensus | 534 | 99.93 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0576|consensus | 829 | 99.91 | ||
| KOG1345|consensus | 378 | 99.87 | ||
| KOG0590|consensus | 601 | 99.83 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0603|consensus | 612 | 99.79 | ||
| KOG1023|consensus | 484 | 99.79 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0195|consensus | 448 | 99.75 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG1164|consensus | 322 | 99.74 | ||
| KOG1165|consensus | 449 | 99.71 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.7 | |
| KOG4158|consensus | 598 | 99.69 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.67 | |
| KOG1163|consensus | 341 | 99.67 | ||
| KOG0606|consensus | 1205 | 99.64 | ||
| KOG1240|consensus | 1431 | 99.64 | ||
| KOG1033|consensus | 516 | 99.61 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.55 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.55 | |
| KOG1166|consensus | 974 | 99.55 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0590|consensus | 601 | 99.47 | ||
| KOG1243|consensus | 690 | 99.43 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.3 | |
| KOG1266|consensus | 458 | 99.28 | ||
| KOG3087|consensus | 229 | 99.2 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.16 | |
| KOG0606|consensus | 1205 | 99.15 | ||
| KOG0601|consensus | 524 | 99.14 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.93 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.92 | |
| KOG2137|consensus | 700 | 98.9 | ||
| KOG0601|consensus | 524 | 98.74 | ||
| KOG3741|consensus | 655 | 98.7 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.6 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| KOG1035|consensus | 1351 | 97.86 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.84 | |
| KOG0576|consensus | 829 | 97.82 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.66 | |
| KOG1235|consensus | 538 | 97.56 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.21 | |
| KOG1826|consensus | 2724 | 96.92 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.36 | |
| KOG2268|consensus | 465 | 96.16 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 94.91 | |
| KOG2270|consensus | 520 | 94.85 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.53 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.3 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.17 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.5 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.36 | |
| KOG1093|consensus | 725 | 92.83 | ||
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.12 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.47 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.47 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.35 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.13 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 91.06 | |
| KOG2269|consensus | 531 | 90.3 | ||
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 90.1 | |
| PLN02236 | 344 | choline kinase | 90.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.99 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 89.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 88.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 88.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 87.15 | |
| KOG4720|consensus | 391 | 86.99 | ||
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 86.48 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=331.12 Aligned_cols=219 Identities=23% Similarity=0.298 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
....+|++++++|+|||||+++++|......|+|+||++||+|.+.+..++.+.+..-..+++|++.|+.|||++||+||
T Consensus 221 ~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HR 300 (475)
T KOG0615|consen 221 RDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHR 300 (475)
T ss_pred hhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccc
Confidence 33579999999999999999999999999999999999999999999888899999999999999999999999999999
Q ss_pred ccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCc--cCCCccchhhHHHHHHHhhccCcc
Q psy763 99 DIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDT--LYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 99 dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
||||+|||+..+ ..+||+|||+|++.+......+.|||+.|.|||++.+.+ .+..++|+||+||++|-+++|.+|
T Consensus 301 DiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 301 DIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 999999999877 789999999999998888889999999999999998543 245588999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
|.+......+.+.+..|.-...++ .|. +.+.++++++++||+-+|
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~------------~w~-----------------------~Iseea~dlI~~mL~VdP 425 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPL------------QWD-----------------------RISEEALDLINWMLVVDP 425 (475)
T ss_pred cccccCCccHHHHHhcCcccccCh------------hhh-----------------------hhhHHHHHHHHHhhEeCc
Confidence 998877663333333222211000 021 245688999999999666
Q ss_pred ceeeccccccccccccceeeeeecCC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.-| +++.+||.||||.+.+
T Consensus 426 ~~R-------~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 426 ENR-------PSADEALNHPWFKDAP 444 (475)
T ss_pred ccC-------cCHHHHhcChhhhccc
Confidence 555 9999999999999876
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=315.05 Aligned_cols=233 Identities=24% Similarity=0.283 Sum_probs=201.5
Q ss_pred CccccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHH
Q psy763 1 LRFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 80 (303)
Q Consensus 1 ~~~~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~ 80 (303)
+|+++|++....+ ..+....|..++..++||.||++...|++.+++|+|+||+.||.|...+++.+.+++..++-++
T Consensus 55 mKvl~K~~iv~~~---e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYl 131 (357)
T KOG0598|consen 55 MKVLKKKKIVEKK---EVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYL 131 (357)
T ss_pred hhhhhhhHhhhhh---hHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHH
Confidence 3677777766654 5667778999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeee-CCCCccccccCCCcccCcccccCCccCCCccchhh
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwS 159 (303)
.+|+.||.|||+.||+||||||+|||+|.+|+++|+|||+|... ..+....+.+||+.|+|||++.+.+ |+.++|.||
T Consensus 132 aEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWs 210 (357)
T KOG0598|consen 132 AEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWS 210 (357)
T ss_pred HHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHh
Confidence 99999999999999999999999999999999999999999854 4455667789999999999999886 999999999
Q ss_pred HHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCch
Q psy763 160 IEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSH 239 (303)
Q Consensus 160 lG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 239 (303)
+|+++|||++|.+||++.+..+....+.+...+. ....-++
T Consensus 211 LGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---------------------------------------~p~~ls~ 251 (357)
T KOG0598|consen 211 LGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---------------------------------------PPGYLSE 251 (357)
T ss_pred HHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---------------------------------------CCccCCH
Confidence 9999999999999999999988888776654111 1111456
Q ss_pred hhHHhhhhhhccccceeeccccccccccccceeeeeecCC
Q psy763 240 GVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 240 ~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
++.|++.++|...+..|-. ....+.+...||||.+.+
T Consensus 252 ~ardll~~LL~rdp~~RLg---~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 252 EARDLLKKLLKRDPRQRLG---GPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHHHHHhccCHHHhcC---CCCChHHhhcCcccccCC
Confidence 7889999999987777744 456777888999998754
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=316.29 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=210.1
Q ss_pred cccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHH
Q psy763 3 FNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRR-----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIK 77 (303)
Q Consensus 3 ~~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~ 77 (303)
+..||-............-.+|+++++.++|+||+.+++++.. -+.+|+|+|+|+ .+|..+++.+..++...+.
T Consensus 50 VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q 128 (359)
T KOG0660|consen 50 VAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQ 128 (359)
T ss_pred eehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHH
Confidence 3445555566667777788899999999999999999999976 357899999995 8999999988889999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCC---CCccccccCCCcccCcccccCCccCCCc
Q psy763 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP---GENYTDYVATRWYRAPELLVGDTLYGPA 154 (303)
Q Consensus 78 ~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~ 154 (303)
.+++|+++||+|+|+.|++||||||+|++++.++.+||+|||+|+...+ ....+..+.|.||+|||++.....|+.+
T Consensus 129 ~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~a 208 (359)
T KOG0660|consen 129 YFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKA 208 (359)
T ss_pred HHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccch
Confidence 9999999999999999999999999999999999999999999999864 3444677899999999999988789999
Q ss_pred cchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCC
Q psy763 155 VDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNT 234 (303)
Q Consensus 155 ~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 234 (303)
.||||+||||.||++|++.|.|....+++..++..-|.++.... ....++.... +-.-+.....+++.+. .
T Consensus 209 iDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l-~~i~s~~ar~-yi~slp~~p~~~f~~~-------f 279 (359)
T KOG0660|consen 209 IDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL-QKIRSEKARP-YIKSLPQIPKQPFSSI-------F 279 (359)
T ss_pred hhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH-HHhccHHHHH-HHHhCCCCCCCCHHHH-------c
Confidence 99999999999999999999999999999999998777642211 1111111111 1111122223334333 1
Q ss_pred CCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 235 DRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 235 ~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+...+.|+|+|.+||+++|..| +++++||.|||+.-
T Consensus 280 p~a~p~AidLlekmL~fdP~kR-------ita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 280 PNANPLAIDLLEKMLVFDPKKR-------ITAEEALAHPYLAP 315 (359)
T ss_pred CCCCHHHHHHHHHHhccCcccc-------CCHHHHhcChhhhh
Confidence 3467899999999999988888 99999999999864
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=311.68 Aligned_cols=240 Identities=43% Similarity=0.701 Sum_probs=200.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
......+|++++++++|+|+|.++++|.....+++|||||+..-|+.+.....+++...+.++++|++.|+.|||+++++
T Consensus 44 VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~I 123 (396)
T KOG0593|consen 44 VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCI 123 (396)
T ss_pred HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCee
Confidence 44556789999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+|||++.+|.+||||||+|+.+. +++.++..+.|+||+|||.+.|+..|+.++||||+||++.||++|.+.+-
T Consensus 124 HRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 124 HRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred cccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 99999999999999999999999999988 77788889999999999999998889999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeec----CCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 176 GNMGSHMARNLLKNNGRVTVILK----SDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
|.+..+++..+....|.+..... ....... ... -.-....|+.+ ..+...+-++|++.++|..
T Consensus 204 G~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G---v~l---P~~~~~epLe~-------k~p~~s~~~ld~~k~cL~~ 270 (396)
T KOG0593|consen 204 GRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG---VRL---PEPEHPEPLER-------KYPKISNVLLDLLKKCLKM 270 (396)
T ss_pred CcchHHHHHHHHHHHcccCHHHHHHhccCCceee---eec---CCCCCccchhh-------hcccchHHHHHHHHHHhcC
Confidence 99999999999888776532111 0000000 000 00011112211 1123455789999999998
Q ss_pred ccceeeccccccccccccceeeeee
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
+|..+ .+-.+|+.|+||.
T Consensus 271 dP~~R-------~sc~qll~H~yFd 288 (396)
T KOG0593|consen 271 DPDDR-------LSCEQLLHHPYFD 288 (396)
T ss_pred Ccccc-------ccHHHHhcChHHH
Confidence 87777 9999999999993
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=322.16 Aligned_cols=248 Identities=31% Similarity=0.422 Sum_probs=202.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.....+|+.+|++|+||||+++.++..+. ..+|+|||||++ +|.-++.. +-.|++.++..++.||+.||.|||++|
T Consensus 160 ~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 160 PITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred hHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 44568899999999999999999999877 689999999995 55555544 458999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|+|||||.+|||+|.+|.+||+|||+|+++.... ..+..+.|.||+|||+|+|...|+.++|+||.||||.||+.|.+
T Consensus 239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 9999999999999999999999999999876543 46778899999999999999999999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcC-CChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSK-TSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.+.|.+..+++..|++.-|.+....++- .++-|...+.. ...+..+.. -...-++.+++|+++||..
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~------~kLP~~~~~kp~~~y~r~l~E------~~~~~~~~~l~Ll~~lL~l 386 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPV------SKLPHATIFKPQQPYKRRLRE------TFKDFPASALDLLEKLLSL 386 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhcccc------ccCCcccccCCCCcccchHHH------HhccCCHHHHHHHHHHhcc
Confidence 9999999999999999877765333221 11112222221 111111111 1344678899999999998
Q ss_pred ccceeeccccccccccccceeeeeecCCcceEEE
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPERKCLEV 285 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 285 (303)
+|..+ .+|.++|.+.||.+.+.+|-..
T Consensus 387 dP~kR-------~tA~~aL~seyF~t~p~~~~p~ 413 (560)
T KOG0600|consen 387 DPDKR-------GTASSALQSEYFTTEPLPCDPS 413 (560)
T ss_pred Ccccc-------ccHHHHhcCcccccCCCCCCcc
Confidence 77777 9999999999998887777543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=322.66 Aligned_cols=217 Identities=23% Similarity=0.269 Sum_probs=194.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 11 YYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 11 ~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
.+.+...++...+|+++.+.|+|||||+++++|++.+.+|+|.|+|..++|..++++.++++|.+++.+++||+.||.||
T Consensus 55 ~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYL 134 (592)
T KOG0575|consen 55 LLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYL 134 (592)
T ss_pred HhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHH
Confidence 33444567778889999999999999999999999999999999999999999999889999999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|+++|+|||||..|+|++++.+|||+|||+|..+.. ++...+.+|||.|.|||++...+ .+..+||||+||+||.|+.
T Consensus 135 H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~ 213 (592)
T KOG0575|consen 135 HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLV 213 (592)
T ss_pred HhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhh
Confidence 999999999999999999999999999999999874 46778899999999999999766 8999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|.+||-.....+....+....+..| ...+.+|.||+.++|
T Consensus 214 G~PPFetk~vkety~~Ik~~~Y~~P----------------------------------------~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 214 GRPPFETKTVKETYNKIKLNEYSMP----------------------------------------SHLSAEAKDLIRKLL 253 (592)
T ss_pred CCCCcccchHHHHHHHHHhcCcccc----------------------------------------cccCHHHHHHHHHHh
Confidence 9999988877777766655544432 024567889999999
Q ss_pred ccccceeeccccccccccccceeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
..+|..| +++.+++.|+||
T Consensus 254 ~~~P~~R-------psl~~vL~h~Ff 272 (592)
T KOG0575|consen 254 RPNPSER-------PSLDEVLDHPFF 272 (592)
T ss_pred cCCcccC-------CCHHHHhcCHhh
Confidence 9888777 999999999999
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=295.61 Aligned_cols=244 Identities=30% Similarity=0.423 Sum_probs=202.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.....+|++.++.++|+||+.+.++|...+.+.+|+||++ .+|..+++.. ..++..++..++.++++|++|||+++|+
T Consensus 45 ~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~Il 123 (318)
T KOG0659|consen 45 NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWIL 123 (318)
T ss_pred cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 4456789999999999999999999999999999999998 7777776654 4799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||.|+|++++|.+||+|||+|+...+... ....+.|.||+|||.+.|...|+..+||||.|||+.||+-+.+.+.
T Consensus 124 HRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp 203 (318)
T KOG0659|consen 124 HRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP 203 (318)
T ss_pred cccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC
Confidence 999999999999999999999999999875443 3335889999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCC-CcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSL-DSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
|.+..+++..++..-|++.....|+.. .++..+.. ....++.. ........+++|++.+|++.+|.
T Consensus 204 G~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~---~~P~~~~~----------~lf~aas~d~ldLl~~m~~ynP~ 270 (318)
T KOG0659|consen 204 GDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ---QFPKPPLN----------NLFPAASSDALDLLSKMLTYNPK 270 (318)
T ss_pred CCchHHHHHHHHHHcCCCCcccCccccccccHHHHh---cCCCCccc----------cccccccHHHHHHHHhhhccCch
Confidence 999999999999999988755544321 11111110 11111111 12345678899999999997777
Q ss_pred eeeccccccccccccceeeeeecCCcce
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
.| +++.+|++|+||..-+..+
T Consensus 271 ~R-------ita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 271 KR-------ITASQALKHPYFKSLPLPT 291 (318)
T ss_pred hc-------ccHHHHhcchhhhcCCCCC
Confidence 77 9999999999998744443
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=305.93 Aligned_cols=221 Identities=23% Similarity=0.323 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 14 EAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKK-KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
+...+....+|+++++..+||+||.+||.|...+ .++++||||++|+|+.++...+.+++.....++.++++||.|||+
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~ 196 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE 196 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3446677889999999999999999999999998 599999999999999999888899999999999999999999996
Q ss_pred -CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 -HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 -~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
.+|+||||||+|+|++..|.|||||||.+..+... .-.+++||..|||||.+.++. |+.++||||||++++|+.+|.
T Consensus 197 ~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~Gr 274 (364)
T KOG0581|consen 197 ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGR 274 (364)
T ss_pred ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCC
Confidence 99999999999999999999999999999887654 457789999999999999887 999999999999999999999
Q ss_pred ccCCCC-----chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 172 FIGLGN-----MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 172 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
+|+... ...+.+. ++...+.+ ..+...-++++.+|++
T Consensus 275 fP~~~~~~~~~~~~~Ll~----------------------------~Iv~~ppP----------~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 275 FPYPPPNPPYLDIFELLC----------------------------AIVDEPPP----------RLPEGEFSPEFRSFVS 316 (364)
T ss_pred CCCCCcCCCCCCHHHHHH----------------------------HHhcCCCC----------CCCcccCCHHHHHHHH
Confidence 887654 1111111 11111110 0011134677899999
Q ss_pred hhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.||..++..| .++++++.|||+..-+.+
T Consensus 317 ~CL~Kdp~~R-------~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 317 CCLRKDPSER-------PSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHhcCCcccC-------CCHHHHhcCHHHhhcccc
Confidence 9999888777 999999999999764443
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=297.84 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=203.5
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
-.+|+.++.+++|||||.+-.+.... +.+|+|||||+ .+|..++.. ..+++..++..++.|++.|++|||+++|+|
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilH 200 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILH 200 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEe
Confidence 46789999999999999999998855 47999999999 566665543 458999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+|+|++..|.+||+|||+|+.++.. ...+..+.|.||+|||.+.|.+.|+.+.|+||+|||+.|++++.+.|.|
T Consensus 201 RDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 201 RDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred cccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999999998744 4556778999999999999999899999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCC-CchhhHHhhhhhhccccce
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDR-NSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~dll~~~l~~~~~~ 255 (303)
....+++..++...+.+.....++-.....+.. --+......++.+. ..-. .+....|+++.+|..+|..
T Consensus 281 ~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~---~~f~~~pyn~lr~k------F~~~~lse~g~~Lln~llt~dP~k 351 (419)
T KOG0663|consen 281 KSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK---MTFSEHPYNNLRKK------FGALSLSEQGFDLLNKLLTYDPGK 351 (419)
T ss_pred CchHHHHHHHHHHhCCCccccCCCccccchhhc---cccCCCCchhhhhh------ccccccchhHHHHHHHHhccCccc
Confidence 999999999999999988777765433332220 01111111222111 1111 4477899999999977766
Q ss_pred eeccccccccccccceeeeeecCCcceEE
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPERKCLE 284 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 284 (303)
+ ++|.++|+|.||.+.+..|+-
T Consensus 352 R-------~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 352 R-------ITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred c-------ccHHHhhcccccccCCCCCCh
Confidence 6 999999999999999888864
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=299.34 Aligned_cols=256 Identities=28% Similarity=0.420 Sum_probs=212.0
Q ss_pred HHHHHHHHHHHHhCCCCC-cceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCC----CCCHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPN-LVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPH----GLPWDLIKQITWQVLRG 86 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~----~l~~~~~~~~~~qi~~~ 86 (303)
.....+|+.+++.++|+| |+++++++.+.+ .+++||||++ .+|..++.... .++...++.+++||+.|
T Consensus 54 P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~g 132 (323)
T KOG0594|consen 54 PSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRG 132 (323)
T ss_pred CchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHH
Confidence 344678999999999999 999999999887 8999999998 67777765543 68889999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|+|||++||+||||||+|++++++|.+||+|||+|+... +.......++|.+|+|||++.|...|+...||||+|||++
T Consensus 133 l~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfa 212 (323)
T KOG0594|consen 133 LAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFA 212 (323)
T ss_pred HHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHH
Confidence 999999999999999999999999999999999999876 5556778899999999999999977999999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
||+++.+.|.|.+..+++..++...+.+.....|.......++..|..| ...+++... . +...+.+.|++
T Consensus 213 Em~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~---~~~~~l~~~----~---~~~~~~~~dll 282 (323)
T KOG0594|consen 213 EMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKW---PGPKDLSSI----L---PKLDPDGIELL 282 (323)
T ss_pred HHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCC---CCccchHHh----c---cccCccHHHHH
Confidence 9999999999999999999999999988766555443333333222222 223444333 1 11237899999
Q ss_pred hhhhccccceeeccccccccccccceeeeeecCCcceEEEEEecce
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKCLEVIFMDSM 291 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 291 (303)
.+||..++..+ ++++.++.|+||...+.+.+.+.-+.+.
T Consensus 283 ~~~L~y~p~~R-------~Sa~~al~h~yf~~~~~~~~~~~~~~~~ 321 (323)
T KOG0594|consen 283 SKLLQYDPAKR-------ISAKGALTHPYFSELPEKSSQLLLQASF 321 (323)
T ss_pred HHHhccCcccC-------cCHHHHhcChhhcccccchhhhhccccc
Confidence 99999666555 9999999999999999888877665543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=311.82 Aligned_cols=245 Identities=25% Similarity=0.441 Sum_probs=200.5
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC-EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKK-KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.+..-.+|+..+++++ |||||++++++.+.. .+|+|||||+....+-+..++..+++..++.|++||++||+|+|.+|
T Consensus 51 ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G 130 (538)
T KOG0661|consen 51 EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG 130 (538)
T ss_pred HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 3445567899999999 999999999999887 99999999996555555556678999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+.|||+||+|||+..+..+||+|||+|+.......++..+.|+||+|||+++..+.|+.+.||||+|||++|+.+..+.|
T Consensus 131 fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 131 FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred cccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 99999999999999999999999999999988888999999999999999998888999999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCC-CCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDS-LDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
-|.+..+++.++++-.|.+.....+.. .....+...| ......++..+ .+...+++++++.+|+.=
T Consensus 211 PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~----P~~~~~~l~~L-------~p~~s~~~~~li~~ll~W-- 277 (538)
T KOG0661|consen 211 PGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF----PQVKPSPLKDL-------LPNASSEAASLIERLLAW-- 277 (538)
T ss_pred CCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC----CcCCCCChHHh-------CcccCHHHHHHHHHHhcC--
Confidence 999999999999998887753333221 0111111111 11222223222 122678899999999884
Q ss_pred ceeeccccccccccccceeeeeecCC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
++..|++|.+|++||||....
T Consensus 278 -----DP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 278 -----DPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred -----CCccCccHHHHhcCccccccc
Confidence 455559999999999997643
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=297.62 Aligned_cols=175 Identities=27% Similarity=0.433 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..++.+..|+.+++.++|||||++++++.+++.+|+|||||+||+|..++.+.+.+++.+++.++.||+.||++||+++|
T Consensus 51 k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~I 130 (429)
T KOG0595|consen 51 KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNI 130 (429)
T ss_pred HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecccCCCcEEEecC------CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTAN------GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
+||||||+|||++.+ -.+||+|||+|+.+.++.-..+.+|++.|||||++..+. |+.++|+||+|+|+|+|++
T Consensus 131 iHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~ 209 (429)
T KOG0595|consen 131 IHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLT 209 (429)
T ss_pred eeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHh
Confidence 999999999999875 468999999999999888788899999999999998665 9999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCC
Q psy763 170 IGFIGLGNMGSHMARNLLKNNG 191 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~ 191 (303)
|..||...+..+....+-+...
T Consensus 210 g~~Pf~a~t~~eL~~~~~k~~~ 231 (429)
T KOG0595|consen 210 GKPPFDAETPKELLLYIKKGNE 231 (429)
T ss_pred CCCCccccCHHHHHHHHhcccc
Confidence 9999998888887764444333
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=308.14 Aligned_cols=223 Identities=22% Similarity=0.328 Sum_probs=192.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHH
Q psy763 10 SYYKEAIRQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 10 ~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
.++-+..+......|...|..| .||.|++++..|+++..+|+|+||+++|+|.+++.+-+.|++..++.++.||+.||.
T Consensus 109 ~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAle 188 (604)
T KOG0592|consen 109 RYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALE 188 (604)
T ss_pred HHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHH
Confidence 3444444556677788888888 899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc--------------ccccCCCcccCcccccCCccCCCc
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--------------TDYVATRWYRAPELLVGDTLYGPA 154 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~y~aPE~l~~~~~~~~~ 154 (303)
|||++||+||||||+|||+|++++++|+|||.|..+.+.... .+++||..|.+||+|.... .+++
T Consensus 189 ylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~ 267 (604)
T KOG0592|consen 189 YLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPS 267 (604)
T ss_pred HHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcc
Confidence 999999999999999999999999999999999887643211 4579999999999998765 7999
Q ss_pred cchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCC
Q psy763 155 VDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNT 234 (303)
Q Consensus 155 ~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 234 (303)
+|+|+||||+|.|+.|.+||.+.+..-..++++......+
T Consensus 268 sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp---------------------------------------- 307 (604)
T KOG0592|consen 268 SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP---------------------------------------- 307 (604)
T ss_pred cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC----------------------------------------
Confidence 9999999999999999999999999888887776544322
Q ss_pred CCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 235 DRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 235 ~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+-.++.+.||++|+|+..+..| ++..++.+||||...+-
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~R-------lt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDR-------LTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CCCCHHHHHHHHHHHccCcccc-------ccHHHHhhCcccccCCh
Confidence 2234678899999999666655 99999999999987553
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=284.37 Aligned_cols=187 Identities=24% Similarity=0.326 Sum_probs=170.4
Q ss_pred ccccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHH
Q psy763 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW 81 (303)
Q Consensus 2 ~~~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~ 81 (303)
|+++|.+...++ ..+....|.++++.+.||+++++.+.|.+.+.+|+||||++||.+.+++++.+++++..++-++.
T Consensus 75 KvL~k~~vVklK---QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAA 151 (355)
T KOG0616|consen 75 KVLDKQKVVKLK---QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAA 151 (355)
T ss_pred hhcCHHHHHHHH---HHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHH
Confidence 555565555555 55667788999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHH
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIE 161 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG 161 (303)
||+.||.|||+.+|++|||||+|||+|++|.+||+|||+|...... .-+.||||.|+|||++.+.+ |..++|.||||
T Consensus 152 eivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalG 228 (355)
T KOG0616|consen 152 EIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALG 228 (355)
T ss_pred HHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHH
Confidence 9999999999999999999999999999999999999999987643 56789999999999999776 89999999999
Q ss_pred HHHHHhhccCccCCCCchHHHHHHHhhcCCcee
Q psy763 162 WTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVT 194 (303)
Q Consensus 162 ~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 194 (303)
+++|||+.|.+||++.+..++..++++...+.|
T Consensus 229 VLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP 261 (355)
T KOG0616|consen 229 VLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP 261 (355)
T ss_pred HHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC
Confidence 999999999999999999999998888766644
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.31 Aligned_cols=210 Identities=22% Similarity=0.302 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
...+.|.+|++++++|+|+|||+++|+|..++++|||||||+.|+|.++++. +..+...+.+.++.||+.|++||+++
T Consensus 243 m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~ 322 (468)
T KOG0197|consen 243 MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK 322 (468)
T ss_pred cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC
Confidence 4557788999999999999999999999999999999999999999999986 45799999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++|||||.++||||+.++.+||+|||+|+....+... ....-+..|.|||.+.... ++.++||||||++|||++|.+
T Consensus 323 ~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 323 NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccC
Confidence 9999999999999999999999999999954433221 2233466799999998655 999999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLI 229 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (303)
..+++......+.+.++.|.|++ .|+.++.++.+++..||-.+|..||.|..+..
T Consensus 402 ~~py~~msn~ev~~~le~GyRlp---~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 402 RVPYPGMSNEEVLELLERGYRLP---RPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CCCCCCCCHHHHHHHHhccCcCC---CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 99999999999999999999976 67788999999999999999999999987543
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=299.82 Aligned_cols=208 Identities=22% Similarity=0.290 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK-KLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+.++++++|||||+++|+|.+.. ..++||||+++|+|..++.. ...++...+..++.||++|+.|||+++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 778999999999999999999999999887 79999999999999999876 578999999999999999999999999
Q ss_pred -ceecccCCCcEEEecCC-cEEEccccceeeeCCC-CccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhhcc
Q psy763 95 -CIHRDIKPENILLTANG-VVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 -ivH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~tg 170 (303)
|+||||||+|+|++.++ ++||+|||+++..... ...+...||..|||||++.+. ..|+.++||||||+++|||+||
T Consensus 163 ~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~ 242 (362)
T KOG0192|consen 163 PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTG 242 (362)
T ss_pred CeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHC
Confidence 99999999999999997 9999999999887654 344457899999999999953 4499999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHh
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLL 228 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 228 (303)
..||.+....+.+..+...+.|+..+ ..+++....++-.||..++..||.+..+.
T Consensus 243 ~~Pf~~~~~~~~~~~v~~~~~Rp~~p---~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 243 EIPFEDLAPVQVASAVVVGGLRPPIP---KECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 99999999988888888888886533 33677777777788899888888776643
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=294.74 Aligned_cols=238 Identities=27% Similarity=0.429 Sum_probs=191.4
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
-.+|+.+++.++|||||++..+|.... ...+||||++ .+|..+++ .+..++...++.+.+||++||+|||
T Consensus 64 knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh 142 (364)
T KOG0658|consen 64 KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH 142 (364)
T ss_pred CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH
Confidence 357899999999999999999886432 3468999998 55666555 3568889999999999999999999
Q ss_pred HCCceecccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 92 RHACIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
+.||+||||||+|+|+|.+ |.+||||||.|+.+.++....+...|+.|+|||.+.|...|+.+.||||.|||+.||+.|
T Consensus 143 ~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g 222 (364)
T KOG0658|consen 143 SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKG 222 (364)
T ss_pred hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcC
Confidence 9999999999999999976 999999999999999888888899999999999999999999999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
++.|.|.+..+++..+++.-|.+.........+.- ....+..+ ..-+|.+ -......++++||+.++|.
T Consensus 223 ~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y-~~~~~p~i----k~~~~~~------~~~~~~~~d~~dll~~~L~ 291 (364)
T KOG0658|consen 223 QPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY-TEFKFPQI----KAHPWHK------VFFKRLPPDALDLLSKLLQ 291 (364)
T ss_pred CcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc-ccccCccc----cccccee------ecccCCCHHHHHHHHHHhc
Confidence 99999999999999999988887532221111110 00000011 1111111 2445678999999999988
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..| ..|.++.+|+.||||-+
T Consensus 292 Y~P-------~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 292 YSP-------SKRLSALEALAHPFFDE 311 (364)
T ss_pred cCh-------hhcCCHHHHhcchhhHH
Confidence 544 55599999999999854
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=273.69 Aligned_cols=220 Identities=25% Similarity=0.295 Sum_probs=191.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.-+.+.+|+++-+.|+||||+++++.+.+....|+|||++.|+++-.-+...-.+++..+-.+++||+.||.|||.+|||
T Consensus 53 ~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~Iv 132 (355)
T KOG0033|consen 53 DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIV 132 (355)
T ss_pred cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCce
Confidence 34567889999999999999999999999999999999999999877544445788999999999999999999999999
Q ss_pred ecccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 97 HRDIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|||+||.|+++.+. .-+||+|||+|..++.+...-..+|||.|+|||+++..+ |+..+||||-|+|||-++.|..|
T Consensus 133 HRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 133 HRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred eccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCC
Confidence 99999999999755 359999999999998666666789999999999999877 89999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
|+|.+......++++.....+ ...-+..++++-+++++||+-+|
T Consensus 212 F~~~~~~rlye~I~~g~yd~~------------------------------------~~~w~~is~~Ak~LvrrML~~dP 255 (355)
T KOG0033|consen 212 FWDEDQHRLYEQIKAGAYDYP------------------------------------SPEWDTVTPEAKSLIRRMLTVNP 255 (355)
T ss_pred CCCccHHHHHHHHhccccCCC------------------------------------CcccCcCCHHHHHHHHHHhccCh
Confidence 999999888888877655432 11112356789999999999888
Q ss_pred ceeeccccccccccccceeeeeecCCc
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
..+ |++.++|.|||+.+-+.
T Consensus 256 ~kR-------Ita~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 256 KKR-------ITADEALKHPWICNRER 275 (355)
T ss_pred hhh-------ccHHHHhCCchhcchHH
Confidence 887 99999999999987543
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=297.40 Aligned_cols=234 Identities=21% Similarity=0.234 Sum_probs=194.7
Q ss_pred ccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHH
Q psy763 4 NKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83 (303)
Q Consensus 4 ~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi 83 (303)
+|+-+++.+.+....+....|..+|...++|+||+++..|++...+||||||++||++..++.+.+.|++..++.++.+.
T Consensus 171 mK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~ 250 (550)
T KOG0605|consen 171 MKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAET 250 (550)
T ss_pred eecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHH
Confidence 46666777777777788889999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCC----------------------CC-c-----c-----
Q psy763 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP----------------------GE-N-----Y----- 130 (303)
Q Consensus 84 ~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~----------------------~~-~-----~----- 130 (303)
+.|+..+|+.|++||||||+|+|||..|++||+|||+|..+.. .. . .
T Consensus 251 vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (550)
T KOG0605|consen 251 VLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSR 330 (550)
T ss_pred HHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhH
Confidence 9999999999999999999999999999999999999843221 00 0 0
Q ss_pred ---------------ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeE
Q psy763 131 ---------------TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTV 195 (303)
Q Consensus 131 ---------------~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (303)
.+.+|||.|+|||++.+.+ |+..+|+||||||||||+.|-+||++.++.+..++++.....
T Consensus 331 ~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--- 406 (550)
T KOG0605|consen 331 REQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--- 406 (550)
T ss_pred HHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---
Confidence 1347999999999999887 999999999999999999999999999999998877763222
Q ss_pred eecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeee
Q psy763 196 ILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
... +.....+.+|.||+.+++..-.+.+ . .-.+.+..+||||
T Consensus 407 -------------------l~f--------------P~~~~~s~eA~DLI~rll~d~~~RL-G----~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 407 -------------------LKF--------------PEEVDLSDEAKDLITRLLCDPENRL-G----SKGAEEIKKHPFF 448 (550)
T ss_pred -------------------ccC--------------CCcCcccHHHHHHHHHHhcCHHHhc-C----cccHHHHhcCCcc
Confidence 221 2222344788899999888333333 1 3467888999999
Q ss_pred ecCC
Q psy763 276 PTPE 279 (303)
Q Consensus 276 ~~~~ 279 (303)
...+
T Consensus 449 ~~v~ 452 (550)
T KOG0605|consen 449 KGVD 452 (550)
T ss_pred ccCC
Confidence 8754
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.66 Aligned_cols=214 Identities=27% Similarity=0.381 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
......+|+.+++.+. ||||+++++++.....+|+||||+.||+|.+++.+.+++++..+..+++|+++|++|||++||
T Consensus 62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi 141 (370)
T KOG0583|consen 62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGI 141 (370)
T ss_pred cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCE
Confidence 3444558999999999 999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecccCCCcEEEecC-CcEEEccccceeee-CCCCccccccCCCcccCcccccCCccC-CCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTAN-GVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLY-GPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~-~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~~~-~~~~DvwSlG~il~el~tg~~ 172 (303)
+||||||+|+|++.+ +.+||+|||++... ..+....+.+||+.|+|||++.+...| +.++||||+|++||.|++|..
T Consensus 142 ~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~ 221 (370)
T KOG0583|consen 142 VHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL 221 (370)
T ss_pred eeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 999999999999999 99999999999988 566777889999999999999987634 689999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCC-chhhHHhhhhhhcc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRN-SHGVVKILGKKLIG 251 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~dll~~~l~~ 251 (303)
||.+.........+.......+ ... ++++.+++.+||..
T Consensus 222 PF~d~~~~~l~~ki~~~~~~~p----------------------------------------~~~~S~~~~~Li~~mL~~ 261 (370)
T KOG0583|consen 222 PFDDSNVPNLYRKIRKGEFKIP----------------------------------------SYLLSPEARSLIEKMLVP 261 (370)
T ss_pred CCCCccHHHHHHHHhcCCccCC----------------------------------------CCcCCHHHHHHHHHHcCC
Confidence 9998666666554333222211 111 67788889888887
Q ss_pred ccceeeccccccccccccceeeeeec
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+|..+ ++..+.+.|+||..
T Consensus 262 ~P~~R-------~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 262 DPSTR-------ITLLEILEHPWFQK 280 (370)
T ss_pred CcccC-------CCHHHHhhChhhcc
Confidence 77665 99999999999886
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=280.49 Aligned_cols=212 Identities=25% Similarity=0.374 Sum_probs=168.8
Q ss_pred cccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEE-EEEeCCE-EEEEEecCCCCcHHHHHc----CCCCCCHHHHHH
Q psy763 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLE-VFRRKKK-LHLVFEFCDHTVLNELEN----HPHGLPWDLIKQ 78 (303)
Q Consensus 5 kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~ 78 (303)
|+.+...+. ...++....|+.+|++|+|||||++++ .|.+++. +++|||+|++|+|...++ ..+.+++..++.
T Consensus 50 K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk 128 (375)
T KOG0591|consen 50 KKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWK 128 (375)
T ss_pred hhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHH
Confidence 344433333 345666789999999999999999999 6666665 899999999999998764 456799999999
Q ss_pred HHHHHHHHHHHHHH--CC--ceecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCC
Q psy763 79 ITWQVLRGVSYCHR--HA--CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGP 153 (303)
Q Consensus 79 ~~~qi~~~l~~lH~--~~--ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~ 153 (303)
++.|++.||.+||+ .. |.||||||.||+++.+|.+||+|||+++++..... ..+.+|||.||+||.+.+.+ |++
T Consensus 129 ~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~ 207 (375)
T KOG0591|consen 129 YFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNF 207 (375)
T ss_pred HHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCc
Confidence 99999999999999 44 89999999999999999999999999999875443 35689999999999999877 999
Q ss_pred ccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCC-cchhhhhhhhhhcCCChhH
Q psy763 154 AVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLD-SETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 154 ~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 222 (303)
++||||+||++|||.....||+|.+..+.-.++-++... + -|+... .++..++-.|+..++..+|
T Consensus 208 kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~-~---~p~~~YS~~l~~li~~ci~vd~~~RP 273 (375)
T KOG0591|consen 208 KSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP-P---LPDEHYSTDLRELINMCIAVDPEQRP 273 (375)
T ss_pred chhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC-C---CcHHHhhhHHHHHHHHHccCCcccCC
Confidence 999999999999999999999999777766655554322 1 222222 2344455556665555555
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=273.36 Aligned_cols=217 Identities=26% Similarity=0.348 Sum_probs=188.9
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.-.+|+.+++++ .||+|+.+.++++.+..+++|+|.|+.|.|.+++...-.++++..+.+++|++.|+.|||.++|
T Consensus 65 ~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~I 144 (411)
T KOG0599|consen 65 MREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNI 144 (411)
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhh
Confidence 344556788888887 5999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCccccc-----CCccCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV-----GDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~-----~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|||||||+|||++++..++|+|||++..+.++......+|||+|+|||.+. +.+.|+..+|+||.|+|||.++.|
T Consensus 145 VHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 145 VHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred hhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 999999999999999999999999999999999999999999999999986 345689999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
.+||+.....-+++.++++..... ++ .|.+ .+.++-|++.++|+
T Consensus 225 cpPFwHRkQmlMLR~ImeGkyqF~---------sp----eWad-----------------------is~~~KdLIsrlLq 268 (411)
T KOG0599|consen 225 CPPFWHRKQMLMLRMIMEGKYQFR---------SP----EWAD-----------------------ISATVKDLISRLLQ 268 (411)
T ss_pred CCchhHHHHHHHHHHHHhcccccC---------Cc----chhh-----------------------ccccHHHHHHHHHe
Confidence 999999888888887777655432 00 0221 23456688888887
Q ss_pred cccceeeccccccccccccceeeeee
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
-.+..+ ++++++|.||||-
T Consensus 269 Vdp~~R-------itake~LaHpff~ 287 (411)
T KOG0599|consen 269 VDPTKR-------ITAKEALAHPFFI 287 (411)
T ss_pred eCchhc-------ccHHHHhcChHHH
Confidence 555555 9999999999993
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.03 Aligned_cols=218 Identities=26% Similarity=0.404 Sum_probs=189.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 13 ~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+++...+|+.+++..+|+|||++++.|..++.++.||||++||+|.+++... .+++.++..+++++++||+|||.
T Consensus 309 ~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~ 387 (550)
T KOG0578|consen 309 RKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHA 387 (550)
T ss_pred ccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHh
Confidence 34456778899999999999999999999999999999999999999999988754 69999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+||+|||||.+|||++.+|.+||+|||+|..+.... ...+.+||+.|||||++.... |+++.||||||++.+||+.|.
T Consensus 388 ~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 388 RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred cceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCC
Confidence 999999999999999999999999999999887554 567789999999999998655 999999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
+|++.....+.+..+... +++. ..+.+..++.+-|||++||..
T Consensus 467 PPYlnE~PlrAlyLIa~n-g~P~------------------------------------lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 467 PPYLNENPLRALYLIATN-GTPK------------------------------------LKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred CCccCCChHHHHHHHhhc-CCCC------------------------------------cCCccccCHHHHHHHHHHhhc
Confidence 999987777776644333 3321 122334567888999999997
Q ss_pred ccceeeccccccccccccceeeeee
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
+...| .++.+||+|||+.
T Consensus 510 dv~~R-------asA~eLL~HpFl~ 527 (550)
T KOG0578|consen 510 DVEQR-------ASAKELLEHPFLK 527 (550)
T ss_pred chhcC-------CCHHHHhcChhhh
Confidence 66666 9999999999994
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.86 Aligned_cols=214 Identities=25% Similarity=0.327 Sum_probs=190.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
......+|+-+++.+.|||++++++++....++|+|.||+++|-|.+++.+.+++++..+..+++||+.|+.|||..+|+
T Consensus 55 ~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~ic 134 (786)
T KOG0588|consen 55 QPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNIC 134 (786)
T ss_pred cccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcce
Confidence 45567889999999999999999999999999999999999999999999899999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||+||+|+|++.++.+||+|||.|..-.++....+.||+++|.|||++.|.+..+.++||||.|||||.|+||..||.+
T Consensus 135 HRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 135 HRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred eccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999988888888999999999999999998778999999999999999999999987
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.+....+.++..+...+ ....+++|.|||.+|+.=++..+
T Consensus 215 dNir~LLlKV~~G~f~M----------------------------------------Ps~Is~eaQdLLr~ml~VDp~~R 254 (786)
T KOG0588|consen 215 DNIRVLLLKVQRGVFEM----------------------------------------PSNISSEAQDLLRRMLDVDPSTR 254 (786)
T ss_pred ccHHHHHHHHHcCcccC----------------------------------------CCcCCHHHHHHHHHHhccCcccc
Confidence 77666655443322211 12356889999999999766666
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
++..+.++|||+.-
T Consensus 255 -------iT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 255 -------ITTEEILKHPFLSG 268 (786)
T ss_pred -------ccHHHHhhCchhhc
Confidence 99999999999864
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.60 Aligned_cols=211 Identities=26% Similarity=0.390 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.-..+.+|+++++.++||||+.++++|+..+++++|+||+.| +|..++...+.+++..+..++.+++.||.|||+.+|.
T Consensus 44 ~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~ril 122 (808)
T KOG0597|consen 44 ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRIL 122 (808)
T ss_pred HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 345678899999999999999999999999999999999996 9999999999999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|||+||+|||++.++.+|+||||+|+..+.+.. .....|||.|||||++.+++ |+..+|+||+|||+||+++|.+||+
T Consensus 123 hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 123 HRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred cccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCch
Confidence 999999999999999999999999998876543 35578999999999999766 9999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
...-.+.++.|+....+++ ...+..+++|++-+|...|..
T Consensus 202 a~si~~Lv~~I~~d~v~~p----------------------------------------~~~S~~f~nfl~gLL~kdP~~ 241 (808)
T KOG0597|consen 202 ARSITQLVKSILKDPVKPP----------------------------------------STASSSFVNFLQGLLIKDPAQ 241 (808)
T ss_pred HHHHHHHHHHHhcCCCCCc----------------------------------------ccccHHHHHHHHHHhhcChhh
Confidence 9988888887766544432 123445667787777766666
Q ss_pred eeccccccccccccceeeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~ 276 (303)
+ ++=.+++.|||..
T Consensus 242 R-------ltW~~Ll~HpF~k 255 (808)
T KOG0597|consen 242 R-------LTWTDLLGHPFWK 255 (808)
T ss_pred c-------ccHHHHhcChHHh
Confidence 5 8888888888764
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=294.71 Aligned_cols=233 Identities=21% Similarity=0.269 Sum_probs=193.9
Q ss_pred CccccccchHHHHHHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHH
Q psy763 1 LRFNKKKKSSYYKEAIRQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI 79 (303)
Q Consensus 1 ~~~~kk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~ 79 (303)
||++||-...... ..+....|.+++... +||.+++++.+|++.+++|+||||+.||++.. +.+.+.+++..++-+
T Consensus 398 IK~LKK~~Il~~d---~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfy 473 (694)
T KOG0694|consen 398 IKVLKKGDILQRD---EVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFY 473 (694)
T ss_pred EEEeeccceeccc---cHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEE-EEecccccHHHHHHH
Confidence 4666666655544 344455555555555 59999999999999999999999999999544 344568999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchh
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVW 158 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~Dvw 158 (303)
+..++.||.|||++||+|||||.+|||+|..|.+||+|||+++..- .+....+.+||+.|+|||++.++. |+.++|.|
T Consensus 474 aAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW 552 (694)
T KOG0694|consen 474 AAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWW 552 (694)
T ss_pred HHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHH
Confidence 9999999999999999999999999999999999999999998754 566778899999999999999877 99999999
Q ss_pred hHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCc
Q psy763 159 AIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNS 238 (303)
Q Consensus 159 SlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 238 (303)
||||+||||+.|..||.|.+..+....|+....+.| ..-+
T Consensus 553 ~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP----------------------------------------~~ls 592 (694)
T KOG0694|consen 553 GLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----------------------------------------RFLS 592 (694)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----------------------------------------Cccc
Confidence 999999999999999999999888876665443322 1134
Q ss_pred hhhHHhhhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 239 HGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 239 ~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
.+++++++++|+.+|..|-... .-.+.+.+.||||..++-
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~--e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSG--ERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHHHHHHHHhccCcccccCCC--CCCchhhhhCCccccCCH
Confidence 5788999999999988885555 345788999999987653
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=280.30 Aligned_cols=218 Identities=22% Similarity=0.271 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK--KLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.+.+.+|+++++.++|||||+++|.....+ .+++.|||+++|+|.+++...+ .+++..++.+.+||++||+|||++|
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g 137 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG 137 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 566889999999999999999999855444 6999999999999999988766 7999999999999999999999999
Q ss_pred ceecccCCCcEEEec-CCcEEEccccceeeeCC----CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTA-NGVVKLCDFGFARLINP----GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|+||||||+|||++. ++.+||+|||++..... ........||+.|||||++.+.....+++||||+||++.||+|
T Consensus 138 ~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 138 IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 999999999999999 79999999999887653 1223457899999999999852223459999999999999999
Q ss_pred cCccCCCC-chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 170 IGFIGLGN-MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 170 g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
|..|+.+. ...+....+......+ ...+..+.++.||+.++
T Consensus 218 g~~PW~~~~~~~~~~~~ig~~~~~P--------------------------------------~ip~~ls~~a~~Fl~~C 259 (313)
T KOG0198|consen 218 GKPPWSEFFEEAEALLLIGREDSLP--------------------------------------EIPDSLSDEAKDFLRKC 259 (313)
T ss_pred CCCcchhhcchHHHHHHHhccCCCC--------------------------------------CCCcccCHHHHHHHHHH
Confidence 97776652 2222222121111000 11122456777888888
Q ss_pred hccccceeeccccccccccccceeeeeecCCc
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+..++..| .++.+||.|||......
T Consensus 260 ~~~~p~~R-------pta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 260 FKRDPEKR-------PTAEELLEHPFLKQNSI 284 (313)
T ss_pred hhcCcccC-------cCHHHHhhChhhhcccc
Confidence 88766666 88999999988866544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=277.16 Aligned_cols=239 Identities=26% Similarity=0.446 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++||||+++++++..++..++|+||+++ ++..++. .+..+++..+..++.|++.||+|||++||+|
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 126 (288)
T cd07871 48 CTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126 (288)
T ss_pred hhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3566899999999999999999999999999999999985 6666554 3446899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+...++.++||||+||++|+|++|..||.+
T Consensus 127 ~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765422 2223456789999999988766689999999999999999999999998
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+.+..+....+.++....+.....+.+. ..........++.. ..+..++++.|++.+||..+|..|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~dll~~mL~~dp~~R 276 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFR---SYLFPQYRAQPLIN-------HAPRLDTDGIDLLSSLLLYETKSR 276 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhh---ccccCccCCCchHH-------hCCCCCHHHHHHHHHhcCcCcccC
Confidence 88888777777665544322222111111000 00011111111111 112356788999999999777766
Q ss_pred eccccccccccccceeeee
Q psy763 257 QSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~ 275 (303)
++++++++||||
T Consensus 277 -------~t~~~~l~hp~f 288 (288)
T cd07871 277 -------ISAEAALRHSYF 288 (288)
T ss_pred -------CCHHHHhcCCCC
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=261.23 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=212.5
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC--EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKK--KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
+.....+|+.+++.|. ||||+.++++..+.. ...+||||+.+.++..+-. .++...++.++.+++.||.|||+.
T Consensus 75 kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~ 151 (338)
T KOG0668|consen 75 KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSM 151 (338)
T ss_pred HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhc
Confidence 4566788999999997 999999999998654 5789999999998887654 688889999999999999999999
Q ss_pred CceecccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh-ccC
Q psy763 94 ACIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS-QIG 171 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~-tg~ 171 (303)
||.|||+||.|+++|.. -.++|+|+|+|.+..++......+.+..|..||.+...+.|+.+-|+|||||++..|. ...
T Consensus 152 GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrke 231 (338)
T KOG0668|consen 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 231 (338)
T ss_pred CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccC
Confidence 99999999999999965 6799999999999999988888899999999999998888999999999999999994 666
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
++|.|.++.+++.++.+-.|+-...-. -....-..+..+..++.+.+.++|.++ ++.+++....++++|+++++|.
T Consensus 232 pFFhG~dN~DQLVkIakVLGt~el~~Y-l~KY~i~Ldp~~~~i~~~~~rk~w~~F--i~~~n~hl~~peaiDlldklLr- 307 (338)
T KOG0668|consen 232 PFFHGHDNYDQLVKIAKVLGTDELYAY-LNKYQIDLDPQFEDILGRHSRKPWSRF--INSENQHLVSPEAIDLLDKLLR- 307 (338)
T ss_pred cccCCCCCHHHHHHHHHHhChHHHHHH-HHHHccCCChhHhhHhhccccccHHHh--CCccccccCChHHHHHHHHHHh-
Confidence 777899999998888887665331110 000111123346777888999999999 8999999999999999999988
Q ss_pred ccceeeccccccccccccceeeeeecC
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
++.|.|.++++|+.||||...
T Consensus 308 ------YDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 308 ------YDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred ------hccccccchHHHhcCchHHHH
Confidence 889999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=279.27 Aligned_cols=219 Identities=20% Similarity=0.238 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++.+|+||||+++|+|...+...+.+++..+..++.|++.||+|||+.||+
T Consensus 38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv 117 (323)
T cd05571 38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 34456788999999999999999999999999999999999999999888778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++.... .........||+.|+|||++.+.. ++.++||||+||++|||++|..||.
T Consensus 118 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCC
Confidence 99999999999999999999999987642 223334567999999999998765 8999999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+...... ......+++.+++.+|+..+|..
T Consensus 197 ~~~~~~~~~~~~~~~~~----------------------------------------~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 197 NQDHEKLFELILMEEIR----------------------------------------FPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CCCHHHHHHHHHcCCCC----------------------------------------CCCCCCHHHHHHHHHHccCCHHH
Confidence 76655544433221110 01123566778888888877766
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
|-.. ...++.++++|+||...
T Consensus 237 R~~~--~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 237 RLGG--GPEDAKEIMEHRFFASI 257 (323)
T ss_pred cCCC--CCCCHHHHHcCCCcCCC
Confidence 6100 00178889999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.65 Aligned_cols=206 Identities=24% Similarity=0.333 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--------------CCCCHHHHHHHHH
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--------------HGLPWDLIKQITW 81 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------~~l~~~~~~~~~~ 81 (303)
..+..|++|++++..++|||||+++|+|..++++|+|||||..|+|..++... .+++..+.+.++.
T Consensus 531 ~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~ 610 (774)
T KOG1026|consen 531 QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIAT 610 (774)
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHH
Confidence 36788999999999999999999999999999999999999999999987532 1388999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcccc---ccCCCcccCcccccCCccCCCccchh
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD---YVATRWYRAPELLVGDTLYGPAVDVW 158 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~l~~~~~~~~~~Dvw 158 (303)
|||.|+.||-++.+|||||.++|+||+++..|||+|||+++..-..+.++. ..-+.+|||||.+.-.. ||.++|||
T Consensus 611 QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVW 689 (774)
T KOG1026|consen 611 QIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVW 689 (774)
T ss_pred HHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhh
Confidence 999999999999999999999999999999999999999988655444332 23467899999999554 99999999
Q ss_pred hHHHHHHHhhccC-ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 159 AIEWTSHSYSQIG-FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 159 SlG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+||+|||+++.+ .|++|-++.+.+ ..++.+.- +..|..+|.++..++-.||...|+.||.++-
T Consensus 690 s~GVvLWEIFsyG~QPy~glSn~EVI-e~i~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 690 SFGVVLWEIFSYGKQPYYGLSNQEVI-ECIRAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred hhhhhhhhhhccccCcccccchHHHH-HHHHcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 9999999999766 555555555554 45554443 4467889999999999999999999998877
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.36 Aligned_cols=218 Identities=22% Similarity=0.229 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|..++...+.+++..+..++.|++.||.|||+.|+
T Consensus 73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 152 (340)
T PTZ00426 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152 (340)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34456778999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+.. ++.++|+||+||++|||++|..||.
T Consensus 153 vHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred EccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCC
Confidence 99999999999999999999999999875432 24467899999999998765 7999999999999999999999998
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+....... ....++.+.+++++|+...+..
T Consensus 230 ~~~~~~~~~~i~~~~~~~----------------------------------------p~~~~~~~~~li~~~l~~dp~~ 269 (340)
T PTZ00426 230 ANEPLLIYQKILEGIIYF----------------------------------------PKFLDNNCKHLMKKLLSHDLTK 269 (340)
T ss_pred CCCHHHHHHHHhcCCCCC----------------------------------------CCCCCHHHHHHHHHHcccCHHH
Confidence 876655555443321110 0112345678888888876666
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
|- ...+.++.++++||||...
T Consensus 270 R~--~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 270 RY--GNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred cC--CCCCCCHHHHHcCCCcCCC
Confidence 52 1233588899999998754
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=264.49 Aligned_cols=256 Identities=28% Similarity=0.450 Sum_probs=192.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
..+..+|+.++|.++|||++.+..+|.. +..+++++||+++..++-+.. +...++...+.++++||+.|+.|||+
T Consensus 71 S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 71 SMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred CHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence 3467889999999999999999999987 789999999999655544322 22468999999999999999999999
Q ss_pred CCceecccCCCcEEEecC----CcEEEccccceeeeCCC----CccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 93 HACIHRDIKPENILLTAN----GVVKLCDFGFARLINPG----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~----~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
+.|+||||||.||++..+ |.|||+|+|+++.+... ......+.|.+|+|||.+.|...||++.||||+|||+
T Consensus 151 NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 151 NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF 230 (438)
T ss_pred hheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence 999999999999999887 89999999999987532 1234567899999999999999999999999999999
Q ss_pred HHhhccCccCCCC---------chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh-cCCChhHHHHHHhHhCCCC
Q psy763 165 HSYSQIGFIGLGN---------MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF-SKTSTTTIFKYLLIRGGNT 234 (303)
Q Consensus 165 ~el~tg~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~ 234 (303)
.||+|..+.|.|. ....++.++++-.+.+.....++-..-..++.....+- .....-.+.++. . ..
T Consensus 231 aElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~--~--~~ 306 (438)
T KOG0666|consen 231 AELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYY--H--KH 306 (438)
T ss_pred HHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHH--H--Hh
Confidence 9999999888775 34567788888877776554443221111111011111 000011122221 0 11
Q ss_pred CCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCcceEE
Q psy763 235 DRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKCLE 284 (303)
Q Consensus 235 ~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 284 (303)
...++.+.++|.+||+-+|..+ +++++||+|+||..++..-+-
T Consensus 307 k~k~~~a~~LL~klL~yDP~kR-------Ita~qAleh~yF~~d~lpp~p 349 (438)
T KOG0666|consen 307 KVKDPSALDLLQKLLTYDPIKR-------ITAEQALEHPYFTEDPLPPLP 349 (438)
T ss_pred cCCCchHHHHHHHHhccCchhh-------ccHHHHhcccccccCCCCCCc
Confidence 2245559999999999665555 999999999999998776443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=278.90 Aligned_cols=173 Identities=21% Similarity=0.228 Sum_probs=151.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 15 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
......+.+|+.+++.++|+||+++++.+.+...+|+||||+++|+|..++.+.+.+++..+..++.|++.||.|||++|
T Consensus 42 ~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g 121 (363)
T cd05628 42 KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121 (363)
T ss_pred hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 33455678899999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC------------------------------------ccccccCCCc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE------------------------------------NYTDYVATRW 138 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~~~~ 138 (303)
|+||||||+|||++.++.+||+|||++....... .....+||+.
T Consensus 122 ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~ 201 (363)
T cd05628 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPD 201 (363)
T ss_pred eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcc
Confidence 9999999999999999999999999987543110 0123478999
Q ss_pred ccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhh
Q psy763 139 YRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLK 188 (303)
Q Consensus 139 y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~ 188 (303)
|+|||++.+.. ++.++|||||||++|||++|..||.+....+....+..
T Consensus 202 Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 250 (363)
T cd05628 202 YIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN 250 (363)
T ss_pred ccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99999998765 89999999999999999999999988877766665554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.08 Aligned_cols=217 Identities=19% Similarity=0.197 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|.+++...+.+++..+..++.|++.||+|||++|++
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 123 (291)
T cd05612 44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123 (291)
T ss_pred HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45567889999999999999999999999999999999999999999988888899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+||+++.++.+||+|||++...... .....|++.|+|||.+.+.. ++.++|||||||++|+|++|..|+.+
T Consensus 124 H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred ecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998765432 23457899999999998766 79999999999999999999999888
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+...... ......+.+.+++.+|+..++..|
T Consensus 201 ~~~~~~~~~i~~~~~~----------------------------------------~~~~~~~~~~~li~~~l~~dp~~R 240 (291)
T cd05612 201 DNPFGIYEKILAGKLE----------------------------------------FPRHLDLYAKDLIKKLLVVDRTRR 240 (291)
T ss_pred CCHHHHHHHHHhCCcC----------------------------------------CCccCCHHHHHHHHHHcCCCHHHc
Confidence 7666555544332110 111234567899999999777666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
-. ....++.+++.|+|+...
T Consensus 241 ~~--~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 241 LG--NMKNGADDVKNHRWFKSV 260 (291)
T ss_pred cC--CccCCHHHHhcCccccCC
Confidence 10 111258999999999653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=273.97 Aligned_cols=214 Identities=24% Similarity=0.284 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++..|+||||+++|+|..++...+.+++..+..++.|++.||.|||+.||+
T Consensus 36 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 115 (312)
T cd05585 36 EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115 (312)
T ss_pred HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 44566788999999999999999999999999999999999999999888778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.++|+|||++...... .......||+.|+|||.+.+.. ++.++||||+||++|||++|..||.
T Consensus 116 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred eCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcC
Confidence 9999999999999999999999998764322 2234457899999999998765 8999999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+....... ....++++.+++.+|+..+|..
T Consensus 195 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~li~~~L~~dp~~ 234 (312)
T cd05585 195 DENVNEMYRKILQEPLRF----------------------------------------PDGFDRDAKDLLIGLLSRDPTR 234 (312)
T ss_pred CCCHHHHHHHHHcCCCCC----------------------------------------CCcCCHHHHHHHHHHcCCCHHH
Confidence 776665555443321110 1123355667777777766655
Q ss_pred eeccccccc---cccccceeeeeecC
Q psy763 256 IQSEKQDSI---RGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~---~~~~~l~~~~~~~~ 278 (303)
| + ++.+++.|||+...
T Consensus 235 R-------~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 235 R-------LGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred c-------CCCCCHHHHHcCCCcCCC
Confidence 5 4 46777888887764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=283.26 Aligned_cols=208 Identities=23% Similarity=0.306 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
+.-..+++.|++|+||||+.+.|+|.+...+|||||||..|-|..+++.+..++......|..+||.|+.|||.+.|+||
T Consensus 157 elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHR 236 (904)
T KOG4721|consen 157 ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHR 236 (904)
T ss_pred hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhh
Confidence 33456789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
|||.-||||..+..|||+|||-++..........++||..|||||++++++ .+.++||||||||||||+||..|+.+..
T Consensus 237 DLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 237 DLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred ccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccc
Confidence 999999999999999999999998877666667789999999999999877 7999999999999999999999887665
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHh
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIR 230 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 230 (303)
...++. ..|...-.++-|..++....-++-+||..++..||.|..++..
T Consensus 316 ssAIIw---GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 316 SSAIIW---GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred hheeEE---eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 544433 2233333345566777777777888888888888877775543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=275.87 Aligned_cols=217 Identities=22% Similarity=0.251 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++.+|+||||+.+|+|...+...+.+++..+..++.|++.||.|||++||+
T Consensus 61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 140 (329)
T PTZ00263 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140 (329)
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 44567889999999999999999999999999999999999999999888778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+||+++.++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.+
T Consensus 141 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 141 YRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred ecCCCHHHEEECCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999875432 23457899999999998766 79999999999999999999999988
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+....... .......+.+++.+||..+|..|
T Consensus 218 ~~~~~~~~~i~~~~~~~----------------------------------------p~~~~~~~~~li~~~L~~dP~~R 257 (329)
T PTZ00263 218 DTPFRIYEKILAGRLKF----------------------------------------PNWFDGRARDLVKGLLQTDHTKR 257 (329)
T ss_pred CCHHHHHHHHhcCCcCC----------------------------------------CCCCCHHHHHHHHHHhhcCHHHc
Confidence 77665555443321110 00123455688888888776666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
-. .-+.++.+++.||||...
T Consensus 258 ~~--~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 258 LG--TLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CC--CCCCCHHHHhcCCccCCC
Confidence 10 011236889999988764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=273.96 Aligned_cols=220 Identities=20% Similarity=0.241 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++...+.+|+||||+++|+|..++...+.+++..+..++.|++.||.|||++|++
T Consensus 38 ~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 117 (323)
T cd05595 38 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 34456778999999999999999999999999999999999999999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++..... ........||+.|+|||.+.+.. ++.++|||||||++|||++|..|+.
T Consensus 118 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred ecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999999999876432 22334467899999999998765 7999999999999999999999987
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+.....+ .....++++.+++.+|+..+|..
T Consensus 197 ~~~~~~~~~~~~~~~~~----------------------------------------~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 197 NQDHERLFELILMEEIR----------------------------------------FPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CCCHHHHHHHHhcCCCC----------------------------------------CCCCCCHHHHHHHHHHccCCHHH
Confidence 76655554433322111 01123456678888888866665
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
|- .....++.++++|+||...+
T Consensus 237 R~--~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 237 RL--GGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred hC--CCCCCCHHHHHcCCCcCCCC
Confidence 51 01112788888888886543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.59 Aligned_cols=187 Identities=25% Similarity=0.414 Sum_probs=172.3
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHH
Q psy763 7 KKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 7 ~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~ 86 (303)
.++...+....-...++|+++++.|+||||+.++.+|+....+.+||||..+|.|.+++.+.+.+++..++.+++||.+|
T Consensus 86 IrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSA 165 (668)
T KOG0611|consen 86 IRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSA 165 (668)
T ss_pred hhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHH
Confidence 34444555556667889999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
+.|||.++++|||||.+|||+|.++++||+|||++..+.......+++|++.|.+||++.|.+.-++.+|-||||++||.
T Consensus 166 VhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYt 245 (668)
T KOG0611|consen 166 VHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYT 245 (668)
T ss_pred HHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHH
Confidence 99999999999999999999999999999999999999888888999999999999999998866899999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCce
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRV 193 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~ 193 (303)
+..|..||.|.....+++++-...++-
T Consensus 246 LVyGtMPFDG~Dhk~lvrQIs~GaYrE 272 (668)
T KOG0611|consen 246 LVYGTMPFDGRDHKRLVRQISRGAYRE 272 (668)
T ss_pred HhhcccccCCchHHHHHHHhhcccccC
Confidence 999999999999988888877665553
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=270.78 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+.+++.++||||+++++++.++...++||||++++.+..+....+.+++..+..++.|++.||.|||+.||+||
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~ 127 (303)
T cd07869 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127 (303)
T ss_pred hhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 34567899999999999999999999999999999999865555455555679999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||||+||+++.++.+||+|||++..... ........+++.|+|||++.+...++.++||||+||++|||++|..||.+.
T Consensus 128 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876432 222344578999999999887666899999999999999999999998876
Q ss_pred chH-HHHHHHhhcCCceeEeecCCCCC-cchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 178 MGS-HMARNLLKNNGRVTVILKSDSLD-SETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 178 ~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
... +.+..+....+.+.....+.... +... ..-........+.... ......+.+.|++++||..+|..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-----~~~~~~~~~~dli~~mL~~dp~~ 278 (303)
T cd07869 208 KDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK----PERFTLYSPKNLRQAW-----NKLSYVNHAEDLASKLLQCFPKN 278 (303)
T ss_pred ccHHHHHHHHHHHhCCCChhhccchhhccccc----cccccccCCccHHHHh-----hccCCChHHHHHHHHHhccCchh
Confidence 443 33333333322221111100000 0000 0000000111111110 01113467889999999977666
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
| +++.+++.||||.+.+
T Consensus 279 R-------~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 279 R-------LSAQAALSHEYFSDLP 295 (303)
T ss_pred c-------cCHHHHhcCcccccCC
Confidence 6 9999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=275.14 Aligned_cols=222 Identities=23% Similarity=0.212 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++++..++..|+||||+++|+|..++...+.+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 122 (333)
T cd05600 43 NEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122 (333)
T ss_pred hHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34456778999999999999999999999999999999999999999999877889999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||||||+||+++.++.+||+|||++..... ......||+.|+|||.+.+.. ++.++||||+||++|||++|..|+.
T Consensus 123 vH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred cccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCC
Confidence 9999999999999999999999999876543 234567899999999998775 8999999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+........ .+. ...+....++++.+++.+|+...+..
T Consensus 200 ~~~~~~~~~~i~~~~~~~~----------------------~~~----------~~~~~~~~s~~~~~li~~~l~~~~~r 247 (333)
T cd05600 200 GSTPNETWENLKYWKETLQ----------------------RPV----------YDDPRFNLSDEAWDLITKLINDPSRR 247 (333)
T ss_pred CCCHHHHHHHHHhcccccc----------------------CCC----------CCccccccCHHHHHHHHHHhhChhhh
Confidence 7766665544433211110 000 00001224567778888888744444
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+.++.+++.|||+.+.+
T Consensus 248 -------r~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 248 -------FGSLEDIKNHPFFKEVD 264 (333)
T ss_pred -------cCCHHHHHhCcccCCCC
Confidence 48899999999988653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=278.43 Aligned_cols=222 Identities=18% Similarity=0.180 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|..++...+.+++..+..++.|++.||.|||+.||
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i 122 (364)
T cd05599 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122 (364)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34456778999999999999999999999999999999999999999998877889999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc---------------------------------------cccccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN---------------------------------------YTDYVAT 136 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---------------------------------------~~~~~~~ 136 (303)
+||||||+|||++.++.++|+|||++........ ..+.+||
T Consensus 123 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 202 (364)
T cd05599 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGT 202 (364)
T ss_pred EeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccC
Confidence 9999999999999999999999999876432110 0123689
Q ss_pred CcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc
Q psy763 137 RWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS 216 (303)
Q Consensus 137 ~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (303)
+.|+|||++.+.. ++.++|||||||++|||++|..||.+....+....++.......
T Consensus 203 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------- 259 (364)
T cd05599 203 PDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ---------------------- 259 (364)
T ss_pred ccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC----------------------
Confidence 9999999998665 89999999999999999999999988777666555543221111
Q ss_pred CCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCC
Q psy763 217 KTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 217 ~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.......++++.+++.+|+. ++..+ ..+.++.+++.||||...+
T Consensus 260 --------------~~~~~~~s~~~~~li~~ll~-~p~~R----~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 260 --------------FPDEVPLSPEAKDLIKRLCC-EAERR----LGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcc-CHhhc----CCCCCHHHHhcCCCcCCCC
Confidence 00001234567788877764 44433 0012488889999886543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=273.83 Aligned_cols=219 Identities=20% Similarity=0.248 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++...+.+|+||||+++|+|...+.....+++..+..++.||+.||.|||++||+
T Consensus 38 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 117 (328)
T cd05593 38 EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117 (328)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 34566788999999999999999999999999999999999999999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++..... ........||+.|+|||.+.+.. ++.++||||+||++|+|++|..||.
T Consensus 118 HrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred ecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCC
Confidence 999999999999999999999999876332 22234457899999999998765 7999999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+....... ....++++.+++.+||..+|..
T Consensus 197 ~~~~~~~~~~~~~~~~~~----------------------------------------p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 197 NQDHEKLFELILMEDIKF----------------------------------------PRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CCCHHHHHHHhccCCccC----------------------------------------CCCCCHHHHHHHHHHcCCCHHH
Confidence 766555444332211100 0123456677888887766665
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
|-.. ...++.++++|+||...
T Consensus 237 R~~~--~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 237 RLGG--GPDDAKEIMRHSFFTGV 257 (328)
T ss_pred cCCC--CCCCHHHHhcCCCcCCC
Confidence 5110 11278888888887553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=275.50 Aligned_cols=221 Identities=27% Similarity=0.349 Sum_probs=191.8
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
......+|+.+++++. ||||+.++++|++...+++|||++.||.|.+.+.+. .+++..+..++.|++.|++|||+.|+
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gv 156 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGV 156 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 5678899999999999 999999999999999999999999999999977655 49999999999999999999999999
Q ss_pred eecccCCCcEEEecC----CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 96 IHRDIKPENILLTAN----GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+|||+||+|+|+... +.+|++|||++.....+......+||+.|+|||++...+ |+..+||||+|+++|.|++|.
T Consensus 157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~ 235 (382)
T KOG0032|consen 157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGV 235 (382)
T ss_pred eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCC
Confidence 999999999999754 479999999999988766778899999999999998655 999999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.||++.+.......+...... +..++-+.....+-|++++++..
T Consensus 236 ~PF~~~~~~~~~~~i~~~~~~------------------------------------f~~~~w~~is~~akd~i~~ll~~ 279 (382)
T KOG0032|consen 236 PPFWGETEFEIFLAILRGDFD------------------------------------FTSEPWDDISESAKDFIRKLLEF 279 (382)
T ss_pred CCCcCCChhHHHHHHHcCCCC------------------------------------CCCCCccccCHHHHHHHHHhccc
Confidence 999999988877766554331 12222233467888999999998
Q ss_pred ccceeeccccccccccccceeeeeecCCcce
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
.+..| .++.++|.|||+..+...+
T Consensus 280 dp~~R-------~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 280 DPRKR-------LTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred CcccC-------CCHHHHhcCccccCCcccc
Confidence 88777 9999999999998764433
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=278.63 Aligned_cols=172 Identities=23% Similarity=0.252 Sum_probs=148.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++.+.+++.+|+||||+++|+|..++.+.+.+++..+..++.|++.||.|||+.||
T Consensus 43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~i 122 (382)
T cd05625 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122 (382)
T ss_pred HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34556788999999999999999999999999999999999999999988877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCC------------------------------------------------
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPG------------------------------------------------ 127 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~------------------------------------------------ 127 (303)
+||||||+|||++.++.+||+|||++......
T Consensus 123 vHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (382)
T cd05625 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQR 202 (382)
T ss_pred ecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence 99999999999999999999999997532100
Q ss_pred CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhh
Q psy763 128 ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLK 188 (303)
Q Consensus 128 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~ 188 (303)
......+||+.|+|||++.+.. ++.++||||+||++|||++|..||.+....+....+..
T Consensus 203 ~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 203 CLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred ccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 0012246899999999998766 89999999999999999999999988776665554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=268.64 Aligned_cols=235 Identities=34% Similarity=0.565 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++..++.+++||||++++++..+......+++..+..++.|++.||.|||+.|++|
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 123 (287)
T cd07848 44 KETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123 (287)
T ss_pred hhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 45567899999999999999999999999999999999999988877766678999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||||+||+++.++.+||+|||++....... ......+++.|+|||++.+.. ++.++|+||+||++|||++|..||.
T Consensus 124 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred CCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998764322 223457899999999998766 7999999999999999999999888
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh------cC-CChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF------SK-TSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
+....+....+....+.++ .+.+...+.... .. ....... .......++.+.|++.+|
T Consensus 203 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~s~~~~dll~~~ 267 (287)
T cd07848 203 GESEIDQLFTIQKVLGPLP---------AEQMKLFYSNPRFHGLRFPAVNHPQSLE------RRYLGILSGVLLDLMKNL 267 (287)
T ss_pred CCCHHHHHHHHHHhhCCCC---------HHHHHhhhccchhcccccCcccCcccHH------HhhhcccCHHHHHHHHHH
Confidence 8776665555444333221 111100000000 00 0000000 011123456789999999
Q ss_pred hccccceeeccccccccccccceeeee
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
|..+|..| +++.++++||||
T Consensus 268 L~~~P~~R-------~s~~~~l~hp~f 287 (287)
T cd07848 268 LKLNPTDR-------YLTEQCLNHPAF 287 (287)
T ss_pred ccCCcccC-------CCHHHHhcCCCC
Confidence 99777777 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.45 Aligned_cols=219 Identities=20% Similarity=0.213 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|..++.+...+++..+..++.|++.||.|||+.||+
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~giv 123 (381)
T cd05626 44 QVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123 (381)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 45568889999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC------------------------------------------------
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE------------------------------------------------ 128 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~------------------------------------------------ 128 (303)
||||||+||+++.++.+||+|||++.......
T Consensus 124 HrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (381)
T cd05626 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC 203 (381)
T ss_pred ecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence 99999999999999999999999875321000
Q ss_pred ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhh
Q psy763 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWD 208 (303)
Q Consensus 129 ~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (303)
...+..||+.|+|||.+.+.. ++.++|||||||++|||++|..||.+....+....+......+.
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 268 (381)
T cd05626 204 LAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH-------------- 268 (381)
T ss_pred ccccccCCccccCHHHHcCCC-CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC--------------
Confidence 012346899999999998765 89999999999999999999999988766555444433211110
Q ss_pred hhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 209 LTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.......++++.+++.+++... .++..|.++.+++.||||..
T Consensus 269 ----------------------~~~~~~~s~~~~dli~~ll~~~-----~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 269 ----------------------IPPQVKLSPEAVDLITKLCCSA-----EERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHccCc-----ccccCCCCHHHHhcCcccCC
Confidence 0011123567788888876521 23344688999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=242.20 Aligned_cols=243 Identities=27% Similarity=0.424 Sum_probs=194.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+..+|+-+++.++|.|||+++++...++.+-+|+|||+...-..+-.-++.++.+.+++++.|+++||.|||++++.|
T Consensus 45 pssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlh 124 (292)
T KOG0662|consen 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLH 124 (292)
T ss_pred cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 45667899999999999999999999999999999999985544445556778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh-ccCccCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS-QIGFIGL 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~-tg~~~~~ 175 (303)
||+||+|.+++.+|.+|++|||+++-.+- -......+.|.+|++|.++.|...|+.+.|+||.|||+.|+. .|.+.|-
T Consensus 125 rdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 99999999999999999999999987763 335567788999999999999988999999999999999996 5677888
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCC-CcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSL-DSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
|....+++++++...+.+.....|... .++ +......+.+..|..+ +. .-...-.|++++++.-+|.
T Consensus 205 g~dvddqlkrif~~lg~p~ed~wps~t~lpd-----yk~yp~ypattswsqi--vp-----~lns~grdllqkll~cnp~ 272 (292)
T KOG0662|consen 205 GNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD-----YKPYPIYPATTSWSQI--VP-----KLNSTGRDLLQKLLKCNPA 272 (292)
T ss_pred CCcHHHHHHHHHHHhCCCccccCCccccCCC-----CcccCCccccchHHHH--hh-----hhcchhHHHHHHHhccCcc
Confidence 889999999999988887654443211 111 1111112233333333 21 1223446999999985555
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
-+ +++.++++||||.|..
T Consensus 273 qr-------isaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 273 QR-------ISAEAALQHPYFSDFS 290 (292)
T ss_pred cc-------cCHHHHhcCccccccC
Confidence 55 9999999999998853
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=277.57 Aligned_cols=220 Identities=19% Similarity=0.201 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|..++...+.+++..+..++.|++.||.|||+.||+
T Consensus 44 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~giv 123 (377)
T cd05629 44 QLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123 (377)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34567789999999999999999999999999999999999999999988778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-------------c----------------------------------
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-------------N---------------------------------- 129 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-------------~---------------------------------- 129 (303)
||||||+||+++.++.+||+|||++....... .
T Consensus 124 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (377)
T cd05629 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL 203 (377)
T ss_pred ccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence 99999999999999999999999986321100 0
Q ss_pred -cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhh
Q psy763 130 -YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWD 208 (303)
Q Consensus 130 -~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (303)
.....||+.|+|||++.+.. ++.++||||+||++|||++|..||.+....+....+......+.
T Consensus 204 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 268 (377)
T cd05629 204 MAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY-------------- 268 (377)
T ss_pred cccccCCCccccCHHHHccCC-CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC--------------
Confidence 01246899999999998765 89999999999999999999999887766555554433211110
Q ss_pred hhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 209 LTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.......++++.+++.+|+. .+..+ ..+.++.+++.|||+...
T Consensus 269 ----------------------~p~~~~~s~~~~dli~~lL~-~~~~r----~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 269 ----------------------FPDDIHLSVEAEDLIRRLIT-NAENR----LGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhc-CHhhc----CCCCCHHHHhcCCCcCCC
Confidence 00011234567788888886 33322 224689999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=265.50 Aligned_cols=228 Identities=19% Similarity=0.154 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++|+||+++++++.+++.+++|+||+++|+|...+.. ...+++..+..++.|++.||.|||+.|
T Consensus 43 ~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (285)
T cd05631 43 GEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122 (285)
T ss_pred hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 445677899999999999999999999999999999999999999876643 346899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
++||||||+||+++.++.++|+|||++.............||..|+|||++.+.. ++.++||||+||++|||++|..||
T Consensus 123 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf 201 (285)
T cd05631 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPF 201 (285)
T ss_pred EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999998765444445567899999999998765 899999999999999999999988
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.........+..... . .........++++.+++.+|+..+|.
T Consensus 202 ~~~~~~~~~~~~~~~~~------------------------~------------~~~~~~~~~s~~~~~li~~~l~~~P~ 245 (285)
T cd05631 202 RKRKERVKREEVDRRVK------------------------E------------DQEEYSEKFSEDAKSICRMLLTKNPK 245 (285)
T ss_pred CCCCcchhHHHHHHHhh------------------------c------------ccccCCccCCHHHHHHHHHHhhcCHH
Confidence 76543221111110000 0 00111123456788999999997777
Q ss_pred eeeccccccccccccceeeeeecCCcceE
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPERKCL 283 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 283 (303)
.|-+ .++.++.+++.||||...+.+.+
T Consensus 246 ~R~~--~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 246 ERLG--CRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred HhcC--CCCCCHHHHhcCHhhcCCCHHHH
Confidence 6611 11124899999999987655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=262.58 Aligned_cols=219 Identities=22% Similarity=0.288 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 15 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
..+......|..+|+.++||.++.+|+.|+.++..|++||||+||+|..++++. +.+++..++-++.+++-||.|||.
T Consensus 118 rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm 197 (459)
T KOG0610|consen 118 RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM 197 (459)
T ss_pred hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh
Confidence 344555677888999999999999999999999999999999999999987653 579999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCC---------------------------------C-C----------
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINP---------------------------------G-E---------- 128 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~---------------------------------~-~---------- 128 (303)
.|||+|||||+||||.++|++-|+||.++....- . .
T Consensus 198 lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~ 277 (459)
T KOG0610|consen 198 LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS 277 (459)
T ss_pred hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccc
Confidence 9999999999999999999999999987543210 0 0
Q ss_pred -------------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeE
Q psy763 129 -------------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTV 195 (303)
Q Consensus 129 -------------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (303)
...+.+||-.|.|||++.|.+ .+.++|+|+||+.+|||+.|..||-|....+.+.+++.+..+.+.
T Consensus 278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~ 356 (459)
T KOG0610|consen 278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE 356 (459)
T ss_pred ccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC
Confidence 012357888999999999988 799999999999999999999999999999999888876554320
Q ss_pred eecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeecccccccc----ccccce
Q psy763 196 ILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIR----GKNCKK 271 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~----~~~~l~ 271 (303)
.+...-.+.||++++|+.+|..| .- |.|..+
T Consensus 357 --------------------------------------~~~vs~~akDLIr~LLvKdP~kR-------lg~~rGA~eIK~ 391 (459)
T KOG0610|consen 357 --------------------------------------EPEVSSAAKDLIRKLLVKDPSKR-------LGSKRGAAEIKR 391 (459)
T ss_pred --------------------------------------CCcchhHHHHHHHHHhccChhhh-------hccccchHHhhc
Confidence 01244567899999999877766 66 889999
Q ss_pred eeeeecCC
Q psy763 272 TFYIPTPE 279 (303)
Q Consensus 272 ~~~~~~~~ 279 (303)
||||.-.+
T Consensus 392 HpFF~gVn 399 (459)
T KOG0610|consen 392 HPFFEGVN 399 (459)
T ss_pred CccccCCC
Confidence 99997643
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.16 Aligned_cols=221 Identities=20% Similarity=0.206 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|..++.. ..+++..+..++.|++.||.|||+.||
T Consensus 85 ~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~i 163 (370)
T cd05596 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGF 163 (370)
T ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3445677899999999999999999999999999999999999999998864 468999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCc---cCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDT---LYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~---~~~~~~DvwSlG~il~el~tg 170 (303)
+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+.. .++.++|||||||++|||++|
T Consensus 164 vHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG 243 (370)
T cd05596 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243 (370)
T ss_pred eccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhC
Confidence 999999999999999999999999998764332 223467999999999987542 378999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+.........++.....+. .......+.++.+++.+||.
T Consensus 244 ~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~s~~~~~li~~~L~ 287 (370)
T cd05596 244 DTPFYADSLVGTYSKIMDHKNSLT------------------------------------FPDDIEISKQAKDLICAFLT 287 (370)
T ss_pred CCCcCCCCHHHHHHHHHcCCCcCC------------------------------------CCCcCCCCHHHHHHHHHHcc
Confidence 999988776655554443221110 00111245677888888887
Q ss_pred cccceeeccccccccccccceeeeeecC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
..+... .|.++.+++.|||+...
T Consensus 288 ~~p~r~-----~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 288 DREVRL-----GRNGVDEIKSHPFFKND 310 (370)
T ss_pred Chhhcc-----CCCCHHHHhcCcccCCC
Confidence 544331 24788999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.55 Aligned_cols=218 Identities=20% Similarity=0.242 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i 95 (303)
....+.+|+++++.++||||+++++++...+.+|+||||+++|+|..++.....+++..+..++.|++.||.|||+ .||
T Consensus 38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~i 117 (325)
T cd05594 38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 3445667889999999999999999999999999999999999999988877889999999999999999999997 799
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+||+++.++.+||+|||++.... .........||+.|+|||++.+.. ++.++||||+||++|||++|..||
T Consensus 118 vHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf 196 (325)
T cd05594 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF 196 (325)
T ss_pred EecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCC
Confidence 999999999999999999999999987643 222334467999999999998765 799999999999999999999998
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.....+. ....++++.+++.+|+..+|.
T Consensus 197 ~~~~~~~~~~~i~~~~~~~----------------------------------------p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 197 YNQDHEKLFELILMEEIRF----------------------------------------PRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred CCCCHHHHHHHHhcCCCCC----------------------------------------CCCCCHHHHHHHHHHhhcCHH
Confidence 8776555444332211110 112345667788888776665
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.|- .....++.++++|+|+..
T Consensus 237 ~R~--~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 237 QRL--GGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HhC--CCCCCCHHHHhcCCCcCC
Confidence 551 011127788888888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=268.86 Aligned_cols=170 Identities=26% Similarity=0.300 Sum_probs=148.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+..|+.+++.++||||+++++++..++.+|+||||+++++|...+...+.+++..+..++.|++.||.|||+.|++
T Consensus 43 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 122 (323)
T cd05584 43 DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGII 122 (323)
T ss_pred hHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34556789999999999999999999999999999999999999999988778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++..... ........|++.|+|||.+.+.. ++.++|||||||++|||++|..||.
T Consensus 123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 123 YRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred cCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCC
Confidence 999999999999999999999999875432 22234457899999999998765 7899999999999999999999988
Q ss_pred CCchHHHHHHHh
Q psy763 176 GNMGSHMARNLL 187 (303)
Q Consensus 176 ~~~~~~~~~~~~ 187 (303)
+.........+.
T Consensus 202 ~~~~~~~~~~~~ 213 (323)
T cd05584 202 AENRKKTIDKIL 213 (323)
T ss_pred CCCHHHHHHHHH
Confidence 776655544443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=268.94 Aligned_cols=221 Identities=24% Similarity=0.228 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+..|.++++.+ +||||+++++++...+.+|+||||+++|+|...+.....+++..+..++.|++.||.|||+.||
T Consensus 38 ~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 117 (321)
T cd05591 38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV 117 (321)
T ss_pred HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 334455677777755 7999999999999999999999999999999988877889999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+||+++.++.+||+|||++..... ........||+.|+|||++.+.. ++.++||||+||++|||++|..|+
T Consensus 118 vHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf 196 (321)
T cd05591 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPF 196 (321)
T ss_pred eccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCC
Confidence 9999999999999999999999999876432 22334467899999999988665 899999999999999999999998
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+....... ....++++.+++.+||..+|.
T Consensus 197 ~~~~~~~~~~~i~~~~~~~----------------------------------------p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 197 EADNEDDLFESILHDDVLY----------------------------------------PVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred CCCCHHHHHHHHHcCCCCC----------------------------------------CCCCCHHHHHHHHHHhccCHH
Confidence 8777666555443321110 011235677888888887776
Q ss_pred eeeccccccccccccceeeeeecC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.|-.-.....++.++++|||+...
T Consensus 237 ~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 237 KRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HcCCCCCCCCCHHHHhcCCccCCC
Confidence 662222222278889999998663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=279.35 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=182.9
Q ss_pred HHHHHHHHhCC------CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 22 ATNKKEKRSLK------HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 22 ~~e~~~l~~l~------h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..|+++|..++ --|+|+++++|...+|+|||+|.++ -+|.++++.+ .+++...++.++.||+.||.+||+.
T Consensus 230 ~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l 308 (586)
T KOG0667|consen 230 QIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL 308 (586)
T ss_pred HHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34566666665 4569999999999999999999997 7788887765 4799999999999999999999999
Q ss_pred CceecccCCCcEEEecC--CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 94 ACIHRDIKPENILLTAN--GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
||+|+||||+|||+... ..|||+|||+|.+.... ..+..-++.|+|||+++|.+ |+.+.||||||||++||++|.
T Consensus 309 ~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~--vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~ 385 (586)
T KOG0667|consen 309 GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR--VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGE 385 (586)
T ss_pred CeeeccCChhheeeccCCcCceeEEecccccccCCc--ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCc
Confidence 99999999999999754 47999999999886543 23778899999999999987 999999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEee-cCCCCCcchh---hhhhh-hhhcC----C---ChhHHH-HHHhHhCC------
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVIL-KSDSLDSETW---DLTWQ-EIFSK----T---STTTIF-KYLLIRGG------ 232 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~-~~~~~----~---~~~~~~-~~l~~~~~------ 232 (303)
+.|.|.+..+++..+++..|.++... ....-..... ...+. +.... . ..+... ........
T Consensus 386 PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~ 465 (586)
T KOG0667|consen 386 PLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRS 465 (586)
T ss_pred cccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcc
Confidence 99999999999999999877655322 1110000000 00011 00000 0 000000 00000001
Q ss_pred ----CCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 233 ----NTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 233 ----~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
....++...+|++.+||.-+|..| +++.++++|||+..
T Consensus 466 l~~~~~~~~~~~F~dflk~~L~~dP~~R-------~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 466 LESGLPKADDKLFIDFLKRCLEWDPAER-------ITPAQALNHPFLTG 507 (586)
T ss_pred cchhcccccHHHHHHHHHHHhccCchhc-------CCHHHHhcCccccc
Confidence 112456677899999999777666 99999999999994
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=268.13 Aligned_cols=215 Identities=24% Similarity=0.355 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
+...+|+.+++++.|||||+++++..+. +.+|||+|||..|.+...-.....+++.+++.+++.++.||.|||.+||+
T Consensus 153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgii 232 (576)
T KOG0585|consen 153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGII 232 (576)
T ss_pred HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCee
Confidence 5678999999999999999999999865 47999999999988776543222399999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC------CccccccCCCcccCcccccCC---ccCCCccchhhHHHHHHHh
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG------ENYTDYVATRWYRAPELLVGD---TLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~---~~~~~~~DvwSlG~il~el 167 (303)
||||||+|+|++++|++||+|||.+.....+ ......+|||.|+|||.+.+. ...+.+.||||+||+||.|
T Consensus 233 HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl 312 (576)
T KOG0585|consen 233 HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL 312 (576)
T ss_pred ccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence 9999999999999999999999999876322 122346899999999999862 2247799999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
+-|..||.+....+...+|....-..+ -.+...+.+-|+|.+
T Consensus 313 lfG~~PF~~~~~~~l~~KIvn~pL~fP--------------------------------------~~pe~~e~~kDli~~ 354 (576)
T KOG0585|consen 313 LFGQLPFFDDFELELFDKIVNDPLEFP--------------------------------------ENPEINEDLKDLIKR 354 (576)
T ss_pred hhccCCcccchHHHHHHHHhcCcccCC--------------------------------------CcccccHHHHHHHHH
Confidence 999999999998888877765432211 111234566799999
Q ss_pred hhccccceeeccccccccccccceeeeeecC
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
||..++..| ++..+...|||.-.+
T Consensus 355 lL~KdP~~R-------i~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 355 LLEKDPEQR-------ITLPDIKLHPWVTRD 378 (576)
T ss_pred HhhcChhhe-------eehhhheecceeccC
Confidence 999877777 999999999999775
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.41 Aligned_cols=169 Identities=22% Similarity=0.250 Sum_probs=146.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++.+.+++.+|+||||+++|+|.+++...+.+++..+..++.||+.||+|||+.||+
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 123 (376)
T cd05598 44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123 (376)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 44567789999999999999999999999999999999999999999988878899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC--------------------------------------------Ccccc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG--------------------------------------------ENYTD 132 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~--------------------------------------------~~~~~ 132 (303)
||||||+||+++.++.+||+|||+|...... .....
T Consensus 124 HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (376)
T cd05598 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS 203 (376)
T ss_pred eCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence 9999999999999999999999997432100 00112
Q ss_pred ccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHH
Q psy763 133 YVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNL 186 (303)
Q Consensus 133 ~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~ 186 (303)
..||+.|+|||++.+.. ++.++||||+||++|||++|..||.+....+....+
T Consensus 204 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 204 LVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256 (376)
T ss_pred cCCCccccCHHHHcCCC-CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH
Confidence 46899999999998766 799999999999999999999999887765554433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=267.58 Aligned_cols=212 Identities=22% Similarity=0.242 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+..|..+++.+ +||||+++++++...+.+|+||||+++|+|..++.....+++..+..++.|++.||.|||+.|++
T Consensus 39 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~iv 118 (320)
T cd05590 39 VECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII 118 (320)
T ss_pred HHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 34455666666655 79999999999999999999999999999999888778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++..... ........||+.|+|||.+.+.. ++.++||||+||++|||++|..||.
T Consensus 119 H~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred eCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCC
Confidence 999999999999999999999999876432 22334467899999999998665 7999999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+....... ....++++.+++.+|+..+|..
T Consensus 198 ~~~~~~~~~~i~~~~~~~----------------------------------------~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 198 AENEDDLFEAILNDEVVY----------------------------------------PTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CCCHHHHHHHHhcCCCCC----------------------------------------CCCCCHHHHHHHHHHcccCHHH
Confidence 777666555443321110 0112456678888888866665
Q ss_pred eeccccccccc------cccceeeeeec
Q psy763 256 IQSEKQDSIRG------KNCKKTFYIPT 277 (303)
Q Consensus 256 ~~~~~~~~~~~------~~~l~~~~~~~ 277 (303)
| +++ ++++.||||..
T Consensus 238 R-------~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 R-------LGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred C-------CCCCCCCCHHHHHcCCCcCC
Confidence 5 666 77888998865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.09 Aligned_cols=218 Identities=21% Similarity=0.240 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++++.+++.+|+||||+++++|..++...+.+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44566888999999999999999999999999999999999999999998877889999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC------------------------------ccccccCCCcccCcccc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE------------------------------NYTDYVATRWYRAPELL 145 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~l 145 (303)
+||||||+||+++.++.+||+|||++....... ......||+.|+|||.+
T Consensus 123 iH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (350)
T cd05573 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202 (350)
T ss_pred eccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 999999999999999999999999987654332 12345789999999999
Q ss_pred cCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 146 VGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 146 ~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.+.. ++.++|||||||++|||++|..|+.+.........+........
T Consensus 203 ~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------- 250 (350)
T cd05573 203 RGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLR------------------------------- 250 (350)
T ss_pred cCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCccc-------------------------------
Confidence 8765 89999999999999999999999988776665554443211110
Q ss_pred HHhHhCCCCCCCchhhHHhhhhhhccccceeecccccccc-ccccceeeeeecC
Q psy763 226 YLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIR-GKNCKKTFYIPTP 278 (303)
Q Consensus 226 ~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~ 278 (303)
.......++++.+++.+|+. .+..| ++ +.+++.|||+...
T Consensus 251 -----~p~~~~~~~~~~~li~~ll~-dp~~R-------~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 251 -----FPPDPPVSPEAIDLICRLLC-DPEDR-------LGSFEEIKSHPFFKGI 291 (350)
T ss_pred -----CCCCCCCCHHHHHHHHHHcc-Chhhc-------CCCHHHHhcCCCcCCC
Confidence 00011135667788877775 44444 77 9999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=267.71 Aligned_cols=211 Identities=21% Similarity=0.266 Sum_probs=165.2
Q ss_pred HHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCc
Q psy763 25 KKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPEN 104 (303)
Q Consensus 25 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~n 104 (303)
...++.++||||+++++++..++..|+||||+++++|...+.. +.+++..+..++.|++.||.|||+.|++||||||+|
T Consensus 53 ~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~N 131 (324)
T cd05589 53 FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131 (324)
T ss_pred HHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHH
Confidence 3445677899999999999999999999999999999988764 479999999999999999999999999999999999
Q ss_pred EEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHH
Q psy763 105 ILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMA 183 (303)
Q Consensus 105 il~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~ 183 (303)
|+++.++.+||+|||++..... ........|++.|+|||.+.+.. ++.++|+|||||++|||++|..|+.+....+..
T Consensus 132 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 132 LLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred eEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999875332 22334567899999999998765 799999999999999999999998877666555
Q ss_pred HHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeecccccc
Q psy763 184 RNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDS 263 (303)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~ 263 (303)
..+....... ....++.+.+++.+||..+|..|-. ...
T Consensus 211 ~~i~~~~~~~----------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~--~~~ 248 (324)
T cd05589 211 DSIVNDEVRY----------------------------------------PRFLSREAISIMRRLLRRNPERRLG--SGE 248 (324)
T ss_pred HHHHhCCCCC----------------------------------------CCCCCHHHHHHHHHHhhcCHhHcCC--CCC
Confidence 5443322111 0112345567777777766655511 111
Q ss_pred ccccccceeeeeecCC
Q psy763 264 IRGKNCKKTFYIPTPE 279 (303)
Q Consensus 264 ~~~~~~l~~~~~~~~~ 279 (303)
.++.++++||||.+..
T Consensus 249 ~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 249 KDAEDVKKQPFFRDIN 264 (324)
T ss_pred CCHHHHhhCCCcCCCC
Confidence 2577778888776643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=274.43 Aligned_cols=244 Identities=23% Similarity=0.257 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+.+++.++||||+++++++..+...++|+|++. +++..++.....+++..++.++.|++.||.|||+.||+||
T Consensus 128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHr 206 (391)
T PHA03212 128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHR 206 (391)
T ss_pred hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 446789999999999999999999999999999999997 6677777666789999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCC--CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPG--ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||+||+++.++.+||+|||++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|..++++
T Consensus 207 DiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 207 DIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred CCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 99999999999999999999998754321 2233457999999999998765 89999999999999999999987765
Q ss_pred Cc-------hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh----cCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 177 NM-------GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF----SKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 177 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
.. ....+..++...+..+.....+ ........+.... ..+..++....+ ...+.++.+++
T Consensus 286 ~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~Li 356 (391)
T PHA03212 286 KDGLDGDCDSDRQIKLIIRRSGTHPNEFPID--AQANLDEIYIGLAKKSSRKPGSRPLWTNL-------YELPIDLEYLI 356 (391)
T ss_pred cccccccCchhHHHHHHHHHhcCChhhcCcc--hhHHHHHHHHHHHhccCCCCCCCCCHHHH-------hhhhhhHHHHH
Confidence 42 2334444554444332111100 0011111111111 111112211110 01244678899
Q ss_pred hhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
.+||..+|..| +++.+++.||||...+.
T Consensus 357 ~~mL~~dP~~R-------pta~elL~hp~f~~~~~ 384 (391)
T PHA03212 357 CKMLAFDAHHR-------PSAEALLDFAAFQDIPD 384 (391)
T ss_pred HHHhcCChhhC-------CCHHHHhcChhhccCCC
Confidence 99999777666 99999999999977443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=272.70 Aligned_cols=172 Identities=23% Similarity=0.255 Sum_probs=150.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++.+.+++.+|+||||+++|+|..++.+.+.+++..+..++.|++.||.|||+.||
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~gi 122 (360)
T cd05627 43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122 (360)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34556778899999999999999999999999999999999999999998877889999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC------------------------------------ccccccCCCcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE------------------------------------NYTDYVATRWY 139 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~~~~y 139 (303)
+||||||+||+++.++.++|+|||++....... .....+||+.|
T Consensus 123 vHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 202 (360)
T cd05627 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202 (360)
T ss_pred EccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccc
Confidence 999999999999999999999999986542110 01134689999
Q ss_pred cCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhh
Q psy763 140 RAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLK 188 (303)
Q Consensus 140 ~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~ 188 (303)
+|||++.+.. ++.++||||+||++|||++|..||.+.........++.
T Consensus 203 ~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~ 250 (360)
T cd05627 203 IAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN 250 (360)
T ss_pred cCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHc
Confidence 9999998766 89999999999999999999999988777666555443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=250.07 Aligned_cols=216 Identities=20% Similarity=0.270 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc--CCCCCCHHHHHHHHHHHHHHHHH
Q psy763 12 YKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN--HPHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 12 ~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
..+...+..+.+|+++.+.|+||||+++|++|.+...+|+++||...|.+...+. ....+++.....++.|++.|+.|
T Consensus 60 i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y 139 (281)
T KOG0580|consen 60 ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLY 139 (281)
T ss_pred HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHH
Confidence 4444567788999999999999999999999999999999999999999988887 55689999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
||..+++||||||+|+|++..+.+|++|||.+.... .....+.+||..|.+||...+.. ++..+|+|++|++.||++.
T Consensus 140 ~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflv 217 (281)
T KOG0580|consen 140 CHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLV 217 (281)
T ss_pred hccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999999887654 56678889999999999999877 7999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|.+||...+..+..+++.+..... ....+.++-|++.+++
T Consensus 218 g~ppFes~~~~etYkrI~k~~~~~----------------------------------------p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 218 GLPPFESQSHSETYKRIRKVDLKF----------------------------------------PSTISGGAADLISRLL 257 (281)
T ss_pred cCCchhhhhhHHHHHHHHHccccC----------------------------------------CcccChhHHHHHHHHh
Confidence 999998887777666555432221 1335678889999998
Q ss_pred ccccceeeccccccccccccceeeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
...+..+ ....+.+.|||+-
T Consensus 258 ~~~p~~r-------~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 258 VKNPIER-------LALTEVMDHPWIV 277 (281)
T ss_pred ccCcccc-------ccHHHHhhhHHHH
Confidence 8555554 9999999999974
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=271.41 Aligned_cols=171 Identities=24% Similarity=0.277 Sum_probs=149.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|..++... .+++..+..++.||+.||.|||++||+
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~Iv 164 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLI 164 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 4556778999999999999999999999999999999999999999988654 689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCc---cCCCccchhhHHHHHHHhhccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDT---LYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~---~~~~~~DvwSlG~il~el~tg~ 171 (303)
||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+.+ .++.++|+||+||++|||++|.
T Consensus 165 HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~ 244 (370)
T cd05621 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 244 (370)
T ss_pred ecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence 999999999999999999999999987643222 23567999999999987542 3688999999999999999999
Q ss_pred ccCCCCchHHHHHHHhh
Q psy763 172 FIGLGNMGSHMARNLLK 188 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~ 188 (303)
.||.+.........++.
T Consensus 245 ~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 245 TPFYADSLVGTYSKIMD 261 (370)
T ss_pred CCCCCCCHHHHHHHHHh
Confidence 99988776666555544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=266.08 Aligned_cols=168 Identities=26% Similarity=0.312 Sum_probs=145.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.++..+++.++||||+++++.+...+..|+||||+++|+|..++.....+++..+..++.||+.||.|||++||+||
T Consensus 41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~ 120 (323)
T cd05575 41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120 (323)
T ss_pred HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 33444455678899999999999999999999999999999999988888889999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||||+|||++.++.+||+|||++..... ........||+.|+|||.+.+.. ++.++|||||||++|||++|..||.+.
T Consensus 121 dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred CCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCC
Confidence 9999999999999999999999875432 22334457899999999998765 899999999999999999999999887
Q ss_pred chHHHHHHHh
Q psy763 178 MGSHMARNLL 187 (303)
Q Consensus 178 ~~~~~~~~~~ 187 (303)
...+....++
T Consensus 200 ~~~~~~~~i~ 209 (323)
T cd05575 200 DTAEMYDNIL 209 (323)
T ss_pred CHHHHHHHHH
Confidence 6666555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=273.65 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=187.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+.+++.++||||+++++++...+ ..|+|+||+. +++...+.....+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 121 (372)
T cd07853 43 CKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121 (372)
T ss_pred HHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345778999999999999999999998776 7899999997 5677767667789999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
.|++||||||+||+++.++.+||+|||++....... ......+++.|+|||.+.+...++.++||||+||++|||++|
T Consensus 122 ~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 201 (372)
T cd07853 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201 (372)
T ss_pred CCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC
Confidence 999999999999999999999999999998754322 223346789999999998766689999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..+|.+....+....+....+.++..... .........+...+...+.... .........+++.+++.+|+.
T Consensus 202 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~mL~ 273 (372)
T cd07853 202 RILFQAQSPIQQLDLITDLLGTPSLEAMR-----SACEGARAHILRGPHKPPSLPV---LYTLSSQATHEAVHLLCRMLV 273 (372)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCHHHHH-----HhhHHHHHHHHhCCCCCCchHH---hcccCCCCCHHHHHHHHHhCC
Confidence 99999988888877776654443210000 0000111112222222221111 011223347788999999999
Q ss_pred cccceeeccccccccccccceeeeeecC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.+|..| +++.+++.|||+...
T Consensus 274 ~dP~~R-------~t~~e~l~hp~~~~~ 294 (372)
T cd07853 274 FDPDKR-------ISAADALAHPYLDEG 294 (372)
T ss_pred CChhhC-------cCHHHHhcCHhhCCC
Confidence 777766 999999999998763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=269.28 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+.+++.++||||+++++++... ..+|+||||++ +++..++.....+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~ 121 (338)
T cd07859 43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121 (338)
T ss_pred HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999998643 35899999996 6788887777789999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHh
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el 167 (303)
+||+||||||+||+++.++.+||+|||++....... ......+|+.|+|||++.+. ..++.++||||+||++|||
T Consensus 122 ~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el 201 (338)
T cd07859 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201 (338)
T ss_pred CCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHH
Confidence 999999999999999999999999999987643211 11345789999999998652 3479999999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
++|..||.+.........+....+.++..... ..........+..+.. ....+... ..+...+.+.+++.+
T Consensus 202 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~li~~ 272 (338)
T cd07859 202 LTGKPLFPGKNVVHQLDLITDLLGTPSPETIS-RVRNEKARRYLSSMRK-KQPVPFSQ-------KFPNADPLALRLLER 272 (338)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH-HhhhhhHHHHHHhhcc-cCCCchHH-------hcCCCChHHHHHHHH
Confidence 99999988877666555444433332110000 0000000000111111 11111111 112345678899999
Q ss_pred hhccccceeeccccccccccccceeeeeecCCc
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
|+..+|..| +++.+++.||||.....
T Consensus 273 ~l~~~P~~R-------pt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 273 LLAFDPKDR-------PTAEEALADPYFKGLAK 298 (338)
T ss_pred HcCcCcccC-------CCHHHHhcCchhhhcCc
Confidence 998666666 99999999999977554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=268.83 Aligned_cols=220 Identities=20% Similarity=0.189 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 15 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
......+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|..++... ..+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 121 (330)
T cd05601 42 QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121 (330)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 335566788999999999999999999999999999999999999999988765 6899999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccC-----CccCCCccchhhHHHHHHH
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVG-----DTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~-----~~~~~~~~DvwSlG~il~e 166 (303)
||+||||||+||+++.++.+||+|||++........ .....+|+.|+|||++.+ ...++.++|||||||++||
T Consensus 122 ~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 999999999999999999999999999987654322 233468999999999863 3347899999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
|++|..||.+.........++...... .........+.+.++++
T Consensus 202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------~~~~~~~~~~~~~~li~ 245 (330)
T cd05601 202 MIYGRSPFHEGTSAKTYNNIMNFQRFL------------------------------------KFPEDPKVSSDFLDLIQ 245 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCcc------------------------------------CCCCCCCCCHHHHHHHH
Confidence 999999988776665555443321110 00111224566778888
Q ss_pred hhhccccceeeccccccccccccceeeeeecC
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+|+. ++..| +++.+++.|||+...
T Consensus 246 ~ll~-~p~~R-------~t~~~l~~h~~~~~~ 269 (330)
T cd05601 246 SLLC-GQKER-------LGYEGLCCHPFFSKI 269 (330)
T ss_pred HHcc-ChhhC-------CCHHHHhCCCCcCCC
Confidence 8775 55555 999999999998764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=278.37 Aligned_cols=240 Identities=23% Similarity=0.366 Sum_probs=179.0
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeC--------CEEEEEEecCCCCcHHHHH----cCCCCCCHHHHHHHHHHHHHHHH
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRK--------KKLHLVFEFCDHTVLNELE----NHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~----~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
..+|+.+++.++||||+++++++... ..+++||||++++ +..++ .....+++..++.++.|++.||.
T Consensus 106 ~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~ 184 (440)
T PTZ00036 106 KNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT-VHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184 (440)
T ss_pred HHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCcc-HHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence 35689999999999999999987532 2467999999865 43332 34567999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCC-cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHh
Q psy763 89 YCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el 167 (303)
|||+.||+||||||+|||++.++ .+||+|||+|.............+|+.|+|||++.+...++.++||||+||++|||
T Consensus 185 yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred HHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999998664 79999999998766554445567899999999988766689999999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
++|..||.+....+.+..++...+.+...... ...+...... +.......+... .....++++.+++.+
T Consensus 265 ltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~-~~~~~~~~~~----~~~~~~~~l~~~------~p~~~~~~~~~li~~ 333 (440)
T PTZ00036 265 ILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK-EMNPNYADIK----FPDVKPKDLKKV------FPKGTPDDAINFISQ 333 (440)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH-Hhchhhhccc----CCccCchhHHHH------hccCCCHHHHHHHHH
Confidence 99999999988888877777655443211000 0000000000 011111112111 122356789999999
Q ss_pred hhccccceeeccccccccccccceeeeeecCC
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
||...|..| +++.+++.||||.+..
T Consensus 334 ~L~~dP~~R-------~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 334 FLKYEPLKR-------LNPIEALADPFFDDLR 358 (440)
T ss_pred HCCCChhHC-------cCHHHHhCChhHHhhh
Confidence 998666666 9999999999997643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.14 Aligned_cols=215 Identities=23% Similarity=0.284 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+..|..+++.+ +||||+++++++...+.+|+||||+++|+|...+.+...+++..+..++.|++.||+|||+.|+
T Consensus 38 ~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i 117 (318)
T cd05570 38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI 117 (318)
T ss_pred HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 344556677777777 6999999999999999999999999999999988877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||||+||+++.++.++|+|||++.... .........+++.|+|||++.+.. ++.++|+||+||++|+|++|..||
T Consensus 118 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf 196 (318)
T cd05570 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPF 196 (318)
T ss_pred EccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCC
Confidence 999999999999999999999999987532 222234457899999999998765 899999999999999999999998
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+...... .....+..+.+++.+|+..+|.
T Consensus 197 ~~~~~~~~~~~i~~~~~~----------------------------------------~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 197 EGDDEDELFQSILEDEVR----------------------------------------YPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred CCCCHHHHHHHHHcCCCC----------------------------------------CCCcCCHHHHHHHHHHccCCHH
Confidence 776655544433221110 0112345667888888886666
Q ss_pred eeeccccccccc-----cccceeeeeecCC
Q psy763 255 YIQSEKQDSIRG-----KNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~-----~~~l~~~~~~~~~ 279 (303)
.| +++ .+++.|||+...+
T Consensus 237 ~R-------~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 237 KR-------LGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred Hc-------CCCCCCCHHHHhcCCCcCCCC
Confidence 66 887 8999999886643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=266.82 Aligned_cols=228 Identities=24% Similarity=0.257 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|..+++.+ +||||+++++++...+.+|+||||+++|+|..++.+.+.+++..+..++.|++.||.|||++|+
T Consensus 38 ~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 117 (329)
T cd05588 38 DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGI 117 (329)
T ss_pred HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345567788888888 7999999999999999999999999999999888777889999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeee-CCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+||+++.++.+||+|||++... ..........||+.|+|||++.+.. ++.++|+||+||++|||++|..||
T Consensus 118 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf 196 (329)
T cd05588 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred EecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCc
Confidence 99999999999999999999999998753 2233344567899999999998765 799999999999999999999887
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
....... .+. ....+..++.+... ........++.+.+++.+|+..+|.
T Consensus 197 ~~~~~~~----------------~~~---~~~~~~~~~~~~~~------------~~~~p~~~~~~~~~li~~~L~~dP~ 245 (329)
T cd05588 197 DIVGMSD----------------NPD---QNTEDYLFQVILEK------------QIRIPRSLSVKASSVLKGFLNKDPK 245 (329)
T ss_pred ccccccc----------------ccc---ccchHHHHHHHHcC------------CCCCCCCCCHHHHHHHHHHhccCHH
Confidence 5321000 000 00000011111110 0011123456778999999987776
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.|-+. ....+..+++.||||..
T Consensus 246 ~R~~~-~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 246 ERLGC-HPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HcCCC-CCCCCHHHHhcCCCCCC
Confidence 66110 00123678999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=263.10 Aligned_cols=166 Identities=22% Similarity=0.278 Sum_probs=142.7
Q ss_pred HHHHHHHHHHH-hCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKR-SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.....|..+++ ..+||||+++++++...+.+|+||||+.+|+|..++.....+++..+..++.|++.||+|||++||+|
T Consensus 40 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 119 (316)
T cd05620 40 ECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119 (316)
T ss_pred HHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 33444555555 45899999999999999999999999999999998887778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.++|+|||++..... ........||+.|+|||++.+.. ++.++||||+||++|||++|..|+.+
T Consensus 120 rDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999875332 22334567899999999998765 89999999999999999999999887
Q ss_pred CchHHHHHH
Q psy763 177 NMGSHMARN 185 (303)
Q Consensus 177 ~~~~~~~~~ 185 (303)
....+....
T Consensus 199 ~~~~~~~~~ 207 (316)
T cd05620 199 DDEDELFES 207 (316)
T ss_pred CCHHHHHHH
Confidence 766555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=263.68 Aligned_cols=168 Identities=28% Similarity=0.312 Sum_probs=144.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.++..+++.++||||+++++++.+.+..|+||||+++|+|...+.....+++..+..++.||+.||.|||+.||+|
T Consensus 40 ~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH 119 (321)
T cd05603 40 NHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119 (321)
T ss_pred HHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 33444445578899999999999999999999999999999999988877778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++.... .........||+.|+|||.+.+.. ++.++||||+||++|||++|..|+.+
T Consensus 120 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred ccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCC
Confidence 9999999999999999999999987532 222334467899999999998665 89999999999999999999999988
Q ss_pred CchHHHHHHH
Q psy763 177 NMGSHMARNL 186 (303)
Q Consensus 177 ~~~~~~~~~~ 186 (303)
....+....+
T Consensus 199 ~~~~~~~~~i 208 (321)
T cd05603 199 RDVSQMYDNI 208 (321)
T ss_pred CCHHHHHHHH
Confidence 7665554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=258.69 Aligned_cols=228 Identities=23% Similarity=0.281 Sum_probs=181.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
-..+.+|+..++.++||||++++..|..++.+++||.||.+|++.++++.. ..+++..+..++++++.||.|||.+|.
T Consensus 68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~ 147 (516)
T KOG0582|consen 68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH 147 (516)
T ss_pred HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence 467889999999999999999999999999999999999999999987653 469999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc----c-ccccCCCcccCccccc-CCccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN----Y-TDYVATRWYRAPELLV-GDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~-~~~~~~~~y~aPE~l~-~~~~~~~~~DvwSlG~il~el~t 169 (303)
+|||+|+.|||++++|.|||+|||.+-.+..... . .+.+||+.|+|||++. .-..|+.++||||||++..|+.+
T Consensus 148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 9999999999999999999999998776543321 1 4568999999999965 33449999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..||....+.+++..-+++..+-+ . ....+.+ ...+ ..-.+..++..||
T Consensus 228 G~aPf~k~pPmkvLl~tLqn~pp~~--~-t~~~~~d----------------~~k~-----------~~ksf~e~i~~CL 277 (516)
T KOG0582|consen 228 GHAPFSKYPPMKVLLLTLQNDPPTL--L-TSGLDKD----------------EDKK-----------FSKSFREMIALCL 277 (516)
T ss_pred CCCCcccCChHHHHHHHhcCCCCCc--c-cccCChH----------------Hhhh-----------hcHHHHHHHHHHh
Confidence 9999988888887766555433211 1 1111100 0001 1114557777788
Q ss_pred ccccceeeccccccccccccceeeeeecCCcce
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
+.+|..| +++.++++|+||...-.+.
T Consensus 278 ~kDP~kR-------ptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 278 VKDPSKR-------PTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred hcCcccC-------CCHHHHhccHHHhhccchh
Confidence 7666665 9999999999987654443
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=262.50 Aligned_cols=165 Identities=22% Similarity=0.335 Sum_probs=143.0
Q ss_pred HHHHHHHH-hCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Q psy763 22 ATNKKEKR-SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 100 (303)
Q Consensus 22 ~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 100 (303)
..|..++. ..+||||+++++++..++.+|+||||+++|+|..++.....+++..+..++.|++.||.|||+.||+||||
T Consensus 43 ~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl 122 (316)
T cd05592 43 MVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122 (316)
T ss_pred HHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 33444444 46899999999999999999999999999999998887778999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCch
Q psy763 101 KPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMG 179 (303)
Q Consensus 101 k~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~ 179 (303)
||+||+++.++.+||+|||++..... ........||+.|+|||.+.+.. ++.++||||+||++|||++|..|+.+...
T Consensus 123 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred CHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999976532 22334567899999999998765 89999999999999999999999988776
Q ss_pred HHHHHHHh
Q psy763 180 SHMARNLL 187 (303)
Q Consensus 180 ~~~~~~~~ 187 (303)
.+....+.
T Consensus 202 ~~~~~~i~ 209 (316)
T cd05592 202 DELFDSIL 209 (316)
T ss_pred HHHHHHHH
Confidence 66655443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=268.01 Aligned_cols=172 Identities=23% Similarity=0.282 Sum_probs=150.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++.+|+||||+++|+|..++... .+++..+..++.|++.||.|||++||+
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv 164 (371)
T cd05622 86 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI 164 (371)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 4556788999999999999999999999999999999999999999988654 689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCc---cCCCccchhhHHHHHHHhhccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDT---LYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~---~~~~~~DvwSlG~il~el~tg~ 171 (303)
||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+.. .++.++||||+||++|||++|.
T Consensus 165 HrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred eCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence 99999999999999999999999998765332 223567999999999987542 3788999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhc
Q psy763 172 FIGLGNMGSHMARNLLKN 189 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~ 189 (303)
.||.+.........++..
T Consensus 245 ~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 245 TPFYADSLVGTYSKIMNH 262 (371)
T ss_pred CCCCCCCHHHHHHHHHcC
Confidence 999888776666655543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=262.78 Aligned_cols=170 Identities=21% Similarity=0.266 Sum_probs=146.6
Q ss_pred HHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHP-NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+..|+++++.++|+ +|+++++++...+.+|+||||+++|+|..++.....+++..+..++.|++.||.|||+.||
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 122 (324)
T cd05587 43 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122 (324)
T ss_pred HHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345566788888888765 5888999999999999999999999999988877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+|||++.++.+||+|||++.... .........||+.|+|||++.+.. ++.++||||+||++|||++|..|+
T Consensus 123 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf 201 (324)
T cd05587 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPF 201 (324)
T ss_pred EecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence 999999999999999999999999987532 222334567899999999998766 799999999999999999999998
Q ss_pred CCCchHHHHHHHh
Q psy763 175 LGNMGSHMARNLL 187 (303)
Q Consensus 175 ~~~~~~~~~~~~~ 187 (303)
.+....+....+.
T Consensus 202 ~~~~~~~~~~~i~ 214 (324)
T cd05587 202 DGEDEDELFQSIM 214 (324)
T ss_pred CCCCHHHHHHHHH
Confidence 8777666655443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=263.31 Aligned_cols=169 Identities=24% Similarity=0.280 Sum_probs=147.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.++..+++.++||||+++++++...+.+|+||||+++|+|..++.....+++..+..++.|++.||.|||+.||+||
T Consensus 41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHr 120 (325)
T cd05602 41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120 (325)
T ss_pred HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 33444455678899999999999999999999999999999999998877889999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||||+||+++.++.+||+|||++.... .........||+.|+|||++.+.. ++.++||||+||++|||++|..||.+.
T Consensus 121 Dlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred CCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCC
Confidence 999999999999999999999987543 222334567999999999998765 899999999999999999999999887
Q ss_pred chHHHHHHHhh
Q psy763 178 MGSHMARNLLK 188 (303)
Q Consensus 178 ~~~~~~~~~~~ 188 (303)
...+....+..
T Consensus 200 ~~~~~~~~i~~ 210 (325)
T cd05602 200 NTAEMYDNILN 210 (325)
T ss_pred CHHHHHHHHHh
Confidence 77666555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.85 Aligned_cols=166 Identities=27% Similarity=0.316 Sum_probs=144.7
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 100 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 100 (303)
..++..+++.++||||+++++++..++..|+||||+++|+|...+.....+++..+..++.||+.||.|||+.|++||||
T Consensus 43 ~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dl 122 (325)
T cd05604 43 MAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122 (325)
T ss_pred HHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 33444567889999999999999999999999999999999998887788999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCch
Q psy763 101 KPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMG 179 (303)
Q Consensus 101 k~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~ 179 (303)
||+||+++.++.+||+|||++.... .........||+.|+|||.+.+.. ++.++||||+||++|||++|..||.+...
T Consensus 123 kp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 123 KPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred CHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCH
Confidence 9999999999999999999987543 222334567899999999998765 79999999999999999999999988776
Q ss_pred HHHHHHHh
Q psy763 180 SHMARNLL 187 (303)
Q Consensus 180 ~~~~~~~~ 187 (303)
.+....++
T Consensus 202 ~~~~~~~~ 209 (325)
T cd05604 202 AEMYDNIL 209 (325)
T ss_pred HHHHHHHH
Confidence 66555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=265.94 Aligned_cols=225 Identities=20% Similarity=0.198 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.....+..|+.+++.+ +||||+++++++..++.+++||||+++|+|..++.....+++..+..++.|++.||.|||+.|
T Consensus 46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 125 (332)
T cd05614 46 KTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125 (332)
T ss_pred hHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3445677888999999 599999999999999999999999999999998877778999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|+||||||+|||++.++.+||+|||++....... ......||+.|+|||.+.+...++.++|||||||++|||++|..
T Consensus 126 ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~ 205 (332)
T cd05614 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205 (332)
T ss_pred cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCC
Confidence 9999999999999999999999999987654322 22345789999999999876557899999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+.+.........+ ...... .........++.+.+++.+|+..+
T Consensus 206 pf~~~~~~~~~~~~------------------------~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~d 249 (332)
T cd05614 206 PFTLEGERNTQSEV------------------------SRRILK------------CDPPFPSFIGPEAQDLLHKLLRKD 249 (332)
T ss_pred CCCCCCCCCCHHHH------------------------HHHHhc------------CCCCCCCCCCHHHHHHHHHHcCCC
Confidence 87532111000000 000000 011112234567789999999877
Q ss_pred cceeeccccccccccccceeeeeecC
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+..|- .....++.+++.|||+.+.
T Consensus 250 p~~R~--~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 250 PKKRL--GAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHcC--CCCCCCHHHHHcCCCcCCC
Confidence 76661 0111177899999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.87 Aligned_cols=241 Identities=26% Similarity=0.431 Sum_probs=181.2
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+.+|+.+++.++||||+++++++..++..++||||+++ ++..++ ..+..+++..+..++.|++.||.|||+.||+||
T Consensus 50 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~ 128 (309)
T cd07872 50 TAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128 (309)
T ss_pred hHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 456789999999999999999999999999999999986 455544 444568999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+...++.++||||+||++|+|++|..||.+.
T Consensus 129 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred CCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765422 22234567899999999877666899999999999999999999999888
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh-cCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF-SKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
...+....+....+.+.....+...... .+.... ......++. ...+..++++.+++.+||..++..|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R 277 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSND----EFKNYNFPKYKPQPLI-------NHAPRLDTEGIELLTKFLQYESKKR 277 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchh----hhhhhhcCccCCCchh-------hhccCCCHHHHHHHHHhccCChhhC
Confidence 7777766666654433211111100000 000000 000011110 0112356788999999999777666
Q ss_pred eccccccccccccceeeeeecCC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+++.+++.||||....
T Consensus 278 -------~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 278 -------ISAEEAMKHAYFRSLG 293 (309)
T ss_pred -------CCHHHHhcChhhhhcc
Confidence 9999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=265.33 Aligned_cols=169 Identities=22% Similarity=0.255 Sum_probs=148.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+..|+.+++.++||||+++++++..++.+|+||||+++|+|..++.+...+++..+..++.|++.||.|||+.|++|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 42 RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 34567788999999999999999999999999999999999999998887778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++...... .......|++.|+|||.+.+.. ++.++|||||||++|||++|..|+.+
T Consensus 122 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred CCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCC
Confidence 999999999999999999999998765433 2334467899999999998765 79999999999999999999999887
Q ss_pred CchHHHHHHHh
Q psy763 177 NMGSHMARNLL 187 (303)
Q Consensus 177 ~~~~~~~~~~~ 187 (303)
....+....+.
T Consensus 201 ~~~~~~~~~i~ 211 (318)
T cd05582 201 KDRKETMTMIL 211 (318)
T ss_pred CCHHHHHHHHH
Confidence 76655555443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=261.04 Aligned_cols=165 Identities=23% Similarity=0.325 Sum_probs=142.2
Q ss_pred HHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRS-LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
....|...++. ++||||+++++++.+.+.+++||||+++|+|..++.....+++..+..++.|++.||.|||+.|++||
T Consensus 41 ~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHr 120 (316)
T cd05619 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120 (316)
T ss_pred HHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence 34445555554 69999999999999999999999999999999998877789999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||||+||+++.++.+||+|||++..... ........||+.|+|||++.+.. ++.++||||+||++|||++|..|+.+.
T Consensus 121 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred CCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999875432 22334457899999999998765 899999999999999999999998877
Q ss_pred chHHHHHH
Q psy763 178 MGSHMARN 185 (303)
Q Consensus 178 ~~~~~~~~ 185 (303)
...+....
T Consensus 200 ~~~~~~~~ 207 (316)
T cd05619 200 DEEELFQS 207 (316)
T ss_pred CHHHHHHH
Confidence 66555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=269.79 Aligned_cols=172 Identities=27% Similarity=0.422 Sum_probs=159.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-EEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKK-LHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
++....|+.++++++|||||.+.+.|..++. ++|||+||+||++...+.+. ..++++.+..|+.|++.|+.|||+++
T Consensus 47 r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~ 126 (426)
T KOG0589|consen 47 RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR 126 (426)
T ss_pred hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh
Confidence 3477889999999999999999999999998 99999999999999977643 46999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|+|||||+.||++++++.|+|+|||+|+.+.+.. ...+..||+.|++||++.+.+ |..++|||||||++|||.+....
T Consensus 127 iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~a 205 (426)
T KOG0589|consen 127 VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPA 205 (426)
T ss_pred hhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccc
Confidence 9999999999999999999999999999998766 567789999999999999877 99999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcC
Q psy763 174 GLGNMGSHMARNLLKNN 190 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~ 190 (303)
|.+.+....+.++.+..
T Consensus 206 F~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 206 FKASNMSELILKINRGL 222 (426)
T ss_pred cCccchHHHHHHHhhcc
Confidence 99999999988888765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=261.78 Aligned_cols=253 Identities=19% Similarity=0.284 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-AC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i 95 (303)
....+.+|+++++.++||||+++++++..++.+++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 125 (331)
T cd06649 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI 125 (331)
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence 34568889999999999999999999999999999999999999999998777899999999999999999999986 69
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+|+||||+||+++.++.++|+|||++...... ......+++.|+|||.+.+.. ++.++|||||||++|||++|..|+.
T Consensus 126 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred EcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998765432 224457899999999998765 8999999999999999999999987
Q ss_pred CCchHHHHHHHhhcCCce------eEeecCCCCCcchhhhhhhhhhcCCCh--hHHHHHHhHhCC---CCCCCchhhHHh
Q psy763 176 GNMGSHMARNLLKNNGRV------TVILKSDSLDSETWDLTWQEIFSKTST--TTIFKYLLIRGG---NTDRNSHGVVKI 244 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~---~~~~~~~~~~dl 244 (303)
+....+... .+...... .............. ........+.. ......+..... ......+++.++
T Consensus 204 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (331)
T cd06649 204 PPDAKELEA-IFGRPVVDGEEGEPHSISPRPRPPGRPV--SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF 280 (331)
T ss_pred CCCHHHHHH-HhcccccccccCCccccCcccccccccc--cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHH
Confidence 665544322 22211000 00000000000000 00000001111 111122111111 112346778999
Q ss_pred hhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+.+|+..+|..| +++.+++.|||+...+..
T Consensus 281 i~~~L~~~P~~R-------pt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 281 VNKCLIKNPAER-------ADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred HHHHccCCcccC-------CCHHHHhcChHHhhcccc
Confidence 999999777666 999999999999765443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.43 Aligned_cols=244 Identities=28% Similarity=0.435 Sum_probs=167.7
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcC---------CCCCCHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENH---------PHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~---------~~~l~~~~~~~~~~qi~~~l~ 88 (303)
...+|+.+++.++||||+++++++.. +..+++|+||+.+ ++..++.. ...+++..+..++.|++.||.
T Consensus 44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~ 122 (317)
T cd07868 44 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122 (317)
T ss_pred HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999864 4578999999975 55554431 225899999999999999999
Q ss_pred HHHHCCceecccCCCcEEEe----cCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 89 YCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~----~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
|||++||+||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+
T Consensus 123 ~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (317)
T cd07868 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred HHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence 99999999999999999994 45789999999998754321 22346789999999999876668999999999
Q ss_pred HHHHHHhhccCccCCCCch---------HHHHHHHhhcCCceeEeecCCC-CCcchhhhhhhhhhcC-CChhHHHHHHhH
Q psy763 161 EWTSHSYSQIGFIGLGNMG---------SHMARNLLKNNGRVTVILKSDS-LDSETWDLTWQEIFSK-TSTTTIFKYLLI 229 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 229 (303)
||++|||++|..+|.+... ...+..++...+.+........ ..++... ..+.+... ........++
T Consensus 203 G~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-- 279 (317)
T cd07868 203 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST-LMKDFRRNTYTNCSLIKYM-- 279 (317)
T ss_pred HHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhh-hhhhhhccccCcccccchH--
Confidence 9999999999988865432 2333333333222111000000 0000000 00000000 0000111111
Q ss_pred hCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeee
Q psy763 230 RGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 230 ~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
..........++|++.+||..+|..| +++.++++||||
T Consensus 280 -~~~~~~~~~~~~dli~~mL~~dP~~R-------~t~~e~l~hp~f 317 (317)
T cd07868 280 -EKHKVKPDSKAFHLLQKLLTMDPIKR-------ITSEQAMQDPYF 317 (317)
T ss_pred -HhcCCCCChHHHHHHHHHhccCcccC-------CCHHHHhcCCCC
Confidence 01112234678999999999777666 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=273.61 Aligned_cols=220 Identities=20% Similarity=0.289 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE--EEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHH
Q psy763 11 YYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKK--LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 11 ~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
..+.....+.+.+|+.+|+.|+||||+++++++.+... +-+|+|.+..|+|..|+++.+..+.+.+..|++||+.||.
T Consensus 78 ~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~ 157 (632)
T KOG0584|consen 78 VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLV 157 (632)
T ss_pred hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhh
Confidence 33444456889999999999999999999999997764 8899999999999999999999999999999999999999
Q ss_pred HHHHCC--ceecccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 89 YCHRHA--CIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 89 ~lH~~~--ivH~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|||++. |+|||||.+||+|+.+ |.|||+|+|+|....... .....|||.|||||+.. ..|...+||||||++|.
T Consensus 158 yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmL 234 (632)
T KOG0584|consen 158 YLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCML 234 (632)
T ss_pred hhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHH
Confidence 999986 9999999999999977 899999999998865433 23478999999999986 34999999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
||.|+.+|+....+..++.+.+-.|-+|.. +. +-..|++.+++
T Consensus 235 EMvT~eYPYsEC~n~AQIYKKV~SGiKP~s---------------------------l~----------kV~dPevr~fI 277 (632)
T KOG0584|consen 235 EMVTSEYPYSECTNPAQIYKKVTSGIKPAA---------------------------LS----------KVKDPEVREFI 277 (632)
T ss_pred HHHhccCChhhhCCHHHHHHHHHcCCCHHH---------------------------hh----------ccCCHHHHHHH
Confidence 999999999998887777766665555421 11 12467888899
Q ss_pred hhhhccccceeeccccccccccccceeeeeecC
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.+||.. . ..|.++++||.|+||-.+
T Consensus 278 ekCl~~-~-------~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 278 EKCLAT-K-------SERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHhcC-c-------hhccCHHHHhhChhhccc
Confidence 999884 3 444999999999998775
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=262.29 Aligned_cols=223 Identities=19% Similarity=0.230 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.....+.+|+.+++.++|+||+++++.+.+.+.+|+||||+++|+|..++.+ ...+++..+..++.|++.||.|||+.|
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ 122 (332)
T cd05623 43 AETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122 (332)
T ss_pred hHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3455678889999999999999999999999999999999999999998876 457899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhh
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~ 168 (303)
++||||||+||+++.++.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 123 iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell 202 (332)
T cd05623 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202 (332)
T ss_pred eEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence 99999999999999999999999999876543222 223578999999999862 334789999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
+|..||.+....+....+.....+.+.+. .....++++.+++.+|
T Consensus 203 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-----------------------------------~~~~~s~~~~~li~~l 247 (332)
T cd05623 203 YGETPFYAESLVETYGKIMNHKERFQFPA-----------------------------------QVTDVSEDAKDLIRRL 247 (332)
T ss_pred cCCCCCCCCCHHHHHHHHhCCCccccCCC-----------------------------------ccccCCHHHHHHHHHH
Confidence 99999988877776665544322221000 0012345677888887
Q ss_pred hccccceeeccccccccccccceeeeeecC
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+...+ ++..+.++.++++||||...
T Consensus 248 l~~~~-----~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 248 ICSRE-----HRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ccChh-----hhcCCCCHHHHhCCCCcCCC
Confidence 76432 22235678889999988653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=261.76 Aligned_cols=223 Identities=18% Similarity=0.226 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.....+.+|+.+++.++|+||+++++++.+++.+|+||||+++|+|..++.+ ...+++..+..++.|++.||+|||++|
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (331)
T cd05597 43 AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122 (331)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3455678899999999999999999999999999999999999999998865 457999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhh
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~ 168 (303)
|+||||||+||+++.++.+||+|||++......... ....||+.|+|||++.+ ...++.++||||+||++|||+
T Consensus 123 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (331)
T cd05597 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202 (331)
T ss_pred eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh
Confidence 999999999999999999999999998775433222 23468999999999863 234788999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
+|..|+.+....+....+......... .......+..+.+++.+|
T Consensus 203 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~l 247 (331)
T cd05597 203 YGETPFYAESLVETYGKIMNHKEHFQF-----------------------------------PPDVTDVSEEAKDLIRRL 247 (331)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCcccC-----------------------------------CCccCCCCHHHHHHHHHH
Confidence 999998877666655544332211110 000111345667788777
Q ss_pred hccccceeeccccccccccccceeeeeecC
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+.. ...+..+.++.+++.||||...
T Consensus 248 l~~-----~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 248 ICS-----PETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ccC-----cccccCCCCHHHHhcCCCCCCC
Confidence 652 1223345788899999998653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=257.01 Aligned_cols=232 Identities=30% Similarity=0.422 Sum_probs=172.4
Q ss_pred HHHHHHHH---hCCCCCcceeEEEEEe-----CCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 22 ATNKKEKR---SLKHPNLVNLLEVFRR-----KKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 22 ~~e~~~l~---~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
.+|+.+++ .++||||+++++++.. ...+++|+||++ +++..++.. ...+++..+..++.|++.||.|||
T Consensus 49 ~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH 127 (290)
T cd07862 49 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127 (290)
T ss_pred HHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34444444 4579999999999863 346899999998 567776643 245899999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+.|++||||||+||+++.++.+||+|||++.............+++.|+|||.+.+.. ++.++||||+||++|||++|.
T Consensus 128 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~ 206 (290)
T cd07862 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRK 206 (290)
T ss_pred HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999998765544445567899999999997655 799999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.+|.+....+.+..++...+.+.....+.. .......+ ......++... .+...+.+.+++.+|+..
T Consensus 207 ~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~ 273 (290)
T cd07862 207 PLFRGSSDVDQLGKILDVIGLPGEEDWPRD-----VALPRQAF-HSKSAQPIEKF-------VTDIDELGKDLLLKCLTF 273 (290)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhchhh-----hcccchhc-cCCCCCCHHHH-------ccCCCHHHHHHHHHHhcc
Confidence 999988888877777765433221100000 00000011 11111122221 112456778999999997
Q ss_pred ccceeeccccccccccccceeeee
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+|..| +++.++++||||
T Consensus 274 ~P~~R-------~s~~~~l~hp~f 290 (290)
T cd07862 274 NPAKR-------ISAYSALSHPYF 290 (290)
T ss_pred Cchhc-------CCHHHHhcCCCC
Confidence 77666 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=263.01 Aligned_cols=159 Identities=27% Similarity=0.359 Sum_probs=141.1
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.+ +||||+++++++...+.+|+||||+++|+|..++...+.+++..+..++.|++.||+|||++|+
T Consensus 38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 117 (327)
T cd05617 38 DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117 (327)
T ss_pred HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 445567788887777 6999999999999999999999999999999988777789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+||+++.++.+||+|||++.... .........||+.|+|||.+.+.. ++.++|||||||++|||++|..||
T Consensus 118 vHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf 196 (327)
T cd05617 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPF 196 (327)
T ss_pred eccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCC
Confidence 999999999999999999999999987532 233344567999999999998765 799999999999999999999887
Q ss_pred CC
Q psy763 175 LG 176 (303)
Q Consensus 175 ~~ 176 (303)
..
T Consensus 197 ~~ 198 (327)
T cd05617 197 DI 198 (327)
T ss_pred Cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=256.02 Aligned_cols=223 Identities=22% Similarity=0.205 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
...+..|+.+++.++|+||+++.+++..++..|+||||+++|+|...+. .+..+++..+..++.|++.||.|||+.
T Consensus 37 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3456778999999999999999999999999999999999999987653 345699999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
||+||||+|+||+++.++.++|+|||++....... ......+|+.|+|||.+.+.. ++.++|+||+||++|||++|..
T Consensus 117 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~ 195 (280)
T cd05608 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARG 195 (280)
T ss_pred CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999997764332 223457899999999998765 7999999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+.+............. .... .....+..++.+.+++.+|+..+
T Consensus 196 pf~~~~~~~~~~~~~~~------------------------~~~~------------~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 196 PFRARGEKVENKELKQR------------------------ILND------------SVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred CCCCCCcchhHHHHHHh------------------------hccc------------CCCCcccCCHHHHHHHHHHhcCC
Confidence 87654321111111000 0000 00111234566788999998877
Q ss_pred cceeeccccccccccccceeeeeecCC
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
|..|- ..+..++.+++.||||....
T Consensus 240 P~~R~--~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 240 PEKRL--GFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHHhc--CCCCCCHHHHhcChhhhcCC
Confidence 76661 11122789999999997744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=264.99 Aligned_cols=228 Identities=24% Similarity=0.252 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.++..+ +||||+++++++..++.+++||||+++|+|...+...+.+++..+..++.|++.||.|||++|++
T Consensus 39 ~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 118 (329)
T cd05618 39 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 118 (329)
T ss_pred HHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34456677776665 89999999999999999999999999999999887778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++.... .........||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 119 H~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCc
Confidence 99999999999999999999999987532 223334567899999999998765 7999999999999999999988874
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
..... ...........++.+... ...........+.+++.+|+..+|..
T Consensus 198 ~~~~~-------------------~~~~~~~~~~~~~~i~~~------------~~~~p~~~~~~~~~ll~~~L~~dP~~ 246 (329)
T cd05618 198 IVGSS-------------------DNPDQNTEDYLFQVILEK------------QIRIPRSLSVKAASVLKSFLNKDPKE 246 (329)
T ss_pred cCCCc-------------------CCcccccHHHHHHHHhcC------------CCCCCCCCCHHHHHHHHHHhcCCHHH
Confidence 21100 000000000001111110 11112234567789999999877777
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
|-.. ....+..+++.||||...
T Consensus 247 R~~~-~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 247 RLGC-HPQTGFADIQGHPFFRNV 268 (329)
T ss_pred cCCC-CCCCCHHHHhcCCCCCCC
Confidence 7110 001124688999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=271.47 Aligned_cols=209 Identities=23% Similarity=0.285 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHH
Q psy763 14 EAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.......+.+|+++++.++|||||+++|++....++++|||+|.||+|.+++++.+ .++..+...++.+++.||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 34567778899999999999999999999999999999999999999999998876 49999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccc-cccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-DYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
++++||||.++|+|++.++.+||+|||+++....-.... ...-+..|+|||.+... .|+.++|||||||++||+++ |
T Consensus 281 k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 281 KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred CCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccC
Confidence 999999999999999999999999999987754211112 22356789999999865 59999999999999999987 6
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..|+.|....+....+...+.+.+. +...+.+....+-+||..++..|+.+..
T Consensus 360 ~~Py~g~~~~~v~~kI~~~~~r~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~ 412 (474)
T KOG0194|consen 360 AEPYPGMKNYEVKAKIVKNGYRMPI---PSKTPKELAKVMKQCWKKDPEDRPTMST 412 (474)
T ss_pred CCCCCCCCHHHHHHHHHhcCccCCC---CCCCHHHHHHHHHHhccCChhhccCHHH
Confidence 6777777777777777688887653 3355666777777888888887776655
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=260.46 Aligned_cols=169 Identities=21% Similarity=0.271 Sum_probs=145.8
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.....|..+++.+ .|++|+++++++...+.+|+||||+++|+|...+...+.+++..+..++.|++.||.|||+.||+|
T Consensus 45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 124 (323)
T cd05616 45 ECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124 (323)
T ss_pred HHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 3445556666665 589999999999999999999999999999998887778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+|||++.++.+||+|||++..... ........||+.|+|||++.+.. ++.++|||||||++|||++|..|+.+
T Consensus 125 rDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred cCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876432 22334567899999999998765 89999999999999999999999988
Q ss_pred CchHHHHHHHhh
Q psy763 177 NMGSHMARNLLK 188 (303)
Q Consensus 177 ~~~~~~~~~~~~ 188 (303)
....+....+..
T Consensus 204 ~~~~~~~~~i~~ 215 (323)
T cd05616 204 EDEDELFQSIME 215 (323)
T ss_pred CCHHHHHHHHHh
Confidence 777666655544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=256.64 Aligned_cols=228 Identities=20% Similarity=0.191 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++||||+++++.+..++.+++||||+++|+|...+.. ...+++..+..++.|++.|+.|||+.|
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (285)
T cd05605 43 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122 (285)
T ss_pred hHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445667899999999999999999999999999999999999999887643 246999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
++|+||+|+||++++++.++|+|||++.............+++.|+|||.+.+.. ++.++|+||+||++|||++|..||
T Consensus 123 ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf 201 (285)
T cd05605 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPF 201 (285)
T ss_pred cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999998765444444567899999999998655 799999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.........+.... .. .........++.+.+++.+|+..+|.
T Consensus 202 ~~~~~~~~~~~~~~~~------------------------~~------------~~~~~~~~~~~~~~~li~~~l~~~P~ 245 (285)
T cd05605 202 RQRKEKVKREEVERRV------------------------KE------------DQEEYSEKFSEAARSICRQLLTKDPG 245 (285)
T ss_pred CCCchhhHHHHHHHHh------------------------hh------------cccccCcccCHHHHHHHHHHccCCHH
Confidence 7654322211111100 00 00011122456677899999998777
Q ss_pred eeeccccccccccccceeeeeecCCcceE
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPERKCL 283 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 283 (303)
.|-.-. ..++.+++.|+|+...+.+..
T Consensus 246 ~R~~~~--~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05605 246 FRLGCR--GEGAEEVKAHPFFRTANFKRL 272 (285)
T ss_pred HhcCCC--CCCHHHHhcCcCccCCCHHHH
Confidence 771111 118899999999988666544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.93 Aligned_cols=214 Identities=21% Similarity=0.203 Sum_probs=168.4
Q ss_pred HHHHHHHhC---CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 23 TNKKEKRSL---KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 23 ~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
.|..++... +||||+++++++...+.+|+||||+++|+|...+...+.+++..+..++.||+.||+|||++||+|||
T Consensus 42 ~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrD 121 (330)
T cd05586 42 GERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121 (330)
T ss_pred HHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 344444443 79999999999999999999999999999999888788899999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
|||+||+++.++.++|+|||++..... ........||+.|+|||.+.+...++.++||||+||++|+|++|..|+.+..
T Consensus 122 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 122 LKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred CCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 999999999999999999999876432 2233456799999999999866558999999999999999999999998876
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeec
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQS 258 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~ 258 (303)
..+....+.....+.+ .....+++.+++.+||..+|..|-
T Consensus 202 ~~~~~~~i~~~~~~~~---------------------------------------~~~~~~~~~~li~~~L~~~P~~R~- 241 (330)
T cd05586 202 TQQMYRNIAFGKVRFP---------------------------------------KNVLSDEGRQFVKGLLNRNPQHRL- 241 (330)
T ss_pred HHHHHHHHHcCCCCCC---------------------------------------CccCCHHHHHHHHHHcCCCHHHCC-
Confidence 6555444332211110 011244566788888876666551
Q ss_pred cccccccccccceeeeeecC
Q psy763 259 EKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 259 ~~~~~~~~~~~l~~~~~~~~ 278 (303)
....++.+++.|||+.+.
T Consensus 242 --~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 242 --GAHRDAVELKEHPFFADI 259 (330)
T ss_pred --CCCCCHHHHhcCccccCC
Confidence 111267788888888653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=255.52 Aligned_cols=204 Identities=12% Similarity=0.105 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR- 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~- 92 (303)
.+.+.+|+.++++++||||++++|++.+ ...+++||||+++|+|..++...+.+++.....++.|++.|+.|||+
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence 4667899999999999999999999977 34689999999999999999888889999999999999999999998
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~tg~ 171 (303)
.+++||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+. ..++.++|||||||++|||++|.
T Consensus 142 ~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~ 219 (283)
T PHA02988 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219 (283)
T ss_pred CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCC
Confidence 49999999999999999999999999998765432 2345688999999998752 34899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.||.+....+....+...+.+++ .+...+.+..+++..||..+|..||....
T Consensus 220 ~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~e 271 (283)
T PHA02988 220 IPFENLTTKEIYDLIINKNNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKE 271 (283)
T ss_pred CCCCCCCHHHHHHHHHhcCCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence 99888777777666666655543 22345666777777777777777765544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.45 Aligned_cols=250 Identities=18% Similarity=0.261 Sum_probs=180.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-AC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i 95 (303)
....+.+|+++++.++||||+++++++..++.+++||||+++++|.+++...+.+++..+..++.|++.||.|||+. ++
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i 125 (333)
T cd06650 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125 (333)
T ss_pred HHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 34567889999999999999999999999999999999999999999988777899999999999999999999985 79
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+|+||||+||+++.++.+||+|||++...... ......++..|+|||.+.+.. ++.++|+|||||++|||++|..|+.
T Consensus 126 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred EecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999998765322 223457899999999998765 7999999999999999999998887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCC-CCcchhhhhhhhhhcCCChhH------HHHHHhHhCCC---CCCCchhhHHhh
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDS-LDSETWDLTWQEIFSKTSTTT------IFKYLLIRGGN---TDRNSHGVVKIL 245 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~------~~~~l~~~~~~---~~~~~~~~~dll 245 (303)
.....+. ...+.............. ........ +. ...+..++ ........... ......++.+++
T Consensus 204 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (333)
T cd06650 204 PPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRP-LS--SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFV 279 (333)
T ss_pred CcchhHH-HHHhcCcccCCccccccCcccCCccch-hh--hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHH
Confidence 6654333 222221111100000000 00000000 00 01111111 11111111111 112356788999
Q ss_pred hhhhccccceeeccccccccccccceeeeeecCC
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.+||..+|..| +++.+++.|+|+....
T Consensus 280 ~~~L~~~P~~R-------pt~~ell~h~~~~~~~ 306 (333)
T cd06650 280 NKCLIKNPAER-------ADLKQLMVHAFIKRSE 306 (333)
T ss_pred HHhccCCcccC-------cCHHHHhhCHHHhcCc
Confidence 99999777666 9999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.48 Aligned_cols=212 Identities=19% Similarity=0.265 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-------CCCCHHHHHHHHHHHHHH
Q psy763 14 EAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-------HGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~l~~~~~~~~~~qi~~~ 86 (303)
+......|.+|+.+++.++|||||+++|++-+....++++|||++|+|..++++. ..++......++.+||+|
T Consensus 735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G 814 (1025)
T KOG1095|consen 735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG 814 (1025)
T ss_pred CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence 3447788999999999999999999999999999999999999999999998765 369999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcccc---ccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD---YVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
+.||+++++|||||.++|+|++....+||+|||+|+.......+.. ..-+..|||||.+... .++.++|||||||+
T Consensus 815 ~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVl 893 (1025)
T KOG1095|consen 815 MNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVL 893 (1025)
T ss_pred hHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHH
Confidence 9999999999999999999999999999999999996554333221 2345679999999864 49999999999999
Q ss_pred HHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhH
Q psy763 164 SHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLI 229 (303)
Q Consensus 164 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (303)
+||++|.+..||+......+......++|++ +|..++..+++++-+||..+|..||.+..+..
T Consensus 894 lWEifslG~~PY~~~~n~~v~~~~~~ggRL~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 894 LWEIFSLGATPYPSRSNFEVLLDVLEGGRLD---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHhCCCCCCCCcchHHHHHHHHhCCccC---CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999998888777777666666654 67788888999999999999999999888665
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=263.89 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++...+ .+|+||||++++....+ . ..+++..+..++.|++.||.||
T Consensus 63 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~-~--~~~~~~~~~~~~~qi~~~L~~L 139 (359)
T cd07876 63 HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-H--MELDHERMSYLLYQMLCGIKHL 139 (359)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHH-h--ccCCHHHHHHHHHHHHHHHHHH
Confidence 3455668899999999999999999987543 57999999987654443 2 2588999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.||+||||||+||+++.++.+||+|||++.............+|+.|+|||.+.+.. ++.++||||+||++|+|++|
T Consensus 140 H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg 218 (359)
T cd07876 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKG 218 (359)
T ss_pred HhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999999997654444445567899999999998765 89999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc-CCCh--hHHHHH----Hh-HhCCCCCCCchhhH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS-KTST--TTIFKY----LL-IRGGNTDRNSHGVV 242 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~----l~-~~~~~~~~~~~~~~ 242 (303)
..||.+.........++...+.+...... .... ....+.. .+.. ..+... .. ............+.
T Consensus 219 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (359)
T cd07876 219 SVIFQGTDHIDQWNKVIEQLGTPSAEFMN-----RLQP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQAR 292 (359)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCcHHHHH-----HHHH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHH
Confidence 99998887776666665554433211000 0000 0000000 0000 000000 00 00011123356788
Q ss_pred Hhhhhhhccccceeeccccccccccccceeeeee
Q psy763 243 KILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 243 dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
+++.+|+..+|..| +++.+++.|||+-
T Consensus 293 ~li~~mL~~dP~~R-------~t~~e~l~hp~~~ 319 (359)
T cd07876 293 DLLSKMLVIDPDKR-------ISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHhccCcccC-------CCHHHHhcCchhh
Confidence 99999998777666 9999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=246.90 Aligned_cols=258 Identities=28% Similarity=0.393 Sum_probs=197.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeC--------CEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRK--------KKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
....+|++++..++|+|++.++++|... ..+|+||.+|++ +|.-++.. ...++..++..++.++..||.|
T Consensus 61 italreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~ 139 (376)
T KOG0669|consen 61 ITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYY 139 (376)
T ss_pred HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999988632 358999999995 44444443 4689999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC-----ccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
+|...|+|||+|+.|+||+.+|.+||+|||+++.++... .++..+.|.+|++||.+.|...|+++.|||+.|||+
T Consensus 140 iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 140 IHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM 219 (376)
T ss_pred HHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence 999999999999999999999999999999997665321 233456799999999999999999999999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
.||.|+.+.+.|.+..+++.-+..--+.......|.-..-++ |+.+...|-.+...+.+..... .--..+++.|+
T Consensus 220 aeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL----~~sie~ePl~~~~~rkv~n~~k-p~~kd~~a~dL 294 (376)
T KOG0669|consen 220 AEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPL----YQSIELEPLPKGQKRKVKNRLK-PYVKDDEALDL 294 (376)
T ss_pred HHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchH----HHhccCCCCCcchhhhhhhhcc-cccCChhHHHH
Confidence 999999999999999998887766555443332222211122 3333222222222222111111 12236789999
Q ss_pred hhhhhccccceeeccccccccccccceeeeeecCCcceEEEEEec
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKCLEVIFMD 289 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 289 (303)
+++++.-.|..+ +.+.+++.|.||..++.+.-++.-|-
T Consensus 295 le~ll~~DP~kR-------~~ad~alnh~~F~kdp~pqanl~~ml 332 (376)
T KOG0669|consen 295 LEKLLKLDPTKR-------IDADQALNHDFFWKDPMPQANLQDML 332 (376)
T ss_pred HHHHhccCcccC-------cchHhhhchhhhhcCCcchhhHHHHH
Confidence 999999777777 99999999999999998876665443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=273.22 Aligned_cols=206 Identities=19% Similarity=0.257 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+..++.++||||+++++++..++.+|+||||+++|+|..++. ...++++..+..++.|++.||.|||+
T Consensus 108 ~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 187 (478)
T PTZ00267 108 QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS 187 (478)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34566789999999999999999999999999999999999999988653 24478999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
.||+||||||+||+++.++.+||+|||++....... .....+||+.|+|||.+.+.. ++.++||||+||++|||++
T Consensus 188 ~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~t 266 (478)
T PTZ00267 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLT 266 (478)
T ss_pred CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHh
Confidence 999999999999999999999999999998764332 234457999999999998765 8999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
|..|+.+....+....++.....+ .+...+.+..+++-.++..+|..|+...-+
T Consensus 267 g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~ 320 (478)
T PTZ00267 267 LHRPFKGPSQREIMQQVLYGKYDP----FPCPVSSGMKALLDPLLSKNPALRPTTQQL 320 (478)
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCC----CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 999998887777766665543321 123344556666666677777666665553
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=267.33 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
...+.+|+.+++.++||||+++++++... ..+|+||||++++ +...+. ..+++..+..++.|++.||.|||
T Consensus 67 ~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH 143 (364)
T cd07875 67 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLH 143 (364)
T ss_pred HHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCC-HHHHHH--hcCCHHHHHHHHHHHHHHHHHHh
Confidence 34566789999999999999999988643 3579999999865 444443 25888999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++||+||||||+||+++.++.+||+|||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 144 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~ 222 (364)
T cd07875 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG 222 (364)
T ss_pred hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCC
Confidence 9999999999999999999999999999998765444445567899999999998765 899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc-CCChh--HHHHHH---h--HhCCCCCCCchhhHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS-KTSTT--TIFKYL---L--IRGGNTDRNSHGVVK 243 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~l---~--~~~~~~~~~~~~~~d 243 (303)
.||.+....+....++...+.+..... ... ......... ++... .+.+.. . .....+......+.+
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 223 VLFPGTDHIDQWNKVIEQLGTPCPEFM-----KKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHH-----Hhh-hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 999998888887777765443321000 000 000000000 00000 000000 0 011122334567889
Q ss_pred hhhhhhccccceeeccccccccccccceeeeeec
Q psy763 244 ILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 244 ll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
++.+|+..+|..| +++.+++.|||+..
T Consensus 297 ll~~mL~~dP~~R-------~t~~e~L~hp~~~~ 323 (364)
T cd07875 297 LLSKMLVIDASKR-------ISVDEALQHPYINV 323 (364)
T ss_pred HHHHhcCcCcccC-------CCHHHHhcCccccc
Confidence 9999999766666 99999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=251.38 Aligned_cols=220 Identities=21% Similarity=0.229 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
......|+.+++.++||||+++++++..+..+++||||+++++|...+... ..+++..+..++.|++.||+|||+.|+
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 116 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 444556889999999999999999999999999999999999998876432 368899999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||||+|+||+++.++.++|+|||++.............++..|+|||.+.+.. ++.++|+||+||++|||++|..|+.
T Consensus 117 vH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred EEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999998766544444567899999999998766 8999999999999999999998875
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+... ..... . .......++++.+++.+||..+|..
T Consensus 196 ~~~~~~~~~~~~~~------------------------~~~~~----------~-~~~~~~~~~~~~~li~~~L~~~P~~ 240 (277)
T cd05607 196 DHKEKVAKEELKRR------------------------TLEDE----------V-KFEHQNFTEESKDICRLFLAKKPED 240 (277)
T ss_pred CCcchhhHHHHHHH------------------------hhccc----------c-ccccccCCHHHHHHHHHHhccCHhh
Confidence 43221111100000 00000 0 0000123566789999998876666
Q ss_pred eeccccccccc----cccceeeeeecCCc
Q psy763 256 IQSEKQDSIRG----KNCKKTFYIPTPER 280 (303)
Q Consensus 256 ~~~~~~~~~~~----~~~l~~~~~~~~~~ 280 (303)
| +++ .+.+.|+||...+.
T Consensus 241 R-------~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 241 R-------LGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred C-------CCCccchhhhhcChhhcCCCH
Confidence 6 887 56779999976443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=257.46 Aligned_cols=244 Identities=30% Similarity=0.443 Sum_probs=165.5
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHc---------CCCCCCHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELEN---------HPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~---------~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
.+.+|+.+++.++||||+++++++.. +..+++|+||++++ +..++. ....+++..+..++.|++.||.
T Consensus 44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 122 (317)
T cd07867 44 SACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD-LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122 (317)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc-HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHH
Confidence 46778999999999999999999854 46789999999864 444432 1235889999999999999999
Q ss_pred HHHHCCceecccCCCcEEE----ecCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 89 YCHRHACIHRDIKPENILL----TANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~----~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
|||+.|++||||||+||++ +.++.+||+|||++....... ......+|+.|+|||.+.+...++.++||||+
T Consensus 123 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred HHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 9999999999999999999 456789999999998754322 12345678999999999876668999999999
Q ss_pred HHHHHHhhccCccCCCCchH---------HHHHHHhhcCCceeEeecCC-CCCcchhhhhhhhhhcC-CChhHHHHHHhH
Q psy763 161 EWTSHSYSQIGFIGLGNMGS---------HMARNLLKNNGRVTVILKSD-SLDSETWDLTWQEIFSK-TSTTTIFKYLLI 229 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 229 (303)
||++|||+||..+|.+.... .....+....+.+....... ...++.... ....... .........
T Consensus 203 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--- 278 (317)
T cd07867 203 GCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTL-QKDFRRTTYANSSLIKY--- 278 (317)
T ss_pred HHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhh-hhhhcccccCCchhhhh---
Confidence 99999999999887654321 12222222211111000000 000000000 0000000 000011111
Q ss_pred hCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeee
Q psy763 230 RGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 230 ~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
...........+.+++.+|+..+|..| +++.+++.||||
T Consensus 279 ~~~~~~~~~~~~~~ll~~~l~~dP~~R-------~t~~e~l~hp~f 317 (317)
T cd07867 279 MEKHKVKPDSKVFLLLQKLLTMDPTKR-------ITSEQALQDPYF 317 (317)
T ss_pred hhcccCCCChHHHHHHHHHhccCcccc-------cCHHHHhcCCCC
Confidence 111222345668899999999777766 999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=258.75 Aligned_cols=175 Identities=22% Similarity=0.271 Sum_probs=151.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 15 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
......+.+|..+++.++|+||+++++++.+++..|+||||+++|+|..++.. ...+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 42 RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456678889999999999999999999999999999999999999998876 46799999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCC----ccCCCccchhhHHHHHHHh
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGD----TLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~----~~~~~~~DvwSlG~il~el 167 (303)
||+||||||+||+++.++.+||+|||++......... ....||+.|+|||++.+. ..++.++|+||+||++|||
T Consensus 122 ~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 9999999999999999999999999999876543222 235689999999998752 3478899999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhc
Q psy763 168 SQIGFIGLGNMGSHMARNLLKN 189 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~ 189 (303)
++|..|+.+....+....+...
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 202 LYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred hhCCCCccCCCHHHHHHHHHcC
Confidence 9999999887776666555543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=256.36 Aligned_cols=243 Identities=27% Similarity=0.418 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+..++.++||||+++++++..++..++|+||+++ ++..++. ....+++..+..++.|++.||.|||+.|++|
T Consensus 49 ~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H 127 (301)
T cd07873 49 CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127 (301)
T ss_pred hHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 3456789999999999999999999999999999999985 6666554 4457899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+...++.++|||||||++|||++|..+|.+
T Consensus 128 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred CCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998764422 2223345788999999988766678999999999999999999999988
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+....+.+.....+.....+ .+..+.. +... ...+ ....+..++.+.+++.+|+..++..|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~~~--~~~~---~~~~~~~~~~~~~li~~ml~~dp~~R 277 (301)
T cd07873 208 STVEEQLHFIFRILGTPTEETWPGILSNE----EFKSYNY-PKYR--ADCL---HNHAPRLDSDGAELLSKLLQFEGRKR 277 (301)
T ss_pred CCHHHHHHHHHHHcCCCChhhchhhhccc----ccccccc-Cccc--cccH---HhhcCCCCHHHHHHHHHHhcCCcccC
Confidence 87776666555543332211110000000 0000000 0000 0000 01112345677899999999777777
Q ss_pred eccccccccccccceeeeeecCC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+++.+++.||||....
T Consensus 278 -------~t~~eil~h~~f~~~~ 293 (301)
T cd07873 278 -------ISAEEAMKHPYFHCLG 293 (301)
T ss_pred -------cCHHHHhcCccccccc
Confidence 9999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=263.10 Aligned_cols=242 Identities=16% Similarity=0.157 Sum_probs=170.6
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 101 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 101 (303)
..|+.+++.++||||+++++++..++..++|+|++.+..+..+......+++..+..++.|++.||.|||+.||+|||||
T Consensus 105 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 184 (357)
T PHA03209 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVK 184 (357)
T ss_pred HHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 45788999999999999999999999999999999754444444555689999999999999999999999999999999
Q ss_pred CCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCch--
Q psy763 102 PENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMG-- 179 (303)
Q Consensus 102 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~-- 179 (303)
|+||+++.++.+||+|||++.............||..|+|||++.+.. ++.++|||||||++|||++++.++++...
T Consensus 185 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~ 263 (357)
T PHA03209 185 TENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263 (357)
T ss_pred HHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCc
Confidence 999999999999999999997644333344567899999999998765 89999999999999999987766654321
Q ss_pred --------HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 180 --------SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 180 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
...+..++...+..+..... ..........+ .+ ......+...+.... ......++.+++.+||..
T Consensus 264 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~mL~~ 337 (357)
T PHA03209 264 PEEYVKSCHSHLLKIISTLKVHPEEFPR-DPGSRLVRGFI-EY-ASLERQPYTRYPCFQ---RVNLPIDGEFLVHKMLTF 337 (357)
T ss_pred HHHHHHHHHHHHHHHHHHhccChhhcCC-CCccHHHHHHH-hh-cccCCCcccccHHHh---ccCCCchHHHHHHHHHcC
Confidence 11222233322221111110 01111111000 00 001111111111111 112345677899999987
Q ss_pred ccceeeccccccccccccceeeeeec
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+|..| +++.+++.||||.+
T Consensus 338 dP~~R-------pta~e~l~hp~f~~ 356 (357)
T PHA03209 338 DAAMR-------PSAEEILNYPMFAQ 356 (357)
T ss_pred CcccC-------cCHHHHhcCchhcc
Confidence 77666 99999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=259.99 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=178.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++... ...|+++|++ ++++..++. ...+++..+..++.|++.||.||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~L 134 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 344566899999999999999999988643 3578999988 578887765 34799999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.||+||||||+||+++.++.+||+|||++..... ......+|+.|+|||++.+...++.++||||+||++|+|++|
T Consensus 135 H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (343)
T cd07878 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212 (343)
T ss_pred HHCCeecccCChhhEEECCCCCEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHC
Confidence 999999999999999999999999999999987543 234457899999999998755589999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..+|.+....+.+..+....+.+..... .....+........ ........+... .....+.+.+++.+|+.
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~li~~mL~ 283 (343)
T cd07878 213 KALFPGNDYIDQLKRIMEVVGTPSPEVL-KKISSEHARKYIQS-LPHMPQQDLKKI-------FRGANPLAIDLLEKMLV 283 (343)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHH-HhcchhhHHHHhhc-cccccchhHHHh-------ccCCCHHHHHHHHHHcC
Confidence 9998887777776666554333221100 00000000000000 000000001010 11235678899999999
Q ss_pred cccceeeccccccccccccceeeeeecC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.++..| +++.+++.||||...
T Consensus 284 ~dp~~R-------~s~~ell~hp~~~~~ 304 (343)
T cd07878 284 LDSDKR-------ISASEALAHPYFSQY 304 (343)
T ss_pred CChhhC-------CCHHHHhcCcchhcc
Confidence 777666 999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=277.00 Aligned_cols=216 Identities=19% Similarity=0.289 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+..|..|+.++-+++||||+++.|+....+.+.+|+|||++|+|+.+++.+ +.++..++..+++.|+.|++||-+.|+
T Consensus 673 qrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~Y 752 (996)
T KOG0196|consen 673 QRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNY 752 (996)
T ss_pred HHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCc
Confidence 5667899999999999999999999999999999999999999999988754 579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccC--CCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVA--TRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~--~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
|||||.++|||++.+..+|++|||+++.+..+. ..++.-| +.+|.|||.+.-.. ++.++||||+|++|||.++.+
T Consensus 753 VHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 753 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred hhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccC
Confidence 999999999999999999999999999886443 2222222 56899999998655 899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
.-||.....+.+.+.++.+.|+| +|-+++..+.+++..||..+...||-|. +.+..|+||+.
T Consensus 832 ERPYWdmSNQdVIkaIe~gyRLP---pPmDCP~aL~qLMldCWqkdR~~RP~F~--------------qiV~~lDklIr 893 (996)
T KOG0196|consen 832 ERPYWDMSNQDVIKAIEQGYRLP---PPMDCPAALYQLMLDCWQKDRNRRPKFA--------------QIVSTLDKLIR 893 (996)
T ss_pred CCcccccchHHHHHHHHhccCCC---CCCCCcHHHHHHHHHHHHHHhhcCCCHH--------------HHHHHHHHHhc
Confidence 88888888888888999999976 4556677777777777776655555443 44567777766
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=256.80 Aligned_cols=170 Identities=21% Similarity=0.256 Sum_probs=146.3
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+..|..+++.+. |++|+++++++...+.+|+||||+++|+|..++...+.+++..+..++.|++.||.|||++|++
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv 123 (323)
T cd05615 44 VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123 (323)
T ss_pred HHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 344566777777775 5778889999999999999999999999999988778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.++|+|||++...... .......||+.|+|||++.+.. ++.++|+||+||++|||++|..|+.
T Consensus 124 HrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 124 YRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred ccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998764322 2234457899999999998765 8999999999999999999999988
Q ss_pred CCchHHHHHHHhh
Q psy763 176 GNMGSHMARNLLK 188 (303)
Q Consensus 176 ~~~~~~~~~~~~~ 188 (303)
+....+....+..
T Consensus 203 ~~~~~~~~~~i~~ 215 (323)
T cd05615 203 GEDEDELFQSIME 215 (323)
T ss_pred CCCHHHHHHHHHh
Confidence 8777666655544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=247.15 Aligned_cols=222 Identities=21% Similarity=0.265 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHH-HHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHH
Q psy763 16 IRQATEATNKKE-KRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 16 ~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~ 88 (303)
......++|+++ +..-.|||||+++++|.. ...+.+|||.++||.|.+.++..+ .+++.++..++.||..|+.
T Consensus 96 ~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~ 175 (400)
T KOG0604|consen 96 LDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVR 175 (400)
T ss_pred hcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHH
Confidence 445566777765 444569999999999863 356889999999999999877655 5999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 89 YCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|||+.+|.||||||+|+|...+ ..+||+|||+|+.........+.+.|+.|.|||++..+. |+.++|+||+||++|
T Consensus 176 ~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimY 254 (400)
T KOG0604|consen 176 YLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMY 254 (400)
T ss_pred HHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchh-cCCCCCccchhHHHH
Confidence 9999999999999999999754 579999999999877667778889999999999987655 999999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
-|++|.+|||......+...+-..-. ...-.++.+ .|.|. +..+-|++
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~-----~gqy~FP~p----EWs~V-----------------------Se~aKdlI 302 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIR-----TGQYEFPEP----EWSCV-----------------------SEAAKDLI 302 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhh-----ccCccCCCh----hHhHH-----------------------HHHHHHHH
Confidence 99999999997644222111111000 000011111 13322 34667999
Q ss_pred hhhhccccceeeccccccccccccceeeeeec
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++|...|..+ .+..+.+.|||+.-
T Consensus 303 R~LLkt~PteR-------lTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 303 RKLLKTEPTER-------LTIEEVMDHPWINQ 327 (400)
T ss_pred HHHhcCCchhh-------eeHHHhhcCchhcc
Confidence 99999777766 99999999999865
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=252.17 Aligned_cols=238 Identities=28% Similarity=0.447 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+|+..++.++||||+++++++..++.+++|+||++ +++..++.. +..+++..+..++.|++.||+|||+.|+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 122 (285)
T cd07861 44 STAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122 (285)
T ss_pred HHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 456678999999999999999999999999999999998 466665532 2568999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..++
T Consensus 123 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~ 202 (285)
T cd07861 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202 (285)
T ss_pred eecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999987654322 2233456888999999887666789999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+..............+.+.....+....... +............ .......++++.+++.+|+..+|.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dP~ 271 (285)
T cd07861 203 HGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD----YKNTFPKWKKGSL-------RSAVKNLDEDGLDLLEKMLIYDPA 271 (285)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhhhcchhhHH----HHhhccccCcchh-------HHhcCCCCHHHHHHHHHHhcCChh
Confidence 88877766666655443322111100000000 1110000000000 011123567888999999997776
Q ss_pred eeeccccccccccccceeeee
Q psy763 255 YIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.| +++.+++.||||
T Consensus 272 ~R-------pt~~~ll~~~~~ 285 (285)
T cd07861 272 KR-------ISAKKALNHPYF 285 (285)
T ss_pred hC-------CCHHHHhcCCCC
Confidence 66 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=258.82 Aligned_cols=213 Identities=28% Similarity=0.406 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+-+|++.++..+|||||++|++......+|||+|.-++|+|.+++ ++..++.+..+.+++.||+.|+.|||+..+|
T Consensus 61 t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVV 140 (864)
T KOG4717|consen 61 TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVV 140 (864)
T ss_pred hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 445667899999999999999999999999999999999999999965 5567899999999999999999999999999
Q ss_pred ecccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+|+.+.+. |-|||.|||++..+.++....+.+|+..|.|||++.|...-.+++||||||||||-+.+|..||.
T Consensus 141 HRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 141 HRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred cccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 99999999987654 89999999999999999999999999999999999998855789999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
..+..+.+-.++.+.+.+| .. .+.++.|++..||+..|+.
T Consensus 221 eANDSETLTmImDCKYtvP-----sh-----------------------------------vS~eCrdLI~sMLvRdPkk 260 (864)
T KOG4717|consen 221 EANDSETLTMIMDCKYTVP-----SH-----------------------------------VSKECRDLIQSMLVRDPKK 260 (864)
T ss_pred cccchhhhhhhhcccccCc-----hh-----------------------------------hhHHHHHHHHHHHhcCchh
Confidence 8888888877777666543 11 2345567777777755555
Q ss_pred eeccccccccccccceeeeeec
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+ .+.++...++|+--
T Consensus 261 R-------AslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 261 R-------ASLEEIVSTSWLQA 275 (864)
T ss_pred h-------ccHHHHhccccccC
Confidence 5 77777777777654
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=263.94 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++... ...|+||||++++.. ..+. ..+++..+..++.|++.||.||
T Consensus 59 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~-~~~~--~~l~~~~~~~~~~qi~~aL~~L 135 (355)
T cd07874 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHL 135 (355)
T ss_pred HHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHH-HHHh--hcCCHHHHHHHHHHHHHHHHHH
Confidence 345566789999999999999999998644 357999999986544 4443 2588999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.||+||||||+||+++.++.+||+|||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 136 H~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g 214 (355)
T cd07874 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRH 214 (355)
T ss_pred HhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999998765444445567899999999998765 89999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcC-CCh--hHHHHH----Hh-HhCCCCCCCchhhH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSK-TST--TTIFKY----LL-IRGGNTDRNSHGVV 242 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~----l~-~~~~~~~~~~~~~~ 242 (303)
..||.+....+.....+...+.+...... ...+ ....+... +.. ..+... +. ............+.
T Consensus 215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T cd07874 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQP-----TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288 (355)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHH-hhcH-----HHHHHHhcCCccccccchhhccccccccccccccccchHHH
Confidence 99998888777766666543332110000 0000 00001000 000 000000 00 01112223355678
Q ss_pred Hhhhhhhccccceeeccccccccccccceeeeee
Q psy763 243 KILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 243 dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
+++.+|+..+|..| +++.+++.|||+.
T Consensus 289 ~li~~mL~~dP~~R-------ps~~ell~hp~~~ 315 (355)
T cd07874 289 DLLSKMLVIDPAKR-------ISVDEALQHPYIN 315 (355)
T ss_pred HHHHHHhcCCchhc-------CCHHHHhcCcchh
Confidence 99999998766666 9999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.41 Aligned_cols=239 Identities=19% Similarity=0.177 Sum_probs=169.8
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
...+|+++++.++|+||+++++++..++..++|+|++. +++..++ .....+++..+..++.|++.||.|||++||+||
T Consensus 206 ~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr 284 (461)
T PHA03211 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHR 284 (461)
T ss_pred CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
Confidence 35679999999999999999999999999999999997 4555554 444579999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||+|||++.++.++|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|||++|..+++
T Consensus 285 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 285 DIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcc
Confidence 9999999999999999999999987543221 22356899999999998766 8999999999999999998776554
Q ss_pred CCc-------hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhh----hcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 176 GNM-------GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEI----FSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 176 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
+.. ....+.+++.......... +............... ........|.++ ....+.+.++
T Consensus 364 ~~~~~~~~~~~~~~l~~~i~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~dl 434 (461)
T PHA03211 364 SASRGDERRPYDAQILRIIRQAQVHVDEF-PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY--------YKLDLDVEYL 434 (461)
T ss_pred cCCcccccCCcHHHHHHHHHhhccccccC-CCCcchHHHHHHHhhhhcccCCccCCcchhhh--------ccccchHHHH
Confidence 332 1233344444322211000 0111111111000000 000000112111 1234578899
Q ss_pred hhhhhccccceeeccccccccccccceeeeee
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
+.+||..++..| +++.++|+||||.
T Consensus 435 i~~mL~~DP~~R-------Psa~elL~hp~f~ 459 (461)
T PHA03211 435 VCRALTFDGARR-------PSAAELLRLPLFQ 459 (461)
T ss_pred HHHHcccChhhC-------cCHHHHhhCcccC
Confidence 999998666555 9999999999984
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=245.71 Aligned_cols=213 Identities=20% Similarity=0.283 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++..+..+++|+||++++++.+.+...+.+++..+..++.|++.|+.|||+.|++
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 126 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34567889999999999999999999999999999999999999999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++||||+||++||+++|..
T Consensus 127 H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred cCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998765432111 2346788999999998766 7999999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+.+................ ..........+.+++.+|+...
T Consensus 206 p~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~l~~~ 247 (263)
T cd06625 206 PWAEFEAMAAIFKIATQPTN--------------------------------------PQLPSHVSPDARNFLRRTFVEN 247 (263)
T ss_pred CccccchHHHHHHHhccCCC--------------------------------------CCCCccCCHHHHHHHHHHhhcC
Confidence 87665444333322211111 0111223456678888888866
Q ss_pred cceeeccccccccccccceeeee
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+..| +++.+++.|+||
T Consensus 248 p~~R-------pt~~~ll~~~~~ 263 (263)
T cd06625 248 AKKR-------PSAEELLRHFFV 263 (263)
T ss_pred cccC-------CCHHHHhhCCCC
Confidence 6666 999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=254.43 Aligned_cols=205 Identities=24% Similarity=0.331 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCC---------------------------
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHP--------------------------- 68 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~--------------------------- 68 (303)
...+.+|+.+++.+ +||||+++++++... +.+++||||+++|+|.+++...
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (338)
T cd05102 54 HKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133 (338)
T ss_pred HHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcc
Confidence 35678899999999 899999999998765 4689999999999999887542
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcE
Q psy763 69 -----------------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 113 (303)
Q Consensus 69 -----------------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~ 113 (303)
.++++..+..++.|++.||.|||+.||+||||||+||+++.++.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~ 213 (338)
T cd05102 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVV 213 (338)
T ss_pred ccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcE
Confidence 247788889999999999999999999999999999999999999
Q ss_pred EEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhc
Q psy763 114 KLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKN 189 (303)
Q Consensus 114 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~ 189 (303)
||+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++ |..|+.+....+.....+..
T Consensus 214 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 292 (338)
T cd05102 214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292 (338)
T ss_pred EEeecccccccccCcchhcccCCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc
Confidence 9999999976543221 12234567899999998665 8999999999999999997 77777665544444455554
Q ss_pred CCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 190 NGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.++. .+...++++.+++..|+..+|..||....
T Consensus 293 ~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 293 GTRMR---APENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred CCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 44332 23445566777777777777776665443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=254.86 Aligned_cols=237 Identities=26% Similarity=0.461 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+..++.++||||+++++++.+.+.+++|+||++++.+..+....+.+++..+..++.||+.||.|||+.|++|+
T Consensus 44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~ 123 (284)
T cd07839 44 SSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR 123 (284)
T ss_pred cchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 45667899999999999999999999999999999999864444444445679999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++||||+||++|+|++|+.|++..
T Consensus 124 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99999999999999999999998765432 22234567889999999887666799999999999999999998876544
Q ss_pred -chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH--hHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 178 -MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL--LIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 178 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
...+....+....+.+... .|..+...+......... .......+..++++.+++.+|+..+|.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 270 (284)
T cd07839 204 NDVDDQLKRIFRLLGTPTEE-------------SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPV 270 (284)
T ss_pred CCHHHHHHHHHHHhCCCChH-------------HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChh
Confidence 3344444443332221100 011111111100000000 000111223567888999999997666
Q ss_pred eeeccccccccccccceeeee
Q psy763 255 YIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.| +++.+++.||||
T Consensus 271 ~R-------~t~~~il~h~~f 284 (284)
T cd07839 271 QR-------ISAEEALQHPYF 284 (284)
T ss_pred hc-------CCHHHHhcCCCC
Confidence 66 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=249.60 Aligned_cols=228 Identities=29% Similarity=0.423 Sum_probs=167.3
Q ss_pred HHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 26 KEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 26 ~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..++.++||||+++++++... ..+++|+|++++ ++..++... ..+++..+..++.|++.||.|||+.|++|+
T Consensus 54 ~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~ 132 (288)
T cd07863 54 KRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR 132 (288)
T ss_pred HHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 334455899999999998642 468999999985 666665432 358999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
||||+||+++.++.+||+|||++.............++..|+|||++.+.. ++.++||||+||++|+|++|..+|.+..
T Consensus 133 dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 133 DLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred CCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 999999999999999999999998765444444567899999999998665 8999999999999999999999988887
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeec
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQS 258 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~ 258 (303)
.......+....+.+.....+... ...... ......+++... .+.....+.|++.+||..+|..|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R-- 276 (288)
T cd07863 212 EADQLGKIFDLIGLPPEDDWPRDV-----TLPRGA-FSPRGPRPVQSV-------VPEIEESGAQLLLEMLTFNPHKR-- 276 (288)
T ss_pred HHHHHHHHHHHhCCCChhhCcccc-----cccccc-cCCCCCCchHHh-------CcCcCHHHHHHHHHHhccCcccC--
Confidence 776666665543322111000000 000000 001111111111 12244567899999998777666
Q ss_pred cccccccccccceeeee
Q psy763 259 EKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 259 ~~~~~~~~~~~l~~~~~ 275 (303)
+++.+++.||||
T Consensus 277 -----~t~~~~l~hp~f 288 (288)
T cd07863 277 -----ISAFRALQHPFF 288 (288)
T ss_pred -----CCHHHHhcCCCC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=263.13 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=178.2
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
...+|+++++.++||||+++++++......|+|||++. +++..++.....+++..+..++.|++.||.|||+.||+|||
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrD 210 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRD 210 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 34578999999999999999999999999999999997 56666666667899999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||+||+++.++.++|+|||++........ .....||+.|+|||++.+.. ++.++||||+||++|||++|..||++
T Consensus 211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999876543222 22457899999999998765 89999999999999999999999987
Q ss_pred Cch---HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCCh-hHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 177 NMG---SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTST-TTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 177 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
... ...+..+++..+..+.... ........ ..+......... -.+... .. ......++.+++.+|+...
T Consensus 290 ~~~~~~~~~l~~i~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~li~~ml~~d 362 (392)
T PHA03207 290 KQVKSSSSQLRSIIRCMQVHPLEFP-QNGSTNLC-KHFKQYAIVLRPPYTIPPV--IR---KYGMHMDVEYLIAKMLTFD 362 (392)
T ss_pred CCCCCcHHHHHHHHHHhccCccccC-CccchhHH-HHHHhhcccccCCccccch--hh---ccCcchhHHHHHHHHhccC
Confidence 643 3444444444332221111 11000100 011111100000 000000 00 0122456778899998866
Q ss_pred cceeeccccccccccccceeeeeecCCcce
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
+..| +++.+++.||||...+...
T Consensus 363 p~~R-------psa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 363 QEFR-------PSAQDILSLPLFTKEPINL 385 (392)
T ss_pred hhhC-------CCHHHHhhCchhhccchhh
Confidence 6555 9999999999997655443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=248.53 Aligned_cols=239 Identities=44% Similarity=0.714 Sum_probs=180.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++..++..++|+||++++++..+......+++..+..++.|++.||.|||+.|++|
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H 123 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 34567899999999999999999999999999999999999999998877778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+||++|+|++|..|+.+
T Consensus 124 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred cCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998765433 223446788899999988766578999999999999999999988887
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCC---hhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTS---TTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
....+....+....+....... ...... .|..-...+. ..++... .+..+..+.+++.+|+...|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p 271 (286)
T cd07847 204 KSDVDQLYLIRKTLGDLIPRHQ-QIFSTN----QFFKGLSIPEPETREPLESK-------FPNISSPALSFLKGCLQMDP 271 (286)
T ss_pred CChHHHHHHHHHHhCCCChHHh-hhcccc----cccccccCCCcccccCHHHH-------hccCCHHHHHHHHHHhcCCc
Confidence 7766555544433222110000 000000 0000000000 0011110 11235778899999998777
Q ss_pred ceeeccccccccccccceeeee
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
..| +++.+++.||||
T Consensus 272 ~~R-------p~~~eil~~~~f 286 (286)
T cd07847 272 TER-------LSCEELLEHPYF 286 (286)
T ss_pred ccc-------CCHHHHhcCCCC
Confidence 666 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=247.44 Aligned_cols=218 Identities=24% Similarity=0.295 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++.+++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~ 123 (290)
T cd05580 44 QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIV 123 (290)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 45667889999999999999999999999999999999999999999988778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||++...... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..|+.+
T Consensus 124 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 124 YRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred cCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998876543 33456889999999987665 78999999999999999999988877
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+....... .....+...+++.+|+..+|..|
T Consensus 201 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~l~~li~~~l~~~p~~R 240 (290)
T cd05580 201 DNPIQIYEKILEGKVRF----------------------------------------PSFFSPDAKDLIRNLLQVDLTKR 240 (290)
T ss_pred CCHHHHHHHHhcCCccC----------------------------------------CccCCHHHHHHHHHHccCCHHHc
Confidence 66444444333211100 00113455677888887666655
Q ss_pred eccccccccccccceeeeeecCC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
- .....++.+++.|||+.+.+
T Consensus 241 ~--~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 241 L--GNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred c--CcccCCHHHHHcCcccccCC
Confidence 1 11113788889999887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=248.81 Aligned_cols=217 Identities=18% Similarity=0.194 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+.+++.++|+||+++++.+.+++.+++||||+++++|..++... ..+++..+..++.|++.||.|||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 345667899999999999999999999999999999999999998877432 368999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+|+||+|+||+++.++.++|+|||++.............|+..|+|||.+.+.. ++.++|+||+||++|+|++|..|+.
T Consensus 124 iH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred EeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999988765444444567899999999998765 8999999999999999999998886
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+......... ....... ..........+++.+++.+|+..++..
T Consensus 203 ~~~~~~~~~~-------------------------~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (285)
T cd05630 203 QRKKKIKREE-------------------------VERLVKE-----------VQEEYSEKFSPDARSLCKMLLCKDPKE 246 (285)
T ss_pred CCCccchHHH-------------------------HHhhhhh-----------hhhhcCccCCHHHHHHHHHHhhcCHHH
Confidence 5422110000 0000000 000111234567789999999977777
Q ss_pred eecccccccc-----ccccceeeeeecC
Q psy763 256 IQSEKQDSIR-----GKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~-----~~~~l~~~~~~~~ 278 (303)
| ++ +.+++.||||...
T Consensus 247 R-------~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 247 R-------LGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred c-------cCCCCCchHHHHcChhhhcc
Confidence 7 76 8999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=267.90 Aligned_cols=250 Identities=19% Similarity=0.203 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
...+.+|+.+++.++||||+++++++...+..|+|+|++.+..+..+... ........+..++.|++.||.|||++
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~ 286 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 34577899999999999999999999999999999999975544433321 12344667888999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
||+||||||+|||++.++.+||+|||++........ .....||..|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 287 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999987653322 23457899999999998766 899999999999999999998
Q ss_pred ccCCCCc---hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 172 FIGLGNM---GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 172 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
.++++.. ....+..++......... .+......++......... ....+... ... .....++.+++.+|
T Consensus 366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~i~~~~~~~-~~~~~~~~--~~~---~~~~~~~~~li~km 437 (501)
T PHA03210 366 FCPIGDGGGKPGKQLLKIIDSLSVCDEE--FPDPPCKLFDYIDSAEIDH-AGHSVPPL--IRN---LGLPADFEYPLVKM 437 (501)
T ss_pred CCCccCCCCCHHHHHHHHHHhcccChhh--cCCcHHHHHHHhhhhhccc-CccchhhH--HHh---cCCChHHHHHHHHH
Confidence 7766543 334444444332221100 0011111111111000000 00111111 111 11345677889999
Q ss_pred hccccceeeccccccccccccceeeeeecCCcceE
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKCL 283 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 283 (303)
|..++..| +++.+++.||||......++
T Consensus 438 L~~DP~~R-------psa~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 438 LTFDWHLR-------PGAAELLALPLFSAEEEEEI 465 (501)
T ss_pred hccCcccC-------cCHHHHhhChhhhcCCchHH
Confidence 98666666 99999999999987655443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=263.16 Aligned_cols=242 Identities=17% Similarity=0.198 Sum_probs=169.7
Q ss_pred hCCCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCCCcEEE
Q psy763 30 SLKHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILL 107 (303)
Q Consensus 30 ~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlk~~nil~ 107 (303)
..+|.+++++++++..+ .++|+|+|++. +++..++.+.+.+++..+..++.||+.||.|||+ .||+||||||+|||+
T Consensus 187 ~~~~~~i~~i~~~~~~~~~~~~iv~~~~g-~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl 265 (467)
T PTZ00284 187 PADRFPLMKIQRYFQNETGHMCIVMPKYG-PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM 265 (467)
T ss_pred cccCcceeeeEEEEEcCCceEEEEEeccC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence 34456689999998765 57899999985 5666666666789999999999999999999998 599999999999999
Q ss_pred ecCC----------------cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 108 TANG----------------VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 108 ~~~~----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+.++ .+||+|||.+.... .......||+.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred ecCCcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCC
Confidence 8765 49999999876432 2234568999999999998766 899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh---cCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF---SKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
.||.+....+.+..+....++++...... +.......++.... .....+.+...............+.+.|||.+|
T Consensus 343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGR-CGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCCCChHHHHHHHHHHcCCCCHHHHhh-ccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 99988887777776666555543221110 00000000110000 000111111110000000111346678999999
Q ss_pred hccccceeeccccccccccccceeeeeecCCcceE
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKCL 283 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 283 (303)
|..+|..| +++.+++.||||..-...|.
T Consensus 422 L~~dP~~R-------~ta~e~L~Hp~~~~~~~~~~ 449 (467)
T PTZ00284 422 LHYDRQKR-------LNARQMTTHPYVLKYYPECR 449 (467)
T ss_pred CCcChhhC-------CCHHHHhcCccccccCCccc
Confidence 99777666 99999999999987555453
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=253.43 Aligned_cols=251 Identities=16% Similarity=0.129 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++||||+++++++..++..++|+||+++|++.+++.. ...+++..+..++.|++.||.|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 121 (327)
T cd08227 42 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121 (327)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445677899999999999999999999999999999999999999998754 346899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC--------ccccccCCCcccCcccccCC-ccCCCccchhhHHHHHH
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~ 165 (303)
++||||||+||+++.++.++++||+.+....... ......++..|+|||.+.+. ..++.++||||+||++|
T Consensus 122 iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 201 (327)
T cd08227 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 201 (327)
T ss_pred EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998654432111 11223466779999998753 34889999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhh---------hhhhhcCCChhHHHHHHhHhCCCCCC
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLT---------WQEIFSKTSTTTIFKYLLIRGGNTDR 236 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~~~~~~~~ 236 (303)
||++|..|+.+....+........ ..+........+.+..... +.........++.... .........
T Consensus 202 el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 278 (327)
T cd08227 202 ELANGHVPFKDMPATQMLLEKLNG--TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGE-SSSHPYNRT 278 (327)
T ss_pred HHHHCCCCCCCcchhHHHHHHhcC--CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccC-Ccccccccc
Confidence 999999988766554444333321 1111111111111100000 0000000000000000 001112233
Q ss_pred CchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 237 NSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 237 ~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.++.+.+++.+|+..+|..| +++.++++||||..
T Consensus 279 ~~~~~~~li~~~l~~dP~~R-------pt~~ell~~p~f~~ 312 (327)
T cd08227 279 FSPHFHHFVEQCLQRNPDAR-------PSASTLLNHSFFKQ 312 (327)
T ss_pred cCHHHHHHHHHHHhhCchhc-------CCHHHHhcChhhhh
Confidence 46678899999998776666 99999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=277.32 Aligned_cols=185 Identities=22% Similarity=0.225 Sum_probs=164.9
Q ss_pred cccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHH
Q psy763 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 84 (303)
Q Consensus 5 kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~ 84 (303)
|+-++-.+-+....+.|.+|..++...+.+.|+.++..|++++++|+||||++||+|-.++.+..++++..++.++..++
T Consensus 106 K~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiV 185 (1317)
T KOG0612|consen 106 KILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIV 185 (1317)
T ss_pred HHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHH
Confidence 33334444556678889999999999999999999999999999999999999999999998887999999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccC----CccCCCccchh
Q psy763 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVG----DTLYGPAVDVW 158 (303)
Q Consensus 85 ~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~----~~~~~~~~Dvw 158 (303)
-||.-+|+.|+|||||||+|||+|..|++||+|||.|-.+..++. ....+|||-|.+||++.. .+.|+..+|.|
T Consensus 186 lAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW 265 (1317)
T KOG0612|consen 186 LALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW 265 (1317)
T ss_pred HHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchh
Confidence 999999999999999999999999999999999999988774432 356799999999999972 24589999999
Q ss_pred hHHHHHHHhhccCccCCCCchHHHHHHHhhc
Q psy763 159 AIEWTSHSYSQIGFIGLGNMGSHMARNLLKN 189 (303)
Q Consensus 159 SlG~il~el~tg~~~~~~~~~~~~~~~~~~~ 189 (303)
|+||++|||+.|..|||..+..+...+|+.-
T Consensus 266 SlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 266 SLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred hhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 9999999999999999999888887777664
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=244.36 Aligned_cols=215 Identities=24% Similarity=0.312 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++.+.+++..++|+||+++++|.+++.+...+++..+..++.|++.||+|||+.|++
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 115 (262)
T cd05572 36 QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115 (262)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 45678889999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||++.............++..|+|||.+.+.. ++.++|+||+|+++|++++|..|+.+
T Consensus 116 h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred cCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 99999999999999999999999998765443334456788999999987655 79999999999999999999888876
Q ss_pred Cc--hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 177 NM--GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 177 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.. ..+....+......+ .......+++.+++.+|+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKL--------------------------------------EFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CCCCHHHHHHHHhccCCCC--------------------------------------CCCcccCHHHHHHHHHHccCChh
Confidence 55 333322222111000 00111245678889899886666
Q ss_pred eeecccccccc-----ccccceeeeeec
Q psy763 255 YIQSEKQDSIR-----GKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~-----~~~~l~~~~~~~ 277 (303)
.| ++ ++++++||||.+
T Consensus 237 ~R-------~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ER-------LGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hC-------cCCcccCHHHHhcChhhhC
Confidence 55 77 899999999875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.13 Aligned_cols=240 Identities=28% Similarity=0.440 Sum_probs=182.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++..++..++|+||+ +++|..++.. ...+++..++.++.|++.||.|||+.|++
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (286)
T cd07832 43 PNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIM 121 (286)
T ss_pred hHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 456778899999999999999999999999999999999 8999887643 45799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++||||+||++|||++|..++
T Consensus 122 H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred cCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 99999999999999999999999988765432 2334578899999999877665799999999999999999998777
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhh-hcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEI-FSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
.+.........++...+.+.....+....... |... .......++.. ..+.....+.+++.+|+..+|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p 270 (286)
T cd07832 202 PGENDIEQLAIVFRTLGTPNEETWPGLTSLPD----YNKITFPESKPIPLEE-------IFPDASPEALDLLKGLLVYDP 270 (286)
T ss_pred CCCCHHHHHHHHHHHcCCCChHHHhhccCcch----hhcccCCCCCcchHHH-------hCCCccHHHHHHHHHHhccCh
Confidence 77777777666666544432211111100000 1110 01111111111 112345788899999998665
Q ss_pred ceeeccccccccccccceeeeee
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
..| +++.+++.||||.
T Consensus 271 ~~R-------~~~~~~l~h~~~~ 286 (286)
T cd07832 271 SKR-------LSAAEALRHPYFT 286 (286)
T ss_pred hhC-------CCHHHHhhCcCcC
Confidence 555 9999999999973
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=245.54 Aligned_cols=221 Identities=21% Similarity=0.204 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++|+||+.+.+.+..++..++|+||++++++...+.. ...+++..+..++.|++.||.|||+.|
T Consensus 43 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 122 (285)
T cd05632 43 GESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122 (285)
T ss_pred HHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345567899999999999999999999999999999999999999887643 336999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|+|+||+|+||+++.++.++|+|||++.............++..|+|||.+.+.. ++.++|+||+||++|++++|..|+
T Consensus 123 iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~ 201 (285)
T cd05632 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPF 201 (285)
T ss_pred eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999987765444444567899999999998765 899999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.........+........ .......++.+.+++.+|+..+|.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~~P~ 245 (285)
T cd05632 202 RGRKEKVKREEVDRRVLETE------------------------------------EVYSAKFSEEAKSICKMLLTKDPK 245 (285)
T ss_pred CCCCHHHHHHHHHHhhhccc------------------------------------cccCccCCHHHHHHHHHHccCCHh
Confidence 76554433322211110000 001122345567888888887776
Q ss_pred eeecccccccc-----ccccceeeeeecCCcc
Q psy763 255 YIQSEKQDSIR-----GKNCKKTFYIPTPERK 281 (303)
Q Consensus 255 ~~~~~~~~~~~-----~~~~l~~~~~~~~~~~ 281 (303)
.| ++ +.+++.|+|+..-+.+
T Consensus 246 ~R-------~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 246 QR-------LGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred Hc-------CCCcccChHHHHcChhhhcCCHH
Confidence 66 66 7899999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=247.73 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=191.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHH
Q psy763 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 15 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
.....+..+|..++..++|+||++++.+|.-.+ ..|+|||+|. .++..++. -.++-.++..++.|++.|++
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik 132 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIK 132 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHH
Confidence 344556678999999999999999999997543 5799999998 56666554 36778899999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
|||+.||+||||||+||++..++.+||+|||+|+.....-..+..+.|..|+|||++.+.+ |...+||||+||++.||+
T Consensus 133 ~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 133 HLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELI 211 (369)
T ss_pred HHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHh
Confidence 9999999999999999999999999999999998866554557788999999999999888 899999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCC---------CcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCch
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSL---------DSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSH 239 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 239 (303)
+|...|.|....++..++.+..+.+.......-. .++.....+...+.+.. +....+..+.+..
T Consensus 212 ~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~-------f~~~~e~~~~~~~ 284 (369)
T KOG0665|consen 212 LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSL-------FPVVLEGSKLDCS 284 (369)
T ss_pred hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccc-------ccccccCCccchH
Confidence 9999999999999999998887776533221100 00111111111111111 0012233356777
Q ss_pred hhHHhhhhhhccccceeeccccccccccccceeeeee
Q psy763 240 GVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 240 ~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
.+.|++.+||.-+|..| +++.++|+|||+.
T Consensus 285 ~ardll~~MLvi~pe~R-------isv~daL~HPY~~ 314 (369)
T KOG0665|consen 285 LARDLLSKMLVIDPEKR-------ISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHHHhhccChhhc-------ccHHHHhcCCeee
Confidence 88999999999777776 9999999999996
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=248.94 Aligned_cols=232 Identities=20% Similarity=0.185 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHH
Q psy763 12 YKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 12 ~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~ 89 (303)
.++.........|..++..++.+.||.+-..|++...+|+|+..|.||+|.-.+.+-+ .+++..+..++.+|+-||.+
T Consensus 223 iKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLeh 302 (591)
T KOG0986|consen 223 IKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEH 302 (591)
T ss_pred HHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHH
Confidence 4445566777888999999999999999999999999999999999999998776655 89999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
||+.+||+||+||+|||+|+.|+++|+|+|+|..+..+......+||.+|||||++.+.. |+.+.|.||+||++|||+.
T Consensus 303 lH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~ 381 (591)
T KOG0986|consen 303 LHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIA 381 (591)
T ss_pred HHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHc
Confidence 999999999999999999999999999999999998888888889999999999999877 9999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..||-..-...- |++.-+.. +....+..+.-++++-++.+-+|
T Consensus 382 G~sPFr~~KeKvk----------------------------~eEvdrr~--------~~~~~ey~~kFS~eakslc~~LL 425 (591)
T KOG0986|consen 382 GHSPFRQRKEKVK----------------------------REEVDRRT--------LEDPEEYSDKFSEEAKSLCEGLL 425 (591)
T ss_pred ccCchhhhhhhhh----------------------------HHHHHHHH--------hcchhhcccccCHHHHHHHHHHH
Confidence 9998864422111 11111000 00112233445666777777777
Q ss_pred ccccceeeccccccccccccceeeeeecCCcce
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
..++..+-.- +...+.+..+||||.+.+.+.
T Consensus 426 ~Kdp~~RLGc--rg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 426 TKDPEKRLGC--RGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred ccCHHHhccC--CCcCcchhhhCcccccCCHhH
Confidence 7666555332 223677778888887755443
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=260.21 Aligned_cols=180 Identities=27% Similarity=0.433 Sum_probs=166.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+++++.++|||||+++.+......+|+||||+.+|.+.+++.+.+...+..+..++.|+++|++|||+++||
T Consensus 98 ~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~iv 177 (596)
T KOG0586|consen 98 KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIV 177 (596)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhccee
Confidence 34448899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||++|+|++.+.++||+|||++.++..+....+.+|++.|.|||+..|....++.+|+||+|+++|.++.|..||.|
T Consensus 178 HrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 178 HRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999999999999999999999888889999999999999999988678999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEe
Q psy763 177 NMGSHMARNLLKNNGRVTVI 196 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~ 196 (303)
....+.-.+.+....++++.
T Consensus 258 ~~lk~Lr~rvl~gk~rIp~~ 277 (596)
T KOG0586|consen 258 QNLKELRPRVLRGKYRIPFY 277 (596)
T ss_pred cccccccchheeeeecccce
Confidence 88877777666666666543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=253.38 Aligned_cols=216 Identities=22% Similarity=0.301 Sum_probs=165.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++|+||+++++++...+.+++|+||+++|+|... ...++..+..++.||+.||.|||++|++
T Consensus 115 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv 190 (353)
T PLN00034 115 VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIV 190 (353)
T ss_pred HHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 345678899999999999999999999999999999999999998643 2456788889999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCC----ccCCCccchhhHHHHHHHhhccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGD----TLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~----~~~~~~~DvwSlG~il~el~tg~ 171 (303)
||||||+|||++.++.+||+|||++...... .......||..|+|||.+... ...+.++|||||||++|||++|.
T Consensus 191 HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~ 270 (353)
T PLN00034 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270 (353)
T ss_pred ecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999876432 222445789999999987532 22456899999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.+|.............. .... ...........++.+++.+|+..
T Consensus 271 ~pf~~~~~~~~~~~~~~-------------------------~~~~-----------~~~~~~~~~~~~l~~li~~~l~~ 314 (353)
T PLN00034 271 FPFGVGRQGDWASLMCA-------------------------ICMS-----------QPPEAPATASREFRHFISCCLQR 314 (353)
T ss_pred CCCCCCCCccHHHHHHH-------------------------Hhcc-----------CCCCCCCccCHHHHHHHHHHccC
Confidence 88753221111000000 0000 00011123356778999999886
Q ss_pred ccceeeccccccccccccceeeeeecCC
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
++..| +++.+++.|+|+....
T Consensus 315 ~P~~R-------pt~~ell~hp~~~~~~ 335 (353)
T PLN00034 315 EPAKR-------WSAMQLLQHPFILRAQ 335 (353)
T ss_pred ChhhC-------cCHHHHhcCcccccCC
Confidence 66665 9999999999998753
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=240.53 Aligned_cols=214 Identities=23% Similarity=0.281 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++|+||+++++++.+.+..++|+||+++++|..++.+...+++..+..++.|++.|++|||+.|++
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 124 (265)
T cd06631 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 34568889999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-------CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-------ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+.. ++.++|+||+||++|++++
T Consensus 125 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~ 203 (265)
T cd06631 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMAT 203 (265)
T ss_pred cCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999998764311 1122346788999999998765 7899999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..|+.+.........+....... .......+..+.+++.+|+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06631 204 GKPPLASMDRLAAMFYIGAHRGLM-------------------------------------PRLPDSFSAAAIDFVTSCL 246 (265)
T ss_pred CCCccccCChHHHHHHhhhccCCC-------------------------------------CCCCCCCCHHHHHHHHHHh
Confidence 998886654333322211110000 0011123456788999999
Q ss_pred ccccceeeccccccccccccceeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
...+..| +++.+++.||||
T Consensus 247 ~~~p~~R-------p~~~~~l~~~~~ 265 (265)
T cd06631 247 TRDQHER-------PSALQLLRHDFL 265 (265)
T ss_pred cCCcccC-------CCHHHHhcCCCC
Confidence 8666666 999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=247.32 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=181.9
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+|+.+++.++|+||+++++++... +.+++|+||+++ ++..++.. ...+++..+..++.|++.||.|||+.|++|
T Consensus 53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 131 (309)
T cd07845 53 SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIH 131 (309)
T ss_pred hhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 45689999999999999999999765 568999999985 56665543 467999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++|||++|..++.+
T Consensus 132 ~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 132 RDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999876543 2223345578899999988766689999999999999999999999988
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+....+.+.....+. .....+...+.. ...+.... . ......++.+.+++.+|+..+|..|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~-~---~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 212 KSEIEQLDLIIQLLGTPNESIWPG-----FSDLPLVGKFTL-PKQPYNNL-K---HKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred CCHHHHHHHHHHhcCCCChhhchh-----hhcccccccccc-cCCCCCch-H---HhccccCHHHHHHHHHHhcCChhhC
Confidence 888877777766544332111110 000000000000 00000000 0 0012246778899999998666666
Q ss_pred eccccccccccccceeeeeecCCcceE
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPERKCL 283 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~~~~~ 283 (303)
+++.+++.|+||.+.+..|.
T Consensus 282 -------~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 282 -------ATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred -------cCHHHHhcChhhccCCCCCC
Confidence 99999999999998887754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=243.00 Aligned_cols=218 Identities=16% Similarity=0.142 Sum_probs=168.8
Q ss_pred HHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCC
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKP 102 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~ 102 (303)
.....++...||||+++++.+...+..++|+||+.+++|..++...+.+++..+..++.|++.|+.|||+.+++|+||+|
T Consensus 46 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p 125 (278)
T cd05606 46 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKP 125 (278)
T ss_pred HHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCH
Confidence 34456666789999999999999999999999999999999888777899999999999999999999999999999999
Q ss_pred CcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHH
Q psy763 103 ENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHM 182 (303)
Q Consensus 103 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~ 182 (303)
+||+++.++.++|+|||++...... ......++..|+|||.+.+...++.++|+||+||++|||++|..|+.+......
T Consensus 126 ~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~ 204 (278)
T cd05606 126 ANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204 (278)
T ss_pred HHEEECCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch
Confidence 9999999999999999998765432 223457899999999997654579999999999999999999988765422111
Q ss_pred HHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccc
Q psy763 183 ARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQD 262 (303)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~ 262 (303)
.. . ...... .........++.+.+++++|+...+..+-.. +
T Consensus 205 ~~-~------------------------~~~~~~------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~--~ 245 (278)
T cd05606 205 HE-I------------------------DRMTLT------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGC--L 245 (278)
T ss_pred HH-H------------------------HHHhhc------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCC--C
Confidence 00 0 000000 0011112235678899999999777666111 1
Q ss_pred cccccccceeeeeecCCc
Q psy763 263 SIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 263 ~~~~~~~l~~~~~~~~~~ 280 (303)
..++.++++|||+.+.+.
T Consensus 246 ~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 246 GRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred CCCHHHHHhCccccCCCc
Confidence 128999999999988653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=246.39 Aligned_cols=243 Identities=30% Similarity=0.407 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+..|+..++.++|+||+++++++.+.+..++|+||+ +++|..++.... .+++..+..++.|++.||.|||+.|++
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~ 124 (298)
T cd07841 46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL 124 (298)
T ss_pred hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 345567889999999999999999999999999999999 899999887665 799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+...++.++|+|||||++|||++|..++.
T Consensus 125 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred ecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 9999999999999999999999999876543 222334567889999998765557999999999999999999977777
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+....+.+.....+... ..............+... ........+.+++.+|+...|..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~ 272 (298)
T cd07841 205 GDSDIDQLGKIFEALGTPTEENWPGVT-----SLPDYVEFKPFPPTPLKQ-------IFPAASDDALDLLQRLLTLNPNK 272 (298)
T ss_pred CCccHHHHHHHHHHcCCCchhhhhhcc-----cccccccccccCCcchhh-------hcccccHHHHHHHHHHhcCCccc
Confidence 776666655555433222111110000 000000011111111111 11234567889999999976666
Q ss_pred eeccccccccccccceeeeeecCCc
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
| .++.+++.|+||...+.
T Consensus 273 R-------~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 273 R-------ITARQALEHPYFSNDPA 290 (298)
T ss_pred C-------cCHHHHhhCccccCCCC
Confidence 6 99999999999988543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=244.77 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i 95 (303)
....+.+|+++++.++||||+++++++..++.+++|+||+++++|..++...+.+++..+..++.|++.||.|||+ .++
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 121 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 3445778999999999999999999999999999999999999999998877889999999999999999999998 599
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..|+.
T Consensus 122 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred EECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998765332 224457889999999987655 7899999999999999999999887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCC---CCCCCchhhHHhhhhhhccc
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGG---NTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~dll~~~l~~~ 252 (303)
+...... ...+................. ..............+......... +....++++.+++.+|+..+
T Consensus 200 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 274 (308)
T cd06615 200 PPDAKEL-EAMFGRPVSEGEAKESHRPVS----GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKN 274 (308)
T ss_pred CcchhhH-HHhhcCccccccccCCccccc----CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCC
Confidence 6654333 222222111100000000000 000000000000011111111101 11123567889999999877
Q ss_pred cceeeccccccccccccceeeeeecCCc
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
|..| +++.+++.|||+...+.
T Consensus 275 P~~R-------pt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 275 PKER-------ADLKELTKHPFIKRAEL 295 (308)
T ss_pred hhhC-------cCHHHHhcChhhhhccc
Confidence 7766 99999999999976443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=246.15 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=208.2
Q ss_pred ccccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHHcCCCCCCHHHH
Q psy763 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELENHPHGLPWDLI 76 (303)
Q Consensus 2 ~~~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~ 76 (303)
|+..||-..+.........+-+|.+++..++|.|++..+++.+-.+ .+|.|+|.+. ++|+.++.....++...+
T Consensus 80 rvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHv 158 (449)
T KOG0664|consen 80 RVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQALTPDHV 158 (449)
T ss_pred chhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCCCCCcchh
Confidence 3445566666677778888899999999999999999999988654 3678999997 889999888899999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCc
Q psy763 77 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPA 154 (303)
Q Consensus 77 ~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~ 154 (303)
.-+++||++||+|||+.||.||||||.|.|+++++.+||||||+++...... ..+..+.|..|+|||++.|...|+.+
T Consensus 159 KVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~A 238 (449)
T KOG0664|consen 159 KVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGA 238 (449)
T ss_pred hhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCc
Confidence 9999999999999999999999999999999999999999999999866433 33456778999999999999989999
Q ss_pred cchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCC
Q psy763 155 VDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNT 234 (303)
Q Consensus 155 ~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 234 (303)
.||||+|||+.|++..+..|....+.+++.-+....+++........ + +..-..+++.+.+.|.+.-+.. ...+
T Consensus 239 vDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A----C-EGAk~H~LR~~~k~Ps~~vLYt-lsS~ 312 (449)
T KOG0664|consen 239 VDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA----C-EGAKNHVLRAGLRAPDTQRLYK-IASP 312 (449)
T ss_pred cceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH----h-hhhHHHhhccCCCCCCccceee-ecCC
Confidence 99999999999999999999999999999888887666542110000 0 0001223333434443333222 2233
Q ss_pred CCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 235 DRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 235 ~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.....++++++.+++.+.+..+ ++..+++.|+|...-
T Consensus 313 ~~~~heav~~~~~~l~~d~dkr-------is~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 313 DDKNHEAVDLLQKLLHFDPDKR-------ISVEEALQHRYLEEG 349 (449)
T ss_pred cccchHHHHHHHHHhCCCCccc-------ccHhhhccccccccc
Confidence 4456788999999999888887 999999999987653
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=240.19 Aligned_cols=214 Identities=23% Similarity=0.322 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+..++.++||||+++++.+..++.+++|+||+++++|.+++...+.+++..+..++.|++.|+.|||+.|++|+
T Consensus 51 ~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 130 (267)
T cd06645 51 AVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130 (267)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 45677889999999999999999999999999999999999999998877889999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCccccc--CCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLV--GDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~--~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||+|+||+++.++.++|+|||++....... ......++..|+|||.+. ....++.++|+||+||++|+|++|..|+.
T Consensus 131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 999999999999999999999987654322 223457899999999974 22337889999999999999999998876
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
.................++ . + ......+..+.+++.+|+..+|..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~------~---------------------~--------~~~~~~~~~~~~li~~~l~~~P~~ 255 (267)
T cd06645 211 DLHPMRALFLMTKSNFQPP------K---------------------L--------KDKMKWSNSFHHFVKMALTKNPKK 255 (267)
T ss_pred cccchhhHHhhhccCCCCC------c---------------------c--------cccCCCCHHHHHHHHHHccCCchh
Confidence 6544333222111110000 0 0 000012345668888888855555
Q ss_pred eeccccccccccccceeee
Q psy763 256 IQSEKQDSIRGKNCKKTFY 274 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~ 274 (303)
| +++.+++.|||
T Consensus 256 R-------~~~~~ll~~~~ 267 (267)
T cd06645 256 R-------PTAEKLLQHPF 267 (267)
T ss_pred C-------cCHHHHhcCCC
Confidence 5 99999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=239.86 Aligned_cols=212 Identities=19% Similarity=0.266 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++||||+++++++...+..++|+||+++++|..++...+.+++..+..++.|++.|+.|||+.|++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~iv 128 (267)
T cd06628 49 MLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGII 128 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 34578889999999999999999999999999999999999999999998777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+||++|+|++
T Consensus 129 H~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~ 207 (267)
T cd06628 129 HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLT 207 (267)
T ss_pred cccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhh
Confidence 99999999999999999999999987764211 112245788899999988655 7899999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..|+.+......+...... . ...........+.+++.+|+
T Consensus 208 g~~p~~~~~~~~~~~~~~~~-~--------------------------------------~~~~~~~~~~~~~~li~~~l 248 (267)
T cd06628 208 GKHPFPDCTQLQAIFKIGEN-A--------------------------------------SPEIPSNISSEAIDFLEKTF 248 (267)
T ss_pred CCCCCCCccHHHHHHHHhcc-C--------------------------------------CCcCCcccCHHHHHHHHHHc
Confidence 99888765444333221110 0 00011123456678888888
Q ss_pred ccccceeeccccccccccccceeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
...+..| +++.++++|+||
T Consensus 249 ~~~p~~R-------p~~~~il~~~~~ 267 (267)
T cd06628 249 EIDHNKR-------PTAAELLKHPFL 267 (267)
T ss_pred cCCchhC-------cCHHHHhhCCCC
Confidence 8666555 999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=240.75 Aligned_cols=206 Identities=19% Similarity=0.260 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
....+.+|+..++.++||||+++++++......++++||+++++|.+++... ..+++..+..++
T Consensus 51 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (283)
T cd05048 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999987643 457889999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||
T Consensus 131 ~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv 209 (283)
T cd05048 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDI 209 (283)
T ss_pred HHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhH
Confidence 9999999999999999999999999999999999999999876543221 22345678899999987655 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
|||||++|||++ |..|+++....+....+. .+... ..+..++.++.+++..||..+|..||....+
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~~~~~~~i~-~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 210 WSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999998 778888777666554433 33222 1245566777888888888888777765553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=241.30 Aligned_cols=214 Identities=28% Similarity=0.389 Sum_probs=171.0
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 101 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 101 (303)
.+|+..++.++||||+++++++...+..++|||++++++|..++.....+++..+..++.|++.||.+||+.|++|+||+
T Consensus 46 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dik 125 (260)
T PF00069_consen 46 IREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIK 125 (260)
T ss_dssp HHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBS
T ss_pred hhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 44889999999999999999999999999999999999999988866789999999999999999999999999999999
Q ss_pred CCcEEEecCCcEEEccccceeee-CCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchH
Q psy763 102 PENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGS 180 (303)
Q Consensus 102 ~~nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~ 180 (303)
|+||+++.++.++|+|||.+... ..........++..|+|||.+.....++.++|+||+|+++|+|++|..|+.+....
T Consensus 126 p~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~ 205 (260)
T PF00069_consen 126 PENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD 205 (260)
T ss_dssp GGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 99999999999999999998864 23344456778999999999883334799999999999999999999888876322
Q ss_pred HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccc
Q psy763 181 HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEK 260 (303)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~ 260 (303)
.....+.+...+ ... ..........+.+.+++.+|+..+|..|
T Consensus 206 ~~~~~~~~~~~~-----------------------------~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R---- 248 (260)
T PF00069_consen 206 DQLEIIEKILKR-----------------------------PLP----SSSQQSREKSEELRDLIKKMLSKDPEQR---- 248 (260)
T ss_dssp HHHHHHHHHHHT-----------------------------HHH----HHTTSHTTSHHHHHHHHHHHSSSSGGGS----
T ss_pred hhhhhhhhcccc-----------------------------ccc----ccccccchhHHHHHHHHHHHccCChhHC----
Confidence 222211111000 000 0011111122678899999998766666
Q ss_pred cccccccccceeeee
Q psy763 261 QDSIRGKNCKKTFYI 275 (303)
Q Consensus 261 ~~~~~~~~~l~~~~~ 275 (303)
+++.++++||||
T Consensus 249 ---~~~~~l~~~~~~ 260 (260)
T PF00069_consen 249 ---PSAEELLKHPWF 260 (260)
T ss_dssp ---TTHHHHHTSGGG
T ss_pred ---cCHHHHhcCCCC
Confidence 999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=243.93 Aligned_cols=209 Identities=20% Similarity=0.269 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-------------------CCCCHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-------------------HGLPWDLIK 77 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------------------~~l~~~~~~ 77 (303)
....+.+|+..++.++||||+++++++.+.+..++||||+++|+|.+++... ..+++..+.
T Consensus 62 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05096 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141 (304)
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHH
Confidence 3456788999999999999999999999999999999999999999877532 236778899
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCc
Q psy763 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPA 154 (303)
Q Consensus 78 ~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~ 154 (303)
.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.+
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~ 220 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTA 220 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCch
Confidence 9999999999999999999999999999999999999999999986543322 12234577899999987655 8999
Q ss_pred cchhhHHHHHHHhhc--cCccCCCCchHHHHHHHhh---cCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 155 VDVWAIEWTSHSYSQ--IGFIGLGNMGSHMARNLLK---NNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 155 ~DvwSlG~il~el~t--g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+|||||||++|||++ +..|+.+....+....... ..........+..++....+++..||..+|..||....
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 999999999999975 4455555444444333221 11111112233455666777777777777776665544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=247.03 Aligned_cols=242 Identities=39% Similarity=0.572 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+++++.++||||+++++++..++..++|+||++++++..+......+++..+..++.|++.||+|||+.|++|
T Consensus 44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h 123 (286)
T cd07846 44 KKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123 (286)
T ss_pred hHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45577899999999999999999999999999999999999999988776667999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||++++++.++|+|||++....... ......++..|+|||.+.+...++.++|||||||++|||++|..++.+
T Consensus 124 ~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred cCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999988754332 223456788999999988766578899999999999999999888877
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+....+.............. .......+........ ....+.....+.+++.+|+..+|..|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R 274 (286)
T cd07846 204 DSDIDQLYHIIKCLGNLIPRHQEIFQKNP-----LFAGMRLPEVKEIEPL----EKRFPKLSGLVLDLAKQCLRIDPDDR 274 (286)
T ss_pred CchHHHHHHHHHHhCCCchhhHHHhccch-----HhhccccccccCcchH----HHhCCCcCHHHHHHHHHHhcCCcccc
Confidence 77666666655544433211000000000 0000000000000000 00112345678899999998666666
Q ss_pred eccccccccccccceeeee
Q psy763 257 QSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~ 275 (303)
++..++++|+||
T Consensus 275 -------p~~~~il~~~~~ 286 (286)
T cd07846 275 -------PSSSQLLHHEFF 286 (286)
T ss_pred -------hhHHHHhcCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=247.44 Aligned_cols=227 Identities=23% Similarity=0.339 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++|+||+++++.+..++..++|+||++++++..++.. +.+++..+..++.|++.|+.|||+.|++
T Consensus 62 ~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~iv 140 (292)
T cd06658 62 RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVI 140 (292)
T ss_pred HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 445678899999999999999999999999999999999999999998754 4689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+.. ++.++|+||+||++||+++|..|+.
T Consensus 141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred ecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998764322 2223456889999999987655 7999999999999999999998887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+...... ........+....+++.+|+..+|..
T Consensus 220 ~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~ 262 (292)
T cd06658 220 NEPPLQAMRRIRDNLPP-------------------------------------RVKDSHKVSSVLRGFLDLMLVREPSQ 262 (292)
T ss_pred CCCHHHHHHHHHhcCCC-------------------------------------ccccccccCHHHHHHHHHHccCChhH
Confidence 66554433221110000 00001123445667888888755555
Q ss_pred eeccccccccccccceeeeeecCCcceEEEEEec
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPERKCLEVIFMD 289 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 289 (303)
| +++.+++.|+|+.....+.+.|.+|+
T Consensus 263 R-------pt~~~il~~~~~~~~~~~~~~~~~~~ 289 (292)
T cd06658 263 R-------ATAQELLQHPFLKLAGPPSCIVPLMR 289 (292)
T ss_pred C-------cCHHHHhhChhhhccCCccccchhhh
Confidence 5 99999999999999888888877765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=244.50 Aligned_cols=239 Identities=26% Similarity=0.405 Sum_probs=171.1
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+.+|+.+++.++|+||+++++++.+++..++|+||+++ +|..++.. ...+++..+..++.|++.||.|||+.|++|+
T Consensus 49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~ 127 (291)
T cd07844 49 TAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127 (291)
T ss_pred hHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 356799999999999999999999999999999999985 77776543 4578999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++||||+||++|+|++|..++.+.
T Consensus 128 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998764321 11222356788999999877655899999999999999999999888766
Q ss_pred c-hHHHHHHHhhcCCceeEeecCCCCC-cchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 178 M-GSHMARNLLKNNGRVTVILKSDSLD-SETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 178 ~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
. ..+....+....+.+.....+.... .+.... .......++.... .........+.+++.+|+..+|..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~~p~~ 278 (291)
T cd07844 208 TDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY----SFPFYPPRPLINH-----APRLDRIPHGEELALKFLQYEPKK 278 (291)
T ss_pred ccHHHHHHHHHHhcCCCChhhhhhhhhccccccc----cccccCChhHHHh-----CcCCCCchhHHHHHHHHhccCccc
Confidence 5 3344333333322221111000000 000000 0000111111111 111112367889999999876666
Q ss_pred eeccccccccccccceeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~ 275 (303)
| +++.+++.|+||
T Consensus 279 R-------ps~~e~l~~~~f 291 (291)
T cd07844 279 R-------ISAAEAMKHPYF 291 (291)
T ss_pred c-------cCHHHHhcCCCC
Confidence 6 999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=243.23 Aligned_cols=210 Identities=17% Similarity=0.192 Sum_probs=166.2
Q ss_pred HHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcE
Q psy763 26 KEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 105 (303)
Q Consensus 26 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~ni 105 (303)
+++...+||||+.+++.+..++..++||||+++++|..++...+.+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Ni 128 (279)
T cd05633 49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANI 128 (279)
T ss_pred HHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHE
Confidence 44555689999999999999999999999999999999888777899999999999999999999999999999999999
Q ss_pred EEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHH--HH
Q psy763 106 LLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSH--MA 183 (303)
Q Consensus 106 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~--~~ 183 (303)
+++.++.++|+|||++....... .....++..|+|||.+.+...++.++|+||+||++|+|++|..||.+..... ..
T Consensus 129 l~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 207 (279)
T cd05633 129 LLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (279)
T ss_pred EECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH
Confidence 99999999999999987654322 2334689999999998754447899999999999999999998876542211 11
Q ss_pred HHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeecccccc
Q psy763 184 RNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDS 263 (303)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~ 263 (303)
.... .. ......+..++++.+++.+|+..++..|
T Consensus 208 ~~~~---------------------------~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R------- 241 (279)
T cd05633 208 DRMT---------------------------LT------------VNVELPDSFSPELKSLLEGLLQRDVSKR------- 241 (279)
T ss_pred HHHh---------------------------hc------------CCcCCccccCHHHHHHHHHHhcCCHHHh-------
Confidence 1000 00 0011112245677899999999777666
Q ss_pred c-----cccccceeeeeecCCcce
Q psy763 264 I-----RGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 264 ~-----~~~~~l~~~~~~~~~~~~ 282 (303)
. +++++++||||...+.+.
T Consensus 242 ~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 242 LGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred cCCCCCCHHHHHhCccccCCCHhH
Confidence 6 699999999998866443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=243.92 Aligned_cols=241 Identities=25% Similarity=0.342 Sum_probs=170.5
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
.+.+|+..++.++|+||+++++++..++..|+|+||+.++.+..+......+++..+..++.|++.||.|||+.|++|+|
T Consensus 49 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~d 128 (291)
T cd07870 49 TAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128 (291)
T ss_pred HHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 45678899999999999999999999999999999998555554554456788899999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
|+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++|||++|..++.+..
T Consensus 129 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 9999999999999999999998764322 222334578899999998765557889999999999999999998887654
Q ss_pred h-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 179 G-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 179 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
. .+.+..+....+.+.....+........ ...+...+....+... . ..-...+++.+++.+|+..+|..|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~ll~~~l~~dp~~R- 279 (291)
T cd07870 209 DVFEQLEKIWTVLGVPTEDTWPGVSKLPNY---KPEWFLPCKPQQLRVV---W--KRLSRPPKAEDLASQMLMMFPKDR- 279 (291)
T ss_pred hHHHHHHHHHHHcCCCChhhhhhhhhcccc---cchhccccCCcchhhh---c--cccCCChHHHHHHHHHhCcCcccC-
Confidence 3 2333333332221110000000000000 0011111111111111 0 011135678899999999766666
Q ss_pred ccccccccccccceeeee
Q psy763 258 SEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~ 275 (303)
+++.+++.||||
T Consensus 280 ------~t~~~~l~h~~~ 291 (291)
T cd07870 280 ------ISAQDALLHPYF 291 (291)
T ss_pred ------cCHHHHhcCCCC
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=241.87 Aligned_cols=217 Identities=22% Similarity=0.271 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+..++.++|+||+++++++.+.+..++|+||+++++|.+++.+.+++++..+..++.|++.||.|||++|+
T Consensus 45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i 124 (268)
T cd06630 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34567888999999999999999999999999999999999999999998877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCC-cEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTANG-VVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
+|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+.. ++.++|+||+||++|++++
T Consensus 125 ~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred ecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHh
Confidence 9999999999998775 699999999877653211 12346788999999987655 7999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..|+...........+.. ..... ......+...+++.+++.+|+
T Consensus 204 g~~p~~~~~~~~~~~~~~~-------------------------~~~~~----------~~~~~~~~~~~~~~~~i~~~l 248 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFK-------------------------IASAT----------TAPSIPEHLSPGLRDVTLRCL 248 (268)
T ss_pred CCCCCCCCCCcchHHHHHH-------------------------HhccC----------CCCCCchhhCHHHHHHHHHHc
Confidence 9877653322111110000 00000 000111224567788999999
Q ss_pred ccccceeeccccccccccccceeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
..+|..| +++.+++.||||
T Consensus 249 ~~~p~~R-------~~~~~ll~~~~~ 267 (268)
T cd06630 249 ELQPEDR-------PPSRELLKHPVF 267 (268)
T ss_pred CCCcccC-------cCHHHHhcCccc
Confidence 8777666 999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=239.21 Aligned_cols=204 Identities=14% Similarity=0.171 Sum_probs=162.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..++.++||||+++++++..++..++||||+++|+|..++.. ...+++..++.++.|++.||+|||+.|++
T Consensus 50 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ii 129 (266)
T cd05064 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129 (266)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 45678899999999999999999999999999999999999999998765 35789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
|+||+|+||+++.++.++++|||.+......... ....++..|+|||.+.+.. ++.++|||||||++||+++ |..|
T Consensus 130 H~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred eccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999987654322211 1234467899999988655 8999999999999999875 7777
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+....+....+ ..+.+.+ .+..++....+.+..||..+|..||...-
T Consensus 209 ~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~ 257 (266)
T cd05064 209 YWDMSGQDVIKAV-EDGFRLP---APRNCPNLLHQLMLDCWQKERGERPRFSQ 257 (266)
T ss_pred cCcCCHHHHHHHH-HCCCCCC---CCCCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 7766666555544 3333322 23445566666777777776666665443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=241.98 Aligned_cols=219 Identities=21% Similarity=0.214 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+..|+.+++.++||||+++++++...+..|+|+||+++++|..++.... .+++..+..++.|++.|+.|||+.|
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 115 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 44556678999999999999999999999999999999999999999876544 7999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+||++|+|++|..|+
T Consensus 116 i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~ 194 (277)
T cd05577 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPF 194 (277)
T ss_pred cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCC
Confidence 9999999999999999999999999987765443444556788999999988766 799999999999999999998887
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.........+... ... ......+..++.+.+++.+|+...|.
T Consensus 195 ~~~~~~~~~~~~~~~------------------------~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 195 RQRKEKVEKEELKRR------------------------TLE------------MAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred CCCcccccHHHHHhc------------------------ccc------------ccccCCccCCHHHHHHHHHHccCChh
Confidence 654321111100000 000 00011122356778999999886665
Q ss_pred eeeccccccc-----cccccceeeeeecCC
Q psy763 255 YIQSEKQDSI-----RGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~-----~~~~~l~~~~~~~~~ 279 (303)
.| + ++.+++.|||+..-+
T Consensus 239 ~R-------~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 239 KR-------LGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred Hc-------cCCCcccHHHHHhChhhhcCC
Confidence 55 7 788899999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=243.55 Aligned_cols=243 Identities=38% Similarity=0.574 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|++.++.++|+||+++++++..++..++|+||++++++..+..+...+++..+..++.|++.|+.|||+.|++|
T Consensus 44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 123 (288)
T cd07833 44 KKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123 (288)
T ss_pred hhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 45678899999999999999999999999999999999999988888777778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+|+++|+|++|..++.
T Consensus 124 ~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred CCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999988765433 33445678899999999877458999999999999999999998887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+.+..+....+..+............+.. .+ ......... .........++++.+++.+|+...|..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (288)
T cd07833 204 GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG--VA-FPEPSQPES-----LERRYPGKVSSPALDFLKACLRMDPKE 275 (288)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc--cc-cCCCCCcHH-----HHHhcCCccchHHHHHHHHHhccCchh
Confidence 7766655555444333322111100000000000 00 000000000 011122234678899999999876666
Q ss_pred eeccccccccccccceeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~ 275 (303)
| +++.++++|+||
T Consensus 276 R-------ps~~~il~~~~f 288 (288)
T cd07833 276 R-------LTCDELLQHPYF 288 (288)
T ss_pred c-------ccHHHHhcCCCC
Confidence 6 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=236.58 Aligned_cols=168 Identities=26% Similarity=0.353 Sum_probs=146.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|++.++.++||||+++++.+...+..++|+||+++++|..++... ..+++..+..++.|++.||.|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~ 121 (256)
T cd08529 42 EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121 (256)
T ss_pred HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4556788899999999999999999999999999999999999999987653 57899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..|
T Consensus 122 i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p 200 (256)
T cd08529 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHP 200 (256)
T ss_pred cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999988765432 223456888999999998765 79999999999999999999988
Q ss_pred CCCCchHHHHHH
Q psy763 174 GLGNMGSHMARN 185 (303)
Q Consensus 174 ~~~~~~~~~~~~ 185 (303)
+.+.........
T Consensus 201 ~~~~~~~~~~~~ 212 (256)
T cd08529 201 FDANNQGALILK 212 (256)
T ss_pred CCCCCHHHHHHH
Confidence 876665544443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=243.15 Aligned_cols=235 Identities=29% Similarity=0.449 Sum_probs=171.2
Q ss_pred HHHHHHHHhCC-CCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 22 ATNKKEKRSLK-HPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 22 ~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+|+..++++. |+|++++++++.++ +.+++|+||++++.+..+......+++..+..++.|++.||.|||+.|++|+
T Consensus 45 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 124 (282)
T cd07831 45 LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR 124 (282)
T ss_pred HHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 35677777775 99999999999987 8899999999865554444445679999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
||+|+||+++. +.+||+|||++.............++..|+|||.+.+...++.++|+||+||++|||++|..|+.+..
T Consensus 125 dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 125 DIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 99999999999 99999999999876544444445678999999987655557899999999999999999988888877
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeec
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQS 258 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~ 258 (303)
..+....+....+...................+ .......+... ....+.++.+++.+|+..+|..|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R-- 270 (282)
T cd07831 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF----PSKKGTGLRKL-------LPNASAEGLDLLKKLLAYDPDER-- 270 (282)
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhcccccccccC----cccccccHHHH-------cccccHHHHHHHHHHhccCcccc--
Confidence 766665554433322210000000000000000 00000000000 11246788999999999777776
Q ss_pred cccccccccccceeeee
Q psy763 259 EKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 259 ~~~~~~~~~~~l~~~~~ 275 (303)
+++.+++.||||
T Consensus 271 -----~~~~~~l~~~~~ 282 (282)
T cd07831 271 -----ITAKQALRHPYF 282 (282)
T ss_pred -----cCHHHHhhCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=236.10 Aligned_cols=212 Identities=21% Similarity=0.317 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
....+.+|+..++.++|+|++++++.+.. +..+|+|+||++++++.+.+.. ...+++.++..++.|++.|+.+||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~ 121 (257)
T cd08223 42 ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121 (257)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34457788999999999999999998864 4468999999999999987754 34689999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|++|+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+.. ++.++|+||+||++|++++|..
T Consensus 122 ~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08223 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKH 200 (257)
T ss_pred CeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999999876432 2233456788999999988765 7899999999999999999988
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
++.+.........+..... .......++.+.+++.+|+..+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~li~~~l~~~ 241 (257)
T cd08223 201 AFNAKDMNSLVYRIIEGKL---------------------------------------PPMPKDYSPELGELIATMLSKR 241 (257)
T ss_pred CCCCCCHHHHHHHHHhcCC---------------------------------------CCCccccCHHHHHHHHHHhccC
Confidence 8766554444332222100 0011123456778999998877
Q ss_pred cceeeccccccccccccceeeee
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
|..| +++.++++|||+
T Consensus 242 p~~R-------p~~~~~l~~~~~ 257 (257)
T cd08223 242 PEKR-------PSVKSILRQPYI 257 (257)
T ss_pred cccC-------CCHHHHhcCCCC
Confidence 7666 999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=237.71 Aligned_cols=218 Identities=23% Similarity=0.327 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++..++..++|+||++++++..++.. ..++++..+..++.|++.||.|||+.|++
T Consensus 46 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~ 125 (282)
T cd06643 46 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125 (282)
T ss_pred HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 44567789999999999999999999999999999999999999887643 45799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhhccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.. ...++.++|+||+||++|||++|.
T Consensus 126 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred ecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence 9999999999999999999999998764322 22234568899999999842 233678999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+.+....+....+....... . ......+..+.+++.+|+..
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~--~-----------------------------------~~~~~~~~~~~~li~~~l~~ 248 (282)
T cd06643 206 PPHHELNPMRVLLKIAKSEPPT--L-----------------------------------AQPSRWSSEFKDFLKKCLEK 248 (282)
T ss_pred CCccccCHHHHHHHHhhcCCCC--C-----------------------------------CCccccCHHHHHHHHHHccC
Confidence 8887766555444332211100 0 00011234567888888886
Q ss_pred ccceeeccccccccccccceeeeeecCC
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
++..| ++..+++.|||+....
T Consensus 249 ~p~~R-------p~~~~il~~~~~~~~~ 269 (282)
T cd06643 249 NVDAR-------WTTTQLLQHPFVTVNS 269 (282)
T ss_pred ChhhC-------cCHHHHhcCCCEeccC
Confidence 66555 8899999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=243.12 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhCC--CCC----cceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLK--HPN----LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~--h~n----iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~ 89 (303)
++...-|++.++++. -|+ ++.+.++|.-.++.|+|+|.++ .++.+++..++ +++..+++.+++|+++++++
T Consensus 129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~f 207 (415)
T KOG0671|consen 129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAF 207 (415)
T ss_pred hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHH
Confidence 334455677777773 222 7888888999999999999995 56777776654 78999999999999999999
Q ss_pred HHHCCceecccCCCcEEEec--------------------CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCc
Q psy763 90 CHRHACIHRDIKPENILLTA--------------------NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDT 149 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~--------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 149 (303)
||+.+++|.||||+|||+.+ +..|+++|||.|.+-. ....+.+.|..|+|||+++|-+
T Consensus 208 Lh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLG 285 (415)
T KOG0671|consen 208 LHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLG 285 (415)
T ss_pred HHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccC
Confidence 99999999999999999832 2368999999998843 3446778999999999999887
Q ss_pred cCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeE-eecCCC--CCcchhhhhhhhhhcCC-------C
Q psy763 150 LYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTV-ILKSDS--LDSETWDLTWQEIFSKT-------S 219 (303)
Q Consensus 150 ~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~-------~ 219 (303)
++..+||||+||||+|+.||...|.+..+.+.+..+-...++.|. ...... ..-.-..+.|.+-..+. .
T Consensus 286 -wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ 364 (415)
T KOG0671|consen 286 -WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEP 364 (415)
T ss_pred -cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcC
Confidence 999999999999999999999999998877755333222333221 111110 00011133444433322 2
Q ss_pred hhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 220 TTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 220 ~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|+..+ ....+....+++||+++||...|..+ +++.|||.||||--
T Consensus 365 ckpl~~~----~~~~d~e~~~LfDLl~~mL~fDP~~R-------iTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 365 CKPLKKY----MLQDDLEHVQLFDLLRRMLEFDPARR-------ITLREALSHPFFAR 411 (415)
T ss_pred CccHHHH----hccCcHHHhHHHHHHHHHHccCcccc-------ccHHHHhcCHHhhc
Confidence 3444444 23445666778999999999666666 99999999999854
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=241.81 Aligned_cols=169 Identities=23% Similarity=0.359 Sum_probs=144.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++.+..++.+++||||+++++|..++...+.+++..+..++.|++.|+.|||+.|++
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 123 (305)
T cd05609 44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIV 123 (305)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34567788999999999999999999999999999999999999999998777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC----------------ccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE----------------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+|||
T Consensus 124 H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~sl 202 (305)
T cd05609 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAM 202 (305)
T ss_pred ccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHH
Confidence 99999999999999999999999886421100 001235678899999988655 7999999999
Q ss_pred HHHHHHhhccCccCCCCchHHHHHHH
Q psy763 161 EWTSHSYSQIGFIGLGNMGSHMARNL 186 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~~~~~~~~ 186 (303)
||++||+++|..|+.+....+.....
T Consensus 203 G~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 203 GIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998877665554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=241.62 Aligned_cols=233 Identities=28% Similarity=0.413 Sum_probs=175.4
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+|+..++.++||||+++++++... +..|+|+||+++ +|..++.. ...+++..+..++.|++.||+|||+.|++
T Consensus 50 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~ 128 (293)
T cd07843 50 TSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWIL 128 (293)
T ss_pred hHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 456788999999999999999999877 889999999985 77776654 34699999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+...++.++|+||+||++|+|++|..++.
T Consensus 129 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred eccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998876543 233345678889999998876657899999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCC------hhHHHHHHhHhCCCCCC-CchhhHHhhhhh
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTS------TTTIFKYLLIRGGNTDR-NSHGVVKILGKK 248 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~~~~~~~~-~~~~~~dll~~~ 248 (303)
+....+....+...-+.+... . |..+..-+. ....... ........ ..+.+.+++.+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~---------~----~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 273 (293)
T cd07843 209 GKSEIDQLNKIFKLLGTPTEK---------I----WPGFSELPGAKKKTFTKYPYNQ--LRKKFPALSLSDNGFDLLNRL 273 (293)
T ss_pred CCChHHHHHHHHHHhCCCchH---------H----HHHhhccchhcccccccccchh--hhccccccCCChHHHHHHHHH
Confidence 877766666555433322110 0 111111000 0000000 01111111 366778999999
Q ss_pred hccccceeeccccccccccccceeeee
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+...|..| +++.+++.|+||
T Consensus 274 l~~~p~~R-------~t~~ell~~~~f 293 (293)
T cd07843 274 LTYDPAKR-------ISAEDALKHPYF 293 (293)
T ss_pred hccCcccc-------CCHHHHhcCCCC
Confidence 98666665 999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=236.06 Aligned_cols=209 Identities=24% Similarity=0.257 Sum_probs=167.9
Q ss_pred HHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCC
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKP 102 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~ 102 (303)
++....+..+|+|++++++++..++.+|+|+||+++++|..++...+.+++..+..++.|++.||.|||+.|++|+||+|
T Consensus 46 e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p 125 (260)
T cd05611 46 ERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125 (260)
T ss_pred HHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 33445566799999999999999999999999999999999998777899999999999999999999999999999999
Q ss_pred CcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHH
Q psy763 103 ENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHM 182 (303)
Q Consensus 103 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~ 182 (303)
+||+++.++.++|+|||++..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|+.+....+.
T Consensus 126 ~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 201 (260)
T cd05611 126 ENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201 (260)
T ss_pred HHeEECCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999999999999876432 23346788899999998766 79999999999999999999988876655444
Q ss_pred HHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccc
Q psy763 183 ARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQD 262 (303)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~ 262 (303)
...+....... ........++++.+++.+|+..+|..|
T Consensus 202 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R------ 239 (260)
T cd05611 202 FDNILSRRINW------------------------------------PEEVKEFCSPEAVDLINRLLCMDPAKR------ 239 (260)
T ss_pred HHHHHhcccCC------------------------------------CCcccccCCHHHHHHHHHHccCCHHHc------
Confidence 33322211000 000011235677899999999777766
Q ss_pred cccc---cccceeeeeecC
Q psy763 263 SIRG---KNCKKTFYIPTP 278 (303)
Q Consensus 263 ~~~~---~~~l~~~~~~~~ 278 (303)
+++ ++++.|||+.+.
T Consensus 240 -~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 240 -LGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -cCCCcHHHHHcChHhhcC
Confidence 755 699999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=256.67 Aligned_cols=208 Identities=15% Similarity=0.163 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.-+.|+.|+..+|+-+|.||+-+.|+|..+.. .+|+-+|+|.+|..++.- ...|+..+...|++|+++|+.|||.++|
T Consensus 431 qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~I 509 (678)
T KOG0193|consen 431 QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNI 509 (678)
T ss_pred HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhh
Confidence 67889999999999999999999999998876 999999999999997653 3479999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCC---CCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINP---GENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg 170 (303)
+|+|||..||++.++++|||+|||++..... ........|...|+|||+++- .-+|++.+||||||||+|||++|
T Consensus 510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG 589 (678)
T ss_pred hhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence 9999999999999999999999999876542 223345578888999999983 33489999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCC-ceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNG-RVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..|+......+++ -++..|+ .+........++.+..++.-.||..++..||++..
T Consensus 590 ~lPysi~~~dqIi-fmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~ 645 (678)
T KOG0193|consen 590 ELPYSIQNRDQII-FMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQ 645 (678)
T ss_pred cCCcCCCChhheE-EEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHH
Confidence 9988844444443 3333332 22222233444545556666666666666665544
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=235.39 Aligned_cols=211 Identities=20% Similarity=0.283 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+.+++.++|+||+++++++.+.+.+++++||+++++|..++... ..+++..+..++.|++.|+.|||+.|+
T Consensus 43 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (256)
T cd08221 43 RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 345678899999999999999999999999999999999999999988654 468999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.+||+|||++....... ......+++.|.|||.+.+.. ++.++|+||+||++|||++|..++
T Consensus 123 ~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08221 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTF 201 (256)
T ss_pred cccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999998764333 234456889999999988765 789999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+........ ....+..+.+++.+|+..++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08221 202 DATNPLNLVVKIVQGNYTPV---------------------------------------VSVYSSELISLVHSLLQQDPE 242 (256)
T ss_pred CCCCHHHHHHHHHcCCCCCC---------------------------------------ccccCHHHHHHHHHHcccCcc
Confidence 77666555544432111100 011234566777777765454
Q ss_pred eeeccccccccccccceeeee
Q psy763 255 YIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.| +++.++++|+|+
T Consensus 243 ~R-------~s~~~ll~~~~l 256 (256)
T cd08221 243 KR-------PTADEVLDQPLL 256 (256)
T ss_pred cC-------CCHHHHhhCcCC
Confidence 44 888888888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=253.92 Aligned_cols=208 Identities=23% Similarity=0.319 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHH
Q psy763 15 AIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 15 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.+..+.|.+|+.+++.++|||+|+++|+|..+..+|||+|||..|+|.+++++.. .++....+.++.||.+|+.||..
T Consensus 304 tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk 383 (1157)
T KOG4278|consen 304 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK 383 (1157)
T ss_pred chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH
Confidence 3567789999999999999999999999999999999999999999999987654 57777888999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccC---CCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA---TRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~---~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
++++||||..+|+|+..+..||++|||+++++..+. ++...| ++-|.|||.+.-.. ++.++|||+|||+|||+.|
T Consensus 384 knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIAT 461 (1157)
T KOG4278|consen 384 KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIAT 461 (1157)
T ss_pred hhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHh
Confidence 999999999999999999999999999999876433 333333 66799999998666 8999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
.+.-+|....-.++..+++.+.|.. .+..|++.+..++..||.-.|+.||.+..+
T Consensus 462 YGMsPYPGidlSqVY~LLEkgyRM~---~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 462 YGMSPYPGIDLSQVYGLLEKGYRMD---GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred cCCCCCCCccHHHHHHHHhcccccc---CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 9988888888888899999999965 678899999999999999999999887653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=250.18 Aligned_cols=205 Identities=23% Similarity=0.305 Sum_probs=159.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------------------
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---------------------------- 68 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------------------- 68 (303)
...+.+|+.+++.+ +|+||+++++.+...+..++||||+++|+|.+++...
T Consensus 85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 85 REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred HHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 45677899999999 8999999999999999999999999999999876431
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEE
Q psy763 69 ------------------------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENIL 106 (303)
Q Consensus 69 ------------------------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil 106 (303)
.++++..+..++.|++.||.|||++|++||||||+||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil 244 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL 244 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence 24788889999999999999999999999999999999
Q ss_pred EecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccCCCCchHHH
Q psy763 107 LTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHM 182 (303)
Q Consensus 107 ~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~ 182 (303)
++.++.++|+|||++......... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+......
T Consensus 245 ~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 245 LTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred EeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 999999999999998765432211 1223456799999987655 8999999999999999997 7777766655555
Q ss_pred HHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 183 ARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.......+.++. .+...+++..+++-.|+..+|..||....
T Consensus 324 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~ 364 (374)
T cd05106 324 FYKMVKRGYQMS---RPDFAPPEIYSIMKMCWNLEPTERPTFSQ 364 (374)
T ss_pred HHHHHHcccCcc---CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 555555443322 22234456666666666666665554443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.82 Aligned_cols=222 Identities=23% Similarity=0.304 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++||||+++++.+..++..|+|+||+.+++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 123 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG 123 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4456788999999999999999999999999999999999999999987643 57899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc------------------------------cccccCCCcccCccc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN------------------------------YTDYVATRWYRAPEL 144 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~------------------------------~~~~~~~~~y~aPE~ 144 (303)
++|+||||+||+++.++.++|+|||++........ .....|+..|+|||.
T Consensus 124 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 203 (316)
T cd05574 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203 (316)
T ss_pred eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHH
Confidence 99999999999999999999999999876432110 112357888999999
Q ss_pred ccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 145 LVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 145 l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
+.+.. ++.++|||||||++|+|++|..|+.+.........+.......
T Consensus 204 ~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------- 251 (316)
T cd05574 204 ISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTF------------------------------- 251 (316)
T ss_pred HcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccC-------------------------------
Confidence 98765 7999999999999999999999988776555444333211110
Q ss_pred HHHhHhCCCCCCCchhhHHhhhhhhccccceeecccccccc----ccccceeeeeecCCcceEE
Q psy763 225 KYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIR----GKNCKKTFYIPTPERKCLE 284 (303)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~----~~~~l~~~~~~~~~~~~~~ 284 (303)
.........+.+++.+|+..++..| ++ +.+++.|+||........+
T Consensus 252 -------~~~~~~~~~~~~li~~~l~~~p~~R-------~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 252 -------PGSPPVSSSARDLIRKLLVKDPSKR-------LGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred -------CCccccCHHHHHHHHHHccCCHhHC-------CCchhhHHHHHcCchhhcCChhhcc
Confidence 0001134567788988988666655 88 9999999998776554443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=241.52 Aligned_cols=205 Identities=25% Similarity=0.355 Sum_probs=160.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|++.++.++||||++++|++...+..++|+||+++|+|.+++... ..+++..+..++.||+.||.|||++++
T Consensus 45 ~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~i 124 (259)
T PF07714_consen 45 EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNI 124 (259)
T ss_dssp HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 667788999999999999999999999888899999999999999988765 689999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc-C
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI-G 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg-~ 171 (303)
+|++|+++||++++++.+||+|||++........ .........|+|||.+.+.. ++.++||||||+++||++++ .
T Consensus 125 iH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~ 203 (259)
T PF07714_consen 125 IHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGK 203 (259)
T ss_dssp EEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence 9999999999999999999999999987632221 13345677899999998766 79999999999999999995 5
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
.|+.+....+....+ ..+.+++ .+..++....+++-.||..+|..||.+..+
T Consensus 204 ~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 204 FPFSDYDNEEIIEKL-KQGQRLP---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp GTTTTSCHHHHHHHH-HTTEETT---SBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred ccccccccccccccc-cccccce---eccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 665555555544444 5444432 334566677777778888878777776554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=243.63 Aligned_cols=238 Identities=29% Similarity=0.477 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+|++.++.++||||+++++++..++..++|+||+. +++..++.. ...+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (284)
T cd07860 44 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122 (284)
T ss_pred hHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 467789999999999999999999999999999999997 567666543 35789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+...++.++|+|||||++|||+||..|+.
T Consensus 123 H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred cCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999987654322 22334568889999998776656889999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+....+.+.....+..... ..+..-+........... .+...+++.+++.+|+..+|..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~ 271 (284)
T cd07860 203 GDSEIDQLFRIFRTLGTPDEVVWPGVTSL----PDYKPSFPKWARQDFSKV-------VPPLDEDGRDLLSQMLHYDPNK 271 (284)
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhhhhHH----HHHHhhcccccccCHHHH-------cccCCHHHHHHHHHhcCCCccc
Confidence 87777666666665444321111100000 000000000000111111 1224567789999999976666
Q ss_pred eeccccccccccccceeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~ 275 (303)
| +++.+++.||||
T Consensus 272 R-------pt~~~~l~~~~f 284 (284)
T cd07860 272 R-------ISAKAALAHPFF 284 (284)
T ss_pred C-------CCHHHHhcCCCC
Confidence 6 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=260.37 Aligned_cols=168 Identities=24% Similarity=0.329 Sum_probs=148.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCC--CHHHHHHHHHHHHHHHHHHHH
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGL--PWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l--~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+-+.+|+.+-++|+|.|||+++|.+.+++.+-+.||.++||+|.++++.. +++ .+.++-.+..||++||.|||+
T Consensus 614 r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe 693 (1226)
T KOG4279|consen 614 REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE 693 (1226)
T ss_pred hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh
Confidence 34556889999999999999999999999999999999999999999988654 566 888999999999999999999
Q ss_pred CCceecccCCCcEEEec-CCcEEEccccceeeeC-CCCccccccCCCcccCccccc-CCccCCCccchhhHHHHHHHhhc
Q psy763 93 HACIHRDIKPENILLTA-NGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLV-GDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~-~~~~~~~~~DvwSlG~il~el~t 169 (303)
+.|||||||-.|+||+. .|.+||+|||-++.+. -.+...++.||..|||||++. |...|+.++|||||||++.||.|
T Consensus 694 n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT 773 (1226)
T KOG4279|consen 694 NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT 773 (1226)
T ss_pred cceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc
Confidence 99999999999999985 5899999999988764 344557789999999999996 44559999999999999999999
Q ss_pred cCccCCCCchHHHH
Q psy763 170 IGFIGLGNMGSHMA 183 (303)
Q Consensus 170 g~~~~~~~~~~~~~ 183 (303)
|++||..--..+.+
T Consensus 774 GrPPF~ElgspqAA 787 (1226)
T KOG4279|consen 774 GRPPFVELGSPQAA 787 (1226)
T ss_pred CCCCeeecCChhHh
Confidence 99999876555544
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=237.66 Aligned_cols=218 Identities=24% Similarity=0.312 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
....+.+|+..++.++|+||+++++.+..++..++|+|+++++++..++... +.+++..+..++.|++.|+++||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4466788899999999999999999999999999999999999999988653 4689999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCcc-----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
|++|+||+|+||++++++.++|+|||++......... ....++..|+|||.+.....++.++|+|||||++|+|+
T Consensus 122 ~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201 (267)
T ss_pred CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence 9999999999999999999999999998776543221 33467889999999886645799999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
+|..|+.+................ .. ....+....++.+.+++.+|
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~--------~~--------------------------~~~~~~~~~~~~~~~li~~~ 247 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPP--------SL--------------------------ETGADYKKYSKSFRKMISLC 247 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCC--------Cc--------------------------CCccccccccHHHHHHHHHH
Confidence 999888766554444333222100 00 00000122346678999999
Q ss_pred hccccceeeccccccccccccceeeee
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+..++..| +++.+++.||||
T Consensus 248 l~~~p~~R-------p~~~~ll~~p~~ 267 (267)
T cd06610 248 LQKDPSKR-------PTAEELLKHKFF 267 (267)
T ss_pred cCCChhhC-------cCHHHHhhCCCC
Confidence 88766666 999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=249.12 Aligned_cols=205 Identities=25% Similarity=0.307 Sum_probs=157.7
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------------------
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---------------------------- 68 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------------------- 68 (303)
...+.+|+.+++.+ +||||+++++++..++..++||||+++|+|..++...
T Consensus 82 ~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (375)
T cd05104 82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMS 161 (375)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhccc
Confidence 45677899999999 8999999999999999999999999999998877532
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Q psy763 69 -----------------------------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 101 (303)
Q Consensus 69 -----------------------------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 101 (303)
..+++..+..++.|++.||.|||+.|++|||||
T Consensus 162 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 241 (375)
T cd05104 162 CDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLA 241 (375)
T ss_pred chhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence 147788899999999999999999999999999
Q ss_pred CCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccCCCC
Q psy763 102 PENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIGLGN 177 (303)
Q Consensus 102 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~~~~ 177 (303)
|+||+++.++.+||+|||++......... ....++..|+|||.+.+.. ++.++|||||||++|||++ |..|+.+.
T Consensus 242 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 242 ARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred hhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999875432211 1233456799999998765 8999999999999999998 55555555
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.........+..+.+.. .+...+.++.+++-.|+..+|..||....
T Consensus 321 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~e 366 (375)
T cd05104 321 PVDSKFYKMIKEGYRML---SPECAPSEMYDIMKSCWDADPLKRPTFKQ 366 (375)
T ss_pred CchHHHHHHHHhCccCC---CCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 44444455555443322 12233445556666666666665554443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=237.92 Aligned_cols=217 Identities=24% Similarity=0.323 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+..++.++||||+++++.+..++.+++||||++++++..++.+ ...+++..+..++.|++.|+.|||+.|+
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 131 (292)
T cd06644 52 ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131 (292)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 345577789999999999999999999999999999999999999886543 4578999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~tg 170 (303)
+|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+ ...++.++|+|||||++|||++|
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g 211 (292)
T cd06644 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 211 (292)
T ss_pred eecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcC
Confidence 99999999999999999999999988764322 22234567889999999853 23368899999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..|+.+.........+..... +. . ......+.++.+++.+|+.
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~-~~-~-----------------------------------~~~~~~~~~~~~li~~~l~ 254 (292)
T cd06644 212 EPPHHELNPMRVLLKIAKSEP-PT-L-----------------------------------SQPSKWSMEFRDFLKTALD 254 (292)
T ss_pred CCCCccccHHHHHHHHhcCCC-cc-C-----------------------------------CCCcccCHHHHHHHHHHhc
Confidence 988876554444333221110 00 0 0001123456778888887
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|..| ++..++++|||+..
T Consensus 255 ~~p~~R-------p~~~~il~~~~~~~ 274 (292)
T cd06644 255 KHPETR-------PSAAQLLEHPFVSS 274 (292)
T ss_pred CCcccC-------cCHHHHhcCccccc
Confidence 555555 88999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=244.02 Aligned_cols=247 Identities=17% Similarity=0.155 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++|+||+++++++...+..++++||+++|++..++.. ...+++..+..++.|++.||+|||+.|
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ 121 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445688899999999999999999999999999999999999999998764 346899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC--------ccccccCCCcccCcccccCC-ccCCCccchhhHHHHHH
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~ 165 (303)
|+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. ..++.++|+||+||++|
T Consensus 122 ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~ 201 (314)
T cd08216 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201 (314)
T ss_pred eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHH
Confidence 9999999999999999999999999887653211 11234567789999998753 33789999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
||++|..|+.+................ ........+...... ............... ............+.+++
T Consensus 202 el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li 275 (314)
T cd08216 202 ELANGHVPFKDMPATQMLLEKVRGTVP--CLLDKSTYPLYEDSM-SQSRSSNEHPNNRDS---VDHPYTRTFSEHFHQFV 275 (314)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhccCc--cccccCchhhhcCCc-Ccccccccccchhhh---hhcchhhHHHHHHHHHH
Confidence 999999988876655544333322111 111101000000000 000000000000000 01111122345678899
Q ss_pred hhhhccccceeeccccccccccccceeeeee
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
.+|+..+|..| +++.++++|||+.
T Consensus 276 ~~~l~~~P~~R-------pt~~~ll~~p~~~ 299 (314)
T cd08216 276 ELCLQRDPESR-------PSASQLLNHSFFK 299 (314)
T ss_pred HHHhhcCCCcC-------cCHHHHhcCchHh
Confidence 99988666665 9999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=253.16 Aligned_cols=210 Identities=21% Similarity=0.284 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+..|.+|++.+.+|+||||++++|+|..++++++|+||+++|+|..++.+.. .+.......++.||++|++||.+.
T Consensus 577 ~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~ 656 (807)
T KOG1094|consen 577 NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL 656 (807)
T ss_pred hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh
Confidence 347889999999999999999999999999999999999999999999987653 234556678999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCccc---cccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT---DYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ- 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t- 169 (303)
++||||+.++|+|++.++++||+|||.++-+-.++... ..+-+.+|+|||.+.... ++.++|+|+||+++||+++
T Consensus 657 nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~ 735 (807)
T KOG1094|consen 657 NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFML 735 (807)
T ss_pred chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHH
Confidence 99999999999999999999999999998766554432 346688999999998655 8999999999999999953
Q ss_pred cCccCCCCchHHHH----HHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 170 IGFIGLGNMGSHMA----RNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 170 g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
....|++....+++ ...+..+++-..+..|..++.++.+++..||..+...||.++-
T Consensus 736 C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~ 796 (807)
T KOG1094|consen 736 CREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQ 796 (807)
T ss_pred HhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHH
Confidence 34555555444433 3344556666777888899999999999999988888887655
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=240.45 Aligned_cols=215 Identities=24% Similarity=0.337 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.+.|+||+++++.+..+...|+|+||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|
T Consensus 61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H 139 (296)
T cd06654 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIH 139 (296)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 35577889999999999999999999999999999999999999998864 46899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+
T Consensus 140 ~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred CCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654332 223357888999999988655 78999999999999999999999877
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.............+ .+. ........+.+.+++.+|+..++..|
T Consensus 219 ~~~~~~~~~~~~~~-~~~------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~R 261 (296)
T cd06654 219 ENPLRALYLIATNG-TPE------------------------------------LQNPEKLSAIFRDFLNRCLDMDVEKR 261 (296)
T ss_pred CCHHHhHHHHhcCC-CCC------------------------------------CCCccccCHHHHHHHHHHCcCCcccC
Confidence 65543332211110 000 00011233556788888887666555
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.+++.|+|+...
T Consensus 262 -------pt~~eil~~~~~~~~ 276 (296)
T cd06654 262 -------GSAKELLQHQFLKIA 276 (296)
T ss_pred -------cCHHHHhhChhhhcc
Confidence 999999999988653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=237.79 Aligned_cols=217 Identities=25% Similarity=0.366 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+..|+.+++.++||||+++++.+..+...++||||+++++|..++.. +..+++..+..++.|++.|+.|||+.|++
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~ 125 (280)
T cd06611 46 LEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125 (280)
T ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34577889999999999999999999999999999999999999998765 35799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhhccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
|+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+ ...++.++|+||+||++|+|++|.
T Consensus 126 h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~ 205 (280)
T cd06611 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205 (280)
T ss_pred cCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999987664322 22233568889999999852 233678999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+.+....+....+... ..+. . .....-+.++.+++.+|+..
T Consensus 206 ~p~~~~~~~~~~~~~~~~-~~~~-~-----------------------------------~~~~~~~~~~~~li~~~l~~ 248 (280)
T cd06611 206 PPHHELNPMRVLLKILKS-EPPT-L-----------------------------------DQPSKWSSSFNDFLKSCLVK 248 (280)
T ss_pred CCcccCCHHHHHHHHhcC-CCCC-c-----------------------------------CCcccCCHHHHHHHHHHhcc
Confidence 888776554444332211 1000 0 00011234567888888886
Q ss_pred ccceeeccccccccccccceeeeeecC
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.|..| +++.++++|+|+...
T Consensus 249 ~p~~R-------ps~~~il~~~~~~~~ 268 (280)
T cd06611 249 DPDDR-------PTAAELLKHPFVSDQ 268 (280)
T ss_pred ChhhC-------cCHHHHhcChhhccc
Confidence 66555 999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=241.89 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+|++.++.++||||+++++++..++..++|+||+++ ++...+.... .+++..+..++.|++.||+|||++|++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~ 124 (294)
T PLN00009 46 STAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124 (294)
T ss_pred HHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4567889999999999999999999999999999999975 5555443322 367888999999999999999999999
Q ss_pred ecccCCCcEEEec-CCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTA-NGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|+||+|+||+++. ++.+||+|||++...... .......+++.|+|||.+.+...++.++||||+||++|+|+||..++
T Consensus 125 H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf 204 (294)
T PLN00009 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204 (294)
T ss_pred CCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999985 467999999999765432 12233456889999999877655789999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....++...+.+............. +........ ..... ...+..++.+.+++.+|+..+|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~------~~~~~~~~~~~~~i~~~l~~~P~ 273 (294)
T PLN00009 205 PGDSEIDELFKIFRILGTPNEETWPGVTSLPD----YKSAFPKWP-PKDLA------TVVPTLEPAGVDLLSKMLRLDPS 273 (294)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhccccccchh----hhhhcccCC-CCCHH------HhCcCCChHHHHHHHHHccCChh
Confidence 87777666666554433322111110000000 000000000 00000 01234567788999999997776
Q ss_pred eeeccccccccccccceeeeeecCCc
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
.| +++.+++.|+||.+.+.
T Consensus 274 ~R-------ps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 274 KR-------ITARAALEHEYFKDLGD 292 (294)
T ss_pred hC-------cCHHHHhcCchHhHHhc
Confidence 66 99999999999987653
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=234.97 Aligned_cols=213 Identities=20% Similarity=0.269 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|++.++.++||||+++++.+..+...|+++||+++++|.+++.. ...+++..+..++.|++.|+.|||+.|++
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~ 121 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 56788899999999999999999999999999999999999999998764 45789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..|+.
T Consensus 122 H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~ 200 (256)
T cd06612 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYS 200 (256)
T ss_pred cCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999988765433 223445788999999987765 7999999999999999999988876
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+..... . ...........+.+++.+|+..+|..
T Consensus 201 ~~~~~~~~~~~~~~~~------------------------~-------------~~~~~~~~~~~~~~~i~~~l~~~P~~ 243 (256)
T cd06612 201 DIHPMRAIFMIPNKPP------------------------P-------------TLSDPEKWSPEFNDFVKKCLVKDPEE 243 (256)
T ss_pred CcchhhhhhhhccCCC------------------------C-------------CCCchhhcCHHHHHHHHHHHhcChhh
Confidence 5443332211100000 0 00000112356778898988866665
Q ss_pred eeccccccccccccceeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~ 275 (303)
| +++.+++.|+|+
T Consensus 244 R-------ps~~~il~~~~~ 256 (256)
T cd06612 244 R-------PSAIQLLQHPFI 256 (256)
T ss_pred C-------cCHHHHhcCCCC
Confidence 5 999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=250.40 Aligned_cols=241 Identities=22% Similarity=0.327 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
..+.+|+.+++.++||||+++++++... ...|+|+||+.+ ++...+.. .+++..+..++.|++.||.|||+
T Consensus 60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~ 136 (353)
T cd07850 60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHS 136 (353)
T ss_pred HHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999998644 357999999975 66665543 38999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
.|++|+||||+||+++.++.+||+|||++.............++..|+|||.+.+.. ++.++||||+||++|+|++|..
T Consensus 137 ~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 137 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCC
Confidence 999999999999999999999999999998765444444556888999999998765 8999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc-CCC--hhHHHHHH------hHhCCCCCCCchhhHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS-KTS--TTTIFKYL------LIRGGNTDRNSHGVVK 243 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~l------~~~~~~~~~~~~~~~d 243 (303)
+|.+.........++...+.++.... .........+.. .+. ..++.... .............+.+
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFM------SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHH------HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence 99888777766666654443221100 000000111111 000 01111110 0001112234556889
Q ss_pred hhhhhhccccceeeccccccccccccceeeeee
Q psy763 244 ILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 244 ll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
++.+|+..+|..| +++.+++.|||+.
T Consensus 290 li~~~L~~dP~~R-------~t~~eiL~~~~~~ 315 (353)
T cd07850 290 LLSKMLVIDPEKR-------ISVDDALQHPYIN 315 (353)
T ss_pred HHHHHcCCChhhC-------cCHHHHhcChhHh
Confidence 9999999777666 9999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=238.31 Aligned_cols=212 Identities=25% Similarity=0.281 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++..++..++|+||+.+++|..++....++++..+..++.|++.||.|||+.|++
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (258)
T cd05578 43 SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGII 122 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 45677889999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||++++++.++|+|||++.............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|+..
T Consensus 123 h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred ccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999988766544445567888999999988765 79999999999999999999988776
Q ss_pred Cch--HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 177 NMG--SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 177 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
... .......... . ........+..+.+++.+|+...+.
T Consensus 202 ~~~~~~~~~~~~~~~-~--------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (258)
T cd05578 202 HSRTIRDQIRAKQET-A--------------------------------------DVLYPATWSTEAIDAINKLLERDPQ 242 (258)
T ss_pred CCccHHHHHHHHhcc-c--------------------------------------cccCcccCcHHHHHHHHHHccCChh
Confidence 543 1111111110 0 0001111235677889999887666
Q ss_pred eeeccccccccc--cccceeeee
Q psy763 255 YIQSEKQDSIRG--KNCKKTFYI 275 (303)
Q Consensus 255 ~~~~~~~~~~~~--~~~l~~~~~ 275 (303)
.| ++. .+++.||||
T Consensus 243 ~R-------~~~~~~~l~~~~~~ 258 (258)
T cd05578 243 KR-------LGDNLKDLKNHPYF 258 (258)
T ss_pred Hc-------CCccHHHHhcCCCC
Confidence 66 888 999999986
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=253.43 Aligned_cols=221 Identities=23% Similarity=0.362 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.-+.+.-|+.+|..++||+||++++.|..++.+++..|||+||-.+.++- -+.++++.++..+++|++.||.|||+++|
T Consensus 72 ELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~i 151 (1187)
T KOG0579|consen 72 ELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNI 151 (1187)
T ss_pred HHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcch
Confidence 34456678899999999999999999999999999999999999998654 35689999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~tg 170 (303)
+|||||+.|||++-+|.++|+|||.+-... ......++.|||+|||||+... ..+|++++||||||++|.||..+
T Consensus 152 IHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi 231 (1187)
T KOG0579|consen 152 IHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI 231 (1187)
T ss_pred hhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence 999999999999999999999999876543 2334567899999999999863 45599999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
.+|....+....+-.+.+..++ . +..| .- | +..+-|+|.++|.
T Consensus 232 EPPHhelnpMRVllKiaKSePP-T-LlqP-----S~----W--------------------------s~~F~DfLk~cL~ 274 (1187)
T KOG0579|consen 232 EPPHHELNPMRVLLKIAKSEPP-T-LLQP-----SH----W--------------------------SRSFSDFLKRCLV 274 (1187)
T ss_pred CCCccccchHHHHHHHhhcCCC-c-ccCc-----ch----h--------------------------hhHHHHHHHHHHh
Confidence 9888888887777655443221 1 1111 00 1 1234588888998
Q ss_pred cccceeeccccccccccccceeeeeecCCcc
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.++.-+ ..+.++++|||+...++.
T Consensus 275 Knp~~R-------p~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 275 KNPRNR-------PPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred cCCccC-------CCHHHHhhCcccccCCcc
Confidence 777766 999999999999866554
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=234.25 Aligned_cols=205 Identities=20% Similarity=0.270 Sum_probs=164.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++||||+++++++. +...++|+||+++|+|.+++.....+++..+..++.|++.|+.|||++|++
T Consensus 39 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 117 (257)
T cd05116 39 LKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117 (257)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 4566788899999999999999999886 456799999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
|+||||+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+|||||++|||++ |.
T Consensus 118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~ 196 (257)
T cd05116 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQ 196 (257)
T ss_pred ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998876433221 1223457899999987554 7899999999999999998 66
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
.|+.+....+. ...+..+.+++ .+...++++.+++-.|+..+|..||....+
T Consensus 197 ~p~~~~~~~~~-~~~i~~~~~~~---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 197 KPYKGMKGNEV-TQMIESGERME---CPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred CCCCCCCHHHH-HHHHHCCCCCC---CCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 66655555444 34444444332 334567788888888888888777766553
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=241.03 Aligned_cols=240 Identities=31% Similarity=0.459 Sum_probs=171.1
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCC--------EEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKK--------KLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
.+.+|+.+++.++||||+++++++...+ ..++|+||+.+ ++...+ .....+++..+..++.|++.||.||
T Consensus 57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 135 (310)
T cd07865 57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI 135 (310)
T ss_pred HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999987654 45999999986 555544 4344789999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|+.|++|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+...++.++|+||+|+++|
T Consensus 136 H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~ 215 (310)
T cd07865 136 HRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMA 215 (310)
T ss_pred HHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHH
Confidence 999999999999999999999999999999876543221 123456788999999877655789999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
||++|..++.+.........+....+..+....+...... .|.............. ...........+.|++
T Consensus 216 el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~----~~l~~~~~~~~~~dli 287 (310)
T cd07865 216 EMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE----LFKKMELPQGQKRKVK----ERLKPYVKDPHALDLI 287 (310)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchh----hhhhccCCCccchhhH----HhcccccCCHHHHHHH
Confidence 9999998887776665554444433333222111111001 1111110000000000 1111112456778999
Q ss_pred hhhhccccceeeccccccccccccceeeee
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+|+..+|..| +++.+++.||||
T Consensus 288 ~~~l~~~P~~R-------~t~~e~l~h~~f 310 (310)
T cd07865 288 DKLLVLDPAKR-------IDADTALNHDFF 310 (310)
T ss_pred HHHhcCChhhc-------cCHHHHhcCCCC
Confidence 99998666666 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=252.95 Aligned_cols=205 Identities=21% Similarity=0.311 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.|..|+.+++.++||||++++|+|.+. +.++|||.++-|.|..+++.++ .++......+++||..||+|||+.++
T Consensus 434 ~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrf 512 (974)
T KOG4257|consen 434 DTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRF 512 (974)
T ss_pred hHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhch
Confidence 467888999999999999999999999854 6899999999999999987664 79999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccC--CCcccCcccccCCccCCCccchhhHHHHHHHhhccC-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA--TRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG-F 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~-~ 172 (303)
|||||..+|||+.+...|||+|||+++.+.....+....| +.-|+|||.+.-.. ++.++|||-|||++||++..+ .
T Consensus 513 VHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvk 591 (974)
T KOG4257|consen 513 VHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVK 591 (974)
T ss_pred hhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999887665554443 56699999997555 899999999999999997644 6
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
||.|-.+.+. ...+++|.|+| .|+.+++-+..++-+||.-+|++||.+.-+
T Consensus 592 PfqgvkNsDV-I~~iEnGeRlP---~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 592 PFQGVKNSDV-IGHIENGERLP---CPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ccccccccce-EEEecCCCCCC---CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 6666655555 45778888865 667788888899999999999999987664
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=251.08 Aligned_cols=259 Identities=28% Similarity=0.373 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+|+.+++.+ +||||+++++++... ..+++|+||++ ++|..++..+ .+++..+..++.|++.||.|||+.|+
T Consensus 51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i 128 (337)
T cd07852 51 QRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNV 128 (337)
T ss_pred hhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4466789999999 999999999998654 46899999998 5788877655 78899999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
+|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+...++.++|+|||||++|+|++
T Consensus 129 ~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t 208 (337)
T cd07852 129 IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208 (337)
T ss_pred ecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh
Confidence 999999999999999999999999988654322 12234678899999998766667899999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..++.+....+....+....+.+...... ..........+.... .....+.. ...+..+..+.+++.+|+
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~l~~li~~~l 279 (337)
T cd07852 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIE-SIKSPFAATMLDSLP-SRPRKPLD-------ELLPKASDDALDLLKKLL 279 (337)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHH-HHHhhhHHHhhhhcc-cccccchh-------hhccCCCHHHHHHHHHhc
Confidence 999988887777776666654433210000 000000000000000 00000000 001113455666666666
Q ss_pred ccccceeeccccccccccccceeeee------------------ecCCcceEEEEEecceeEEE
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYI------------------PTPERKCLEVIFMDSMVFIM 295 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~------------------~~~~~~~~~~~~~~~~~~~~ 295 (303)
..+|..| +++.+++.|+|+ +.++.....+..|||+||+-
T Consensus 280 ~~~P~~R-------ps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 280 VFNPNKR-------LTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE 336 (337)
T ss_pred cCCcccc-------cCHHHHhhChhhhhhccCCCCCCCCCCccCCccccceeeHHHHHhhhhhc
Confidence 6544444 666666666655 34566677888899999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.67 Aligned_cols=161 Identities=26% Similarity=0.378 Sum_probs=148.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
-+...+|+.++..++++||.++|+.+..+..++++||||.||++.+.++.+..+++..+..++++++.|+.|||+++.+|
T Consensus 55 Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiH 134 (467)
T KOG0201|consen 55 IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIH 134 (467)
T ss_pred hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceec
Confidence 44567899999999999999999999999999999999999999999998878899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||+.|||+..+|.+|++|||.+..+..... ..+.+||+.|||||++.+.+ |+.++||||||++.+||.+|.+|+.+
T Consensus 135 rDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 135 RDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred ccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 99999999999999999999999988775433 37889999999999999666 99999999999999999999988876
Q ss_pred Cch
Q psy763 177 NMG 179 (303)
Q Consensus 177 ~~~ 179 (303)
..+
T Consensus 214 ~hP 216 (467)
T KOG0201|consen 214 LHP 216 (467)
T ss_pred cCc
Confidence 655
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=233.60 Aligned_cols=213 Identities=24% Similarity=0.295 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.++|+||+++++++..+..+++|+||+++++|..++.+...+++..+..++.|++.|++|||+.|++|
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 125 (258)
T cd06632 46 VKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125 (258)
T ss_pred HHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45678899999999999999999999999999999999999999999887777999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
+||+|+||+++.++.+||+|||++.............++..|+|||.+.....++.++|+||+||++|++++|..|+...
T Consensus 126 ~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred CCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999999999887654443445678899999999875444789999999999999999998887654
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
...+........... ........+.+.+++.+|+...+..|
T Consensus 206 ~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R- 246 (258)
T cd06632 206 EGVAAVFKIGRSKEL--------------------------------------PPIPDHLSDEAKDFILKCLQRDPSLR- 246 (258)
T ss_pred cHHHHHHHHHhcccC--------------------------------------CCcCCCcCHHHHHHHHHHhhcCcccC-
Confidence 433322211110000 00111234566788888887555555
Q ss_pred ccccccccccccceeeee
Q psy763 258 SEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~ 275 (303)
+++.+++.|||+
T Consensus 247 ------p~~~~~l~~~~~ 258 (258)
T cd06632 247 ------PTAAELLEHPFV 258 (258)
T ss_pred ------cCHHHHhcCCCC
Confidence 999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=237.44 Aligned_cols=170 Identities=24% Similarity=0.339 Sum_probs=153.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.-..|-++++..+||.+..+...|+...++|+||||+.||.|.-.+.+...+++...+.+...|+.||.|||+++||+
T Consensus 212 VAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivY 291 (516)
T KOG0690|consen 212 VAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVY 291 (516)
T ss_pred hhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeee
Confidence 34445677899999999999999999999999999999999999998888889999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeee-CCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||+|.+|.++|.+|++||+|||++..- ..+...++.+|||.|+|||++.... |+.++|.|.+||+||||++|..||+.
T Consensus 292 RDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 292 RDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred eechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccc
Confidence 999999999999999999999999864 4566778899999999999998665 99999999999999999999999998
Q ss_pred CchHHHHHHHhh
Q psy763 177 NMGSHMARNLLK 188 (303)
Q Consensus 177 ~~~~~~~~~~~~ 188 (303)
........-++.
T Consensus 371 ~dh~kLFeLIl~ 382 (516)
T KOG0690|consen 371 KDHEKLFELILM 382 (516)
T ss_pred cchhHHHHHHHh
Confidence 766655544433
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=234.15 Aligned_cols=172 Identities=26% Similarity=0.401 Sum_probs=149.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||+++++.+..++.++++|||++++++..++... ..+++..+..++.|++.|+.|||+.|+
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i 122 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3466788999999999999999999999999999999999999999988665 689999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCC--ccCCCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGD--TLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~--~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. +.++.++|+||+||++|+|++|..
T Consensus 123 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~ 202 (262)
T cd06613 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202 (262)
T ss_pred eecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654322 22345678899999998765 247899999999999999999999
Q ss_pred cCCCCchHHHHHHHhh
Q psy763 173 IGLGNMGSHMARNLLK 188 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~ 188 (303)
|+.+....+.......
T Consensus 203 p~~~~~~~~~~~~~~~ 218 (262)
T cd06613 203 PMFDLHPMRALFLISK 218 (262)
T ss_pred CCCCCCHHHHHHHHHh
Confidence 9988776665554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=244.88 Aligned_cols=156 Identities=28% Similarity=0.321 Sum_probs=138.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKK-KLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA- 94 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~- 94 (303)
..|..|+.++.+++|||+|+++|+|.+.+ +.+||+||+++|+|.+.+.... ++++..+..|+.++|+||+|||...
T Consensus 116 ~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~ 195 (361)
T KOG1187|consen 116 REFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCP 195 (361)
T ss_pred hHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCC
Confidence 34999999999999999999999999998 5999999999999999877654 8999999999999999999999854
Q ss_pred --ceecccCCCcEEEecCCcEEEccccceeeeCC-CCccccc-cCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 --CIHRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDY-VATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 --ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+|||||++|||+|++...||+|||+|..... .....+. .||.+|+|||...... .+.++||||||+++.|++||
T Consensus 196 ~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitg 274 (361)
T KOG1187|consen 196 PPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITG 274 (361)
T ss_pred CCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhC
Confidence 99999999999999999999999999966544 3333333 8999999999997643 79999999999999999999
Q ss_pred CccCC
Q psy763 171 GFIGL 175 (303)
Q Consensus 171 ~~~~~ 175 (303)
+.+..
T Consensus 275 r~~~d 279 (361)
T KOG1187|consen 275 RKAVD 279 (361)
T ss_pred CcccC
Confidence 96554
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=241.39 Aligned_cols=220 Identities=22% Similarity=0.305 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.++||||+++++++..++..++|+||++++++..++.. ..+++..+..++.|++.||.|||+.|++|
T Consensus 62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 140 (297)
T cd06659 62 RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIH 140 (297)
T ss_pred HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 45577889999999999999999999999999999999999999987754 47899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||+||++|||++|..|+.+
T Consensus 141 ~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred CCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987544322 223456889999999998665 79999999999999999999998887
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+...... .........+.+.+++.+|+...|..+
T Consensus 220 ~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~l~~~i~~~l~~~P~~R 262 (297)
T cd06659 220 DSPVQAMKRLRDSPPP-------------------------------------KLKNAHKISPVLRDFLERMLTREPQER 262 (297)
T ss_pred CCHHHHHHHHhccCCC-------------------------------------CccccCCCCHHHHHHHHHHhcCCcccC
Confidence 6655554432111000 000001123456788888887555544
Q ss_pred eccccccccccccceeeeeecCCcceE
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPERKCL 283 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~~~~~ 283 (303)
+++.+++.|+|+.......|
T Consensus 263 -------ps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 263 -------ATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred -------cCHHHHhhChhhccCCCccc
Confidence 99999999999988765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=251.87 Aligned_cols=189 Identities=27% Similarity=0.316 Sum_probs=172.3
Q ss_pred CccccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHH
Q psy763 1 LRFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 80 (303)
Q Consensus 1 ~~~~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~ 80 (303)
+|++||+.....+ .++....|..++..+..|.||++|..|.++..+|+.||-|-||.+..+++..+.+++.+...++
T Consensus 450 lKilkK~hIVdtk---QqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~ 526 (732)
T KOG0614|consen 450 LKILKKKHIVDTK---QQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYV 526 (732)
T ss_pred HHHHhHhhccchh---HHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhH
Confidence 3556666665555 5566667888999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
..+++|+.|||++||++|||||+|.+++.+|-+||.|||+|+.+..+...-+++||+.|.|||++.+.+ .+.++|.|||
T Consensus 527 acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaL 605 (732)
T KOG0614|consen 527 ACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWAL 605 (732)
T ss_pred HHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHH
Confidence 999999999999999999999999999999999999999999999888888999999999999999877 7999999999
Q ss_pred HHHHHHhhccCccCCCCchHHHHHHHhhcCCce
Q psy763 161 EWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRV 193 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 193 (303)
|+++||+++|.+||.|..+......+++.-...
T Consensus 606 GIli~ELL~G~pPFs~~dpmktYn~ILkGid~i 638 (732)
T KOG0614|consen 606 GILIYELLTGSPPFSGVDPMKTYNLILKGIDKI 638 (732)
T ss_pred HHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh
Confidence 999999999999999999998888887764443
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=235.05 Aligned_cols=217 Identities=18% Similarity=0.223 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+..|+..++.++|||++++++++...+..++|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 131 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH 131 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 35677899999999999999999999999999999999999999999887778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCc-cCCCccchhhHHHHHHHhhccCcc
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDT-LYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~-~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||+|+||+++.++.++++|||++....... ......++..|+|||.+.+.. .++.++|+||+|+++|++++|..|
T Consensus 132 ~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 211 (272)
T cd06629 132 RDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211 (272)
T ss_pred cCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999987643211 122346788999999987543 368999999999999999999888
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+......+............. + ...........+.+++.+|+...|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~----------------------------~------~~~~~~~~~~~~~~li~~~l~~~p 257 (272)
T cd06629 212 WSDEEAIAAMFKLGNKRSAPP----------------------------I------PPDVSMNLSPVALDFLNACFTINP 257 (272)
T ss_pred CcCcchHHHHHHhhccccCCc----------------------------C------CccccccCCHHHHHHHHHHhcCCh
Confidence 765444333322111100000 0 000011134567788989988666
Q ss_pred ceeeccccccccccccceeeee
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
..| ++..+++.|||+
T Consensus 258 ~~R-------ps~~~il~~~~~ 272 (272)
T cd06629 258 DNR-------PTARELLQHPFI 272 (272)
T ss_pred hhC-------CCHHHHhhCCCC
Confidence 555 999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=235.48 Aligned_cols=162 Identities=27% Similarity=0.402 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+..++.++||||+++++++..++.+++|+||+++++|.+++...+.+++..+..++.|++.|+.|||+.|++|+
T Consensus 51 ~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 130 (267)
T cd06646 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130 (267)
T ss_pred HHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 35677899999999999999999999999999999999999999988777789999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCccCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|++|+||+++.++.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||+||++|||++|..|+.
T Consensus 131 dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 999999999999999999999998764322 2234568889999998852 3336889999999999999999998876
Q ss_pred CCchH
Q psy763 176 GNMGS 180 (303)
Q Consensus 176 ~~~~~ 180 (303)
.....
T Consensus 211 ~~~~~ 215 (267)
T cd06646 211 DLHPM 215 (267)
T ss_pred ccchh
Confidence 55443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=238.74 Aligned_cols=214 Identities=24% Similarity=0.356 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.++||||+++++++..++.+++|+||+++++|..++.. ..+++..+..++.|++.|+.|||+.|++|
T Consensus 60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H 138 (296)
T cd06655 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIH 138 (296)
T ss_pred HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 44567889999999999999999999999999999999999999998864 36899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|++++|..|+.+
T Consensus 139 ~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred CCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544322 23356888999999988655 78999999999999999999999887
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+.... ... ... ....++.+.+++.+|+..++..|
T Consensus 218 ~~~~~~~~~~~~~~-~~~-~~~-----------------------------------~~~~~~~~~~li~~~l~~dp~~R 260 (296)
T cd06655 218 ENPLRALYLIATNG-TPE-LQN-----------------------------------PEKLSPIFRDFLNRCLEMDVEKR 260 (296)
T ss_pred CCHHHHHHHHHhcC-Ccc-cCC-----------------------------------cccCCHHHHHHHHHHhhcChhhC
Confidence 76655443332211 100 000 01123455677777777555444
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.+++.|+|+..
T Consensus 261 -------pt~~~il~~~~~~~ 274 (296)
T cd06655 261 -------GSAKELLQHPFLKL 274 (296)
T ss_pred -------CCHHHHhhChHhhh
Confidence 88888888888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=235.09 Aligned_cols=217 Identities=23% Similarity=0.293 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++.+..+...|+|+||+++++|..++.+.+.+++..+..++.|++.||.|||+.|+
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 114 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI 114 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 45567788899999999999999999999999999999999999999998876789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC---------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE---------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
+|+||+|+||+++.++.++|+|||++....... ......++..|+|||...+.. ++.++|+||||+++|+
T Consensus 115 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~ 193 (265)
T cd05579 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYE 193 (265)
T ss_pred ecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHH
Confidence 999999999999999999999999987654321 122346788899999988666 7899999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
+++|..|+......+....+....... .......+.+.+++.
T Consensus 194 l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~i~ 235 (265)
T cd05579 194 FLVGIPPFHGETPEEIFQNILNGKIEW--------------------------------------PEDVEVSDEAIDLIS 235 (265)
T ss_pred HHhCCCCCCCCCHHHHHHHHhcCCcCC--------------------------------------CccccCCHHHHHHHH
Confidence 999988877665544443322211000 000002456778999
Q ss_pred hhhccccceeeccccccccc---cccceeeeeecC
Q psy763 247 KKLIGRFTYIQSEKQDSIRG---KNCKKTFYIPTP 278 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~ 278 (303)
+|+..++..| ++. .+++.||||.+.
T Consensus 236 ~~l~~~p~~R-------pt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 236 KLLVPDPEKR-------LGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHhcCCHhhc-------CCCccHHHHhcCccccCC
Confidence 9988666666 988 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=235.60 Aligned_cols=216 Identities=23% Similarity=0.356 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++..++..++|+||+++++|.+++.. ..+++..+..++.|++.|+++||+.|++
T Consensus 59 ~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~ 137 (285)
T cd06648 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVI 137 (285)
T ss_pred HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 345577889999999999999999999999999999999999999998876 5789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+||++|||++|..|+.
T Consensus 138 H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred cCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999876544322 223356889999999988765 7999999999999999999999887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+.... .. ........+..+.+++++|+..+|..
T Consensus 217 ~~~~~~~~~~~~~~~-~~------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~ 259 (285)
T cd06648 217 NEPPLQAMKRIRDNL-PP------------------------------------KLKNLHKVSPRLRSFLDRMLVRDPAQ 259 (285)
T ss_pred CCCHHHHHHHHHhcC-CC------------------------------------CCcccccCCHHHHHHHHHHcccChhh
Confidence 766554444322210 00 00001113456789999999865555
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
| +++.+++.|+|+...
T Consensus 260 R-------pt~~~il~~~~~~~~ 275 (285)
T cd06648 260 R-------ATAAELLNHPFLAKA 275 (285)
T ss_pred C-------cCHHHHccCcccccC
Confidence 5 999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=234.96 Aligned_cols=220 Identities=21% Similarity=0.276 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++.+...+..++|+||++++++..+ ..+++..+..++.|++.||.|||+.|++
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 117 (279)
T cd06619 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKIL 117 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 345677899999999999999999999999999999999999998765 2578889999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+.. ++.++|+||+||++|+|++|..|+..
T Consensus 118 H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchh
Confidence 9999999999999999999999998765432 233457899999999998765 79999999999999999999888764
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+... .......++..... ........++++.+++.+|+..+|..|
T Consensus 196 ~~~~~~~~---------------------~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~R 244 (279)
T cd06619 196 IQKNQGSL---------------------MPLQLLQCIVDEDP----------PVLPVGQFSEKFVHFITQCMRKQPKER 244 (279)
T ss_pred hccccccc---------------------chHHHHHHHhccCC----------CCCCCCcCCHHHHHHHHHHhhCChhhC
Confidence 22111000 00000111111000 001112245677899999888666665
Q ss_pred eccccccccccccceeeeeecCCc
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+++.+++.|||+.....
T Consensus 245 -------p~~~eil~~~~~~~~~~ 261 (279)
T cd06619 245 -------PAPENLMDHPFIVQYND 261 (279)
T ss_pred -------CCHHHHhcCcccccccC
Confidence 99999999999876543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=231.81 Aligned_cols=201 Identities=15% Similarity=0.123 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+.+|+.+++.++||||+++++++..+...++||||+++|+|..++... ..+++..+..++.|++.||+|||+.|++
T Consensus 43 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii 122 (258)
T cd05078 43 SESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122 (258)
T ss_pred HHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 456778899999999999999999999999999999999999999988654 3689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCc--------EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 97 HRDIKPENILLTANGV--------VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 97 H~dlk~~nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
||||||+||+++.++. ++++|||++....+. ....++..|+|||.+.+...++.++|+|||||++|||+
T Consensus 123 H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~ 199 (258)
T cd05078 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF 199 (258)
T ss_pred cCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999987754 699999988664432 23467888999999986555799999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+|+.+++.................. +.....+..+++.+|+..+|..||...-
T Consensus 200 ~g~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ 252 (258)
T cd05078 200 SGGDKPLSALDSQKKLQFYEDRHQL-----PAPKWTELANLINQCMDYEPDFRPSFRA 252 (258)
T ss_pred cCCCCChhhccHHHHHHHHHccccC-----CCCCcHHHHHHHHHHhccChhhCCCHHH
Confidence 9976665554444333333322221 1223345556666666666666655444
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=245.71 Aligned_cols=243 Identities=24% Similarity=0.365 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
...+.+|+.+++.++||||+++++++.. ...+++|+||+. +++..++...+.+++..+..++.|++.||.|||+.
T Consensus 48 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 126 (334)
T cd07855 48 AKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126 (334)
T ss_pred hHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3455678999999999999999998863 357899999996 57888887777899999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
|++|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+...++.++|+||+||++|||+
T Consensus 127 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence 999999999999999999999999999877543221 123468889999999876555899999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
+|..+|.+......+..+....+.++...... ...+.....+..+.. ....++... .+..+..+.+++.+|
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~li~~~ 277 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR-IGSDRVRKYIQNLPR-KQPVPWSKI-------FPKASPEALDLLSQM 277 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCChhHhhhh-hchhhHHHHHhhccc-CCCCCHHHH-------cccCCHHHHHHHHHH
Confidence 99999988877766666655544443111100 000000011111110 011111111 122467788999999
Q ss_pred hccccceeeccccccccccccceeeeeec
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+...|..| +++.+++.|||+..
T Consensus 278 l~~~P~~R-------pt~~~~l~~~~~~~ 299 (334)
T cd07855 278 LQFDPEER-------ITVEQALQHPFLAQ 299 (334)
T ss_pred ccCChhhC-------cCHHHHHhChhhhh
Confidence 98666666 99999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=233.65 Aligned_cols=230 Identities=17% Similarity=0.221 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+...-+|+..+.+.+ |+||++++++|+++..+|||||-|.||.+...+.+...+++..+..+..+|+.||.|||.+||
T Consensus 118 sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgI 197 (463)
T KOG0607|consen 118 SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGI 197 (463)
T ss_pred HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCc
Confidence 4556678888888886 999999999999999999999999999999988888899999999999999999999999999
Q ss_pred eecccCCCcEEEecCC---cEEEccccceeeeCCC--------CccccccCCCcccCccccc---C-CccCCCccchhhH
Q psy763 96 IHRDIKPENILLTANG---VVKLCDFGFARLINPG--------ENYTDYVATRWYRAPELLV---G-DTLYGPAVDVWAI 160 (303)
Q Consensus 96 vH~dlk~~nil~~~~~---~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~l~---~-~~~~~~~~DvwSl 160 (303)
.|||+||+|||-.+.. -+|||||.++...... +...+.+|+..|||||++. + ...|+.++|.|||
T Consensus 198 AHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSL 277 (463)
T KOG0607|consen 198 AHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSL 277 (463)
T ss_pred ccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHH
Confidence 9999999999997654 4899999887654311 1224568899999999974 2 3458999999999
Q ss_pred HHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCC----
Q psy763 161 EWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDR---- 236 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~---- 236 (303)
|+|+|-|++|.+||.|.-..+- |. .....-..+....+..+... .-+..+.
T Consensus 278 GvIlYImLsGYpPFvG~Cg~dC-------GW------drGe~Cr~CQ~~LFesIQEG------------kYeFPdkdWah 332 (463)
T KOG0607|consen 278 GVILYIMLSGYPPFVGHCGADC-------GW------DRGEVCRVCQNKLFESIQEG------------KYEFPDKDWAH 332 (463)
T ss_pred HHHHHHHHhCCCCccCccCCcC-------Cc------cCCCccHHHHHHHHHHHhcc------------CCcCChhhhHH
Confidence 9999999999999987643111 00 00000011111111111110 0011122
Q ss_pred CchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 237 NSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 237 ~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.+.++-|++.+++...+.-+ .++...+.|||+.-.
T Consensus 333 IS~eakdlisnLlvrda~~r-------lsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 333 ISSEAKDLISNLLVRDAKQR-------LSAAQVLNHPWVQRC 367 (463)
T ss_pred hhHHHHHHHHHHHhccHHhh-------hhhhhccCCcccccc
Confidence 24567788888888555444 999999999998753
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=235.38 Aligned_cols=240 Identities=30% Similarity=0.409 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+.+++.++|+|++++++++... +..++|+||+++ ++..++... ..+++..++.++.|++.||+|||+.|
T Consensus 42 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ 120 (287)
T cd07840 42 PITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120 (287)
T ss_pred hHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567789999999999999999999988 889999999985 677766544 58999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+...++.++|||||||++|||++|..
T Consensus 121 ~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~ 200 (287)
T cd07840 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP 200 (287)
T ss_pred ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998765432 12334567889999988766557999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhh-hhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDL-TWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
++.+.........+....+.+.....+ ...+. .+............... .......+.+++++.+|+..
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~ 270 (287)
T cd07840 201 IFQGSTELEQLEKIFELCGSPTDENWP-----GVSKLPWFENLKPKKPYKRRLRE-----FFKHLIDPSALDLLDKLLTL 270 (287)
T ss_pred CCCCCChHHHHHHHHHHhCCCchhhcc-----ccccchhhhhccccccchhHHHH-----HhcccCCHHHHHHHHHHcCC
Confidence 988887777666666543333211111 11111 11112111111111111 11112467889999999997
Q ss_pred ccceeeccccccccccccceeeee
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+|..| +++.+++.|+||
T Consensus 271 ~P~~R-------p~~~~~l~~~~~ 287 (287)
T cd07840 271 DPKKR-------ISADQALQHEYF 287 (287)
T ss_pred ChhhC-------cCHHHHhhCcCC
Confidence 77666 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=267.27 Aligned_cols=172 Identities=28% Similarity=0.425 Sum_probs=142.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+..|+.+++.++||||++++++|... ..+|+||||+++|+|..++.. ...+++..++.++.||+.||.||
T Consensus 55 ~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYL 134 (1021)
T PTZ00266 55 EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134 (1021)
T ss_pred HHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999998643 578999999999999987754 35799999999999999999999
Q ss_pred HHC-------CceecccCCCcEEEec-----------------CCcEEEccccceeeeCCCCccccccCCCcccCccccc
Q psy763 91 HRH-------ACIHRDIKPENILLTA-----------------NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV 146 (303)
Q Consensus 91 H~~-------~ivH~dlk~~nil~~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~ 146 (303)
|+. +|+|+||||+|||++. .+.+||+|||++.............+|+.|+|||++.
T Consensus 135 Hs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ 214 (1021)
T PTZ00266 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL 214 (1021)
T ss_pred HhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHh
Confidence 985 4999999999999964 2358999999998765444444567999999999986
Q ss_pred CC-ccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhh
Q psy763 147 GD-TLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLK 188 (303)
Q Consensus 147 ~~-~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~ 188 (303)
+. ..++.++||||||||||||++|..||........+...+.
T Consensus 215 ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk 257 (1021)
T PTZ00266 215 HETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK 257 (1021)
T ss_pred ccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh
Confidence 43 3478999999999999999999999876655544444333
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=231.47 Aligned_cols=212 Identities=22% Similarity=0.268 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++||||+++++.+..++..++|+||+++++|.+++... ..+++..+..++.|++.|++|||++|
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 121 (256)
T cd08220 42 ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121 (256)
T ss_pred HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456788999999999999999999999999999999999999999988653 35899999999999999999999999
Q ss_pred ceecccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 95 CIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
++|+||+|+||+++.+ +.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..+
T Consensus 122 i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~ 200 (256)
T cd08220 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRA 200 (256)
T ss_pred eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCC
Confidence 9999999999999865 568999999998776544444567888999999998655 78999999999999999999888
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+.+.........+...... ...+...+++.+++.+|+...|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~l~~li~~~l~~~p 241 (256)
T cd08220 201 FEAANLPALVLKIMSGTFA---------------------------------------PISDRYSPDLRQLILSMLNLDP 241 (256)
T ss_pred cccCchHHHHHHHHhcCCC---------------------------------------CCCCCcCHHHHHHHHHHccCCh
Confidence 7665544443332221100 0011234566788888887666
Q ss_pred ceeeccccccccccccceeeee
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
..| ++..+++.||++
T Consensus 242 ~~R-------pt~~~ll~~p~~ 256 (256)
T cd08220 242 SKR-------PQLSQIMAQPIC 256 (256)
T ss_pred hhC-------CCHHHHhhCCCC
Confidence 555 999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=233.76 Aligned_cols=212 Identities=24% Similarity=0.344 Sum_probs=164.0
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
..+..|+.+++.+ +|+||+++++++... ..+++|+||+++++|..++.. ...+++..+..++.|++.|++|
T Consensus 47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~ 126 (272)
T cd06637 47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126 (272)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4556778888887 699999999998753 468999999999999998765 3468999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccC----CccCCCccchhhHHHHH
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il 164 (303)
||+.|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||++.+ ...++.++|+||+||++
T Consensus 127 LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l 206 (272)
T cd06637 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 206 (272)
T ss_pred HHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHH
Confidence 99999999999999999999999999999998765432 22344578899999999863 22478899999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
|||++|..|+.+............... ........+..+.++
T Consensus 207 ~el~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~l 248 (272)
T cd06637 207 IEMAEGAPPLCDMHPMRALFLIPRNPA--------------------------------------PRLKSKKWSKKFQSF 248 (272)
T ss_pred HHHHhCCCCccccCHHHHHHHHhcCCC--------------------------------------CCCCCCCcCHHHHHH
Confidence 999999988765443322221110000 000111223567789
Q ss_pred hhhhhccccceeeccccccccccccceeeee
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+.+|+...+..| +++.++++||||
T Consensus 249 i~~~l~~~p~~R-------pt~~~il~~~~~ 272 (272)
T cd06637 249 IESCLVKNHSQR-------PTTEQLMKHPFI 272 (272)
T ss_pred HHHHcCCChhhC-------CCHHHHhhCCCC
Confidence 999998666555 999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=230.95 Aligned_cols=204 Identities=19% Similarity=0.251 Sum_probs=158.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++||||+++++++.. ...++|+||+++++|.+++.. ...+++..++.++.|++.||.|||++|+
T Consensus 38 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 116 (257)
T cd05115 38 VRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence 34568889999999999999999999864 468999999999999998764 4579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
+|+||||+||+++.++.+||+|||++......... ....++..|+|||.+.+.. ++.++|||||||++||+++ |
T Consensus 117 ~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g 195 (257)
T cd05115 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYG 195 (257)
T ss_pred eecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999998765433221 1122356899999987655 7999999999999999997 6
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..|+.+....... ..+..+.++. .+...+++..+++-.||..++..||...-
T Consensus 196 ~~p~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~ 247 (257)
T cd05115 196 QKPYKKMKGPEVM-SFIEQGKRLD---CPAECPPEMYALMKDCWIYKWEDRPNFAK 247 (257)
T ss_pred CCCcCcCCHHHHH-HHHHCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 6666665554443 4444444322 23344566666666777666665554433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=233.55 Aligned_cols=165 Identities=24% Similarity=0.365 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++||||+++++++.. +..+++++||+++++|..++...+.+++..+..++.|++.||.|||+.|
T Consensus 47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 126 (266)
T cd06651 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126 (266)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567889999999999999999999875 3578999999999999998877778999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCC----CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPG----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+.. ++.++|+||+||++||+++|
T Consensus 127 i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g 205 (266)
T cd06651 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTE 205 (266)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHC
Confidence 999999999999999999999999998765321 1122345788999999998765 79999999999999999999
Q ss_pred CccCCCCchHHH
Q psy763 171 GFIGLGNMGSHM 182 (303)
Q Consensus 171 ~~~~~~~~~~~~ 182 (303)
..|+.+....+.
T Consensus 206 ~~pf~~~~~~~~ 217 (266)
T cd06651 206 KPPWAEYEAMAA 217 (266)
T ss_pred CCCccccchHHH
Confidence 888765544333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=244.92 Aligned_cols=254 Identities=17% Similarity=0.171 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||++++++|..++..++|+||+.++++..++... ..+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i 122 (328)
T cd08226 43 LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122 (328)
T ss_pred HHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 467788899999999999999999999999999999999999999987653 358999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-cc-------ccccCCCcccCcccccCC-ccCCCccchhhHHHHHHH
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NY-------TDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~-------~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~e 166 (303)
+||||||+||+++.++.++++||+.+....... .. ....++..|+|||.+.+. ..++.++||||+||++||
T Consensus 123 vHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~e 202 (328)
T cd08226 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202 (328)
T ss_pred ecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999998654322111 00 112345679999999764 337899999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh----cCCCh---hHHHHHHhHhCCCCCCCch
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF----SKTST---TTIFKYLLIRGGNTDRNSH 239 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~l~~~~~~~~~~~~ 239 (303)
|++|..|+.+....+.....+......+............+......+. ..... .................++
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (328)
T cd08226 203 LATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSP 282 (328)
T ss_pred HHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhH
Confidence 9999999887766666555544322211110000000000000000000 00000 0000000001111223456
Q ss_pred hhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 240 GVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 240 ~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
++.+++.+|+..+|..| +++.++++|+|+...
T Consensus 283 ~~~~li~~~l~~dP~~R-------pta~e~l~~~~~~~~ 314 (328)
T cd08226 283 AFQNLVELCLQQDPEKR-------PSASSLLSHAFFKQV 314 (328)
T ss_pred HHHHHHHHHccCCcccC-------CCHHHHhhCHHHHHH
Confidence 78899999998666555 999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=236.29 Aligned_cols=205 Identities=18% Similarity=0.224 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
....+.+|+..++.++||||+++++++......++||||+++++|.+++... ..+++..++.++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999988543 248899999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.|++|||++|++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++||
T Consensus 130 ~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 208 (291)
T cd05094 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDV 208 (291)
T ss_pred HHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhH
Confidence 9999999999999999999999999999999999999999876543221 12234577899999988765 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||||++|||++ |..|+.+....+....+ ..+.... .+...+.+..+++.+|+..+|..||....
T Consensus 209 ~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 274 (291)
T cd05094 209 WSFGVILWEIFTYGKQPWFQLSNTEVIECI-TQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKE 274 (291)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999999999998 66666666555544433 3222221 22334556666777777766666664433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=241.27 Aligned_cols=245 Identities=30% Similarity=0.437 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+|+.+++.++||||+++++++... ..+++|+||++++++..+.. ....+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 126 (316)
T cd07842 47 QSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126 (316)
T ss_pred HHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh
Confidence 4456788999999999999999999988 78999999998654443321 12368999999999999999999999
Q ss_pred CCceecccCCCcEEEec----CCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 93 HACIHRDIKPENILLTA----NGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~----~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
.|++|+||+|+||+++. ++.+||+|||++........ .....++..|+|||.+.+...++.++|||||||++
T Consensus 127 ~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 206 (316)
T cd07842 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIF 206 (316)
T ss_pred CCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 99999999999999999 89999999999887543221 23346788899999988766579999999999999
Q ss_pred HHhhccCccCCCCchHH---------HHHHHhhcCCceeEeecCC-CCCcchhhhhhhhhhcCCCh-hHHHHHHhHhCCC
Q psy763 165 HSYSQIGFIGLGNMGSH---------MARNLLKNNGRVTVILKSD-SLDSETWDLTWQEIFSKTST-TTIFKYLLIRGGN 233 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~ 233 (303)
|+|++|..++.+..... .+..++..-+.+....... ...++... ..+........ ...... .+.
T Consensus 207 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~ 281 (316)
T cd07842 207 AELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT-LMKDFKTKTYPSNSLAKW----MEK 281 (316)
T ss_pred HHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchh-hhhhccCCCCCCccHHHH----HHh
Confidence 99999998887654322 2222222211111000000 00000000 00000000000 001011 001
Q ss_pred CCCCchhhHHhhhhhhccccceeeccccccccccccceeeee
Q psy763 234 TDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 234 ~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.......+.+++.+|+..+|..| +++.+++.||||
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~R-------ps~~eil~~~~f 316 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKR-------ITAEEALEHPYF 316 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccC-------cCHHHHhcCCCC
Confidence 12456778999999999777666 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=234.66 Aligned_cols=203 Identities=18% Similarity=0.221 Sum_probs=158.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-------------CCCHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-------------GLPWDLIKQITWQV 83 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------------~l~~~~~~~~~~qi 83 (303)
....+.+|+..++.++||||+++++++...+.+++|+||+++++|.+++...+ .+++..+..++.|+
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql 129 (288)
T cd05093 50 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999875332 48999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhH
Q psy763 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 84 ~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
+.||+|||+.|++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+|||
T Consensus 130 ~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwsl 208 (288)
T cd05093 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSL 208 (288)
T ss_pred HHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHH
Confidence 9999999999999999999999999999999999999876543221 12234567899999988655 7999999999
Q ss_pred HHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 161 EWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 161 G~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
||++|+|++ |..|+.+.........+..... . ..+...+.+..+++-+|+..+|..||..
T Consensus 209 G~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 269 (288)
T cd05093 209 GVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-L---QRPRTCPKEVYDLMLGCWQREPHMRLNI 269 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-C---CCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999998 6666666666555555443321 1 1223344555666666666655555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=243.45 Aligned_cols=245 Identities=28% Similarity=0.418 Sum_probs=187.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
.....+.+|+..++.++|+||+++++++.... .+|+|+||++ +++..++.+...+++..+..++.|++.||++|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~L 119 (330)
T cd07834 41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119 (330)
T ss_pred hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566788999999999999999999998775 7899999998 57888777777899999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
|+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++|+
T Consensus 120 H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~ 199 (330)
T cd07834 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199 (330)
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHH
Confidence 99999999999999999999999999999998876443 23345678899999999877458999999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
|++|..++.+....+....+....+.++.................. .......++... .+...+.+.+++.
T Consensus 200 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-------~~~~~~~~~~li~ 270 (330)
T cd07834 200 LLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS--LPKKPKKPLSKL-------FPGASPEAIDLLE 270 (330)
T ss_pred HHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhh--cccCCcchhHHh-------cccCCHHHHHHHH
Confidence 9999999998888777777766554443111110000010000000 111111111111 1225677889999
Q ss_pred hhhccccceeeccccccccccccceeeeeec
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+|+...|..| +++.+++.||||..
T Consensus 271 ~~l~~~P~~R-------pt~~~ll~~~~~~~ 294 (330)
T cd07834 271 KMLVFDPKKR-------ITADEALAHPYLAQ 294 (330)
T ss_pred HHccCChhhC-------CCHHHHHhCccHHh
Confidence 9999666666 99999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=238.98 Aligned_cols=214 Identities=25% Similarity=0.354 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++|+||+++++.+..++..++|+||++++++..++.+ ..+++..+..++.|++.||.|||+.|++|
T Consensus 60 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H 138 (297)
T cd06656 60 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIH 138 (297)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45577889999999999999999999999999999999999999998864 46899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++........ .....+++.|+|||.+.+.. ++.++|+||+||++|++++|..|+.+
T Consensus 139 ~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred CCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877544322 23356788999999998655 78999999999999999999988876
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
............ .+.+. .......++.+.+++.+|+..++..|
T Consensus 218 ~~~~~~~~~~~~-~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 260 (297)
T cd06656 218 ENPLRALYLIAT-NGTPE------------------------------------LQNPERLSAVFRDFLNRCLEMDVDRR 260 (297)
T ss_pred CCcchheeeecc-CCCCC------------------------------------CCCccccCHHHHHHHHHHccCChhhC
Confidence 543322211100 00000 00011233456788888888666665
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.+++.|||+..
T Consensus 261 -------ps~~~il~~~~~~~ 274 (297)
T cd06656 261 -------GSAKELLQHPFLKL 274 (297)
T ss_pred -------cCHHHHhcCchhcc
Confidence 99999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=230.11 Aligned_cols=204 Identities=22% Similarity=0.302 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..++.++||||+++++++...+..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34577899999999999999999999999999999999999999998764 34689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+.. ++.++|+|||||++||+++ |..|
T Consensus 123 H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p 201 (256)
T cd05114 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMP 201 (256)
T ss_pred ccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999998765432221 1223456799999988665 7999999999999999999 6677
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+....+....+... .++ ..+...+.+..+++..||..+|..||....
T Consensus 202 ~~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 202 FEKKSNYEVVEMISRG-FRL---YRPKLASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred CCCCCHHHHHHHHHCC-CCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 7666666665554442 222 122233445666667777777666665444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=254.44 Aligned_cols=170 Identities=24% Similarity=0.293 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC--------EEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK--------KLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLR 85 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~ 85 (303)
...+.+|+..+..++|+||+++++.+.... .+++||||+++|+|.+++.. ...+++..+..++.|++.
T Consensus 75 ~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~ 154 (496)
T PTZ00283 75 KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154 (496)
T ss_pred HHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHH
Confidence 445678899999999999999998876432 36899999999999987753 347899999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCC---CccccccCCCcccCcccccCCccCCCccchhhHHH
Q psy763 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG---ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEW 162 (303)
Q Consensus 86 ~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~ 162 (303)
||.|||+.||+||||||+||+++.++.+||+|||++...... .......||+.|+|||.+.+.. ++.++|||||||
T Consensus 155 aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGv 233 (496)
T PTZ00283 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGV 233 (496)
T ss_pred HHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHH
Confidence 999999999999999999999999999999999999875432 2234567999999999998765 899999999999
Q ss_pred HHHHhhccCccCCCCchHHHHHHHhh
Q psy763 163 TSHSYSQIGFIGLGNMGSHMARNLLK 188 (303)
Q Consensus 163 il~el~tg~~~~~~~~~~~~~~~~~~ 188 (303)
++|||++|..||.+....+.....+.
T Consensus 234 ilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 234 LLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99999999999887766655554443
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=232.00 Aligned_cols=201 Identities=18% Similarity=0.151 Sum_probs=152.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+++.+++.++||||+++++++......++|+||+++|++..++.. ...+++..+..++.|++.|++|||+.|+
T Consensus 47 ~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 126 (262)
T cd05077 47 ISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDL 126 (262)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCe
Confidence 345678889999999999999999999998899999999999999988764 4579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCc-------EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 96 IHRDIKPENILLTANGV-------VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
+||||||+||+++.++. ++++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+
T Consensus 127 vH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~ 203 (262)
T cd05077 127 VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC 203 (262)
T ss_pred ECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHH
Confidence 99999999999986653 899999998654322 23457888999999875555899999999999999997
Q ss_pred c-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 169 Q-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 169 t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+ |..|+.+. .............. .......+..+++-+||..+|..||.+..
T Consensus 204 ~~~~~p~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~ 256 (262)
T cd05077 204 YNGEIPLKDK-TLAEKERFYEGQCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRA 256 (262)
T ss_pred hCCCCCCCCc-chhHHHHHHhcCcc-----CCCCChHHHHHHHHHHcCCChhhCcCHHH
Confidence 5 54444433 33332322222111 11112234445556666666666665544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=234.25 Aligned_cols=206 Identities=18% Similarity=0.256 Sum_probs=161.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----------------CCCCCHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----------------PHGLPWDLIKQIT 80 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~~l~~~~~~~~~ 80 (303)
..+.+.+|+.+++.++||||+++++++......++++||+.++++..++.. ...+++..+..++
T Consensus 51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (283)
T cd05091 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130 (283)
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 345678899999999999999999999999999999999999999988742 1247888899999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+.. ++.++||
T Consensus 131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 209 (283)
T cd05091 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDI 209 (283)
T ss_pred HHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhH
Confidence 9999999999999999999999999999999999999999876543221 12334567899999987655 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
||+||++|||++ |..++.+....+....+... ... ..+..++.+..+++..|+..+|..||....+
T Consensus 210 ~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 210 WSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR-QVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 999999999998 55555555555544443333 221 2234566667777777777777777765553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=233.28 Aligned_cols=202 Identities=18% Similarity=0.225 Sum_probs=159.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--------------CCCCHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--------------HGLPWDLIKQITWQ 82 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------~~l~~~~~~~~~~q 82 (303)
....+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++... ..+++..+..++.|
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 3467788999999999999999999999999999999999999999987643 24788899999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhh
Q psy763 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWA 159 (303)
Q Consensus 83 i~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwS 159 (303)
++.|+.+||++|++|+||+|+||+++.++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||
T Consensus 131 i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s 209 (280)
T cd05049 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWS 209 (280)
T ss_pred HHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHH
Confidence 99999999999999999999999999999999999999876533221 12334567899999998765 899999999
Q ss_pred HHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 160 IEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 160 lG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|||++|||++ |..|+.+....+....+...... ..+...+.+..+++..|+..+|..||.
T Consensus 210 lG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~ 270 (280)
T cd05049 210 FGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL----QRPRTCPSEVYDIMLGCWKRDPQQRIN 270 (280)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence 9999999998 77887777666655544422111 112334455555556666555555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=241.69 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=182.4
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
.+.+|+.+++.++|+||+++++++..++..++|+||+. |++..++.....+++..+..++.|++.||.|||+.|++|+|
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 45688999999999999999999999999999999998 57888777777899999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCCC---------------CccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINPG---------------ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
|+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999998765411 1112234677899999998765579999999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
|||++|..++.+....+....+....+.+.....+.... ...+.. ............ .......+.++
T Consensus 225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~l 292 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKK----LPLYTE-FTPRKPKDLKTI-------FPNASDDAIDL 292 (335)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhh----cccccc-cCcCCcccHHHh-------CcCCChHHHHH
Confidence 999999988888877776666655444332111100000 000000 000000111111 12245678899
Q ss_pred hhhhhccccceeeccccccccccccceeeeeecCCcce
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
+.+|+...|..| +++.+++.|+|+...+..+
T Consensus 293 i~~~l~~~P~~R-------~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 293 LQSLLKLNPLER-------ISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHHHcCCCchhc-------cCHHHHhcCcccCCCCCCC
Confidence 999998666555 9999999999998776654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=232.92 Aligned_cols=165 Identities=24% Similarity=0.345 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++||||+++++++.+. ..+++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|
T Consensus 47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 126 (265)
T cd06652 47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345678899999999999999999998764 468899999999999998877677899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCC----CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPG----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+|||||++||+++|
T Consensus 127 i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g 205 (265)
T cd06652 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTE 205 (265)
T ss_pred EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhC
Confidence 999999999999999999999999998765321 1223346888999999998765 79999999999999999999
Q ss_pred CccCCCCchHHH
Q psy763 171 GFIGLGNMGSHM 182 (303)
Q Consensus 171 ~~~~~~~~~~~~ 182 (303)
..|+.+......
T Consensus 206 ~~p~~~~~~~~~ 217 (265)
T cd06652 206 KPPWAEFEAMAA 217 (265)
T ss_pred CCCCCccchHHH
Confidence 988765544433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=231.24 Aligned_cols=204 Identities=22% Similarity=0.249 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|++.++.++||||+++++++..++.+++|+||+++++|.+++... ..+++..+..++.|++.||+|||++|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 125 (263)
T cd05052 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125 (263)
T ss_pred HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 345778999999999999999999999999999999999999999987543 368999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||+++.++.+||+|||++......... .....+..|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 126 ~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~ 204 (263)
T cd05052 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMS 204 (263)
T ss_pred eecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998876533221 1223456799999987665 7999999999999999998 666
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+.. ..+....++ ..+...+.+..+++-+|+..+|+.||....
T Consensus 205 p~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 205 PYPGIDLSQVY-ELLEKGYRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred CCCCCCHHHHH-HHHHCCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 66555544443 333333322 123445566667777777766666665444
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=231.86 Aligned_cols=211 Identities=21% Similarity=0.320 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+..++.++||||+++++++...+..++|+||+.++++.+.+... ..+++..+..++.|++.|+.|||+.|+
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (256)
T cd08218 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 346788899999999999999999999999999999999999999877543 368899999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.++|+|||++........ .....+++.|+|||.+.+.. ++.++|+|||||++|++++|..++
T Consensus 123 ~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08218 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAF 201 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCc
Confidence 9999999999999999999999999877543221 22346788899999988765 789999999999999999999887
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
......+....++..... ........++.+++.+|+...|.
T Consensus 202 ~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~li~~~l~~~p~ 242 (256)
T cd08218 202 EAGNMKNLVLKIIRGSYP---------------------------------------PVSSHYSYDLRNLVSQLFKRNPR 242 (256)
T ss_pred cCCCHHHHHHHHhcCCCC---------------------------------------CCcccCCHHHHHHHHHHhhCChh
Confidence 665554444333221100 01112345667888888875555
Q ss_pred eeeccccccccccccceeeee
Q psy763 255 YIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.| ++..++++|+||
T Consensus 243 ~R-------p~~~~vl~~~~~ 256 (256)
T cd08218 243 DR-------PSVNSILEKNFI 256 (256)
T ss_pred hC-------cCHHHHhhCcCC
Confidence 44 999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=245.74 Aligned_cols=206 Identities=26% Similarity=0.345 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---------------------------
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--------------------------- 68 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------------------- 68 (303)
..+.+.+|+.+++.+. ||||+++++++...+.+|+||||+++|+|.+++...
T Consensus 83 ~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (400)
T cd05105 83 EKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADES 162 (400)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccc
Confidence 3456888999999996 999999999999999999999999999998876431
Q ss_pred ---------------------------------------------------------------------CCCCHHHHHHH
Q psy763 69 ---------------------------------------------------------------------HGLPWDLIKQI 79 (303)
Q Consensus 69 ---------------------------------------------------------------------~~l~~~~~~~~ 79 (303)
..+++..+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~ 242 (400)
T cd05105 163 TRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSF 242 (400)
T ss_pred ccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHH
Confidence 24778888999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccc
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVD 156 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~D 156 (303)
+.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|
T Consensus 243 ~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D 321 (400)
T cd05105 243 TYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSD 321 (400)
T ss_pred HHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhh
Confidence 99999999999999999999999999999999999999999987543221 12234667899999988665 799999
Q ss_pred hhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 157 VWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 157 vwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||||||++|||++ |..|+.+..........+..+.+++ .+...+.+..+++..|+..+|..||....
T Consensus 322 iwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 322 VWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred HHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 9999999999997 6677666555444444555444332 23445566677777777777766665433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=248.45 Aligned_cols=223 Identities=19% Similarity=0.241 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+..+.|.++|..-+.+.||++|..|+++..+|+||+|++||++-.++-+-+-|.+..++.++.++.-|+.+.|..|++
T Consensus 672 QvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFI 751 (1034)
T KOG0608|consen 672 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFI 751 (1034)
T ss_pred hhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccce
Confidence 34456778899999999999999999999999999999999999999888788999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeC---------CCCcc----------------------------------ccc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLIN---------PGENY----------------------------------TDY 133 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~---------~~~~~----------------------------------~~~ 133 (303)
||||||+|||||.+|++||+|||+|.-+. .++.. -..
T Consensus 752 HRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahsl 831 (1034)
T KOG0608|consen 752 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSL 831 (1034)
T ss_pred ecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhh
Confidence 99999999999999999999999985432 11100 034
Q ss_pred cCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhh
Q psy763 134 VATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQE 213 (303)
Q Consensus 134 ~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (303)
+||+.|+|||++...+ |+..+|.||.|||||||+.|..||...+..+.-.+++. |..
T Consensus 832 vgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n----------------------w~~ 888 (1034)
T KOG0608|consen 832 VGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN----------------------WRN 888 (1034)
T ss_pred cCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee----------------------hhh
Confidence 7899999999999766 89999999999999999999999987765443322211 333
Q ss_pred hhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 214 IFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 214 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.+ ....+-.-+.++++++.++.-.-.+.+-. --+.++..||||..++..
T Consensus 889 ~l--------------~~~~~~~ls~e~~~li~kLc~sad~RLGk-----ng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 889 FL--------------HIPYQGNLSKEALDLIQKLCCSADSRLGK-----NGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred cc--------------ccccccccCHHHHHHHHHHhcChhhhhcc-----cchhhhhcCccccccchH
Confidence 22 23344456778888888877654443311 122357888888876654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=237.23 Aligned_cols=238 Identities=31% Similarity=0.487 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+|+..++.++|||++++++++.+++..|+|+||++ +++..++.... .+++..+..++.|++.||.|||+.|++
T Consensus 43 ~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~ 121 (283)
T cd07835 43 STAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121 (283)
T ss_pred hHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 446678999999999999999999999999999999996 57887765544 689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++|+|++|..|+.
T Consensus 122 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred CCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998765422 122233568889999998766557899999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+........++....+++.....+..... .+ +..-......... ....+..+..+.+++.+|+...|..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~P~~ 270 (283)
T cd07835 202 GDSEIDQLFRIFRTLGTPDEDVWPGVTSL--PD--YKPTFPKWARQDL-------SKVVPNLDEDGLDLLSKMLVYDPAK 270 (283)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhhhhhhc--hh--hhhhcccccccch-------hhhcCCCCHHHHHHHHHHhcCChhh
Confidence 87777766666655443321110000000 00 0000000000000 0112334577889999999977776
Q ss_pred eeccccccccccccceeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~ 275 (303)
| ++..+++.|+||
T Consensus 271 R-------pt~~~il~~~~~ 283 (283)
T cd07835 271 R-------ISAKAALQHPYF 283 (283)
T ss_pred C-------cCHHHHhcCCCC
Confidence 6 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=232.50 Aligned_cols=204 Identities=17% Similarity=0.212 Sum_probs=163.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---------------CCCCHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---------------HGLPWDLIKQITWQ 82 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------~~l~~~~~~~~~~q 82 (303)
...+.+|+..++.++|+||+++++++......++|+||+++++|.+++... ..+++..+..++.|
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 130 (280)
T cd05092 51 RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999987643 24889999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhh
Q psy763 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWA 159 (303)
Q Consensus 83 i~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwS 159 (303)
++.|++|||+.|++|+||+|+||++++++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||
T Consensus 131 i~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s 209 (280)
T cd05092 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWS 209 (280)
T ss_pred HHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHH
Confidence 99999999999999999999999999999999999999876543221 12233467899999988766 799999999
Q ss_pred HHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 160 IEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 160 lG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||++|||++ |..|+......+....+.. +... ..+...+++..+++..|+..+|..||....
T Consensus 210 lG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 210 FGVVLWEIFTYGKQPWYQLSNTEAIECITQ-GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHHHHHHHHcCCCCCCccCCHHHHHHHHHc-CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999999998 5566555555554444333 2222 223456677888888888887777766554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=229.57 Aligned_cols=201 Identities=21% Similarity=0.290 Sum_probs=158.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---------CCCCHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---------HGLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------~~l~~~~~~~~~~qi~~~l 87 (303)
....+.+|++.++.++|+||+++++++..+..+++|+||+++++|.+++... ..+++..+..++.|++.||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 4567788999999999999999999999999999999999999999998775 7899999999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
.|||++|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+||++
T Consensus 119 ~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il 197 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLL 197 (262)
T ss_pred HHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHH
Confidence 99999999999999999999999999999999998765432 223345788899999988664 79999999999999
Q ss_pred HHhhcc-CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 165 HSYSQI-GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 165 ~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|||+++ ..|+.+....+... .+..+.+. ..+...++++.+.+..|+..++..||
T Consensus 198 ~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd00192 198 WEIFTLGATPYPGLSNEEVLE-YLRKGYRL---PKPEYCPDELYELMLSCWQLDPEDRP 252 (262)
T ss_pred HHHHhcCCCCCCCCCHHHHHH-HHHcCCCC---CCCccCChHHHHHHHHHccCCcccCc
Confidence 999995 55555554444444 33333222 12233344555544455444444443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=232.20 Aligned_cols=172 Identities=21% Similarity=0.249 Sum_probs=138.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-----CCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-----GLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+..++.++||||+++++.+......++||||+++|+|.+++.... ..++..+..++.|++.|++|||+
T Consensus 39 ~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (269)
T cd05042 39 QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118 (269)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 4567788999999999999999999999999999999999999999876532 24677888999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccC------CccCCCccchhhHHHH
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVG------DTLYGPAVDVWAIEWT 163 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~------~~~~~~~~DvwSlG~i 163 (303)
+|++||||||+||+++.++.+||+|||++........ .....++..|+|||++.. ...++.++||||+||+
T Consensus 119 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05042 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT 198 (269)
T ss_pred cCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHH
Confidence 9999999999999999999999999999865432211 122345677999998753 2236889999999999
Q ss_pred HHHhhccC-ccCCCCchHHHHHHHhhc
Q psy763 164 SHSYSQIG-FIGLGNMGSHMARNLLKN 189 (303)
Q Consensus 164 l~el~tg~-~~~~~~~~~~~~~~~~~~ 189 (303)
+|||++++ .|+......+........
T Consensus 199 l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 199 MWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred HHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 99999854 455454445555544443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=233.23 Aligned_cols=198 Identities=21% Similarity=0.271 Sum_probs=159.6
Q ss_pred CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC
Q psy763 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 111 (303)
Q Consensus 32 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~ 111 (303)
+||||+++++.+...+.+++||||+++++|..++.....+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK 146 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC
Confidence 79999999999999999999999999999999988777899999999999999999999999999999999999999988
Q ss_pred -cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcC
Q psy763 112 -VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNN 190 (303)
Q Consensus 112 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~ 190 (303)
.++|+|||++...... ....++..|+|||.+.+.. ++.++|+||+||++|||++|..|+.+..........+.
T Consensus 147 ~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~-- 220 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL-- 220 (267)
T ss_pred CeEEEecCccceecCCC---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH--
Confidence 9999999998765432 2346889999999998765 79999999999999999999988764432211000000
Q ss_pred CceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeecccccccc-cccc
Q psy763 191 GRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIR-GKNC 269 (303)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~-~~~~ 269 (303)
... . ......+..++.+.+++.+|+..+|..| ++ ..++
T Consensus 221 ---------------------~~~-~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R-------~~~~~~~ 259 (267)
T PHA03390 221 ---------------------KRQ-Q------------KKLPFIKNVSKNANDFVQSMLKYNINYR-------LTNYNEI 259 (267)
T ss_pred ---------------------Hhh-c------------ccCCcccccCHHHHHHHHHHhccChhhC-------CchHHHH
Confidence 000 0 0011112356778899999999777766 85 5999
Q ss_pred ceeeeee
Q psy763 270 KKTFYIP 276 (303)
Q Consensus 270 l~~~~~~ 276 (303)
++|||+.
T Consensus 260 l~h~~~~ 266 (267)
T PHA03390 260 IKHPFLK 266 (267)
T ss_pred hcCCccc
Confidence 9999985
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-33 Score=248.65 Aligned_cols=214 Identities=23% Similarity=0.331 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
+..++.|+.+++.+.||.||.+...|++.+.++.|||-+.|.-|.-++.. .+++++.....++.||+-||+|||.+||+
T Consensus 607 esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIv 686 (888)
T KOG4236|consen 607 ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIV 686 (888)
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhccee
Confidence 36678899999999999999999999999999999999987777766654 46899999999999999999999999999
Q ss_pred ecccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 97 HRDIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|+||||+|||+.+. -.+||||||+|+..+......+.+||+.|+|||++++.+ |..+-|+||+|+|+|--++|.+|
T Consensus 687 HCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 687 HCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred eccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEeccccc
Confidence 99999999999866 379999999999998888888899999999999999877 89999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
|........- ++. ..++- .+.|| ....++++|+++++|+-..
T Consensus 766 FNEdEdIndQ---IQN----------------------AaFMy--Pp~PW-----------~eis~~AidlIn~LLqVkm 807 (888)
T KOG4236|consen 766 FNEDEDINDQ---IQN----------------------AAFMY--PPNPW-----------SEISPEAIDLINNLLQVKM 807 (888)
T ss_pred CCCccchhHH---hhc----------------------ccccc--CCCch-----------hhcCHHHHHHHHHHHHHHH
Confidence 8765432221 111 00110 01222 2246789999999888666
Q ss_pred ceeeccccccccccccceeeeeec
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..+ .+...++.|||+-+
T Consensus 808 ~kR-------ysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 808 RKR-------YSVDKSLSHPWLQD 824 (888)
T ss_pred HHh-------cchHhhccchhhhc
Confidence 666 88889999998865
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=233.80 Aligned_cols=216 Identities=21% Similarity=0.263 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.++||||+++++++.+++..++|+||+++++|.+++.. +++++..+..++.|++.|+.|||+.|++|
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH 124 (277)
T cd06640 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIH 124 (277)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 45678889999999999999999999999999999999999999998864 47899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|||++|..|+.+
T Consensus 125 ~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999977654322 23346788899999988665 79999999999999999999988776
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+.. ...+ .........+.+++.+|+...|..|
T Consensus 204 ~~~~~~~~~~~~-~~~~--------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R 244 (277)
T cd06640 204 MHPMRVLFLIPK-NNPP--------------------------------------TLTGEFSKPFKEFIDACLNKDPSFR 244 (277)
T ss_pred cChHhHhhhhhc-CCCC--------------------------------------CCchhhhHHHHHHHHHHcccCcccC
Confidence 554433321100 0000 0000122445678888877544444
Q ss_pred eccccccccccccceeeeeecCCcc
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+++.+++.|+|+.....+
T Consensus 245 -------p~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 245 -------PTAKELLKHKFIVKNAKK 262 (277)
T ss_pred -------cCHHHHHhChHhhhcchh
Confidence 899999999998776665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=230.43 Aligned_cols=206 Identities=24% Similarity=0.307 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+..++.++|+||+++++++.++..+++|+||+++++|.+++... .+++..+..++.|++.|+.|||+.|++|+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~ 122 (274)
T cd06609 44 EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHR 122 (274)
T ss_pred HHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 45678899999999999999999999999999999999999999988765 89999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+.. ++.++|||||||++|+|++|..|+.+.
T Consensus 123 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred CCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999999999887643 2334457788999999998766 899999999999999999999888776
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhH
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLI 229 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (303)
........+.... .+ .......+.+..+.+-.|+..+|..|+..+-++.
T Consensus 202 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 202 HPMRVLFLIPKNN-PP--SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred chHHHHHHhhhcC-CC--CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 6555444333321 11 1111114556677777777777777776555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=238.10 Aligned_cols=239 Identities=31% Similarity=0.454 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCC----------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKK----------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~----------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
..+.+|+..++.++||||+++++++.+.. .+++|+||++++.+..+......+++..+..++.|++.||+
T Consensus 51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~ 130 (302)
T cd07864 51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130 (302)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 45567899999999999999999987654 78999999997554444444457999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
|||+.|++|+||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+...++.++||||+||++||
T Consensus 131 ~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~e 210 (302)
T cd07864 131 YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 210 (302)
T ss_pred HHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHH
Confidence 9999999999999999999999999999999988764332 11223457789999998765557899999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCC-hhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTS-TTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
|++|..++......+.+..+.+..+.+.....++..... .+........ .+.+ . ......++.+.+++
T Consensus 211 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~------~-~~~~~~~~~~~~li 279 (302)
T cd07864 211 LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLP----YFNTMKPKKQYRRRL------R-EEFSFIPTPALDLL 279 (302)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccc----cccccccccccccch------h-hhcCCCCHHHHHHH
Confidence 999998887777666666655543332211111000000 0000000000 0000 0 01112356788999
Q ss_pred hhhhccccceeeccccccccccccceeeee
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+|+...|..| +++.+++.|||+
T Consensus 280 ~~~l~~~P~~R-------p~~~~il~~~~~ 302 (302)
T cd07864 280 DHMLTLDPSKR-------CTAEEALNSPWL 302 (302)
T ss_pred HHHccCChhhC-------CCHHHHhcCCCC
Confidence 99998666666 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=238.03 Aligned_cols=239 Identities=34% Similarity=0.518 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+..++.++|+||+++++++..++..++|+||+++ ++..++ .....+++..+..++.|++.||.|||+.|+
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345677789999999999999999999999999999999986 555544 434689999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++|+|++|..++
T Consensus 120 ~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 199 (283)
T cd05118 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199 (283)
T ss_pred eecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999998776443 2233467888999999987645899999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCC--hhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTS--TTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
.+....+....+....+.+..... .......+......+. ...... ..+..+..+.+++.+|+..+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~~ 267 (283)
T cd05118 200 PGKSEIDQLFKIFRTLGTPDPEVW-----PKFTSLARNYKFSFPKKAGMPLPK-------LFPNASPQALDLLSQMLHYD 267 (283)
T ss_pred CCCCHHHHHHHHHHHcCCCchHhc-----ccchhhhhhhhhhhccccccCHHH-------hhhhhCHHHHHHHHHHhccC
Confidence 888777776666655443221100 0000000000000000 000000 01224677889999999876
Q ss_pred cceeeccccccccccccceeeee
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
|..| +++.+++.|||+
T Consensus 268 P~~R-------p~~~~ll~~~~~ 283 (283)
T cd05118 268 PHKR-------ITAEQALAHPYF 283 (283)
T ss_pred cccC-------cCHHHHhhCCCC
Confidence 6666 999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=237.18 Aligned_cols=204 Identities=16% Similarity=0.224 Sum_probs=160.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||++++|++..+ ..++|+||+.+|++.+++... ..++...+..++.|++.||+|||+.|+
T Consensus 52 ~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 130 (316)
T cd05108 52 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence 345577889999999999999999999865 467999999999999987653 468899999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
+||||||+||+++.++.+||+|||++......... ....++..|+|||.+.+.. ++.++|||||||++||+++ |.
T Consensus 131 iH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~ 209 (316)
T cd05108 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGS 209 (316)
T ss_pred eccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876543222 1223466799999998665 7999999999999999998 66
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+.+.. ......++..+.+++ .+..++.+...++..||..+|..||...-
T Consensus 210 ~p~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~ 260 (316)
T cd05108 210 KPYDGIP-ASEISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRE 260 (316)
T ss_pred CCCCCCC-HHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 6655544 344455565555443 23345556667777777777777665544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=235.69 Aligned_cols=238 Identities=24% Similarity=0.430 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+|+.+++.++||||+++++.+...+..++|+||+++ ++..++... ..+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (284)
T cd07836 43 STAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121 (284)
T ss_pred HHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4456789999999999999999999999999999999995 666655432 468999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||++++++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++|++++|..++
T Consensus 122 ~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~ 201 (284)
T cd07836 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201 (284)
T ss_pred eeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765432 22233467889999999877665789999999999999999999998
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....++.....+........ . .. ..+..-........... ..+...+.+.+++.+|+..+|.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~--~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~~p~ 270 (284)
T cd07836 202 PGTNNEDQLLKIFRIMGTPTESTWPGI-S-QL--PEYKPTFPRYPPQDLQQ-------LFPHADPLGIDLLHRLLQLNPE 270 (284)
T ss_pred CCCCcHHHHHHHHHHhCCCChhhHHHH-h-cC--chhcccccCCChHHHHH-------HhhhcCcHHHHHHHHHhcCCcc
Confidence 888777666665554332211000000 0 00 00000000000011111 1122467788999999997666
Q ss_pred eeeccccccccccccceeeee
Q psy763 255 YIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.| ++..++++||||
T Consensus 271 ~R-------~~~~~~l~~~~f 284 (284)
T cd07836 271 LR-------ISAHDALQHPWF 284 (284)
T ss_pred cC-------CCHHHHhcCCCC
Confidence 66 999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=229.80 Aligned_cols=204 Identities=19% Similarity=0.262 Sum_probs=158.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..++.++||||+++++++......++||||+.+|+|.+++... ..+++..++.++.|++.||+|||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 355788999999999999999999999888999999999999999987653 4789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
|+||+|+||+++.++.+||+|||.+......... ....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..|
T Consensus 123 H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p 201 (256)
T cd05113 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMP 201 (256)
T ss_pred ccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999998765433221 1223456799999998655 7999999999999999998 6666
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+......+....+.. +.+.. .+...+.+..+++..||..+|..||....
T Consensus 202 ~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 250 (256)
T cd05113 202 YERFNNSETVEKVSQ-GLRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQ 250 (256)
T ss_pred cCcCCHHHHHHHHhc-CCCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 555554444444433 33221 12233445566666666666665554433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=233.18 Aligned_cols=200 Identities=17% Similarity=0.234 Sum_probs=150.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------CCCCHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~l~~~~~~~~~~qi~~~l 87 (303)
...+.+|+.+++.++||||+++++++..++..++|+||+++++|.+++... ..++...+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 53 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH
Confidence 345778899999999999999999999999999999999999999987542 2357788999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
.|||+.|++|+||||+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+|||||++
T Consensus 133 ~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l 211 (277)
T cd05062 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVL 211 (277)
T ss_pred HHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHH
Confidence 9999999999999999999999999999999998765432211 1234567899999988655 79999999999999
Q ss_pred HHhhcc-CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 165 HSYSQI-GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 165 ~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|||+++ ..|+.+....+...... .+.... .+...+....+.+.+|+..+|..||
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05062 212 WEIATLAEQPYQGMSNEQVLRFVM-EGGLLD---KPDNCPDMLFELMRMCWQYNPKMRP 266 (277)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHH-cCCcCC---CCCCCCHHHHHHHHHHcCCChhhCc
Confidence 999995 55555554444443333 222211 1233344444444555554444444
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=229.55 Aligned_cols=216 Identities=26% Similarity=0.315 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++|+||+++++++...+.+++|+||+++++|.+++..+..+++..+..++.|++.|+.|||+.|++
T Consensus 42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~ 121 (264)
T cd06626 42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121 (264)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45667889999999999999999999999999999999999999999998777799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc-----ccccCCCcccCcccccCCc--cCCCccchhhHHHHHHHhhc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY-----TDYVATRWYRAPELLVGDT--LYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~l~~~~--~~~~~~DvwSlG~il~el~t 169 (303)
|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. .++.++|||||||++|++++
T Consensus 122 H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred cCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence 9999999999999999999999998876533221 1246788999999987543 26889999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..|+.+.............+..+. .+......+.+.+++.+|+
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~l 245 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPP------------------------------------IPDSLQLSPEGKDFLDRCL 245 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCC------------------------------------CCcccccCHHHHHHHHHHc
Confidence 9988765432222211111110000 0001112556678898888
Q ss_pred ccccceeeccccccccccccceeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
...|..| ++..+++.|||+
T Consensus 246 ~~~p~~R-------~~~~~i~~~~~~ 264 (264)
T cd06626 246 ESDPKKR-------PTASELLQHPFV 264 (264)
T ss_pred cCCcccC-------CCHHHHhcCCCC
Confidence 8666555 999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=230.14 Aligned_cols=211 Identities=24% Similarity=0.307 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++.+..++..++|||++++++|.+++.....+++..+..++.|++.|+.+||+.|++
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~ 115 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 45567888999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||.+...... .......++..|+|||...+.. .+.++|+||||+++|++++|..|+.
T Consensus 116 H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred ecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999998876543 2234456788999999988665 6899999999999999999988886
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
.....+....+.... .......+....+++.+|+..++..
T Consensus 195 ~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~~~i~~~l~~~p~~ 234 (250)
T cd05123 195 AEDRKEIYEKILKDP----------------------------------------LRFPEFLSPEARDLISGLLQKDPTK 234 (250)
T ss_pred CCCHHHHHHHHhcCC----------------------------------------CCCCCCCCHHHHHHHHHHhcCCHhh
Confidence 655433333222200 0111112456678899998866666
Q ss_pred eeccccccccc---cccceeeee
Q psy763 256 IQSEKQDSIRG---KNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~---~~~l~~~~~ 275 (303)
| +++ .+++.||||
T Consensus 235 R-------~~~~~~~~l~~~~~f 250 (250)
T cd05123 235 R-------LGSGGAEEIKAHPFF 250 (250)
T ss_pred C-------CCcccHHHHHhCCCC
Confidence 6 888 899999986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=228.13 Aligned_cols=205 Identities=21% Similarity=0.302 Sum_probs=154.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++...+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++
T Consensus 37 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 116 (252)
T cd05084 37 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116 (252)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 456778999999999999999999999999999999999999999987653 4689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccc---cccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYT---DYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|+||+|+||+++.++.+||+|||++.......... ....+..|+|||.+.+.. ++.++|+||+||++|||++++.+
T Consensus 117 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~ 195 (252)
T cd05084 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAV 195 (252)
T ss_pred ccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987644321111 112345699999987665 79999999999999999985544
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++.....+.....+....+.+ .+...+.+..+++-+|+..+|..||....
T Consensus 196 p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 245 (252)
T cd05084 196 PYANLSNQQTREAIEQGVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFST 245 (252)
T ss_pred CccccCHHHHHHHHHcCCCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 444333333344444333321 22333445555555555555555554433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=236.90 Aligned_cols=237 Identities=28% Similarity=0.399 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhCC-CCCcceeEEEEEeCCE-----EEEEEecCCCCcHHHHHcC-----CCCCCHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLK-HPNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELENH-----PHGLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 19 ~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~~lv~e~~~~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~~l 87 (303)
..+.+|+.+++.+. ||||+++++++..... .|+|+||+++ ++..++.. ...+++..++.++.|++.||
T Consensus 45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L 123 (295)
T cd07837 45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123 (295)
T ss_pred hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Confidence 45667889999995 6999999999987665 8999999996 56665432 23589999999999999999
Q ss_pred HHHHHCCceecccCCCcEEEec-CCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 88 SYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
.|||+.|++|+||+|+||+++. ++.++|+|||++...... .......+++.|+|||.+.+...++.++|+|||||++|
T Consensus 124 ~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 203 (295)
T cd07837 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFA 203 (295)
T ss_pred HHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHH
Confidence 9999999999999999999998 889999999998765422 22233456888999999876555799999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
+|++|..++.+....+....+...-..+.....+. .... ..+...+...+.. .....+...+.+.+++
T Consensus 204 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i 271 (295)
T cd07837 204 EMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG-----VSKL--RDWHEFPQWKPQD-----LSRAVPDLSPEGLDLL 271 (295)
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc-----hhhc--cchhhcCcccchh-----HHHhccccCHHHHHHH
Confidence 99999999888877777666655433221110000 0000 0000001000000 0011223567788999
Q ss_pred hhhhccccceeeccccccccccccceeeee
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+|+..+|..| +++.+++.|||+
T Consensus 272 ~~~l~~~P~~R-------~~~~eil~~~~~ 294 (295)
T cd07837 272 QKMLRYDPAKR-------ISAKAALTHPYF 294 (295)
T ss_pred HHHccCChhhc-------CCHHHHhcCCCc
Confidence 99998666665 999999999997
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=244.51 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+.+|+.+++.++|+||+++++++... ...|+|+||+. +++..++...+.+++..+..++.|++.||.|||+.
T Consensus 49 ~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 127 (337)
T cd07858 49 KRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127 (337)
T ss_pred HHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456789999999999999999988654 35899999997 67777777777899999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|++|+||+|+||+++.++.+||+|||++...... .......++..|+|||.+.+...++.++|+|||||++|+|++|..
T Consensus 128 ~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 128 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999999876433 223345678899999998764448999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
++.+.........+....+.+..... .. .....+..+.......+...+ ....+...+.+.+++.+|+...
T Consensus 208 pf~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~ 278 (337)
T cd07858 208 LFPGKDYVHQLKLITELLGSPSEEDL-GF----IRNEKARRYIRSLPYTPRQSF----ARLFPHANPLAIDLLEKMLVFD 278 (337)
T ss_pred CCCCCChHHHHHHHHHHhCCCChHHh-hh----cCchhhhHHHHhcCcccccCH----HHHcccCCHHHHHHHHHHhcCC
Confidence 88877655554444443322210000 00 000001111110000000000 0011235677899999999977
Q ss_pred cceeeccccccccccccceeeeeec
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
|..| +++.+++.|||+..
T Consensus 279 P~~R-------ps~~ell~h~~~~~ 296 (337)
T cd07858 279 PSKR-------ITVEEALAHPYLAS 296 (337)
T ss_pred hhhc-------cCHHHHHcCcchhh
Confidence 7666 99999999999966
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=234.85 Aligned_cols=239 Identities=19% Similarity=0.240 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++||||+++++++... ..++++||+++|++.+++... ..+++..+..++.|++.||.|||++|++|
T Consensus 54 ~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 132 (303)
T cd05110 54 VEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132 (303)
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeec
Confidence 3577889999999999999999998754 467999999999999987654 46899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|||||||++||+++ |+.|
T Consensus 133 ~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred cccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987543222 12234567899999988665 7999999999999999997 6666
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+.+.. .......+..+.+++ .+...+....+.+..||..+|..||.... ++..+..+.....
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~--------------l~~~l~~~~~~~~ 273 (303)
T cd05110 212 YDGIP-TREIPDLLEKGERLP---QPPICTIDVYMVMVKCWMIDADSRPKFKE--------------LAAEFSRMARDPQ 273 (303)
T ss_pred CCCCC-HHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHH--------------HHHHHHHHHhchh
Confidence 55544 344455555554432 12233445555566666665555554333 3344555555666
Q ss_pred ceeeccccccccccccceeeeeec
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.++..++..+..+.....++||..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~ 297 (303)
T cd05110 274 RYLVIQGDDRMKLPSPNDSKFFQN 297 (303)
T ss_pred hheeeccCCcCCCCCCchhhHHhc
Confidence 777788888888888888888865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=231.75 Aligned_cols=207 Identities=22% Similarity=0.349 Sum_probs=161.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+.+++.++||||+++++++...+..++|+||+++++|..++. ....+++..+..++.|++.||.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08228 45 ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124 (267)
T ss_pred HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 45567789999999999999999999999999999999999999988764 23458999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+|++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||+|+++|||++|.
T Consensus 125 ~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~ 203 (267)
T cd08228 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999887653221 22346888999999998765 789999999999999999999
Q ss_pred ccCCCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+.+... .......+.....++ ......+....+++-+||..+|+.||....
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 257 (267)
T cd08228 204 SPFYGDKMNLFSLCQKIEQCDYPP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGY 257 (267)
T ss_pred CCCccccccHHHHHHHHhcCCCCC--CChhhcCHHHHHHHHHHCCCCcccCcCHHH
Confidence 88866532 222333333333221 111233445666666777777776666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=231.48 Aligned_cols=204 Identities=19% Similarity=0.263 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-----------------CCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-----------------HGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----------------~~l~~~~~~~~~ 80 (303)
...+.+|+.+++.++||||+++++++..+...|+||||+++++|.+++... ..+++..+..++
T Consensus 51 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 130 (283)
T cd05090 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHH
Confidence 356778999999999999999999999999999999999999999987421 247888999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|+
T Consensus 131 ~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 209 (283)
T cd05090 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDI 209 (283)
T ss_pred HHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhh
Confidence 9999999999999999999999999999999999999999977543221 22334567799999987655 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||||++|||++ |..|+.+........ .+.....++ .+...+++..+.+-.|+..+|..||...-
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 275 (283)
T cd05090 210 WSFGVVLWEIFSFGLQPYYGFSNQEVIE-MVRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKD 275 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 999999999998 666666655444433 333333221 22344555556666666666666654433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=230.56 Aligned_cols=208 Identities=23% Similarity=0.331 Sum_probs=158.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
.....+.+|+.+++.++||||+++++++..++..++++||+++++|.+++.. ...+++..+..++.|++.|+.|||
T Consensus 44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08229 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456678899999999999999999999999999999999999999987652 346899999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|
T Consensus 124 ~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999877543322 23356888999999997665 78999999999999999999
Q ss_pred CccCCCCchH-HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 171 GFIGLGNMGS-HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 171 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..|+.+.... ......+.....+ ...+...+.+..+.+-+|+..+|..||....
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 257 (267)
T cd08229 203 QSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDITY 257 (267)
T ss_pred CCCcccccchHHHHhhhhhcCCCC--CCCcccccHHHHHHHHHhcCCCcccCCCHHH
Confidence 9888765432 1221222111111 1111223344455555555555555555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=233.77 Aligned_cols=201 Identities=23% Similarity=0.299 Sum_probs=155.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.+.+.+|+.+++++ +||||+++++++...+..++|+||+.+|+|..++.... .+++..+..++.|++.||.|||++|
T Consensus 82 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 161 (302)
T cd05055 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161 (302)
T ss_pred HHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678899999999 79999999999999999999999999999999876432 4899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
++|+||+|+||+++.++.++++|||++........ .....++..|+|||.+.+.. ++.++||||+||++|||++ |
T Consensus 162 ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g 240 (302)
T cd05055 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLG 240 (302)
T ss_pred eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876543221 11234567899999998765 7999999999999999998 7
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
..|+.+..........+..+.+.. .+...+.+..+++-.|+..+|..||
T Consensus 241 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp 289 (302)
T cd05055 241 SNPYPGMPVDSKFYKLIKEGYRMA---QPEHAPAEIYDIMKTCWDADPLKRP 289 (302)
T ss_pred CCCcCCCCchHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCchhCc
Confidence 777666655555555544433221 1122333444444455444444443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=227.85 Aligned_cols=203 Identities=22% Similarity=0.258 Sum_probs=159.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.....+.+|+..+++++||||+++++++.. ...++|+||+++++|...+... ..+++..++.++.|++.||.|||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 345677889999999999999999999988 8899999999999999987654 3689999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|++|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 117 ~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t 195 (257)
T cd05040 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFT 195 (257)
T ss_pred CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999887653221 11234677899999987665 7999999999999999998
Q ss_pred -cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 170 -IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 170 -g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|..|+.+....+....+........ .+...+....+++..|+..+|..||.
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps 247 (257)
T cd05040 196 YGEEPWAGLSGSQILKKIDKEGERLE---RPEACPQDIYNVMLQCWAHNPADRPT 247 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCcCC---CCccCCHHHHHHHHHHCCCCcccCCC
Confidence 7777766666666655544332221 22333444445555555555554443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-31 Score=230.09 Aligned_cols=199 Identities=19% Similarity=0.165 Sum_probs=150.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+++.+++.++||||+++++++..+...++||||+++|+|..++.. .+.+++..+..++.|++.||.|||++|+
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 138 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNL 138 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 345677888999999999999999999999999999999999999998764 4578999999999999999999999999
Q ss_pred eecccCCCcEEEecCC-------cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 96 IHRDIKPENILLTANG-------VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 96 vH~dlk~~nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
+||||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+...++.++|||||||++||++
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999997643 4899999987653321 22356788999999876555899999999999999995
Q ss_pred -ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 169 -QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 169 -tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
+|..|+.+....+. ..........+ .....+..+++-.||..+|..||.+
T Consensus 216 ~~g~~p~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~ 266 (274)
T cd05076 216 FDGEVPLKERTPSEK-ERFYEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSF 266 (274)
T ss_pred hCCCCCccccChHHH-HHHHHhccCCC-----CCCChHHHHHHHHHcccChhhCcCH
Confidence 56666655544333 22333222211 1122344455555555555555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=233.36 Aligned_cols=204 Identities=23% Similarity=0.237 Sum_probs=157.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
.+.+.+|+..++++ +||||+++++++...+.+++|+||+++++|.+++... ..+++..+..++
T Consensus 46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred HHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence 34577889999888 7999999999999999999999999999999987543 248889999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
.|++.||+|||+.|++|+||||+||+++.++.+||+|||++..............+..|+|||.+.+.. ++.++|||||
T Consensus 126 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSl 204 (297)
T cd05089 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSF 204 (297)
T ss_pred HHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHH
Confidence 999999999999999999999999999999999999999986432211112223355799999987665 7999999999
Q ss_pred HHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 161 EWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 161 G~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||++|||++ |..|+.+....+....+.. +.... .+...+.+..+++..|+..+|..||....
T Consensus 205 G~il~el~t~g~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 205 GVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999997 7777777666665544332 22211 22334555666666666666666655444
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=240.21 Aligned_cols=237 Identities=29% Similarity=0.386 Sum_probs=172.0
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeC--------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRK--------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
...+|+..++.++||||+++++++.+. ..+++|+||+.++.+..+......+++..+..++.|+++||.|||
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH 132 (311)
T cd07866 53 TALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH 132 (311)
T ss_pred hHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 446788999999999999999987543 346999999986554445444568999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc------------ccccCCCcccCcccccCCccCCCccchhh
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY------------TDYVATRWYRAPELLVGDTLYGPAVDVWA 159 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~y~aPE~l~~~~~~~~~~DvwS 159 (303)
+.|++|+||+|+||+++.++.++|+|||++......... ....+++.|+|||.+.+...++.++||||
T Consensus 133 ~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 212 (311)
T cd07866 133 ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG 212 (311)
T ss_pred hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHH
Confidence 999999999999999999999999999998765422111 12345788999999876655799999999
Q ss_pred HHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCC--CCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCC
Q psy763 160 IEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSD--SLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRN 237 (303)
Q Consensus 160 lG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 237 (303)
+||++|||++|..++.+.........+....+.+.....+. ..+.. .. +. ... ..+..+.. .....
T Consensus 213 lG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~-~~~-~~~~~~~~-------~~~~~ 280 (311)
T cd07866 213 IGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGC-EG--VH-SFT-NYPRTLEE-------RFGKL 280 (311)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccc-cc--cc-cCC-CCCccHHH-------HcccC
Confidence 99999999999999888877776666665444332111110 00000 00 00 000 00011111 01123
Q ss_pred chhhHHhhhhhhccccceeeccccccccccccceeeee
Q psy763 238 SHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 238 ~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+.+.+++.+|+..++..| +++.+++.|+||
T Consensus 281 ~~~~~~~i~~~l~~~p~~R-------~t~~ell~~~~f 311 (311)
T cd07866 281 GPEGLDLLSKLLSLDPYKR-------LTASDALEHPYF 311 (311)
T ss_pred ChhHHHHHHHHcccCcccC-------cCHHHHhcCCCC
Confidence 3678899999998766665 999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=237.12 Aligned_cols=203 Identities=26% Similarity=0.273 Sum_probs=154.4
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQI 79 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~ 79 (303)
....+.+|+..++++ +||||+++++++..++.+++|+||+++++|..++... ..+++..++.+
T Consensus 50 ~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (303)
T cd05088 50 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129 (303)
T ss_pred HHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHH
Confidence 345677789999999 8999999999999999999999999999999987543 25789999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhh
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwS 159 (303)
+.|++.|++|||++|++||||||+||+++.++.+||+|||++..............+..|+|||.+.+.. ++.++||||
T Consensus 130 ~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s 208 (303)
T cd05088 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWS 208 (303)
T ss_pred HHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-Ccccccchh
Confidence 9999999999999999999999999999999999999999986432211112223456799999887655 799999999
Q ss_pred HHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 160 IEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 160 lG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
|||++|||+| |..|+.+....+.... +..+.+.. .+...+++..+++..|+..+|..||..
T Consensus 209 lG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~ 270 (303)
T cd05088 209 YGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSF 270 (303)
T ss_pred hhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999999998 7777766655544433 22222211 122334455555666666555555443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-31 Score=230.25 Aligned_cols=202 Identities=21% Similarity=0.293 Sum_probs=157.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+..++..++.++||||+++++++. +...++|+||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.|++|
T Consensus 54 ~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 132 (279)
T cd05111 54 QEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH 132 (279)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 45666777889999999999999876 4557899999999999998864 457899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
+||||+||+++.++.+||+|||++....+... .....++..|+|||.+.+.. ++.++|||||||++||+++ |..|
T Consensus 133 ~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p 211 (279)
T cd05111 133 RNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEP 211 (279)
T ss_pred cccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999987643321 12345677899999997655 8999999999999999998 6666
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+... .....++..+.+++ .+..++.+....+-.||..+|..||....
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 212 YAGMRP-HEVPDLLEKGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred CCCCCH-HHHHHHHHCCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 655544 33455555554433 22334455666666777777766665444
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-31 Score=227.30 Aligned_cols=202 Identities=21% Similarity=0.291 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++. .+..++|+||+++|+|.+++.....+++..+..++.|++.|++|||+.|++
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~ 117 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 4456788999999999999999999876 456899999999999999998777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
|+||+|+||+++.++.+||+|||++......... ....++..|+|||.+.+.. ++.++|||||||++|++++ |.
T Consensus 118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999998876533321 1122346799999987655 8999999999999999998 55
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
.|+..... ......+..+.+. ..+...+....+++-+|+..+|..||..
T Consensus 197 ~p~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~ 245 (257)
T cd05060 197 KPYGEMKG-AEVIAMLESGERL---PRPEECPQEIYSIMLSCWKYRPEDRPTF 245 (257)
T ss_pred CCcccCCH-HHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 55544444 3334444443332 2333445555666666666655555543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=227.75 Aligned_cols=203 Identities=20% Similarity=0.265 Sum_probs=157.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++||||+++++++...+..++|+||+++++|.+++.. ...+++..+..++.|++.|++|||+.|++|
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 123 (256)
T cd05059 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4567789999999999999999999999999999999999999998754 347899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
+||+|+||+++.++.+||+|||++......... ....++..|+|||.+.+.. ++.++|+|||||++||+++ |..|+
T Consensus 124 ~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~ 202 (256)
T cd05059 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPY 202 (256)
T ss_pred ccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCC
Confidence 999999999999999999999998765432211 1122345799999998765 7999999999999999998 55665
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.+....+.... +..+.+.. .+...+.+..+++..|+..+|..||....
T Consensus 203 ~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 203 ERFSNSEVVES-VSAGYRLY---RPKLAPTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred CCCCHHHHHHH-HHcCCcCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 55555444433 33332221 22334556666666666666665554433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=230.89 Aligned_cols=214 Identities=25% Similarity=0.355 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~ 86 (303)
...+.+|+.+++.+ +|+||+++++++.... .+++|+||+++++|.+++.. +..+++..+..++.|++.|
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~a 125 (275)
T cd06608 46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125 (275)
T ss_pred HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence 45678899999998 6999999999997644 48999999999999987653 4579999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCC----ccCCCccchhhHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGD----TLYGPAVDVWAIE 161 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~----~~~~~~~DvwSlG 161 (303)
|.|||+.|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+. ..++.++||||+|
T Consensus 126 l~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 205 (275)
T cd06608 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205 (275)
T ss_pred HHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhH
Confidence 99999999999999999999999999999999998765432 222345688899999987532 3367899999999
Q ss_pred HHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhh
Q psy763 162 WTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGV 241 (303)
Q Consensus 162 ~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 241 (303)
|++|+|++|..|+.+.........+...... . .......+..+
T Consensus 206 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~-----------------------------~~~~~~~~~~~ 248 (275)
T cd06608 206 ITAIELADGKPPLCDMHPMRALFKIPRNPPP--------T-----------------------------LKSPENWSKKF 248 (275)
T ss_pred HHHHHHHhCCCCccccchHHHHHHhhccCCC--------C-----------------------------CCchhhcCHHH
Confidence 9999999999888765444433322211000 0 00001123466
Q ss_pred HHhhhhhhccccceeeccccccccccccceeeee
Q psy763 242 VKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 242 ~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+++.+|+..+|..| +++.+++.|||+
T Consensus 249 ~~li~~~l~~dp~~R-------pt~~~ll~~~~~ 275 (275)
T cd06608 249 NDFISECLIKNYEQR-------PFMEELLEHPFI 275 (275)
T ss_pred HHHHHHHhhcChhhC-------cCHHHHhcCCCC
Confidence 788999988666555 999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-31 Score=230.11 Aligned_cols=204 Identities=17% Similarity=0.229 Sum_probs=156.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..++.++||||+++++++... ..++++||+++|++.+++.. .+.+++..+..++.|++.||+|||++|++
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ii 131 (279)
T cd05109 53 NKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45577888899999999999999999754 47899999999999998865 35689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|+||||+||+++.++.+||+|||++......... ....++..|+|||.+.+.. ++.++|||||||++||+++.+.+
T Consensus 132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~ 210 (279)
T cd05109 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876533221 1223467799999997665 79999999999999999984444
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++...........+..+.+++. +...+.+..+++..|+..+|..||....
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 260 (279)
T cd05109 211 PYDGIPAREIPDLLEKGERLPQ---PPICTIDVYMIMVKCWMIDSECRPRFRE 260 (279)
T ss_pred CCCCCCHHHHHHHHHCCCcCCC---CccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 4444444444555555444321 2334455566666666666665554444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=235.55 Aligned_cols=238 Identities=29% Similarity=0.452 Sum_probs=178.7
Q ss_pred HHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 20 TEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 20 ~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+|+..++.++ |+||+++++++..++..++||||+ +|++...+... ..+++..+..++.|++.||.|||++|++
T Consensus 43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~ 121 (283)
T cd07830 43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121 (283)
T ss_pred HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3456788889999 999999999999999999999999 67777766554 3789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||++.............++..|+|||.+.+...++.++|+||||+++|||++|..++.+
T Consensus 122 H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 122 HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred cCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 99999999999999999999999998766544445567888999999987655579999999999999999999988888
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+....+.+......... .....+.............. ..+...+.+.+++.+|+...|..|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~R 271 (283)
T cd07830 202 SSEIDQLYKICSVLGTPTKQDWPEGY---KLASKLGFRFPQFAPTSLHQ-------LIPNASPEAIDLIKDMLRWDPKKR 271 (283)
T ss_pred CChHHHHHHHHHhcCCCChhhhhhHh---hhhccccccccccccccHHH-------HcccCCHHHHHHHHHhcccCcccC
Confidence 87777776666654443211111000 00000000011011111111 111236778899999998555555
Q ss_pred eccccccccccccceeeee
Q psy763 257 QSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~ 275 (303)
+++.+++.|||+
T Consensus 272 -------pt~~ei~~~~~~ 283 (283)
T cd07830 272 -------PTASQALQHPYF 283 (283)
T ss_pred -------CCHHHHhhCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=229.08 Aligned_cols=154 Identities=20% Similarity=0.221 Sum_probs=134.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..++.++||||+++++++.. ...++|+||+++|+|..++.... .++...+..++.|++.||+|||++|++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 5677889999999999999999999988 77899999999999999887655 789999999999999999999999999
Q ss_pred ecccCCCcEEEecCC-------cEEEccccceeeeCCCCccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhh
Q psy763 97 HRDIKPENILLTANG-------VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 97 H~dlk~~nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~ 168 (303)
|+||||+||+++.++ .++|+|||++..... .....++..|+|||.+.+. ..++.++|+||+||++||++
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999999887 799999999877543 2234567789999998865 34799999999999999999
Q ss_pred ccCccCC
Q psy763 169 QIGFIGL 175 (303)
Q Consensus 169 tg~~~~~ 175 (303)
+|+.+++
T Consensus 201 ~~~~~p~ 207 (259)
T cd05037 201 SNGEEPL 207 (259)
T ss_pred hCCCCCc
Confidence 8654444
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=229.86 Aligned_cols=202 Identities=26% Similarity=0.276 Sum_probs=153.2
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC----------------CCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH----------------GLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~l~~~~~~~~~ 80 (303)
...+.+|+..++.+ +||||+++++++...+.+++||||+++|+|.+++.... .+++..+..++
T Consensus 39 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 118 (270)
T cd05047 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118 (270)
T ss_pred HHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHH
Confidence 44677889999999 79999999999999999999999999999999875432 47889999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
.|++.|++|||+.|++|+||+|+||+++.++.+||+|||++..............+..|+|||.+.+.. ++.++|+|||
T Consensus 119 ~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~sl 197 (270)
T cd05047 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSY 197 (270)
T ss_pred HHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCC-CCchhhHHHH
Confidence 999999999999999999999999999999999999999985432111112223456799999987655 7999999999
Q ss_pred HHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 161 EWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 161 G~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
||++|||++ |..|+.+....+....+ ..+.+.. .+...+.+..+++.+|+..+|..||..
T Consensus 198 G~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~ 258 (270)
T cd05047 198 GVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSF 258 (270)
T ss_pred HHHHHHHHcCCCCCccccCHHHHHHHH-hCCCCCC---CCCcCCHHHHHHHHHHcccChhhCCCH
Confidence 999999997 77777665555444433 2222221 122334455555566665555554443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=234.39 Aligned_cols=159 Identities=24% Similarity=0.368 Sum_probs=140.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.++||||+++++++..++..++|+||++++++..++.. +.+++..+..++.|++.|+.|||++|++|
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH 124 (277)
T cd06642 46 IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIH 124 (277)
T ss_pred HHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 45678899999999999999999999999999999999999999998764 57899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+|||||++|||++|..|+.+
T Consensus 125 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999987655332 223346788999999998765 79999999999999999999887664
Q ss_pred Cc
Q psy763 177 NM 178 (303)
Q Consensus 177 ~~ 178 (303)
..
T Consensus 204 ~~ 205 (277)
T cd06642 204 LH 205 (277)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-33 Score=249.09 Aligned_cols=213 Identities=27% Similarity=0.376 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
+=....+|++++++++|||++.+-|+|..+...+||||||-|+--+-+-...+++.+..+..++.+.+.||+|||+.+.+
T Consensus 69 KWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~I 148 (948)
T KOG0577|consen 69 KWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRI 148 (948)
T ss_pred HHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHH
Confidence 34557889999999999999999999999999999999998543333334556899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCccccc--CCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV--GDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~--~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+.|||+++.|.|||+|||.|....+. .+++|||.|||||++. ..+.|+-++||||||++-.|+.-..+|.
T Consensus 149 HRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 149 HRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred hhhccccceEecCCCeeeeccccchhhcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 9999999999999999999999999886543 5689999999999987 4556999999999999999999888888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
+.-+....+.-+.+...+ .+.+. .|.. .+..|++.||...|.
T Consensus 226 FnMNAMSALYHIAQNesP--------tLqs~----------------eWS~--------------~F~~Fvd~CLqKipq 267 (948)
T KOG0577|consen 226 FNMNAMSALYHIAQNESP--------TLQSN----------------EWSD--------------YFRNFVDSCLQKIPQ 267 (948)
T ss_pred cCchHHHHHHHHHhcCCC--------CCCCc----------------hhHH--------------HHHHHHHHHHhhCcc
Confidence 877777666655443221 11111 1111 234778888875554
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+ ++..+|++|+|+-.
T Consensus 268 eR-------ptse~ll~H~fv~R 283 (948)
T KOG0577|consen 268 ER-------PTSEELLKHRFVLR 283 (948)
T ss_pred cC-------CcHHHHhhcchhcc
Confidence 44 99999999998754
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=232.01 Aligned_cols=199 Identities=27% Similarity=0.368 Sum_probs=152.1
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----------------CCCCCHHHHHHHHH
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----------------PHGLPWDLIKQITW 81 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~~l~~~~~~~~~~ 81 (303)
..+.+|+..++.+ +|+||+++++++..++.+++||||+++|+|..++.. ...+++..+..++.
T Consensus 60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 139 (293)
T cd05053 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 4477888999999 799999999999999999999999999999998743 34688999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchh
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVW 158 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~Dvw 158 (303)
|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|||
T Consensus 140 qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~ 218 (293)
T cd05053 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVW 218 (293)
T ss_pred HHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCccccee
Confidence 9999999999999999999999999999999999999999875432211 1223456799999987655 79999999
Q ss_pred hHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 159 AIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 159 SlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
||||++||+++ |..|+.+....+. ...+..+.++. .+...+.+..+++..|+..+|..||
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 279 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEEL-FKLLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRP 279 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHH-HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCc
Confidence 99999999998 5555555444443 44444433322 2223344445555555554444444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=246.38 Aligned_cols=198 Identities=21% Similarity=0.233 Sum_probs=163.7
Q ss_pred HHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcE
Q psy763 26 KEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 105 (303)
Q Consensus 26 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~ni 105 (303)
..++.-+||||+++++++.++.+.|+|||.+.|+.+.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+||
T Consensus 368 ~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NI 446 (612)
T KOG0603|consen 368 ISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNI 446 (612)
T ss_pred hhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhhe
Confidence 34555689999999999999999999999999988777666554444 78888999999999999999999999999999
Q ss_pred EE-ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHH
Q psy763 106 LL-TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMAR 184 (303)
Q Consensus 106 l~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~ 184 (303)
|+ ++.++++|+|||.++..... ..+.+-|..|.|||++...+ |+.++|+||||++||+|++|..|+........+.
T Consensus 447 L~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~ 523 (612)
T KOG0603|consen 447 LLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH 523 (612)
T ss_pred eecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHH
Confidence 99 58899999999999886654 33456788899999999655 9999999999999999999999987665553332
Q ss_pred HHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccc
Q psy763 185 NLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSI 264 (303)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~ 264 (303)
..+.. + ......+..|-|++.+||+..|..| .
T Consensus 524 ~~i~~---~--------------------------------------~~s~~vS~~AKdLl~~LL~~dP~~R-------l 555 (612)
T KOG0603|consen 524 TRIQM---P--------------------------------------KFSECVSDEAKDLLQQLLQVDPALR-------L 555 (612)
T ss_pred HhhcC---C--------------------------------------ccccccCHHHHHHHHHhccCChhhC-------c
Confidence 21111 0 0113467889999999999888877 9
Q ss_pred cccccceeeee
Q psy763 265 RGKNCKKTFYI 275 (303)
Q Consensus 265 ~~~~~l~~~~~ 275 (303)
++.+++.|+|+
T Consensus 556 ~~~~i~~h~w~ 566 (612)
T KOG0603|consen 556 GADEIGAHPWF 566 (612)
T ss_pred ChhhhccCcch
Confidence 99999999999
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=231.56 Aligned_cols=203 Identities=19% Similarity=0.260 Sum_probs=154.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-------GLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~ 89 (303)
....+.+|+..++.++|+||+++++++.+.+..++|+||+++++|.+++...+ .+++..+..++.||+.|+.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 52 DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999876542 58899999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCC---cEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 90 CHRHACIHRDIKPENILLTANG---VVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~---~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
||+.|++|+||+|+||+++.++ .+||+|||++......... .....+..|+|||.+.+.. ++.++|||||||+
T Consensus 132 LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~i 210 (277)
T cd05036 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVL 210 (277)
T ss_pred HHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHH
Confidence 9999999999999999998764 5999999998875322111 1223356799999998665 8999999999999
Q ss_pred HHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 164 SHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 164 l~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
+|||++ |..|+.+........ .+....+.. .+...+.+..+++..|+..+|..||..
T Consensus 211 l~el~~~g~~pf~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~ 268 (277)
T cd05036 211 LWEIFSLGYMPYPGRTNQEVME-FVTGGGRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNF 268 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHH-HHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 999997 666665555544433 333333322 123344555555556665555555443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=237.26 Aligned_cols=241 Identities=25% Similarity=0.360 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+..++.++||||+++++++... +..|++++++ ++++..++.. ..+++..+..++.|++.||.||
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~L 136 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 136 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 345567899999999999999999998643 3478888887 5788887764 3699999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.|++|+||+|+||+++.++.++|+|||++..... ......++..|+|||.+.+...++.++|+||+||++|+|++|
T Consensus 137 H~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 214 (345)
T cd07877 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214 (345)
T ss_pred HHCCeeecCCChHHEEEcCCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999876432 223456788999999987655578999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..|+.+.........+....+..+...... ...........+....+ ...... .....++.+.+++.+|+.
T Consensus 215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~li~~~L~ 285 (345)
T cd07877 215 RTLFPGTDHIDQLKLILRLVGTPGAELLKK-ISSESARNYIQSLTQMP-KMNFAN-------VFIGANPLAVDLLEKMLV 285 (345)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHhh-cccHhHHHHHHHhcccC-Ccchhh-------hcCCCCHHHHHHHHHHcC
Confidence 988877766666665555443332111110 11111100011100000 000000 011246778999999998
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.++..| +++.+++.|+||..
T Consensus 286 ~dp~~R-------~t~~e~l~h~~f~~ 305 (345)
T cd07877 286 LDSDKR-------ITAAQALAHAYFAQ 305 (345)
T ss_pred CChhhc-------CCHHHHhcChhhhh
Confidence 777666 99999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=227.26 Aligned_cols=203 Identities=27% Similarity=0.336 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+..++.++|+||+++++.+.+++.+|+|+||++++++..++.. +..+++..+..++.|++.||.+||+.|+
T Consensus 42 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 121 (255)
T cd08219 42 VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121 (255)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 34566788899999999999999999999999999999999999887653 3468999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.++++|||.+....... ......+++.|+|||++.+.. ++.++|+||+|+++|+|++|..|+
T Consensus 122 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~ 200 (255)
T cd08219 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPF 200 (255)
T ss_pred ccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCC
Confidence 999999999999999999999999987764322 223457888999999988765 799999999999999999999998
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.+.........+...... + .+...+.+..+++-+++..+|..||...
T Consensus 201 ~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 247 (255)
T cd08219 201 QANSWKNLILKVCQGSYK-P---LPSHYSYELRSLIKQMFKRNPRSRPSAT 247 (255)
T ss_pred CCCCHHHHHHHHhcCCCC-C---CCcccCHHHHHHHHHHHhCCcccCCCHH
Confidence 877665555544332221 1 1122334444455555555555555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=225.85 Aligned_cols=204 Identities=20% Similarity=0.267 Sum_probs=158.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+..++.++||||+++++++...+..++|+||+++++|.+++... ..+++..+..++.|++.|+.+||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 124 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 345778999999999999999999999999999999999999999988654 368999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||+++.++.++|+|||++......... .....+..|+|||.+.+.. ++.++|+|||||++|||++ |..
T Consensus 125 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~ 203 (261)
T cd05068 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRM 203 (261)
T ss_pred eeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999876532211 1122345799999988665 7999999999999999999 666
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+....+ ....+.+ .+...+....+.+-.|+..+|..||....
T Consensus 204 p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 253 (261)
T cd05068 204 PYPGMTNAEVLQQV-DQGYRMP---CPPGCPKELYDIMLDCWKEDPDDRPTFET 253 (261)
T ss_pred CCCCCCHHHHHHHH-HcCCCCC---CCCcCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 66665555554433 3333221 22334445555555666666665555444
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=233.22 Aligned_cols=201 Identities=24% Similarity=0.343 Sum_probs=153.6
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
...+..|+.+++.+ +||||+++++++...+.+++|+||+++|+|..++... ..++...+..++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred HHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 34567788899988 6999999999999999999999999999999987542 348889999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++||
T Consensus 141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 219 (314)
T cd05099 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDV 219 (314)
T ss_pred HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchh
Confidence 9999999999999999999999999999999999999999976543221 11223446799999988655 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|||||++|||++ |..|+.+. ..+.....+..+.... .+...+.+..+++..|+..+|..||.
T Consensus 220 wslG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps 282 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHRMD---KPSNCTHELYMLMRECWHAVPTQRPT 282 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 999999999999 45555444 4444444444433221 22344555666666666665555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=233.09 Aligned_cols=221 Identities=24% Similarity=0.331 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++|+||+++++.+..++..++|+||++++++..+... ..+++..+..++.|++.|++|||+.|++
T Consensus 60 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~giv 138 (292)
T cd06657 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVI 138 (292)
T ss_pred HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 456678889999999999999999999999999999999999999998754 4689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|+.
T Consensus 139 H~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred cCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654322 223356788999999887655 7899999999999999999998887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+...... .........+.+.+++.+|+..+|..
T Consensus 218 ~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 218 NEPPLKAMKMIRDNLPP-------------------------------------KLKNLHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred CCCHHHHHHHHHhhCCc-------------------------------------ccCCcccCCHHHHHHHHHHHhCCccc
Confidence 76555443322110000 00000123455678898988865554
Q ss_pred eeccccccccccccceeeeeecCCcceE
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPERKCL 283 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 283 (303)
| +++.+++.|+|+..--.+.+
T Consensus 261 R-------~~~~~ll~~~~~~~~~~~~~ 281 (292)
T cd06657 261 R-------ATAAELLKHPFLAKAGPPSC 281 (292)
T ss_pred C-------cCHHHHhcChHHhccCCCcc
Confidence 4 99999999999887443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=258.81 Aligned_cols=202 Identities=18% Similarity=0.215 Sum_probs=155.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-----------CCCCCHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-----------PHGLPWDLIKQITWQVLR 85 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----------~~~l~~~~~~~~~~qi~~ 85 (303)
....+.+|+++++.++||||+++++++.+++..++||||++||+|.+++.. ....+...+..++.|++.
T Consensus 45 ~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~ 124 (932)
T PRK13184 45 LKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124 (932)
T ss_pred HHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHH
Confidence 455678899999999999999999999999999999999999999987753 123556778899999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC-------------------ccccccCCCcccCccccc
Q psy763 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-------------------NYTDYVATRWYRAPELLV 146 (303)
Q Consensus 86 ~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-------------------~~~~~~~~~~y~aPE~l~ 146 (303)
||+|||+.||+||||||+||+++.++.++|+|||++....... ......||+.|+|||.+.
T Consensus 125 AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~ 204 (932)
T PRK13184 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL 204 (932)
T ss_pred HHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence 9999999999999999999999999999999999998752100 011246899999999998
Q ss_pred CCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChh
Q psy763 147 GDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTT 221 (303)
Q Consensus 147 ~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
+.. ++.++||||+||++|||++|..|+.+........... ...+.........++...+.+-+++..+|..|
T Consensus 205 g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~--i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR 276 (932)
T PRK13184 205 GVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV--ILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276 (932)
T ss_pred CCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhh--ccChhhccccccCCHHHHHHHHHHccCChhhC
Confidence 766 7999999999999999999999987755443322211 11111111122344555566666666666655
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=228.59 Aligned_cols=205 Identities=16% Similarity=0.245 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+..|+..++.++||||+++++++..++..++|+||+++++|..++.. .+.+++..+..++.|++.|+.|||+.|+
T Consensus 48 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~ 127 (269)
T cd05065 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127 (269)
T ss_pred HHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 345688899999999999999999999999999999999999999998765 4568999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcccc----c--cCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD----Y--VATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~----~--~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
+|+||+|+||+++.++.++|+|||++........... . ..+..|+|||.+.+.. ++.++||||+||++||+++
T Consensus 128 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~ 206 (269)
T cd05065 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMS 206 (269)
T ss_pred eecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhc
Confidence 9999999999999999999999999876543221111 1 1245799999987655 7999999999999999886
Q ss_pred -cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 170 -IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 170 -g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|..|+.+....+....+ ....+.+ .+...+....+.+..|+..++..||....
T Consensus 207 ~g~~p~~~~~~~~~~~~i-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (269)
T cd05065 207 YGERPYWDMSNQDVINAI-EQDYRLP---PPMDCPTALHQLMLDCWQKDRNARPKFGQ 260 (269)
T ss_pred CCCCCCCCCCHHHHHHHH-HcCCcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 77777776666555544 3332222 22344555566666666666666555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=228.31 Aligned_cols=203 Identities=20% Similarity=0.256 Sum_probs=152.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHc------CCCCCCHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELEN------HPHGLPWDLIKQITWQVL 84 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~------~~~~l~~~~~~~~~~qi~ 84 (303)
..+.+.+|+..++.++||||+++++.+... ...++|+||+++|++..++. ....+++..+..++.|++
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 122 (272)
T cd05075 43 EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122 (272)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHH
Confidence 345677889999999999999999987532 24689999999999988753 223588999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHH
Q psy763 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIE 161 (303)
Q Consensus 85 ~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG 161 (303)
.||+|||+.||+|+||||+||+++.++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||
T Consensus 123 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG 201 (272)
T cd05075 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFG 201 (272)
T ss_pred HHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHH
Confidence 999999999999999999999999999999999999987643321 12234567899999988665 79999999999
Q ss_pred HHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 162 WTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 162 ~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
|++|||++ |..|+.+....+... .+..+.+++ .+...+....+++-.|+..+|..||..
T Consensus 202 ~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~ 261 (272)
T cd05075 202 VTMWEIATRGQTPYPGVENSEIYD-YLRQGNRLK---QPPDCLDGLYSLMSSCWLLNPKDRPSF 261 (272)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHH-HHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 99999998 555555555544443 334333322 122344445555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=232.23 Aligned_cols=218 Identities=20% Similarity=0.268 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHH-C
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHR-H 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~-~ 93 (303)
...+.+|+.+++.++||||+++++.+...+.+++|+||++++++..++... ..+++..+..++.|++.|+.|||+ .
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 122 (286)
T cd06622 43 FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122 (286)
T ss_pred HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 356778999999999999999999999999999999999999999987753 378999999999999999999997 5
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCc-----cCCCccchhhHHHHHHHhh
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDT-----LYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-----~~~~~~DvwSlG~il~el~ 168 (303)
|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+.. .++.++|+||+||++|+|+
T Consensus 123 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~ 201 (286)
T cd06622 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201 (286)
T ss_pred CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence 9999999999999999999999999998765322 223456788999999986432 2588999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
+|..|+...........+....... ..........++.+++.+|
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~ 245 (286)
T cd06622 202 LGRYPYPPETYANIFAQLSAIVDGD------------------------------------PPTLPSGYSDDAQDFVAKC 245 (286)
T ss_pred hCCCCCCCcchhhHHHHHHHHhhcC------------------------------------CCCCCcccCHHHHHHHHHH
Confidence 9998875443322211111000000 0000111345566888888
Q ss_pred hccccceeeccccccccccccceeeeeecCC
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+...|..| ++..+++.|||+..-.
T Consensus 246 l~~~p~~R-------p~~~~l~~~~~~~~~~ 269 (286)
T cd06622 246 LNKIPNRR-------PTYAQLLEHPWLVKYK 269 (286)
T ss_pred cccCcccC-------CCHHHHhcChhhhhcc
Confidence 77555555 8899999999876544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=231.03 Aligned_cols=212 Identities=24% Similarity=0.345 Sum_probs=163.6
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEe------CCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRR------KKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
..+..|+..++.+ +|+||+++++++.. ...+|+||||+++|++..++.. ...+++..+..++.|++.|+.|
T Consensus 57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 136 (282)
T cd06636 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136 (282)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4466777788877 79999999999853 4578999999999999998754 3458899999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccC----CccCCCccchhhHHHHH
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il 164 (303)
||+.|++|+||+|+||+++.++.++|+|||++..... ........++..|+|||.+.. ...++.++|+||+||++
T Consensus 137 LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l 216 (282)
T cd06636 137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216 (282)
T ss_pred HHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence 9999999999999999999999999999999876432 122344568889999999863 23478899999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
|||++|..|+.+.........+..... + .......+..+.++
T Consensus 217 ~el~~g~~p~~~~~~~~~~~~~~~~~~--------------------------~------------~~~~~~~~~~~~~l 258 (282)
T cd06636 217 IEMAEGAPPLCDMHPMRALFLIPRNPP--------------------------P------------KLKSKKWSKKFIDF 258 (282)
T ss_pred HHHHhCCCCccccCHHhhhhhHhhCCC--------------------------C------------CCcccccCHHHHHH
Confidence 999999988866543333221110000 0 00001234567899
Q ss_pred hhhhhccccceeeccccccccccccceeeee
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+.+|+...+..| +++.++++||||
T Consensus 259 i~~cl~~~p~~R-------p~~~ell~~~~~ 282 (282)
T cd06636 259 IEGCLVKNYLSR-------PSTEQLLKHPFI 282 (282)
T ss_pred HHHHhCCChhhC-------cCHHHHhcCCCC
Confidence 999998766666 999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=230.12 Aligned_cols=213 Identities=25% Similarity=0.340 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
..+.+|+.+++.+ +|||++++++++... +.+++|+||+++++|.+++. ....+++..++.++.|++.||.
T Consensus 63 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 142 (291)
T cd06639 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142 (291)
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Confidence 4456778888888 899999999998754 36899999999999998764 3457899999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCc----cCCCccchhhHHHH
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDT----LYGPAVDVWAIEWT 163 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~----~~~~~~DvwSlG~i 163 (303)
|||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.... .++.++|+||+||+
T Consensus 143 ~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi 222 (291)
T cd06639 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222 (291)
T ss_pred HHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence 9999999999999999999999999999999987654322 223356788999999986432 25889999999999
Q ss_pred HHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHH
Q psy763 164 SHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVK 243 (303)
Q Consensus 164 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~d 243 (303)
+|||++|..|+.+....+.+..+..... .. ....+.....+.+
T Consensus 223 ~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~------------------------------------~~~~~~~~~~l~~ 265 (291)
T cd06639 223 AIELGDGDPPLFDMHPVKTLFKIPRNPP-PT------------------------------------LLHPEKWCRSFNH 265 (291)
T ss_pred HHHHhhCCCCCCCCcHHHHHHHHhcCCC-CC------------------------------------CCcccccCHHHHH
Confidence 9999999888876554444332211100 00 0001112345678
Q ss_pred hhhhhhccccceeeccccccccccccceeeee
Q psy763 244 ILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 244 ll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
++.+|+..++..| ++..+++.||||
T Consensus 266 li~~~l~~~p~~R-------ps~~~il~~~~~ 290 (291)
T cd06639 266 FISQCLIKDFEAR-------PSVTHLLEHPFI 290 (291)
T ss_pred HHHHHhhcChhhC-------cCHHHHhcCccc
Confidence 8999988666666 999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=231.79 Aligned_cols=200 Identities=26% Similarity=0.350 Sum_probs=154.7
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
...+.+|+..++.+ +||||+++++++......++||||+++|+|..++... ..++...+..++
T Consensus 64 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (304)
T cd05101 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143 (304)
T ss_pred HHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHH
Confidence 45677889999999 8999999999999999999999999999999987643 247788899999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+.. ++.++||
T Consensus 144 ~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 222 (304)
T cd05101 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDV 222 (304)
T ss_pred HHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhH
Confidence 9999999999999999999999999999999999999999987643221 12234567899999997655 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|||||++|++++ |..++.+....+. ...+..+.+.. .+...+.+..+++-.|+...|..||
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHH-HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCC
Confidence 999999999998 4555555544444 33444433321 2234455555566666655555444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=226.99 Aligned_cols=172 Identities=22% Similarity=0.287 Sum_probs=138.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+..++.++||||+++++.+......|+||||+++|+|..++.+. ...+...+..++.|++.||+|||+
T Consensus 38 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 117 (268)
T cd05086 38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117 (268)
T ss_pred HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3567888899999999999999999999999999999999999999987643 246677788999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCC------ccCCCccchhhHHHH
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGD------TLYGPAVDVWAIEWT 163 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~------~~~~~~~DvwSlG~i 163 (303)
.+++|+||||+||+++.++.++|+|||++....... ......++..|+|||++.+. ..++.++|||||||+
T Consensus 118 ~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 197 (268)
T cd05086 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVT 197 (268)
T ss_pred CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHH
Confidence 999999999999999999999999999976432211 12334678899999997531 125789999999999
Q ss_pred HHHhhccCccCC-CCchHHHHHHHhh
Q psy763 164 SHSYSQIGFIGL-GNMGSHMARNLLK 188 (303)
Q Consensus 164 l~el~tg~~~~~-~~~~~~~~~~~~~ 188 (303)
+|||++++.+++ +....+....++.
T Consensus 198 l~el~~~~~~p~~~~~~~~~~~~~~~ 223 (268)
T cd05086 198 LWELFENAAQPYSHLSDREVLNHVIK 223 (268)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999997655444 4444455554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=230.68 Aligned_cols=216 Identities=24% Similarity=0.346 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+..++.++|+|++++++.+..++..++|+||+++++|.+++.... .++...+..++.|++.||+|||+.|+
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34567788999999999999999999999999999999999999999988765 89999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..|+
T Consensus 138 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~ 216 (286)
T cd06614 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPY 216 (286)
T ss_pred eeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876654322 223345788899999988665 799999999999999999999887
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.........+....... .......+..+.+++.+|+...+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~l~~li~~~l~~~p~ 259 (286)
T cd06614 217 LREPPLRALFLITTKGIPP-------------------------------------LKNPEKWSPEFKDFLNKCLVKDPE 259 (286)
T ss_pred CCCCHHHHHHHHHhcCCCC-------------------------------------CcchhhCCHHHHHHHHHHhccChh
Confidence 7655544433222211100 000000234566778888886655
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.+++.|+|+..
T Consensus 260 ~R-------pt~~~il~~~~~~~ 275 (286)
T cd06614 260 KR-------PSAEELLQHPFLKK 275 (286)
T ss_pred hC-------cCHHHHhhChHhhc
Confidence 55 88889998888866
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=228.65 Aligned_cols=203 Identities=16% Similarity=0.200 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------CCCCHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~l~~~~~~~~~~qi~~~l 87 (303)
...+.+|+.+++.++||||+++++++..+...++|+||+++|+|..++... ..+++..+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 53 RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 456778999999999999999999999999999999999999999987532 2367888999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
.|||+.|++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++
T Consensus 133 ~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il 211 (277)
T cd05032 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVL 211 (277)
T ss_pred HHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHH
Confidence 999999999999999999999999999999999876543321 22345678899999987655 79999999999999
Q ss_pred HHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 165 HSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 165 ~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
||+++ |..|+.+....+... .+..+..+. .+...+.+..+++-.|+..+|..||...
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 269 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLK-FVIDGGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFL 269 (277)
T ss_pred HHhhccCCCCCccCCHHHHHH-HHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 99998 556655555544444 333333322 2233344555555555555555555433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=233.89 Aligned_cols=239 Identities=33% Similarity=0.498 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+..|+..++.++|+|++++++++...+..++|+||++ ++|..++.+. ..+++..+..++.|++.||++||+.|++
T Consensus 42 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 120 (282)
T cd07829 42 PSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120 (282)
T ss_pred cHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3455678899999999999999999999999999999998 4788877665 5899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++||+++|..++.
T Consensus 121 H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred cCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999988764332 22334567889999998866458999999999999999999988888
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+....+.+.....+....... +............. ...+.....+.+++.+|+...|..
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~~P~~ 269 (282)
T cd07829 201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPD----YKPTFPKFPPKDLE-------KVLPRLDPEGIDLLSKMLQYNPAK 269 (282)
T ss_pred CccHHHHHHHHHHHhCCCcHHHHHhhccccc----ccccccccCccchH-------HhcccccHHHHHHHHHhhccCccc
Confidence 8777766666655433322111000000000 01111111111110 011123667899999999977665
Q ss_pred eeccccccccccccceeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~ 275 (303)
| +++.+++.||||
T Consensus 270 R-------p~~~~~l~~p~~ 282 (282)
T cd07829 270 R-------ISAKEALKHPYF 282 (282)
T ss_pred C-------CCHHHHhhCcCC
Confidence 5 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=229.78 Aligned_cols=215 Identities=21% Similarity=0.315 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 19 ATEATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+|+.+++.++ |||++++++++..+...++|+||+++++|..++..+ .+++..+..++.|++.||.|||+.|+
T Consensus 44 ~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i 122 (277)
T cd06917 44 SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGV 122 (277)
T ss_pred HHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34567788888886 999999999999999999999999999999988654 79999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+...++.++|+|||||++|+|++|..|+
T Consensus 123 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~ 202 (277)
T cd06917 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202 (277)
T ss_pred ccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999998765432 2234568889999999876555789999999999999999998887
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.........+ ... .+ .. -.......++.+++.+|+..+|.
T Consensus 203 ~~~~~~~~~~~~-~~~-~~------~~------------------------------~~~~~~~~~~~~~i~~~l~~~p~ 244 (277)
T cd06917 203 SDVDAFRAMMLI-PKS-KP------PR------------------------------LEDNGYSKLLREFVAACLDEEPK 244 (277)
T ss_pred CCCChhhhhhcc-ccC-CC------CC------------------------------CCcccCCHHHHHHHHHHcCCCcc
Confidence 655433222110 000 00 00 00001335677888888886666
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.| +++.+++.|+|+....
T Consensus 245 ~R-------~~~~~il~~~~~~~~~ 262 (277)
T cd06917 245 ER-------LSAEELLKSKWIKAHS 262 (277)
T ss_pred cC-------cCHHHHhhChHhhccc
Confidence 55 9999999999986644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=227.68 Aligned_cols=214 Identities=21% Similarity=0.221 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCC--CHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGL--PWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l--~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+.+++.++|+||+++++++..++..++|+||+++++|..++... ..+ ++..+..++.|++.|++|||+.|
T Consensus 49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 128 (268)
T cd06624 49 VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128 (268)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 446788899999999999999999999999999999999999999987653 455 88889999999999999999999
Q ss_pred ceecccCCCcEEEec-CCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhhccC
Q psy763 95 CIHRDIKPENILLTA-NGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 95 ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++|+||+|+||+++. ++.++|+|||.+....... ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|.
T Consensus 129 i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~ 208 (268)
T cd06624 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208 (268)
T ss_pred EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCC
Confidence 999999999999986 6799999999987654322 22334678899999998653 23788999999999999999988
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+.......... +..... . ..........+++.+++.+|+..
T Consensus 209 ~p~~~~~~~~~~~--------------------------~~~~~~--------~---~~~~~~~~~~~~~~~li~~~l~~ 251 (268)
T cd06624 209 PPFIELGEPQAAM--------------------------FKVGMF--------K---IHPEIPESLSAEAKNFILRCFEP 251 (268)
T ss_pred CCCccccChhhhH--------------------------hhhhhh--------c---cCCCCCcccCHHHHHHHHHHcCC
Confidence 7765432211110 000000 0 00011122345677888888875
Q ss_pred ccceeeccccccccccccceeeee
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+..| +++.+++.||||
T Consensus 252 ~p~~R-------pt~~~ll~~~~~ 268 (268)
T cd06624 252 DPDKR-------ASAHDLLQDPFL 268 (268)
T ss_pred CchhC-------CCHHHHHhCCCC
Confidence 55444 999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=226.99 Aligned_cols=204 Identities=20% Similarity=0.246 Sum_probs=152.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFR-RKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++||||+++++++. .++..++|+||+.+++|..++... ...+...+..++.|++.||.|||+.|
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 118 (262)
T cd05058 39 EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118 (262)
T ss_pred HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456678888999999999999999876 455689999999999999988653 35677888899999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC-----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
++|+||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 119 i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~ 197 (262)
T cd05058 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT 197 (262)
T ss_pred ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHc
Confidence 9999999999999999999999999987643221 111234567899999987655 7999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
|+.+++...........+..+.++. .+...+....+++-.|+..+|..||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~ 249 (262)
T cd05058 198 RGAPPYPDVDSFDITVYLLQGRRLL---QPEYCPDPLYEVMLSCWHPKPEMRPTF 249 (262)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 7766555444333333333333221 122334455555566665555555433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=230.57 Aligned_cols=207 Identities=18% Similarity=0.230 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-----------CCCHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-----------GLPWDLIKQITWQVLR 85 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------~l~~~~~~~~~~qi~~ 85 (303)
....+.+|+++++.++||||+++++++..+...++|+|++++++|..++.... .+++..++.++.|++.
T Consensus 62 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999886554 6899999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHH
Q psy763 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEW 162 (303)
Q Consensus 86 ~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~ 162 (303)
||+|||+.|++|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|||||||
T Consensus 142 al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~ 220 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGV 220 (296)
T ss_pred HHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHH
Confidence 9999999999999999999999999999999999987654322 122345577899999987655 799999999999
Q ss_pred HHHHhhc--cCccCCCCchHHHHHHHhhc---CCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 163 TSHSYSQ--IGFIGLGNMGSHMARNLLKN---NGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 163 il~el~t--g~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
++|||++ +..|+......+........ .........+...+.+..+++-.|+..+|..||..
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 287 (296)
T cd05051 221 TLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287 (296)
T ss_pred HHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence 9999987 44555444444443333222 11111111222334455555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-33 Score=269.60 Aligned_cols=175 Identities=29% Similarity=0.380 Sum_probs=152.5
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
...+|..++..++|||+|+++|+-...+..+|.||||++|+|.+++..++-.++.....+..|++.|++|||+.||||||
T Consensus 1280 ~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRD 1359 (1509)
T KOG4645|consen 1280 LIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRD 1359 (1509)
T ss_pred chHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecC
Confidence 35678899999999999999999999999999999999999999999988899999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCCCC-----ccccccCCCcccCcccccCCc--cCCCccchhhHHHHHHHhhccCc
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATRWYRAPELLVGDT--LYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~--~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|||.||+++.+|.+|++|||.|....+.. ......||+.|||||++.+.. ....++||||+|||..||.||+-
T Consensus 1360 IK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1360 IKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred CCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 99999999999999999999998876543 124468999999999998643 25679999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCcee
Q psy763 173 IGLGNMGSHMARNLLKNNGRVT 194 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~ 194 (303)
|+..-...-.+.=++..|.+|+
T Consensus 1440 PW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1440 PWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred chhhccchhHHHhHHhccCCCC
Confidence 9877665555555555555543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=230.73 Aligned_cols=213 Identities=22% Similarity=0.345 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHH-CC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHR-HA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~-~~ 94 (303)
....+.+|+..++.++||||+++++++..++.+++|+||+++++|.+++... ..+++..+..++.|++.|+.|||+ .|
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 121 (265)
T cd06605 42 IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121 (265)
T ss_pred HHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4556778899999999999999999999999999999999999999988765 689999999999999999999999 99
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+.. ++.++|+||+||++|++++|..|+
T Consensus 122 i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~ 199 (265)
T cd06605 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPY 199 (265)
T ss_pred eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999999876543222 2267888999999988765 799999999999999999998887
Q ss_pred CCCch-----HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 175 LGNMG-----SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 175 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
..... .+....+... .. ........+.++.+++.+|+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~----------------------------~~----------~~~~~~~~~~~~~~li~~~l 241 (265)
T cd06605 200 PPENDPPDGIFELLQYIVNE----------------------------PP----------PRLPSGKFSPDFQDFVNLCL 241 (265)
T ss_pred CccccccccHHHHHHHHhcC----------------------------CC----------CCCChhhcCHHHHHHHHHHc
Confidence 65421 1111111100 00 00000013456788898888
Q ss_pred ccccceeeccccccccccccceeeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
..+|..| +++.+++.||||-
T Consensus 242 ~~~p~~R-------pt~~~ll~~~~~~ 261 (265)
T cd06605 242 IKDPRER-------PSYKELLEHPFIK 261 (265)
T ss_pred CCCchhC-------cCHHHHhhCchhh
Confidence 8666555 9999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=225.67 Aligned_cols=205 Identities=17% Similarity=0.267 Sum_probs=159.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+..++.++||||+++++++...+..++|+||+++++|.+++... +.+++..+..++.|++.|+.|||+.|+
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i 127 (266)
T cd05033 48 QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127 (266)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3455778999999999999999999999999999999999999999987653 478999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCC-Ccc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPG-ENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
+|+||+|+||+++.++.++|+|||++...... ... ....++..|+|||.+.+.. ++.++|||||||++|++++ |.
T Consensus 128 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~ 206 (266)
T cd05033 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGE 206 (266)
T ss_pred ccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCC
Confidence 99999999999999999999999999876421 111 1223457899999988655 7999999999999999998 66
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+......+....+ ..+.+.+ .+...+..+.+++..|+..+|..||....
T Consensus 207 ~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 257 (266)
T cd05033 207 RPYWDMSNQDVIKAV-EDGYRLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQ 257 (266)
T ss_pred CCCCCCCHHHHHHHH-HcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 666555555444433 3333322 12344556666666666666665554433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=226.12 Aligned_cols=204 Identities=20% Similarity=0.292 Sum_probs=159.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++|+||+++++.+..++..++|+||+++++|.+++.. ...++...+..++.|++.||+|||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i 124 (261)
T cd05072 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124 (261)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45678899999999999999999999999999999999999999998754 3568889999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..
T Consensus 125 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~ 203 (261)
T cd05072 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKI 203 (261)
T ss_pred eccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCC
Confidence 9999999999999999999999999987543221 12234567799999987655 7899999999999999998 666
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+.........+ ..+.+.+ .....+.++.+++-.|+..+|..||....
T Consensus 204 p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (261)
T cd05072 204 PYPGMSNSDVMSAL-QRGYRMP---RMENCPDELYDIMKTCWKEKAEERPTFDY 253 (261)
T ss_pred CCCCCCHHHHHHHH-HcCCCCC---CCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 65555444444433 3333221 22334556666666666666666665444
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=231.34 Aligned_cols=225 Identities=20% Similarity=0.277 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iv 96 (303)
...+.+|+++++.++||||+++++.+...+.+++|+||+++++|..++...+.+++..+..++.+++.|+.|||+ .|++
T Consensus 47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~ 126 (284)
T cd06620 47 RKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126 (284)
T ss_pred HHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCee
Confidence 456778999999999999999999999999999999999999999988877789999999999999999999997 6899
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+.. ++.++|+||+||++|++++|..|+..
T Consensus 127 H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred ccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999998654322 223457899999999987654 79999999999999999999988775
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
........ ........ ....+...... ..........+.+++.+|+..+|..|
T Consensus 205 ~~~~~~~~----------------~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~R 257 (284)
T cd06620 205 SNIDDDGQ----------------DDPMGILD-LLQQIVQEPPP----------RLPSSDFPEDLRDFVDACLLKDPTER 257 (284)
T ss_pred cchhhhhh----------------hhhhHHHH-HHHHHhhccCC----------CCCchhcCHHHHHHHHHHhcCCcccC
Confidence 44321100 00000000 00111100000 00001134567889999988666666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.+++.|+|+...
T Consensus 258 -------pt~~e~~~~~~~~~~ 272 (284)
T cd06620 258 -------PTPQQLCAMPPFIQA 272 (284)
T ss_pred -------cCHHHHhcCcccccc
Confidence 999999999988653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=230.02 Aligned_cols=158 Identities=23% Similarity=0.327 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++||||+++++++... ..+++||||+++++|.+++... .+++..+..++.|++.||.|||+.|
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~ 127 (283)
T cd05080 49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH 127 (283)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345677899999999999999999988753 4689999999999999988654 6999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++|
T Consensus 128 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg 206 (283)
T cd05080 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTH 206 (283)
T ss_pred eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhC
Confidence 99999999999999999999999999887543221 12234566799999987655 79999999999999999999
Q ss_pred CccCCC
Q psy763 171 GFIGLG 176 (303)
Q Consensus 171 ~~~~~~ 176 (303)
..|+..
T Consensus 207 ~~p~~~ 212 (283)
T cd05080 207 CDSKQS 212 (283)
T ss_pred CCCCCC
Confidence 877643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=227.10 Aligned_cols=201 Identities=20% Similarity=0.291 Sum_probs=152.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCE------EEEEEecCCCCcHHHHHcC------CCCCCHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKK------LHLVFEFCDHTVLNELENH------PHGLPWDLIKQITWQVLR 85 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~~l~~~~~~------~~~l~~~~~~~~~~qi~~ 85 (303)
...+..|+..++.++||||+++++++...+. .++|+||+++++|..++.. ...+++..+..++.|++.
T Consensus 45 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 124 (273)
T cd05035 45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124 (273)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHH
Confidence 4567888999999999999999999876554 7999999999999887632 236899999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHH
Q psy763 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEW 162 (303)
Q Consensus 86 ~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~ 162 (303)
||.|||+.|++|+||||+||++++++.+||+|||++......... .....+..|+|||.+.+.. ++.++|||||||
T Consensus 125 aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~ 203 (273)
T cd05035 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGV 203 (273)
T ss_pred HHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHH
Confidence 999999999999999999999999999999999999876533221 1223466799999987655 799999999999
Q ss_pred HHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 163 TSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 163 il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
++|||++ |..|+.+....+....+ ..+..+. .+...+.+..+++-+|+..+|..||.
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~ 261 (273)
T cd05035 204 TMWEIATRGQTPYPGVENHEIYDYL-RHGNRLK---QPEDCLDELYDLMYSCWRADPKDRPT 261 (273)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCC---CCcCCCHHHHHHHHHHcCCChhhCcC
Confidence 9999998 55666555555544333 3332221 22344455555555555555555543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=229.77 Aligned_cols=213 Identities=23% Similarity=0.321 Sum_probs=162.3
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEE-----eCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFR-----RKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
..+..|+.+++.+ +||||+++++++. .++.+++||||+++++|..++. ....+++..+..++.|++.|+.
T Consensus 59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ 138 (286)
T cd06638 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138 (286)
T ss_pred HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence 4566788888888 6999999999884 3457899999999999988753 3457889999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCC----ccCCCccchhhHHHH
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGD----TLYGPAVDVWAIEWT 163 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~----~~~~~~~DvwSlG~i 163 (303)
|||+.+++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+. ..++.++|+||+||+
T Consensus 139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred HHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 9999999999999999999999999999999988754322 22345688999999998532 337889999999999
Q ss_pred HHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHH
Q psy763 164 SHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVK 243 (303)
Q Consensus 164 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~d 243 (303)
+|||++|..|+.+............. .... ..........+.+
T Consensus 219 ~~el~~g~~p~~~~~~~~~~~~~~~~-~~~~------------------------------------~~~~~~~~~~~~~ 261 (286)
T cd06638 219 AIELGDGDPPLADLHPMRALFKIPRN-PPPT------------------------------------LHQPELWSNEFND 261 (286)
T ss_pred HHHHhcCCCCCCCCchhHHHhhcccc-CCCc------------------------------------ccCCCCcCHHHHH
Confidence 99999999887765443332211110 0000 0000112345678
Q ss_pred hhhhhhccccceeeccccccccccccceeeee
Q psy763 244 ILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 244 ll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
++.+|+..++..| +++.++++|+|+
T Consensus 262 li~~~l~~~p~~R-------ps~~ell~~~~~ 286 (286)
T cd06638 262 FIRKCLTKDYEKR-------PTVSDLLQHVFI 286 (286)
T ss_pred HHHHHccCCcccC-------CCHHHHhhcccC
Confidence 8888887555555 999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=226.60 Aligned_cols=202 Identities=17% Similarity=0.231 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..++.++||||+++++++..++..++||||+++++|.+++... +.++...+..++.|++.|+.+||+.|++
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 128 (267)
T cd05066 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128 (267)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 456788999999999999999999999999999999999999999987654 4689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+|||||++||+++ |.
T Consensus 129 h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999876533211 1122356799999998655 7999999999999999886 77
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
.|+.+....+....+.. +.+.+ .+...+....+.+..|+..++..||..
T Consensus 208 ~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (267)
T cd05066 208 RPYWEMSNQDVIKAIEE-GYRLP---APMDCPAALHQLMLDCWQKDRNERPKF 256 (267)
T ss_pred CCcccCCHHHHHHHHhC-CCcCC---CCCCCCHHHHHHHHHHcccCchhCCCH
Confidence 77777666555544433 32221 223445566666666666666655543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=231.17 Aligned_cols=204 Identities=20% Similarity=0.288 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC------------------------CCCCH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP------------------------HGLPW 73 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------------------~~l~~ 73 (303)
...+.+|+..++.++||||+++++.+..++..++|+||+.+++|..++... ..+++
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 126 (290)
T cd05045 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126 (290)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCH
Confidence 356778899999999999999999999999999999999999999886532 24788
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCcc
Q psy763 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTL 150 (303)
Q Consensus 74 ~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~ 150 (303)
..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++........ .....++..|+|||.+.+..
T Consensus 127 ~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~- 205 (290)
T cd05045 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI- 205 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-
Confidence 99999999999999999999999999999999999999999999999876543221 12234567899999987655
Q ss_pred CCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 151 YGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 151 ~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++.++|||||||++|||++ |..|+.+.... .+......+.+.+ .+...+.++.+.+..|+..+|..||....
T Consensus 206 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 206 YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred cchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 7999999999999999998 66665554443 3344444433322 23344556666666666666655554433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=232.08 Aligned_cols=212 Identities=23% Similarity=0.304 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.....+.+|+.+++.++ ||||+++++++..++..++|||++++++|.+++...+.+++..+..++.|++.||.+||+.|
T Consensus 43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~ 122 (280)
T cd05581 43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122 (280)
T ss_pred HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34466778889999998 99999999999999999999999999999999988778999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc---------------------cccccCCCcccCcccccCCccCCC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---------------------YTDYVATRWYRAPELLVGDTLYGP 153 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---------------------~~~~~~~~~y~aPE~l~~~~~~~~ 153 (303)
++|+||+|+||+++.++.++++|||++........ .....++..|+|||...+.. ++.
T Consensus 123 ~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~ 201 (280)
T cd05581 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGK 201 (280)
T ss_pred eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CCh
Confidence 99999999999999999999999999877543221 12245678899999987655 789
Q ss_pred ccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCC
Q psy763 154 AVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGN 233 (303)
Q Consensus 154 ~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 233 (303)
++|+||+|+++|++++|..|+................. ..
T Consensus 202 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------------------------~~ 241 (280)
T cd05581 202 SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY----------------------------------------SF 241 (280)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC----------------------------------------CC
Confidence 99999999999999999888776654444333221100 11
Q ss_pred CCCCchhhHHhhhhhhccccceeeccccccccc----cccceeeee
Q psy763 234 TDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRG----KNCKKTFYI 275 (303)
Q Consensus 234 ~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~----~~~l~~~~~ 275 (303)
.....+.+.+++.+|+..+|..| +++ .+++.||||
T Consensus 242 ~~~~~~~~~~li~~~l~~~p~~R-------~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 242 PPNFPPDAKDLIEKLLVLDPQDR-------LGVNEGYDELKAHPFF 280 (280)
T ss_pred CCccCHHHHHHHHHHhcCCHhhC-------CCcccCHHHHhcCCCC
Confidence 11125667899999998666555 999 999999986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=237.70 Aligned_cols=215 Identities=20% Similarity=0.196 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCC-CCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+..|+.+|.+|+ |.+||+++++-..++.+|+|||+-+ .+|..++++... +..-.++.+..|++.|+.++|..|
T Consensus 402 tl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g 480 (677)
T KOG0596|consen 402 TLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG 480 (677)
T ss_pred HHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc
Confidence 4556889999999996 9999999999999999999999766 788888876654 343588899999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCc----------cCCCccchhhHH
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDT----------LYGPAVDVWAIE 161 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~----------~~~~~~DvwSlG 161 (303)
|||.||||.|+|+- .|.+||+|||.|....++.. ..+.+||+.||+||.+.... ..+.++||||+|
T Consensus 481 IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 481 IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 99999999999985 68999999999998876543 35679999999999986321 146799999999
Q ss_pred HHHHHhhccCccCCCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchh
Q psy763 162 WTSHSYSQIGFIGLGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHG 240 (303)
Q Consensus 162 ~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 240 (303)
||||+|+.|..||....+ ..-+..+..-+...+ + +.-....+
T Consensus 560 CILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie----------------------------f---------p~~~~~~~ 602 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE----------------------------F---------PDIPENDE 602 (677)
T ss_pred hHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc----------------------------c---------cCCCCchH
Confidence 999999998887654332 111111111111100 0 00001112
Q ss_pred hHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 241 VVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 241 ~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++++..||..+|+.| .+..++|.|||.--
T Consensus 603 li~~mK~CL~rdPkkR-------~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 603 LIDVMKCCLARDPKKR-------WSIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHHHHhcCcccC-------CCcHHHhcCccccc
Confidence 7888888888777766 88888999988643
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=236.98 Aligned_cols=240 Identities=26% Similarity=0.389 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
...+.+|+..++.++||||+++++++..+. .+++|+|++ ++++..++.. ..+++..+..++.|++.||.|||
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH 135 (343)
T cd07880 58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIH 135 (343)
T ss_pred HHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999999997654 468999999 5788887764 47999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+.|++|+||+|+||+++.++.++|+|||++...... .....+++.|+|||.+.+...++.++|+||+||++|++++|.
T Consensus 136 ~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999998765432 233467889999999876444789999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+.+.........++...+..+...... ........ ............+ . ...+...+.+.+++.+|+..
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~-~------~~~~~~~~~~~~li~~~l~~ 284 (343)
T cd07880 214 PLFKGHDHLDQLMEIMKVTGTPSKEFVQK-LQSEDAKN-YVKKLPRFRKKDF-R------SLLPNANPLAVNVLEKMLVL 284 (343)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHh-hcchhHHH-HHHhccccCcchH-H------HhccCCChHHHHHHHHHcCC
Confidence 99988877766666666444332110000 00000000 0000000000000 0 11123566788999999997
Q ss_pred ccceeeccccccccccccceeeeeec
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+|..| +++.+++.||||..
T Consensus 285 dP~~R-------~t~~~~l~~~~~~~ 303 (343)
T cd07880 285 DAESR-------ITAAEALAHPYFEE 303 (343)
T ss_pred ChhhC-------CCHHHHhcCccHhh
Confidence 77666 99999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=238.62 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCE------EEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKK------LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
..+.+|+.+++.++||||+++++++...+. .++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+
T Consensus 59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~ 136 (343)
T cd07851 59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS 136 (343)
T ss_pred HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999998876554 899999994 688887765 479999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
.|++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+...++.++||||+||++|++++|..
T Consensus 137 ~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~ 214 (343)
T cd07851 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214 (343)
T ss_pred CCeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998765432 3345678889999998765457899999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+.+....+.+..++...+.++.... .....+... .+...........+... ....++.+.+++.+|+..+
T Consensus 215 pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~-------~~~~s~~l~dli~~~l~~~ 285 (343)
T cd07851 215 LFPGSDHIDQLKRIMNLVGTPDEELL-QKISSESAR-NYIQSLPQMPKKDFKEV-------FSGANPLAIDLLEKMLVLD 285 (343)
T ss_pred CCCCCChHHHHHHHHHhcCCCCHHHH-hhccchhHH-HHHHhccccCCCCHHHH-------hccCCHHHHHHHHHhCCCC
Confidence 98888777777766655333221100 000000000 00000000000001000 1123678899999999877
Q ss_pred cceeeccccccccccccceeeeeecCCcc
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
|..| +++.+++.|||+.....+
T Consensus 286 P~~R-------pt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 286 PDKR-------ITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hhhC-------CCHHHHhcCCCccccCCC
Confidence 7666 999999999999764433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=231.69 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=153.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
...+.+|+.+++.+ +||||+++++++...+..++|+||+++|+|.+++... ..++...+..++
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 146 (307)
T cd05098 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146 (307)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 34567788899999 7999999999999999999999999999999988643 247889999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+
T Consensus 147 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 225 (307)
T cd05098 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDV 225 (307)
T ss_pred HHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHH
Confidence 99999999999999999999999999999999999999998765422111 1123456799999998765 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
||+||++|||++ |..|+.+ ...+.....+..+.+.. .+...+.+..+++..|+..+|..||.
T Consensus 226 wslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps 288 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPT 288 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcC
Confidence 999999999998 4455544 44444444444443322 22334455555555666555554443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=226.46 Aligned_cols=214 Identities=23% Similarity=0.342 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i 95 (303)
....+.+|+..++.++|+||+++++++..++..++|+||+++++|.+++.....+++..+..++.|++.|+.|||+ .|+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~ 121 (264)
T cd06623 42 FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121 (264)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence 4566788999999999999999999999999999999999999999998877889999999999999999999999 999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc-ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY-TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+
T Consensus 122 ~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~ 200 (264)
T cd06623 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPF 200 (264)
T ss_pred ccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998876543322 2456788999999987664 799999999999999999998887
Q ss_pred CCCc--h-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCC-CchhhHHhhhhhhc
Q psy763 175 LGNM--G-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDR-NSHGVVKILGKKLI 250 (303)
Q Consensus 175 ~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~dll~~~l~ 250 (303)
.+.. . .+....+.. ... ...... .+..+.+++.+|+.
T Consensus 201 ~~~~~~~~~~~~~~~~~-~~~--------------------------------------~~~~~~~~~~~l~~li~~~l~ 241 (264)
T cd06623 201 LPPGQPSFFELMQAICD-GPP--------------------------------------PSLPAEEFSPEFRDFISACLQ 241 (264)
T ss_pred ccccccCHHHHHHHHhc-CCC--------------------------------------CCCCcccCCHHHHHHHHHHcc
Confidence 6553 1 111111110 000 000011 34567788888888
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..+..| +++.++++|||+..
T Consensus 242 ~~p~~R-------~~~~~ll~~~~~~~ 261 (264)
T cd06623 242 KDPKKR-------PSAAELLQHPFIKK 261 (264)
T ss_pred CChhhC-------CCHHHHHhCHHHHh
Confidence 666666 99999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=226.23 Aligned_cols=212 Identities=24% Similarity=0.334 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+..|+..++.++||||+++++.+.. +...++++||+++++|..++.. ...+++..++.++.|++.||.+|
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 121 (265)
T cd08217 42 EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121 (265)
T ss_pred HHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999998764 4578999999999999987754 45799999999999999999999
Q ss_pred H-----HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 91 H-----RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 91 H-----~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
| +.+++|+||+|+||+++.++.++|+|||++........ .....+++.|+|||.+.+.. ++.++|+||||+++
T Consensus 122 H~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il 200 (265)
T cd08217 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLI 200 (265)
T ss_pred hcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHH
Confidence 9 89999999999999999999999999999887654332 34457899999999988655 78999999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
|+|++|..|+.+.........+.. +... ......+..+.++
T Consensus 201 ~~l~~g~~p~~~~~~~~~~~~~~~-~~~~--------------------------------------~~~~~~~~~~~~l 241 (265)
T cd08217 201 YELCALSPPFTARNQLQLASKIKE-GKFR--------------------------------------RIPYRYSSELNEV 241 (265)
T ss_pred HHHHHCCCcccCcCHHHHHHHHhc-CCCC--------------------------------------CCccccCHHHHHH
Confidence 999999988776654433322211 1000 0011123566788
Q ss_pred hhhhhccccceeeccccccccccccceeeee
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+.+|+...|..| +++.++++|||+
T Consensus 242 ~~~~l~~~p~~R-------p~~~~il~~~~~ 265 (265)
T cd08217 242 IKSMLNVDPDKR-------PSTEELLQLPLI 265 (265)
T ss_pred HHHHccCCcccC-------CCHHHHhhCCCC
Confidence 888888666555 999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=225.38 Aligned_cols=204 Identities=16% Similarity=0.201 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+..|+.+++.++||||+++.+++...+..++||||+++++|..++.. .+.+++..+..++.|++.|+.|||+.|++
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~ 129 (268)
T cd05063 50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129 (268)
T ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45677889999999999999999999999999999999999999998764 35789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
|+||+|+||+++.++.++|+|||++......... .....+..|+|||.+.+.. ++.++|||||||++||+++ |.
T Consensus 130 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred ccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998776432211 1122345799999987655 7999999999999999987 77
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+.+....+....+.. +.+.+ .+...+.++++.+..|+..+|..||....
T Consensus 209 ~p~~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 259 (268)
T cd05063 209 RPYWDMSNHEVMKAIND-GFRLP---APMDCPSAVYQLMLQCWQQDRARRPRFVD 259 (268)
T ss_pred CCCCcCCHHHHHHHHhc-CCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 77777666655554433 33222 23345667777777887777776664433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=230.53 Aligned_cols=224 Identities=20% Similarity=0.219 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.+ +|+||++++++++.+...|+|+||+++++|.+++.....+++..+..++.|++.||.|||+.|+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 126 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 445667889999999 5999999999999999999999999999999988877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
+|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..
T Consensus 127 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 206 (290)
T cd05613 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206 (290)
T ss_pred eccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999987754322 22335688899999998753 236789999999999999999887
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+...........+... ... ......+...+.+.+++.+|+..+
T Consensus 207 p~~~~~~~~~~~~~~~~------------------------~~~------------~~~~~~~~~~~~~~~ll~~~l~~~ 250 (290)
T cd05613 207 PFTVDGEKNSQAEISRR------------------------ILK------------SEPPYPQEMSALAKDIIQRLLMKD 250 (290)
T ss_pred CCCcCCccccHHHHHHH------------------------hhc------------cCCCCCccCCHHHHHHHHHHhcCC
Confidence 76422111000000000 000 000111223456678888888877
Q ss_pred cceeeccccccccccccceeeeeecC
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+..|- .....++.+++.|||+...
T Consensus 251 p~~R~--~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 251 PKKRL--GCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHhc--CCCCCCHHHHHcCcccccC
Confidence 66551 1123478899999988654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=231.06 Aligned_cols=213 Identities=26% Similarity=0.345 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+..++.++|||++++++++.++...|+|+||+.++.+..+.....++++..+..++.|++.|+.|||+.|++|+
T Consensus 66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~ 145 (313)
T cd06633 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145 (313)
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 45677899999999999999999999999999999999865444444455679999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||+|+||+++.++.++|+|||++..... .....++..|+|||.+.+ ...++.++|+|||||++|+|++|..|+.+
T Consensus 146 dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 146 DIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred CCChhhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998865322 234568889999999852 23478899999999999999999988877
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
................ . .........+.+++.+|+...|..|
T Consensus 223 ~~~~~~~~~~~~~~~~-~-------------------------------------~~~~~~~~~l~~li~~~l~~~P~~R 264 (313)
T cd06633 223 MNAMSALYHIAQNDSP-T-------------------------------------LQSNEWTDSFRGFVDYCLQKIPQER 264 (313)
T ss_pred CChHHHHHHHHhcCCC-C-------------------------------------CCccccCHHHHHHHHHHccCChhhC
Confidence 6655544433221100 0 0001112345678888887665555
Q ss_pred eccccccccccccceeeeeecCC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
++..+++.|||+...+
T Consensus 265 -------p~~~~~l~~~~~~~~~ 280 (313)
T cd06633 265 -------PASAELLRHDFVRRDR 280 (313)
T ss_pred -------cCHHHHhcCcccCCCc
Confidence 9999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=226.91 Aligned_cols=165 Identities=21% Similarity=0.205 Sum_probs=135.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-----HGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+..++.++||||+++++++.+....++||||+++|+|.+++... ...+...+..++.|++.|+.|||+
T Consensus 39 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 118 (269)
T cd05087 39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118 (269)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 346778999999999999999999999999999999999999999987532 245677888999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCc------cCCCccchhhHHHH
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDT------LYGPAVDVWAIEWT 163 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~------~~~~~~DvwSlG~i 163 (303)
.|++|+||||+||+++.++.++|+|||.+........ .....++..|+|||++.+.. .++.++|+|||||+
T Consensus 119 ~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05087 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198 (269)
T ss_pred CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHH
Confidence 9999999999999999999999999999865432221 12345678899999986421 25789999999999
Q ss_pred HHHhhc-cCccCCCCchHHH
Q psy763 164 SHSYSQ-IGFIGLGNMGSHM 182 (303)
Q Consensus 164 l~el~t-g~~~~~~~~~~~~ 182 (303)
+|||++ |..|+......+.
T Consensus 199 l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 199 IWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred HHHHHhCCCCCCCCCChHHH
Confidence 999996 7666655444443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=244.60 Aligned_cols=163 Identities=27% Similarity=0.393 Sum_probs=145.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCC---CCCCHHHHHHHHHHHHHH
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHP---HGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~~~~qi~~~ 86 (303)
..++.-.+|++++++++|+|||+++++=.+.. ...+|||||.||+|..+++++ .++++...+.++..+..|
T Consensus 53 r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~a 132 (732)
T KOG4250|consen 53 RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSA 132 (732)
T ss_pred chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHH
Confidence 35667788999999999999999999976544 468999999999999999765 379999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecC----CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTAN----GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEW 162 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~ 162 (303)
|.|||++||+||||||.||++... ...||+|||.|+.+..+....+.+||..|.+||+...+..|+..+|.|||||
T Consensus 133 l~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 133 LRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred HHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 999999999999999999998532 3579999999999998888888999999999999986667999999999999
Q ss_pred HHHHhhccCccCCCCc
Q psy763 163 TSHSYSQIGFIGLGNM 178 (303)
Q Consensus 163 il~el~tg~~~~~~~~ 178 (303)
++||+.||..||...-
T Consensus 213 tlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 213 TLYECATGELPFIPFG 228 (732)
T ss_pred HHHHHhccCCCCCcCC
Confidence 9999999998886543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=231.79 Aligned_cols=215 Identities=27% Similarity=0.355 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.++|||++++++++..++..++|+||+.++.+..+.....++++..+..++.|++.|+.|||+.|++|
T Consensus 69 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H 148 (317)
T cd06635 69 WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148 (317)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 34577889999999999999999999999999999999986444434444567999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCccCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.+ ...++.++|+|||||++|||++|..|+.
T Consensus 149 ~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 149 RDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CCCCcccEEECCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876433 233468889999999752 2347899999999999999999999988
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+........ ......+.+.+++.+|+...|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~l~~li~~~l~~~p~~ 267 (317)
T cd06635 226 NMNAMSALYHIAQNESPTL--------------------------------------QSNEWSDYFRNFVDSCLQKIPQD 267 (317)
T ss_pred CccHHHHHHHHHhccCCCC--------------------------------------CCccccHHHHHHHHHHccCCccc
Confidence 7665555444333221100 00012234567777777655544
Q ss_pred eeccccccccccccceeeeeecCCc
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
| +++.++++|+|+.....
T Consensus 268 R-------pt~~~il~~~~~~~~~~ 285 (317)
T cd06635 268 R-------PTSEELLKHMFVLRERP 285 (317)
T ss_pred C-------cCHHHHHhChhhhccCc
Confidence 4 78888888887765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=225.04 Aligned_cols=212 Identities=25% Similarity=0.347 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|++.++.++|||++++.+.+..+...++|+|++++++|..++.. +..+++..+..++.+++.|+.+||+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 121 (258)
T cd08215 42 EREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121 (258)
T ss_pred HHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 445577889999999999999999999999999999999999999998765 3679999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
.|++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|.
T Consensus 122 ~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~ 200 (258)
T cd08215 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLK 200 (258)
T ss_pred CCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999988765432 223456788999999987665 799999999999999999998
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+......+........... .........+.+++.+|+..
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~i~~~l~~ 241 (258)
T cd08215 201 HPFEGENLLELALKILKGQYP---------------------------------------PIPSQYSSELRNLVSSLLQK 241 (258)
T ss_pred CCCCCCcHHHHHHHHhcCCCC---------------------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 887665544444332221100 00001234567888888886
Q ss_pred ccceeeccccccccccccceeeee
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.|..| +++.+++.||||
T Consensus 242 ~p~~R-------p~~~~ll~~~~~ 258 (258)
T cd08215 242 DPEER-------PSIAQILQSPFI 258 (258)
T ss_pred ChhhC-------cCHHHHhcCCCC
Confidence 66666 999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=222.41 Aligned_cols=213 Identities=25% Similarity=0.354 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+..++.++|+|++++++++..++..++++||+++++|.+++... ..+++..+..++.|++.|+.+||+.|+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 119 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence 4566788999999999999999999999999999999999999999988765 589999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|+.
T Consensus 120 ~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred ecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999988766543334557888999999998665 7899999999999999999998876
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
.....+........... ........+..+.+++.+|+..++..
T Consensus 199 ~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~ 241 (253)
T cd05122 199 ELPPMKALFKIATNGPP-------------------------------------GLRNPEKWSDEFKDFLKKCLQKNPEK 241 (253)
T ss_pred CCchHHHHHHHHhcCCC-------------------------------------CcCcccccCHHHHHHHHHHccCChhh
Confidence 65433332221110000 00000012456778898888866665
Q ss_pred eeccccccccccccceeee
Q psy763 256 IQSEKQDSIRGKNCKKTFY 274 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~ 274 (303)
| +++.++++|||
T Consensus 242 R-------~t~~~~l~~~~ 253 (253)
T cd05122 242 R-------PTAEQLLKHPF 253 (253)
T ss_pred C-------CCHHHHhcCCC
Confidence 5 99999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=236.65 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeC----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRK----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+.+++.+ +||||+++++.+... ...++++|+++ ++|...+.....+++..+..++.|++.||.|||+
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 123 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 44566788888888 599999999976432 45789999987 5788877777789999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHh
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el 167 (303)
.|++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+.+...++.++|+||+||++|++
T Consensus 124 ~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l 203 (332)
T cd07857 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203 (332)
T ss_pred CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999986543211 12346889999999987655589999999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
++|..++.+.........++...+.++.............. .... .......++.. ..+.....+.+++.+
T Consensus 204 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~-------~~~~~~~~~~~li~~ 274 (332)
T cd07857 204 LGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN-YIRS-LPNIPKKPFES-------IFPNANPLALDLLEK 274 (332)
T ss_pred HhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHH-HHHh-ccccCCcchHh-------hCCCCCHHHHHHHHH
Confidence 99998888877777766666654432211000000000000 0000 00000011111 012235678899999
Q ss_pred hhccccceeeccccccccccccceeeeee
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
|+..+|..| +++.+++.|||+.
T Consensus 275 ~l~~~P~~R-------~t~~~ll~~~~~~ 296 (332)
T cd07857 275 LLAFDPTKR-------ISVEEALEHPYLA 296 (332)
T ss_pred HccCCcccC-------CCHHHHhcChhhh
Confidence 998666666 9999999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=229.19 Aligned_cols=209 Identities=20% Similarity=0.237 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC------------CCCHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH------------GLPWDLIKQITWQVL 84 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------~l~~~~~~~~~~qi~ 84 (303)
....+.+|++.++.++|+|++++++++...+..++||||+++++|.+++.... .+++..+..++.|++
T Consensus 60 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 139 (295)
T cd05097 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139 (295)
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999875321 367888999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHH
Q psy763 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIE 161 (303)
Q Consensus 85 ~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG 161 (303)
.|++|||+.|++|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|+||||
T Consensus 140 ~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG 218 (295)
T cd05097 140 SGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFG 218 (295)
T ss_pred HHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHH
Confidence 999999999999999999999999999999999999876543221 12234467899999988655 79999999999
Q ss_pred HHHHHhhc--cCccCCCCchHHHHHHHhh---cCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 162 WTSHSYSQ--IGFIGLGNMGSHMARNLLK---NNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 162 ~il~el~t--g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|++|+|++ +..|+......+.+....+ ..........+...++.+.+++..|+..+|..||....
T Consensus 219 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 219 VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred HHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 99999987 4556655555554443322 11111111222334455666666666666666655443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=223.93 Aligned_cols=202 Identities=19% Similarity=0.221 Sum_probs=153.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFR-RKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+..++.++|+|++++++++. .++..++|+||+++++|.+++.... .+++..+..++.|++.||+|||++|
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (256)
T cd05082 43 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345778999999999999999999764 4567899999999999999876543 4889999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
++|+||+|+||+++.++.+||+|||++....... ....++..|+|||.+.+.. ++.++|||||||++|||++ |..|
T Consensus 123 i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p 199 (256)
T cd05082 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred EeccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999987644322 2334567899999987665 7999999999999999998 6655
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+......+... .+..+... ..++..++...+++-+|+..+|..||....
T Consensus 200 ~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 248 (256)
T cd05082 200 YPRIPLKDVVP-RVEKGYKM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQ 248 (256)
T ss_pred CCCCCHHHHHH-HHhcCCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 55444434333 33333222 122344555566666666665655554433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=235.60 Aligned_cols=239 Identities=27% Similarity=0.409 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+..++.++||||+++++++... ...|+|+||+++ ++..++. ...+++..+..++.|++.||.+||+
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~ 124 (336)
T cd07849 47 CQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHS 124 (336)
T ss_pred HHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34566789999999999999999987644 358999999985 6666654 3479999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
.|++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+...++.++||||+||++|+|+
T Consensus 125 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred CCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999877543221 123467889999998876555799999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh---cCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF---SKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
+|..++.+.........+....+.+.. .. ...........+. ......++... .+...+.+.+++
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li 272 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQ----ED-LNCIISLRARNYIKSLPFKPKVPWNKL-------FPNADPKALDLL 272 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCH----HH-HHHhhchhhhhHHhhcCcCCcccHHHH-------hcccCcHHHHHH
Confidence 999888777665555444433222110 00 0000000000000 00111111111 122467788999
Q ss_pred hhhhccccceeeccccccccccccceeeeeec
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|+...|..| +++.+++.|||+..
T Consensus 273 ~~~l~~dP~~R-------pt~~e~l~hp~~~~ 297 (336)
T cd07849 273 DKMLTFNPHKR-------ITVEEALAHPYLEQ 297 (336)
T ss_pred HHHcCCChhhC-------cCHHHHhcCccccc
Confidence 99999777666 99999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=222.80 Aligned_cols=213 Identities=25% Similarity=0.336 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..+++++||||+++++.+... +..++|+|++++++|.+++.....+++..+..++.|++.|+.|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (260)
T cd06606 42 ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG 121 (260)
T ss_pred HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456778899999999999999999999988 899999999999999999887778999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+.. .+.++|+||||+++|++++|.
T Consensus 122 ~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999988765443 34567888999999988665 799999999999999999988
Q ss_pred ccCCCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 172 FIGLGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 172 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
.|+.+... ......... ... .............+++.+|+.
T Consensus 201 ~p~~~~~~~~~~~~~~~~-~~~-------------------------------------~~~~~~~~~~~l~~~i~~~l~ 242 (260)
T cd06606 201 PPWSELGNPMAALYKIGS-SGE-------------------------------------PPEIPEHLSEEAKDFLRKCLR 242 (260)
T ss_pred CCCCCCCchHHHHHhccc-cCC-------------------------------------CcCCCcccCHHHHHHHHHhCc
Confidence 88766541 111111000 000 000011124567788888888
Q ss_pred cccceeeccccccccccccceeeee
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.++..| ++..+++.|||+
T Consensus 243 ~~p~~R-------p~~~~ll~~~~~ 260 (260)
T cd06606 243 RDPKKR-------PTADELLQHPFL 260 (260)
T ss_pred CChhhC-------CCHHHHhhCCCC
Confidence 655555 999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=223.19 Aligned_cols=201 Identities=19% Similarity=0.233 Sum_probs=156.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+..|+.+++.++|+||+++++++......++|+||+++++|.+++.... .+++..+..++.|++.|+.|||+.|
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~ 122 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567789999999999999999999999999999999999999999886654 7999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
++|+||+|+||+++.++.++|+|||.+....... .....+..|+|||.+.+.. ++.++|+|||||++||+++ |..|
T Consensus 123 i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p 199 (256)
T cd05039 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred ccchhcccceEEEeCCCCEEEccccccccccccc--ccCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999988763222 2334566799999987655 7899999999999999997 5555
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
+... ........+..+.+.. .+...+.+..+++..|+..+|..||..
T Consensus 200 ~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~ 246 (256)
T cd05039 200 YPRI-PLKDVVPHVEKGYRME---APEGCPPEVYKVMKDCWELDPAKRPTF 246 (256)
T ss_pred CCCC-CHHHHHHHHhcCCCCC---CccCCCHHHHHHHHHHhccChhhCcCH
Confidence 5444 4444444444433321 123344555555555555555544443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=221.08 Aligned_cols=204 Identities=19% Similarity=0.253 Sum_probs=158.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..++.++||||+++++++...+..++||||++++++..++.. ...+++..+..++.|++.||.|+|+.|++
T Consensus 36 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 115 (250)
T cd05085 36 KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115 (250)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34577899999999999999999999999999999999999999998754 34689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+|||||++|++++ |..|
T Consensus 116 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p 194 (250)
T cd05085 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCP 194 (250)
T ss_pred ecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999998764432211 1223456799999987655 7899999999999999998 6666
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+......... ...+.+.. .+...+.+..+++.+|+..+|..||....
T Consensus 195 ~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 243 (250)
T cd05085 195 YPGMTNQQAREQ-VEKGYRMS---CPQKCPDDVYKVMQRCWDYKPENRPKFSE 243 (250)
T ss_pred CCCCCHHHHHHH-HHcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 666555544443 33333321 22344556666666666666665554433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=224.90 Aligned_cols=204 Identities=21% Similarity=0.275 Sum_probs=161.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+..++.++||||+++++++...+..++||||+++++|.+++.. +..++...+..++.|++.|+.|||+.|+
T Consensus 46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 125 (261)
T cd05148 46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125 (261)
T ss_pred HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44577889999999999999999999999999999999999999998865 3468999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
+|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..|
T Consensus 126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p 204 (261)
T cd05148 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVP 204 (261)
T ss_pred eccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999876543221 12334567799999987655 7999999999999999998 5666
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+....+....+. .+.+.+ .+...+....+.+-.|+..+|..||....
T Consensus 205 ~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (261)
T cd05148 205 YPGMNNHEVYDQIT-AGYRMP---CPAKCPQEIYKIMLECWAAEPEDRPSFKA 253 (261)
T ss_pred CCcCCHHHHHHHHH-hCCcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 66655555555444 333322 23445556666666777666666665544
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=245.50 Aligned_cols=205 Identities=20% Similarity=0.288 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....|.+|+.++..|+|+|++++||+..+ ....+|||.++.|+|.+.+.+ ...|-......++.|||.|+.||.+++
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 56779999999999999999999999987 678999999999999997765 346888899999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccc----cCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY----VATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~----~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
+|||||..+|+++.....|||+|||+.+-+..++..... .-...|+|||.+.... ++.++|||+|||++|||+|+
T Consensus 233 lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFty 311 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTY 311 (1039)
T ss_pred hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhcc
Confidence 999999999999999999999999999998766554432 2355699999998665 89999999999999999987
Q ss_pred C-ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 171 G-FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 171 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
+ .|+-|....+++.++= .+.+++ .+..++..+.+++-+||..++..|+.|..+
T Consensus 312 GEePW~G~~g~qIL~~iD-~~erLp---RPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 312 GEEPWVGCRGIQILKNID-AGERLP---RPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCCCCCCCCHHHHHHhcc-ccccCC---CCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 6 5556667777766554 777754 667788899999999999999999988775
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=229.55 Aligned_cols=204 Identities=27% Similarity=0.385 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++..++..++|+||+.++.+..+....+.+++..+..++.|++.||.|||+.|++|
T Consensus 59 ~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H 138 (307)
T cd06607 59 WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138 (307)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 34577889999999999999999999999999999999986544444444567999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCccCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||+|+||+++.++.++|+|||++....+. ....++..|+|||.+.+ ...++.++||||||+++|||++|..|+.
T Consensus 139 ~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 139 RDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred cCCCcccEEECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999998765432 23467888999998852 3447899999999999999999998888
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
+.........+... ..+ .......+.+..+++-.|+..+|..||...-+
T Consensus 216 ~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 264 (307)
T cd06607 216 NMNAMSALYHIAQN-DSP--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEEL 264 (307)
T ss_pred CccHHHHHHHHhcC-CCC--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 77655554433322 111 11122234455566667777777777655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=221.93 Aligned_cols=205 Identities=22% Similarity=0.285 Sum_probs=157.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+++++.++|+||+++++++...+..++|+||++++++..++.. ...++...+..++.+++.|+.|||++|+
T Consensus 35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i 114 (251)
T cd05041 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114 (251)
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 345678899999999999999999999999999999999999999998754 4578999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC-
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG- 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~- 171 (303)
+|+||+|+||+++.++.++|+|||.+......... .....+..|+|||.+.+.. ++.++|+|||||++|||++++
T Consensus 115 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~ 193 (251)
T cd05041 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGD 193 (251)
T ss_pred ehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccC
Confidence 99999999999999999999999998765422111 1123356799999987655 799999999999999999954
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+.+..... ....+..+.+++ .+...+.+..+++.+|+..+|..||....
T Consensus 194 ~p~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 244 (251)
T cd05041 194 TPYPGMSNQQ-TRERIESGYRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSE 244 (251)
T ss_pred CCCccCCHHH-HHHHHhcCCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 4444444433 333343333221 23445566666667776666665554433
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=225.23 Aligned_cols=203 Identities=19% Similarity=0.255 Sum_probs=158.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+..++.++||||+++++++.. ...++|+||+++|++.+++... ..+++..+..++.|++.|++|||+.|+
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 130 (279)
T cd05057 52 ANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL 130 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 44567789999999999999999999987 7889999999999999987653 469999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccc---cccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYT---DYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
+|+||+|+||+++.++.+||+|||.+.......... ...++..|+|||.+.+.. ++.++|+|||||++||+++ |.
T Consensus 131 ~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~ 209 (279)
T cd05057 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGA 209 (279)
T ss_pred EecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999998765332211 122356799999987554 7999999999999999998 77
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.|+.+....+. ...+..+...+ .+.....+..+.+-+||..++..||...
T Consensus 210 ~p~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~p~~Rp~~~ 259 (279)
T cd05057 210 KPYEGIPAVEI-PDLLEKGERLP---QPPICTIDVYMVLVKCWMIDAESRPTFK 259 (279)
T ss_pred CCCCCCCHHHH-HHHHhCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 77766655444 44444433322 2233445555666667666666555433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=232.63 Aligned_cols=202 Identities=25% Similarity=0.351 Sum_probs=154.6
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCC----------------------------
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHP---------------------------- 68 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~---------------------------- 68 (303)
..+..|+..++++ +|+||+++++++... ..+++++||+++++|.+++...
T Consensus 55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (337)
T cd05054 55 KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134 (337)
T ss_pred HHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccc
Confidence 4456788899998 899999999988654 5789999999999999876431
Q ss_pred ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEE
Q psy763 69 ---------------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKL 115 (303)
Q Consensus 69 ---------------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl 115 (303)
.++++..+..++.|++.||.|||++||+||||||+||+++.++.++|
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL 214 (337)
T cd05054 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI 214 (337)
T ss_pred cCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEE
Confidence 25788999999999999999999999999999999999999999999
Q ss_pred ccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCC
Q psy763 116 CDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNG 191 (303)
Q Consensus 116 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~ 191 (303)
+|||++........ .....++..|+|||.+.+.. ++.++||||+||++|||++ |..|+.+....+.....+..+.
T Consensus 215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 293 (337)
T cd05054 215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293 (337)
T ss_pred eccccchhcccCcchhhccCCCCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC
Confidence 99999987643221 12234567899999998766 8999999999999999997 7777766555555555554443
Q ss_pred ceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 192 RVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
+.. .+.....+..+++..|+..+|..||..
T Consensus 294 ~~~---~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 294 RMR---APEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred CCC---CCccCCHHHHHHHHHHccCChhhCcCH
Confidence 321 123344455555556665555555443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=222.35 Aligned_cols=212 Identities=24% Similarity=0.315 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|++.++.++|||++++++++..++..++|+|++++++|.+++.....+++..+..++.|++.|+.+||+.|++
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (254)
T cd06627 42 ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121 (254)
T ss_pred HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 34568889999999999999999999999999999999999999999988778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|+.
T Consensus 122 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred cCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999987654332 23456788999999987665 7899999999999999999988876
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+............. . .....+.....+.+++.+|+...+..
T Consensus 201 ~~~~~~~~~~~~~~-~--------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~ 241 (254)
T cd06627 201 DLNPMAALFRIVQD-D--------------------------------------HPPLPEGISPELKDFLMQCFQKDPNL 241 (254)
T ss_pred CccHHHHHHHHhcc-C--------------------------------------CCCCCCCCCHHHHHHHHHHHhCChhh
Confidence 55433322211100 0 00111223456678888888866655
Q ss_pred eeccccccccccccceeeee
Q psy763 256 IQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~ 275 (303)
| +++.+++.|+||
T Consensus 242 R-------~~~~~~l~~~~~ 254 (254)
T cd06627 242 R-------PTAKQLLKHPWI 254 (254)
T ss_pred C-------cCHHHHhcCCCC
Confidence 5 999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=228.27 Aligned_cols=233 Identities=29% Similarity=0.423 Sum_probs=170.2
Q ss_pred HHHHHHHHH---hCCCCCcceeEEEEEeCCE-----EEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHH
Q psy763 21 EATNKKEKR---SLKHPNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 21 ~~~e~~~l~---~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~l 90 (303)
+.+|+..++ .++|||++++++++..... +++++||+.+ ++.+++... ..+++..+..++.|++.||.||
T Consensus 45 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L 123 (287)
T cd07838 45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123 (287)
T ss_pred HHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334555444 4579999999999988776 9999999985 676665543 3589999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.|++|+||+|+||+++.++.++|+|||++.............++..|+|||.+.+.. ++.++|+||+||++|+|++|
T Consensus 124 H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~ 202 (287)
T cd07838 124 HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRR 202 (287)
T ss_pred HHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhC
Confidence 99999999999999999999999999999998765444444456788999999998765 79999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..++.+....+...++............+.... .....+..... .+.... .+...+.+.+++.+|+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~li~~~l~ 269 (287)
T cd07838 203 RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS-----LPRSSFPSYTP-RSFKSF-------VPEICEEGLDLLKKMLT 269 (287)
T ss_pred CCcccCCChHHHHHHHHHHcCCCChHhcCCCcc-----cchhhcccccc-cchhhh-------hhhhhHHHHHHHHHHhc
Confidence 888888877777766665433221100000000 00000101000 111000 11235677899999998
Q ss_pred cccceeeccccccccccccceeeee
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+|..| +++.+++.|+||
T Consensus 270 ~dp~~R-------p~~~~il~~~~~ 287 (287)
T cd07838 270 FNPHKR-------ISAFEALQHPYF 287 (287)
T ss_pred cCCccC-------CCHHHHhcCcCC
Confidence 666666 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=225.27 Aligned_cols=212 Identities=23% Similarity=0.306 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++|+||+++++.+..++..++|+||+++++|.+++.... .+++..+..++.|++.|+.|||+.|
T Consensus 42 ~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (257)
T cd08225 42 EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121 (257)
T ss_pred hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34566789999999999999999999999999999999999999999876433 5799999999999999999999999
Q ss_pred ceecccCCCcEEEecCC-cEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 95 CIHRDIKPENILLTANG-VVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
++|+||+|+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+.. ++.++|+||+||++||+++|..
T Consensus 122 i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08225 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKH 200 (257)
T ss_pred cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999875 56999999987654332 223346888999999987655 7999999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+.+....+........... ...+..+.++.+++.+|+...
T Consensus 201 p~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~i~~~l~~~ 241 (257)
T cd08225 201 PFEGNNLHQLVLKICQGYFA---------------------------------------PISPNFSRDLRSLISQLFKVS 241 (257)
T ss_pred CCCCccHHHHHHHHhcccCC---------------------------------------CCCCCCCHHHHHHHHHHhccC
Confidence 88766554444332221000 001123345678888888755
Q ss_pred cceeeccccccccccccceeeee
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
|..| +++.+++.||||
T Consensus 242 p~~R-------pt~~~ll~~~~~ 257 (257)
T cd08225 242 PRDR-------PSITSILKRPFL 257 (257)
T ss_pred hhhC-------cCHHHHhhCCCC
Confidence 5555 999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=236.64 Aligned_cols=236 Identities=24% Similarity=0.354 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
..+.+|+.+++.++||||+++++++.... .+++|+||+.. ++..+.. ..+++..+..++.|++.||+|||+
T Consensus 59 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~ 135 (342)
T cd07879 59 KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHS 135 (342)
T ss_pred hHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44678899999999999999999987543 56999999974 6666543 468999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
.|++||||+|+||+++.++.++|+|||++..... ......++..|+|||.+.+...++.++|+|||||++|||++|..
T Consensus 136 ~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~ 213 (342)
T cd07879 136 AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213 (342)
T ss_pred CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999876432 22334678889999998765557899999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc---CCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS---KTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
+|.+......+..++...+....... ..........+.. .....++.. ..+...+.+.+++.+|+
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l 281 (342)
T cd07879 214 LFKGKDYLDQLTQILKVTGVPGPEFV-----QKLEDKAAKSYIKSLPKYPRKDFST-------LFPKASPQAVDLLEKML 281 (342)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHH-----HHhcccchHHHHhhcCCcccchHHH-------HhcCCCHHHHHHHHHHc
Confidence 99888776666666654332210000 0000000000000 000011111 01234567889999999
Q ss_pred ccccceeeccccccccccccceeeeeecC
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
..+|..| +++.+++.||||...
T Consensus 282 ~~dP~~R-------~~~~e~l~h~~f~~~ 303 (342)
T cd07879 282 ELDVDKR-------LTATEALEHPYFDSF 303 (342)
T ss_pred CCChhhC-------cCHHHHhcCcchhhc
Confidence 9777666 999999999999774
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=236.86 Aligned_cols=204 Identities=23% Similarity=0.309 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC----------------------------
Q psy763 19 ATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH---------------------------- 69 (303)
Q Consensus 19 ~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------------------------- 69 (303)
..+.+|+.++..+. ||||+++++.+...+..++|+||+++|+|.+++.+.+
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence 45778999999997 9999999999999999999999999999998875321
Q ss_pred ----------------------------------------------------------------------CCCHHHHHHH
Q psy763 70 ----------------------------------------------------------------------GLPWDLIKQI 79 (303)
Q Consensus 70 ----------------------------------------------------------------------~l~~~~~~~~ 79 (303)
.++...+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 244 (401)
T cd05107 165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF 244 (401)
T ss_pred ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence 3567778899
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccc
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVD 156 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~D 156 (303)
+.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|
T Consensus 245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D 323 (401)
T cd05107 245 SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSD 323 (401)
T ss_pred HHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhH
Confidence 99999999999999999999999999999999999999999986532211 12235678899999998655 799999
Q ss_pred hhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 157 VWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 157 vwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||||||++|||++ |+.|+.+....+.....+..+.+++ .+...+.++.+++-+||..+|..||....
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999998 6666655555555555555554432 23344566667777777777776666554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=237.49 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC--------------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK--------------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi 83 (303)
...+.+|+++++.++||||+++++++... ...|+|+||++ +++..++.. +.+++..++.++.|+
T Consensus 46 ~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi 123 (342)
T cd07854 46 VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQL 123 (342)
T ss_pred HHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHH
Confidence 35567789999999999999999876643 35799999998 577777754 478999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEec-CCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchh
Q psy763 84 LRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVW 158 (303)
Q Consensus 84 ~~~l~~lH~~~ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~Dvw 158 (303)
+.||.|||+.|++|+||+|+||+++. ++.++|+|||.+....... ......++..|+|||.+.+...++.++|+|
T Consensus 124 ~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 203 (342)
T cd07854 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203 (342)
T ss_pred HHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHH
Confidence 99999999999999999999999974 5678999999987653221 112345788899999876555578999999
Q ss_pred hHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCc
Q psy763 159 AIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNS 238 (303)
Q Consensus 159 SlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 238 (303)
||||++|+|++|..||.+..........+...+....... ..........+.. ......++.... .+...
T Consensus 204 SlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~-------~~~~~ 273 (342)
T cd07854 204 AAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR-NELLNVIPSFVRN--DGGEPRRPLRDL-------LPGVN 273 (342)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh-hhhhhhhhhhhhh--cccccCCCHHHH-------ccCCC
Confidence 9999999999999999988877777666654322110000 0000000000000 001111122111 12345
Q ss_pred hhhHHhhhhhhccccceeeccccccccccccceeeeee
Q psy763 239 HGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 239 ~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
.++.+++.+|+..+|..| +++.+++.|+|+.
T Consensus 274 ~~~~~li~~~L~~dP~~R-------~t~~ell~h~~~~ 304 (342)
T cd07854 274 PEALDFLEQILTFNPMDR-------LTAEEALMHPYMS 304 (342)
T ss_pred HHHHHHHHHHhCCCchhc-------cCHHHHhCCCccc
Confidence 678899999998766666 9999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=228.86 Aligned_cols=220 Identities=22% Similarity=0.262 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHH---H--cCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---E--NHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~---~--~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+..+.++. |+||+++++++..++..++++||+.. ++..+ + .....+++..+..++.|++.||+||
T Consensus 45 ~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l 123 (288)
T cd06616 45 EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123 (288)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3455677888888886 99999999999999999999999875 33332 1 2245799999999999999999999
Q ss_pred HHC-CceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCC--ccCCCccchhhHHHHHHHh
Q psy763 91 HRH-ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD--TLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 91 H~~-~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~DvwSlG~il~el 167 (303)
|+. |++||||+|+||+++.++.++|+|||++.............++..|+|||.+.+. ..++.++||||+||++|+|
T Consensus 124 h~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 203 (288)
T cd06616 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203 (288)
T ss_pred hhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHH
Confidence 985 9999999999999999999999999998765443333445688899999999765 3579999999999999999
Q ss_pred hccCccCCCCchH-HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 168 SQIGFIGLGNMGS-HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 168 ~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
++|..|+...... +....... +..+. .........+..+.+++.
T Consensus 204 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~----------------------------------~~~~~~~~~~~~l~~li~ 248 (288)
T cd06616 204 ATGKFPYPKWNSVFDQLTQVVK-GDPPI----------------------------------LSNSEEREFSPSFVNFIN 248 (288)
T ss_pred HhCCCCchhcchHHHHHhhhcC-CCCCc----------------------------------CCCcCCCccCHHHHHHHH
Confidence 9999887654311 11111111 00000 000111224556789999
Q ss_pred hhhccccceeeccccccccccccceeeeeecCC
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+|+..+|..| ++..+++.|||+....
T Consensus 249 ~~l~~~p~~R-------pt~~~i~~~~~~~~~~ 274 (288)
T cd06616 249 LCLIKDESKR-------PKYKELLEHPFIKDYE 274 (288)
T ss_pred HHccCChhhC-------cCHHHHhcChhhhchh
Confidence 9998666666 9999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=224.84 Aligned_cols=160 Identities=26% Similarity=0.431 Sum_probs=140.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|++.++.++|+|++++++.+..++..++||||+++++|..++.. ...+++..+..++.|++.|+.|||+
T Consensus 45 ~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 124 (267)
T cd08224 45 ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124 (267)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 356678899999999999999999999999999999999999999987743 3468999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||+||++|+|++|.
T Consensus 125 ~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~ 203 (267)
T cd08224 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999987654322 223356888999999988665 799999999999999999999
Q ss_pred ccCCCC
Q psy763 172 FIGLGN 177 (303)
Q Consensus 172 ~~~~~~ 177 (303)
.|+.+.
T Consensus 204 ~p~~~~ 209 (267)
T cd08224 204 SPFYGD 209 (267)
T ss_pred CCcccC
Confidence 887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=231.25 Aligned_cols=161 Identities=29% Similarity=0.476 Sum_probs=140.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+..++.++||||+++++++..++..++|+||++++++..++.+. .+++..+..++.|++.|+.|||++|++|
T Consensus 60 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H 138 (293)
T cd06647 60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIH 138 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 456778889999999999999999999999999999999999999988653 6889999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+.. ++.++|+|||||++|++++|..|+.+
T Consensus 139 ~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred ccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999887654332 223346788899999987654 79999999999999999999988876
Q ss_pred CchH
Q psy763 177 NMGS 180 (303)
Q Consensus 177 ~~~~ 180 (303)
....
T Consensus 218 ~~~~ 221 (293)
T cd06647 218 ENPL 221 (293)
T ss_pred CChh
Confidence 5443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=223.06 Aligned_cols=200 Identities=22% Similarity=0.282 Sum_probs=150.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+.+++.++||||+++++.+.. ...++||||+++|++.+++.. +..+++..+..++.|++.||.|||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i 123 (262)
T cd05071 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123 (262)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3467889999999999999999998754 558999999999999998864 2458899999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG-F 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~-~ 172 (303)
+|+||+|+||+++.++.++|+|||.+......... ....++..|+|||...+.. ++.++|+|||||++||+++++ .
T Consensus 124 ~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~ 202 (262)
T cd05071 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRV 202 (262)
T ss_pred cccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999766433221 2234567899999887655 799999999999999999955 4
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|+.+....+....+ ..+.+.+ .+...+....+++..|+..+|..||.
T Consensus 203 p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~ 249 (262)
T cd05071 203 PYPGMVNREVLDQV-ERGYRMP---CPPECPESLHDLMCQCWRKEPEERPT 249 (262)
T ss_pred CCCCCChHHHHHHH-hcCCCCC---CccccCHHHHHHHHHHccCCcccCCC
Confidence 44444444444333 3322221 12233444555555555555554443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=226.38 Aligned_cols=202 Identities=25% Similarity=0.263 Sum_probs=155.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------------CCCCHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------------HGLPWDL 75 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------------~~l~~~~ 75 (303)
...+.+|+..++.++||||+++++++..+...++|+||+++|+|..++... ..+++..
T Consensus 52 ~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 131 (288)
T cd05050 52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131 (288)
T ss_pred HHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHH
Confidence 355778999999999999999999999999999999999999999987532 2467888
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCC
Q psy763 76 IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYG 152 (303)
Q Consensus 76 ~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~ 152 (303)
++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ......+..|+|||.+.+.. ++
T Consensus 132 ~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~ 210 (288)
T cd05050 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YT 210 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CC
Confidence 999999999999999999999999999999999999999999999876543221 12233466799999987665 89
Q ss_pred CccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 153 PAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 153 ~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
.++|||||||++|||++ |..|+.+....+....+.. +... ..+...+.++.+++..|+..+|..||..
T Consensus 211 ~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 279 (288)
T cd05050 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD-GNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSF 279 (288)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 99999999999999997 5567777666655544332 2221 1123344555555556655555555443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=219.91 Aligned_cols=210 Identities=20% Similarity=0.288 Sum_probs=163.1
Q ss_pred HHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCCCc
Q psy763 27 EKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPEN 104 (303)
Q Consensus 27 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlk~~n 104 (303)
+++..++|+||+++|+|..+..+++.||.|.. .+..++ .-.+++++..+-.+...++.||.||.. +||+|||+||+|
T Consensus 144 v~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 144 VLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred HhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 34455699999999999999999999999863 344433 335689999999999999999999986 689999999999
Q ss_pred EEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCccCCCCchH-H
Q psy763 105 ILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGS-H 181 (303)
Q Consensus 105 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~-~ 181 (303)
||+|..|.+|+||||.+-++......+...|-+.|||||.+.. .+.|+..+||||||++++|+.||.+|+.+.... +
T Consensus 223 ILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe 302 (391)
T KOG0983|consen 223 ILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE 302 (391)
T ss_pred eEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence 9999999999999999998877766677789999999999863 355899999999999999999999999887554 4
Q ss_pred HHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeecccc
Q psy763 182 MARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQ 261 (303)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~ 261 (303)
.+-.++. ..+ +.+... ...++...+|++.+|+.+...+
T Consensus 303 ~ltkvln-~eP-P~L~~~-----------------------------------~gFSp~F~~fv~~CL~kd~r~R----- 340 (391)
T KOG0983|consen 303 VLTKVLN-EEP-PLLPGH-----------------------------------MGFSPDFQSFVKDCLTKDHRKR----- 340 (391)
T ss_pred HHHHHHh-cCC-CCCCcc-----------------------------------cCcCHHHHHHHHHHhhcCcccC-----
Confidence 4444443 222 101110 0134566777878887655555
Q ss_pred ccccccccceeeeeecCCcc
Q psy763 262 DSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 262 ~~~~~~~~l~~~~~~~~~~~ 281 (303)
+.-.+||+|||+.+-+..
T Consensus 341 --P~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 341 --PKYNKLLEHPFIKRYETA 358 (391)
T ss_pred --cchHHHhcCcceeecchh
Confidence 777788888887664443
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=221.77 Aligned_cols=202 Identities=22% Similarity=0.280 Sum_probs=156.3
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+|+.+++.++|+|++++++++. .+..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~ 124 (260)
T cd05070 46 ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124 (260)
T ss_pred HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45788999999999999999999885 4568999999999999998764 23589999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..|
T Consensus 125 H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p 203 (260)
T cd05070 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred cCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999875433211 1233456799999987655 7999999999999999999 5666
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+....+....+ ..+.+++ .+...+....+++.+|+..+|..||....
T Consensus 204 ~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 252 (260)
T cd05070 204 YPGMNNREVLEQV-ERGYRMP---CPQDCPISLHELMLQCWKKDPEERPTFEY 252 (260)
T ss_pred CCCCCHHHHHHHH-HcCCCCC---CCCcCCHHHHHHHHHHcccCcccCcCHHH
Confidence 6665555554443 3332221 22344555566666666666666665443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=228.71 Aligned_cols=161 Identities=30% Similarity=0.494 Sum_probs=136.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHH-HcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++|+|++++++++..+...++|+||+.+ ++..+ ......+++..+..++.|++.|+.|||+.|++|
T Consensus 60 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H 138 (308)
T cd06634 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138 (308)
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 4566789999999999999999999999999999999985 55554 444567899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCccCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||+|+||+++.++.++|+|||++....+. ....++..|+|||.+.+ ...++.++|||||||++|+|++|..|+.
T Consensus 139 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CCCCHHhEEECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999998775432 33467889999999753 2336889999999999999999998877
Q ss_pred CCchHHHH
Q psy763 176 GNMGSHMA 183 (303)
Q Consensus 176 ~~~~~~~~ 183 (303)
+....+..
T Consensus 216 ~~~~~~~~ 223 (308)
T cd06634 216 NMNAMSAL 223 (308)
T ss_pred cccHHHHH
Confidence 65544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=230.55 Aligned_cols=201 Identities=24% Similarity=0.341 Sum_probs=153.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
...+.+|+.+++.+ +||||+++++++..++.+++|+||+++|+|.+++... ..++...+..++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (334)
T cd05100 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140 (334)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 45677889999999 7999999999999999999999999999999987542 247788899999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.|++.||.|||++|++|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++||
T Consensus 141 ~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 219 (334)
T cd05100 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDV 219 (334)
T ss_pred HHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhh
Confidence 9999999999999999999999999999999999999999876543221 12223456799999998665 7999999
Q ss_pred hhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 158 WAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 158 wSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|||||++|||++ |..|+.+....+... .+..+.+.. .+...+.+..+++..|+..+|..||.
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps 282 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFK-LLKEGHRMD---KPANCTHELYMIMRECWHAVPSQRPT 282 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcC
Confidence 999999999998 555555554444433 333333221 12334445555666666555555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=224.78 Aligned_cols=170 Identities=25% Similarity=0.366 Sum_probs=145.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++|+||+++++.+.+. +.+++++||+++++|.+++...+.+++..+..++.|++.|+.|||+.|
T Consensus 47 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~ 126 (264)
T cd06653 47 EVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126 (264)
T ss_pred HHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 445788899999999999999999998764 468999999999999998877677999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCC----CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPG----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+.. ++.++|+|||||++|++++|
T Consensus 127 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g 205 (264)
T cd06653 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTE 205 (264)
T ss_pred EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765321 1122346788999999998765 78999999999999999999
Q ss_pred CccCCCCchHHHHHHHh
Q psy763 171 GFIGLGNMGSHMARNLL 187 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~ 187 (303)
..|+.+.........+.
T Consensus 206 ~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 206 KPPWAEYEAMAAIFKIA 222 (264)
T ss_pred CCCCCccCHHHHHHHHH
Confidence 98887765555554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=224.93 Aligned_cols=214 Identities=21% Similarity=0.271 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++.+..+...++|+||++++++..++.. ..+++..+..++.|++.|+.+||+.|++
T Consensus 45 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (277)
T cd06641 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI 123 (277)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCee
Confidence 345678899999999999999999999999999999999999999998764 4789999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||+||++|+|++|..|+.
T Consensus 124 h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred cCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999987654322 223346788899999987655 7899999999999999999988876
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+.. +..+ ......+.++.+++.+|+...|..
T Consensus 203 ~~~~~~~~~~~~~-~~~~--------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~ 243 (277)
T cd06641 203 ELHPMKVLFLIPK-NNPP--------------------------------------TLEGNYSKPLKEFVEACLNKEPSF 243 (277)
T ss_pred ccchHHHHHHHhc-CCCC--------------------------------------CCCcccCHHHHHHHHHHccCChhh
Confidence 5544333322111 1000 001123455677888887644544
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
| ++..+++.|+|+...
T Consensus 244 R-------p~~~~~l~~~~~~~~ 259 (277)
T cd06641 244 R-------PTAKELLKHKFIVRF 259 (277)
T ss_pred C-------cCHHHHHhCHHHhhh
Confidence 4 888899999888764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=226.05 Aligned_cols=159 Identities=31% Similarity=0.495 Sum_probs=135.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|++.++.++||||+++++++... +.+++||||+++++|.+++. ....+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 445677899999999999999999998654 47899999999999988653 345689999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.|++|+||+|+||+++.++.++|+|||++........ ....++..|+|||.+.+.. ++.++|+||+||++|+|++|
T Consensus 122 H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g 199 (287)
T cd06621 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQN 199 (287)
T ss_pred HHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999876443221 2345788899999987655 79999999999999999999
Q ss_pred CccCCCC
Q psy763 171 GFIGLGN 177 (303)
Q Consensus 171 ~~~~~~~ 177 (303)
..|+...
T Consensus 200 ~~p~~~~ 206 (287)
T cd06621 200 RFPFPPE 206 (287)
T ss_pred CCCCCcc
Confidence 8887644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=226.27 Aligned_cols=165 Identities=21% Similarity=0.285 Sum_probs=137.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-----------CCCHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-----------GLPWDLIKQITWQVLRG 86 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------~l~~~~~~~~~~qi~~~ 86 (303)
...+.+|+..++.++|+||+++++++..+...++|+||+++++|..++.... .+++..+..++.|++.|
T Consensus 63 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05095 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASG 142 (296)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999999999999999999999875432 36778899999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
++|||+.|++|+||||+||+++.++.++|+|||++........ .....++..|++||...+.. ++.++|+|||||+
T Consensus 143 l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~ 221 (296)
T cd05095 143 MKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVT 221 (296)
T ss_pred HHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHH
Confidence 9999999999999999999999999999999999876543221 11223467899999887655 8999999999999
Q ss_pred HHHhhc--cCccCCCCchHHHH
Q psy763 164 SHSYSQ--IGFIGLGNMGSHMA 183 (303)
Q Consensus 164 l~el~t--g~~~~~~~~~~~~~ 183 (303)
+|||++ |..|+.+....+..
T Consensus 222 l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 222 LWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred HHHHHHhCCCCCccccChHHHH
Confidence 999987 55666555544443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=222.64 Aligned_cols=204 Identities=22% Similarity=0.286 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-------CCCCCHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-------PHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
...+.+|+..++.++||||+++++++......++|+||+++++|..++.. ...+++..+..++.|++.|+.||
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (269)
T cd05044 43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122 (269)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH
Confidence 44677899999999999999999999999999999999999999998753 23478899999999999999999
Q ss_pred HHCCceecccCCCcEEEecCC-----cEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHH
Q psy763 91 HRHACIHRDIKPENILLTANG-----VVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEW 162 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~-----~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~ 162 (303)
|+.+++|+||+|+||+++.++ .++++|||++........ .....++..|+|||.+.+.. ++.++|||||||
T Consensus 123 H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~ 201 (269)
T cd05044 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGV 201 (269)
T ss_pred HhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHH
Confidence 999999999999999999877 899999999876543221 12234567899999998655 799999999999
Q ss_pred HHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 163 TSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 163 il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++|||++ |..|+......+.... +..+.++. .+...+...++++-+|+..+|..||....
T Consensus 202 il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 202 LMWEILTLGQQPYPALNNQEVLQH-VTAGGRLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred HHHHHHHcCCCCCcccCHHHHHHH-HhcCCccC---CcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999998 6666655555444333 33332221 22334556666666666666666665444
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=223.90 Aligned_cols=149 Identities=19% Similarity=0.209 Sum_probs=128.9
Q ss_pred HHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCC
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKP 102 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~ 102 (303)
++...+....||||+++++++...+..++||||+++|+|.+++.+...+++..+..++.|++.||.|||+.|++|+||||
T Consensus 34 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp 113 (237)
T cd05576 34 RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113 (237)
T ss_pred hHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 34445556679999999999999999999999999999999887767899999999999999999999999999999999
Q ss_pred CcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 103 ENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 103 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||+++.++.++++|||.+...... .....++..|+|||.+.+.. ++.++|+||+||++|||++|..++
T Consensus 114 ~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~ 182 (237)
T cd05576 114 NNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLV 182 (237)
T ss_pred HHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchh
Confidence 9999999999999999987665432 22345577799999987655 789999999999999999987553
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=220.81 Aligned_cols=203 Identities=22% Similarity=0.276 Sum_probs=155.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++|+|++++++++. .+..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 123 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 355778999999999999999999885 45688999999999999987643 358899999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||++++++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|||++ |..
T Consensus 124 ~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~ 202 (260)
T cd05069 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred eecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999977543221 12234567799999887655 7999999999999999999 666
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+....+ ..+.+.+ .+...+....+.+.+|+..+|..||....
T Consensus 203 p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05069 203 PYPGMVNREVLEQV-ERGYRMP---CPQGCPESLHELMKLCWKKDPDERPTFEY 252 (260)
T ss_pred CCCCCCHHHHHHHH-HcCCCCC---CCcccCHHHHHHHHHHccCCcccCcCHHH
Confidence 66665555544433 3333221 12334555666666666666666654433
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=223.06 Aligned_cols=211 Identities=21% Similarity=0.279 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+..++.++|+||+++++++......++|+||+++++|..++.+ ...+++..++.++.|++.||++||+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~ 121 (256)
T cd08530 42 EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121 (256)
T ss_pred HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345567789999999999999999999999999999999999999987754 3578999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+.. ++.++|+||+|+++|++++|..
T Consensus 122 ~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~ 199 (256)
T cd08530 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAP 199 (256)
T ss_pred CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998876544 333456788999999998655 7899999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+.+............. ... ........++.+++.+|+..+
T Consensus 200 p~~~~~~~~~~~~~~~~-~~~--------------------------------------~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08530 200 PFEARSMQDLRYKVQRG-KYP--------------------------------------PIPPIYSQDLQNFIRSMLQVK 240 (256)
T ss_pred CCCCCCHHHHHHHHhcC-CCC--------------------------------------CCchhhCHHHHHHHHHHcCCC
Confidence 87665544333222110 000 000112345678888888866
Q ss_pred cceeeccccccccccccceeeee
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
+..| +++.+++.||++
T Consensus 241 p~~R-------p~~~~~l~~p~~ 256 (256)
T cd08530 241 PKLR-------PNCDKILASPAV 256 (256)
T ss_pred cccC-------CCHHHHhcCCCC
Confidence 6666 999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=220.10 Aligned_cols=168 Identities=25% Similarity=0.354 Sum_probs=141.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCC--CCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+..|+..++.++|+||+++++++.+.+..++++|+++++++.+++..... +++..+..++.|++.|+.+||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 445678899999999999999999999999999999999999999998865443 999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccc--cccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC-
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT--DYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG- 171 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~- 171 (303)
++|+||+|+||+++.++.++|+|||.+.......... ...++..|+|||.+.+.. ++.++|+||+||++|+|++++
T Consensus 124 ~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~ 202 (258)
T smart00219 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGE 202 (258)
T ss_pred eeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998765432222 123678899999986544 799999999999999999854
Q ss_pred ccCCCCchHHHHHH
Q psy763 172 FIGLGNMGSHMARN 185 (303)
Q Consensus 172 ~~~~~~~~~~~~~~ 185 (303)
.|+.+....+....
T Consensus 203 ~p~~~~~~~~~~~~ 216 (258)
T smart00219 203 SPYPGMSNEEVLEY 216 (258)
T ss_pred CCCCCCCHHHHHHH
Confidence 55444444444443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=220.60 Aligned_cols=204 Identities=22% Similarity=0.284 Sum_probs=160.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+..++.++|+||+++++++..+...++|+||+++++|.+++... ..++...+..++.|++.|+.|||++|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i 124 (261)
T cd05034 45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY 124 (261)
T ss_pred HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 345778999999999999999999999989999999999999999988653 368999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||+++.++.++|+|||++........ ......+..|+|||.+.+.. ++.++|+||+||++|++++ |..
T Consensus 125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~ 203 (261)
T cd05034 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRV 203 (261)
T ss_pred ccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999877543211 11223456799999988655 7999999999999999998 777
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+.........+... .+. ..+...+.+..+.+.+++..+|..||..+.
T Consensus 204 p~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 253 (261)
T cd05034 204 PYPGMTNREVLEQVERG-YRM---PRPPNCPEELYDLMLQCWDKDPEERPTFEY 253 (261)
T ss_pred CCCCCCHHHHHHHHHcC-CCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 77666655555544332 221 122334556666666677666666665444
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=226.87 Aligned_cols=211 Identities=21% Similarity=0.291 Sum_probs=158.9
Q ss_pred HHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRH-ACIH 97 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH 97 (303)
+....++.++||||+++++++..++..|+|+||++ |++..++. ....+++..++.++.|++.||.|||++ +++|
T Consensus 49 e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h 127 (283)
T cd06617 49 DLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH 127 (283)
T ss_pred HHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence 33445778899999999999999999999999998 55555443 334789999999999999999999997 9999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCC---ccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD---TLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||+|+||+++.++.+||+|||++.............++..|+|||.+.+. ..++.++|+||+||++|+|++|..|+
T Consensus 128 ~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 128 RDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred CCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence 999999999999999999999998875433333335678899999988652 23688999999999999999998877
Q ss_pred CCCc-hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 175 LGNM-GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 175 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
.... ..+........ ..+ ..+....+.++.+++.+|+...|
T Consensus 208 ~~~~~~~~~~~~~~~~-~~~-------------------------------------~~~~~~~~~~l~~li~~~l~~~p 249 (283)
T cd06617 208 DSWKTPFQQLKQVVEE-PSP-------------------------------------QLPAEKFSPEFQDFVNKCLKKNY 249 (283)
T ss_pred CccccCHHHHHHHHhc-CCC-------------------------------------CCCccccCHHHHHHHHHHccCCh
Confidence 5322 11222211110 000 00011124567788888888666
Q ss_pred ceeeccccccccccccceeeeeecCC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
..| ++..+++.|+|+....
T Consensus 250 ~~R-------p~~~~il~~~~~~~~~ 268 (283)
T cd06617 250 KER-------PNYPELLQHPFFELHL 268 (283)
T ss_pred hhC-------cCHHHHhcCchhhhcc
Confidence 555 9999999999987754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=224.95 Aligned_cols=199 Identities=17% Similarity=0.210 Sum_probs=148.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------CCCCHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~l~~~~~~~~~~qi~~~l~ 88 (303)
..+.+|+..++.++||||+++++++...+..|+||||+++|+|.+++... ..++...+..++.|++.||.
T Consensus 54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 133 (288)
T cd05061 54 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133 (288)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999999999988532 23466788899999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|||++|++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|
T Consensus 134 ~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~ 212 (288)
T cd05061 134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLW 212 (288)
T ss_pred HHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHH
Confidence 99999999999999999999999999999999876543221 12234467799999988655 799999999999999
Q ss_pred Hhhcc-CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 166 SYSQI-GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 166 el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
||+++ ..|+.+....+....+ ..+.... .+...+.+..+++..|+..+|..||
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 266 (288)
T cd05061 213 EITSLAEQPYQGLSNEQVLKFV-MDGGYLD---QPDNCPERVTDLMRMCWQFNPKMRP 266 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHH-HcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCc
Confidence 99985 4555555444443333 2222221 1222334444444455544444443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=241.66 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=188.3
Q ss_pred HHHHHHHHHhCC------CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHH
Q psy763 21 EATNKKEKRSLK------HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 21 ~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH 91 (303)
-.+|+++|+.|+ --++++++..|...+|+|||||.+. -+|..++++-+ +|....+..++.|+..||.+|-
T Consensus 475 Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK 553 (752)
T KOG0670|consen 475 GLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK 553 (752)
T ss_pred hhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH
Confidence 356788888884 3468999999999999999999886 67777776543 6888999999999999999999
Q ss_pred HCCceecccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 92 RHACIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
..||+|.||||.||||+.+ ..+||||||.|.+.+... .++...+..|+|||++.|-+ |+...|+||+||+|||++||
T Consensus 554 ~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtG 631 (752)
T KOG0670|consen 554 KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTG 631 (752)
T ss_pred hcCeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeecc
Confidence 9999999999999999976 678999999998876543 35566788899999999987 99999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecC-CCC-----Ccc-------hhhhhhh---hhhcCC-ChhHHHHHHhHhCCC
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKS-DSL-----DSE-------TWDLTWQ---EIFSKT-STTTIFKYLLIRGGN 233 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~-------~~~~~~~---~~~~~~-~~~~~~~~l~~~~~~ 233 (303)
...|.|.++.+++.-.+...|+.+-.... ..+ ... .-...-. ..+... .++.+...+.-.+..
T Consensus 632 kIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~ 711 (752)
T KOG0670|consen 632 KILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL 711 (752)
T ss_pred ceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC
Confidence 99999999999999999988876642211 111 100 0000000 011111 224455555443333
Q ss_pred C---CCCchhhHHhhhhhhccccceeeccccccccccccceeeeee
Q psy763 234 T---DRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 234 ~---~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
. ......+.|||++|+...|..+ ++..+||.||||-
T Consensus 712 ~deq~~~~~~~rdLLdkml~LdP~KR-------it~nqAL~HpFi~ 750 (752)
T KOG0670|consen 712 PDEQPKIVQQLRDLLDKMLILDPEKR-------ITVNQALKHPFIT 750 (752)
T ss_pred CchhHHHHHHHHHHHHHHhccChhhc-------CCHHHHhcCCccc
Confidence 2 3335667789999999777776 9999999999984
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=218.89 Aligned_cols=201 Identities=20% Similarity=0.242 Sum_probs=154.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+..++.++|||++++++++..+. .++|+||+++++|..++... ..+++..+..++.|++.|+.|||+.|+
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~ 121 (254)
T cd05083 43 AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121 (254)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356778999999999999999999987654 79999999999999987643 358899999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
+||||+|+||+++.++.++|+|||++...... ......+..|+|||.+.+.. ++.++|+|||||++|||++ |..|+
T Consensus 122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~ 198 (254)
T cd05083 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPY 198 (254)
T ss_pred eccccCcceEEEcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998764322 22234466799999987655 7999999999999999998 66665
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.+....+. ......+.++. .+...+.+..+.+-.|+..+|..||....
T Consensus 199 ~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 199 PKMSLKEV-KECVEKGYRME---PPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred ccCCHHHH-HHHHhCCCCCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 55554443 33444443322 22344555566666666666665554433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=222.41 Aligned_cols=167 Identities=19% Similarity=0.234 Sum_probs=140.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC---------CCCHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH---------GLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------~l~~~~~~~~~~qi~~~l 87 (303)
....+.+|+++++.++|+||+++++++......++||||+++|+|.+++.... .+++..+..++.|++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999899999999999999999887554 689999999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
+|||+.|++|+||||+||+++.++.++++|||++....... ......++..|+|||.+.+.. ++.++|||||||++|
T Consensus 131 ~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~ 209 (275)
T cd05046 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMW 209 (275)
T ss_pred HHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHH
Confidence 99999999999999999999999999999999986543221 123345677799999987655 789999999999999
Q ss_pred Hhhcc-CccCCCCchHHHHH
Q psy763 166 SYSQI-GFIGLGNMGSHMAR 184 (303)
Q Consensus 166 el~tg-~~~~~~~~~~~~~~ 184 (303)
+++++ ..|+.+........
T Consensus 210 ~l~~~~~~p~~~~~~~~~~~ 229 (275)
T cd05046 210 EVFTQGELPFYGLSDEEVLN 229 (275)
T ss_pred HHHhCCCCCccccchHHHHH
Confidence 99984 45555544444443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=228.58 Aligned_cols=240 Identities=25% Similarity=0.368 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++.. .+..++|+||+. +++..++.. ..+++..+..++.|++.||+|||+.|++
T Consensus 53 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~ii 130 (328)
T cd07856 53 AKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVV 130 (328)
T ss_pred hHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4556678999999999999999999875 557899999995 678877764 4688899999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||.+..... ......++..|+|||.+.+...++.++|+||+||++|+|++|..++.+
T Consensus 131 H~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 131 HRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred cCCCCHHHEeECCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999876432 223446788899999987645589999999999999999999988877
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+.+..+.++............. ..+.. .......+... ..+...+.+.+++.+|+..+|..|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 209 KDHVNQFSIITDLLGTPPDDVINTICSENTL-RFVQS-LPKREPVPFSE-------KFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccchhhH-HHHhh-ccccCCCcHHH-------HcCCCCHHHHHHHHHHcCCChhhC
Confidence 6654444433333222211100000000000 00000 00000011100 112235678899999987665555
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.+++.|+|+..
T Consensus 280 -------~t~~ell~~~~~~~ 293 (328)
T cd07856 280 -------ISAAEALAHPYLAP 293 (328)
T ss_pred -------CCHHHHhcCCcccc
Confidence 99999999999954
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=219.90 Aligned_cols=201 Identities=19% Similarity=0.235 Sum_probs=156.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+..++.++||||+++++++.+ +..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 50 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 128 (270)
T cd05056 50 VREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128 (270)
T ss_pred HHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34567889999999999999999999875 4578999999999999988654 368999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|||||||++||+++ |..
T Consensus 129 ~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~ 207 (270)
T cd05056 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVK 207 (270)
T ss_pred eccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999998876533221 1223456799999987655 7999999999999999986 777
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|+.+....+.... +..+.+++ .+..++.+..+++-+++..+|..||.
T Consensus 208 pf~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt 254 (270)
T cd05056 208 PFQGVKNNDVIGR-IENGERLP---MPPNCPPTLYSLMTKCWAYDPSKRPR 254 (270)
T ss_pred CCCCCCHHHHHHH-HHcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 7766665555443 33333332 23444556666665666555555543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=246.61 Aligned_cols=208 Identities=23% Similarity=0.366 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC----------------CCCHHHHHH
Q psy763 16 IRQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH----------------GLPWDLIKQ 78 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~l~~~~~~~ 78 (303)
.....+..|+.+++.+. |+||+.++|.|...+.+++|.||+..|+|..++++.+ .++....+.
T Consensus 343 ~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLls 422 (609)
T KOG0200|consen 343 SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLS 422 (609)
T ss_pred HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHH
Confidence 45667788888888875 9999999999999999999999999999999887654 389999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcccc--cc--CCCcccCcccccCCccCCCc
Q psy763 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD--YV--ATRWYRAPELLVGDTLYGPA 154 (303)
Q Consensus 79 ~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~--~~~~y~aPE~l~~~~~~~~~ 154 (303)
+++||+.|++||++.+++||||..+|||+..+..+||+|||+|+.......... .. -+..|+|||.+.. ..|+.+
T Consensus 423 fa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~k 501 (609)
T KOG0200|consen 423 FAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSK 501 (609)
T ss_pred HHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Cccccc
Confidence 999999999999999999999999999999999999999999997654443321 22 3456999999987 459999
Q ss_pred cchhhHHHHHHHhhccCccCCCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 155 VDVWAIEWTSHSYSQIGFIGLGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 155 ~DvwSlG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
+||||||++|||++|.+..|++... .+.+.+.++.|.++. .|..+..+.+.++-.||..+|..||.+..+
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~---~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRME---QPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 9999999999999998877777643 444466888888865 566678888888999998888888877664
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=218.46 Aligned_cols=202 Identities=20% Similarity=0.305 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+|+.+++.++|+||+++++++.. ...++++||++++++.+++.. +..++...+..++.|++.||.|||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i 123 (260)
T cd05073 45 VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4567789999999999999999999987 778999999999999998765 3467888999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+.. ++.++|+|||||++|++++ |..
T Consensus 124 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~ 202 (260)
T cd05073 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRI 202 (260)
T ss_pred cccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCC
Confidence 99999999999999999999999998765432211 2234567799999987654 7999999999999999999 566
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
|+.+........ .+..+...+ .+...+.+..+.+.+|+..+|..||...
T Consensus 203 p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 203 PYPGMSNPEVIR-ALERGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred CCCCCCHHHHHH-HHhCCCCCC---CcccCCHHHHHHHHHHcccCcccCcCHH
Confidence 665555444443 333333221 2234555666677777766666666443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=217.53 Aligned_cols=200 Identities=21% Similarity=0.285 Sum_probs=153.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+..++.++|||++++++++......++|+||+++++|.+++.. .+.+++..+..++.|++.|+++||+.|++|
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h 123 (256)
T cd05112 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4577899999999999999999999999999999999999999998764 356899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+.. ++.++|+||+||++||+++ |..|+
T Consensus 124 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~ 202 (256)
T cd05112 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPY 202 (256)
T ss_pred cccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999876543221 11223457899999988655 7899999999999999998 66666
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
...........+. .+.+. ..+...+....+++-.|+..+|..||.
T Consensus 203 ~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 247 (256)
T cd05112 203 ENRSNSEVVETIN-AGFRL---YKPRLASQSVYELMQHCWKERPEDRPS 247 (256)
T ss_pred CcCCHHHHHHHHh-CCCCC---CCCCCCCHHHHHHHHHHcccChhhCCC
Confidence 5555555444432 22221 112223344444555555544444443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=221.39 Aligned_cols=205 Identities=18% Similarity=0.175 Sum_probs=157.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHcCC--------CCCCHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELENHP--------HGLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--------~~l~~~~~~~~~~qi~~~l 87 (303)
....+.+|+..++.++||||+++++++.. +...++++||+++++|..++... ..+++..+..++.|++.||
T Consensus 51 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 130 (280)
T cd05043 51 QVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130 (280)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 45667788999999999999999998776 46789999999999999987542 4589999999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
.|||+.|++|+||+|+||++++++.+||+|||+++.+.+.... ....++..|+|||.+.+.. ++.++|||||||++
T Consensus 131 ~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l 209 (280)
T cd05043 131 SYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLL 209 (280)
T ss_pred HHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHH
Confidence 9999999999999999999999999999999999765433211 2234567799999998665 79999999999999
Q ss_pred HHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 165 HSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 165 ~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||+++ |..|+.+....+ +...+..+.++. .+..++.++.+.+..|+..+|+.||....
T Consensus 210 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 268 (280)
T cd05043 210 WELMTLGQTPYVEIDPFE-MAAYLKDGYRLA---QPINCPDELFAVMACCWALDPEERPSFSQ 268 (280)
T ss_pred HHHhcCCCCCcCcCCHHH-HHHHHHcCCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99998 777666655444 344444443332 12334555666666666666655554433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=224.34 Aligned_cols=160 Identities=24% Similarity=0.309 Sum_probs=138.7
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.....+.+|+.+++.+ +||||+++++.+..+...++||||+++++|...+.....+++..+..++.|++.||.|||+.|
T Consensus 46 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 125 (288)
T cd05583 46 KTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125 (288)
T ss_pred hHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3455677889999999 599999999999999999999999999999998877778999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCc-cCCCccchhhHHHHHHHhhccC
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDT-LYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~-~~~~~~DvwSlG~il~el~tg~ 171 (303)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ..+.++|+||+|+++|||++|.
T Consensus 126 ~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~ 205 (288)
T cd05583 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA 205 (288)
T ss_pred eeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876543321 12346788999999986543 2578999999999999999988
Q ss_pred ccCC
Q psy763 172 FIGL 175 (303)
Q Consensus 172 ~~~~ 175 (303)
.|+.
T Consensus 206 ~p~~ 209 (288)
T cd05583 206 SPFT 209 (288)
T ss_pred CCcc
Confidence 7764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=246.22 Aligned_cols=208 Identities=21% Similarity=0.284 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+-.+.+++|||+++++|+|..+. +.||++|++.|+|.++++. ...+..+..+.|+.||++|++|||.+++
T Consensus 741 ~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrl 819 (1177)
T KOG1025|consen 741 ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRL 819 (1177)
T ss_pred hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcch
Confidence 4566788899999999999999999999776 8899999999999997764 4579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcccc---ccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD---YVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|||||.++||||.+...+||.|||+++.+.+...... ....+.|+|-|.++... |+.++|||||||++||++|.+.
T Consensus 820 VHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 820 VHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred hhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCC
Confidence 9999999999999999999999999999876554332 23356799999998655 9999999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLI 229 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (303)
.++.....+.+.++++.+.|+ ..|+.++-++|..+-+||+.++..||.++.+..
T Consensus 899 ~Py~gi~~~eI~dlle~geRL---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 899 KPYDGIPAEEIPDLLEKGERL---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CccCCCCHHHhhHHHhccccC---CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 889899999999999999995 467788889999999999999999998887654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=222.04 Aligned_cols=157 Identities=22% Similarity=0.327 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+..++.++||||+++++++... ...++|+||+++++|..++.+. ..+++..+..++.|++.||+|||++|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g 129 (284)
T cd05079 50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45688999999999999999999999875 5689999999999999988654 46899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++||++++
T Consensus 130 i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~ 208 (284)
T cd05079 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTY 208 (284)
T ss_pred eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcC
Confidence 99999999999999999999999999887643321 12345667799999988655 79999999999999999987
Q ss_pred CccCC
Q psy763 171 GFIGL 175 (303)
Q Consensus 171 ~~~~~ 175 (303)
..++.
T Consensus 209 ~~~~~ 213 (284)
T cd05079 209 CDSES 213 (284)
T ss_pred CCCCc
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=228.21 Aligned_cols=169 Identities=22% Similarity=0.287 Sum_probs=152.5
Q ss_pred HHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCC
Q psy763 24 NKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKP 102 (303)
Q Consensus 24 e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~ 102 (303)
|.++|... +-|.+++++.+|++-..+|+||||+.||+|-..+++-+.+.+..+..++.+|+-||-+||++||++||||.
T Consensus 399 EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKL 478 (683)
T KOG0696|consen 399 EKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKL 478 (683)
T ss_pred hhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccc
Confidence 33444443 57889999999999999999999999999999999889999999999999999999999999999999999
Q ss_pred CcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHH
Q psy763 103 ENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSH 181 (303)
Q Consensus 103 ~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~ 181 (303)
.||+++..|++||+|||++..-- .+....+.+||+.|+|||++.-++ |+.++|.||+||+||||+.|.+||.|....+
T Consensus 479 DNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 479 DNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred cceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999999998744 445667899999999999998666 9999999999999999999999999999999
Q ss_pred HHHHHhhcCCce
Q psy763 182 MARNLLKNNGRV 193 (303)
Q Consensus 182 ~~~~~~~~~~~~ 193 (303)
....++...-..
T Consensus 558 lF~aI~ehnvsy 569 (683)
T KOG0696|consen 558 LFQAIMEHNVSY 569 (683)
T ss_pred HHHHHHHccCcC
Confidence 998888866554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=221.89 Aligned_cols=208 Identities=20% Similarity=0.314 Sum_probs=165.2
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+..|+..++.++||||+++++.+.+.+..++|+||++++++..++. ....+++..+..++.|++.|+.|||+.|+
T Consensus 48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i 127 (260)
T cd08222 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127 (260)
T ss_pred HHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 45567889999999999999999999999999999999999988764 34579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+|+||+|+||+++. +.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||+|+++|++++|..++
T Consensus 128 ~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~ 205 (260)
T cd08222 128 LHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAF 205 (260)
T ss_pred cccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999975 569999999987764332 223456788999999987655 788999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.........+.... .+ ......+.++.+++.+|+..+|.
T Consensus 206 ~~~~~~~~~~~~~~~~-~~--------------------------------------~~~~~~~~~~~~li~~~l~~~p~ 246 (260)
T cd08222 206 EGQNFLSVVLRIVEGP-TP--------------------------------------SLPETYSRQLNSIMQSMLNKDPS 246 (260)
T ss_pred CCccHHHHHHHHHcCC-CC--------------------------------------CCcchhcHHHHHHHHHHhcCChh
Confidence 7655544443322110 00 00012234667889899886665
Q ss_pred eeeccccccccccccceeeee
Q psy763 255 YIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.| ++..++++|||+
T Consensus 247 ~R-------p~~~~il~~~~~ 260 (260)
T cd08222 247 LR-------PSAAEILRNPFI 260 (260)
T ss_pred hC-------cCHHHHhhCCCC
Confidence 55 999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=217.60 Aligned_cols=202 Identities=23% Similarity=0.339 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+|+.+++.++|+||+++++++. .+..++++||+.+++|.+++.. +..++...+..++.|++.||.|||+.|++
T Consensus 46 ~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~ 124 (260)
T cd05067 46 EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124 (260)
T ss_pred HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence 45778999999999999999999875 4568999999999999987654 34689999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||||+++||+++ |..|
T Consensus 125 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p 203 (260)
T cd05067 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIP 203 (260)
T ss_pred cccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999877552221 12234567899999987655 7899999999999999998 6777
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+....+....+ ..+.+.+ .+...+.+..+.+-+|+..+|..||....
T Consensus 204 ~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05067 204 YPGMTNPEVIQNL-ERGYRMP---RPDNCPEELYELMRLCWKEKPEERPTFEY 252 (260)
T ss_pred CCCCChHHHHHHH-HcCCCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 6666555554433 3333221 23344556666666777666666665544
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=225.23 Aligned_cols=217 Identities=22% Similarity=0.321 Sum_probs=174.7
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ce
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--CI 96 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iv 96 (303)
...+|.++-+.|+||-||++|++|.-+ ..+|-|+|||+|.+|+-+++....+++..+++|+.||+.||.||.... |+
T Consensus 513 HAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPII 592 (775)
T KOG1151|consen 513 HACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPII 592 (775)
T ss_pred HHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCee
Confidence 345788899999999999999999754 578999999999999999999999999999999999999999999864 99
Q ss_pred ecccCCCcEEEecC---CcEEEccccceeeeCCCCc--------cccccCCCcccCccccc-C--CccCCCccchhhHHH
Q psy763 97 HRDIKPENILLTAN---GVVKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLV-G--DTLYGPAVDVWAIEW 162 (303)
Q Consensus 97 H~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~-~--~~~~~~~~DvwSlG~ 162 (303)
|-||||.|||+-.. |.+||+|||++..+..+.. .....||.||++||.+. + .+..+.++||||+||
T Consensus 593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV 672 (775)
T KOG1151|consen 593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV 672 (775)
T ss_pred eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence 99999999999644 7899999999988764321 23468999999999975 3 344788999999999
Q ss_pred HHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhH
Q psy763 163 TSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVV 242 (303)
Q Consensus 163 il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 242 (303)
|||.++.|.-||-.....+.+ ++. ..+ .+--.+..+..+..++++-
T Consensus 673 IFyQClYGrKPFGhnqsQQdI---Lqe----------------------NTI---------lkAtEVqFP~KPvVsseAk 718 (775)
T KOG1151|consen 673 IFYQCLYGRKPFGHNQSQQDI---LQE----------------------NTI---------LKATEVQFPPKPVVSSEAK 718 (775)
T ss_pred hhhhhhccCCCCCCchhHHHH---Hhh----------------------hch---------hcceeccCCCCCccCHHHH
Confidence 999999998776544332222 221 111 1111245667777889999
Q ss_pred Hhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 243 KILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 243 dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+|+++||. +.+.+|+.+.+|..|||+.-
T Consensus 719 aFIRRCLa-------YRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 719 AFIRRCLA-------YRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHHHHHHH-------hhhhhhhhHHHHccCccccc
Confidence 99999998 45566699999999999865
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=222.62 Aligned_cols=213 Identities=22% Similarity=0.298 Sum_probs=157.4
Q ss_pred HHHHHHH-HhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceec
Q psy763 22 ATNKKEK-RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHR-HACIHR 98 (303)
Q Consensus 22 ~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 98 (303)
.+++..+ +...||||+++++++.++...|+||||+.+ ++..+... ...+++..+..++.|++.|++|||+ .|++|+
T Consensus 61 ~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~ 139 (296)
T cd06618 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR 139 (296)
T ss_pred HHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecC
Confidence 3344444 444699999999999999999999999864 55555443 4579999999999999999999997 599999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCC---ccCCCccchhhHHHHHHHhhccCccCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD---TLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||+|+||+++.++.++|+|||++.............++..|+|||.+.+. +.++.++|+||||+++|+|++|..|+.
T Consensus 140 dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred CCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998765443333444678889999998754 337889999999999999999998876
Q ss_pred CCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 176 GNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 176 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.... .+.+...+...... .........++.+++.+|+...|.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~l~~li~~~l~~~p~ 262 (296)
T cd06618 220 NCKTEFEVLTKILQEEPPS-------------------------------------LPPNEGFSPDFCSFVDLCLTKDHR 262 (296)
T ss_pred cchhHHHHHHHHhcCCCCC-------------------------------------CCCCCCCCHHHHHHHHHHccCChh
Confidence 5332 22222222211000 000001234567888888876665
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.| ++..+++.|+|+..-.
T Consensus 263 ~R-------p~~~~il~~~~~~~~~ 280 (296)
T cd06618 263 KR-------PKYRELLQHPFIRRYE 280 (296)
T ss_pred hC-------CCHHHHhcChhhhccc
Confidence 55 8899999998876533
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=226.85 Aligned_cols=205 Identities=25% Similarity=0.330 Sum_probs=152.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCC---------------------------
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHP--------------------------- 68 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~--------------------------- 68 (303)
...+.+|+..++.+ +||||+++++++... ..+++|+||+++|+|.+++...
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (343)
T cd05103 54 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133 (343)
T ss_pred HHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhh
Confidence 34567789999999 689999999988654 5689999999999999877532
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEe
Q psy763 69 ----------------------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108 (303)
Q Consensus 69 ----------------------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~ 108 (303)
..++...+..++.|++.||+|||++|++||||||+||+++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 213 (343)
T cd05103 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 213 (343)
T ss_pred hhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc
Confidence 2367788889999999999999999999999999999999
Q ss_pred cCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHH
Q psy763 109 ANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMAR 184 (303)
Q Consensus 109 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~ 184 (303)
.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..|+.+........
T Consensus 214 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 292 (343)
T cd05103 214 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292 (343)
T ss_pred CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH
Confidence 999999999999876533221 11233466799999987665 7999999999999999997 555555544334444
Q ss_pred HHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 185 NLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..+..+.+++ .+...+++..+++..|+..+|..||....
T Consensus 293 ~~~~~~~~~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 293 RRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred HHHhccCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 4444443322 12233445566666666666665554433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=217.39 Aligned_cols=201 Identities=22% Similarity=0.345 Sum_probs=156.0
Q ss_pred HHHHHHHHHH-hCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHH-C
Q psy763 20 TEATNKKEKR-SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHR-H 93 (303)
Q Consensus 20 ~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~ 93 (303)
.+..|+.+++ .++||||+++++++..++..++|+||++++++.+++. ....+++..++.++.|++.|+.|||+ .
T Consensus 54 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 133 (269)
T cd08528 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK 133 (269)
T ss_pred HHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence 3455666665 5899999999999999999999999999999988652 34579999999999999999999996 7
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|..|
T Consensus 134 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 134 RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred ceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCc
Confidence 89999999999999999999999999998766544445567889999999998655 79999999999999999999888
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
+...........+......+ ......+.++.+.+-+|+..+|..||..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~ 260 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDI 260 (269)
T ss_pred ccccCHHHHHHHHhhccCCc---CCcccCCHHHHHHHHHHCCCCCccCCCH
Confidence 87666555554443332221 1111233445555555555555555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=220.30 Aligned_cols=157 Identities=22% Similarity=0.338 Sum_probs=132.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+.+++.++||||+++++++.. ...+++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|
T Consensus 49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~ 128 (284)
T cd05081 49 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3567789999999999999999998754 34689999999999999987643 46899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||||+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+|||||++|||++|
T Consensus 129 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~ 207 (284)
T cd05081 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTY 207 (284)
T ss_pred ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhc
Confidence 999999999999999999999999999876433221 1223345699999987655 79999999999999999997
Q ss_pred CccCC
Q psy763 171 GFIGL 175 (303)
Q Consensus 171 ~~~~~ 175 (303)
..++.
T Consensus 208 ~~~~~ 212 (284)
T cd05081 208 SDKSC 212 (284)
T ss_pred CCcCC
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=220.04 Aligned_cols=160 Identities=23% Similarity=0.392 Sum_probs=137.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
....+.+|++.++.++|+||+++++++.. +...++|+||++++++..++.... .+++..+..++.|++.||.|||+.
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678889999999999999999999887 557899999999999999886543 699999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+.. ++.++|+|||||++|||++
T Consensus 129 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~t 207 (284)
T cd05038 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFT 207 (284)
T ss_pred CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeec
Confidence 9999999999999999999999999999876532211 1234456699999987665 7999999999999999999
Q ss_pred cCccCCCC
Q psy763 170 IGFIGLGN 177 (303)
Q Consensus 170 g~~~~~~~ 177 (303)
|..++...
T Consensus 208 g~~p~~~~ 215 (284)
T cd05038 208 YGDPSQSP 215 (284)
T ss_pred cCCCcccc
Confidence 99877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=242.27 Aligned_cols=215 Identities=19% Similarity=0.220 Sum_probs=172.0
Q ss_pred HHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCC----CCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 20 TEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG----LPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 20 ~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+|+.+++.-+ |||||++++.-++....|+..|.|. .+|++++...+. ......+..+.|++.||+|||+.+
T Consensus 548 ~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~ 626 (903)
T KOG1027|consen 548 FAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK 626 (903)
T ss_pred HHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc
Confidence 4678898888875 9999999999999999999999998 678887765311 111345788999999999999999
Q ss_pred ceecccCCCcEEEecC-----CcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 95 CIHRDIKPENILLTAN-----GVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 95 ivH~dlk~~nil~~~~-----~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
||||||||.||||+.. ..++|+|||+++.+..+... ....||-+|+|||.+.+.. -+.++||+|+||++|
T Consensus 627 iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfy 705 (903)
T KOG1027|consen 627 IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFY 705 (903)
T ss_pred cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEE
Confidence 9999999999999862 46899999999998765432 4567899999999999877 478999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
+.++|+..++|.....+.. ++.....+..+ ... ..+ +|.|++
T Consensus 706 YvltgG~HpFGd~~~R~~N-Il~~~~~L~~L-----------------------------------~~~-~d~-eA~dLI 747 (903)
T KOG1027|consen 706 YVLTGGSHPFGDSLERQAN-ILTGNYTLVHL-----------------------------------EPL-PDC-EAKDLI 747 (903)
T ss_pred EEecCCccCCCchHHhhhh-hhcCccceeee-----------------------------------ccC-chH-HHHHHH
Confidence 9999999999988777654 33332222100 000 011 788999
Q ss_pred hhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.+|+...|..| ++|.++|.||+|.+-+.+
T Consensus 748 ~~ml~~dP~~R-------Psa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 748 SRMLNPDPQLR-------PSATDVLNHPLFWDSEKR 776 (903)
T ss_pred HHhcCCCcccC-------CCHHHHhCCCccCChHHH
Confidence 99999777777 999999999999986654
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=209.66 Aligned_cols=181 Identities=22% Similarity=0.259 Sum_probs=143.4
Q ss_pred cccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHHc----CCCCCCHHH
Q psy763 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELEN----HPHGLPWDL 75 (303)
Q Consensus 5 kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~----~~~~l~~~~ 75 (303)
||...+. ....+...+|++.-+.++|||++++++....+. ..|++++|...|++.+.+. ++..+++.+
T Consensus 52 KkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~ 128 (302)
T KOG2345|consen 52 KKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQ 128 (302)
T ss_pred heeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHH
Confidence 4444444 235667788999999999999999998875433 4899999999998888654 344799999
Q ss_pred HHHHHHHHHHHHHHHHHCC--ceecccCCCcEEEecCCcEEEccccceeeeCCCC----------ccccccCCCcccCcc
Q psy763 76 IKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGFARLINPGE----------NYTDYVATRWYRAPE 143 (303)
Q Consensus 76 ~~~~~~qi~~~l~~lH~~~--ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~~y~aPE 143 (303)
++.|+.++.+||.+||+.. +.||||||.|||+.+.+.++|.|||.+......- .......|..|+|||
T Consensus 129 iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPE 208 (302)
T KOG2345|consen 129 ILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPE 208 (302)
T ss_pred HHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCch
Confidence 9999999999999999999 9999999999999999999999999987643211 012346799999999
Q ss_pred cccCC--ccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEee
Q psy763 144 LLVGD--TLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVIL 197 (303)
Q Consensus 144 ~l~~~--~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (303)
.+.-. ...+.++|||||||+||+|+-|..||. .+.+.|+.+....
T Consensus 209 Lf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe---------~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 209 LFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE---------RIYQQGGSLALAV 255 (302)
T ss_pred heecccCcccccccchhhhhHHHHHHHHcCCcch---------HHhhcCCeEEEee
Confidence 98632 236899999999999999998877763 3445666665433
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-31 Score=221.36 Aligned_cols=163 Identities=23% Similarity=0.357 Sum_probs=145.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
-+...+|+.++++++.|++|++||.+-....+++|||||..|+..++++ +++++++..+..+++.-+.||.|||...-+
T Consensus 72 LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KI 151 (502)
T KOG0574|consen 72 LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKI 151 (502)
T ss_pred HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHH
Confidence 3456789999999999999999999998889999999999999999765 456899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|||||..|||++.+|..||+|||.|-.+... ....+..||+.|+|||++..-+ |...+||||||++..||..|++|+.
T Consensus 152 HRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 152 HRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred HhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcc
Confidence 9999999999999999999999999776532 3446678999999999998666 8999999999999999999998877
Q ss_pred CCchHH
Q psy763 176 GNMGSH 181 (303)
Q Consensus 176 ~~~~~~ 181 (303)
+..+..
T Consensus 231 DIHPMR 236 (502)
T KOG0574|consen 231 DIHPMR 236 (502)
T ss_pred cccccc
Confidence 655433
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=215.76 Aligned_cols=203 Identities=22% Similarity=0.293 Sum_probs=150.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcC------CCCCCHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENH------PHGLPWDLIKQITWQVLR 85 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~------~~~l~~~~~~~~~~qi~~ 85 (303)
.+.+.+|+..++.++||||+++++++.... ..++++||+.+|++..++.. ...++...+..++.|++.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 124 (273)
T cd05074 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124 (273)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Confidence 445678899999999999999999986542 24789999999999876532 125788999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHH
Q psy763 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEW 162 (303)
Q Consensus 86 ~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~ 162 (303)
|++|||+.|++|+||||+||+++.++.+||+|||++........ .....++..|++||.+.+.. ++.++|||||||
T Consensus 125 ~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~ 203 (273)
T cd05074 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGV 203 (273)
T ss_pred HHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHH
Confidence 99999999999999999999999999999999999887543221 12234557799999987665 789999999999
Q ss_pred HHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 163 TSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 163 il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
++|||++ |..++.+....+. ......+..+. .+...+....+++-.|+..+|+.||...
T Consensus 204 il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~ 263 (273)
T cd05074 204 TMWEIMTRGQTPYAGVENSEI-YNYLIKGNRLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQ 263 (273)
T ss_pred HHHHHhhCCCCCCCCCCHHHH-HHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999998 4555544444333 33333333221 2233445556666666666665555433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=240.87 Aligned_cols=106 Identities=25% Similarity=0.396 Sum_probs=99.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.....+|+||||+.+++|..++...+.+++..++.++.||+.||.|||+.||+
T Consensus 47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIi 126 (669)
T cd05610 47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126 (669)
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 34567888999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEcccccee
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
||||||+|||++.++.+||+|||++.
T Consensus 127 HrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 127 HRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=210.36 Aligned_cols=214 Identities=31% Similarity=0.409 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|++.++.++|+||+++++++......++++|++++++|..++.....++...+..++.+++.++.+||+.|++|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 56788899999999999999999999999999999999999999998876666999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
+||+|+||+++.++.++|+|||.+.............++..|+|||...+.. ++.++|+||+|+++|++++|..++...
T Consensus 111 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 111 RDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999998876554455667888999999987555 788999999999999999998877663
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
.........+..+...... ..........+++.+|+...+..|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~i~~~l~~~p~~R- 232 (244)
T smart00220 190 DQLLELFKKIGKPKPPFPP------------------------------------PEWKISPEAKDLIRKLLVKDPEKR- 232 (244)
T ss_pred CcHHHHHHHHhccCCCCcc------------------------------------ccccCCHHHHHHHHHHccCCchhc-
Confidence 3333333222221111000 000023456677777777555555
Q ss_pred ccccccccccccceeeee
Q psy763 258 SEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~ 275 (303)
+++.++++|+|+
T Consensus 233 ------p~~~~~~~~~~~ 244 (244)
T smart00220 233 ------LTAEEALQHPFF 244 (244)
T ss_pred ------cCHHHHhhCCCC
Confidence 888888888875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=215.09 Aligned_cols=154 Identities=20% Similarity=0.180 Sum_probs=125.4
Q ss_pred HHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+...++.++|+|++++++.+.... ..++++|++.. ++...+......++..+..++.|++.||.|||+.|++||
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr 150 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG 150 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3344566789999999999876543 34678887753 455555554557888999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCC--------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
||||+||+++.++.++|+|||+|....... ......||+.|+|||...+.. ++.++||||+||++|||++|
T Consensus 151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999998764221 112346899999999988766 89999999999999999999
Q ss_pred CccCCCCc
Q psy763 171 GFIGLGNM 178 (303)
Q Consensus 171 ~~~~~~~~ 178 (303)
..||.+..
T Consensus 230 ~~P~~~~~ 237 (294)
T PHA02882 230 KLPWKGFG 237 (294)
T ss_pred CCCCCccc
Confidence 99987663
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=236.72 Aligned_cols=201 Identities=23% Similarity=0.285 Sum_probs=149.2
Q ss_pred HHHHHHHHHHHHHHHHhCC-CCCcceeEEEE-Ee---C---CEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHH
Q psy763 14 EAIRQATEATNKKEKRSLK-HPNLVNLLEVF-RR---K---KKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQV 83 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~---~---~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi 83 (303)
....-+...+|+++++.|+ |+|||.+++.. .. . -.++|.||||+||.|-++++. ...|++.+++.|++++
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv 153 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV 153 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence 3345667899999999998 99999999943 21 1 257899999999898888763 2469999999999999
Q ss_pred HHHHHHHHHCC--ceecccCCCcEEEecCCcEEEccccceeeeCCCCcc----------ccccCCCcccCccccc---CC
Q psy763 84 LRGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----------TDYVATRWYRAPELLV---GD 148 (303)
Q Consensus 84 ~~~l~~lH~~~--ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~y~aPE~l~---~~ 148 (303)
++|+++||... |+|||||.+|||++.++.+||||||.+......... -....|+.|+|||++. +.
T Consensus 154 ~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~ 233 (738)
T KOG1989|consen 154 CEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGL 233 (738)
T ss_pred HHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCC
Confidence 99999999998 999999999999999999999999998764432211 1235689999999985 44
Q ss_pred ccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 149 TLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 149 ~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
+ .+.++|||||||+||-|+....||-+.-... |+...+..|. .+..+....+++-.++..+|..||
T Consensus 234 p-I~eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 234 P-IGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred C-CcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEeccccCCC---CccHHHHHHHHHHHHhccCcccCC
Confidence 4 7999999999999999987777776542322 2223332221 122233444455555555555555
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=210.20 Aligned_cols=146 Identities=27% Similarity=0.425 Sum_probs=137.2
Q ss_pred HhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEe
Q psy763 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108 (303)
Q Consensus 29 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~ 108 (303)
+.-+||.+|-++.+|+++..+++|.||++||+|--.+++...++++.++.+..+|..||.|||++||++||||..|+|++
T Consensus 306 ~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 306 QASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred hccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 34579999999999999999999999999999998888888999999999999999999999999999999999999999
Q ss_pred cCCcEEEccccceeee-CCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 109 ANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 109 ~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
..|++||+|+|.++.- .+++...+.+||+.|.|||+++|.. |+.++|.|++|++|+||+.|..||.
T Consensus 386 aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcc
Confidence 9999999999999874 4677778899999999999999987 9999999999999999999998874
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=195.89 Aligned_cols=175 Identities=23% Similarity=0.367 Sum_probs=144.3
Q ss_pred HHHHHHHHHHHHHH-HhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHH----HHcCCCCCCHHHHHHHHHHHHHHHHH
Q psy763 15 AIRQATEATNKKEK-RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE----LENHPHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 15 ~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~----~~~~~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
...+.....++.+. +...+|.+|.+||..-+...+++.||.|+ .+++. .+.+++.+++..+-.++..++.||.|
T Consensus 85 ~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~ 163 (282)
T KOG0984|consen 85 SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEF 163 (282)
T ss_pred hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHH
Confidence 34455555666544 44579999999999988999999999998 45544 45678899999999999999999999
Q ss_pred HHHC-CceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC---CccCCCccchhhHHHHHH
Q psy763 90 CHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG---DTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 90 lH~~-~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~DvwSlG~il~ 165 (303)
||++ .++|||+||+|||++..|.+|+||||.+-.+..+-..+...|...|+|||.+.. +..|+-++||||||+++.
T Consensus 164 L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmi 243 (282)
T KOG0984|consen 164 LHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMI 243 (282)
T ss_pred HHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhh
Confidence 9985 799999999999999999999999999988766544444678888999999863 335899999999999999
Q ss_pred HhhccCccCC-CCchHHHHHHHhhcC
Q psy763 166 SYSQIGFIGL-GNMGSHMARNLLKNN 190 (303)
Q Consensus 166 el~tg~~~~~-~~~~~~~~~~~~~~~ 190 (303)
||.++.+|+. +.++.+++.++++..
T Consensus 244 ElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 244 EMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred hhhhccccccccCCHHHHHHHHhcCC
Confidence 9999987775 447778888777653
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=225.33 Aligned_cols=167 Identities=26% Similarity=0.421 Sum_probs=142.9
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEe-----CCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRR-----KKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
.+..+.|..+++.. .|||++.++|+|.. ++.++||||||.+|+..++++. +..+.+..+..|++.++.|+.|
T Consensus 59 deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~H 138 (953)
T KOG0587|consen 59 EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAH 138 (953)
T ss_pred cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHH
Confidence 44556667777776 59999999999973 4589999999999999998764 4579999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCc----cCCCccchhhHHHHH
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDT----LYGPAVDVWAIEWTS 164 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~----~~~~~~DvwSlG~il 164 (303)
||.+.++|||+|-.|||++.++.|||+|||.+..+... ....+..||+.|||||++.... .|+..+|+||||++.
T Consensus 139 LH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITa 218 (953)
T KOG0587|consen 139 LHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITA 218 (953)
T ss_pred HhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhcccee
Confidence 99999999999999999999999999999998877543 3456789999999999997532 377899999999999
Q ss_pred HHhhccCccCCCCchHHHHH
Q psy763 165 HSYSQIGFIGLGNMGSHMAR 184 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~ 184 (303)
.||.-|.+|..+..+...+.
T Consensus 219 IEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 219 IEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred ehhcCCCCCccCcchhhhhc
Confidence 99999998888776655543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=230.94 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=138.7
Q ss_pred EEEEEecCCCCcHHHHHcCCCCC-CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeC--
Q psy763 49 LHLVFEFCDHTVLNELENHPHGL-PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-- 125 (303)
Q Consensus 49 ~~lv~e~~~~~~l~~~~~~~~~l-~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~-- 125 (303)
+||-||||+..++.+++.++... .....+.++++|+.||+|+|++|++||||||.||+++.++.|||+|||+|....
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~ 750 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKEN 750 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhh
Confidence 58999999999999998877654 567889999999999999999999999999999999999999999999998721
Q ss_pred ---------C--------CCccccccCCCcccCcccccCCc--cCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHH
Q psy763 126 ---------P--------GENYTDYVATRWYRAPELLVGDT--LYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNL 186 (303)
Q Consensus 126 ---------~--------~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~ 186 (303)
+ ....+..+||..|.|||++.+.. .|+.++|+||+|+||+||+. ||...+.-..+-.-
T Consensus 751 ~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~ 827 (1351)
T KOG1035|consen 751 LESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN 827 (1351)
T ss_pred hhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh
Confidence 0 01234578999999999998766 69999999999999999975 44444443333333
Q ss_pred hhcCCceeEeec-CCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 187 LKNNGRVTVILK-SDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 187 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
++ .+..|.... .....+.....+-.-...+|++||...-++...-..+ +.+++...+.+.+.
T Consensus 828 LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp-e~~el~~~~~h~~~ 890 (1351)
T KOG1035|consen 828 LR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP-EESELLVFLQHLYI 890 (1351)
T ss_pred cc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc-cchHHHHHHHHHHH
Confidence 33 222222200 1111222222333333447888887777665444433 55555555555444
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=212.27 Aligned_cols=250 Identities=19% Similarity=0.253 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
......|++.+..+. +.||+++.+++...++..+|+||+++....++.. .++...+..+++.++.||+++|++||+
T Consensus 78 p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIv 154 (418)
T KOG1167|consen 78 PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIV 154 (418)
T ss_pred chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCcc
Confidence 445778888888885 9999999999999999999999999999999876 577899999999999999999999999
Q ss_pred ecccCCCcEEEecC-CcEEEccccceeeeC-----------------C-CCc---------------------------c
Q psy763 97 HRDIKPENILLTAN-GVVKLCDFGFARLIN-----------------P-GEN---------------------------Y 130 (303)
Q Consensus 97 H~dlk~~nil~~~~-~~~kl~dfg~~~~~~-----------------~-~~~---------------------------~ 130 (303)
|||+||+|+|.+.. +.-.|+|||+|.... + ... .
T Consensus 155 HRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~ 234 (418)
T KOG1167|consen 155 HRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSER 234 (418)
T ss_pred ccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcccee
Confidence 99999999999855 678999999987211 0 000 0
Q ss_pred ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCch-HH------------HHHHHhhcCCceeEee
Q psy763 131 TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMG-SH------------MARNLLKNNGRVTVIL 197 (303)
Q Consensus 131 ~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~-~~------------~~~~~~~~~~~~~~~~ 197 (303)
....||++|+|||++...+..+.++||||.|+|+..++++.+||+.... .. .+++.-...++.. ..
T Consensus 235 anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~-l~ 313 (418)
T KOG1167|consen 235 ANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRIL-LW 313 (418)
T ss_pred cccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCcee-ee
Confidence 1246899999999999887789999999999999999999998875522 11 1222222233311 11
Q ss_pred cCCCCCc-chhhhhhhhhh-cCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeee
Q psy763 198 KSDSLDS-ETWDLTWQEIF-SKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 198 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
..+..+. ......|...- ..+ .+..+.........+-....++|++++++..+|..+ +++++||+||||
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~--~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kR-------itAEeALkHpFF 384 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESI--YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKR-------ITAEDALKHPFF 384 (418)
T ss_pred ccccccccHHHHhchhccChhhc--ccccccceeeccccccccHHHHHHHHHHccCChhhc-------ccHHHHhcCcCC
Confidence 1011111 11112222221 100 000000112333445556689999999999777777 999999999999
Q ss_pred ecCCc
Q psy763 276 PTPER 280 (303)
Q Consensus 276 ~~~~~ 280 (303)
.+.+.
T Consensus 385 ~~~~~ 389 (418)
T KOG1167|consen 385 DEADR 389 (418)
T ss_pred cchhh
Confidence 96443
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=206.68 Aligned_cols=171 Identities=25% Similarity=0.331 Sum_probs=138.7
Q ss_pred HHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHH-----HcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKK-EKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-----ENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
.+..+..|.+ .++.-++||||++||.+-.++..++-||.|+ .+++.+ ..+...+++.-+..+....+.||.||
T Consensus 105 eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yL 183 (361)
T KOG1006|consen 105 EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYL 183 (361)
T ss_pred HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHH
Confidence 4444555554 5666789999999999988888999999998 444442 23456899999999999999999999
Q ss_pred HH-CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCcc-CCCccchhhHHHHHHHhh
Q psy763 91 HR-HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTL-YGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 91 H~-~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~-~~~~~DvwSlG~il~el~ 168 (303)
.. ..|+|||+||+|||++..|.+||||||.+-.+..+-..+.-.|-..|+|||.+..... |+.++||||||++|||+.
T Consensus 184 K~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 184 KEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred HHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeee
Confidence 86 5799999999999999999999999999987765544455678899999999985544 899999999999999999
Q ss_pred ccCccCCCCch-HHHHHHHhh
Q psy763 169 QIGFIGLGNMG-SHMARNLLK 188 (303)
Q Consensus 169 tg~~~~~~~~~-~~~~~~~~~ 188 (303)
||.+|+.+.+. .+++..+..
T Consensus 264 tG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 264 TGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred cCCCCcchHHHHHHHHHHHHc
Confidence 99999988765 334443333
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=200.06 Aligned_cols=208 Identities=18% Similarity=0.197 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHc-----C---CCCCCHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELEN-----H---PHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~-----~---~~~l~~~~~~~~~~qi~~~l~ 88 (303)
...+..|.-++..+.|||++++.+++.++ ...+.++.++.-|+|..++. . .+.++-.+...++.|++.|+.
T Consensus 331 v~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~ 410 (563)
T KOG1024|consen 331 VNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAME 410 (563)
T ss_pred HHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHH
Confidence 34466677778888999999999998765 46788889999999999886 2 124777888999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|||+.|++|.||.++|++|++...+||+|-.+++.+-+.+.. .....+..||+||.+.+.. |+.++|+||||++||
T Consensus 411 hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllW 489 (563)
T KOG1024|consen 411 HLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLW 489 (563)
T ss_pred HHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHH
Confidence 999999999999999999999999999999999987665432 2334577899999999776 899999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhH
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLI 229 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (303)
||+|.+..|+......++...++.|.|+. .|..++.++...+-.||.-.|..||.+.-+..
T Consensus 490 ELmtlg~~PyaeIDPfEm~~ylkdGyRla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 490 ELMTLGKLPYAEIDPFEMEHYLKDGYRLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHhcCCCCccccCHHHHHHHHhccceec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 99998888888888888888999999965 56667778888888888887777777666443
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=215.25 Aligned_cols=154 Identities=28% Similarity=0.375 Sum_probs=138.6
Q ss_pred HHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEecC-CCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 22 ATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFC-DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 22 ~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~-~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
--|++++..++ |+||++++++|++++.+||+||-- ++-+|.+++.....+++..+..++.|++.|+++||++||||
T Consensus 614 p~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivh 693 (772)
T KOG1152|consen 614 PSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVH 693 (772)
T ss_pred chhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCcee
Confidence 34788888887 999999999999999999999965 56688889988889999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||-+|+.++++|-+||+|||.|..... .+....+||..|.|||++.|.+..+..-|||++|++||.+.....|+|.
T Consensus 694 rdikdenvivd~~g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 694 RDIKDENVIVDSNGFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cccccccEEEecCCeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999999999999876554 3457789999999999999988778999999999999999877766653
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=204.08 Aligned_cols=247 Identities=22% Similarity=0.382 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHhCC--------CCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLK--------HPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVL 84 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~--------h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~ 84 (303)
.+....|+++|+++. ..+||++++.|.. +.|+|+|+|++....|.-+...+ +.++...+..|++|++
T Consensus 118 tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL 197 (590)
T KOG1290|consen 118 TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVL 197 (590)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHH
Confidence 344566788888762 3349999999974 45899999999866666655443 5799999999999999
Q ss_pred HHHHHHHH-CCceecccCCCcEEEec------------------------------------------------------
Q psy763 85 RGVSYCHR-HACIHRDIKPENILLTA------------------------------------------------------ 109 (303)
Q Consensus 85 ~~l~~lH~-~~ivH~dlk~~nil~~~------------------------------------------------------ 109 (303)
.||.|||. .||+|.||||+|||+..
T Consensus 198 ~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~ 277 (590)
T KOG1290|consen 198 TGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKL 277 (590)
T ss_pred HHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHH
Confidence 99999997 69999999999999900
Q ss_pred --------------------------------------------------------------------------------
Q psy763 110 -------------------------------------------------------------------------------- 109 (303)
Q Consensus 110 -------------------------------------------------------------------------------- 109 (303)
T Consensus 278 ~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~ 357 (590)
T KOG1290|consen 278 KRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDS 357 (590)
T ss_pred hhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccc
Confidence
Q ss_pred --------------------------------CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccch
Q psy763 110 --------------------------------NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 110 --------------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
+-.+||+|||.|.... ...+.-..|..|+|||++.|.+ |+..+||
T Consensus 358 ~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADi 434 (590)
T KOG1290|consen 358 ATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADI 434 (590)
T ss_pred cccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhH
Confidence 0024555555554422 1223335678899999999987 9999999
Q ss_pred hhHHHHHHHhhccCccCCCCc------hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc---------CCChhH
Q psy763 158 WAIEWTSHSYSQIGFIGLGNM------GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS---------KTSTTT 222 (303)
Q Consensus 158 wSlG~il~el~tg~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 222 (303)
||++|+.|||.||-+.|.... ...-+..+++..+.+|..+...... +.+++. +-..-+
T Consensus 435 WS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~-------SRdFFnr~G~LrhI~~LK~Wp 507 (590)
T KOG1290|consen 435 WSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKY-------SRDFFNRRGELRHIRRLKPWP 507 (590)
T ss_pred HHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcc-------hHhhhccccceecccccCCCc
Confidence 999999999999997774331 2233445556555554333322221 122222 233456
Q ss_pred HHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 223 IFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 223 ~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+.+.|...=.+......+..|||--||.+.|..| ++|.+|+.|||+-..+..
T Consensus 508 L~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR-------~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 508 LYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR-------PTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc-------ccHHHHhcCccccCCCCC
Confidence 7777777778888888899999999999888887 999999999999865553
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=189.83 Aligned_cols=176 Identities=31% Similarity=0.453 Sum_probs=150.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|++.++.++|+|++++++.+......++++|++++++|..++..... +++..+..++.+++.++.+||+.|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 119 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI 119 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356778889999999999999999999999999999999999999998876655 8999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+|+|++|.||+++.++.++|+|||.+....... ......++..|++||.+.+...++.++|+||+|+++++|++|..|
T Consensus 120 ~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~p 199 (225)
T smart00221 120 VHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEP 199 (225)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999988865442 334456788899999984334478899999999999999999999
Q ss_pred CCC-CchHHHHHHHhhcCCc
Q psy763 174 GLG-NMGSHMARNLLKNNGR 192 (303)
Q Consensus 174 ~~~-~~~~~~~~~~~~~~~~ 192 (303)
+.+ ......+.+.+..+..
T Consensus 200 f~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 200 FSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccccchhHHHHHHHHhcCCc
Confidence 977 5555555555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=218.17 Aligned_cols=211 Identities=18% Similarity=0.206 Sum_probs=140.2
Q ss_pred EeCCEEEEEEecCCCCcHHHHHcCCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q psy763 44 RRKKKLHLVFEFCDHTVLNELENHPHG--------------------LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPE 103 (303)
Q Consensus 44 ~~~~~~~lv~e~~~~~~l~~~~~~~~~--------------------l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~ 103 (303)
..+...++|+||+++++|.+++..... .....+..++.|++.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 355679999999999999988764321 123446689999999999999999999999999
Q ss_pred cEEEec-CCcEEEccccceeeeCCC--CccccccCCCcccCcccccCCc---------------------cCCCccchhh
Q psy763 104 NILLTA-NGVVKLCDFGFARLINPG--ENYTDYVATRWYRAPELLVGDT---------------------LYGPAVDVWA 159 (303)
Q Consensus 104 nil~~~-~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~---------------------~~~~~~DvwS 159 (303)
|||++. ++.+||+|||++...... .......+++.|+|||.+.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 579999999999765432 2234567899999999764221 1344569999
Q ss_pred HHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCch
Q psy763 160 IEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSH 239 (303)
Q Consensus 160 lG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 239 (303)
+||++|||+++..++. .........+...+.. ...|...........+... ....+....
T Consensus 365 lGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~--------------~~~~~~~~~~~~~~~~~~~----~~~~d~~~~ 424 (566)
T PLN03225 365 AGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD--------------LVAWRKLVEPRASPDLRRG----FEVLDLDGG 424 (566)
T ss_pred HHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc--------------HHHHHHhhccccchhhhhh----hhhccccch
Confidence 9999999998654432 2222222222221110 0112222221111111111 011122344
Q ss_pred hhHHhhhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 240 GVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 240 ~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
...||+.+||..+|..| +++.++++||||......
T Consensus 425 ~~~dLi~~mL~~dP~kR-------~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 425 AGWELLKSMMRFKGRQR-------ISAKAALAHPYFDREGLL 459 (566)
T ss_pred HHHHHHHHHccCCcccC-------CCHHHHhCCcCcCCCCcc
Confidence 56799999999777666 999999999999775543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=233.13 Aligned_cols=147 Identities=16% Similarity=0.172 Sum_probs=113.8
Q ss_pred HHHHhCCC-CCcceeEEEEE-------eCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 26 KEKRSLKH-PNLVNLLEVFR-------RKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 26 ~~l~~l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
+..+.+.| +||.++++.|. ....+++++|+++ ++|..++.. ...+++..++.++.||+.||.|||++||+
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 24 DGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred CccchhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34556777 68889999882 3346778889875 688888865 34699999999999999999999999999
Q ss_pred ecccCCCcEEEec-------------------CCcEEEccccceeeeCCCC-----------------ccccccCCCccc
Q psy763 97 HRDIKPENILLTA-------------------NGVVKLCDFGFARLINPGE-----------------NYTDYVATRWYR 140 (303)
Q Consensus 97 H~dlk~~nil~~~-------------------~~~~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~ 140 (303)
||||||+|||++. ++.+|++|||+++...... ......+|++|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 3456667777665321000 001235788999
Q ss_pred CcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 141 APELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 141 aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||++.+.. ++.++|||||||+||||++|..++
T Consensus 183 APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~ 215 (793)
T PLN00181 183 SPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSR 215 (793)
T ss_pred ChhhhccCC-CCchhhhhhHHHHHHHHhhCCCch
Confidence 999998766 899999999999999999866543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=228.92 Aligned_cols=146 Identities=19% Similarity=0.314 Sum_probs=126.1
Q ss_pred HHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecc
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH---RHACIHRD 99 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~d 99 (303)
+|+..+++++||||++++|++.+++..++||||+++|+|.+++. .+++..+..++.|++.|++||| +.+++|||
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 808 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence 45788999999999999999999999999999999999999986 4889999999999999999999 66999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+||+++.++..++. +|.+..... .....+++.|+|||.+.+.. ++.++|||||||++|||+||..|+..
T Consensus 809 lkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 809 LSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCHHhEEECCCCceEEE-ecccccccc---CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCc
Confidence 99999999988877765 555433221 12346789999999988665 89999999999999999999988743
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=211.41 Aligned_cols=223 Identities=23% Similarity=0.259 Sum_probs=149.5
Q ss_pred HHHHHHHhCCCCCc-----ceeEEEEEe--------CCEEEEEEecCCCCcHHHHHcCC---------------------
Q psy763 23 TNKKEKRSLKHPNL-----VNLLEVFRR--------KKKLHLVFEFCDHTVLNELENHP--------------------- 68 (303)
Q Consensus 23 ~e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~--------------------- 68 (303)
.|+..+..++|.++ ++++++|.. .+..++|+||+++++|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 35556666666654 677777653 34689999999999998877531
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcccc--ccCCCcccCcc
Q psy763 69 ---HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD--YVATRWYRAPE 143 (303)
Q Consensus 69 ---~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~y~aPE 143 (303)
..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++........... ..+++.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1235667889999999999999999999999999999999999999999999976543322222 23478999999
Q ss_pred cccCCcc-------------------C--CCccchhhHHHHHHHhhccCccCCCC-chHHHHHHHhhcCCceeEeecCCC
Q psy763 144 LLVGDTL-------------------Y--GPAVDVWAIEWTSHSYSQIGFIGLGN-MGSHMARNLLKNNGRVTVILKSDS 201 (303)
Q Consensus 144 ~l~~~~~-------------------~--~~~~DvwSlG~il~el~tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 201 (303)
.+..... + ....|+||+||++++|+++...++.. ...... +... .
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~----------~ 447 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY----------D 447 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc----------c
Confidence 9863210 1 12479999999999999977543322 111110 0000 0
Q ss_pred CCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeee
Q psy763 202 LDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
.. ...|..+.... ......+..++.+.|++.++|..++. .+..|+++.++|.||||.
T Consensus 448 ~~----~~~~r~~~~~~----------~~~~~~d~~s~~~~dLi~~LL~~~~~----~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 448 ND----LNRWRMYKGQK----------YDFSLLDRNKEAGWDLACKLITKRDQ----ANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ch----HHHHHhhcccC----------CCcccccccChHHHHHHHHHhccCCC----CcccCCCHHHHhCCCCcC
Confidence 00 00122111100 01112344678889999999985442 224669999999999984
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=200.67 Aligned_cols=151 Identities=22% Similarity=0.350 Sum_probs=126.0
Q ss_pred HHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRS--LKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
.+++..+|.++.+. |+|+||+.+++.=..++ +++||++|-+.|+|.+++.+ ..++......++..+|.||+||
T Consensus 246 dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHL 324 (513)
T KOG2052|consen 246 DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHL 324 (513)
T ss_pred chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHH
Confidence 35556666666654 69999999998865443 68999999999999999987 5899999999999999999999
Q ss_pred HHC--------CceecccCCCcEEEecCCcEEEccccceeeeCCCC-----ccccccCCCcccCcccccCCcc---C--C
Q psy763 91 HRH--------ACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATRWYRAPELLVGDTL---Y--G 152 (303)
Q Consensus 91 H~~--------~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~---~--~ 152 (303)
|.. +|.|||||+.||||.+++.+.|+|+|+|....... .....+||.+|||||++...-. + -
T Consensus 325 H~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy 404 (513)
T KOG2052|consen 325 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY 404 (513)
T ss_pred HHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh
Confidence 963 49999999999999999999999999998866432 2356799999999999974321 1 2
Q ss_pred CccchhhHHHHHHHhh
Q psy763 153 PAVDVWAIEWTSHSYS 168 (303)
Q Consensus 153 ~~~DvwSlG~il~el~ 168 (303)
..+||||||.|+||+.
T Consensus 405 k~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 405 KRADIYAFGLVLWEIA 420 (513)
T ss_pred hHHHHHHHHHHHHHHH
Confidence 3689999999999994
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=197.53 Aligned_cols=153 Identities=25% Similarity=0.410 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRS--LKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
..+++..|.++.+. ++|+||+++++.-..+. .+.||+||-+.|+|.+++..+ .+++.....++..+++||+||
T Consensus 245 ~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~L 323 (534)
T KOG3653|consen 245 EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHL 323 (534)
T ss_pred HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHh
Confidence 45677777777775 57999999999876555 789999999999999999854 899999999999999999999
Q ss_pred HHC---------CceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCC-----C
Q psy763 91 HRH---------ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYG-----P 153 (303)
Q Consensus 91 H~~---------~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~-----~ 153 (303)
|+. .|+|||||++||||..+++..|+|||+|..+.++... -..+||.+|||||++.|.-.+. .
T Consensus 324 Hee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afk 403 (534)
T KOG3653|consen 324 HEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFK 403 (534)
T ss_pred cccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHH
Confidence 963 5999999999999999999999999999998754332 2368999999999998754443 4
Q ss_pred ccchhhHHHHHHHhhcc
Q psy763 154 AVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 154 ~~DvwSlG~il~el~tg 170 (303)
+.||||+|.|+|||.+.
T Consensus 404 r~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 404 RIDVYAMGLVLWEIASR 420 (534)
T ss_pred HHHHHHHHHHHHHHHhh
Confidence 68999999999999653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-24 Score=174.81 Aligned_cols=150 Identities=37% Similarity=0.612 Sum_probs=133.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|++.++.++|++|+++++++......++++|+++++++..++... ..++...+..++.++++++++||+.|++
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 114 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 467888999999999999999999999999999999999999999988765 4789999999999999999999999999
Q ss_pred ecccCCCcEEEec-CCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHh
Q psy763 97 HRDIKPENILLTA-NGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 97 H~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el 167 (303)
|+||+|.||+++. ++.++|+|||.+....... ......+...|++||.+.....++.++|+||+|++++++
T Consensus 115 H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 9999999999999 8999999999998765432 123356788899999987653478999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=175.27 Aligned_cols=169 Identities=17% Similarity=0.155 Sum_probs=122.2
Q ss_pred CcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCC
Q psy763 59 TVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR 137 (303)
Q Consensus 59 ~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 137 (303)
|+|.+++.. +.++++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+....... ..+|+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 678887765 457999999999999999999999998 999999999999999 99988764422 36889
Q ss_pred cccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchH-HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc
Q psy763 138 WYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGS-HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS 216 (303)
Q Consensus 138 ~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (303)
.|+|||++.+.. ++.++|||||||++|||++|..|+...... .....+........
T Consensus 69 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 125 (176)
T smart00750 69 YFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---------------------- 125 (176)
T ss_pred cccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------------
Confidence 999999998766 899999999999999999999887655332 22222221111000
Q ss_pred CCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 217 KTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 217 ~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+..++.... .. ....+.+++.+|+..++..| +++.+++.|+++...
T Consensus 126 -~~~~~~~~~--~~------~~~~~~~~i~~cl~~~p~~R-------p~~~~ll~~~~~~~~ 171 (176)
T smart00750 126 -PRDRSNLES--VS------AARSFADFMRVCASRLPQRR-------EAANHYLAHCRALFA 171 (176)
T ss_pred -ccccccHHH--HH------hhhhHHHHHHHHHhcccccc-------cCHHHHHHHHHHHHH
Confidence 000000000 00 00356788888888666666 899999988877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-25 Score=201.81 Aligned_cols=236 Identities=21% Similarity=0.267 Sum_probs=189.9
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 100 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 100 (303)
...|+-+++..+||||+.++|.+.....+++.||||.+|+|++.-.-.+++++-++...+++.++|++|||+.|-+||||
T Consensus 59 iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdi 138 (829)
T KOG0576|consen 59 IQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDI 138 (829)
T ss_pred cccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccc
Confidence 55677788899999999999999999999999999999999998776789999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCccccc--CCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 101 KPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLV--GDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 101 k~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~--~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
|-.||++++.|.+|+.|||.+-.+... ...+.+.||+.|+|||+-. ..+.|...+|+|++|++..|+....+|.+..
T Consensus 139 KGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl 218 (829)
T KOG0576|consen 139 KGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL 218 (829)
T ss_pred cccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc
Confidence 999999999999999999998766532 3457789999999999964 3344899999999999999998888888888
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhH-hCCCCCCCchhhHHhhhhhhcccccee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLI-RGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.+.+.+.-+-+.+..++..-....-.+..-...-.++...+.+||...-++. ..-.+...+..++++|+|+...++.++
T Consensus 219 hpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~ 298 (829)
T KOG0576|consen 219 HPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVR 298 (829)
T ss_pred chHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCccc
Confidence 8888888777777766544443333333333334455567777776655443 222335678889999999988775444
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-23 Score=169.59 Aligned_cols=157 Identities=26% Similarity=0.326 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEE-EEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.|.+|.----.| .|.||+.-|++ |++.+.+++++||++.|+|.+-+.. .++-+.....++.|+++|+.|+|++++
T Consensus 64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknl 142 (378)
T KOG1345|consen 64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNL 142 (378)
T ss_pred HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccch
Confidence 34444443322223 49999988776 6777788899999999999987654 578899999999999999999999999
Q ss_pred eecccCCCcEEEecC--CcEEEccccceeeeCCCCccccccCCCcccCcccccCC----ccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTAN--GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD----TLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~----~~~~~~~DvwSlG~il~el~t 169 (303)
||||||.+||||-.. -.+||||||..+..+... ....-+..|.+||+...- -...+++|+|.||+++|.++|
T Consensus 143 VHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt 220 (378)
T KOG1345|consen 143 VHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT 220 (378)
T ss_pred hhcccccceEEEecCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec
Confidence 999999999999643 479999999987644322 122334558899986521 125789999999999999999
Q ss_pred cCccCCCC
Q psy763 170 IGFIGLGN 177 (303)
Q Consensus 170 g~~~~~~~ 177 (303)
|.+|+...
T Consensus 221 G~~PWQka 228 (378)
T KOG1345|consen 221 GKFPWQKA 228 (378)
T ss_pred CCCcchhh
Confidence 99988643
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=184.54 Aligned_cols=225 Identities=24% Similarity=0.232 Sum_probs=169.1
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 100 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 100 (303)
...|.-+-..+.|||++..+..+.+....+-+||||++ +|..++...+.++...+..++.|++.|++|+|+.|+.|||+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 56666777789999998888877766655566999998 99998887778999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEccccceeeeCCCC-----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 101 KPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 101 k~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|++|+++..+|.+||+|||.+....-+. .....+|+..|.|||++.+...-....||||.|+++..|.+|..++.
T Consensus 447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 9999999999999999999988765322 22457899999999999987744668999999999999999887765
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
-....+... .+.....|... .....++... .+.....++.+||.-.|..
T Consensus 527 ~a~~~~~~~-------------------~~~~~~~~~~~--~~~~~~~~~~----------lp~~~~~~~~~~l~~~P~~ 575 (601)
T KOG0590|consen 527 VAKKSDNSF-------------------KTNNYSDQRNI--FEGPNRLLSL----------LPRETRIIIYRMLQLDPTK 575 (601)
T ss_pred cccccccch-------------------hhhcccccccc--ccChHHHHHh----------chhhHHHHHHHHccCChhh
Confidence 443322211 00000001000 0111122222 2344567788888877777
Q ss_pred eeccccccccccccceeeeeecCCcceEEEE
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPERKCLEVI 286 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 286 (303)
| +++.+++..+|+..+ +||.|+
T Consensus 576 R-------~ti~~i~~d~W~~~i--~~c~v~ 597 (601)
T KOG0590|consen 576 R-------ITIEQILNDEWIRSI--ECCHVD 597 (601)
T ss_pred e-------ecHHHHhhChHhhhc--ceEEec
Confidence 7 999999999999764 577765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-19 Score=155.20 Aligned_cols=162 Identities=34% Similarity=0.424 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHP-NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+..++.+.|+ +++++.+.+......+++++++.++++..+..... .++......++.|++.++.++|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456678888899999988 79999999988888899999999999998777654 79999999999999999999999
Q ss_pred CCceecccCCCcEEEecCC-cEEEccccceeeeCCCC-------ccccccCCCcccCcccccCC--ccCCCccchhhHHH
Q psy763 93 HACIHRDIKPENILLTANG-VVKLCDFGFARLINPGE-------NYTDYVATRWYRAPELLVGD--TLYGPAVDVWAIEW 162 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~--~~~~~~~DvwSlG~ 162 (303)
.|++|||+||+||+++..+ .++++|||.+....... ......++..|++||.+.+. ..++...|+||+|+
T Consensus 120 ~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~ 199 (384)
T COG0515 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199 (384)
T ss_pred CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHH
Confidence 9999999999999999988 79999999998654332 23567899999999999874 35799999999999
Q ss_pred HHHHhhccCccCCCCc
Q psy763 163 TSHSYSQIGFIGLGNM 178 (303)
Q Consensus 163 il~el~tg~~~~~~~~ 178 (303)
+++++++|..|+....
T Consensus 200 ~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 200 TLYELLTGLPPFEGEK 215 (384)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999988866555
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=170.16 Aligned_cols=159 Identities=23% Similarity=0.227 Sum_probs=140.5
Q ss_pred HHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.-..|..++...+ ||.+++++..++.++..+++.++..+|.+...+.....+++.....+...++-++.++|+.|++|+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr 121 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR 121 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence 3344666777777 999999999999999999999999999999988888889999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
|+|++||+++.+|++++.|||+++....... .+||..|||||++.+ ...++|.||+|++++||+||..+|.+
T Consensus 122 d~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~-- 193 (612)
T KOG0603|consen 122 DYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG-- 193 (612)
T ss_pred cccccceeecccCccccCCchhhhHhHhhhh---cccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch--
Confidence 9999999999999999999999987654332 289999999999983 68899999999999999999999988
Q ss_pred hHHHHHHHhh
Q psy763 179 GSHMARNLLK 188 (303)
Q Consensus 179 ~~~~~~~~~~ 188 (303)
+....+++
T Consensus 194 --~~~~~Il~ 201 (612)
T KOG0603|consen 194 --DTMKRILK 201 (612)
T ss_pred --HHHHHHhh
Confidence 55555555
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=162.49 Aligned_cols=229 Identities=16% Similarity=0.166 Sum_probs=162.4
Q ss_pred HHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecccCCCcE
Q psy763 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC-IHRDIKPENI 105 (303)
Q Consensus 28 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i-vH~dlk~~ni 105 (303)
++.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ...++......++++|+.||.|+|+..| .|+.++++|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999998776 4578899999999999999999999776 9999999999
Q ss_pred EEecCCcEEEccccceeeeCCC---CccccccCCCcccCcccccCCc--c----CCCccchhhHHHHHHHhhccCccCCC
Q psy763 106 LLTANGVVKLCDFGFARLINPG---ENYTDYVATRWYRAPELLVGDT--L----YGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 106 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~--~----~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+++....+|++|||+....... ...........|.|||.+++.. . .+.+.|+||+|++++|+++...|+..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998776421 1111223455699999998631 1 36789999999999999887777654
Q ss_pred C----chHHHHHHHhhcCCceeEe-ec-CCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 177 N----MGSHMARNLLKNNGRVTVI-LK-SDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 177 ~----~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
. ...+.+..+...+..+..+ .. ....+++...++-+||...|..+|..+-......+.......--.+.|.|+.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~m~~ 240 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDSLFR 240 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHHHHH
Confidence 2 2223444433312222211 11 1244556777888999988888887766333222221111111144555555
Q ss_pred ccccee
Q psy763 251 GRFTYI 256 (303)
Q Consensus 251 ~~~~~~ 256 (303)
..+.|.
T Consensus 241 ~le~Y~ 246 (484)
T KOG1023|consen 241 MLESYA 246 (484)
T ss_pred HHHHHH
Confidence 555444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-19 Score=157.57 Aligned_cols=120 Identities=20% Similarity=0.240 Sum_probs=95.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcce-eEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVN-LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+++++.++|+|++. +++ .+..|+||||++|++|... . ... ...++.|++.||.|||+.||
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gI 132 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGI 132 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCC
Confidence 4567899999999999999985 443 2457999999999999732 1 111 14678999999999999999
Q ss_pred eeccc-CCCcEEEecCCcEEEccccceeeeCCCCcc---------ccccCCCcccCcccccC
Q psy763 96 IHRDI-KPENILLTANGVVKLCDFGFARLINPGENY---------TDYVATRWYRAPELLVG 147 (303)
Q Consensus 96 vH~dl-k~~nil~~~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~y~aPE~l~~ 147 (303)
+|||| ||+||+++.++.++|+|||+|+........ ....+++.|.|||.+..
T Consensus 133 iHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 133 THNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999 999999998999999999999976543211 23456778999999863
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.8e-19 Score=143.74 Aligned_cols=151 Identities=15% Similarity=0.039 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|++++++++ |+++++++++ +..+++|||+.|.+|...... ....++.|++.++.++|++||+
T Consensus 45 ~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIv 113 (218)
T PRK12274 45 WWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVA 113 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCc
Confidence 346889999999995 5889999886 346999999999998754321 1235788999999999999999
Q ss_pred eccc-CCCcEEEecCCcEEEccccceeeeCCCCcc----c----------cccCCCcccCcccccCCccCC-CccchhhH
Q psy763 97 HRDI-KPENILLTANGVVKLCDFGFARLINPGENY----T----------DYVATRWYRAPELLVGDTLYG-PAVDVWAI 160 (303)
Q Consensus 97 H~dl-k~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~----------~~~~~~~y~aPE~l~~~~~~~-~~~DvwSl 160 (303)
|||| ||+||+++.++.++|+|||++....+.... . -...++.|++|+.-.-....+ ...+.++.
T Consensus 114 HrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~ 193 (218)
T PRK12274 114 HNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFAT 193 (218)
T ss_pred cCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHh
Confidence 9999 799999999999999999999865543210 0 012456677776544322234 56788899
Q ss_pred HHHHHHhhccCccCCCCch
Q psy763 161 EWTSHSYSQIGFIGLGNMG 179 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~ 179 (303)
|+-+|.++|++.+.++...
T Consensus 194 g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 194 GKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHhccCCccccCC
Confidence 9999999999998887643
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-18 Score=144.07 Aligned_cols=201 Identities=11% Similarity=0.110 Sum_probs=156.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
..+.|.+|.-.++.+.||||+.++|.|....++.+|..||+.|+|..++.... ..+-.++..++.++++|++|||+..
T Consensus 230 isrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle 309 (448)
T KOG0195|consen 230 ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE 309 (448)
T ss_pred hcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc
Confidence 34568889999999999999999999999999999999999999999987654 4677889999999999999999975
Q ss_pred --ceecccCCCcEEEecCCcEEEc--cccceeeeCCCCccccccCCCcccCcccccCCcc--CCCccchhhHHHHHHHhh
Q psy763 95 --CIHRDIKPENILLTANGVVKLC--DFGFARLINPGENYTDYVATRWYRAPELLVGDTL--YGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 95 --ivH~dlk~~nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~--~~~~~DvwSlG~il~el~ 168 (303)
|.---|....+++|++.+.+|+ |--++.. . ....-++.|++||.+...+. .-.++|+|||++++||+-
T Consensus 310 p~ipr~~lns~hvmidedltarismad~kfsfq--e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~ 383 (448)
T KOG0195|consen 310 PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN 383 (448)
T ss_pred hhhhhhhcccceEEecchhhhheecccceeeee--c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh
Confidence 4455688899999999877664 3322221 1 11234678999999975442 245899999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|...||.+..+.+.-.++.-.+-|+. .|+......-.++--|+.++|.+||-+..
T Consensus 384 trevpfadlspmecgmkialeglrv~---ippgis~hm~klm~icmnedpgkrpkfdm 438 (448)
T KOG0195|consen 384 TREVPFADLSPMECGMKIALEGLRVH---IPPGISRHMNKLMNICMNEDPGKRPKFDM 438 (448)
T ss_pred ccccccccCCchhhhhhhhhcccccc---CCCCccHHHHHHHHHHhcCCCCcCCCcce
Confidence 99999999998888877777777754 33444455555556666777776665443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=144.64 Aligned_cols=127 Identities=13% Similarity=0.242 Sum_probs=99.9
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeC--------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRK--------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
.+.+|+..+.++.|++|..+.+++... +..++||||++|.+|.++. .+++ ....+++.++..+|
T Consensus 81 ~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH 152 (232)
T PRK10359 81 YYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLH 152 (232)
T ss_pred HHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHH
Confidence 368899999999999999999886643 3578999999999998873 2333 34669999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHh
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el 167 (303)
+.|++|||++|+||+++.++ ++|+|||......... |-+.+.-...+..++|+||||+++.-+
T Consensus 153 ~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~------------a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 153 QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK------------AKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh------------hHHHHHHHhHhcccccccceeEeehHH
Confidence 99999999999999999888 9999999876542211 112222233477899999999998765
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=146.70 Aligned_cols=157 Identities=20% Similarity=0.216 Sum_probs=126.3
Q ss_pred HHHHHHHHHHhCC----CCCcceeEEEE-EeCCEEEEEEecCCCCcHHHHHc-CC-CCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLK----HPNLVNLLEVF-RRKKKLHLVFEFCDHTVLNELEN-HP-HGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 20 ~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~~~l~~~~~-~~-~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.+..|..+++.+. .+++..+++.. ..+...++||+.+. .+|.++.. .. +.++..++..++.|++.+|.++|+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G-~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLG-PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccC-ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 4556667777765 36899999999 47778899999885 67777653 33 689999999999999999999999
Q ss_pred CCceecccCCCcEEEecC-----CcEEEcccccee--eeC-CCC-------c-cccccCCCcccCcccccCCccCCCccc
Q psy763 93 HACIHRDIKPENILLTAN-----GVVKLCDFGFAR--LIN-PGE-------N-YTDYVATRWYRAPELLVGDTLYGPAVD 156 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~-----~~~kl~dfg~~~--~~~-~~~-------~-~~~~~~~~~y~aPE~l~~~~~~~~~~D 156 (303)
.|++||||||.|++++.. ..+.|.|||+++ ... ... . .....||..|.++....+.. .+.+.|
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DD 219 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDD 219 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchh
Confidence 999999999999999865 469999999998 321 111 1 12345999999999988776 699999
Q ss_pred hhhHHHHHHHhhccCccCCCCc
Q psy763 157 VWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 157 vwSlG~il~el~tg~~~~~~~~ 178 (303)
+||++.++.|+..|..|+.+..
T Consensus 220 les~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 220 LESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred hhhHHHHHHHHhcCCCCCcccc
Confidence 9999999999999886664544
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-17 Score=138.49 Aligned_cols=158 Identities=17% Similarity=0.196 Sum_probs=134.0
Q ss_pred HHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.++.|.+..+.| ..++|..++.+.+++.+-.||+|.+..+.-+-+--++..++.+++..++.|++.-++++|++.+++|
T Consensus 69 QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYR 148 (449)
T KOG1165|consen 69 QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYR 148 (449)
T ss_pred hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeec
Confidence 355667777766 4899999999999999999999999755444455677899999999999999999999999999999
Q ss_pred ccCCCcEEEecC-----CcEEEccccceeeeCCCC--------ccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 99 DIKPENILLTAN-----GVVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 99 dlk~~nil~~~~-----~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
||||+|+||... ..+.++|||+|+.+.... ..++..||.+||+-....|.. .+...|+-|+|-+|.
T Consensus 149 DIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFm 227 (449)
T KOG1165|consen 149 DIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFM 227 (449)
T ss_pred ccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhh
Confidence 999999999765 369999999998875332 235678999999998888876 699999999999999
Q ss_pred HhhccCccCCCCc
Q psy763 166 SYSQIGFIGLGNM 178 (303)
Q Consensus 166 el~tg~~~~~~~~ 178 (303)
..+.|..|+.|..
T Consensus 228 YFLRGsLPWQGLK 240 (449)
T KOG1165|consen 228 YFLRGSLPWQGLK 240 (449)
T ss_pred hhccCCCcccccc
Confidence 9999999988763
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=131.70 Aligned_cols=103 Identities=15% Similarity=0.131 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC-HRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l-H~~~ivH 97 (303)
.....|+..++.+.++++.....+.. .+ .++||||++++++........+++...+..++.|++.+|.++ |+.||+|
T Consensus 64 ~~~~~E~~~l~~l~~~~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH 141 (190)
T cd05147 64 TWAEKEMRNLKRLVTAGIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHHCCCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 34456889999998887744333322 22 389999999887765544456899999999999999999999 7999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeee
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
|||||+||+++ ++.++|+|||+|...
T Consensus 142 rDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 142 ADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999998 578999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=138.53 Aligned_cols=188 Identities=20% Similarity=0.183 Sum_probs=128.6
Q ss_pred CCCCcceeEEEEEeC---------------------------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHH
Q psy763 32 KHPNLVNLLEVFRRK---------------------------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 84 (303)
Q Consensus 32 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~ 84 (303)
+|||||++++.|.++ ..+|+||.-.+ .+|..++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 699999999998642 35789998777 5677776543 567788888999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEec--C--CcEEEccccceeeeCCCC-------ccccccCCCcccCcccccCCcc---
Q psy763 85 RGVSYCHRHACIHRDIKPENILLTA--N--GVVKLCDFGFARLINPGE-------NYTDYVATRWYRAPELLVGDTL--- 150 (303)
Q Consensus 85 ~~l~~lH~~~ivH~dlk~~nil~~~--~--~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~--- 150 (303)
+|+.|||++|+.|||+|.+|||+.- + -.+.++|||.+--..... ......|...-+|||+...-+.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999953 3 358999999875432211 1122346666899999753321
Q ss_pred --CCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 151 --YGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 151 --~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
.-.++|.|+.|.+-||+++...|||+.-....--+--+ . -..+.-++.+++..-++.+.-+-.++++|+..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-e--~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-E--SQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-h--hhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 23479999999999999999999998321111000000 0 01122345566666666666666666665543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=130.37 Aligned_cols=101 Identities=16% Similarity=0.154 Sum_probs=82.5
Q ss_pred HHHHHHHHHHHHhC-----CCCCcceeEEEEEeCC---EEE-EEEec--CCCCcHHHHHcCCCCCCHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-----KHPNLVNLLEVFRRKK---KLH-LVFEF--CDHTVLNELENHPHGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv~e~--~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~ 86 (303)
.+...+|++.++.+ +||||++++|++.++. .++ +|+|| +.+++|.+++++. .+++. ..++.|++.+
T Consensus 40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~ 116 (210)
T PRK10345 40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKK 116 (210)
T ss_pred HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHH
Confidence 45678899999999 6799999999999874 333 78999 5589999999764 56655 3567888888
Q ss_pred H-HHHHHCCceecccCCCcEEEecC----CcEEEccccce
Q psy763 87 V-SYCHRHACIHRDIKPENILLTAN----GVVKLCDFGFA 121 (303)
Q Consensus 87 l-~~lH~~~ivH~dlk~~nil~~~~----~~~kl~dfg~~ 121 (303)
+ +|||+++|+||||||+||+++.. ..++|+|++.+
T Consensus 117 l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 117 LKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7 89999999999999999999743 37999995544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.4e-16 Score=127.82 Aligned_cols=105 Identities=17% Similarity=0.116 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iv 96 (303)
......|.+.+..+.|+++.....+.... .++||||++|+++.........++......++.|++.++.++|+ .||+
T Consensus 63 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~giv 140 (190)
T cd05145 63 FAWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLV 140 (190)
T ss_pred HHHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 34456788999999999885444443332 48999999988544332234578889999999999999999999 9999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLIN 125 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~ 125 (303)
||||||+||+++ ++.++|+|||++....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999998 8899999999997754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-16 Score=130.72 Aligned_cols=187 Identities=17% Similarity=0.184 Sum_probs=144.8
Q ss_pred HHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHH-HcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 20 TEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 20 ~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+..|.++.+.|+ ...|..+..+..+...-.+||+...+ +|.++ --+...++..+++-++-|++.-+.|+|.++++|
T Consensus 56 qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiH 134 (341)
T KOG1163|consen 56 QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIH 134 (341)
T ss_pred chhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcccc
Confidence 4566777777776 56788888888888889999999975 45554 445668999999999999999999999999999
Q ss_pred cccCCCcEEEecC---CcEEEccccceeeeCCCC--------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 98 RDIKPENILLTAN---GVVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 98 ~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
|||||+|+|..-+ ..+.++|||+|...-... ......||.+|.+-....+-. .+...|+-|+|.++..
T Consensus 135 RDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmY 213 (341)
T KOG1163|consen 135 RDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMY 213 (341)
T ss_pred ccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeee
Confidence 9999999999744 579999999998764321 123467899999888777655 5889999999999999
Q ss_pred hhccCccCCCCch---HHHHHHHhhcCCceeEeecCCCCCcchhh
Q psy763 167 YSQIGFIGLGNMG---SHMARNLLKNNGRVTVILKSDSLDSETWD 208 (303)
Q Consensus 167 l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (303)
+..|..|+.|... .+-...+.+.....+...-+...|.|..-
T Consensus 214 fnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~m 258 (341)
T KOG1163|consen 214 FNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAM 258 (341)
T ss_pred eecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHH
Confidence 9899988887643 44455566655555544455666665433
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.4e-16 Score=150.72 Aligned_cols=105 Identities=28% Similarity=0.450 Sum_probs=90.7
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC----------------ccccccCCCcccCcccccC
Q psy763 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----------------NYTDYVATRWYRAPELLVG 147 (303)
Q Consensus 84 ~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~l~~ 147 (303)
+.+++|||+-||+|||+||+|.+|..-|++|+.|||++....-.. ..+..+||+.|+|||++..
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 778999999999999999999999999999999999976533110 0134589999999999997
Q ss_pred CccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhc
Q psy763 148 DTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKN 189 (303)
Q Consensus 148 ~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~ 189 (303)
++ |+..+|+|++|+|+||.+.|..+|+|.++.+.....+..
T Consensus 233 qg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 233 QG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 77 999999999999999999999999999988887665554
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.5e-17 Score=155.92 Aligned_cols=148 Identities=27% Similarity=0.294 Sum_probs=115.6
Q ss_pred HHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEE
Q psy763 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 107 (303)
Q Consensus 28 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~ 107 (303)
.+..++||++++.-+...+.--|+|-+|+. .+|.+.+....-+...+.+.++-|++.|+..||..||+|||||.+|||+
T Consensus 75 ~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 75 FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 667799999999888777777889999997 5666666655567888999999999999999999999999999999999
Q ss_pred ecCCcEEEccccceeee-CCCCcc-------ccccCCCcccCcccccCC----------ccCCCccchhhHHHHHHHhhc
Q psy763 108 TANGVVKLCDFGFARLI-NPGENY-------TDYVATRWYRAPELLVGD----------TLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 108 ~~~~~~kl~dfg~~~~~-~~~~~~-------~~~~~~~~y~aPE~l~~~----------~~~~~~~DvwSlG~il~el~t 169 (303)
++=+.+.|+||..-+.. .+.+.. .+...-..|.|||.+... +..+++-||||+||+++|+++
T Consensus 154 TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 154 TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL 233 (1431)
T ss_pred eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence 99999999999765332 122111 111222349999998631 125789999999999999988
Q ss_pred cCccCCC
Q psy763 170 IGFIGLG 176 (303)
Q Consensus 170 g~~~~~~ 176 (303)
-+.|.+.
T Consensus 234 Eg~PlF~ 240 (1431)
T KOG1240|consen 234 EGRPLFT 240 (1431)
T ss_pred cCCCccc
Confidence 7666554
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-16 Score=143.30 Aligned_cols=118 Identities=27% Similarity=0.462 Sum_probs=104.3
Q ss_pred EEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeee
Q psy763 48 KLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 48 ~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
.+|+.|++|..++|.+.+.+.. ..+......++.|++.|+.| +|.+|+|+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 4789999999999999886432 46677889999999999999 99999999999999999999999999998776
Q ss_pred CCCC-------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 125 NPGE-------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 125 ~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
.... ..+...||.+|++||.+.++. |+.++||||||++++|+++
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLI 457 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHH
Confidence 5443 345678999999999999887 8999999999999999975
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=120.40 Aligned_cols=106 Identities=22% Similarity=0.317 Sum_probs=91.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 13 ~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
........+.+|+..++.+.|+++.....++...+..++||||++|++|.+++..... ....++.+++.+|.++|+
T Consensus 38 ~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~ 113 (211)
T PRK14879 38 DERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS 113 (211)
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh
Confidence 3344556778899999999999988777777777788999999999999998864322 778999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 114 ~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 114 AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999999999 78899999998765
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=137.05 Aligned_cols=101 Identities=15% Similarity=0.232 Sum_probs=89.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 14 EAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.......+.+|+++++.++|++++....++......++||||+++++|.+++. ....++.+++.+|.+||+.
T Consensus 376 ~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~ 447 (535)
T PRK09605 376 ERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA 447 (535)
T ss_pred HHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC
Confidence 33455678899999999999999988877777777899999999999998775 3567899999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
|++|||+||+||++ .++.++|+|||++..
T Consensus 448 giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 448 GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999 678899999999876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.8e-15 Score=127.24 Aligned_cols=124 Identities=27% Similarity=0.229 Sum_probs=84.4
Q ss_pred EEEEecCCCCcHHHHHc---CC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEcccccee
Q psy763 50 HLVFEFCDHTVLNELEN---HP----HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 50 ~lv~e~~~~~~l~~~~~---~~----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
+++|+-+. ++|..++. .. ..+...-...+..|+++.+++||+.|++|+||+|+|++++.+|.+.|+||+...
T Consensus 115 ~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~ 193 (288)
T PF14531_consen 115 FLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV 193 (288)
T ss_dssp EEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred hhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence 67777775 67777532 11 123334445677999999999999999999999999999999999999998776
Q ss_pred eeCCCCccccccCCCcccCcccccCC-------ccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 123 LINPGENYTDYVATRWYRAPELLVGD-------TLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 123 ~~~~~~~~~~~~~~~~y~aPE~l~~~-------~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
..+. .......+..|.|||..... ..++.+.|.|++|+++|.|.++..|+..
T Consensus 194 r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 194 RAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp ETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred ecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 6432 22223455778999976432 2378899999999999999998877654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.2e-14 Score=117.97 Aligned_cols=102 Identities=17% Similarity=0.292 Sum_probs=85.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 14 EAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.......+.+|+++++.+.|+++.....++...+..++||||++|+++..++..... .++.+++.+|.++|+.
T Consensus 37 ~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~ 109 (199)
T TIGR03724 37 ERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA 109 (199)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC
Confidence 334556778899999999988766555555566677999999999999987754321 7899999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
|++|+|++|.||+++ ++.++++|||++..
T Consensus 110 gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 110 GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=6e-15 Score=144.04 Aligned_cols=139 Identities=24% Similarity=0.294 Sum_probs=119.7
Q ss_pred CCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEec----
Q psy763 34 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---- 109 (303)
Q Consensus 34 ~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~---- 109 (303)
+.|+.+...+.-.+.-++|+||.+.|+|.++++..+.+++..+..++.|++..+.+||..+|+||||||+|+++..
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 4466666666666777899999999999999998889999999999999999999999999999999999999953
Q ss_pred ---CCcEEEccccceeeeC---CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 110 ---NGVVKLCDFGFARLIN---PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 110 ---~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
...++|+|||.+..+. ++......++|-.+-++|++.|.+ +++.+|.|.++.++|-|+-|.+.
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHHH
Confidence 2469999999998764 333456678899999999999877 99999999999999999876643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.5e-14 Score=120.13 Aligned_cols=101 Identities=15% Similarity=0.116 Sum_probs=81.5
Q ss_pred HHHHHHHHHHHhCCCCC--cceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-c
Q psy763 19 ATEATNKKEKRSLKHPN--LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA-C 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i 95 (303)
..+..|+..++.+.+.+ +.++++. . ..++||||++++++.........+....+..++.|++.++.+||+.| +
T Consensus 95 ~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~i 170 (237)
T smart00090 95 LWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGEL 170 (237)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence 45678999999997633 3444442 2 34899999999888765544456677778899999999999999999 9
Q ss_pred eecccCCCcEEEecCCcEEEccccceeee
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
+|+||||+||+++ ++.++|+|||.+...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999998653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.2e-14 Score=119.10 Aligned_cols=103 Identities=17% Similarity=0.183 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCc--ceeEEEEEeCC----EEEEEEecCCC-CcHHHHHcCCCCCCHHHHHHHHHHHHHHHH
Q psy763 16 IRQATEATNKKEKRSLKHPNL--VNLLEVFRRKK----KLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~----~~~lv~e~~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
.....+.+|..+++.+.|++| ++.+++..... ..++|+|+++| .+|..++... .+++.. +.+++.++.
T Consensus 82 ~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~ 156 (239)
T PRK01723 82 LERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIA 156 (239)
T ss_pred hhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHH
Confidence 345667889999999998885 67777654332 23599999997 6888887643 555543 578999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceee
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
+||+.||+|+||||.|||++.++.++|+|||.+..
T Consensus 157 ~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 157 RFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999999999888999999998865
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.9e-15 Score=140.57 Aligned_cols=159 Identities=27% Similarity=0.361 Sum_probs=135.0
Q ss_pred HHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCC-CCCHHHHHHHHHHHHHHHHHHH-HCCce
Q psy763 21 EATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPH-GLPWDLIKQITWQVLRGVSYCH-RHACI 96 (303)
Q Consensus 21 ~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~-~l~~~~~~~~~~qi~~~l~~lH-~~~iv 96 (303)
...|..+.+.+. |+|++.+++.....+..++++++..++++...+ .... ..+...+-.++.|+..++.|+| ..+++
T Consensus 67 i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~ 146 (601)
T KOG0590|consen 67 IDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVT 146 (601)
T ss_pred cCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccc
Confidence 344566666776 999999999999999999999999999998877 4444 6777888899999999999999 99999
Q ss_pred ecccCCCcEEEecCC-cEEEccccceeeeCC-CC---ccccccC-CCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 97 HRDIKPENILLTANG-VVKLCDFGFARLINP-GE---NYTDYVA-TRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 97 H~dlk~~nil~~~~~-~~kl~dfg~~~~~~~-~~---~~~~~~~-~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+|++|+|.+++..+ .++++|||+|..... .. .....+| ++.|.|||...+.....+..|+||.|+++..+++|
T Consensus 147 h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 147 HRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred cCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence 999999999999999 999999999987665 22 2234577 99999999998755568899999999999999999
Q ss_pred CccCCCCch
Q psy763 171 GFIGLGNMG 179 (303)
Q Consensus 171 ~~~~~~~~~ 179 (303)
..++.-...
T Consensus 227 ~~p~~~~~~ 235 (601)
T KOG0590|consen 227 ELPWDFPSR 235 (601)
T ss_pred CCCcccccc
Confidence 887765433
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.6e-13 Score=122.56 Aligned_cols=145 Identities=16% Similarity=0.221 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~iv 96 (303)
.....+.++.++.++||||+++++.++.++.+|+|+|-+.. |..++++ +....+..-+.||+.||.||| +.+++
T Consensus 53 ~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lv 127 (690)
T KOG1243|consen 53 TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLV 127 (690)
T ss_pred hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCee
Confidence 34456778899999999999999999999999999999865 4455543 336677788999999999998 57799
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+++....|+|+..|..||++|.++........ ......--.|..|+.+... ..+.|.|-|||++||++.|
T Consensus 128 HgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 128 HGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 999999999999999999999988765432221 1111122235667655422 3678999999999999887
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-12 Score=108.35 Aligned_cols=97 Identities=14% Similarity=0.201 Sum_probs=78.2
Q ss_pred HHHHHHHHHHHhCCCCC--cceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 19 ATEATNKKEKRSLKHPN--LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.....|...+..+.|++ ++..++ ....++||||++++++..+... .....++.+++.++.++|+.|++
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 34677888888888874 444443 2345899999999998775431 34567889999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLIN 125 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~ 125 (303)
|+||+|+||+++.++.++|+|||.+....
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.8e-12 Score=99.30 Aligned_cols=114 Identities=17% Similarity=0.267 Sum_probs=93.8
Q ss_pred ccccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHH
Q psy763 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW 81 (303)
Q Consensus 2 ~~~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~ 81 (303)
|..|....+.+.+..+...-.+|+++++.+.--.|.--.=+..+...-.++|||++|..+.+++... ...++.
T Consensus 27 Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r 99 (204)
T COG3642 27 RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLR 99 (204)
T ss_pred ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHH
Confidence 5678888888999999999999999999987555544333444666668999999999999888755 245677
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceee
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.+-.-+.-||..||+|+||.++|+++.+.. +.++|||++.+
T Consensus 100 ~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 100 EVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred HHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 788888899999999999999999997655 99999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.8e-12 Score=98.04 Aligned_cols=99 Identities=18% Similarity=0.219 Sum_probs=85.0
Q ss_pred HHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Q psy763 18 QATEATNKKEKRSLKH--PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-- 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-- 93 (303)
...+.+|...++.+.| .++++++++...++..++++||++++.+..+ +......++.+++.+++.+|..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~ 107 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL 107 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence 3467778888888876 5899999998888889999999998877654 4566778899999999999985
Q ss_pred -CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 -ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 -~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
+++|+|++|.||+++..+.++++|||.+..
T Consensus 108 ~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 699999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.28 E-value=3e-12 Score=109.68 Aligned_cols=143 Identities=20% Similarity=0.282 Sum_probs=108.4
Q ss_pred HHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q psy763 27 EKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHA--C 95 (303)
Q Consensus 27 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~--i 95 (303)
.+-.+.|.||++++.++.+.. ...+++||+..|++..++++ ...+......+|+-||++||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344567999999999997543 57899999999999998764 346888889999999999999999986 9
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCC------CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPG------ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
+|+++..+.|++..+|-+|+.--.-.. ..+. .......+-++|.+||.=.-.. .+-++|||+||+...||--
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHH
Confidence 999999999999988888875322111 1111 0112235577889998754333 5779999999999999854
Q ss_pred cC
Q psy763 170 IG 171 (303)
Q Consensus 170 g~ 171 (303)
+.
T Consensus 278 lE 279 (458)
T KOG1266|consen 278 LE 279 (458)
T ss_pred he
Confidence 44
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-10 Score=92.07 Aligned_cols=122 Identities=16% Similarity=0.258 Sum_probs=97.6
Q ss_pred ccccccchHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCC-CcHHHHHcCC--CCCCHHHHHH
Q psy763 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHP--HGLPWDLIKQ 78 (303)
Q Consensus 2 ~~~kk~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~--~~l~~~~~~~ 78 (303)
||.|+.+.+.+.....+.....|++.+.++.--.|.--.-++.+.+.-.++|||++| .++.+++... ..........
T Consensus 38 Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~ 117 (229)
T KOG3087|consen 38 RFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAE 117 (229)
T ss_pred cccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHH
Confidence 788999999999999999999999999998766665555556677777899999987 4666655432 2333334478
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCC---cEEEccccceee
Q psy763 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARL 123 (303)
Q Consensus 79 ~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~---~~kl~dfg~~~~ 123 (303)
++..|-+.+.-||..+++|+||.++||++..++ .+.++|||++..
T Consensus 118 ~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 118 LARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 899999999999999999999999999997664 458999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-10 Score=94.65 Aligned_cols=103 Identities=17% Similarity=0.148 Sum_probs=77.1
Q ss_pred HHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEecCCCCcHHH-HHcCCCCCCHHHHHHHHHHHHHHHHHH-HH
Q psy763 17 RQATEATNKKEKRSLKH--PNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYC-HR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~l~~~~~~~~~~qi~~~l~~l-H~ 92 (303)
......+|.+.|+++.- -+++..+++ ...++||||++++.+.. .++ ...++......+..+++.++..+ |+
T Consensus 69 ~~~wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~ 143 (197)
T cd05146 69 IRMWAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKE 143 (197)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHh
Confidence 34445678888888753 456666664 34689999998754322 222 23456667778889999999998 89
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLIN 125 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~ 125 (303)
.|++|+||++.||+++ ++.+.++|||.+....
T Consensus 144 ~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 144 CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999999999996 5789999999887643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-10 Score=95.31 Aligned_cols=96 Identities=20% Similarity=0.205 Sum_probs=69.1
Q ss_pred HHHHHHHHhCCCCC--cceeEEEEEeCCEEEEEEecCCCCcHHH-HHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Q psy763 22 ATNKKEKRSLKHPN--LVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIH 97 (303)
Q Consensus 22 ~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH 97 (303)
..|...+..+.+.+ +.+.++. ...++||||++++.+.. .+... ... ..+..++.+++.++.++|+ .|++|
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCc
Confidence 34455555554433 4455543 23589999999844321 11111 111 5678899999999999999 99999
Q ss_pred cccCCCcEEEecCCcEEEccccceeee
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
+||+|+||+++ ++.++++|||.+...
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.9e-11 Score=116.37 Aligned_cols=159 Identities=21% Similarity=0.236 Sum_probs=128.2
Q ss_pred CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCc
Q psy763 33 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV 112 (303)
Q Consensus 33 h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~ 112 (303)
+|-++...-.+......+++++|..++++...+...++.+..-.+.....+..++.+||+..+.|+|++|.|.+...++.
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC
Confidence 35455544445566788999999999999998887778888888999999999999999999999999999999999999
Q ss_pred EEEccccceeeeC------CC--C------------------------ccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 113 VKLCDFGFARLIN------PG--E------------------------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 113 ~kl~dfg~~~~~~------~~--~------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
.++.|||...... .. . ......+|+.|.+||.+.+.. ...++|+|++
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSS 1021 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhh
Confidence 9999997322211 00 0 011246788999999999877 6889999999
Q ss_pred HHHHHHhhccCccCCCCchHHHHHHHhhcCCc
Q psy763 161 EWTSHSYSQIGFIGLGNMGSHMARNLLKNNGR 192 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~ 192 (303)
|++++|.++|..++......+...+++.....
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~ 1053 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQIFENILNRDIP 1053 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhhhhhccccCCCC
Confidence 99999999999999998888887766554433
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.4e-11 Score=113.23 Aligned_cols=152 Identities=22% Similarity=0.227 Sum_probs=122.8
Q ss_pred HHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCceec
Q psy763 24 NKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLR----GVSYCHRHACIHR 98 (303)
Q Consensus 24 e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~----~l~~lH~~~ivH~ 98 (303)
+..-.+.+ .|+|.++.+..+..++..++-+|.+.............-++...++..+.+..+ |+.++|+.+++|-
T Consensus 167 ~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~ 246 (524)
T KOG0601|consen 167 EFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHD 246 (524)
T ss_pred hhhcccccCccccccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCccccc
Confidence 33334444 499999999999999999999999984444434444445888899999999999 9999999999999
Q ss_pred ccCCCcEEEecC-CcEEEccccceeeeCCCCcc------ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 99 DIKPENILLTAN-GVVKLCDFGFARLINPGENY------TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 99 dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
|++|.||+...+ ...+++|||+......+... ....+...|++||++.+. ++.+.|++|+|.++.+...+.
T Consensus 247 ~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 247 DLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred ccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhc
Confidence 999999999999 88999999999888765422 122577789999998754 699999999999999998776
Q ss_pred ccCCCC
Q psy763 172 FIGLGN 177 (303)
Q Consensus 172 ~~~~~~ 177 (303)
..+...
T Consensus 325 ~~~~~g 330 (524)
T KOG0601|consen 325 HLPSVG 330 (524)
T ss_pred ccccCC
Confidence 666554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.8e-09 Score=91.24 Aligned_cols=103 Identities=16% Similarity=0.089 Sum_probs=78.2
Q ss_pred HHHHHHHHHhCCCCCc--ceeEEEEEe-----CCEEEEEEecCCCC-cHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHH
Q psy763 21 EATNKKEKRSLKHPNL--VNLLEVFRR-----KKKLHLVFEFCDHT-VLNELENH--PHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 21 ~~~e~~~l~~l~h~ni--v~~~~~~~~-----~~~~~lv~e~~~~~-~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
+.+|.+.+..+..-+| +..+++... ...-++|||++++. ++.+++.. ..+.+......++.+++..+..|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 5667777766643333 344444432 23568999999976 78887653 34566778889999999999999
Q ss_pred HHCCceecccCCCcEEEec-------CCcEEEccccceee
Q psy763 91 HRHACIHRDIKPENILLTA-------NGVVKLCDFGFARL 123 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~-------~~~~kl~dfg~~~~ 123 (303)
|+.|++|+|++++|||++. +..+.++||+.+..
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999999999999999985 46799999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.5e-09 Score=87.29 Aligned_cols=92 Identities=17% Similarity=0.189 Sum_probs=68.0
Q ss_pred HHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc----
Q psy763 21 EATNKKEKRSLKHPNL-VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC---- 95 (303)
Q Consensus 21 ~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---- 95 (303)
+.+|+..++.+.+.++ .+++++.. ...++|||+++|.++... . ......+.+++.+++.||+.++
T Consensus 39 ~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~ 108 (170)
T cd05151 39 RENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLV 108 (170)
T ss_pred HHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCce
Confidence 4567777777765454 45555433 334799999999887643 0 1123457899999999999885
Q ss_pred -eecccCCCcEEEecCCcEEEccccceee
Q psy763 96 -IHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 96 -vH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
+|+|++|.||+++ ++.++++|||.+..
T Consensus 109 ~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 109 PCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred eecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9999999999998 67899999998643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.6e-09 Score=87.23 Aligned_cols=105 Identities=18% Similarity=0.207 Sum_probs=72.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCC--CcceeEEEEEeCCEEEEEEecCC--CCcHHHHHcCCCCCCHHHHHHHHHHHHHHHH
Q psy763 13 KEAIRQATEATNKKEKRSLKHP--NLVNLLEVFRRKKKLHLVFEFCD--HTVLNELENHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 13 ~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~--~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
.....+....+|.+.|+.+..- ++++.+++ .. .++||||++ |..+..+.... ++......++.+++..+.
T Consensus 47 ~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~ 120 (188)
T PF01163_consen 47 WRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--NR--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEII 120 (188)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--ET--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--eC--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHH
Confidence 4455677888999999999866 46677654 23 379999998 66665554322 223445677788888555
Q ss_pred H-HHHCCceecccCCCcEEEecCCcEEEccccceeee
Q psy763 89 Y-CHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 89 ~-lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
. +|..|++||||.+.||+++.+ .+.++|||.+...
T Consensus 121 ~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 121 KMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 5 579999999999999999877 9999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.7e-09 Score=85.91 Aligned_cols=107 Identities=19% Similarity=0.218 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHHHhCCCCC--cceeEEEEEeCC----EEEEEEecCCCC-cHHHHHcCCCCCCHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPN--LVNLLEVFRRKK----KLHLVFEFCDHT-VLNELENHPHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~----~~~lv~e~~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
......+|...+..|..-+ .++.+++..... ..++|+|++++. +|.+++......+......++.+++..++-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 4445566666665554333 455566655432 458999999874 788888764457778889999999999999
Q ss_pred HHHCCceecccCCCcEEEecCC---cEEEccccceee
Q psy763 90 CHRHACIHRDIKPENILLTANG---VVKLCDFGFARL 123 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~---~~kl~dfg~~~~ 123 (303)
||..||+|+|+++.|||++.++ .+.++||+.+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999998766
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.92 E-value=4e-09 Score=97.67 Aligned_cols=104 Identities=23% Similarity=0.331 Sum_probs=71.4
Q ss_pred HHHHHHHHHHhC----CCCCcceeEEEEE-eCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHH-HHHHHHH
Q psy763 20 TEATNKKEKRSL----KHPNLVNLLEVFR-RKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLR-GVSYCHR 92 (303)
Q Consensus 20 ~~~~e~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~-~l~~lH~ 92 (303)
.+.+|++.+..+ +|.+-+.+-.++. ..+..++||||++|+++.++.... ...+ ...++.+++. .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 355566555554 3333333333332 233468999999999988765321 1222 2345556655 4788999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINP 126 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~ 126 (303)
.|++|+|++|.||+++.++.++++|||++..+.+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.3e-10 Score=103.35 Aligned_cols=143 Identities=26% Similarity=0.296 Sum_probs=93.0
Q ss_pred HHHHHHHHHHHHHHH-CCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc-----c-----cccCCCcccCccccc
Q psy763 78 QITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-----T-----DYVATRWYRAPELLV 146 (303)
Q Consensus 78 ~~~~qi~~~l~~lH~-~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~-----~~~~~~~y~aPE~l~ 146 (303)
.=+.+++.|+.|+|. .++||++|.|++|.++.++.+||+.|+++....++... . -......|.|||.+.
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345567789999997 47999999999999999999999999987665432111 1 123455699999998
Q ss_pred CCccCCCccchhhHHHHHHHhhccC-ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 147 GDTLYGPAVDVWAIEWTSHSYSQIG-FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 147 ~~~~~~~~~DvwSlG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
+.. .+.++|++|+||++|.+..|+ ..+.+... ......-...........+...+++..+.+-+........||
T Consensus 183 ~~~-~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 183 GTT-NTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred ccc-ccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 855 699999999999999998444 44333311 111112222222222223345566665555555555555555
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.4e-09 Score=98.75 Aligned_cols=152 Identities=18% Similarity=0.177 Sum_probs=116.3
Q ss_pred HHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCC
Q psy763 24 NKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKP 102 (303)
Q Consensus 24 e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~ 102 (303)
|+.+...+ .|.+++..+..+....+.|+-.|||++++......-...+++...+.+..|++.++.++|+..++|+|++|
T Consensus 315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~p 394 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKP 394 (524)
T ss_pred hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccc
Confidence 33344444 59999999888888888889999999998887665555788899999999999999999999999999999
Q ss_pred CcEEEecC-CcEEEccccceeeeCCCCccccccCCCccc-CcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 103 ENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYR-APELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 103 ~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~-aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
+||++..+ +..++.|||.+..+.-. .......-++. ..|++.....+..+.|++|||..+.|..++.......
T Consensus 395 sni~i~~~~~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~ 469 (524)
T KOG0601|consen 395 SNILISNDGFFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG 469 (524)
T ss_pred cceeeccchhhhhcccccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccc
Confidence 99999876 77899999987642111 11122233333 3555555555789999999999999998877555443
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-07 Score=85.26 Aligned_cols=139 Identities=16% Similarity=0.177 Sum_probs=108.4
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCC-CcHHHHH-c--------------CCCCCCHHHHHHHHH
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDH-TVLNELE-N--------------HPHGLPWDLIKQITW 81 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-~~l~~~~-~--------------~~~~l~~~~~~~~~~ 81 (303)
..-++.++++.|+|+|++.++|.. +..+++|++|.++ ++|.++- . .+...++..+|.++.
T Consensus 321 t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~ 400 (655)
T KOG3741|consen 321 TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYIS 400 (655)
T ss_pred hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHH
Confidence 345788999999999999999983 3578999999875 4555532 1 233577899999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHH
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIE 161 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG 161 (303)
|+..||.++|+.|+.-+-|.+.+|+++++..++|+.-|....+.++. + +-+.+ ..+-|.-.||
T Consensus 401 QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------~-------~~le~----~Qq~D~~~lG 463 (655)
T KOG3741|consen 401 QLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------T-------EPLES----QQQNDLRDLG 463 (655)
T ss_pred HHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC------C-------cchhH----HhhhhHHHHH
Confidence 99999999999999999999999999999999999888877765433 0 11221 3456888999
Q ss_pred HHHHHhhccCccCCCC
Q psy763 162 WTSHSYSQIGFIGLGN 177 (303)
Q Consensus 162 ~il~el~tg~~~~~~~ 177 (303)
.++..+.||..-....
T Consensus 464 ~ll~aLAt~~~ns~~~ 479 (655)
T KOG3741|consen 464 LLLLALATGTENSNRT 479 (655)
T ss_pred HHHHHHhhcccccccc
Confidence 9999999886554433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.5e-08 Score=91.59 Aligned_cols=87 Identities=20% Similarity=0.247 Sum_probs=60.4
Q ss_pred CCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHH--cCCC----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcE
Q psy763 33 HPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELE--NHPH----GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 105 (303)
Q Consensus 33 h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~--~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~ni 105 (303)
+.+.+.+-.++.+ .+..++||||++|+.+.++. ...+ .+.+..+..++.|+ ...|++|+|+||.||
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNI 291 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNI 291 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHe
Confidence 4444444444432 34568999999999998742 2222 23333334444444 468999999999999
Q ss_pred EEecCC----cEEEccccceeeeCC
Q psy763 106 LLTANG----VVKLCDFGFARLINP 126 (303)
Q Consensus 106 l~~~~~----~~kl~dfg~~~~~~~ 126 (303)
+++.++ .++++|||.+..+++
T Consensus 292 lv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 292 FVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred EEecCCCCCCeEEEEecceEEECCH
Confidence 999887 999999999988764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.8e-07 Score=82.34 Aligned_cols=129 Identities=13% Similarity=0.131 Sum_probs=98.8
Q ss_pred EEEEEEecCCCCc-HHHHH------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccc
Q psy763 48 KLHLVFEFCDHTV-LNELE------NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 120 (303)
Q Consensus 48 ~~~lv~e~~~~~~-l~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~ 120 (303)
.+.+.|..+.+-- ...+. +......+...+..++.++.+.+-||..|.+-+|+.++|+|+++++.|.|.|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 3677888776532 12221 1223477888999999999999999999999999999999999999999998665
Q ss_pred eeeeCCCCccccccCCCcccCccccc-----CCccCCCccchhhHHHHHHHhhcc-CccCCCC
Q psy763 121 ARLINPGENYTDYVATRWYRAPELLV-----GDTLYGPAVDVWAIEWTSHSYSQI-GFIGLGN 177 (303)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~y~aPE~l~-----~~~~~~~~~DvwSlG~il~el~tg-~~~~~~~ 177 (303)
......+......+|...|.+||.-. +.. -+...|.|.+|+++++++-| ..|+.|.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 54444555556678999999999754 222 46789999999999999766 5666654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.7e-07 Score=77.32 Aligned_cols=104 Identities=19% Similarity=0.212 Sum_probs=79.3
Q ss_pred HHHHHHHHHHHhCCCC--CcceeEEEEEeC---CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy763 19 ATEATNKKEKRSLKHP--NLVNLLEVFRRK---KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR- 92 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~- 92 (303)
..+..|+..++.+.+. ++.+++.+.... +..++||||++|+++...... ..+++.....++.+++.+|..||+
T Consensus 40 ~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~ 118 (223)
T cd05154 40 HDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSV 118 (223)
T ss_pred ccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 3567778888888753 457777776653 256899999999888775432 357777777888888888888874
Q ss_pred -------------------------------------------------------CCceecccCCCcEEEec--CCcEEE
Q psy763 93 -------------------------------------------------------HACIHRDIKPENILLTA--NGVVKL 115 (303)
Q Consensus 93 -------------------------------------------------------~~ivH~dlk~~nil~~~--~~~~kl 115 (303)
..++|+|+++.||+++. ++.+.|
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~i 198 (223)
T cd05154 119 DPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAV 198 (223)
T ss_pred ChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEE
Confidence 23589999999999998 567899
Q ss_pred ccccceee
Q psy763 116 CDFGFARL 123 (303)
Q Consensus 116 ~dfg~~~~ 123 (303)
+||+.+..
T Consensus 199 ID~e~~~~ 206 (223)
T cd05154 199 LDWELATL 206 (223)
T ss_pred Eecccccc
Confidence 99997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=72.79 Aligned_cols=66 Identities=21% Similarity=0.415 Sum_probs=52.4
Q ss_pred EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEcccccee
Q psy763 48 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 48 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
..++|+||++|..+.++.. +++ .+...+++++.-+|+.|++|+|++|+|++++. +.++++||+...
T Consensus 117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECcccc
Confidence 4568999999988766532 232 24567788899999999999999999999985 459999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=3e-06 Score=70.01 Aligned_cols=107 Identities=12% Similarity=0.019 Sum_probs=79.6
Q ss_pred HHHHHHHHHHHHHhCCCCC--cceeEEEEEeC----CEEEEEEecCCC-CcHHHHHcCC--CCCCHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPN--LVNLLEVFRRK----KKLHLVFEFCDH-TVLNELENHP--HGLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~e~~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l 87 (303)
.+..+.+|...++.+..-+ +.+........ -.-+||+|-+++ -+|.+++... .+.+......++.+++.++
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~i 141 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAF 141 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHH
Confidence 3567888888888775333 44444222111 146799997754 5787776543 3567888899999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCc--EEEccccceee
Q psy763 88 SYCHRHACIHRDIKPENILLTANGV--VKLCDFGFARL 123 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~~~~--~kl~dfg~~~~ 123 (303)
+-||+.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 142 a~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 142 KKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999999999999999999986666 99999986544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3e-06 Score=72.00 Aligned_cols=98 Identities=19% Similarity=0.250 Sum_probs=76.1
Q ss_pred HHHHHHHHHHHHHHhCCCC--CcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 16 IRQATEATNKKEKRSLKHP--NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+....+|...|..|... .+.+.+++ +...+|||+++|-.|.... ++....-.++..|+.-+...-..
T Consensus 151 ~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~ 221 (304)
T COG0478 151 VSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR 221 (304)
T ss_pred hHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc
Confidence 3566678888999988765 67776664 4568999999986665542 23445556777777777777799
Q ss_pred CceecccCCCcEEEecCCcEEEcccccee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
|+||||+++-||+++.+|.+.++||--+.
T Consensus 222 GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 222 GIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred CccccCCchheEEEecCCCEEEEeCcccc
Confidence 99999999999999999999999996543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.1e-05 Score=63.47 Aligned_cols=99 Identities=19% Similarity=0.215 Sum_probs=79.5
Q ss_pred HHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEecCCCCcHHHH---HcCCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q psy763 22 ATNKKEKRSLKH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYCHR---HA 94 (303)
Q Consensus 22 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ 94 (303)
..|.-+++.+++ +++++++|+|.. ++|+||.+.+++... +.+-...++..+..++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457778888886 699999999852 578999997755421 1122356789999999999999999998 45
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeee
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
+.-.|++++|+-+++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00012 Score=73.16 Aligned_cols=153 Identities=18% Similarity=0.228 Sum_probs=113.1
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCCEE----EEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKL----HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...|...+..+.|+|++.++.+-...... .+..|++.+-++...+..-+.++..+.+.+..++..|+.++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 34566677888999999999987654322 34557888888888888888999999999999999999999999776
Q ss_pred ecccCCC---cEEEecCCcEEEc--cccceeeeCCCCccccccCCCcccCcccccCCc-cCCCccchhhHHHHHHHhhcc
Q psy763 97 HRDIKPE---NILLTANGVVKLC--DFGFARLINPGENYTDYVATRWYRAPELLVGDT-LYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 97 H~dlk~~---nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~DvwSlG~il~el~tg 170 (303)
|.-+..+ +.-.+..+.+.++ ||+.+..............+..+.+||...... ..+...|+|.+|....-+..|
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence 6666655 4444555666666 888877766555545555666677888776433 123347999999999888765
Q ss_pred Ccc
Q psy763 171 GFI 173 (303)
Q Consensus 171 ~~~ 173 (303)
...
T Consensus 389 ~~i 391 (1351)
T KOG1035|consen 389 EDI 391 (1351)
T ss_pred Ccc
Confidence 544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00017 Score=60.92 Aligned_cols=102 Identities=12% Similarity=0.200 Sum_probs=60.4
Q ss_pred HHHHHHHHHhCCCCC--cceeEEEEEeCCEEEEEEecCCCCc-HHHHH---------------------cCC--CCCCHH
Q psy763 21 EATNKKEKRSLKHPN--LVNLLEVFRRKKKLHLVFEFCDHTV-LNELE---------------------NHP--HGLPWD 74 (303)
Q Consensus 21 ~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~-l~~~~---------------------~~~--~~l~~~ 74 (303)
..+|.+.++.+..-+ +.+.+++...++...+|||+++|.. +.... ..- ......
T Consensus 39 i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~ 118 (226)
T TIGR02172 39 IKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQ 118 (226)
T ss_pred HHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHH
Confidence 466788887776444 4788888888888899999999863 11111 000 011111
Q ss_pred HH-HHHHHH----------HHH-HHHHHHH----CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 75 LI-KQITWQ----------VLR-GVSYCHR----HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 75 ~~-~~~~~q----------i~~-~l~~lH~----~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.. ..+..+ +.. ...+|.. ..++|+|+.|.||+++.++ +.++||+.+..
T Consensus 119 ~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 119 SYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred HHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 10 011000 011 1122221 2468999999999999888 99999997643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.82 E-value=5.9e-06 Score=77.52 Aligned_cols=147 Identities=18% Similarity=0.131 Sum_probs=108.5
Q ss_pred HHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEEEEecCCCC-cHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 20 TEATNKKEKRSLKHPN-LVNLLEVFRRKKKLHLVFEFCDHT-VLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~-~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...-++++|.+++||| .+..++-++.+....++++++.++ +..... ...-.+...+....++.-..+++++|+.-=+
T Consensus 279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~ 358 (829)
T KOG0576|consen 279 SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKV 358 (829)
T ss_pred hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccccc
Confidence 3455678999999999 777777777777889999999877 221111 1111234445556777888899999998778
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|+| ||+.. ++..+..||+....+.......+..+++.++|||+..... +....|.||+|.--.++--|..
T Consensus 359 ~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 359 HRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred Ccc----ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCC
Confidence 888 66654 4778999999988777665667788999999999988766 7889999999986555544433
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00023 Score=60.72 Aligned_cols=29 Identities=21% Similarity=0.250 Sum_probs=25.6
Q ss_pred CceecccCCCcEEEecCCcEEEcccccee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
.++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999988778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00029 Score=59.40 Aligned_cols=103 Identities=16% Similarity=0.098 Sum_probs=72.0
Q ss_pred HHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEecCCCC-cHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy763 17 RQATEATNKKEKRSLK--HPNLVNLLEVFRRKKKLHLVFEFCDHT-VLNELENHPHGLPWDLIKQITWQVLRGVSYCHR- 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~- 92 (303)
...=..+|.+.|+++. +-.+.+-+++.. -.|||||+... .-...++. -++.......+..++++.+.-|-.
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHh
Confidence 3444566777777764 334455555432 46999999654 22222322 133444677888999999998887
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLIN 125 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~ 125 (303)
.|+||+||+.=|||+. ++.+.++|||-|....
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 8999999999999999 8899999999876543
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00027 Score=66.48 Aligned_cols=86 Identities=21% Similarity=0.277 Sum_probs=57.4
Q ss_pred cceeEEEEEeCCEEEEEEecCCCCcHHHH--HcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEec----
Q psy763 36 LVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---- 109 (303)
Q Consensus 36 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~--~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~---- 109 (303)
|.+++.-+.. .-.|+||||+|.-+.++ +.+ ..++...+..-+.++.. .-+-..|++|+|.+|.||++..
T Consensus 266 VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~ 340 (538)
T KOG1235|consen 266 VPKVYWDLST--KRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEG 340 (538)
T ss_pred CCeehhhcCc--ceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCC
Confidence 5555555443 45899999999766653 222 25555544333333222 2334578999999999999994
Q ss_pred CCcEEEccccceeeeCC
Q psy763 110 NGVVKLCDFGFARLINP 126 (303)
Q Consensus 110 ~~~~kl~dfg~~~~~~~ 126 (303)
++.+.+.|||+....+.
T Consensus 341 ~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 341 DEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccEEEEcccccccccH
Confidence 56899999999877553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0007 Score=63.81 Aligned_cols=78 Identities=22% Similarity=0.405 Sum_probs=55.9
Q ss_pred CEEEEEEecCCCCcHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeee
Q psy763 47 KKLHLVFEFCDHTVLNELE--NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 47 ~~~~lv~e~~~~~~l~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
+.-.++|||++|-.+.++. .. ..++.+.+.....++ .+..+-..|+.|+|.+|.||+++.+|.+.+.|||....+
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 4458999999998887763 33 355533333222221 133444589999999999999999999999999998776
Q ss_pred CCC
Q psy763 125 NPG 127 (303)
Q Consensus 125 ~~~ 127 (303)
.+.
T Consensus 316 ~~~ 318 (517)
T COG0661 316 DPK 318 (517)
T ss_pred CHH
Confidence 643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0023 Score=52.76 Aligned_cols=83 Identities=19% Similarity=0.261 Sum_probs=61.6
Q ss_pred hCCCCCcceeEEEEEeCCEEEEEEecCCC------CcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q psy763 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDH------TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPE 103 (303)
Q Consensus 30 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~------~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~ 103 (303)
...+.+|.+++|+.+++....+|+|.+.. -+|.+++.++ .++. .. ...+-.-..+|-+.+|+.+|++|.
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~ 147 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPH 147 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcc
Confidence 34488999999999999999999998743 2477777544 5655 33 333444566788999999999999
Q ss_pred cEEEecCC----cEEEcc
Q psy763 104 NILLTANG----VVKLCD 117 (303)
Q Consensus 104 nil~~~~~----~~kl~d 117 (303)
||++.... .+.|+|
T Consensus 148 NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cEEEEecCCCceEEEEEe
Confidence 99997542 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.005 Score=51.54 Aligned_cols=31 Identities=35% Similarity=0.578 Sum_probs=21.5
Q ss_pred CCceecccCCCcEEEe-cCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLT-ANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~-~~~~~kl~dfg~~~~ 123 (303)
..++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 3589999999999999 667778999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0021 Score=64.67 Aligned_cols=42 Identities=10% Similarity=0.196 Sum_probs=32.7
Q ss_pred HHHHHHHHHHHhCC-CCCc--ceeEEEEEeC---CEEEEEEecCCCCc
Q psy763 19 ATEATNKKEKRSLK-HPNL--VNLLEVFRRK---KKLHLVFEFCDHTV 60 (303)
Q Consensus 19 ~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~e~~~~~~ 60 (303)
..+.+|.++++.+. |+++ .+++.++.+. +..|+|||+++|..
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 45678899999885 6665 7888888764 46789999999764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0012 Score=56.11 Aligned_cols=30 Identities=27% Similarity=0.542 Sum_probs=25.3
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
+++|+|+.+.|++++.+...-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998766667999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.92 E-value=8.3e-05 Score=76.29 Aligned_cols=156 Identities=11% Similarity=-0.040 Sum_probs=111.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPH----GLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH 91 (303)
.+....|+...+...|+++.....-.... ...+.+++++.+|.+.+++-++. .++...+.....+.+.+..-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 44555666677888999988776665433 34688999999999999775442 3444444444444466667766
Q ss_pred HCC-----ceecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 92 RHA-----CIHRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 92 ~~~-----ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
+.. -+|+++++.|.++..+..+++.++|+.+...+ ........+++.|++|+....-. ++.++|+|+.|+-+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHH
Confidence 531 68999999999999999999999999984332 22334567788888888655333 677899999999999
Q ss_pred HhhccCccC
Q psy763 166 SYSQIGFIG 174 (303)
Q Consensus 166 el~tg~~~~ 174 (303)
+...|..++
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 986655443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.011 Score=50.75 Aligned_cols=29 Identities=34% Similarity=0.591 Sum_probs=25.0
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.++|+|+.|.||+++.++ +.++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999876 78999987644
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.013 Score=51.86 Aligned_cols=32 Identities=22% Similarity=0.448 Sum_probs=28.1
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeC
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLIN 125 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~ 125 (303)
.++|+|+.+.|++++...-+-+.||+++..-.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 48999999999999988889999999886633
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0067 Score=53.44 Aligned_cols=99 Identities=13% Similarity=0.137 Sum_probs=69.6
Q ss_pred HHHHHHHHHHHHHHhCCCCC--cceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 16 IRQATEATNKKEKRSLKHPN--LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+-+..+|...++.|.-.. +++.++. +..++|||++.|-.+..+.. ..+. ..+...+..-+.-|...
T Consensus 152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~---v~d~---~~ly~~lm~~Iv~la~~ 221 (465)
T KOG2268|consen 152 LSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH---VEDP---PTLYDDLMGLIVRLANH 221 (465)
T ss_pred hHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee---cCCh---HHHHHHHHHHHHHHHHc
Confidence 34556677888888876422 4444443 45789999999877765432 1222 23445555567778899
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
|++|||..-=||+++.++.++++||--....
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhhcc
Confidence 9999999999999999999999999655443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.1 Score=43.04 Aligned_cols=84 Identities=21% Similarity=0.192 Sum_probs=58.1
Q ss_pred HHHHHHHH---HHhCCCCCc--ceeEEEEEeC------------------CEEEEEEecCCCCcHHHHHcCCCCCCHHHH
Q psy763 20 TEATNKKE---KRSLKHPNL--VNLLEVFRRK------------------KKLHLVFEFCDHTVLNELENHPHGLPWDLI 76 (303)
Q Consensus 20 ~~~~e~~~---l~~l~h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~ 76 (303)
-|..|.+. ++...+.++ ++++|+..-. ....||.||++... .++..
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~-- 168 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR-- 168 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh--
Confidence 45555554 445556677 9999998422 12467888876543 23333
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccce
Q psy763 77 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 121 (303)
Q Consensus 77 ~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~ 121 (303)
-+.++.+-+..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 169 --~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 --DIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred --HHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 3556777788999999999999999986 2378899864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.1 Score=42.14 Aligned_cols=97 Identities=18% Similarity=0.117 Sum_probs=67.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcc-eeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLV-NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+..+..|++++..++-.++- +++.+-. .++.|||+.|-.|....... +..+ +..++..-.-|-..||
T Consensus 58 ~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI 126 (201)
T COG2112 58 PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGI 126 (201)
T ss_pred chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhcc
Confidence 466788899999998877764 4554433 23569999998888765422 3333 3345555566777899
Q ss_pred eecccC-CCcEEEecCCcEEEccccceeee
Q psy763 96 IHRDIK-PENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 96 vH~dlk-~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
-|+.++ |...++..++.+.|+||..|.+.
T Consensus 127 ~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 127 EHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 999997 55555556669999999998753
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.11 Score=46.77 Aligned_cols=103 Identities=14% Similarity=0.145 Sum_probs=70.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iv 96 (303)
..=..+|.+.|+++....|.----+... ...|||+++.......=.-+...++...+..+-.|++.-+..|-+ .++|
T Consensus 210 k~WAEKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LV 287 (520)
T KOG2270|consen 210 KTWAEKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLV 287 (520)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhcee
Confidence 3345667777888776665422222222 247899999754333212223467777888888888888887764 6899
Q ss_pred ecccCCCcEEEecCCcEEEccccceee
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
|.||.--|+|+. +|.+.++|.+-+..
T Consensus 288 HADLSEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 288 HADLSEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred ccchhhhhheEE-CCEEEEEEcccccc
Confidence 999999999985 67899999886654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.054 Score=47.89 Aligned_cols=30 Identities=37% Similarity=0.636 Sum_probs=26.8
Q ss_pred CCceecccCCCcEEEecCCcEEEcccccee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
.+++|+|+++.|++++.++.+.++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 579999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.18 Score=45.34 Aligned_cols=89 Identities=22% Similarity=0.232 Sum_probs=60.2
Q ss_pred hCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCCCcEEE
Q psy763 30 SLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILL 107 (303)
Q Consensus 30 ~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlk~~nil~ 107 (303)
...-++..+.+-+-.+ ....|++|++- |+.+... +....+++..++++.+..+.-+... .+-|||+...||++
T Consensus 281 ~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 281 ECGSVFLETLKVVSLDETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred hccchhhhcceEEecCCceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 3334444444333322 23456666654 3443332 2345678889999988877777654 58999999999999
Q ss_pred ecCCcEEEccccceeee
Q psy763 108 TANGVVKLCDFGFARLI 124 (303)
Q Consensus 108 ~~~~~~kl~dfg~~~~~ 124 (303)
+ +|.|.|+||-+++.-
T Consensus 356 d-~GnvtLIDfklsRl~ 371 (488)
T COG5072 356 D-EGNVTLIDFKLSRLS 371 (488)
T ss_pred e-cCceEEEEeeeeecc
Confidence 9 999999999999853
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.088 Score=46.45 Aligned_cols=29 Identities=31% Similarity=0.471 Sum_probs=25.1
Q ss_pred CCceecccCCCcEEEecCCcEEEcccccee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
.+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.072 Score=46.68 Aligned_cols=31 Identities=29% Similarity=0.488 Sum_probs=26.9
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.+++|+|+.|.|++++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887788999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.093 Score=46.59 Aligned_cols=31 Identities=29% Similarity=0.469 Sum_probs=26.2
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.|++|+|+.|.||+++.+....++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4799999999999998766668999997643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.071 Score=44.99 Aligned_cols=29 Identities=28% Similarity=0.504 Sum_probs=25.7
Q ss_pred CceecccCCCcEEEec-CCcEEEcccccee
Q psy763 94 ACIHRDIKPENILLTA-NGVVKLCDFGFAR 122 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~-~~~~kl~dfg~~~ 122 (303)
+++|+|+.+.||++++ ++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.11 Score=45.66 Aligned_cols=29 Identities=34% Similarity=0.505 Sum_probs=25.6
Q ss_pred CceecccCCCcEEEecC----CcEEEcccccee
Q psy763 94 ACIHRDIKPENILLTAN----GVVKLCDFGFAR 122 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~----~~~kl~dfg~~~ 122 (303)
+++|+|+.+.||+++.+ +.++++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 57999999999999974 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.064 Score=43.73 Aligned_cols=28 Identities=29% Similarity=0.563 Sum_probs=24.6
Q ss_pred ceecccCCCcEEEecCCcEEEccccceee
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.+|+|+.|.|+++++++ ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 59999999999998777 88999998754
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.47 Score=44.70 Aligned_cols=46 Identities=24% Similarity=0.325 Sum_probs=34.4
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCC
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHP 68 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~ 68 (303)
......++.+.|+|....+++.... ....+|+|++. .++.++...+
T Consensus 30 lgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~ 76 (725)
T KOG1093|consen 30 LGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG 76 (725)
T ss_pred hhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence 3456788999999999999987643 35788999997 5666655543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.12 E-value=0.1 Score=43.33 Aligned_cols=30 Identities=43% Similarity=0.757 Sum_probs=21.2
Q ss_pred CceecccCCCcEEE-ecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILL-TANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~-~~~~~~kl~dfg~~~~ 123 (303)
.++|+|+.+.||++ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47999999999999 7889999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.91 Score=41.56 Aligned_cols=30 Identities=33% Similarity=0.342 Sum_probs=24.3
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
..++|.|+.+.||+.+ ++.+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence 4579999999999875 45699999987654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.27 Score=43.49 Aligned_cols=30 Identities=13% Similarity=0.171 Sum_probs=27.2
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
+++|+|+.+.|++++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999998999999987654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.35 E-value=0.29 Score=42.44 Aligned_cols=30 Identities=40% Similarity=0.640 Sum_probs=26.7
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
-++|+|+.|.|++.++.+.++|+||..|..
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 479999999999999989999999987643
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.13 E-value=0.42 Score=39.32 Aligned_cols=31 Identities=26% Similarity=0.403 Sum_probs=25.3
Q ss_pred CCceecccCCCcEEEecCC-----cEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANG-----VVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~-----~~kl~dfg~~~~ 123 (303)
..++|||+.+.|+++..++ .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4589999999999997543 589999987644
|
subfamily of choline kinases |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=91.06 E-value=2.1 Score=39.50 Aligned_cols=29 Identities=24% Similarity=0.448 Sum_probs=23.3
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.++|||+.|.||+++.++ .+++|..++..
T Consensus 231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~~~ 259 (418)
T PLN02756 231 ALVHGDLHTGSVMVTPDS-TQVIDPEFAFY 259 (418)
T ss_pred ceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence 589999999999998765 77888665543
|
|
| >KOG2269|consensus | Back alignment and domain information |
|---|
Probab=90.30 E-value=2.5 Score=37.78 Aligned_cols=84 Identities=24% Similarity=0.154 Sum_probs=60.1
Q ss_pred CCCCCcceeEEEEEeCCEEEEEEecCCCCcHHH-HHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCCCcEEEe
Q psy763 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLT 108 (303)
Q Consensus 31 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlk~~nil~~ 108 (303)
+.+|-+|.+- ...|||.|+...-+.. -++ +..++.......-.|+..++..|-. .-+||.|+.--|+|..
T Consensus 347 lpcP~vV~lk-------khvLVMsFiGd~~~aAPkLK-~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~ 418 (531)
T KOG2269|consen 347 LPCPQVVKLK-------KHVLVMSFIGDQGLAAPKLK-NVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWT 418 (531)
T ss_pred CCCCceeeee-------cceEEEEeecCCCCCCcccc-ccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheec
Confidence 5677777653 3468898885433222 222 3368888888888999998888754 5689999999999997
Q ss_pred cCCcEEEccccceee
Q psy763 109 ANGVVKLCDFGFARL 123 (303)
Q Consensus 109 ~~~~~kl~dfg~~~~ 123 (303)
.+ .+-++|..-+..
T Consensus 419 ~g-Kvw~IDVsQsve 432 (531)
T KOG2269|consen 419 PG-KVWVIDVSQSVE 432 (531)
T ss_pred CC-ceEEEechhccC
Confidence 65 788888765543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.12 E-value=0.4 Score=42.86 Aligned_cols=28 Identities=32% Similarity=0.532 Sum_probs=25.0
Q ss_pred ceecccCCCcEEEecCCc-EEEcccccee
Q psy763 95 CIHRDIKPENILLTANGV-VKLCDFGFAR 122 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~-~kl~dfg~~~ 122 (303)
++|+|+.|.||+++.+.. +.++|||-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 8899999764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.10 E-value=1.2 Score=39.14 Aligned_cols=71 Identities=13% Similarity=0.079 Sum_probs=52.7
Q ss_pred HHHHHHHHHHHHhCCC---CCcceeEEEEEeC---CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKH---PNLVNLLEVFRRK---KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
...+..|+..++.+.- -.+.++++++..+ +..++|||+++++++.+. ..+......+..+++++++-||
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH 125 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWH 125 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHh
Confidence 3577888888888753 3578889887643 568999999999877652 1334455667788899999999
Q ss_pred HC
Q psy763 92 RH 93 (303)
Q Consensus 92 ~~ 93 (303)
+.
T Consensus 126 ~~ 127 (297)
T PRK10593 126 RI 127 (297)
T ss_pred CC
Confidence 85
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=90.08 E-value=0.38 Score=43.35 Aligned_cols=30 Identities=20% Similarity=0.492 Sum_probs=26.0
Q ss_pred CceecccCCCcEEEec-CCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTA-NGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~-~~~~kl~dfg~~~~ 123 (303)
.++|+|+++.||++++ ++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986 46899999988754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.99 E-value=0.23 Score=43.26 Aligned_cols=30 Identities=27% Similarity=0.515 Sum_probs=24.8
Q ss_pred CceecccCCCcEEEecCCc-EEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGV-VKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~-~kl~dfg~~~~ 123 (303)
.++|+|+++.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3799999999999997554 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=89.31 E-value=0.51 Score=42.19 Aligned_cols=75 Identities=20% Similarity=0.242 Sum_probs=41.6
Q ss_pred EEEEecCCCCcH----HHHHcCCCCCCHHHHHHHHHHHHHHHHHH---H-HCCceecccCCCcEEEecCC----------
Q psy763 50 HLVFEFCDHTVL----NELENHPHGLPWDLIKQITWQVLRGVSYC---H-RHACIHRDIKPENILLTANG---------- 111 (303)
Q Consensus 50 ~lv~e~~~~~~l----~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H-~~~ivH~dlk~~nil~~~~~---------- 111 (303)
.+|++.+.+++- .....-+-..-.+-++.+..|+|--.--+ - -.+++|-||||.|||+-++.
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 578887764331 11222111222334555666665433112 1 24689999999999995432
Q ss_pred --------cEEEccccceeee
Q psy763 112 --------VVKLCDFGFARLI 124 (303)
Q Consensus 112 --------~~kl~dfg~~~~~ 124 (303)
..+|.||.+|...
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EEEecccceeeecccCHHHhc
Confidence 3566777776653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=88.63 E-value=1.6 Score=38.26 Aligned_cols=41 Identities=10% Similarity=0.097 Sum_probs=24.1
Q ss_pred HHHHHHHHHHHhC---CCCCcceeEEEEEeCCEEEEEEecCCCC
Q psy763 19 ATEATNKKEKRSL---KHPNLVNLLEVFRRKKKLHLVFEFCDHT 59 (303)
Q Consensus 19 ~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~~ 59 (303)
..+..|..-|+.| ..-.+++++++....+..+||+||++.+
T Consensus 54 ~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 54 DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4556666666666 4555789999988777779999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=88.49 E-value=2 Score=36.43 Aligned_cols=44 Identities=14% Similarity=0.137 Sum_probs=32.3
Q ss_pred HHHHHHHHHHHhC---CCCCcceeEEEEEeCCEEEEEEecCCCCcHH
Q psy763 19 ATEATNKKEKRSL---KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN 62 (303)
Q Consensus 19 ~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~ 62 (303)
..|..|+.-|+.+ +.-.+.+++.+..+..+.|+|+||++.+.+.
T Consensus 53 ~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 53 SMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 4556666555554 4556788888888889999999999875544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=87.15 E-value=0.98 Score=40.43 Aligned_cols=29 Identities=24% Similarity=0.533 Sum_probs=25.1
Q ss_pred ceecccCCCcEEEec-CCcEEEccccceee
Q psy763 95 CIHRDIKPENILLTA-NGVVKLCDFGFARL 123 (303)
Q Consensus 95 ivH~dlk~~nil~~~-~~~~kl~dfg~~~~ 123 (303)
++|+|+.+.||+++. ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 699999999999975 47899999997744
|
|
| >KOG4720|consensus | Back alignment and domain information |
|---|
Probab=86.99 E-value=1.3 Score=38.74 Aligned_cols=28 Identities=29% Similarity=0.538 Sum_probs=23.9
Q ss_pred ceecccCCCcEEEecC-CcEEEcccccee
Q psy763 95 CIHRDIKPENILLTAN-GVVKLCDFGFAR 122 (303)
Q Consensus 95 ivH~dlk~~nil~~~~-~~~kl~dfg~~~ 122 (303)
+.|.||-..||+.++. +++..+|+..+.
T Consensus 250 FcHNDLL~~Niiy~~~~~~v~fIDYEYa~ 278 (391)
T KOG4720|consen 250 FCHNDLLCGNIIYDSEKGSVEFIDYEYAG 278 (391)
T ss_pred EeecchhhcceeeccccCcEEEEeecccc
Confidence 5799999999999865 899999997653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.48 E-value=0.86 Score=40.69 Aligned_cols=28 Identities=32% Similarity=0.400 Sum_probs=23.5
Q ss_pred CCceecccCCCcEEEecCCcEEEcccccee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFAR 122 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~ 122 (303)
.+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 3 57899999764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 303 | ||||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-54 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-46 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-29 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-29 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-29 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-29 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-29 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-29 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-29 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-29 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-29 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-29 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-29 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-29 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-29 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-29 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-29 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-29 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-29 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-29 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-29 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-29 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-29 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-29 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-29 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-29 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-29 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-28 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-28 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-28 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-28 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-28 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-28 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-28 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-28 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-28 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-28 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-28 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-28 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-27 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-26 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-26 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-26 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-26 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-26 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-25 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-25 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-25 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-25 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-25 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-25 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-24 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-24 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-24 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-24 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-23 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-23 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-21 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-20 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-20 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-20 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-19 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-19 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-19 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-19 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-19 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-19 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-19 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-19 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-19 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-19 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-19 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-19 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-18 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-18 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-16 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-16 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-16 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-16 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-16 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-16 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-16 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-16 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-16 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-15 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-15 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-13 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-06 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 8e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-04 |
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-78
Identities = 93/133 (69%), Positives = 113/133 (84%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKHPNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V+
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H CIHRD+KPENIL+T + V+KLCDFGFARL+ P + Y D VATRWYR+PELLVG
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 148 DTLYGPAVDVWAI 160
DT YGP VDVWAI
Sbjct: 177 DTQYGPPVDVWAI 189
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 8e-78
Identities = 83/133 (62%), Positives = 107/133 (80%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+H NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL + ++++ +Q++ G+
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH H IHRDIKPENIL++ +GVVKLCDFGFAR + PGE Y D VATRWYRAPELLVG
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198
Query: 148 DTLYGPAVDVWAI 160
D YG AVDVWAI
Sbjct: 199 DVKYGKAVDVWAI 211
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-59
Identities = 53/133 (39%), Positives = 77/133 (57%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L +V KK+L LVFE D + L+ GL K Q+L G++
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
YCH +HRD+KP+N+L+ G +K+ DFG AR P YT + T WYRAP++L+G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 148 DTLYGPAVDVWAI 160
Y +D+W++
Sbjct: 175 SKKYSTTIDIWSV 187
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-59
Identities = 53/133 (39%), Positives = 81/133 (60%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L +V KKL LVFEFCD + ++ L +++K +Q+L+G+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH +HRD+KP+N+L+ NG +KL +FG AR P Y+ V T WYR P++L G
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 148 DTLYGPAVDVWAI 160
LY ++D+W+
Sbjct: 176 AKLYSTSIDMWSA 188
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-58
Identities = 58/133 (43%), Positives = 89/133 (66%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L HPN+V+L++V ++ L LVFEF + + L+ + GL IK +Q+LRGV+
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH+H +HRD+KP+N+L+ ++G +KL DFG AR P +YT V T WYRAP++L+G
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 148 DTLYGPAVDVWAI 160
Y +VD+W+I
Sbjct: 194 SKKYSTSVDIWSI 206
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-58
Identities = 52/133 (39%), Positives = 83/133 (62%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L ++ +K L LVFE+ D + L++ + + +K +Q+LRG++
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
YCHR +HRD+KP+N+L+ G +KL DFG AR + P + Y + V T WYR P++L+G
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 148 DTLYGPAVDVWAI 160
T Y +D+W +
Sbjct: 175 STDYSTQIDMWGV 187
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-57
Identities = 58/133 (43%), Positives = 81/133 (60%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L HPN++ LL+ F K + LVF+F + + ++++ L IK L+G+
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
Y H+H +HRD+KP N+LL NGV+KL DFG A+ P YT V TRWYRAPELL G
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 186
Query: 148 DTLYGPAVDVWAI 160
+YG VD+WA+
Sbjct: 187 ARMYGVGVDMWAV 199
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-56
Identities = 54/138 (39%), Positives = 86/138 (62%), Gaps = 6/138 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-----PHGLPWDLIKQITWQV 83
+ LKH N+V L +V + KL LVFEF D+ + +++ P GL +L+K WQ+
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAP 142
L+G+++CH + +HRD+KP+N+L+ G +KL DFG AR P ++ V T WYRAP
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 143 ELLVGDTLYGPAVDVWAI 160
++L+G Y ++D+W+
Sbjct: 178 DVLMGSRTYSTSIDIWSC 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-55
Identities = 49/138 (35%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+H N++ L V +LHL+FE+ ++ + ++ +P + +IK +Q++ GV+
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVN 146
Query: 89 YCHRHACIHRDIKPENILLTAN-----GVVKLCDFGFARLIN-PGENYTDYVATRWYRAP 142
+CH C+HRD+KP+N+LL+ + V+K+ DFG AR P +T + T WYR P
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+L+G Y +VD+W+I
Sbjct: 207 EILLGSRHYSTSVDIWSI 224
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-54
Identities = 52/142 (36%), Positives = 78/142 (54%), Gaps = 10/142 (7%)
Query: 29 RSLKHPNLVNLLEVF------RRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQI 79
R L H N+V L F + + L+LV ++ TV ++ LP +K
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRW 138
+Q+ R ++Y H HRDIKP+N+LL + V+KLCDFG A+ + GE Y+ +R+
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 139 YRAPELLVGDTLYGPAVDVWAI 160
YRAPEL+ G T Y ++DVW+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSA 243
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-54
Identities = 60/152 (39%), Positives = 90/152 (59%), Gaps = 10/152 (6%)
Query: 15 AIRQATEATNKKEKRSLKHPNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPH 69
IR E + + +HPN+V L +V R+ KL LVFE D + L+ P
Sbjct: 58 TIR---EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 114
Query: 70 -GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE 128
G+P + IK + +Q+LRG+ + H H +HRD+KP+NIL+T++G +KL DFG AR+ +
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T V T WYRAPE+L+ + Y VD+W++
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSV 205
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-53
Identities = 61/152 (40%), Positives = 88/152 (57%), Gaps = 10/152 (6%)
Query: 15 AIRQATEATNKKEKRSLKHPNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPH 69
+R E + + +HPN+V L++V R+ K+ LVFE D + L+ P
Sbjct: 58 TVR---EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP 114
Query: 70 -GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE 128
GLP + IK + Q LRG+ + H + +HRD+KPENIL+T+ G VKL DFG AR+ +
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T V T WYRAPE+L+ T Y VD+W++
Sbjct: 175 ALTPVVVTLWYRAPEVLLQST-YATPVDMWSV 205
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 55/142 (38%), Positives = 82/142 (57%), Gaps = 10/142 (7%)
Query: 29 RSLKHPNLVNLLEVF------RRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQI 79
R +KHPN+V+L F + + L+LV E+ TV ++ +P LIK
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRW 138
+Q+LR ++Y H HRDIKP+N+LL GV+KL DFG A+++ GE Y+ +R+
Sbjct: 147 MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 139 YRAPELLVGDTLYGPAVDVWAI 160
YRAPEL+ G T Y +D+W+
Sbjct: 207 YRAPELIFGATNYTTNIDIWST 228
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-53
Identities = 59/150 (39%), Positives = 88/150 (58%), Gaps = 18/150 (12%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHG--------LPWDLIKQ 78
R LKHPN+++L +VF +K+ L+F++ +H + + ++ H LP ++K
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA----NGVVKLCDFGFARLIN-PGENYTDY 133
+ +Q+L G+ Y H + +HRD+KP NIL+ G VK+ D GFARL N P + D
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 134 ---VATRWYRAPELLVGDTLYGPAVDVWAI 160
V T WYRAPELL+G Y A+D+WAI
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAI 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-52
Identities = 59/145 (40%), Positives = 86/145 (59%), Gaps = 13/145 (8%)
Query: 29 RSLKHPNLVNLLEVF--------RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 80
+ LKH N+VNL+E+ R K ++LVF+FC+H + L N IK++
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVA 135
+L G+ Y HR+ +HRD+K N+L+T +GV+KL DFG AR + +N YT+ V
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T WYR PELL+G+ YGP +D+W
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGA 215
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-50
Identities = 52/148 (35%), Positives = 78/148 (52%), Gaps = 13/148 (8%)
Query: 26 KEKRSLKHPNLVNLLEVFR-------RKKKLHLVFEFCD---HTVLNELENHPHGLPWDL 75
++ L HPN+V L F R L++V E+ H P L
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 76 IKQITWQVLRGVSYCHRHAC--IHRDIKPENILL-TANGVVKLCDFGFARLINPGENYTD 132
IK +Q++R + H + HRDIKP N+L+ A+G +KLCDFG A+ ++P E
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 133 YVATRWYRAPELLVGDTLYGPAVDVWAI 160
Y+ +R+YRAPEL+ G+ Y AVD+W++
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSV 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-44
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 42/174 (24%)
Query: 29 RSLKHPNLVNLLEVFRRKKK--------------------------------------LH 50
+ L H N++ L++ F L+
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 51 LVFEFCD---HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 107
++ E+ H VL +P +LI +Q+ R V + H HRDIKP+N+L+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 108 TAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ +KLCDFG A+ + P E Y+ +R+YRAPEL++G T Y P++D+W+I
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-44
Identities = 44/146 (30%), Positives = 81/146 (55%), Gaps = 13/146 (8%)
Query: 25 KKEKRSLK-------HPNLVNLLEVFR--RKKKLHLVFEFCDHTVLNELENHPHGLPWDL 75
KK KR +K PN++ L ++ + + LVFE ++T +L L
Sbjct: 75 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYD 131
Query: 76 IKQITWQVLRGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFARLINPGENYTDYV 134
I+ +++L+ + YCH +HRD+KP N+++ + ++L D+G A +PG+ Y V
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
A+R+++ PELLV +Y ++D+W++
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSL 217
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 34/165 (20%)
Query: 29 RSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83
L H ++V +L++ K +L++V E D + +L P L IK + + +
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNL 165
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-------------- 129
L GV Y H +HRD+KP N L+ + VK+CDFG AR ++ EN
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 130 --------------YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T +V TRWYRAPEL++ Y A+DVW+I
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-40
Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 29 RSLKHPNLVNLLEVFRRK-----KKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQIT 80
HPN++ L ++F KL+LV E V++ + + I+
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH---DQRIVISPQHIQYFM 140
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYR 140
+ +L G+ H +HRD+ P NILL N + +CDF AR N T YV RWYR
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 141 APELLVGDTLYGPAVDVWAI 160
APEL++ + VD+W+
Sbjct: 201 APELVMQFKGFTKLVDMWSA 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 42/155 (27%), Positives = 61/155 (39%), Gaps = 2/155 (1%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL 64
K+ S + R A ++ +HP V L + + L+L E C ++
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHC 147
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
E LP + L +++ H +H D+KP NI L G KL DFG +
Sbjct: 148 EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207
Query: 125 NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
Y APELL G YG A DV++
Sbjct: 208 GTAGAGEVQEGDPRYMAPELLQGS--YGTAADVFS 240
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 43/141 (30%), Positives = 72/141 (51%), Gaps = 17/141 (12%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH------LVFEFCD---HTVLNELENHPHGLPWDLIKQI 79
+ ++H N++ LL+VF L LV F ++ + I+ +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK------IQYL 131
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWY 139
+Q+L+G+ Y H +HRD+KP N+ + + +K+ DFG AR + T YV TRWY
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWY 189
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
RAPE+++ Y VD+W++
Sbjct: 190 RAPEVILSWMHYNQTVDIWSV 210
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 47/146 (32%), Positives = 81/146 (55%), Gaps = 21/146 (14%)
Query: 29 RSLKHPNLVNLLEVFRRK-----KKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQ 78
+H N++ + ++ R K +++V + + + +L L N D I
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN-------DHICY 132
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYV 134
+Q+LRG+ Y H +HRD+KP N+LL +K+CDFG AR+ +P ++ T+YV
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
ATRWYRAPE+++ Y ++D+W++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSV 218
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 46/141 (32%), Positives = 74/141 (52%), Gaps = 16/141 (11%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH------LVFEFCD---HTVLNELENHPHGLPWDLIKQI 79
+ ++H N++ LL+VF + L LV F ++ L D I+ +
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFL 133
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWY 139
+Q+L+G+ Y H IHRD+KP N+ + + +K+ DFG AR + T YV TRWY
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWY 191
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
RAPE+++ Y VD+W++
Sbjct: 192 RAPEVILNWMRYTQTVDIWSV 212
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 47/138 (34%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH------LVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ + H N+++LL VF +K L LV E D L ++ L + + + +Q
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME--LDHERMSYLLYQ 172
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L G+ + H IHRD+KP NI++ ++ +K+ DFG AR T YV TR+YRAP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++G Y VD+W++
Sbjct: 233 EVILG-MGYKENVDIWSV 249
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 28/153 (18%)
Query: 29 RSLKHPNLVNLLEVFR-----RKKKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQ 78
+ KH N++ + + R +++++ E H V+ L + D I+
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-------DHIQY 116
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-------- 130
+Q LR V H IHRD+KP N+L+ +N +K+CDFG AR+I+
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 131 ---TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
++VATRWYRAPE+++ Y A+DVW+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 46/141 (32%), Positives = 74/141 (52%), Gaps = 16/141 (11%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH------LVFEFCD---HTVLNELENHPHGLPWDLIKQI 79
+ + H N++ LL VF +K L +V E D V+ +H + +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYL 132
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWY 139
+Q+L G+ + H IHRD+KP NI++ ++ +K+ DFG AR T YV TR+Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
RAPE+++G Y VD+W++
Sbjct: 193 RAPEVILG-MGYKENVDIWSV 212
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 47/143 (32%), Positives = 76/143 (53%), Gaps = 20/143 (13%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH------LVFEFCD---HTVL--NELENHPHGLPWDLIK 77
+ +KH N++ LL+VF + L LV + ++ +L + D ++
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-------DHVQ 135
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR 137
+ +Q+LRG+ Y H IHRD+KP N+ + + +K+ DFG AR T YVATR
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATR 193
Query: 138 WYRAPELLVGDTLYGPAVDVWAI 160
WYRAPE+++ Y VD+W++
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSV 216
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 29/160 (18%)
Query: 29 RSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83
LK ++ L ++ +L++V E D + L +L P L + IK I + +
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY------------- 130
L G ++ H IHRD+KP N LL + VK+CDFG AR IN ++
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 131 ----------TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T +V TRWYRAPEL++ Y ++D+W+
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 31/156 (19%)
Query: 29 RSLKHPNLVNLLEVFRRKKK--------------LHLVFEFCD---HTVL--NELENHPH 69
R L H N+V + E+ +++V E+ + VL L
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE--- 119
Query: 70 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLINPGE 128
+ + +Q+LRG+ Y H +HRD+KP N+ + + V+K+ DFG AR+++P
Sbjct: 120 ----EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 129 NY----TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
++ ++ + T+WYR+P LL+ Y A+D+WA
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 55/157 (35%), Positives = 80/157 (50%), Gaps = 36/157 (22%)
Query: 33 HPNLVNLLEVFRRK--KKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQITWQVLR 85
H N+VNLL V R + ++LVF++ + H V+ N LE H + + +Q+++
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-H------KQYVVYQLIK 120
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--------------- 130
+ Y H +HRD+KP NILL A VK+ DFG +R
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 131 -------TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
TDYVATRWYRAPE+L+G T Y +D+W++
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 45/146 (30%), Positives = 66/146 (45%), Gaps = 25/146 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
R ++HPN++ L ++F K + L+ E + L E E +KQ
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT------QFLKQ 116
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLINPGENYTDYV 134
I L GV Y H H D+KPENI+L N +KL DFG A I G + +
Sbjct: 117 I----LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE++ + G D+W+I
Sbjct: 173 GTPEFVAPEIVNYEP-LGLEADMWSI 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-35
Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 30/177 (16%)
Query: 3 FNKKKKSSYYKEAIRQATEATNKKEKRSLK----HPNLVNLLEVFRRKKKLHLVFEFC-- 56
+ S+ E +++ EAT KE L+ HPN++ L + + LVF+
Sbjct: 50 IDVTGGGSFSAEEVQELREAT-LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK 108
Query: 57 --------DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
+ L+E E ++I +L + H+ +HRD+KPENILL
Sbjct: 109 GELFDYLTEKVTLSEKE----------TRKIMRALLEVICALHKLNIVHRDLKPENILLD 158
Query: 109 ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTL-----YGPAVDVWAI 160
+ +KL DFGF+ ++PGE + T Y APE++ YG VD+W+
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 41/136 (30%), Positives = 65/136 (47%), Gaps = 8/136 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVL 84
++KHPN+V E F L++V ++C+ +N + D I Q+
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQIC 135
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVATRWYRAPE 143
+ + H +HRDIK +NI LT +G V+L DFG AR++N + T +Y +PE
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 144 LLVGDTLYGPAVDVWA 159
+ Y D+WA
Sbjct: 196 ICENKP-YNNKSDIWA 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 24/145 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
R L+HPN+V L + + + +LVF+ +E + I+Q
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQ 113
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVA 135
I L ++YCH + +HR++KPEN+LL + VKL DFG A +N E + +
Sbjct: 114 I----LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T Y +PE+L D Y VD+WA
Sbjct: 170 TPGYLSPEVLKKD-PYSKPVDIWAC 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 41/145 (28%), Positives = 64/145 (44%), Gaps = 24/145 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIK 77
+H N+++L E F ++L ++FEF LNE E I
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE----------IV 105
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVA 135
QV + + H H H DI+PENI+ + +K+ +FG AR + PG+N+
Sbjct: 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
Y APE+ D A D+W++
Sbjct: 166 APEYYAPEVHQHDV-VSTATDMWSL 189
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 6/137 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVL 84
+ L HPN++ F +L++V E D ++ + +P + + Q+
Sbjct: 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-TDYVATRWYRAPE 143
+ + H +HRDIKP N+ +TA GVVKL D G R + V T +Y +PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 144 LLVGDTLYGPAVDVWAI 160
+ + Y D+W++
Sbjct: 207 -RIHENGYNFKSDIWSL 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 31/144 (21%), Positives = 60/144 (41%), Gaps = 11/144 (7%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 87
+ S +HPN++ + ++ ++ E C T+ +E + Q G+
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131
Query: 88 SYCHRHACIHRDIKPENILLTANG-----VVKLCDFGFARLINPGENY----TDYVATRW 138
++ H +HRD+KP NIL++ + DFG + + G + + T
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 139 YRAPELLVGDTL--YGPAVDVWAI 160
+ APE+L D VD+++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSA 215
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 25/146 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ ++HPN++ L EV+ K + L+ E + L E E + +KQ
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT------EFLKQ 122
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLINPGENYTDYV 134
I L GV Y H H D+KPENI+L +K+ DFG A I+ G + +
Sbjct: 123 I----LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE++ + G D+W+I
Sbjct: 179 GTPEFVAPEIVNYEP-LGLEADMWSI 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 24/145 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD----------HTVLNELENHPHGLPWDLIKQ 78
R L+HPN+V L + + + +LVF+ +E + I+Q
Sbjct: 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQ 136
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVA 135
I L ++YCH + +HR++KPEN+LL + VKL DFG A +N E + +
Sbjct: 137 I----LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T Y +PE+L Y VD+WA
Sbjct: 193 TPGYLSPEVLKK-DPYSKPVDIWAC 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 3 FNKKKKSSYYKEAIRQATEATNKKE----KRSLKHPNLVNLLEVFRRKKKLHLVFEFC-- 56
+ + ++E ++ HP+++ L++ + + LVF+
Sbjct: 127 MEVTAERL--SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 57 --------DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
+ L+E E + I +L VS+ H + +HRD+KPENILL
Sbjct: 185 GELFDYLTEKVALSEKE----------TRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 109 ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTL-----YGPAVDVWAI 160
N ++L DFGF+ + PGE + T Y APE+L YG VD+WA
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-34
Identities = 43/146 (29%), Positives = 64/146 (43%), Gaps = 25/146 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
R + H N++ L +V+ + + L+ E L+E E IKQ
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------SFIKQ 123
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA----NGVVKLCDFGFARLINPGENYTDYV 134
I L GV+Y H H D+KPENI+L +KL DFG A I G + +
Sbjct: 124 I----LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE++ + G D+W+I
Sbjct: 180 GTPEFVAPEIVNYEP-LGLEADMWSI 204
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 43/144 (29%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQ 82
R LKHPN+V + R L++V E+C+ +V+ + L + + ++ Q
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 83 VLRGVSYCHR-----HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVAT 136
+ + CHR H +HRD+KP N+ L VKL DFG AR++N ++ +V T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 137 RWYRAPELLVGDTLYGPAVDVWAI 160
+Y +PE + + Y D+W++
Sbjct: 180 PYYMSPEQMNRMS-YNEKSDIWSL 202
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 18/149 (12%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQ 82
+ L H N+V L + + L+ EFC +TVL E N +GLP +
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRD 120
Query: 83 VLRGVSYCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLINPGENYTDYVATRW 138
V+ G+++ + +HR+IKP NI+ V KL DFG AR + E + T
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 139 YRAPELLVGDTL-------YGPAVDVWAI 160
Y P++ L YG VD+W+I
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSI 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 48/145 (33%), Positives = 66/145 (45%), Gaps = 25/145 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+SL HPN++ L E F ++LV E C V E + +
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD----------AAR 110
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVA 135
I VL V+YCH+ HRD+KPEN L + +KL DFG A PG+ V
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T +Y +P++L G YGP D W+
Sbjct: 171 TPYYVSPQVLEGL--YGPECDEWSA 193
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
R + HPN++ L +V+ + + L+ E L+E E
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----------ATS 119
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA----NGVVKLCDFGFARLINPGENYTDYV 134
Q+L GV+Y H H D+KPENI+L +KL DFG A I G + +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 135 ATRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE++ + G D+W+I
Sbjct: 180 GTPEFVAPEIVNYEP-LGLEADMWSI 204
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 18/149 (12%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQ 82
+ L H N+V L + + L+ EFC +TVL E N +GLP +
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRD 120
Query: 83 VLRGVSYCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLINPGENYTDYVATRW 138
V+ G+++ + +HR+IKP NI+ V KL DFG AR + E + T
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 139 YRAPELLVGDTL-------YGPAVDVWAI 160
Y P++ L YG VD+W+I
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSI 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT--VLNELENHPHGLPWDLIKQITWQVLRG 86
++H N++ +L++F + LV E + ++ HP L L I Q++
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSA 142
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV 146
V Y IHRDIK ENI++ + +KL DFG A + G+ + + T Y APE+L+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 147 GDTLYGPAVDVWA 159
G+ GP +++W+
Sbjct: 203 GNPYRGPELEMWS 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 13/141 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC------DHTVLNELENHPHGLPWDLIKQITWQ 82
+SL HPN++ + EVF +++V E C + V + L + ++ Q
Sbjct: 75 KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIV--SAQARGKALSEGYVAELMKQ 132
Query: 83 VLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVATRWY 139
++ ++Y H +H+D+KPENIL + +K+ DFG A L E+ T+ T Y
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 140 RAPELLVGDTLYGPAVDVWAI 160
APE+ D D+W+
Sbjct: 193 MAPEVFKRD--VTFKCDIWSA 211
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 47/134 (35%), Positives = 70/134 (52%), Gaps = 6/134 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 85
+ L HPN+V L EV +K L+L+ E+ E+ ++ HG + + Q++
Sbjct: 69 KILNHPNIVKLFEVIETEKTLYLIMEYASG---GEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
V YCH+ +HRD+K EN+LL A+ +K+ DFGF+ G + Y APEL
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185
Query: 146 VGDTLYGPAVDVWA 159
G GP VDVW+
Sbjct: 186 QGKKYDGPEVDVWS 199
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 26/143 (18%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFC------------DHTVLNELENHPHGLPWDLIKQIT 80
P ++NL EV+ ++ L+ E+ +++E + LIKQI
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIKQI- 140
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLINPGENYTDYVATR 137
L GV Y H++ +H D+KP+NILL G +K+ DFG +R I + + T
Sbjct: 141 ---LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 138 WYRAPELLVGDTLYGPAVDVWAI 160
Y APE+L D A D+W I
Sbjct: 198 EYLAPEILNYDP-ITTATDMWNI 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-33
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 15/140 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
LKHP+++ L F ++LV E C + + L+N + + Q++ G+
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YT-----DYVATRWYR 140
Y H H +HRD+ N+LLT N +K+ DFG A + YT +Y+
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI------ 179
Query: 141 APELLVGDTLYGPAVDVWAI 160
+PE+ + +G DVW++
Sbjct: 180 SPEIATR-SAHGLESDVWSL 198
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-33
Identities = 38/152 (25%), Positives = 59/152 (38%), Gaps = 20/152 (13%)
Query: 28 KRSLKHPNLVNLLEVFRRKK----KLHLVFEFCD----HTVLNELENHPHGLPWDLIKQI 79
R HPN++ L+ R++ + L+ F + L++ + L D I +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG----------EN 129
+ RG+ H HRD+KP NILL G L D G ++
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 130 YTDYVATRWYRAPEL--LVGDTLYGPAVDVWA 159
+ T YRAPEL + + DVW+
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 41/150 (27%), Positives = 61/150 (40%), Gaps = 19/150 (12%)
Query: 29 RSLKHPNLVNLLEVF----------------RRKKKLHLVFEFCDHTVLNEL--ENHPHG 70
L H N+V+ + + K L + EFCD L + +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 71 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY 130
L L ++ Q+ +GV Y H I+RD+KP NI L VK+ DFG +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 131 TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T T Y +PE + YG VD++A+
Sbjct: 179 TRSKGTLRYMSPEQISSQD-YGKEVDLYAL 207
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 25/145 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ L HPN++ L E+ ++V E +E + +
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD----------AAR 125
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVA 135
I QV G++Y H+H +HRD+KPENILL + +K+ DFG + D +
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T +Y APE+L G Y DVW+
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSA 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-33
Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 25/145 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ L HPN++ L E+ ++V E +E + +
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD----------AAR 125
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVA 135
I QV G++Y H+H +HRD+KPENILL + + +K+ DFG + D +
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T +Y APE+L G Y DVW+
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSA 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-33
Identities = 44/145 (30%), Positives = 65/145 (44%), Gaps = 24/145 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIK 77
L HP L+NL + F K ++ L+ EF + ++E E +
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----------VI 152
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVA 135
Q G+ + H H+ +H DIKPENI+ VK+ DFG A +NP E A
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE++ + G D+WAI
Sbjct: 213 TAEFAAPEIVDREP-VGFYTDMWAI 236
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 33/147 (22%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 29 RSLKHPNL--VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
L+ + + L + + +++V E + + + L+ + K +L
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEA 139
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPE 143
V H+H +H D+KP N L+ +G++KL DFG A + P V T Y PE
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 144 LLVG----------DTLYGPAVDVWAI 160
+ + P DVW++
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSL 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 43/139 (30%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 25 KKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITW 81
K HP ++ LL+ F ++ LV E +L ++ G L +
Sbjct: 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ--DLFDYITEKGPLGEGPSRCFFG 146
Query: 82 QVLRGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFARLINPGENYTDYVATRWYR 140
QV+ + +CH +HRDIK ENIL+ G KL DFG L+ E YTD+ TR Y
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYS 205
Query: 141 APELLVGDTLYGPAVDVWA 159
PE + + VW+
Sbjct: 206 PPEWISRHQYHALPATVWS 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 25/145 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD----------HTVLNELENHPHGLPWDLIKQ 78
+SL HPN++ L +VF KK +LV EF + +E +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD----------AAN 150
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVA 135
I Q+L G+ Y H+H +HRDIKPENILL + +K+ DFG + + D +
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T +Y APE+L Y DVW+
Sbjct: 211 TAYYIAPEVLKKK--YNEKCDVWSC 233
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 20/141 (14%), Positives = 40/141 (28%), Gaps = 11/141 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH--LVFEFCD------HTVLNELENHPHGLPWDLIKQIT 80
P L + L+ + L+ + + +T
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYR 140
Q++R + +H P+N+ + +G + L D G Y
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASSVPVTYA 258
Query: 141 APELLVGDTL-YGPAVDVWAI 160
E L T + A++ W +
Sbjct: 259 PREFLNASTATFTHALNAWQL 279
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 25/145 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ L HPN++ L E F K +LV E +E++ +
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD----------AAR 130
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVA 135
I QVL G++Y H++ +HRD+KPEN+LL + + +++ DFG + + D +
Sbjct: 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T +Y APE+L G Y DVW+
Sbjct: 191 TAYYIAPEVLHGT--YDEKCDVWST 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 25/145 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ L HPN++ L + F K+ +LV E NE++
Sbjct: 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD----------AAV 140
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVA 135
I QVL GV+Y H+H +HRD+KPEN+LL + ++K+ DFG + + + + +
Sbjct: 141 IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T +Y APE+L Y DVW+I
Sbjct: 201 TAYYIAPEVLRKK--YDEKCDVWSI 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 48/144 (33%), Positives = 66/144 (45%), Gaps = 17/144 (11%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL-NELENHPHGLPW-------DLIKQIT 80
LKHP++V LLE + L++VFEF D L E+ ++QI
Sbjct: 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI- 139
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIN-PGENYTDYVAT 136
L + YCH + IHRD+KP +LL + + VKL FG A + G V T
Sbjct: 140 ---LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 137 RWYRAPELLVGDTLYGPAVDVWAI 160
+ APE++ YG VDVW
Sbjct: 197 PHFMAPEVVKR-EPYGKPVDVWGC 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 24/145 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIK 77
L+HP LVNL + F ++ +++EF +H ++E E
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE----------AV 258
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLT--ANGVVKLCDFGFARLINPGENYTDYVA 135
+ QV +G+ + H + +H D+KPENI+ T + +KL DFG ++P ++
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 318
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE+ G G D+W++
Sbjct: 319 TAEFAAPEVAEGKP-VGYYTDMWSV 342
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 29 RSLKHPNLVNLLEVF-------------RRKKKLHLVFEFCD-HTVLNELENHPHGLPWD 74
SL H +V + ++K L + E+C+ T+ + + + D
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN--------- 125
++ Q+L +SY H IHRD+KP NI + + VK+ DFG A+ ++
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 126 ------PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+N T + T Y A E+L G Y +D++++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 41/145 (28%), Positives = 61/145 (42%), Gaps = 24/145 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIK 77
L H NL+ L + F K + LV E+ + L EL+ +K
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI------LFMK 194
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLT--ANGVVKLCDFGFARLINPGENYTDYVA 135
QI G+ + H+ +H D+KPENIL +K+ DFG AR P E
Sbjct: 195 QI----CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE++ D D+W++
Sbjct: 251 TPEFLAPEVVNYDF-VSFPTDMWSV 274
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 12/137 (8%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
L+HPN++ L F +++L+ E+ + ++ +S
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-----DYVATRWYRAPE 143
YCH IHRDIKPEN+LL + G +K+ DFG++ DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 144 LLVGDTLYGPAVDVWAI 160
++ G + VD+W++
Sbjct: 178 MIEGRM-HDEKVDLWSL 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 26/147 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ L HP ++ + F + ++V E + L E K
Sbjct: 70 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEAT----------CKL 118
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVA 135
+Q+L V Y H + IHRD+KPEN+LL++ + ++K+ DFG ++++
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178
Query: 136 TRWYRAPELLVGDTL--YGPAVDVWAI 160
T Y APE+LV Y AVD W++
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSL 205
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 36/146 (24%), Positives = 64/146 (43%), Gaps = 21/146 (14%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC------DHTVLNEL--ENHPHGLPWDLIKQIT 80
+K+ + + ++++++E+ + +N+ +P +IK I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 81 WQVLRGVSYCHRHACI-HRDIKPENILLTANGVVKLCDFGFARLINPGENYT-----DYV 134
VL SY H I HRD+KP NIL+ NG VKL DFG + + + +++
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM 217
Query: 135 ATRWYRAPELLVGDTLY-GPAVDVWA 159
PE ++ Y G VD+W+
Sbjct: 218 ------PPEFFSNESSYNGAKVDIWS 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 14/138 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL-NELENHPHGLPWDLIKQITWQVLRGV 87
L+HPN++ + F +K+++L+ EF L EL+ H ++ +
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADAL 127
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT-----DYVATRWYRAP 142
YCH IHRDIKPEN+L+ G +K+ DFG++ T DY+ P
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PP 181
Query: 143 ELLVGDTLYGPAVDVWAI 160
E++ G + VD+W
Sbjct: 182 EMIEG-KTHDEKVDLWCA 198
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 30/152 (19%)
Query: 28 KRSLKHPNLVNLLEVF----RRKKKLHLVFEFCD------------HTVLNELENHPHGL 71
R+ + P++V +++V+ +K L +V E D E E
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE------ 162
Query: 72 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGE 128
+I + + Y H HRD+KPEN+L T N ++KL DFGFA+
Sbjct: 163 ----ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ T T +Y APE+L + Y + D+W++
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSL 249
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 24/145 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
L HPN++ L E+F ++ LV E + +E + D +KQ
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA------DAVKQ 156
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVA 135
I L V+Y H + +HRD+KPEN+L + +K+ DFG ++++
Sbjct: 157 I----LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T Y APE+L G YGP VD+W++
Sbjct: 213 TPGYCAPEILRGCA-YGPEVDMWSV 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 26/147 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ L HP ++ + F + ++V E + L E K
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEAT----------CKL 243
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVA 135
+Q+L V Y H + IHRD+KPEN+LL++ + ++K+ DFG ++++
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303
Query: 136 TRWYRAPELLVGDTL--YGPAVDVWAI 160
T Y APE+LV Y AVD W++
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSL 330
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 45/137 (32%), Positives = 66/137 (48%), Gaps = 9/137 (6%)
Query: 29 RSLKH--PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQV 83
+ + ++ LL+ F R L+ E + +L + G L +L + WQV
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ--DLFDFITERGALQEELARSFFWQV 158
Query: 84 LRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
L V +CH +HRDIK ENIL+ N G +KL DFG L+ YTD+ TR Y P
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPP 217
Query: 143 ELLVGDTLYGPAVDVWA 159
E + +G + VW+
Sbjct: 218 EWIRYHRYHGRSAAVWS 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 33/147 (22%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 29 RSLKHPNL--VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
L+ + + L + + +++V E + + + L+ + K +L
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEA 120
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPE 143
V H+H +H D+KP N L+ +G++KL DFG A + P V T Y PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 144 LLVG----------DTLYGPAVDVWAI 160
+ + P DVW++
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSL 206
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 50/145 (34%), Positives = 73/145 (50%), Gaps = 15/145 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH------LVFEFCD----HTVLNELENHPHGLPWDLIKQ 78
+ L HPN+V+ EV +KL L E+C+ LN+ EN GL I+
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRT 125
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLINPGENYTDYVA 135
+ + + Y H + IHRD+KPENI+L + K+ D G+A+ ++ GE T++V
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T Y APELL Y VD W+
Sbjct: 186 TLQYLAPELLEQK-KYTVTVDYWSF 209
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 32/147 (21%), Positives = 58/147 (39%), Gaps = 17/147 (11%)
Query: 29 RSLKHPNL--VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
L+ + + L + + +++V E + + + L+ + K +L
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEA 167
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD---YVATRWYRAPE 143
V H+H +H D+KP N L+ +G++KL DFG A + P V Y PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 144 LLVG----------DTLYGPAVDVWAI 160
+ + P DVW++
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSL 253
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 30/172 (17%)
Query: 3 FNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFC------ 56
N KK S+ + + + R LKHPN+V L + + +L+F+
Sbjct: 44 INTKKLSARDHQKLEREARIC-----RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF 98
Query: 57 ----DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---A 109
+E + I+QI L V +CH+ +HR++KPEN+LL
Sbjct: 99 EDIVAREYYSEADAS------HCIQQI----LEAVLHCHQMGVVHRNLKPENLLLASKLK 148
Query: 110 NGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
VKL DFG A + + + + T Y +PE+L D YG VD+WA
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWAC 199
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 41/139 (29%), Positives = 59/139 (42%), Gaps = 14/139 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
RSL H ++V F + +V E C L EL L + Q++ G
Sbjct: 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YT-----DYVATRWYRA 141
Y HR+ IHRD+K N+ L + VK+ DFG A + +Y+ A
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI------A 209
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE+L + VDVW+I
Sbjct: 210 PEVLSK-KGHSFEVDVWSI 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 29 RSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 86
+ L HPN+V L+EV + L++VFE + + E+ L D + +++G
Sbjct: 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQDLIKG 149
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA-TRWYRAPELL 145
+ Y H IHRDIKP N+L+ +G +K+ DFG + + T + APE L
Sbjct: 150 IEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209
Query: 146 VGDT-LY-GPAVDVWA 159
++ G A+DVWA
Sbjct: 210 SETRKIFSGKALDVWA 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-31
Identities = 41/139 (29%), Positives = 59/139 (42%), Gaps = 14/139 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
RSL H ++V F + +V E C L EL L + Q++ G
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YT-----DYVATRWYRA 141
Y HR+ IHRD+K N+ L + VK+ DFG A + +Y+ A
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI------A 183
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE+L + VDVW+I
Sbjct: 184 PEVLSK-KGHSFEVDVWSI 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 13/140 (9%)
Query: 29 RSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENH-PHG-LPWDLIKQITWQVL 84
R L+H N++ L++V K+K+++V E+C + E+ + P P Q++
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW-----Y 139
G+ Y H +H+DIKP N+LLT G +K+ G A ++P D +
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA--DDTCRTSQGSPAF 177
Query: 140 RAPELLVGDTLY-GPAVDVW 158
+ PE+ G + G VD+W
Sbjct: 178 QPPEIANGLDTFSGFKVDIW 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 47/159 (29%), Positives = 68/159 (42%), Gaps = 27/159 (16%)
Query: 28 KRSLKHPNLVNLLEVFRRKKK--------LHLVFEFCDHTVLNELENHPHG--LPWDLIK 77
K+ HPN+V K+ L+ E C ++ L+ L D +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 78 QITWQVLRGVSYCHRHAC--IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA 135
+I +Q R V + HR IHRD+K EN+LL+ G +KLCDFG A I+ +Y+
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 136 TRW-------------YRAPEL--LVGDTLYGPAVDVWA 159
R YR PE+ L + G D+WA
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-30
Identities = 38/158 (24%), Positives = 58/158 (36%), Gaps = 35/158 (22%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFC------DHTV----LNELENHPHGLPWDLIK 77
+ H N++ L+E F + + +LVFE H NELE
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----------AS 114
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYV 134
+ V + + H HRD+KPENIL VK+CDF I + +
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 135 ATRW--------YRAPELLVGDTL----YGPAVDVWAI 160
Y APE++ + Y D+W++
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 26/148 (17%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIK 77
R +HPN++ L +V+ K +++V E +E E
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE----------AS 119
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLINPGEN-YTD 132
+ + + + V Y H +HRD+KP NIL +++CDFGFA+ +
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 133 YVATRWYRAPELLVGDTLYGPAVDVWAI 160
T + APE+L Y A D+W++
Sbjct: 180 PCYTANFVAPEVLER-QGYDAACDIWSL 206
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 25/145 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 78
+ +KH N+V L +++ +LV + + V E +
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD----------ASL 110
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVA 135
+ QVL V Y H + +HRD+KPEN+L N + + DFG +++ G +
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACG 169
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAI 160
T Y APE+L Y AVD W+I
Sbjct: 170 TPGYVAPEVLAQ-KPYSKAVDCWSI 193
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 31/152 (20%)
Query: 28 KRSLKHPNLVNLLEVF----RRKKKLHLVFEFCD------------HTVLNELENHPHGL 71
++ P++V +L+V+ K+ L ++ E + E E
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE------ 129
Query: 72 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGE 128
+I + + + H H HRD+KPEN+L T + V+KL DFGFA+
Sbjct: 130 ----AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
T +Y APE+L + Y + D+W++
Sbjct: 186 -LQTPCYTPYYVAPEVLGPEK-YDKSCDMWSL 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 47/135 (34%), Positives = 63/135 (46%), Gaps = 8/135 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 85
RSL+HPN+V EV L ++ E+ EL G D + Q+L
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASG---GELYERICNAGRFSEDEARFFFQQLLS 127
Query: 86 GVSYCHRHACIHRDIKPENILLTANGV--VKLCDFGFARLINPGENYTDYVATRWYRAPE 143
GVSYCH HRD+K EN LL + +K+CDFG+++ V T Y APE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 144 LLVGDTLYGPAVDVW 158
+L+ G DVW
Sbjct: 188 VLLRQEYDGKIADVW 202
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 46/142 (32%), Positives = 64/142 (45%), Gaps = 25/142 (17%)
Query: 33 HPNLVNLLEVFRRKKKLHLVFEFC------DHTV----LNELENHPHGLPWDLIKQITWQ 82
HPN+V L EVF + LV E + +E E I +
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----------ASYIMRK 114
Query: 83 VLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINP-GENYTDYVATRW 138
++ VS+ H +HRD+KPEN+L T N +K+ DFGFARL P + T
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 139 YRAPELLVGDTLYGPAVDVWAI 160
Y APELL Y + D+W++
Sbjct: 175 YAAPELLNQ-NGYDESCDLWSL 195
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 34/163 (20%), Positives = 67/163 (41%), Gaps = 30/163 (18%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH------PHGLPWDLIKQITW 81
S HPN++ + L++ E C+ + + +E+ +
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 82 QVLRGVSYCHRHACIHRDIKPENILLT-------------ANGVVKLCDFGFARLINPGE 128
Q+ GV++ H IHRD+KP+NIL++ N + + DFG + ++ G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 129 NY-----TDYVATRWYRAPELLVGDTL------YGPAVDVWAI 160
+ + T +RAPELL ++D++++
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM 225
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 36/160 (22%), Positives = 62/160 (38%), Gaps = 29/160 (18%)
Query: 29 RSLKHPNLVNLLEVF------------RRKKKLHLVFEFCDHTVLNEL---ENHPHGLPW 73
L+HP +V + K L++ + C L +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-------- 125
+ I Q+ V + H +HRD+KP NI T + VVK+ DFG ++
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 126 -----PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+T V T+ Y +PE + G++ Y VD++++
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSL 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-28
Identities = 44/133 (33%), Positives = 72/133 (54%), Gaps = 6/133 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 85
+ +HP+++ L +V +V E+ EL ++ HG + +++ Q+L
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSG---GELFDYICKHGRVEEMEARRLFQQILS 122
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
V YCHRH +HRD+KPEN+LL A+ K+ DFG + +++ GE + Y APE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182
Query: 146 VGDTLYGPAVDVW 158
G GP VD+W
Sbjct: 183 SGRLYAGPEVDIW 195
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 50/140 (35%), Positives = 74/140 (52%), Gaps = 10/140 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+HPN + + R+ LV E+C + + LE H L I +T L+G++
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG- 147
Y H H IHRD+K NILL+ G+VKL DFG A ++ P +V T ++ APE+++
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM 225
Query: 148 -DTLYGPAVDVW-----AIE 161
+ Y VDVW IE
Sbjct: 226 DEGQYDGKVDVWSLGITCIE 245
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 42/180 (23%), Positives = 63/180 (35%), Gaps = 48/180 (26%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC------DHTVLNELENHPHGLPWDLI------ 76
+ L HPN+ L EV+ ++ + LV E C D + ++ +
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 77 ----------------------------KQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
I Q+ + Y H HRDIKPEN L +
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 109 A--NGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTL-YGPAVDVWAI 160
+ +KL DFG ++ N T T ++ APE+L YGP D W+
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
+ HP +V LL + KL ++ EFC V + GL I+ + Q+L +
Sbjct: 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELLV 146
++ H IHRD+K N+L+T G ++L DFG A+ + + ++ T ++ APE+++
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 147 GDTL----YGPAVDVW-----AIE 161
+T+ Y D+W IE
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 13/136 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFC-----DHTVLNELENHPHG-LPWDLIKQITWQ 82
+ L+HP+++ L +V + +V E+ D+ V + D ++ Q
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV-------EKKRMTEDEGRRFFQQ 116
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
++ + YCHRH +HRD+KPEN+LL N VK+ DFG + ++ G + Y AP
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176
Query: 143 ELLVGDTLYGPAVDVW 158
E++ G GP VDVW
Sbjct: 177 EVINGKLYAGPEVDVW 192
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 29/152 (19%), Positives = 56/152 (36%), Gaps = 26/152 (17%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRG 86
+H ++V + + + E+C+ ++E +K + QV RG
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 87 VSYCHRHACIHRDIKPENILLTANGV-------------------VKLCDFGFARLINPG 127
+ Y H + +H DIKP NI ++ + K+ D G I+
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS-- 185
Query: 128 ENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ + A E+L + + P D++A
Sbjct: 186 -SPQVEEGDSRFLANEVLQENYTHLPKADIFA 216
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 13/138 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 85
+ L H N+V R +L E+C EL + P +P ++ Q++
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW-----YR 140
GV Y H HRDIKPEN+LL +K+ DFG A + + + + Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYV 174
Query: 141 APELLVGDTLYGPAVDVW 158
APELL + VDVW
Sbjct: 175 APELLKRREFHAEPVDVW 192
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 13/138 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 85
+ L H N+V R +L E+C EL + P +P ++ Q++
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW-----YR 140
GV Y H HRDIKPEN+LL +K+ DFG A + + + + Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYV 174
Query: 141 APELLVGDTLYGPAVDVW 158
APELL + VDVW
Sbjct: 175 APELLKRREFHAEPVDVW 192
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 45/133 (33%), Positives = 74/133 (55%), Gaps = 6/133 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 85
+ +HP+++ L +V + +V E+ EL ++ +G L +++ Q+L
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSG---GELFDYICKNGRLDEKESRRLFQQILS 127
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
GV YCHRH +HRD+KPEN+LL A+ K+ DFG + +++ GE + Y APE++
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 187
Query: 146 VGDTLYGPAVDVW 158
G GP VD+W
Sbjct: 188 SGRLYAGPEVDIW 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 8/140 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
+ P++V + + L +V E+C +V + + L D I I L+G+
Sbjct: 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELLV 146
Y H IHRDIK NILL G KL DFG +L + + T ++ APE ++
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE-VI 197
Query: 147 GDTLYGPAVDVW-----AIE 161
+ Y D+W AIE
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 31/149 (20%), Positives = 51/149 (34%), Gaps = 21/149 (14%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEF-----CDHTVLNELENHP--HG-LPWDLIKQIT 80
+ + ++ + R L F + T L +H H L Q+T
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYR 140
QV+R ++ H + +H ++P +I+L G V L F +R +
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGARVVSSVSRGFE 269
Query: 141 APELLV----------GDTLYGPAVDVWA 159
PEL TL + D WA
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWA 298
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 48/139 (34%), Positives = 73/139 (52%), Gaps = 8/139 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R K+PN+VN L+ + +L +V E+ L ++ + I + + L+ +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALE 130
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELLVG 147
+ H + IHRDIK +NILL +G VKL DFGF A++ + V T ++ APE +V
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVT 189
Query: 148 DTLYGPAVDVW-----AIE 161
YGP VD+W AIE
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 34/149 (22%), Positives = 59/149 (39%), Gaps = 16/149 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENH-PHGLPWDLIKQITWQVLRG 86
+ HPN+V F +L +V F + + + + H G+ I I VL+
Sbjct: 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPG-------ENYTDYVATRW 138
+ Y H +HR +K +IL++ +G V L +I+ G + V
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 139 YRAPELLV-GDTLYGPAVDVW-----AIE 161
+ +PE+L Y D++ A E
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 26/148 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD---------HTVLNELENHPHGLPWDLIKQI 79
R +H N+V + + + ++L ++ EF LNE + I +
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------IATV 146
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRW 138
VL+ ++Y H IHRDIK ++ILLT +G VKL DFGF A++ V T +
Sbjct: 147 CEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 206
Query: 139 YRAPELLVGDTLYGPAVDVW-----AIE 161
+ APE ++ +LY VD+W IE
Sbjct: 207 WMAPE-VISRSLYATEVDIWSLGIMVIE 233
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 17/146 (11%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
R L+HPN++ + V + K+L+ + E+ T+ +++ PW + G+
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY-------------- 133
+Y H IHRD+ N L+ N V + DFG ARL+ + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 134 -VATRWYRAPELLVGDTLYGPAVDVW 158
V ++ APE++ G + Y VDV+
Sbjct: 182 VVGNPYWMAPEMINGRS-YDEKVDVF 206
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 13/145 (8%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
L P +V L R +++ E + L +L LP D Q L G+
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 89 YCHRHACIHRDIKPENILLTANGV-VKLCDFGFARLINPGENYT------DYVATRWYRA 141
Y H +H D+K +N+LL+++G LCDFG A + P T + A
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 142 PELLVGDTLYGPAVDVW-----AIE 161
PE+++G VD+W +
Sbjct: 225 PEVVMGKP-CDAKVDIWSSCCMMLH 248
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 17/153 (11%)
Query: 24 NKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQIT 80
+ N V L+ K L++ + C L + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-------------PG 127
Q+ V + H +HRD+KP NI T + VVK+ DFG ++
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 128 ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+T V T+ Y +PE + G+ Y VD++++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSL 262
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD--------HTVLNELENHPHGLPWDLIKQIT 80
HPN+V+ F K +L LV + ++ + E+ L I I
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD------YV 134
+VL G+ Y H++ IHRD+K NILL +G V++ DFG + + G + T +V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 135 ATRWYRAPELLVGDTLYGPAVDVW-----AIE 161
T + APE++ Y D+W AIE
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 34/137 (24%), Positives = 57/137 (41%), Gaps = 7/137 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
R +H N++ + +L +V ++C+ ++ + L + I Q RG+
Sbjct: 75 RKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR-WYR--APEL 144
Y H + IHRD+K NI L + VK+ DFG A + + APE+
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 145 LVGDTL--YGPAVDVWA 159
+ Y DV+A
Sbjct: 194 IRMQDSNPYSFQSDVYA 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 41/139 (29%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
P + + + KL ++ E+ +L P L I I ++L+G+
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLD 133
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPELLVG 147
Y H IHRDIK N+LL+ +G VKL DFG +L + +V T ++ APE ++
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIK 192
Query: 148 DTLYGPAVDVW-----AIE 161
+ Y D+W AIE
Sbjct: 193 QSAYDSKADIWSLGITAIE 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 22/171 (12%)
Query: 6 KKKSSYYKEAI------RQATEATNKKEKRSLKHPNLVNLLEVF--RRKKKLH--LVFEF 55
+ Y + A ++ +A N KE + +++ LL+ F + +H +VFE
Sbjct: 53 RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN-HILKLLDHFNHKGPNGVHVVMVFEV 111
Query: 56 CDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGVSYCHRHA-CIHRDIKPENILL------ 107
+L + + G+P +KQI+ Q+L G+ Y HR IH DIKPEN+L+
Sbjct: 112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171
Query: 108 TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVW 158
+K+ D G A + E+YT+ + TR YR+PE+L+G +G D+W
Sbjct: 172 ENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIW 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 29/145 (20%), Positives = 48/145 (33%), Gaps = 14/145 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEF----CD-HTVLNELENHPHG---LPWDLIKQIT 80
+ + ++ + R L F + + T L +H L Q+T
Sbjct: 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 217
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRW 138
QV+R ++ H + +H ++P +I+L G V L F A
Sbjct: 218 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPE 277
Query: 139 YRAPELLVGD----TLYGPAVDVWA 159
A +L TL A D W
Sbjct: 278 TTAERMLPFGQHHPTLMTFAFDTWT 302
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 37/147 (25%), Positives = 66/147 (44%), Gaps = 14/147 (9%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQITWQVL 84
R++ P V R+ + + E D ++ + +P D++ +I ++
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 85 RGVSYCH-RHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAP 142
+ + + H + + IHRD+KP N+L+ A G VK+CDFG L++ D + Y AP
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAP 178
Query: 143 ELLVGDTL---YGPAVDVW-----AIE 161
E + + Y D+W IE
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 6/136 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWD--LIKQITWQVLR 85
+ LKH N+V L F + + E ++ L + L + I T Q+L
Sbjct: 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 86 GVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPE 143
G+ Y H + +HRDIK +N+L+ T +GV+K+ DFG + RL + T Y APE
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 144 LLVGDTL-YGPAVDVW 158
++ YG A D+W
Sbjct: 194 IIDKGPRGYGKAADIW 209
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 9/138 (6%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVL 84
+ L+HPN+V + + L +V E+ + +L++ L + + V
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVA 147
Query: 85 RGVSYCHRHAC--IHRDIKPENILLTANGVVKLCDFGFARLINPGENY-TDYVATRWYRA 141
+G++Y H +HR++K N+L+ VK+CDFG +RL T + A
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 142 PELLVGDTLYGPAVDVWA 159
PE+L + DV++
Sbjct: 208 PEVLRDEP-SNEKSDVYS 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-25
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 12/140 (8%)
Query: 29 RSLKHPNLVNLLEVF----RRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQV 83
+ L+HPN+V + + + KK + LV E T+ L+ + +++ Q+
Sbjct: 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQI 138
Query: 84 LRGVSYCHRH--ACIHRDIKPENILLTA-NGVVKLCDFGFARLINPGENYTDYVATRWYR 140
L+G+ + H IHRD+K +NI +T G VK+ D G A L + T +
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFM 197
Query: 141 APELLVGDTLYGPAVDVWAI 160
APE + + Y +VDV+A
Sbjct: 198 APE--MYEEKYDESVDVYAF 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 44/161 (27%), Positives = 87/161 (54%), Gaps = 12/161 (7%)
Query: 6 KKKSSYYKEAIRQAT--EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
+ + ++++A + E K++K + + ++++LE F + + + FE L E
Sbjct: 131 RNEKRFHRQAAEEIRILEHLRKQDKDNTMN--VIHMLENFTFRNHICMTFELLSMN-LYE 187
Query: 64 L--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG--VVKLCDFG 119
L +N G L+++ +L+ + H++ IH D+KPENILL G +K+ DFG
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 120 FARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ + + Y+ +R+YRAPE+++G YG +D+W++
Sbjct: 248 SSCYEH--QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSL 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 37/145 (25%), Positives = 57/145 (39%), Gaps = 12/145 (8%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 87
+S P +V F + + E + +P ++ ++T +++ +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 88 SYCH-RHACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRAPE-- 143
Y +H IHRD+KP NILL G +KLCDFG RL++ Y APE
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERI 196
Query: 144 --LLVGDTLYGPAVDVW-----AIE 161
Y DVW +E
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 6 KKKSSYYKEAIRQAT--EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
K K ++ +A + E NK + + +V+L F + L LVFE + L +
Sbjct: 88 KNKKAFLNQAQIEVRLLELMNKHDTEMKYY--IVHLKRHFMFRNHLCLVFEMLSYN-LYD 144
Query: 64 L--ENHPHGLPWDLIKQITWQVLRGVSYCHRHAC--IHRDIKPENILLT--ANGVVKLCD 117
L + G+ +L ++ Q+ + + IH D+KPENILL +K+ D
Sbjct: 145 LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 118 FGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
FG + + + Y+ +R+YR+PE+L+G Y A+D+W++
Sbjct: 205 FGSSCQLG--QRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSL 244
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 5/132 (3%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
P +V F ++ + E D L+++ +P ++ +++ V++G++
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 145
Query: 89 YCH-RHACIHRDIKPENILLTANGVVKLCDFGFA-RLINPGENYTDYVATRWYRAPELLV 146
Y +H +HRD+KP NIL+ + G +KLCDFG + +LI+ N +V TR Y +PE L
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQ 203
Query: 147 GDTLYGPAVDVW 158
G Y D+W
Sbjct: 204 GTH-YSVQSDIW 214
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 27/151 (17%), Positives = 50/151 (33%), Gaps = 20/151 (13%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-----PHGLPWDLIKQITWQV 83
+ + + LV E + L N +P L+ ++
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 84 LRGVSYCHRHACIHRDIKPENILLT-----------ANGVVKLCDFGFA---RLINPGEN 129
L + H IH DIKP+N +L + + L D G + +L G
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 130 YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+T T ++ E+L + +D + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKP-WNYQIDYFGV 271
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 31/132 (23%), Positives = 50/132 (37%), Gaps = 3/132 (2%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 89
L+ P++V + + +L++ + L + L I Q+ +
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYV-ATRWYRAPELLVG 147
H HRD+KPENIL++A+ L DFG A T +Y APE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 148 DTLYGPAVDVWA 159
D++A
Sbjct: 210 SHA-TYRADIYA 220
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 44/139 (31%), Positives = 65/139 (46%), Gaps = 14/139 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVL 84
+ HPN+V L + LV E+ + + VL+ E P+ Q
Sbjct: 56 SRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCS 112
Query: 85 RGVSYCHRHAC---IHRDIKPENILLTANG-VVKLCDFGFARLINPGENYTDYVATRWYR 140
+GV+Y H IHRD+KP N+LL A G V+K+CDFG A I + T+ + +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWM 170
Query: 141 APELLVGDTLYGPAVDVWA 159
APE+ G Y DV++
Sbjct: 171 APEVFEGSN-YSEKCDVFS 188
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-24
Identities = 30/146 (20%), Positives = 60/146 (41%), Gaps = 16/146 (10%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
R +H N+V + L ++ C T+ + + + L + +QI ++++G+
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY----VATRWYR--A 141
Y H +H+D+K +N+ NG V + DFG + + + W A
Sbjct: 144 GYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 142 PELLVGDTL--------YGPAVDVWA 159
PE++ + + DV+A
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFA 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 31/139 (22%), Positives = 55/139 (39%), Gaps = 19/139 (13%)
Query: 30 SLKHPNLVNLLEV-----FRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 84
+ HP++V + ++V E+ L + LP ++L
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEIL 192
Query: 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY---VATRWYRA 141
+SY H ++ D+KPENI+LT +KL D G I + T ++A
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI------NSFGYLYGTPGFQA 245
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE++ A D++ +
Sbjct: 246 PEIVRTGP--TVATDIYTV 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-24
Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 9/138 (6%)
Query: 30 SLKHPNLVNLL---EVFRRKKKLH-LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLR 85
+L HP +V + E L +V E+ D L ++ + + ++ +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYV-ATRWYRA 141
+++ H++ IHRD+KP NI+++A VK+ DFG AR I N T V T Y +
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 142 PELLVGDTLYGPAVDVWA 159
PE GD++ DV++
Sbjct: 188 PEQARGDSV-DARSDVYS 204
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 39/148 (26%), Positives = 58/148 (39%), Gaps = 15/148 (10%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQV 83
RS P +V R+ + E +P +++ +IT
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 84 LRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGF-ARLINPGENYTDYVATRWYRA 141
++ +++ IHRDIKP NILL +G +KLCDFG +L++ T R Y A
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMA 193
Query: 142 PELLVGDTL---YGPAVDVW-----AIE 161
PE + Y DVW E
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-24
Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 28 KRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDH-TVLNELENHPHG-LPWDLIKQI 79
K+ H N+ F +K +L LV EFC +V + ++N L + I I
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-YVATRW 138
++LRG+S+ H+H IHRDIK +N+LLT N VKL DFG + ++ + ++ T +
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 139 YRAPELLVGDTL----YGPAVDVW-----AIE 161
+ APE++ D Y D+W AIE
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-24
Identities = 29/140 (20%), Positives = 57/140 (40%), Gaps = 13/140 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
+L HPN+V L + +V EF + + L + H + W + ++ + G+
Sbjct: 78 SNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 88 SYCHRHA--CIHRDIKPENILLTANG-----VVKLCDFGFARLINPGENYTDYVATRWYR 140
Y +HRD++ NI L + K+ DFG ++ + + + +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWM 193
Query: 141 APELLVG-DTLYGPAVDVWA 159
APE + + Y D ++
Sbjct: 194 APETIGAEEESYTEKADTYS 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 3/133 (2%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 89
L H N+V++++V +LV E+ + L+E L D T Q+L G+ +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYV-ATRWYRAPELLVG 147
H +HRDIKP+NIL+ +N +K+ DFG A+ ++ T++V T Y +PE G
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 148 DTLYGPAVDVWAI 160
+ D+++I
Sbjct: 187 EAT-DECTDIYSI 198
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-23
Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
LKHPN++ L V ++ L LV EF LN + +P D++ Q+ RG++
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMN 119
Query: 89 YCHRHA---CIHRDIKPENILLT--------ANGVVKLCDFGFARLINPGENYTDYVATR 137
Y H A IHRD+K NIL+ +N ++K+ DFG AR +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAY 178
Query: 138 WYRAPELLVGDTLYGPAVDVW 158
+ APE++ + DVW
Sbjct: 179 AWMAPEVIRASM-FSKGSDVW 198
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 51/152 (33%)
Query: 28 KRSLKHPNLVNLLEVF----RRKKKLHLVFEFCD------------HTVLNELENHPHGL 71
R+ + P++V +++V+ +K L +V E D E E
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE------ 118
Query: 72 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGE 128
+I + + Y H HRD+KPEN+L T N ++KL DFGF
Sbjct: 119 ----ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------- 166
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
A E Y + D+W++
Sbjct: 167 ------------AKETTGEK--YDKSCDMWSL 184
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 29 RSLKHPNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLR 85
++L +V V ++ L LV E+ L + L+ H L + + Q+ +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RW 138
G+ Y C+HRD+ NIL+ + VK+ DFG A+L+ ++Y YV W
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--YVVREPGQSPIFW 196
Query: 139 YRAPELLVGDTLYGPAVDVWA 159
Y APE L D ++ DVW+
Sbjct: 197 Y-APESLS-DNIFSRQSDVWS 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 5 KKKKSSYY------KEAIRQATEATNKKEKR----SLKHPNLVNLLEVFRRKKKLHLVFE 54
K + K + + E +E+R + + L F+ L+LV +
Sbjct: 95 LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154
Query: 55 FC---DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 111
+ D +L L LP ++ + +++ + H+ +HRDIKP+NIL+ NG
Sbjct: 155 YYVGGD--LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 112 VVKLCDFGFA-RLINPGENYTD-YVATRWYRAPELL----VGDTLYGPAVDVWAI 160
++L DFG +L+ G + V T Y +PE+L G YGP D W++
Sbjct: 213 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-22
Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 14/141 (9%)
Query: 29 RSLKHPNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLR 85
+SL+H N+V V ++ L L+ E+ + L + L+ H + + Q T Q+ +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RW 138
G+ Y IHRD+ NIL+ VK+ DFG +++ + Y Y W
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFW 214
Query: 139 YRAPELLVGDTLYGPAVDVWA 159
Y APE L ++ + A DVW+
Sbjct: 215 Y-APESLT-ESKFSVASDVWS 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-22
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 23/176 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATNKKEKRSL----KHPNLVNLLEVFRRKKKLHLVFE 54
K+ Y K + + E + +E+R + + L F+ + L+LV E
Sbjct: 82 MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141
Query: 55 FC---DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 111
+ D +L L +P ++ + +++ + HR +HRDIKP+NILL G
Sbjct: 142 YYVGGD--LLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG 199
Query: 112 VVKLCDFGFA-RLINPGENYTD-YVATRWYRAPELL------VGDTLYGPAVDVWA 159
++L DFG +L G + V T Y +PE+L G YGP D WA
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-22
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 24/174 (13%)
Query: 5 KKKKSSYY-------KEAIRQATEATNKKEKRSL---KHPNLVNLLEVFRRKKKLHLVFE 54
K Y E I+++ A +E+ + P +V L F+ + L++V E
Sbjct: 90 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149
Query: 55 FCDHTVLN--ELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 110
+ +L N + +P + T +V+ + H IHRD+KP+N+LL +
Sbjct: 150 YM-----PGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
Query: 111 GVVKLCDFGFA-RLINPGENYTD-YVATRWYRAPELLV---GDTLYGPAVDVWA 159
G +KL DFG ++ G D V T Y +PE+L GD YG D W+
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 258
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-22
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 23/153 (15%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH----LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 84
L+H N++ + + L+ + + L + L +I +
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIA 115
Query: 85 RGVSYCH--------RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY--- 133
G+++ H + A HRD+K +NIL+ NG + D G A + + N D
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 134 --VATRWYRAPELLVG-----DTLYGPAVDVWA 159
V T+ Y APE+L VD+WA
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 14/141 (9%)
Query: 29 RSLKHPNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLR 85
+SL+H N+V V ++ L L+ E+ + L + L+ H + + Q T Q+ +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RW 138
G+ Y IHRD+ NIL+ VK+ DFG +++ + + + W
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFW 183
Query: 139 YRAPELLVGDTLYGPAVDVWA 159
Y APE L ++ + A DVW+
Sbjct: 184 Y-APESLT-ESKFSVASDVWS 202
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 37/141 (26%), Positives = 61/141 (43%), Gaps = 14/141 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKK--LHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLR 85
R+L H N+V + + L+ EF L E L + + + + Q+ +
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RW 138
G+ Y +HRD+ N+L+ + VK+ DFG + I + Y Y W
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDRDSPVFW 195
Query: 139 YRAPELLVGDTLYGPAVDVWA 159
Y APE L+ + + A DVW+
Sbjct: 196 Y-APECLM-QSKFYIASDVWS 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 40/178 (22%), Positives = 73/178 (41%), Gaps = 29/178 (16%)
Query: 6 KKKSSYYKEAIRQAT--EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
+ Y + A + + +K+K + V + + F + + FE E
Sbjct: 54 RNVGKYREAARLEINVLKKIKEKDKENKFL--CVLMSDWFNFHGHMCIAFELLGKN-TFE 110
Query: 64 L--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--------- 112
EN+ P ++ + +Q+ + + H + H D+KPENIL +
Sbjct: 111 FLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170
Query: 113 ----------VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+++ DFG A + E++T VATR YR PE+++ + DVW+I
Sbjct: 171 CEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSI 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-21
Identities = 23/142 (16%), Positives = 50/142 (35%), Gaps = 18/142 (12%)
Query: 29 RSLKHPNLVNLLEVFRR--KKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQ 82
R HPN++ +L + L+ + + VL+E N + +
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALD 119
Query: 83 VLRGVSYCHRHAC--IHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWY 139
+ RG+++ H + ++++ + ++ +PG Y W
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA----PAWV 175
Query: 140 RAPELLVG--DTLYGPAVDVWA 159
APE L + + D+W+
Sbjct: 176 -APEALQKKPEDTNRRSADMWS 196
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 29/178 (16%)
Query: 6 KKKSSYYKEAIRQAT--EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE 63
K Y + A + E N + S V +LE F + +VFE + +
Sbjct: 49 KNVDRYCEAARSEIQVLEHLNTTDPNSTFR--CVQMLEWFEHHGHICIVFELLGLS-TYD 105
Query: 64 L--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--------- 112
EN D I+++ +Q+ + V++ H + H D+KPENIL +
Sbjct: 106 FIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165
Query: 113 ----------VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+K+ DFG A + E+++ V+TR YRAPE+++ + DVW+I
Sbjct: 166 RDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSI 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 41/160 (25%), Positives = 61/160 (38%), Gaps = 17/160 (10%)
Query: 15 AIRQATEATNKKEK----------RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE- 63
A++ E K + HPN+V L+ V +K+ +++V E
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 64 LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 123
L L + Q+ G+ Y CIHRD+ N L+T V+K+ DFG +R
Sbjct: 203 LRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
Query: 124 INPGENYTDYVAT----RWYRAPELLVGDTLYGPAVDVWA 159
G +W APE L Y DVW+
Sbjct: 263 EADGVYAASGGLRQVPVKWT-APEALN-YGRYSSESDVWS 300
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 24/173 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATNKK-EKR------SLKHPNLVNLLEVFRRKKKLHL 51
K Y K+ I+ T E+ + P +V + F KL
Sbjct: 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269
Query: 52 VFEFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENIL 106
+ + N +L H ++ +++ G+ + H ++RD+KP NIL
Sbjct: 270 ILDLM-----NGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 107 LTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
L +G V++ D G A + + + V T Y APE+L Y + D ++
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFS 376
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 22/172 (12%)
Query: 5 KKKKSSYY------KEAI--RQATEATNKKEKR---SLKHPNLVNLLEVFRRKKKLHLVF 53
+ S Y K I + E+ L HP V L F+ +KL+
Sbjct: 51 ELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 109
Query: 54 EFCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 110
+ + EL + + T +++ + Y H IHRD+KPENILL +
Sbjct: 110 SYAKN---GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 111 GVVKLCDFGFARLINPGENYTD---YVATRWYRAPELLVGDTLYGPAVDVWA 159
+++ DFG A++++P +V T Y +PELL + + D+WA
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWA 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-21
Identities = 28/154 (18%), Positives = 61/154 (39%), Gaps = 25/154 (16%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH----LVFEFCDH-TVLNELENHPHGLPWDLIKQITWQV 83
++H N++ + + L+ ++ ++ ++ + L++ L + ++ +
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSS 143
Query: 84 LRGVSYCH--------RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA 135
+ G+ + H + A HRD+K +NIL+ NG + D G A N D
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 136 -----TRWYRAPELLVG-----DTLYGPAVDVWA 159
T+ Y PE+L D+++
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-21
Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 16/141 (11%)
Query: 29 RSLKHPNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLR 85
R+L H +++ L LV E+ L + L H GL L+ Q+
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA-QLL-LFAQQICE 145
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RW 138
G++Y H IHRD+ N+LL + +VK+ DFG A+ + G Y Y W
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGDSPVFW 203
Query: 139 YRAPELLVGDTLYGPAVDVWA 159
Y APE L + + A DVW+
Sbjct: 204 Y-APECLK-EYKFYYASDVWS 222
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-21
Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 22/152 (14%)
Query: 29 RSLKHPNLVNLL----EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 84
+KH N++ + L L+ F + L++ + + W+ + I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMA 131
Query: 85 RGVSYCHRHAC----------IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD-- 132
RG++Y H HRDIK +N+LL N + DFG A G++ D
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 133 -YVATRWYRAPELLVG----DTLYGPAVDVWA 159
V TR Y APE+L G +D++A
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-21
Identities = 44/172 (25%), Positives = 70/172 (40%), Gaps = 23/172 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL---KHPNLVNLLEVFRRKKKLHLVFE 54
+ Y K+ I++ EK+ L +V+L + K L LV
Sbjct: 205 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264
Query: 55 FCDHTVLN--ELENH-----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 107
N +L+ H G P ++ G+ HR ++RD+KPENILL
Sbjct: 265 LM-----NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 108 TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+G +++ D G A + G+ V T Y APE++ + Y + D WA
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWA 370
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
S+ +P++ LL + + L+ + L + + H + + Q+ +G++
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYRAP 142
Y +HRD+ N+L+ VK+ DFG A+L+ E Y A +W A
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWM-AL 188
Query: 143 ELLVGDTLYGPAVDVWA 159
E ++ +Y DVW+
Sbjct: 189 ESIL-HRIYTHQSDVWS 204
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 7e-21
Identities = 31/153 (20%), Positives = 61/153 (39%), Gaps = 23/153 (15%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH----LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 84
L+H N++ + + LV ++ +H L + + + + + + ++
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTA 149
Query: 85 RGVSYCH--------RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA- 135
G+++ H + A HRD+K +NIL+ NG + D G A + + D
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 136 ----TRWYRAPELLVGDTL-----YGPAVDVWA 159
T+ Y APE+L D++A
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 20/172 (11%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL---KHPNLVNLLEVFRRKKKLHLVFE 54
K Y K+ +++ EK+ L +V+L F K L LV
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265
Query: 55 FCD------HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
+ H + ++ G T Q++ G+ + H+ I+RD+KPEN+LL
Sbjct: 266 IMNGGDIRYH--IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD 323
Query: 109 ANGVVKLCDFGFARLINPGENYTD-YVATRWYRAPELLVGDTLYGPAVDVWA 159
+G V++ D G A + G+ T Y T + APELL+G+ Y +VD +A
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFA 374
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 29/152 (19%)
Query: 35 NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGVSYCHRH 93
N+V F + L+FE ++ + N+ +G + IK ++L+ ++Y +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 94 ACIHRDIKPENILLTANGV-------------------------VKLCDFGFARLINPGE 128
+ H D+KPENILL +KL DFG A + +
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--D 214
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ + TR YRAPE+++ + + D+W+
Sbjct: 215 YHGSIINTRQYRAPEVILN-LGWDVSSDMWSF 245
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 22/172 (12%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKR---SLKHPNLVNLLEVFRRKKKLHLVFE 54
K Y K+ + E N KE + L+HP LVNL F+ ++ + +V +
Sbjct: 36 KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95
Query: 55 FCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA 109
+L H + +K +++ + Y IHRD+KP+NILL
Sbjct: 96 LL-----LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE 150
Query: 110 NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV--GDTLYGPAVDVWA 159
+G V + DF A ++ T T+ Y APE+ Y AVD W+
Sbjct: 151 HGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 9/137 (6%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRG 86
+ +KHPNLV LL V R+ +++ EF + L + E + + ++ + Q+
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT----DYVATRWYRAP 142
+ Y + IHR++ N L+ N +VK+ DFG +RL+ G+ YT +W AP
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT-AP 388
Query: 143 ELLVGDTLYGPAVDVWA 159
E L + DVWA
Sbjct: 389 ESLA-YNKFSIKSDVWA 404
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-20
Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 8/136 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
SL H ++V LL + L LV ++ L + + H L L+ Q+ +G+
Sbjct: 70 GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPE 143
Y H +HR++ N+LL + V++ DFG A L+ P + Y +W A E
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALE 187
Query: 144 LLVGDTLYGPAVDVWA 159
+ Y DVW+
Sbjct: 188 SIH-FGKYTHQSDVWS 202
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-20
Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
S+ +P++ LL + + L+ + L + + H + + Q+ +G++
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYRAP 142
Y +HRD+ N+L+ VK+ DFG A+L+ E Y A +W A
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWM-AL 188
Query: 143 ELLVGDTLYGPAVDVWA 159
E ++ +Y DVW+
Sbjct: 189 ESIL-HRIYTHQSDVWS 204
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-20
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 26/151 (17%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-------------------LENHPHGLP 72
H N+VNLL ++ E+C + L ++
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTD 132
DL+ ++QV +G+++ CIHRD+ NILLT + K+CDFG AR I NY
Sbjct: 145 EDLL-SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 133 YVAT----RWYRAPELLVGDTLYGPAVDVWA 159
+W APE + + +Y DVW+
Sbjct: 204 KGNARLPVKWM-APESIF-NCVYTFESDVWS 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 43/170 (25%), Positives = 70/170 (41%), Gaps = 19/170 (11%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL----KHPNLVNLLEVFRRKKKLHLVF 53
+K Y K+ + Q + EKR L K P L L F+ +L+ V
Sbjct: 362 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421
Query: 54 EFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 110
E+ + +L H ++ G+ + I+RD+K +N++L +
Sbjct: 422 EYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 111 GVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
G +K+ DFG + I G + T Y APE++ YG +VD WA
Sbjct: 479 GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWA 527
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 44/147 (29%), Positives = 64/147 (43%), Gaps = 22/147 (14%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGL--------------PWDLI 76
+H N+VNLL + ++ E+C + L L L DL+
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 77 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT 136
+ QV +G+++ CIHRD+ N+LLT V K+ DFG AR I NY
Sbjct: 168 -HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 137 ----RWYRAPELLVGDTLYGPAVDVWA 159
+W APE + D +Y DVW+
Sbjct: 227 RLPVKWM-APESIF-DCVYTVQSDVWS 251
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 39/140 (27%), Positives = 60/140 (42%), Gaps = 12/140 (8%)
Query: 29 RSLKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPW-DLIKQITWQVLR 85
R L HPN++ L+ + + H++ + H L + + + DLI QV R
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-SFGLQVAR 135
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWY 139
G+ Y +HRD+ N +L + VK+ DFG AR I E Y+ +W
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 140 RAPELLVGDTLYGPAVDVWA 159
A E L + DVW+
Sbjct: 196 -ALESLQ-TYRFTTKSDVWS 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKR---SLKHPNLVNLLEVFRRKKKLHLVFE 54
K+ ++Y K+ + + + + EKR ++ P LV L F+ L++V E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 55 FCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA 109
+ E+ +H + Q++ Y H I+RD+KPEN+L+
Sbjct: 122 YV-----AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 176
Query: 110 NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
G +++ DFGFA+ + G +T T APE+++ Y AVD WA
Sbjct: 177 QGYIQVTDFGFAKRV-KGRTWT-LCGTPEALAPEIILSKG-YNKAVDWWA 223
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 11/157 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRG 86
+ L+H LV L V ++ +++V E+ L + L + + Q+ G
Sbjct: 317 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT---DYVATRWYRAPE 143
++Y R +HRD++ NIL+ N V K+ DFG ARLI E +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE 434
Query: 144 LLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
+ + DVW+ + + ++ + G+ N
Sbjct: 435 AAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 9/136 (6%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHGLPWDLIKQITWQVLRGV 87
+KHPNLV LL V R+ +++ EF + L + E + + ++ + Q+ +
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPE 143
Y + IHRD+ N L+ N +VK+ DFG +RL+ G+ YT + +W APE
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT-APE 182
Query: 144 LLVGDTLYGPAVDVWA 159
L + DVWA
Sbjct: 183 SLA-YNKFSIKSDVWA 197
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-19
Identities = 40/134 (29%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSY 89
L HP LV L V + + LV EF +H L++ L + + + V G++Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPELL 145
IHRD+ N L+ N V+K+ DFG R + + YT T +W +PE+
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWA-SPEVF 177
Query: 146 VGDTLYGPAVDVWA 159
+ Y DVW+
Sbjct: 178 S-FSRYSSKSDVWS 190
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 23/172 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKR----SLKHPNLVNLLEVFRRKKKLHLVF 53
KK + ++ K+ + + EKR + +HP L ++ F+ K+ L V
Sbjct: 38 FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97
Query: 54 EFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
E+ N +L H +++ G+ + H ++RD+K +NILL
Sbjct: 98 EYL-----NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 109 ANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+G +K+ DFG + + + T Y APE+L+G Y +VD W+
Sbjct: 153 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWS 203
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 43/170 (25%), Positives = 70/170 (41%), Gaps = 19/170 (11%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL----KHPNLVNLLEVFRRKKKLHLVF 53
+K Y K+ + Q + EKR L K P L L F+ +L+ V
Sbjct: 41 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100
Query: 54 EFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 110
E+ + +L H ++ G+ + I+RD+K +N++L +
Sbjct: 101 EYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157
Query: 111 GVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
G +K+ DFG + I G + T Y APE++ YG +VD WA
Sbjct: 158 GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWA 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 40/180 (22%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL---KHPNLVNLLEVFRRKKKLHLVFE 54
+K YY KE I E + E R L +HP L L F+ +L V E
Sbjct: 26 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85
Query: 55 FCDHTVLNELENHPHGLPWDLIKQITWQ--------------VLRGVSYCHRHACIHRDI 100
+ G +L ++ + ++ + Y H ++RDI
Sbjct: 86 YA-----------NGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 101 KPENILLTANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
K EN++L +G +K+ DFG + I+ G + T Y APE+L YG AVD W
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWG 190
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-19
Identities = 37/139 (26%), Positives = 61/139 (43%), Gaps = 16/139 (11%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSY 89
HPN++ L V R + +V E+ ++ L+ L H + + V G+ Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYRAPE 143
+HRD+ N+L+ +N V K+ DFG +R++ + Y T RW APE
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWT-APE 224
Query: 144 LLVGDTLYG---PAVDVWA 159
+ + A DVW+
Sbjct: 225 AI----AFRTFSSASDVWS 239
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-19
Identities = 37/138 (26%), Positives = 58/138 (42%), Gaps = 10/138 (7%)
Query: 30 SLKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
HPN+++LL + R + +V + H L + N H + QV +G+
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYRA 141
Y +HRD+ N +L VK+ DFG AR + E Y+ + T +W A
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-A 200
Query: 142 PELLVGDTLYGPAVDVWA 159
E L + DVW+
Sbjct: 201 LESLQ-TQKFTTKSDVWS 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 11/157 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRG 86
+ L+H LV L V ++ +++V E+ L + L + + Q+ G
Sbjct: 234 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT---DYVATRWYRAPE 143
++Y R +HRD++ NIL+ N V K+ DFG ARLI E +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE 351
Query: 144 LLVGDTLYGPAVDVWA---IEWTSHSYSQIGFIGLGN 177
+ + DVW+ + + ++ + G+ N
Sbjct: 352 AAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 33/136 (24%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSY 89
H N++ L V + K + ++ E+ ++ L++ L + + + G+ Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYRAPE 143
+HRD+ NIL+ +N V K+ DFG +R++ + Y + RW APE
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWT-APE 220
Query: 144 LLVGDTLYGPAVDVWA 159
+ + A DVW+
Sbjct: 221 AIS-YRKFTSASDVWS 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-19
Identities = 39/141 (27%), Positives = 54/141 (38%), Gaps = 19/141 (13%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
SL H NL+ L V + +V E L + L H + + QV G+
Sbjct: 77 SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RWYRA 141
Y IHRD+ N+LL +VK+ DFG R + +++ YV W A
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC-A 192
Query: 142 PELLVGDTLYG---PAVDVWA 159
PE L A D W
Sbjct: 193 PESL----KTRTFSHASDTWM 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-18
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSY 89
L HP LV V ++ +++V E+ + L L +H GL + ++ + V G+++
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPELL 145
H IHRD+ N L+ + VK+ DFG R + + Y V T +W APE+
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWS-APEVF 177
Query: 146 VGDTLYGPAVDVWA 159
Y DVWA
Sbjct: 178 H-YFKYSSKSDVWA 190
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 10/136 (7%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSY 89
HPN++ L V + K + +V E+ ++ L+ L H + + + G+ Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYRAPE 143
+HRD+ NIL+ +N V K+ DFG R++ + Y RW +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWT-SPE 220
Query: 144 LLVGDTLYGPAVDVWA 159
+ + A DVW+
Sbjct: 221 AIA-YRKFTSASDVWS 235
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 52/172 (30%), Positives = 71/172 (41%), Gaps = 23/172 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL----KHPNLVNLLEVFRRKKKLHLVF 53
K+ Y K+ I Q + EKR L HP L L F+ +L V
Sbjct: 44 VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103
Query: 54 EFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
EF N +L H + +++ + + H I+RD+K +N+LL
Sbjct: 104 EFV-----NGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 109 ANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
G KL DFG + I G + T Y APE+L LYGPAVD WA
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWA 209
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 24/149 (16%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDH------------TVLNELENHPHGLPW-----D 74
KH N++NLL + L+++ E+ L N H D
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR I+ + Y
Sbjct: 193 LV-SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 135 AT----RWYRAPELLVGDTLYGPAVDVWA 159
+W APE L D +Y DVW+
Sbjct: 252 NGRLPVKWM-APEALF-DRIYTHQSDVWS 278
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 24/149 (16%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDH--------------TVLNELENHPHGLP---WD 74
KH N++NLL + L+++ E+ + N D
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ T+Q+ RG+ Y CIHRD+ N+L+T N V+K+ DFG AR IN + Y
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 135 AT----RWYRAPELLVGDTLYGPAVDVWA 159
+W APE L D +Y DVW+
Sbjct: 218 NGRLPVKWM-APEALF-DRVYTHQSDVWS 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 18/147 (12%)
Query: 29 RSLKHPNLVNLLEV------FRRKKKLHLVFEFCDHTVLNE------LENHPHGLPWDLI 76
+ HP++ L+ V R ++ F H L+ + +P LP +
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 77 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT 136
+ + G+ Y IHRD+ N +L + V + DFG +R I G+ Y A+
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 137 ----RWYRAPELLVGDTLYGPAVDVWA 159
+W A E L D LY DVWA
Sbjct: 200 KLPVKWL-ALESLA-DNLYTVHSDVWA 224
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 31/156 (19%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDH------------------------TVLNELENH 67
H N+VNLL ++L+FE+C + L E E+
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 68 PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG 127
DL+ +QV +G+ + +C+HRD+ N+L+T VVK+CDFG AR I
Sbjct: 167 NVLTFEDLL-CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 128 ENYTDYVAT----RWYRAPELLVGDTLYGPAVDVWA 159
NY +W APE L + +Y DVW+
Sbjct: 226 SNYVVRGNARLPVKWM-APESLF-EGIYTIKSDVWS 259
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 6/134 (4%)
Query: 29 RSLKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLR 85
L+H NLV LL V K L++V E+ L + L D + + + V
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
+ Y + +HRD+ N+L++ + V K+ DFG + + ++ + +W APE L
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVKWT-APEAL 358
Query: 146 VGDTLYGPAVDVWA 159
+ + DVW+
Sbjct: 359 R-EKKFSTKSDVWS 371
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 32/140 (22%), Positives = 54/140 (38%), Gaps = 24/140 (17%)
Query: 31 LKHPNLVNLLEVFRR-----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLR 85
++H N+ + R + + LV E+ + L + H W ++ V R
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTR 122
Query: 86 GVSYCH---------RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY--- 133
G++Y H + A HRD+ N+L+ +G + DFG + +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 134 ------VATRWYRAPELLVG 147
V T Y APE+L G
Sbjct: 183 NAAISEVGTIRYMAPEVLEG 202
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSY 89
L H LV L V +++ + ++ E+ + L L H + ++ V + Y
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPELL 145
+HRD+ N L+ GVVK+ DFG +R + + YT V + RW PE+L
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWS-PPEVL 193
Query: 146 VGDTLYGPAVDVWA 159
+ + + D+WA
Sbjct: 194 M-YSKFSSKSDIWA 206
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 24/149 (16%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDH--------------TVLNELENHPHGLP---WD 74
KH N++NLL + L+++ E+ + N D
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ T+Q+ RG+ Y CIHRD+ N+L+T N V+K+ DFG AR IN + Y
Sbjct: 205 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 135 AT----RWYRAPELLVGDTLYGPAVDVWA 159
+W APE L D +Y DVW+
Sbjct: 264 NGRLPVKWM-APEALF-DRVYTHQSDVWS 290
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL----KHPNLVNLLEVFRRKKKLHLVF 53
KK Y KE + + + EK HP LV L F+ + +L V
Sbjct: 30 LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89
Query: 54 EFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
E+ N +L H LP + + + ++ ++Y H I+RD+K +N+LL
Sbjct: 90 EYV-----NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 144
Query: 109 ANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ G +KL D+G + + PG+ + + T Y APE+L G YG +VD WA
Sbjct: 145 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWA 195
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 35/139 (25%), Positives = 58/139 (41%), Gaps = 10/139 (7%)
Query: 29 RSLKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRG 86
+ HPN+++LL + R + +V + H L + N H + QV +G
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 204
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT------RWYR 140
+ + +HRD+ N +L VK+ DFG AR + E + + T +W
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM- 263
Query: 141 APELLVGDTLYGPAVDVWA 159
A E L + DVW+
Sbjct: 264 ALESLQ-TQKFTTKSDVWS 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 19/141 (13%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
L +P +V L+ V + + L LV E L++ L +P + ++ QV G+
Sbjct: 66 QLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RWYRA 141
Y +HRD+ N+LL K+ DFG ++ + ++Y Y A +WY A
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWY-A 181
Query: 142 PELLVGDTLYG---PAVDVWA 159
PE + + DVW+
Sbjct: 182 PECI----NFRKFSSRSDVWS 198
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-18
Identities = 44/150 (29%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 32 KHPNLVNLLEV-FRRKKKLHLVFEFCDH--------------TVLNELENHPHGLPW--- 73
H N+VNLL + L ++ EFC +
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY 133
LI ++QV +G+ + CIHRD+ NILL+ VVK+CDFG AR I +Y
Sbjct: 149 HLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 134 VAT----RWYRAPELLVGDTLYGPAVDVWA 159
+W APE + D +Y DVW+
Sbjct: 208 GDARLPLKWM-APETIF-DRVYTIQSDVWS 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-18
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 29/163 (17%)
Query: 13 KEAIRQATEATNKKEKRSL---KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH 67
K ++ K E+ L HP +V L F+ + KL+L+ +F +L
Sbjct: 62 KATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL-----RGGDLFTR 116
Query: 68 PHGLPWDLIKQITW----------QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCD 117
L K++ + ++ + + H I+RD+KPENILL G +KL D
Sbjct: 117 -------LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTD 169
Query: 118 FGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
FG ++ I+ + + T Y APE++ + + D W+
Sbjct: 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWS 211
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL----KHPNLVNLLEVFRRKKKLHLVF 53
KK Y KE + + + EK HP LV L F+ + +L V
Sbjct: 73 LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132
Query: 54 EFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
E+ N +L H LP + + + ++ ++Y H I+RD+K +N+LL
Sbjct: 133 EYV-----NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 187
Query: 109 ANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ G +KL D+G + + PG+ + + T Y APE+L G YG +VD WA
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWA 238
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 19/147 (12%)
Query: 29 RSLKHPNLVNLLEV-----FRRKKKLHLVFEFCDHTVLNE------LENHPHGLPW-DLI 76
+ HPN++ LL V + K ++ F + L+ LE P +P L+
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 77 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT 136
+ + G+ Y +HRD+ N +L + V + DFG ++ I G+ Y
Sbjct: 151 -KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 137 ----RWYRAPELLVGDTLYGPAVDVWA 159
+W A E L D +Y DVWA
Sbjct: 210 KMPVKWI-AIESLA-DRVYTSKSDVWA 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-18
Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 33/175 (18%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKR---SLKHPNLVNLLEVFRRKKKLHLVFE 54
+ YY KE + + + + E+ + HP ++ + F+ +++ ++ +
Sbjct: 27 SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86
Query: 55 FCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA 109
+ EL + P + K +V + Y H I+RD+KPENILL
Sbjct: 87 YI-----EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 141
Query: 110 NGVVKLCDFGFARLINPGENYT-----DYVATRWYRAPELLVGDTLYGPAVDVWA 159
NG +K+ DFGFA+ P YT DY+ APE++ Y ++D W+
Sbjct: 142 NGHIKITDFGFAK-YVPDVTYTLCGTPDYI------APEVVSTKP-YNKSIDWWS 188
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-18
Identities = 35/143 (24%), Positives = 61/143 (42%), Gaps = 16/143 (11%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE--------LENHPHGLPWDLIK--QIT 80
++V LL V + + ++ E L + N+P P L K Q+
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT---- 136
++ G++Y + + +HRD+ N ++ + VK+ DFG R I + Y
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 137 RWYRAPELLVGDTLYGPAVDVWA 159
RW +PE L D ++ DVW+
Sbjct: 205 RWM-SPESLK-DGVFTTYSDVWS 225
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-18
Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 20/141 (14%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
L +P +V ++ + + LV E + LN+ L+ + H ++I ++ QV G+
Sbjct: 74 QLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMK 131
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RWYRA 141
Y +HRD+ N+LL K+ DFG ++ + ENY Y A +WY A
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWY-A 188
Query: 142 PELLVGDTLYG---PAVDVWA 159
PE + Y DVW+
Sbjct: 189 PECI----NYYKFSSKSDVWS 205
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 49/172 (28%), Positives = 72/172 (41%), Gaps = 23/172 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL----KHPNLVNLLEVFRRKKKLHLVF 53
K + +Y K+AI + E + E+ L KHP LV L F+ KL+ V
Sbjct: 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 54 EFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 108
++ N EL H + ++ + Y H ++RD+KPENILL
Sbjct: 119 DYI-----NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173
Query: 109 ANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ G + L DFG + I + + T Y APE+L Y VD W
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWC 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 36/136 (26%), Positives = 59/136 (43%), Gaps = 14/136 (10%)
Query: 31 LKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGV 87
L+H NLV LL V K L++V E+ L + L D + + + V +
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPE 143
Y + +HRD+ N+L++ + V K+ DFG + E + +W APE
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWT-APE 184
Query: 144 LLVGDTLYGPAVDVWA 159
L + + DVW+
Sbjct: 185 ALR-EKKFSTKSDVWS 199
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 36/158 (22%), Positives = 62/158 (39%), Gaps = 32/158 (20%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDH----------------------TVLNELENHP 68
+ HP+++ L + L L+ E+ + + + +HP
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 69 HGLP---WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN 125
DLI WQ+ +G+ Y +HRD+ NIL+ +K+ DFG +R +
Sbjct: 143 DERALTMGDLI-SFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 126 PGENYTDYVAT----RWYRAPELLVGDTLYGPAVDVWA 159
++Y +W A E L D +Y DVW+
Sbjct: 202 EEDSYVKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWS 237
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
HP++V L+ V + + ++ E C L L+ + L + +Q+ ++
Sbjct: 72 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT---RWYRAPELL 145
Y +HRDI N+L+++N VKL DFG +R + Y +W APE +
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI 189
Query: 146 VGDTLYGPAVDVWA 159
+ A DVW
Sbjct: 190 N-FRRFTSASDVWM 202
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 10/136 (7%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGV 87
+L+H LV L V K+ ++++ EF L + + P + + Q+ G+
Sbjct: 239 TLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT----RWYRAPE 143
++ + IHRD++ NIL++A+ V K+ DFG AR+I YT +W APE
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT-APE 355
Query: 144 LLVGDTLYGPAVDVWA 159
+ + DVW+
Sbjct: 356 AIN-FGSFTIKSDVWS 370
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 19/142 (13%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
L +P +V L+ V + + L LV E L++ L +P + ++ QV G+
Sbjct: 391 HQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RWYR 140
Y +HR++ N+LL K+ DFG ++ + ++Y Y A +WY
Sbjct: 450 KYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWY- 506
Query: 141 APELLVGDTLYG---PAVDVWA 159
APE + + DVW+
Sbjct: 507 APECI----NFRKFSSRSDVWS 524
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 50/172 (29%), Positives = 73/172 (42%), Gaps = 23/172 (13%)
Query: 5 KKKKSSYY------KEAIRQATEATN-KKEKRSL---KHPNLVNLLEVFRRKKKLHLVFE 54
+K YY KE I E + E R L +HP L L F+ +L V E
Sbjct: 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228
Query: 55 FCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLT 108
+ N EL H D + +++ + Y H ++RD+K EN++L
Sbjct: 229 YA-----NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD 283
Query: 109 ANGVVKLCDFGFARL-INPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+G +K+ DFG + I G + T Y APE+L + YG AVD W
Sbjct: 284 KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWG 334
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 35/134 (26%), Positives = 58/134 (43%), Gaps = 7/134 (5%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
HP++V L+ V + + ++ E C L L+ L + +Q+ ++
Sbjct: 447 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA---TRWYRAPELL 145
Y +HRDI N+L+++N VKL DFG +R + Y +W APE +
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI 564
Query: 146 VGDTLYGPAVDVWA 159
+ A DVW
Sbjct: 565 N-FRRFTSASDVWM 577
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-17
Identities = 37/129 (28%), Positives = 53/129 (41%), Gaps = 26/129 (20%)
Query: 31 LKHPNLVNLL----EVFRRKKKLHLVFEFCDHTVLNE-LENHPHG------LPWDLIKQI 79
+H NLV LL + LV+ + + N L + L W + +I
Sbjct: 87 CQHENLVELLGFSSD---GDDLC-LVYVY----MPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW- 138
G+++ H + IHRDIK NILL K+ DFG AR + T + +R
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA-SEKFAQT-VMTSRIV 196
Query: 139 ----YRAPE 143
Y APE
Sbjct: 197 GTTAYMAPE 205
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 33/168 (19%)
Query: 13 KEAIRQATEATN--KKEKRSL----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--EL 64
K I Q + T + E++ L + P LV L F+ + KLHL+ ++ N EL
Sbjct: 92 KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI-----NGGEL 146
Query: 65 ENHPHGLPWDLIKQITW----------QVLRGVSYCHRHACIHRDIKPENILLTANGVVK 114
H L ++ + +++ + + H+ I+RDIK ENILL +NG V
Sbjct: 147 FTH-------LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199
Query: 115 LCDFGFARLINPGENYTDY--VATRWYRAPELLVGDTL-YGPAVDVWA 159
L DFG ++ E Y T Y AP+++ G + AVD W+
Sbjct: 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 17/125 (13%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-------LPWDLIKQITWQV 83
+HP+LV+L+ + ++ L++++ ++ L+ H +G + W+ +I
Sbjct: 92 CRHPHLVSLIGFCDERNEMILIYKYMEN---GNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRW----- 138
RG+ Y H A IHRD+K NILL N V K+ DFG ++ + T +++T
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK-GTELDQT-HLSTVVKGTLG 206
Query: 139 YRAPE 143
Y PE
Sbjct: 207 YIDPE 211
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 24/150 (16%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW--------------- 73
L+H ++V V L +VFE+ H LN+ + P +
Sbjct: 74 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY 133
++ I Q+ G+ Y +HRD+ N L+ AN +VK+ DFG +R + + Y
Sbjct: 134 QML-HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 134 VAT----RWYRAPELLVGDTLYGPAVDVWA 159
T RW PE ++ + DVW+
Sbjct: 193 GHTMLPIRWM-PPESIM-YRKFTTESDVWS 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-17
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 29/151 (19%)
Query: 25 KKEKRSL---KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENHPHGLPWDLIKQI 79
K E+ L KHP +V+L+ F+ KL+L+ E+ + EL L ++
Sbjct: 69 KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL-----SGGELFMQ-------LEREG 116
Query: 80 TW----------QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL-INPGE 128
+ ++ + + H+ I+RD+KPENI+L G VKL DFG + I+ G
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ T Y APE+L+ + + AVD W+
Sbjct: 177 VTHTFCGTIEYMAPEILMR-SGHNRAVDWWS 206
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 39/149 (26%), Positives = 59/149 (39%), Gaps = 23/149 (15%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW--------------D 74
L+H ++V V + L +VFE+ H LN + P
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ + QV G+ Y +HRD+ N L+ VVK+ DFG +R I + Y
Sbjct: 160 LL-AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 135 AT----RWYRAPELLVGDTLYGPAVDVWA 159
T RW PE ++ + DVW+
Sbjct: 219 RTMLPIRWM-PPESIL-YRKFTTESDVWS 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-17
Identities = 29/138 (21%), Positives = 53/138 (38%), Gaps = 12/138 (8%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSY 89
L H +LV V + LV EF L+ L+ + + + ++ Q+ + +
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 90 CHRHACIHRDIKPENILLTA--------NGVVKLCDFGFARLINPGENYTDYVATRWYRA 141
+ IH ++ +NILL +KL D G + + P + + + W
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWV-P 185
Query: 142 PELLVGDTLYGPAVDVWA 159
PE + A D W+
Sbjct: 186 PECIENPKNLNLATDKWS 203
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 34/143 (23%), Positives = 52/143 (36%), Gaps = 16/143 (11%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-------LENHPHGLPWDLIKQITWQV 83
H N+V + V + ++ E L + P L + + +
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLINPGENYT----DYVAT 136
G Y + IHRDI N LLT G V K+ DFG AR I Y +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 137 RWYRAPELLVGDTLYGPAVDVWA 159
+W PE + + ++ D W+
Sbjct: 210 KWM-PPEAFM-EGIFTSKTDTWS 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 8/135 (5%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGV 87
L+H LV L V ++ ++++ E+ ++ L + L + + + Q+ G+
Sbjct: 64 QLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA---TRWYRAPEL 144
++ IHRD++ NIL++ K+ DFG ARLI E A +W APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-APEA 181
Query: 145 LVGDTLYGPAVDVWA 159
+ + DVW+
Sbjct: 182 IN-YGTFTIKSDVWS 195
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 34/143 (23%), Positives = 52/143 (36%), Gaps = 16/143 (11%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-------LENHPHGLPWDLIKQITWQV 83
H N+V + V + ++ E L + P L + + +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLINPGENYT----DYVAT 136
G Y + IHRDI N LLT G V K+ DFG AR I Y +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 137 RWYRAPELLVGDTLYGPAVDVWA 159
+W PE + + ++ D W+
Sbjct: 251 KWM-PPEAFM-EGIFTSKTDTWS 271
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 44/158 (27%), Positives = 62/158 (39%), Gaps = 32/158 (20%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHGLPW--------------- 73
+PN+V LL V K + L+FE+ + LNE PH +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 74 --------DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN 125
+ + I QV G++Y +HRD+ N L+ N VVK+ DFG +R I
Sbjct: 167 GPPPLSCAEQL-CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 126 PGENYTDYVAT----RWYRAPELLVGDTLYGPAVDVWA 159
+ Y RW PE + Y DVWA
Sbjct: 226 SADYYKADGNDAIPIRWM-PPESIF-YNRYTTESDVWA 261
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 19/132 (14%), Positives = 34/132 (25%), Gaps = 31/132 (23%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
+ P + +L+V + +V E+ L E + P P I + +
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP--SPVGAI-RAMQSLAAAAD 143
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
HR P + ++ +G V L
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA----- 179
Query: 149 TLYGPAVDVWAI 160
P D+ I
Sbjct: 180 ---NPQDDIRGI 188
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 33/125 (26%), Positives = 52/125 (41%), Gaps = 15/125 (12%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-------LPWDLIKQITWQV 83
H NL+ L + LV+ + + + + L W ++I
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMAN---GSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 84 LRGVSYCHRHAC---IHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRW 138
RG++Y H H IHRD+K NILL + DFG A+L++ + + T T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 139 YRAPE 143
+ APE
Sbjct: 201 HIAPE 205
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-16
Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 15/138 (10%)
Query: 30 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVS 88
+L HP++V L+ + ++ ++ E + L LE + + L + + Q+ + ++
Sbjct: 69 NLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVAT-------RWYRA 141
Y C+HRDI NIL+ + VKL DFG +R I DY +W +
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED----EDYYKASVTRLPIKWM-S 182
Query: 142 PELLVGDTLYGPAVDVWA 159
PE + + A DVW
Sbjct: 183 PESIN-FRRFTTASDVWM 199
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 41/152 (26%), Positives = 59/152 (38%), Gaps = 33/152 (21%)
Query: 32 KHPNLVNLLEVFRRKKKLHLVFEFCDH------------TVLNELENHPHGL-----PWD 74
HPN++NLL + L+L E+ H + +
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 75 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV 134
L+ V RG+ Y + IHRD+ NIL+ N V K+ DFG +R G+ YV
Sbjct: 144 LL-HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEV--YV 196
Query: 135 AT-------RWYRAPELLVGDTLYGPAVDVWA 159
RW A E L ++Y DVW+
Sbjct: 197 KKTMGRLPVRWM-AIESLN-YSVYTTNSDVWS 226
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-16
Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 24/150 (16%)
Query: 31 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW--------------- 73
L+HPN+V LL V + + L ++F +C H L+E PH
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 74 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY 133
D + + Q+ G+ Y H +H+D+ N+L+ VK+ D G R + + Y
Sbjct: 129 DFV-HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 134 VAT----RWYRAPELLVGDTLYGPAVDVWA 159
+ RW APE ++ + D+W+
Sbjct: 188 GNSLLPIRWM-APEAIM-YGKFSIDSDIWS 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 54/212 (25%), Positives = 79/212 (37%), Gaps = 61/212 (28%)
Query: 7 KKSSYYKEAIRQATEATNKKEKRSLKHPN---LVNLLEVF--RRKKKLH--LVFEFCDHT 59
K + +Y E PN +V LL+ F H +VFE H
Sbjct: 71 KSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHH 130
Query: 60 VLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHA-CIHRDIKPENILLTAN------- 110
+L + ++ GLP +K+I QVL+G+ Y H IH DIKPENILL+ N
Sbjct: 131 LLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190
Query: 111 ------------------------------------------GVVKLCDFGFARLINPGE 128
VK+ D G A +
Sbjct: 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHK 248
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
++T+ + TR YR+ E+L+G Y D+W+
Sbjct: 249 HFTEDIQTRQYRSLEVLIGSG-YNTPADIWST 279
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 35/92 (38%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 72 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT 131
LI ++QV +G+ + CIHRD+ NILL+ VVK+CDFG AR I +Y
Sbjct: 192 LEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 132 DYVATR----WYRAPELLVGDTLYGPAVDVWA 159
R W APE + D +Y DVW+
Sbjct: 251 RKGDARLPLKWM-APETIF-DRVYTIQSDVWS 280
|
| >2gf2_A Hibadh, 3-hydroxyisobutyrate dehydrogenase; structural genomics, structural genomics consortium, SGC, oxidoreductase; 2.38A {Homo sapiens} PDB: 2i9p_A* Length = 296 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 14/27 (51%), Positives = 21/27 (77%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
+GFIGLGNMG+ MA+NL+K+ + +
Sbjct: 2 PVGFIGLGNMGNPMAKNLMKHGYPLII 28
|
| >3qha_A Putative oxidoreductase; seattle structural genomics center for infectious disease, S mycobacterium avium 104, rossmann fold; 2.25A {Mycobacterium avium} Length = 296 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 14/27 (51%), Positives = 20/27 (74%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
++G+IGLGNMG+ MA + + G VTV
Sbjct: 17 KLGYIGLGNMGAPMATRMTEWPGGVTV 43
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 1e-09
Identities = 25/131 (19%), Positives = 40/131 (30%), Gaps = 18/131 (13%)
Query: 38 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACI 96
N F + +L +V EF + E + K I Q+ ++
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLE-QMRTKLSSLATAKSILHQLTASLAVAEASLRFE 184
Query: 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATR-----------WYR 140
HRD+ N+LL + KL + + DY +R
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 141 APELLVGDTLY 151
+L GD Y
Sbjct: 245 DEDLFTGDGDY 255
|
| >3cky_A 2-hydroxymethyl glutarate dehydrogenase; rossmann fold, two domain enzyme, oxidoreductase; 2.30A {Eubacterium barkeri} Length = 301 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 16/27 (59%), Positives = 17/27 (62%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
+IGFIGLG MG MA NLLK V
Sbjct: 6 KIGFIGLGAMGKPMAINLLKEGVTVYA 32
|
| >1i36_A Conserved hypothetical protein MTH1747; NADP binding domain, protein NADP complex, structural genomics, PSI; HET: NAP; 2.00A {Methanothermobacterthermautotrophicus} SCOP: a.100.1.8 c.2.1.6 Length = 264 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 10/33 (30%), Positives = 15/33 (45%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDS 201
++GFIG G + +A L V L+ S
Sbjct: 2 RVGFIGFGEVAQTLASRLRSRGVEVVTSLEGRS 34
|
| >3l6d_A Putative oxidoreductase; structural genomics, protein structure initiative, oxidoredu PSI-2; HET: MSE; 1.90A {Pseudomonas putida} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 13/33 (39%), Positives = 17/33 (51%)
Query: 163 TSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTV 195
+ IGLG MG+ MA+ LLK RV +
Sbjct: 5 DESFEFDVSVIGLGAMGTIMAQVLLKQGKRVAI 37
|
| >3pdu_A 3-hydroxyisobutyrate dehydrogenase family protein; gamma-hydroxybutyrate dehydrogenase, succinic semialdehyde R glyoxylate metabolism; HET: NAP; 1.89A {Geobacter sulfurreducens} Length = 287 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 14/26 (53%), Positives = 17/26 (65%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
GF+GLG MG MA NL++ VTV
Sbjct: 4 YGFLGLGIMGGPMAANLVRAGFDVTV 29
|
| >3pef_A 6-phosphogluconate dehydrogenase, NAD-binding; gamma-hydroxybutyrate dehydrogenase, succinic semialdehyde R geobacter metallireducens; HET: NAP; 2.07A {Geobacter metallireducens} Length = 287 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 16/26 (61%), Positives = 19/26 (73%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
GFIGLG MGS MA+NL+K VT+
Sbjct: 4 FGFIGLGIMGSAMAKNLVKAGCSVTI 29
|
| >1vpd_A Tartronate semialdehyde reductase; structural genomics, MCSG, protein structure initiative, PSI, midwest center for structural genomics; HET: MSE TLA; 1.65A {Salmonella typhimurium} SCOP: a.100.1.1 c.2.1.6 Length = 299 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-08
Identities = 14/26 (53%), Positives = 18/26 (69%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
+GFIGLG MG M++NLLK + V
Sbjct: 8 VGFIGLGIMGKPMSKNLLKAGYSLVV 33
|
| >4ezb_A Uncharacterized conserved protein; structural genomics, protein structure initiative, NEW YORK structural genomix research consortium; 2.10A {Sinorhizobium meliloti} Length = 317 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 10/46 (21%), Positives = 15/46 (32%), Gaps = 12/46 (26%)
Query: 168 SQIGFIGLGNMGSHMARNLLKNNGR-VTVILKSDSLDSETWDLTWQ 212
+ I FIG G +A L N + +DL +
Sbjct: 25 TTIAFIGFGEAAQSIAGGLGGRNAARLAA-----------YDLRFN 59
|
| >3g0o_A 3-hydroxyisobutyrate dehydrogenase; NAD(P), valine catabolism, tartaric acid, target 11128H, NYSGXRC, PSI-2, structural genomics; HET: TLA; 1.80A {Salmonella typhimurium} Length = 303 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-08
Identities = 9/27 (33%), Positives = 14/27 (51%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
+G +GLG+MG AR+ L+
Sbjct: 9 HVGIVGLGSMGMGAARSCLRAGLSTWG 35
|
| >2cvz_A Dehydrogenase, 3-hydroxyisobutyrate dehydrogenase; valine catabolism, NADP+, structural GEN riken structural genomics/proteomics initiative; HET: NDP; 1.80A {Thermus thermophilus} SCOP: a.100.1.1 c.2.1.6 PDB: 1wp4_A* Length = 289 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 11/28 (39%), Positives = 15/28 (53%), Gaps = 1/28 (3%)
Query: 168 SQIGFIGLGNMGSHMARNLLKNNGRVTV 195
++ FIGLG MG MA +L + V
Sbjct: 2 EKVAFIGLGAMGYPMAGHLAR-RFPTLV 28
|
| >3qsg_A NAD-binding phosphogluconate dehydrogenase-like P; structural genomics, PSI-biology, midwest center for structu genomics; 1.90A {Alicyclobacillus acidocaldarius subsp} Length = 312 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 8/27 (29%), Positives = 12/27 (44%), Gaps = 1/27 (3%)
Query: 170 IGFIGLGNMGSHMARNLLKN-NGRVTV 195
+GFIG G S +A L + +
Sbjct: 27 LGFIGFGEAASAIASGLRQAGAIDMAA 53
|
| >2uyy_A N-PAC protein; long-chain dehydrogenase, cytokine; HET: NA7; 2.5A {Homo sapiens} Length = 316 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 16/26 (61%), Positives = 18/26 (69%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
IGF+GLG MGS + NLLK VTV
Sbjct: 33 IGFLGLGLMGSGIVSNLLKMGHTVTV 58
|
| >3doj_A AT3G25530, dehydrogenase-like protein; gamma-hydroxybutyrate dehydrogenase, 4-hydroxybutyrate dehydrogenase; 2.10A {Arabidopsis thaliana} Length = 310 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-08
Identities = 16/26 (61%), Positives = 20/26 (76%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
+GF+GLG MG M+ NLLKN +VTV
Sbjct: 24 VGFLGLGIMGKAMSMNLLKNGFKVTV 49
|
| >1yb4_A Tartronic semialdehyde reductase; structural genomics, oxidoreductase, salmonella typhimurium LT2, PSI, protein ST initiative; 2.40A {Salmonella typhimurium} Length = 295 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 7e-08
Identities = 14/26 (53%), Positives = 18/26 (69%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
+GFIGLG MGS MA NL + ++ V
Sbjct: 6 LGFIGLGIMGSPMAINLARAGHQLHV 31
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 6/76 (7%)
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILL--TANGVVKLCDFGFARLINPGENYTDYVA 135
Q+ ++L + Y H + +H DIK N+LL V L D+G + P N+ Y
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ- 213
Query: 136 TRWYRAPELLVGDTLY 151
+ G +
Sbjct: 214 ---ENPRKGHNGTIEF 226
|
| >4dll_A 2-hydroxy-3-oxopropionate reductase; structural genomics, PSI-biology, NEW YORK structural genomi research consortium, nysgrc, oxidoreductase; 2.11A {Polaromonas SP} Length = 320 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 11/26 (42%), Positives = 15/26 (57%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
I F+G G+MG MAR L + + V
Sbjct: 34 ITFLGTGSMGLPMARRLCEAGYALQV 59
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 16/50 (32%), Positives = 25/50 (50%), Gaps = 5/50 (10%)
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILL-----TANGVVKLCDFGFAR 122
I Q++ + Y H I+RD+KPEN L+ V+ + DF A+
Sbjct: 109 MIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 17/47 (36%), Positives = 25/47 (53%), Gaps = 2/47 (4%)
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILL--TANGVVKLCDFGFAR 122
Q++ ++L + Y H H +H DIK N+LL V L D+G A
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 12/47 (25%), Positives = 23/47 (48%), Gaps = 2/47 (4%)
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILL--TANGVVKLCDFGFAR 122
Q+ ++L + + H + +H ++ ENI + V L +GFA
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 14/50 (28%), Positives = 24/50 (48%), Gaps = 5/50 (10%)
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANG-----VVKLCDFGFAR 122
Q+L V H + ++RDIKP+N L+ ++ + DFG +
Sbjct: 110 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 18/49 (36%), Positives = 28/49 (57%), Gaps = 5/49 (10%)
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILL----TANGVVKLCDFGFAR 122
+ Q++ V + H + +HRDIKP+N L+ AN V + DFG A+
Sbjct: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAK 154
|
| >2vns_A Metalloreductase steap3; metal-binding, transmembrane, rossmann fold, transport, cell cycle, transferrin, flavoprotein, alternative splicing; HET: CIT; 2.0A {Homo sapiens} PDB: 2vq3_A* Length = 215 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 7/26 (26%), Positives = 14/26 (53%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
+G +G G+ +A L+ + +V V
Sbjct: 31 VGILGSGDFARSLATRLVGSGFKVVV 56
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 17/49 (34%), Positives = 26/49 (53%), Gaps = 5/49 (10%)
Query: 78 QITWQVLRGVSYCHRHACIHRDIKPENILL----TANGVVKLCDFGFAR 122
+ Q++ + Y H IHRD+KP+N L+ N V + DFG A+
Sbjct: 109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY-IIDFGLAK 156
|
| >3d1l_A Putative NADP oxidoreductase BF3122; structural genomics, PSI-2, protein structure initiative, M center for structural genomics, MCSG; 2.19A {Bacteroides fragilis} Length = 266 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-05
Identities = 8/27 (29%), Positives = 16/27 (59%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTVI 196
I IG GN+ +++A+ L + R+ +
Sbjct: 13 IVLIGAGNLATNLAKALYRKGFRIVQV 39
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 16/101 (15%), Positives = 30/101 (29%), Gaps = 10/101 (9%)
Query: 68 PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG 127
P+ +++ + L+ H D+ NI + V D G + +
Sbjct: 159 EEDTPFKDPREL-YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADK- 216
Query: 128 ENYTD----YVATRWYRAPELLVGDTL--YGPAVDVWAIEW 162
+ D + R E V G D I++
Sbjct: 217 --WYDIAFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKY 255
|
| >2i76_A Hypothetical protein; NADP, dehydrogenase, TM1727, structural genomics, PSI-2, protein structure initiative; HET: NDP; 3.00A {Thermotoga maritima} SCOP: a.100.1.10 c.2.1.6 Length = 276 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 5e-05
Identities = 6/27 (22%), Positives = 11/27 (40%), Gaps = 1/27 (3%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTVI 196
+ F+G G + LK+ + I
Sbjct: 5 LNFVGTGTLTRFFLE-CLKDRYEIGYI 30
|
| >4e21_A 6-phosphogluconate dehydrogenase (decarboxylating; structural genomics, PSI-biology, NEW YORK structural genomi research consortium; 2.30A {Geobacter metallireducens} Length = 358 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 14/27 (51%), Positives = 15/27 (55%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
QIG IGLG MG+ M R L K V
Sbjct: 24 QIGMIGLGRMGADMVRRLRKGGHECVV 50
|
| >3c24_A Putative oxidoreductase; YP_511008.1, structural genomics, center for structural genomics, JCSG, protein structure INI PSI-2; HET: MSE; 1.62A {Jannaschia SP} Length = 286 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 6/33 (18%), Positives = 14/33 (42%), Gaps = 1/33 (3%)
Query: 170 IGFIGL-GNMGSHMARNLLKNNGRVTVILKSDS 201
+ +G G MG+ + R + + + I +
Sbjct: 14 VAILGAGGKMGARITRKIHDSAHHLAAIEIAPE 46
|
| >2raf_A Putative dinucleotide-binding oxidoreductase; NP_786167.1, NADP oxidoreductase coenzyme F420-dependent, structural genomics; HET: MSE NAP; 1.60A {Lactobacillus plantarum WCFS1} Length = 209 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 2e-04
Identities = 10/31 (32%), Positives = 11/31 (35%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSD 200
I G GNMG + N VT D
Sbjct: 22 ITIFGKGNMGQAIGHNFEIAGHEVTYYGSKD 52
|
| >2yjz_A Metalloreductase steap4; oxidoreductase, metabolic syndrome; HET: NAP; 2.20A {Rattus norvegicus} Length = 201 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 3e-04
Identities = 5/26 (19%), Positives = 10/26 (38%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
+ G G+ G + +L+ V
Sbjct: 22 VCIFGTGDFGKSLGLKMLQCGYSVVF 47
|
| >2ahr_A Putative pyrroline carboxylate reductase; pyrroline reductase, proline biosynthesis, NAD(P protein, rossmann fold, doain swapping; HET: NAP; 2.15A {Streptococcus pyogenes} SCOP: a.100.1.10 c.2.1.6 PDB: 2amf_A Length = 259 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 4e-04
Identities = 8/26 (30%), Positives = 14/26 (53%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
IG IG+G M S + + L + + +
Sbjct: 6 IGIIGVGKMASAIIKGLKQTPHELII 31
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.52 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.81 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.77 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.56 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.23 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.12 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.46 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.31 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.08 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.33 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.58 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.01 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.83 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.11 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 86.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 85.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.72 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=349.46 Aligned_cols=216 Identities=20% Similarity=0.258 Sum_probs=188.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+.+|+++++.++|||||++++++++++.+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||
T Consensus 74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~I 153 (311)
T 4aw0_A 74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153 (311)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 34567889999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
+||||||+|||++.++.+||+|||+|....... ...+.+||+.|+|||++.+.+ |+.++||||+||++|||++|..
T Consensus 154 iHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999875432 345678999999999998766 8999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+.+..+....++......+ +..++++.|++.+||..+
T Consensus 233 PF~~~~~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~dli~~lL~~d 272 (311)
T 4aw0_A 233 PFRAGNEGLIFAKIIKLEYDFP----------------------------------------EKFFPKARDLVEKLLVLD 272 (311)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCC----------------------------------------TTCCHHHHHHHHHHSCSS
T ss_pred CCCCCCHHHHHHHHHcCCCCCC----------------------------------------cccCHHHHHHHHHHccCC
Confidence 9999888888777665432210 123467889999999977
Q ss_pred cceeecccccccccccc------ceeeeeecCC
Q psy763 253 FTYIQSEKQDSIRGKNC------KKTFYIPTPE 279 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~------l~~~~~~~~~ 279 (303)
|..| +++.++ ++||||.+.+
T Consensus 273 p~~R-------~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 273 ATKR-------LGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp GGGS-------TTSGGGTCHHHHHTSGGGTTCC
T ss_pred HhHC-------cChHHHcCCHHHHCCCCcCCCC
Confidence 7666 888885 7899998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=341.18 Aligned_cols=214 Identities=23% Similarity=0.340 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++|||||++++++.+++.+|+||||+ +|+|.+++.+.+++++..+..++.||+.||+|||++||
T Consensus 55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~I 133 (275)
T 3hyh_A 55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133 (275)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567889999999999999999999999999999999999 57888877777899999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||||||+|||++.++.+||+|||+|..........+.+||+.|+|||++.+.+.++.++||||+||++|||++|..||.
T Consensus 134 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp CCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999999887666666678999999999999987745789999999999999999999998
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.+..+....+....... .+..++++.+++.+||..+|..
T Consensus 214 ~~~~~~~~~~i~~~~~~~----------------------------------------p~~~s~~~~~li~~~L~~dP~~ 253 (275)
T 3hyh_A 214 DESIPVLFKNISNGVYTL----------------------------------------PKFLSPGAAGLIKRMLIVNPLN 253 (275)
T ss_dssp CSSHHHHHHHHHHTCCCC----------------------------------------CTTSCHHHHHHHHHHSCSSGGG
T ss_pred CCCHHHHHHHHHcCCCCC----------------------------------------CCCCCHHHHHHHHHHccCChhH
Confidence 887776665554432111 0123567889999999977766
Q ss_pred eeccccccccccccceeeeeec
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
| +++.++++||||..
T Consensus 254 R-------~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 254 R-------ISIHEIMQDDWFKV 268 (275)
T ss_dssp S-------CCHHHHHHCHHHHT
T ss_pred C-------cCHHHHHcCccccc
Confidence 6 99999999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=346.90 Aligned_cols=215 Identities=24% Similarity=0.331 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++|||||+++++|.+++.+|+|||||+||+|.+++.+ +.+++..+..++.||+.||.|||++||+|
T Consensus 115 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiH 193 (346)
T 4fih_A 115 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIH 193 (346)
T ss_dssp GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 34577899999999999999999999999999999999999999998875 47999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+|||++.++.+||+|||+|...... ....+.+||+.|+|||++.+.+ |+.++||||+||++|||++|..||.+
T Consensus 194 RDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999887543 3456789999999999998766 89999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+....... .......++++.||+.+||..+|..|
T Consensus 273 ~~~~~~~~~i~~~~~~~-------------------------------------~~~~~~~s~~~~dli~~~L~~dP~~R 315 (346)
T 4fih_A 273 EPPLKAMKMIRDNLPPR-------------------------------------LKNLHKVSPSLKGFLDRLLVRDPAQR 315 (346)
T ss_dssp SCHHHHHHHHHHSSCCC-------------------------------------CSCGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred cCHHHHHHHHHcCCCCC-------------------------------------CCccccCCHHHHHHHHHHcCCChhHC
Confidence 88877776654421110 00001235678899999999777666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.++++||||...
T Consensus 316 -------~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 316 -------ATAAELLKHPFLAKA 330 (346)
T ss_dssp -------CCHHHHTTCGGGGGC
T ss_pred -------cCHHHHhcCHhhcCC
Confidence 999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=347.35 Aligned_cols=214 Identities=21% Similarity=0.274 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
..+.+.+|+++++.++|||||++++++.+++.+|+|||||+||+|.+++.. +..+++..++.++.||+.||.|||++|
T Consensus 66 ~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~ 145 (350)
T 4b9d_A 66 EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145 (350)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356788999999999999999999999999999999999999999998853 346899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|+||||||+|||++.++.+||+|||+|+...... ...+.+||+.|+|||++.+.+ |+.++||||+||++|||++|..|
T Consensus 146 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~P 224 (350)
T 4b9d_A 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHA 224 (350)
T ss_dssp CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999998765322 234568999999999998866 89999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
|.+.+..+.+..++.....+ . ....++++.+++.+||..+|
T Consensus 225 F~~~~~~~~~~~i~~~~~~~----~-----------------------------------~~~~s~~~~~li~~~L~~dP 265 (350)
T 4b9d_A 225 FEAGSMKNLVLKIISGSFPP----V-----------------------------------SLHYSYDLRSLVSQLFKRNP 265 (350)
T ss_dssp CCCSSHHHHHHHHHHTCCCC----C-----------------------------------CTTSCHHHHHHHHHHTCSSG
T ss_pred CCCcCHHHHHHHHHcCCCCC----C-----------------------------------CccCCHHHHHHHHHHccCCh
Confidence 99998888877776543211 0 01124566788888888666
Q ss_pred ceeeccccccccccccceeeeeec
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..| +++.++++|||+..
T Consensus 266 ~~R-------~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 266 RDR-------PSVNSILEKGFIAK 282 (350)
T ss_dssp GGS-------CCHHHHHTSHHHHT
T ss_pred hHC-------cCHHHHhcCHHhhc
Confidence 655 88888888888754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=337.82 Aligned_cols=214 Identities=20% Similarity=0.259 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
..+.+.+|+++++.++|||||+++++|.+ ++.+|+|||||++|+|.+++.+.+.+++..+..++.||+.||+|||+
T Consensus 68 ~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~ 147 (290)
T 3fpq_A 68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147 (290)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999975 34689999999999999999888899999999999999999999999
Q ss_pred CC--ceecccCCCcEEEec-CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 93 HA--CIHRDIKPENILLTA-NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 93 ~~--ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
+| |+||||||+|||++. ++.+||+|||+|..... ....+.+||+.|+|||++.+ .|+.++|||||||++|||+|
T Consensus 148 ~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyellt 224 (290)
T 3fpq_A 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHH
Confidence 99 999999999999985 78999999999976433 34456789999999999864 38999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..||.+......+...+..+.++. . + ....++++.+++.+||
T Consensus 225 g~~Pf~~~~~~~~~~~~i~~~~~~~----------~-----------------~----------~~~~~~~~~~li~~~L 267 (290)
T 3fpq_A 225 SEYPYSECQNAAQIYRRVTSGVKPA----------S-----------------F----------DKVAIPEVKEIIEGCI 267 (290)
T ss_dssp SSCTTTTCSSHHHHHHHHTTTCCCG----------G-----------------G----------GGCCCHHHHHHHHHHS
T ss_pred CCCCCCCCCcHHHHHHHHHcCCCCC----------C-----------------C----------CccCCHHHHHHHHHHc
Confidence 9999987766655554444332211 0 0 0113456789999999
Q ss_pred ccccceeeccccccccccccceeeeeec
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..+|..| +++.++++||||.+
T Consensus 268 ~~dP~~R-------~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 268 RQNKDER-------YSIKDLLNHAFFQE 288 (290)
T ss_dssp CSSGGGS-------CCHHHHHTSGGGC-
T ss_pred cCChhHC-------cCHHHHhcCccccC
Confidence 9777666 99999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=341.70 Aligned_cols=212 Identities=20% Similarity=0.203 Sum_probs=178.9
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
.+.+|+++++.++|||||++++++.+++.+|+|||||+||+|.+++.+.+.+++..+..++.|++.||.|||++||+|||
T Consensus 72 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 151 (304)
T 3ubd_A 72 RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151 (304)
T ss_dssp ------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred HHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 46779999999999999999999999999999999999999999998888999999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
|||+|||++.++.+||+|||+|+.... .....+.+||+.|+|||++.+.+ |+.++||||+||++|||++|..||.+.+
T Consensus 152 lKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 152 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp CCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 999999999999999999999987543 33445678999999999998776 8999999999999999999999999988
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeec
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQS 258 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~ 258 (303)
..+....+.......+ +..++++.+++.+||..+|..|
T Consensus 231 ~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~~li~~~L~~dP~~R-- 268 (304)
T 3ubd_A 231 RKETMTMILKAKLGMP----------------------------------------QFLSPEAQSLLRMLFKRNPANR-- 268 (304)
T ss_dssp HHHHHHHHHHCCCCCC----------------------------------------TTSCHHHHHHHHHHTCSSGGGS--
T ss_pred HHHHHHHHHcCCCCCC----------------------------------------CcCCHHHHHHHHHHcccCHHHC--
Confidence 8888777665322110 1135678899999999777666
Q ss_pred cccccccc-----cccceeeeeecCC
Q psy763 259 EKQDSIRG-----KNCKKTFYIPTPE 279 (303)
Q Consensus 259 ~~~~~~~~-----~~~l~~~~~~~~~ 279 (303)
+++ .++++||||.+.+
T Consensus 269 -----~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 269 -----LGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp -----TTCSTTTHHHHHTSGGGTTCC
T ss_pred -----CCCCcCCHHHHHcCccccCCC
Confidence 764 6899999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=348.11 Aligned_cols=214 Identities=24% Similarity=0.333 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++|||||+++++|.+++.+|+|||||+||+|.+++.. +.+++..+..++.||+.||.|||++||+|
T Consensus 192 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiH 270 (423)
T 4fie_A 192 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIH 270 (423)
T ss_dssp GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 34577899999999999999999999999999999999999999998875 47999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+|||++.+|.+||+|||+|...... ....+.+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+
T Consensus 271 RDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999887543 3456789999999999998766 89999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+.+..+....... .......++++.+|+.+||..++..|
T Consensus 350 ~~~~~~~~~i~~~~~~~-------------------------------------~~~~~~~s~~~~dli~~~L~~dP~~R 392 (423)
T 4fie_A 350 EPPLKAMKMIRDNLPPR-------------------------------------LKNLHKVSPSLKGFLDRLLVRDPAQR 392 (423)
T ss_dssp SCHHHHHHHHHHSCCCC-------------------------------------CSCTTSSCHHHHHHHHHHSCSSTTTS
T ss_pred cCHHHHHHHHHcCCCCC-------------------------------------CcccccCCHHHHHHHHHHcCCChhHC
Confidence 88877776554431110 00112245778899999999777666
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.++++||||..
T Consensus 393 -------~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 393 -------ATAAELLKHPFLAK 406 (423)
T ss_dssp -------CCHHHHTTCGGGGG
T ss_pred -------cCHHHHhcCHHhcC
Confidence 99999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=335.77 Aligned_cols=167 Identities=23% Similarity=0.311 Sum_probs=148.2
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 101 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 101 (303)
.+|+.+++.++|||||++++++.+++.+|||||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+|||||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 177 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence 46899999999999999999999999999999999999999999888899999999999999999999999999999999
Q ss_pred CCcEEEecCC-cEEEccccceeeeCCCCc------cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 102 PENILLTANG-VVKLCDFGFARLINPGEN------YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 102 ~~nil~~~~~-~~kl~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|+|||++.++ .+||+|||+|+....... ....+||+.|+|||++.+.+ |+.++||||+||++|||++|..||
T Consensus 178 p~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf 256 (336)
T 4g3f_A 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPW 256 (336)
T ss_dssp GGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCC
Confidence 9999999887 699999999988754321 13357999999999999866 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhc
Q psy763 175 LGNMGSHMARNLLKN 189 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~ 189 (303)
.+....+....+...
T Consensus 257 ~~~~~~~~~~~i~~~ 271 (336)
T 4g3f_A 257 TQYFRGPLCLKIASE 271 (336)
T ss_dssp TTTCCSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHcC
Confidence 887766666655554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=340.06 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=190.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe------CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR------KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
...+.+|+++++.++|||||++++++.. .+.+|+|||||+ |+|..++...+++++..+..++.||+.||.|||
T Consensus 97 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH 175 (398)
T 4b99_A 97 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 175 (398)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999864 357999999997 678888888889999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCC-----CccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
++||+||||||+|||++.++.+||+|||+|+..... ....+.+||+.|+|||++.+...++.++||||+|||+||
T Consensus 176 ~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~e 255 (398)
T 4b99_A 176 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 255 (398)
T ss_dssp HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHH
Confidence 999999999999999999999999999999875422 233567999999999999887768999999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
|++|..||.|.+..+++..++...+.++....... ........... .......++... .+..++++.|||.
T Consensus 256 ll~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~s~~~~dLl~ 326 (398)
T 4b99_A 256 MLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV-GAERVRAYIQS-LPPRQPVPWETV-------YPGADRQALSLLG 326 (398)
T ss_dssp HHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC------CHHHHHHS-SCCCCCCCHHHH-------STTCCHHHHHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh-hhhhhhhhhhc-CCCcCCCCHHHh-------CCCCCHHHHHHHH
Confidence 99999999999999999988887666542211110 00000000000 011111222222 1235678999999
Q ss_pred hhhccccceeeccccccccccccceeeeeec
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+||..+|..| +++.++|+||||..
T Consensus 327 ~mL~~dP~~R-------~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 327 RMLRFEPSAR-------ISAAAALRHPFLAK 350 (398)
T ss_dssp HHSCSSTTTS-------CCHHHHTTSGGGTT
T ss_pred HHCcCChhHC-------cCHHHHhcCHhhCc
Confidence 9999777666 99999999999965
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=332.12 Aligned_cols=205 Identities=18% Similarity=0.240 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-------------CCCCHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-------------HGLPWDLIKQITWQV 83 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------------~~l~~~~~~~~~~qi 83 (303)
..+.+.+|++++++++|||||+++|+|.+++.+|+|||||++|+|.+++... ..+++..+..++.||
T Consensus 58 ~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 137 (299)
T 4asz_A 58 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999988542 369999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhH
Q psy763 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 84 ~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
+.||.|||+++|+||||||+|||++.++.+||+|||+|+........ ....||+.|+|||++.+.. |+.++|||||
T Consensus 138 a~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~ 216 (299)
T 4asz_A 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSL 216 (299)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHH
T ss_pred HHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHH
Confidence 99999999999999999999999999999999999999876433222 2346899999999998766 8999999999
Q ss_pred HHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 161 EWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 161 G~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||++|||+| |..||.+....+....+.. +.+++ .+..++.++.+++..||..+|..||.+..
T Consensus 217 Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~ 279 (299)
T 4asz_A 217 GVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKG 279 (299)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHH-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999998 7788888777776665554 44332 35667888888999999988888876554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=323.30 Aligned_cols=209 Identities=16% Similarity=0.167 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++|||||+++|++.+ +.+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++||
T Consensus 75 ~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~I 153 (307)
T 3omv_A 75 QFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNI 153 (307)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 35678999999999999999999998865 568999999999999998854 4579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCC---CccccccCCCcccCcccccCC--ccCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPG---ENYTDYVATRWYRAPELLVGD--TLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~--~~~~~~~DvwSlG~il~el~tg 170 (303)
+||||||+|||++.++.+||+|||+|+..... ......+||+.|+|||++.+. .+|+.++|||||||++|||+||
T Consensus 154 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg 233 (307)
T 3omv_A 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233 (307)
T ss_dssp BCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHC
Confidence 99999999999999999999999999876432 223456899999999999743 3489999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEe-ecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVI-LKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..||.+......+...+..+...+.. ..+..++.+..+++..||..+|..||.+.-
T Consensus 234 ~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 290 (307)
T 3omv_A 234 ELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQ 290 (307)
T ss_dssp SCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 99998887777777777766554432 234566777888888888888887776554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=330.55 Aligned_cols=250 Identities=16% Similarity=0.190 Sum_probs=181.1
Q ss_pred HHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+.+|+++++.+ +||||+++++++.+.+++|+||||+++|+|.+++. .+++..++.++.|++.||+|||++||+||
T Consensus 65 ~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHR 141 (361)
T 4f9c_A 65 RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHR 141 (361)
T ss_dssp HHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 456788889888 69999999999999999999999999999999884 69999999999999999999999999999
Q ss_pred ccCCCcEEEecC-CcEEEccccceeeeCCCC-----------------------------ccccccCCCcccCcccccCC
Q psy763 99 DIKPENILLTAN-GVVKLCDFGFARLINPGE-----------------------------NYTDYVATRWYRAPELLVGD 148 (303)
Q Consensus 99 dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~l~~~ 148 (303)
||||+|||++.+ +.+||+|||+|+...... ...+.+||+.|+|||++.+.
T Consensus 142 DiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 142 DVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred cCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 999999999977 799999999998654321 12345799999999999887
Q ss_pred ccCCCccchhhHHHHHHHhhccCccCCCC-chHHHHHHHhhcCCceeE----------eecCCCCCcchhhhhhhhhhcC
Q psy763 149 TLYGPAVDVWAIEWTSHSYSQIGFIGLGN-MGSHMARNLLKNNGRVTV----------ILKSDSLDSETWDLTWQEIFSK 217 (303)
Q Consensus 149 ~~~~~~~DvwSlG~il~el~tg~~~~~~~-~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~ 217 (303)
+.|+.++||||+|||+|||++|..||++. +..+++..+....+.++. .......+..............
T Consensus 222 ~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 301 (361)
T 4f9c_A 222 PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGM 301 (361)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--
T ss_pred CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccc
Confidence 66899999999999999999999888654 455666666554332211 0111111111111111111110
Q ss_pred CChhHH----HHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCC
Q psy763 218 TSTTTI----FKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 218 ~~~~~~----~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
....|. ..............++++.||+.+||..+|..| +++.+||+||||.+.+
T Consensus 302 ~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R-------~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 302 DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASR-------ITAEEALLHPFFKDMS 360 (361)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSCTTTS-------CCHHHHHTSGGGTTC-
T ss_pred cccccccccccccccccccccccCCHHHHHHHHHHCcCChhHC-------cCHHHHhcCcccCCCC
Confidence 000000 000001122234567899999999999777766 9999999999997754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=327.71 Aligned_cols=205 Identities=18% Similarity=0.204 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---------------CCCCHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---------------HGLPWDLIKQITW 81 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------~~l~~~~~~~~~~ 81 (303)
..+.|.+|+++++.++|||||+++|+|.+++.+|+|||||++|+|.+++... +++++..+..++.
T Consensus 86 ~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 165 (329)
T 4aoj_A 86 ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165 (329)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999988643 3599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchh
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVW 158 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dvw 158 (303)
|++.||.|||+++|+||||||+|||++.++.+||+|||+|+....... .....||+.|+|||++.+.. |+.++|||
T Consensus 166 qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvw 244 (329)
T 4aoj_A 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVW 244 (329)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHH
T ss_pred HHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCcccccc
Confidence 999999999999999999999999999999999999999987653322 23467999999999998766 89999999
Q ss_pred hHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 159 AIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 159 SlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||||++|||+| |..||.+....+.+..+.. +.+++ .+..+++++.+++..||..+|..||.+.-
T Consensus 245 S~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-g~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~e 309 (329)
T 4aoj_A 245 SFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-GRELE---RPRACPPEVYAIMRGCWQREPQQRHSIKD 309 (329)
T ss_dssp HHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH-TCCCC---CCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred chHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCC---CcccccHHHHHHHHHHcCcChhHCcCHHH
Confidence 99999999999 7888888777777665544 44432 34567888888888999888888876554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=322.70 Aligned_cols=205 Identities=20% Similarity=0.271 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITW 81 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~~ 81 (303)
.+.|.+|+.++++++|||||+++|+|.+++.+++|||||++|+|.+++... ..+++..+..++.
T Consensus 73 ~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 152 (308)
T 4gt4_A 73 REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152 (308)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHH
Confidence 467899999999999999999999999999999999999999999988542 3589999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchh
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVW 158 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~Dvw 158 (303)
||+.||.|||+++|+||||||+|||+++++.+||+|||+|+...... ......||+.|+|||++.+.. |+.++|||
T Consensus 153 qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVw 231 (308)
T 4gt4_A 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIW 231 (308)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhh
Confidence 99999999999999999999999999999999999999998764322 234467899999999998765 89999999
Q ss_pred hHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 159 AIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 159 SlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
||||++|||+| |..||.+....+.... +..+.+++ .++.++.++.+++..||..+|..||.+.-+
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~~~~~~~-i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSNQDVVEM-IRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCHHHHHHH-HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999998 6677777766666554 44455443 456778888999999999888888766553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=319.37 Aligned_cols=215 Identities=20% Similarity=0.275 Sum_probs=160.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------------EEEEEEecCCCCcHHHHHcCCCC---CCHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK------------KLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITW 81 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------------~~~lv~e~~~~~~l~~~~~~~~~---l~~~~~~~~~~ 81 (303)
..+.+.+|+++++.++|||||++++++.+.+ .+|+|||||++|+|.+++..... .+...++.++.
T Consensus 46 ~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~ 125 (299)
T 4g31_A 46 AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHH
Confidence 3456789999999999999999999997544 37999999999999999876654 45567889999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-------------cccccCCCcccCcccccCC
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-------------YTDYVATRWYRAPELLVGD 148 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~l~~~ 148 (303)
||+.||.|||++||+||||||+|||++.++.+||+|||+|+....... ..+.+||+.|+|||++.+.
T Consensus 126 qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC
T ss_pred HHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC
Confidence 999999999999999999999999999999999999999987653221 1335799999999999876
Q ss_pred ccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHh
Q psy763 149 TLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLL 228 (303)
Q Consensus 149 ~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 228 (303)
+ |+.++||||+||++|||++ ||.+..........+..... .+....
T Consensus 206 ~-y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~----------------------------p~~~~~-- 251 (299)
T 4g31_A 206 S-YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKF----------------------------PPLFTQ-- 251 (299)
T ss_dssp C-CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCC----------------------------CHHHHH--
T ss_pred C-CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCC----------------------------CCCCcc--
Confidence 6 8999999999999999986 44433221111111111000 011111
Q ss_pred HhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 229 IRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 229 ~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
..+.+.+++.+||..+|..| +++.++++||||.+.+.
T Consensus 252 --------~~~~~~~li~~~L~~dP~~R-------ps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 252 --------KYPCEYVMVQDMLSPSPMER-------PEAINIIENAVFEDLDF 288 (299)
T ss_dssp --------HCHHHHHHHHHHTCSSGGGS-------CCHHHHHTSGGGCCC--
T ss_pred --------cCHHHHHHHHHHcCCChhHC-------cCHHHHhcCHhhCCCCC
Confidence 23456789999998777666 99999999999987554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=343.13 Aligned_cols=211 Identities=18% Similarity=0.180 Sum_probs=175.9
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
.+..++.+++.++|||||+++++|++.+.+|+|||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+|||
T Consensus 238 ~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRD 317 (689)
T 3v5w_A 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRD 317 (689)
T ss_dssp HHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 34455677888999999999999999999999999999999999998888999999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCch
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMG 179 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~ 179 (303)
|||+|||++.+|.+||+|||+|....... ..+.+||+.|+|||++.+...|+.++|+||+||++|||++|..||.+...
T Consensus 318 LKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 318 LKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred CchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999998875433 35679999999999997554589999999999999999999999987532
Q ss_pred H---HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 180 S---HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 180 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
. +....+.... .......++++.+++.+||..+|..|
T Consensus 397 ~~~~~i~~~i~~~~----------------------------------------~~~p~~~S~~a~dLI~~lL~~dP~~R 436 (689)
T 3v5w_A 397 KDKHEIDRMTLTMA----------------------------------------VELPDSFSPELRSLLEGLLQRDVNRR 436 (689)
T ss_dssp CCHHHHHHHHHHCC----------------------------------------CCCCTTSCHHHHHHHHHHTCSCGGGC
T ss_pred HHHHHHHHhhcCCC----------------------------------------CCCCccCCHHHHHHHHHHccCCHhHC
Confidence 2 2222111111 11112346788899999999777776
Q ss_pred ecccccccc-----ccccceeeeeecC
Q psy763 257 QSEKQDSIR-----GKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~-----~~~~l~~~~~~~~ 278 (303)
++ +.+++.||||...
T Consensus 437 -------l~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 437 -------LGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp -------TTCSSSTHHHHTTSGGGTTC
T ss_pred -------CCCCCCCHHHHhcCccccCC
Confidence 55 6899999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=320.93 Aligned_cols=206 Identities=25% Similarity=0.320 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHHhCCC-CCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcC----------------CCCCCHHHHHH
Q psy763 17 RQATEATNKKEKRSLKH-PNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENH----------------PHGLPWDLIKQ 78 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~----------------~~~l~~~~~~~ 78 (303)
..+.+.+|++++++++| ||||+++|+|.+. +.+|+|||||++|+|.+++.. ...+++..+..
T Consensus 110 ~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 189 (353)
T 4ase_A 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHH
Confidence 34568899999999976 8999999999764 578999999999999998853 23589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCcc
Q psy763 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAV 155 (303)
Q Consensus 79 ~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~ 155 (303)
++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....... .....||+.|+|||++.+.. |+.++
T Consensus 190 ~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ks 268 (353)
T 4ase_A 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQS 268 (353)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHH
T ss_pred HHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcc
Confidence 999999999999999999999999999999999999999999987654332 23457899999999998765 89999
Q ss_pred chhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 156 DVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 156 DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||||||++|||+| |..||.+....+.+...+..+.+++ .++.+++++.+++..||..+|..||.+.-
T Consensus 269 DVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~---~p~~~~~~~~~li~~c~~~dP~~RPt~~e 337 (353)
T 4ase_A 269 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSE 337 (353)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 99999999999998 7788877776777777777777654 44567788888888999888887776554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=334.59 Aligned_cols=217 Identities=22% Similarity=0.283 Sum_probs=188.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+.+|+.+++.++|||||+++++|.+++.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+
T Consensus 198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii 277 (573)
T 3uto_A 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277 (573)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45678899999999999999999999999999999999999999998754 46899999999999999999999999999
Q ss_pred ecccCCCcEEEecC--CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTAN--GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+|||++.+ +.+||+|||+|..+.+.......+||+.|+|||++.+.+ |+.++||||+||++|||++|..||
T Consensus 278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf 356 (573)
T 3uto_A 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPF 356 (573)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred eccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999854 899999999999988777777789999999999999876 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+......++. . .| ...++++.||+.+||..+|.
T Consensus 357 ~~~~~~~~~~~i~~~~~~~~~---------~----~~-----------------------~~~s~~~~dli~~~L~~dp~ 400 (573)
T 3uto_A 357 GGENDDETLRNVKSCDWNMDD---------S----AF-----------------------SGISEDGKDFIRKLLLADPN 400 (573)
T ss_dssp CCSSHHHHHHHHHTTCCCCCS---------G----GG-----------------------TTSCHHHHHHHHTTSCSSGG
T ss_pred CCcCHHHHHHHHHhCCCCCCc---------c----cc-----------------------cCCCHHHHHHHHHHccCChh
Confidence 999988888777665433210 0 00 11356788999999987766
Q ss_pred eeeccccccccccccceeeeeecC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.| +++.++++||||...
T Consensus 401 ~R-------~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 401 TR-------MTIHQALEHPWLTPG 417 (573)
T ss_dssp GS-------CCHHHHHHSTTTSCC
T ss_pred HC-------cCHHHHhcCcCcCCC
Confidence 66 999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=297.80 Aligned_cols=213 Identities=24% Similarity=0.342 Sum_probs=184.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+++++.++||||+++++++...+.+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+|
T Consensus 58 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivH 137 (328)
T 3fe3_A 58 LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137 (328)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 45577899999999999999999999999999999999999999998877778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
|||||+||+++.++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.
T Consensus 138 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp SCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999987766666677889999999999988764458999999999999999999999888
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
...+....+.....+.+ ...++++.+++.+|+..+|..|
T Consensus 218 ~~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~~li~~~L~~dP~~R- 256 (328)
T 3fe3_A 218 NLKELRERVLRGKYRIP----------------------------------------FYMSTDCENLLKRFLVLNPIKR- 256 (328)
T ss_dssp SHHHHHHHHHHCCCCCC----------------------------------------TTSCHHHHHHHHHHCCSSTTTS-
T ss_pred CHHHHHHHHHhCCCCCC----------------------------------------CCCCHHHHHHHHHHCCCChhHC-
Confidence 77776665554322211 1134667889999998666666
Q ss_pred ccccccccccccceeeeeec
Q psy763 258 SEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.++++|||+..
T Consensus 257 ------~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 257 ------GTLEQIMKDRWINA 270 (328)
T ss_dssp ------CCHHHHTTCTTTTT
T ss_pred ------cCHHHHhcCHhhcC
Confidence 99999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=302.61 Aligned_cols=218 Identities=22% Similarity=0.322 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.+.+.+++||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+|
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 138 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45678899999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred cccCCCcEEEecCC----cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 98 RDIKPENILLTANG----VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|||||+||+++.++ .+||+|||++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..|
T Consensus 139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCC
Confidence 99999999998776 79999999999877665566778999999999998765 89999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
|.+....+....+.......+ ++. | ...++.+.+++.+||..+|
T Consensus 218 f~~~~~~~~~~~i~~~~~~~~---------~~~----~-----------------------~~~s~~~~~li~~~L~~dP 261 (361)
T 2yab_A 218 FLGDTKQETLANITAVSYDFD---------EEF----F-----------------------SQTSELAKDFIRKLLVKET 261 (361)
T ss_dssp SCCSSHHHHHHHHHTTCCCCC---------HHH----H-----------------------TTSCHHHHHHHHHHSCSST
T ss_pred CCCCCHHHHHHHHHhcCCCCC---------chh----c-----------------------cCCCHHHHHHHHHHCCCCh
Confidence 999888777766655322211 000 0 1235678899999999777
Q ss_pred ceeeccccccccccccceeeeeecCC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
..| +++.++++|||+...+
T Consensus 262 ~~R-------~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 262 RKR-------LTIQEALRHPWITPVD 280 (361)
T ss_dssp TTS-------CCHHHHHTSTTTSCSS
T ss_pred hHC-------cCHHHHhcCcCcCCCc
Confidence 666 9999999999998543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=295.11 Aligned_cols=153 Identities=23% Similarity=0.337 Sum_probs=130.1
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH--- 93 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--- 93 (303)
...|+..+..++|||||+++|++.+++ .+|+|||||++|+|.+++.. .++++..+..++.|++.||+|||++
T Consensus 44 ~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~ 122 (303)
T 3hmm_A 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 345677778899999999999998654 68999999999999999875 4799999999999999999999987
Q ss_pred -----CceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCc-----cCCCccchh
Q psy763 94 -----ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDT-----LYGPAVDVW 158 (303)
Q Consensus 94 -----~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~-----~~~~~~Dvw 158 (303)
+|+||||||+|||++.++.+||+|||+|+....... ....+||+.|+|||++.+.. .++.++|||
T Consensus 123 ~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVw 202 (303)
T 3hmm_A 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202 (303)
T ss_dssp TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred ccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhh
Confidence 999999999999999999999999999988754332 12357999999999997542 367899999
Q ss_pred hHHHHHHHhhccCccC
Q psy763 159 AIEWTSHSYSQIGFIG 174 (303)
Q Consensus 159 SlG~il~el~tg~~~~ 174 (303)
||||++|||+||..++
T Consensus 203 S~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 203 AMGLVFWEIARRCSIG 218 (303)
T ss_dssp HHHHHHHHHHHTBCBT
T ss_pred hHHHHHHHHHHCCCCC
Confidence 9999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=293.51 Aligned_cols=172 Identities=23% Similarity=0.325 Sum_probs=154.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|..++...+.+++..++.++.||+.||.|||++||+
T Consensus 48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 127 (337)
T 1o6l_A 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 44567789999999999999999999999999999999999999999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++.... ........+||+.|+|||++.+.. ++.++|+||+||++|||++|..||.
T Consensus 128 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCC
Confidence 99999999999999999999999998643 333445678999999999998765 8999999999999999999999999
Q ss_pred CCchHHHHHHHhhc
Q psy763 176 GNMGSHMARNLLKN 189 (303)
Q Consensus 176 ~~~~~~~~~~~~~~ 189 (303)
+....+....+...
T Consensus 207 ~~~~~~~~~~i~~~ 220 (337)
T 1o6l_A 207 NQDHERLFELILME 220 (337)
T ss_dssp CSSHHHHHHHHHHC
T ss_pred CCCHHHHHHHHHcC
Confidence 88777766655543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=295.61 Aligned_cols=218 Identities=21% Similarity=0.229 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 14 EAIRQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.........+|..+++.+ +||||+++++++.+.+.+|+||||+++|+|..++...+.+++..++.++.||+.||.|||+
T Consensus 63 ~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 142 (353)
T 3txo_A 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142 (353)
T ss_dssp HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 333455677888888887 7999999999999999999999999999999998877889999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+||+||||||+|||++.++.+||+|||++.... ........+||+.|+|||++.+.. ++.++||||+||++|||++|.
T Consensus 143 ~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~ 221 (353)
T 3txo_A 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGH 221 (353)
T ss_dssp TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCC
Confidence 999999999999999999999999999998643 233445678999999999998665 899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.||.+....+....+....... ....++++.+++.+||..
T Consensus 222 ~Pf~~~~~~~~~~~i~~~~~~~----------------------------------------p~~~~~~~~~li~~lL~~ 261 (353)
T 3txo_A 222 APFEAENEDDLFEAILNDEVVY----------------------------------------PTWLHEDATGILKSFMTK 261 (353)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCC----------------------------------------CTTSCHHHHHHHHHHTCS
T ss_pred CCCCCCCHHHHHHHHHcCCCCC----------------------------------------CCCCCHHHHHHHHHHhhh
Confidence 9999988877777665532211 111345677888888887
Q ss_pred ccceeeccccccccc------cccceeeeeecCC
Q psy763 252 RFTYIQSEKQDSIRG------KNCKKTFYIPTPE 279 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~------~~~l~~~~~~~~~ 279 (303)
+|..| +++ .+++.||||...+
T Consensus 262 dP~~R-------~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 262 NPTMR-------LGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp SGGGS-------TTSGGGTCTHHHHTSGGGTTCC
T ss_pred CHHHc-------cCCcccCCHHHHhhCCcccCCC
Confidence 76666 666 7899999997643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.44 Aligned_cols=216 Identities=19% Similarity=0.274 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|..++.....+++..+..++.|++.||.|||++||+
T Consensus 49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 128 (318)
T 1fot_A 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 128 (318)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 44567789999999999999999999999999999999999999999998878899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+||+++.++.+||+|||++..... .....+||+.|+|||++.+.. ++.++|+||+||++|||++|..||.+
T Consensus 129 HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 129 YRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCChheEEEcCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999987543 334568999999999998765 89999999999999999999999998
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....++....+.+ ...++++.+++.+|+..++..|
T Consensus 206 ~~~~~~~~~i~~~~~~~p----------------------------------------~~~~~~~~~li~~lL~~dp~~R 245 (318)
T 1fot_A 206 SNTMKTYEKILNAELRFP----------------------------------------PFFNEDVKDLLSRLITRDLSQR 245 (318)
T ss_dssp SSHHHHHHHHHHCCCCCC----------------------------------------TTSCHHHHHHHHHHTCSCTTTC
T ss_pred CCHHHHHHHHHhCCCCCC----------------------------------------CCCCHHHHHHHHHHhccCHHHc
Confidence 887777666655322211 1134566788888887666555
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
-. ..+.++.+++.||||..
T Consensus 246 ~~--~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 246 LG--NLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp TT--SSTTTTHHHHTSGGGSS
T ss_pred CC--CcCCCHHHHhcCccccC
Confidence 11 01127788888888865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=292.01 Aligned_cols=243 Identities=27% Similarity=0.451 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+++.+++||||++++.+..+......+++..+..++.|++.||.|||+.||+|
T Consensus 63 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 142 (311)
T 3niz_A 63 PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45677899999999999999999999999999999999996544445555567999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+
T Consensus 143 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999876532 3334567899999999998766689999999999999999999999988
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhh-hhhhh-hhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWD-LTWQE-IFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
....+....+....+.+... . .+.... ..|.. ........++... .+..++++.+++.+||..+|.
T Consensus 223 ~~~~~~~~~i~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~ 290 (311)
T 3niz_A 223 VTDDDQLPKIFSILGTPNPR----E-WPQVQELPLWKQRTFQVFEKKPWSSI-------IPGFCQEGIDLLSNMLCFDPN 290 (311)
T ss_dssp SSTTTHHHHHHHHHCCCCTT----T-SGGGTTSHHHHSCCCCCCCCCCHHHH-------STTCCHHHHHHHHHHSCSCTT
T ss_pred CChHHHHHHHHHHHCCCChH----H-hhhhhccchhhhcccccccCCcHHHh-------CcccCHHHHHHHHHHcCCChh
Confidence 88777777766654432210 0 000000 01111 0111111222222 123467889999999997776
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.| +++.++++||||.+.+
T Consensus 291 ~R-------pt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 291 KR-------ISARDAMNHPYFKDLD 308 (311)
T ss_dssp TS-------CCHHHHHTSGGGTTSC
T ss_pred HC-------CCHHHHhcCcccccCC
Confidence 66 9999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.01 Aligned_cols=218 Identities=22% Similarity=0.302 Sum_probs=185.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+|
T Consensus 58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 137 (326)
T 2y0a_A 58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137 (326)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence 45678899999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred cccCCCcEEEecCC----cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 98 RDIKPENILLTANG----VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|||||+||+++.++ .+||+|||++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..|
T Consensus 138 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp CCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCC
Confidence 99999999998877 79999999998876555556678999999999998665 89999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
|.+....+....+.......+ . .. ....++.+.+++.+|+..+|
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~---------~-----------------~~----------~~~~~~~~~~li~~~L~~dP 260 (326)
T 2y0a_A 217 FLGDTKQETLANVSAVNYEFE---------D-----------------EY----------FSNTSALAKDFIRRLLVKDP 260 (326)
T ss_dssp SCCSSHHHHHHHHHHTCCCCC---------H-----------------HH----------HTTSCHHHHHHHHHHSCSSG
T ss_pred CCCCCHHHHHHHHHhcCCCcC---------c-----------------cc----------cccCCHHHHHHHHHHccCCh
Confidence 988877776665544322211 0 00 01234567899999998666
Q ss_pred ceeeccccccccccccceeeeeecCC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
..| +++.+++.||||...+
T Consensus 261 ~~R-------pt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 261 KKR-------MTIQDSLQHPWIKPKD 279 (326)
T ss_dssp GGS-------CCHHHHHHSTTTSCCS
T ss_pred hhC-------CCHHHHhcCCCccCCc
Confidence 666 9999999999997654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=289.15 Aligned_cols=213 Identities=19% Similarity=0.241 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
......|..+++.+ +||||+++++++.+.+.+|+||||+++|+|..++...+.+++..+..++.|++.||.|||++||+
T Consensus 61 ~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 140 (345)
T 1xjd_A 61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140 (345)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 34456677777765 99999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++..... .......+||+.|+|||++.+.. ++.++|+||+||++|||++|..||.
T Consensus 141 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 141 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999999986432 23345678999999999998766 8999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+....... ....++++.+++.+||..++..
T Consensus 220 ~~~~~~~~~~i~~~~~~~----------------------------------------p~~~s~~~~~li~~lL~~dp~~ 259 (345)
T 1xjd_A 220 GQDEEELFHSIRMDNPFY----------------------------------------PRWLEKEAKDLLVKLFVREPEK 259 (345)
T ss_dssp CSSHHHHHHHHHHCCCCC----------------------------------------CTTSCHHHHHHHHHHSCSSGGG
T ss_pred CCCHHHHHHHHHhCCCCC----------------------------------------CcccCHHHHHHHHHHhcCCHhH
Confidence 887777666554432111 0113456788999999877666
Q ss_pred eecccccccccc-ccceeeeeecC
Q psy763 256 IQSEKQDSIRGK-NCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~-~~l~~~~~~~~ 278 (303)
| +++. +++.||||...
T Consensus 260 R-------~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 260 R-------LGVRGDIRQHPLFREI 276 (345)
T ss_dssp S-------BTTBSCGGGSGGGTTC
T ss_pred c-------CCChHHHHcCccccCC
Confidence 6 8877 89999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.46 Aligned_cols=241 Identities=26% Similarity=0.441 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+++.+++||||++++.+..+....+.+++..+..++.|++.||.|||++||+|
T Consensus 45 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH 124 (292)
T 3o0g_A 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124 (292)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 35567899999999999999999999999999999999998777777777788999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC-
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL- 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~- 175 (303)
|||||+||+++.++.+||+|||++..... ........+|+.|+|||++.+...++.++||||+||++|||++|+.|++
T Consensus 125 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 99999999999999999999999987653 2334556889999999999877668999999999999999998887755
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH--HhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY--LLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+....+....+....+.+.... |..+...+...+.... ........+..++++.+++.+||..+|
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 271 (292)
T 3o0g_A 205 GNDVDDQLKRIFRLLGTPTEEQ-------------WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTT-------------CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred CCCHHHHHHHHHHHhCCCChhh-------------hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccCh
Confidence 4455555565555433322110 1100000000000000 000011123456788899999999766
Q ss_pred ceeeccccccccccccceeeeeecC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
..| +++.++++||||.+.
T Consensus 272 ~~R-------~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 272 VQR-------ISAEEALQHPYFSDF 289 (292)
T ss_dssp GGS-------CCHHHHHTSGGGTTC
T ss_pred hhC-------CCHHHHhcCcccccC
Confidence 666 999999999999763
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=300.91 Aligned_cols=220 Identities=20% Similarity=0.235 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||++++++|.+++.+|+||||+++|+|..++.. .+.+++..++.++.|++.||.|||+.||+
T Consensus 118 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gii 197 (437)
T 4aw2_A 118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197 (437)
T ss_dssp TCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 34478899999999999999999999999999999999999999999876 56899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCccccc----CCccCCCccchhhHHHHHHHhhcc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLV----GDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~----~~~~~~~~~DvwSlG~il~el~tg 170 (303)
||||||+|||++.++.+||+|||++........ ....+||+.|+|||++. +...++.++||||+||++|||++|
T Consensus 198 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG 277 (437)
T 4aw2_A 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277 (437)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred ecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence 999999999999999999999999987654332 23468999999999987 234489999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+....+....++....++..+ ......++++.+++.+||.
T Consensus 278 ~~Pf~~~~~~~~~~~i~~~~~~~~~p-----------------------------------~~~~~~s~~~~dLi~~lL~ 322 (437)
T 4aw2_A 278 ETPFYAESLVETYGKIMNHKERFQFP-----------------------------------TQVTDVSENAKDLIRRLIC 322 (437)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCC-----------------------------------SSCCCSCHHHHHHHHTTSS
T ss_pred CCCCCCCChhHHHHhhhhccccccCC-----------------------------------cccccCCHHHHHHHHHHhc
Confidence 99999988877777665432211100 0012245677888888886
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..+.. ..+.++.++++||||..
T Consensus 323 ~~~~r-----~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 323 SREHR-----LGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CGGGC-----TTTTTTHHHHTSGGGTT
T ss_pred ccccc-----cCCCCHHHHhCCCccCC
Confidence 43322 22578889999999865
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.71 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC--EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRRKK--KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
......+|+.+++.+. ||||+++++++...+ .+|+||||++ ++|..++.. +.+++..+..++.|++.||+|||+.
T Consensus 51 ~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~ 128 (388)
T 3oz6_A 51 DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG 128 (388)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4455678899999997 999999999998654 7999999998 578877764 4799999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCC----------------------CccccccCCCcccCcccccCCccC
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPG----------------------ENYTDYVATRWYRAPELLVGDTLY 151 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~----------------------~~~~~~~~~~~y~aPE~l~~~~~~ 151 (303)
||+||||||+|||++.++.+||+|||+++..... ......+||++|+|||++.+...+
T Consensus 129 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (388)
T 3oz6_A 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208 (388)
T ss_dssp TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCC
T ss_pred CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCC
Confidence 9999999999999999999999999999875321 112345799999999999876668
Q ss_pred CCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcC---------CChhH
Q psy763 152 GPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSK---------TSTTT 222 (303)
Q Consensus 152 ~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 222 (303)
+.++||||+||++|||++|..||.+....+++..++...+.+....... ..+............. .....
T Consensus 209 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (388)
T 3oz6_A 209 TKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVES-IQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287 (388)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHT-SCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh-ccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence 9999999999999999999999999999998888887655443211100 0011111111111000 00011
Q ss_pred HHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeee
Q psy763 223 IFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 223 ~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
+... ..........++++.+++.+||..+|..| +++.++++|||+.
T Consensus 288 ~~~~-~~~~~~~~~~~~~~~dll~~~L~~dP~~R-------~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 288 WKNL-LLKINPKADCNEEALDLLDKLLQFNPNKR-------ISANDALKHPFVS 333 (388)
T ss_dssp HHHH-HHHHCTTCCCCHHHHHHHHHHCCSSGGGS-------CCHHHHTTSTTTT
T ss_pred hhhh-cccccccccCCHHHHHHHHHhhccCcccC-------CCHHHHhCCHHHH
Confidence 1111 12223334567889999999999777777 9999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=288.96 Aligned_cols=216 Identities=24% Similarity=0.304 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+.+.....+++..+..++.|++.||.|||++||+|
T Consensus 72 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 151 (362)
T 2bdw_A 72 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151 (362)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 45678999999999999999999999999999999999999999998888888999999999999999999999999999
Q ss_pred cccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++.+ +.+||+|||++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..||
T Consensus 152 ~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf 230 (362)
T 2bdw_A 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPF 230 (362)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999865 459999999998876555556678999999999998765 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+ ... | +..++++.+++.+||..+|.
T Consensus 231 ~~~~~~~~~~~i~~~~~~~~---------~~~----~-----------------------~~~~~~~~~li~~~L~~dP~ 274 (362)
T 2bdw_A 231 WDEDQHRLYAQIKAGAYDYP---------SPE----W-----------------------DTVTPEAKSLIDSMLTVNPK 274 (362)
T ss_dssp CCSSHHHHHHHHHHTCCCCC---------TTG----G-----------------------GGSCHHHHHHHHHHSCSSGG
T ss_pred CCCCHHHHHHHHHhCCCCCC---------ccc----c-----------------------cCCCHHHHHHHHHHcCCChh
Confidence 98877776665554432211 000 1 11346778999999987766
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.++++|||+..
T Consensus 275 ~R-------~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 275 KR-------ITADQALKVPWICN 290 (362)
T ss_dssp GS-------CCHHHHTTSHHHHT
T ss_pred hC-------cCHHHHhcCcccCC
Confidence 66 99999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=285.61 Aligned_cols=218 Identities=21% Similarity=0.276 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++.+.+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+
T Consensus 45 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~giv 124 (321)
T 1tki_A 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124 (321)
T ss_dssp HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 456788999999999999999999999999999999999999999988765 4799999999999999999999999999
Q ss_pred ecccCCCcEEEec--CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+||+++. ++.+||+|||++.............+|+.|+|||++.+.. ++.++||||+||++|+|++|..||
T Consensus 125 H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf 203 (321)
T 1tki_A 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999987 7899999999999877666666678999999999998765 799999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+ . ..+ +..++++.+++.+|+..+|.
T Consensus 204 ~~~~~~~~~~~i~~~~~~~~---------~----------------~~~-----------~~~s~~~~~li~~~L~~dp~ 247 (321)
T 1tki_A 204 LAETNQQIIENIMNAEYTFD---------E----------------EAF-----------KEISIEAMDFVDRLLVKERK 247 (321)
T ss_dssp CCSSHHHHHHHHHHTCCCCC---------H----------------HHH-----------TTSCHHHHHHHHTTSCSSGG
T ss_pred cCCCHHHHHHHHHcCCCCCC---------h----------------hhh-----------ccCCHHHHHHHHHHcCCChh
Confidence 99888877776665433221 0 000 12356788999999997776
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.| +++.++++|||+....
T Consensus 248 ~R-------pt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 248 SR-------MTASEALQHPWLKQKI 265 (321)
T ss_dssp GS-------CCHHHHHHSHHHHSCG
T ss_pred HC-------cCHHHHhcChhhccCc
Confidence 66 9999999999997653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=290.11 Aligned_cols=161 Identities=24% Similarity=0.322 Sum_probs=148.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+.+.+|+||||+.+|+|..++.....+++..+..++.|++.||.|||+.||+
T Consensus 58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~giv 137 (384)
T 4fr4_A 58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137 (384)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 34567889999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCC--ccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD--TLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+||+++.++.+||+|||++............+||+.|+|||++.+. ..++.++|||||||++|||++|..||
T Consensus 138 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 9999999999999999999999999987766666778999999999999742 34899999999999999999999998
Q ss_pred CCC
Q psy763 175 LGN 177 (303)
Q Consensus 175 ~~~ 177 (303)
.+.
T Consensus 218 ~~~ 220 (384)
T 4fr4_A 218 HIR 220 (384)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=294.95 Aligned_cols=217 Identities=24% Similarity=0.271 Sum_probs=183.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+.+...+.+++..+..++.||+.||.|||++||+
T Consensus 53 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~giv 132 (444)
T 3soa_A 53 DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132 (444)
T ss_dssp HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34567899999999999999999999999999999999999999999887778899999999999999999999999999
Q ss_pred ecccCCCcEEEec---CCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 97 HRDIKPENILLTA---NGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 97 H~dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
||||||+||+++. ++.+||+|||++....... ......||+.|+|||++.+.. ++.++||||+||++|+|++|..
T Consensus 133 HrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp CCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCC
Confidence 9999999999984 5789999999998765432 334568999999999998765 8999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+....+....+.......+ . ...+..++++.+++.+||..+
T Consensus 212 Pf~~~~~~~~~~~i~~~~~~~~---------~---------------------------~~~~~~s~~~~~li~~~L~~d 255 (444)
T 3soa_A 212 PFWDEDQHRLYQQIKAGAYDFP---------S---------------------------PEWDTVTPEAKDLINKMLTIN 255 (444)
T ss_dssp SCCCSSHHHHHHHHHHTCCCCC---------T---------------------------TTTTTSCHHHHHHHHHHSCSS
T ss_pred CCCCccHHHHHHHHHhCCCCCC---------c---------------------------cccccCCHHHHHHHHHHcCCC
Confidence 9998888777766655433221 0 000123567889999999876
Q ss_pred cceeeccccccccccccceeeeeec
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
|..| +++.++++|||+..
T Consensus 256 P~~R-------pta~e~L~hp~~~~ 273 (444)
T 3soa_A 256 PSKR-------ITAAEALKHPWISH 273 (444)
T ss_dssp TTTS-------CCHHHHHHSCTTHH
T ss_pred hhHC-------CCHHHHhcCccccC
Confidence 6666 99999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=287.88 Aligned_cols=170 Identities=21% Similarity=0.279 Sum_probs=154.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|..++.+.+.+++..++.++.|++.||.|||++||+
T Consensus 84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 163 (350)
T 1rdq_E 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34567889999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+||+++.++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+
T Consensus 164 HrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCC
Confidence 9999999999999999999999999876432 34568999999999998765 89999999999999999999999998
Q ss_pred CchHHHHHHHhhc
Q psy763 177 NMGSHMARNLLKN 189 (303)
Q Consensus 177 ~~~~~~~~~~~~~ 189 (303)
....+....+...
T Consensus 241 ~~~~~~~~~i~~~ 253 (350)
T 1rdq_E 241 DQPIQIYEKIVSG 253 (350)
T ss_dssp SSHHHHHHHHHHC
T ss_pred CCHHHHHHHHHcC
Confidence 8877777666554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=279.48 Aligned_cols=215 Identities=24% Similarity=0.342 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++..++.+++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+|
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H 139 (297)
T 3fxz_A 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIH 139 (297)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcee
Confidence 355788999999999999999999999999999999999999999988754 7999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+.. ++.++||||+||++|||++|..||.+
T Consensus 140 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998765433 334568999999999998766 89999999999999999999999988
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+........ ......++.+.+++.+|+..+|..|
T Consensus 219 ~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R 261 (297)
T 3fxz_A 219 ENPLRALYLIATNGTPEL-------------------------------------QNPEKLSAIFRDFLNRCLEMDVEKR 261 (297)
T ss_dssp SCHHHHHHHHHHHCSCCC-------------------------------------SCGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred CCHHHHHHHHHhCCCCCC-------------------------------------CCccccCHHHHHHHHHHccCChhHC
Confidence 777666554433222110 0011234567789999998766666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.++++|||+...
T Consensus 262 -------ps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 262 -------GSAKELLQHQFLKIA 276 (297)
T ss_dssp -------CCHHHHTTCGGGGGC
T ss_pred -------cCHHHHhhChhhccc
Confidence 999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=295.31 Aligned_cols=222 Identities=23% Similarity=0.257 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|..+++.+ +||||+++++++++.+.+|+||||+++|+|..++.+.+.+++..++.++.||+.||.|||++||+
T Consensus 96 ~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~giv 175 (396)
T 4dc2_A 96 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 175 (396)
T ss_dssp CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 34456677777765 89999999999999999999999999999999888778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeee-CCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+|||++.++.+||+|||++... .........+||+.|+|||++.+.. ++.++||||+||++|||++|..||.
T Consensus 176 HrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred eccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999999863 3444556678999999999998766 8999999999999999999999986
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+........ .......+..+.. .........++++.+++.+||..+|..
T Consensus 255 ~~~~~~~~~-------------------~~~~~~~~~~i~~------------~~~~~p~~~s~~~~~li~~lL~~dP~~ 303 (396)
T 4dc2_A 255 IVGSSDNPD-------------------QNTEDYLFQVILE------------KQIRIPRSLSVKAASVLKSFLNKDPKE 303 (396)
T ss_dssp TTTC-------------------------CCHHHHHHHHHH------------CCCCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred ccccccccc-------------------hhhHHHHHHHHhc------------cccCCCCcCCHHHHHHHHHHhcCCHhH
Confidence 432111100 0000000111110 111122335678889999999877766
Q ss_pred eeccccccccc------cccceeeeeecC
Q psy763 256 IQSEKQDSIRG------KNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~------~~~l~~~~~~~~ 278 (303)
| +++ .+++.||||...
T Consensus 304 R-------~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 304 R-------LGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp S-------TTCSTTTHHHHHHHSTTTTTC
T ss_pred c-------CCCCCCCCHHHHhcCccccCC
Confidence 6 664 689999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.86 Aligned_cols=219 Identities=21% Similarity=0.240 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|..++.. ..+++..++.++.|++.||.|||++||+|
T Consensus 113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givH 191 (410)
T 3v8s_A 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH 191 (410)
T ss_dssp CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 34477899999999999999999999999999999999999999998875 47999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCc---cCCCccchhhHHHHHHHhhccCc
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDT---LYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~---~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|||||+|||++.++.+||+|||++........ ..+.+||+.|+|||++.+.+ .++.++|||||||++|||++|..
T Consensus 192 rDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 99999999999999999999999987654432 34678999999999998643 26899999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+....+....++.....+. .......++++.+++.+||...
T Consensus 272 Pf~~~~~~~~~~~i~~~~~~~~------------------------------------~p~~~~~s~~~~~li~~lL~~~ 315 (410)
T 3v8s_A 272 PFYADSLVGTYSKIMNHKNSLT------------------------------------FPDDNDISKEAKNLICAFLTDR 315 (410)
T ss_dssp TTCCSSHHHHHHHHHTHHHHCC------------------------------------CCTTCCCCHHHHHHHHHHSSCG
T ss_pred CCCCCChhhHHHHHHhcccccc------------------------------------CCCcccccHHHHHHHHHHccCh
Confidence 9998887777666554321111 0111224567788888888744
Q ss_pred cceeeccccccccccccceeeeeecC
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+..+ .|.++.++++||||...
T Consensus 316 ~~rl-----gR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 316 EVRL-----GRNGVEEIKRHLFFKND 336 (410)
T ss_dssp GGCT-----TSSCHHHHHTSGGGCCS
T ss_pred hhhC-----CCCCHHHHhcCccccCC
Confidence 4331 15888889999988764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=282.93 Aligned_cols=246 Identities=25% Similarity=0.433 Sum_probs=188.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC------CCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP------HGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
..+.+|+.+++.++||||+++++++..++.+++||||++ |+|.+++... ..+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~ 126 (317)
T 2pmi_A 48 STAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126 (317)
T ss_dssp HHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999 5777765432 369999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
.||+||||||+||+++.++.+||+|||++...... .......+|+.|+|||++.+...++.++|||||||++|||++|.
T Consensus 127 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (317)
T 2pmi_A 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206 (317)
T ss_dssp TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999876532 33345678999999999987666899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhh-hhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDL-TWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
.||.+....+....+....+.+.... .+..... .+...........+... .........++++.+++.+||.
T Consensus 207 ~pf~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 207 PLFPGTNDEEQLKLIFDIMGTPNESL-----WPSVTKLPKYNPNIQQRPPRDLRQV--LQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCTTT-----CGGGGGCTTCCTTCCCCCCCCSHHH--HGGGCSSCCCHHHHHHHHHHSC
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhH-----hhhhhhhhhcccccccccchhHHHh--hcccccccCCHHHHHHHHHHCC
Confidence 99999888888777776544332110 0000000 00000011111112222 1222333467789999999999
Q ss_pred cccceeeccccccccccccceeeeeecCC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.+|..| +++.++++||||.+..
T Consensus 280 ~dP~~R-------pt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 280 LNPDMR-------LSAKQALHHPWFAEYY 301 (317)
T ss_dssp SSGGGS-------CCHHHHTTSGGGGGGC
T ss_pred CCcccC-------CCHHHHhCChhhhccc
Confidence 777666 9999999999998743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=288.01 Aligned_cols=172 Identities=20% Similarity=0.262 Sum_probs=153.5
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+..|..+++.+ +||||+++++++++.+.+|+||||+++|+|..++...+.+++..++.++.|++.||.|||++||
T Consensus 63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi 142 (353)
T 2i0e_A 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142 (353)
T ss_dssp CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 345567788888887 7999999999999999999999999999999998877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+||+++.++.+||+|||++.... ........+||+.|+|||++.+.+ ++.++|+|||||++|||++|..||
T Consensus 143 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf 221 (353)
T 2i0e_A 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPF 221 (353)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCC
Confidence 999999999999999999999999998643 333445678999999999998766 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhc
Q psy763 175 LGNMGSHMARNLLKN 189 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~ 189 (303)
.+....+....++..
T Consensus 222 ~~~~~~~~~~~i~~~ 236 (353)
T 2i0e_A 222 EGEDEDELFQSIMEH 236 (353)
T ss_dssp CCSSHHHHHHHHHHC
T ss_pred CCCCHHHHHHHHHhC
Confidence 988877777666653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=299.74 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++... ..+|+||||++++.+..+ .. .+++..+..++.|++.||+||
T Consensus 104 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~-~~--~l~~~~~~~~~~qil~aL~~l 180 (464)
T 3ttj_A 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QM--ELDHERMSYLLYQMLCGIKHL 180 (464)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHH-TS--CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHH-hh--cCCHHHHHHHHHHHHHHHHHH
Confidence 445677899999999999999999999754 468999999997654444 32 599999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+.. ++.++||||+||++|||++|
T Consensus 181 H~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g 259 (464)
T 3ttj_A 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRH 259 (464)
T ss_dssp HHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHS
T ss_pred HHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999998876655566678999999999999865 89999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcC---CChhHHHHHHhHhCCCC-----CCCchhhH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSK---TSTTTIFKYLLIRGGNT-----DRNSHGVV 242 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~~-----~~~~~~~~ 242 (303)
..||.|....+++..++...+.+...... ..... ...+... .....+...+.....+. ....+++.
T Consensus 260 ~~pF~g~~~~~~~~~i~~~lg~p~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 333 (464)
T 3ttj_A 260 KILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPT-----VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 333 (464)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHT-TSCHH-----HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHH-Hcchh-----hhhHhhcccccCCCChHHhCcccccccccccccccCHHHH
Confidence 99999999999988888875554311110 00000 0011100 00011111100000000 01146789
Q ss_pred Hhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 243 KILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 243 dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
|++.+||..+|..| +++.++++||||..
T Consensus 334 dLl~~mL~~dP~~R-------~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 334 DLLSKMLVIDPAKR-------ISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHSCSSTTTS-------CCHHHHHTSTTTGG
T ss_pred HHHHHHcCCChhhC-------CCHHHHhcChhhhh
Confidence 99999999777666 99999999999963
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.10 Aligned_cols=245 Identities=26% Similarity=0.432 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++.+++||||++ |+|.+++.....+++..+..++.|++.||.|||++||+
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~iv 154 (329)
T 3gbz_A 76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL 154 (329)
T ss_dssp ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 34556789999999999999999999999999999999998 58888887777899999999999999999999999999
Q ss_pred ecccCCCcEEEe-----cCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 97 HRDIKPENILLT-----ANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 97 H~dlk~~nil~~-----~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
||||||+||+++ ..+.+||+|||++...... .......+|+.|+|||++.+...++.++|||||||++|||++|
T Consensus 155 H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 234 (329)
T 3gbz_A 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234 (329)
T ss_dssp CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999994 4456999999999876432 2334457899999999998766689999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+....+....+....+.+.....+. ......|...........+...+ ....++++.+++.+||.
T Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~ 304 (329)
T 3gbz_A 235 TPLFPGDSEIDQLFKIFEVLGLPDDTTWPG----VTALPDWKQSFPKFRGKTLKRVL------GALLDDEGLDLLTAMLE 304 (329)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCTTTSTT----GGGSTTCCTTCCCCCCCCHHHHH------GGGSCHHHHHHHHHHTC
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCchhhhhh----hhhhhhhhhhhhhhccccHhhhc------ccccCHHHHHHHHHHcc
Confidence 999999988888887777644332111110 00001122212211122222221 11246788999999999
Q ss_pred cccceeeccccccccccccceeeeeecCC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.+|..| +++.++++||||...+
T Consensus 305 ~dP~~R-------~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 305 MDPVKR-------ISAKNALEHPYFSHND 326 (329)
T ss_dssp SSGGGS-------CCHHHHHTSGGGSSSC
T ss_pred CChhhC-------CCHHHHhCCcccCCCC
Confidence 777666 9999999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=295.09 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
....+.+|+.+++.++||||+++++++... +.+|+||||++ |+|..++.....+++..+..++.||+.||+|||
T Consensus 68 ~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH 146 (432)
T 3n9x_A 68 DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146 (432)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456678999999999999999999999866 57999999998 589998888888999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCC-----------------------ccccccCCCcccCcccccCC
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-----------------------NYTDYVATRWYRAPELLVGD 148 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~l~~~ 148 (303)
+.||+||||||+|||++.++.+||+|||++....... .....+||++|+|||++.+.
T Consensus 147 ~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 226 (432)
T 3n9x_A 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226 (432)
T ss_dssp HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC
T ss_pred HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC
Confidence 9999999999999999999999999999998765322 12556889999999997666
Q ss_pred ccCCCccchhhHHHHHHHhhccCcc-----------CCCCc-----------------hHHHHHHHhhcCCceeEeecCC
Q psy763 149 TLYGPAVDVWAIEWTSHSYSQIGFI-----------GLGNM-----------------GSHMARNLLKNNGRVTVILKSD 200 (303)
Q Consensus 149 ~~~~~~~DvwSlG~il~el~tg~~~-----------~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~ 200 (303)
..++.++||||+||++|||++|..+ |.|.. ..+++..++...+.++....
T Consensus 227 ~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~-- 304 (432)
T 3n9x_A 227 ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL-- 304 (432)
T ss_dssp SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHH--
T ss_pred CCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHH--
Confidence 6689999999999999999974333 22322 23344444443333221100
Q ss_pred CCCcchhhhhhhhhhcCCChhHHHHHHhHhCCC--------CCCCchhhHHhhhhhhccccceeecccccccccccccee
Q psy763 201 SLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGN--------TDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKT 272 (303)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--------~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~ 272 (303)
..........++...... .+..++++.+++.+||..+|..| +++.++++|
T Consensus 305 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R-------~ta~e~L~H 362 (432)
T 3n9x_A 305 ---------------KNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKR-------ITIDQALDH 362 (432)
T ss_dssp ---------------HTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTS-------CCHHHHHTC
T ss_pred ---------------HhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccC-------CCHHHHhcC
Confidence 000111111111100000 12357889999999999777777 999999999
Q ss_pred eeeecCCc
Q psy763 273 FYIPTPER 280 (303)
Q Consensus 273 ~~~~~~~~ 280 (303)
|||.....
T Consensus 363 p~f~~~~~ 370 (432)
T 3n9x_A 363 PYLKDVRK 370 (432)
T ss_dssp GGGTTTCC
T ss_pred hhhhhccC
Confidence 99987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=286.26 Aligned_cols=224 Identities=23% Similarity=0.253 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.+ +||||+++++++.+.+.+|+||||+++|+|..++.+.+.+++..++.++.|++.||.|||++||
T Consensus 52 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 131 (345)
T 3a8x_A 52 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131 (345)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 445667888888887 8999999999999999999999999999999988877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+||+++.++.+||+|||++.... ........+||+.|+|||++.+.. ++.++|+||+||++|||++|..||
T Consensus 132 vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf 210 (345)
T 3a8x_A 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 210 (345)
T ss_dssp BCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCc
Confidence 999999999999999999999999998643 334445678999999999998765 899999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+........ .......+..+.. .........++++.+++.+||..+|.
T Consensus 211 ~~~~~~~~~~-------------------~~~~~~~~~~i~~------------~~~~~p~~~s~~~~~li~~lL~~dP~ 259 (345)
T 3a8x_A 211 DIVGSSDNPD-------------------QNTEDYLFQVILE------------KQIRIPRSLSVKAASVLKSFLNKDPK 259 (345)
T ss_dssp TTTTC--------------------------CHHHHHHHHHH------------CCCCCCTTSCHHHHHHHHHHTCSSTT
T ss_pred CCcccccccc-------------------cccHHHHHHHHHc------------CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 6421110000 0000000111110 01111233567788999999887666
Q ss_pred eeeccccccccc------cccceeeeeecCC
Q psy763 255 YIQSEKQDSIRG------KNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~------~~~l~~~~~~~~~ 279 (303)
.| +++ .+++.||||...+
T Consensus 260 ~R-------~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 260 ER-------LGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp TS-------TTCCTTTHHHHHHTSGGGTTCC
T ss_pred HC-------CCCCCcCCHHHHhcCCccCCCC
Confidence 66 664 6899999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=289.48 Aligned_cols=242 Identities=25% Similarity=0.378 Sum_probs=188.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++...+ .+|+||||+ +++|..++.. ..+++..+..++.|++.||.||
T Consensus 67 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~L 144 (367)
T 1cm8_A 67 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYI 144 (367)
T ss_dssp HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999998653 469999999 7899998875 5799999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.||+||||||+||+++.++.+||+|||++..... ......+|+.|+|||++.+...++.++||||+||++|||++|
T Consensus 145 H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 222 (367)
T 1cm8_A 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222 (367)
T ss_dssp HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred HHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999987543 334568899999999998755689999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+....+.+..++...+.++...... ..+......... .......++. ...+..++.+.+++.+||.
T Consensus 223 ~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~ll~~mL~ 293 (367)
T 1cm8_A 223 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQR-LQSDEAKNYMKG-LPELEKKDFA-------SILTNASPLAVNLLEKMLV 293 (367)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHT-CSCHHHHHHHHH-SCCCCCCCGG-------GTCTTCCHHHHHHHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHH-hhhHHHHHHHHh-CCCCCCCCHH-------HHCCCCCHHHHHHHHHHcc
Confidence 999999999888888887665543111100 000000000000 0000001110 0112357789999999999
Q ss_pred cccceeeccccccccccccceeeeeecC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.+|..| +++.+++.||||...
T Consensus 294 ~dP~~R-------~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 294 LDAEQR-------VTAGEALAHPYFESL 314 (367)
T ss_dssp SSTTTS-------CCHHHHHHSGGGTTT
T ss_pred CChhHC-------CCHHHHhcChHHHhh
Confidence 777666 999999999999763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.48 Aligned_cols=214 Identities=22% Similarity=0.331 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++...+.+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv 138 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 34568899999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+||+++.++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+
T Consensus 139 HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 99999999999999999999999999877666666778999999999998776457899999999999999999999988
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+....... ....++++.+++.+|+..+|..|
T Consensus 219 ~~~~~~~~~i~~~~~~~----------------------------------------p~~~s~~~~~Li~~~L~~dP~~R 258 (476)
T 2y94_A 219 DHVPTLFKKICDGIFYT----------------------------------------PQYLNPSVISLLKHMLQVDPMKR 258 (476)
T ss_dssp SSSHHHHHHHHTTCCCC----------------------------------------CTTCCHHHHHHHHHHTCSSTTTS
T ss_pred CCHHHHHHHHhcCCcCC----------------------------------------CccCCHHHHHHHHHHcCCCchhC
Confidence 77666655544322110 01124566777777777555555
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.++++||||..
T Consensus 259 -------pt~~eil~hp~~~~ 272 (476)
T 2y94_A 259 -------ATIKDIREHEWFKQ 272 (476)
T ss_dssp -------CCHHHHHTCHHHHT
T ss_pred -------cCHHHHHhCHHhhh
Confidence 88888888888753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=283.61 Aligned_cols=248 Identities=29% Similarity=0.447 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEe--------CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRR--------KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
..+.+|+.+++.++||||+++++++.. .+.+++||||++++.+..+......+++..++.++.|++.||.||
T Consensus 61 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L 140 (351)
T 3mi9_A 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140 (351)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 345679999999999999999999987 457899999999755555665557899999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCC-----CccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|++||+||||||+||+++.++.+||+|||++...... .......+|+.|+|||++.+...++.++|||||||++|
T Consensus 141 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 220 (351)
T 3mi9_A 141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 220 (351)
T ss_dssp HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred HHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHH
Confidence 9999999999999999999999999999999876522 22244578999999999987666899999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhh-hcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEI-FSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
||++|..|+.+.........+....+.++....+.....+. +..+ ......+.....+... ..++.+.++
T Consensus 221 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l 291 (351)
T 3mi9_A 221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL----YEKLELVKGQKRKVKDRLKAY-----VRDPYALDL 291 (351)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGG----GTSSCCCSSCCCCHHHHHHHH-----HCCHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchh----hcccccccccccCHHHHhhhc-----cCChHHHHH
Confidence 99999999999888887777766544433111111000000 0000 0001111111111000 135678899
Q ss_pred hhhhhccccceeeccccccccccccceeeeeecCCcce
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
+.+||..+|..| +++.++++||||...+...
T Consensus 292 i~~~L~~dP~~R-------~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 292 IDKLLVLDPAQR-------IDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp HHHHSCSSGGGS-------CCHHHHHTSGGGGSSSCCC
T ss_pred HHHHhcCChhhC-------CCHHHHhCCCCcCCCCCcc
Confidence 999999776666 9999999999998765543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=297.39 Aligned_cols=239 Identities=26% Similarity=0.377 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
....+.+|+.+++.++||||+++++++... ..+|+|||+++ ++|..++.....+++..++.++.||+.||.|||
T Consensus 95 ~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 173 (458)
T 3rp9_A 95 DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173 (458)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 455678899999999999999999999543 57999999986 788888888888999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCC----------------------------ccccccCCCcccCcc
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----------------------------NYTDYVATRWYRAPE 143 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----------------------------~~~~~~~~~~y~aPE 143 (303)
+.||+||||||+|||++.++.+||+|||++....... .....+||++|+|||
T Consensus 174 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 9999999999999999999999999999998754221 123457899999999
Q ss_pred cccCCccCCCccchhhHHHHHHHhhc-----------cCccCCCCch--------------------HHHHHHHhhcCCc
Q psy763 144 LLVGDTLYGPAVDVWAIEWTSHSYSQ-----------IGFIGLGNMG--------------------SHMARNLLKNNGR 192 (303)
Q Consensus 144 ~l~~~~~~~~~~DvwSlG~il~el~t-----------g~~~~~~~~~--------------------~~~~~~~~~~~~~ 192 (303)
++.+...++.++|||||||++|||++ |.++|.|... .+.+..++...+.
T Consensus 254 ~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~ 333 (458)
T 3rp9_A 254 LILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333 (458)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCC
T ss_pred HhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCC
Confidence 87655568999999999999999998 4555544331 2222323322222
Q ss_pred eeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHh--------CCCCCCCchhhHHhhhhhhccccceeeccccccc
Q psy763 193 VTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIR--------GGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSI 264 (303)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--------~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~ 264 (303)
++. +.+ ..........++... ....+..++++.+|+.+||..+|..| +
T Consensus 334 p~~---------~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R-------~ 389 (458)
T 3rp9_A 334 PSE---------EDI--------EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKR-------I 389 (458)
T ss_dssp CCH---------HHH--------HTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTS-------C
T ss_pred CCH---------HHH--------hhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCcccc-------C
Confidence 110 000 000000111110000 00112347889999999999777777 9
Q ss_pred cccccceeeeeecCCc
Q psy763 265 RGKNCKKTFYIPTPER 280 (303)
Q Consensus 265 ~~~~~l~~~~~~~~~~ 280 (303)
++.++++||||.....
T Consensus 390 t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 390 TINECLAHPFFKEVRI 405 (458)
T ss_dssp CHHHHHHSGGGTTTCC
T ss_pred CHHHHhcCHhhhhcCC
Confidence 9999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=280.48 Aligned_cols=240 Identities=27% Similarity=0.409 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++||||+++++++...+..++||||+++ ++..++.. .+.+++..+..++.|++.||.|||++||+|
T Consensus 45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 123 (288)
T 1ob3_A 45 STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123 (288)
T ss_dssp HHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4567899999999999999999999999999999999996 67666554 468999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++...... .......+|+.|+|||++.+...++.++||||+||++|||++|..||.+
T Consensus 124 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp SCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999765432 2334457899999999998766689999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhh-hhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDL-TWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
....+....+....+.+.....+ ..... .+..........++. ...+..++++.+++.+||..+|..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~ 271 (288)
T 1ob3_A 204 VSEADQLMRIFRILGTPNSKNWP-----NVTELPKYDPNFTVYEPLPWE-------SFLKGLDESGIDLLSKMLKLDPNQ 271 (288)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTST-----TGGGSTTCCTTCCCCCCCCGG-------GTCCSCCHHHHHHHHHHTCSSTTT
T ss_pred CCHHHHHHHHHHHHCCCChhhch-----hhhcccccccccccccCccHH-------HHhhhcCHHHHHHHHHHcCCCccc
Confidence 88887777776643332211000 00000 000000000001110 112335677889999999976666
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
| +++.++++||||.+.
T Consensus 272 R-------pt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 272 R-------ITAKQALEHAYFKEN 287 (288)
T ss_dssp S-------CCHHHHHTSGGGGC-
T ss_pred C-------CCHHHHhcCcchhhc
Confidence 6 999999999999754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=282.63 Aligned_cols=218 Identities=22% Similarity=0.217 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++.+|+||||+++++|..++...+.+++..+..++.|++.||.|||++||+
T Consensus 64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 143 (327)
T 3a62_A 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143 (327)
T ss_dssp -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 44567789999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++.++.+||+|||++..... ........||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 144 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp CCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999999876432 23334568999999999998765 7999999999999999999999998
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+....... .+..++++.+++.+|+..++..
T Consensus 223 ~~~~~~~~~~i~~~~~~~----------------------------------------p~~~~~~~~~li~~~L~~dp~~ 262 (327)
T 3a62_A 223 GENRKKTIDKILKCKLNL----------------------------------------PPYLTQEARDLLKKLLKRNAAS 262 (327)
T ss_dssp CSSHHHHHHHHHHTCCCC----------------------------------------CTTSCHHHHHHHHHHSCSCGGG
T ss_pred CCCHHHHHHHHHhCCCCC----------------------------------------CCCCCHHHHHHHHHHHhcCHhh
Confidence 887777666555432211 1123456778888888866665
Q ss_pred eeccccccccccccceeeeeec
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
|-. ....++.+++.||||..
T Consensus 263 R~~--~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 263 RLG--AGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp STT--SSTTTHHHHHHSGGGSS
T ss_pred ccC--CCCCCHHHHHcCCcccC
Confidence 510 00126778899999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=290.08 Aligned_cols=212 Identities=22% Similarity=0.338 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++...+..++||||+ +|++.+++...+.+++..+..++.|++.||.|||+.||+|
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 131 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 456789999999999999999999999999999999999 5777777766678999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
|||||+||+++.++.+||+|||++.....+......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.
T Consensus 132 ~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp CCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred cCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999988766666667789999999999987764578999999999999999999888654
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
....... .+... .....+..++++.+++.+|+..+|..|
T Consensus 212 ~~~~~~~----------------------------~i~~~------------~~~~p~~~s~~~~~li~~~L~~dP~~R- 250 (336)
T 3h4j_B 212 FIPNLFK----------------------------KVNSC------------VYVMPDFLSPGAQSLIRRMIVADPMQR- 250 (336)
T ss_dssp SSTTCBC----------------------------CCCSS------------CCCCCTTSCHHHHHHHHTTSCSSGGGS-
T ss_pred cHHHHHH----------------------------HHHcC------------CCCCcccCCHHHHHHHHHHcCCChhHC-
Confidence 2211100 00000 001112346778899999998766666
Q ss_pred ccccccccccccceeeeeec
Q psy763 258 SEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.++++||||..
T Consensus 251 ------pt~~eil~hp~~~~ 264 (336)
T 3h4j_B 251 ------ITIQEIRRDPWFNV 264 (336)
T ss_dssp ------CCHHHHTTCHHHHT
T ss_pred ------cCHHHHHhChhhcc
Confidence 99999999999965
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=286.24 Aligned_cols=218 Identities=22% Similarity=0.237 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++.+.+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+
T Consensus 92 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv 171 (387)
T 1kob_A 92 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171 (387)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 346788999999999999999999999999999999999999999988755 4799999999999999999999999999
Q ss_pred ecccCCCcEEEec--CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+||+++. ++.+||+|||++.............+|+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 172 HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf 250 (387)
T 1kob_A 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF 250 (387)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCC
Confidence 9999999999974 4779999999999877655555668999999999998765 799999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+ .......++++.+++.+||..+|.
T Consensus 251 ~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~s~~~~~li~~~L~~dP~ 294 (387)
T 1kob_A 251 AGEDDLETLQNVKRCDWEFD------------------------------------EDAFSSVSPEAKDFIKNLLQKEPR 294 (387)
T ss_dssp CCSSHHHHHHHHHHCCCCCC------------------------------------SSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred CCCCHHHHHHHHHhCCCCCC------------------------------------ccccccCCHHHHHHHHHHcCCChh
Confidence 98877776665544322211 001112456778999999986666
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.| +++.++++|||+....
T Consensus 295 ~R-------pt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 295 KR-------LTVHDALEHPWLKGDH 312 (387)
T ss_dssp GS-------CCHHHHHTSTTTSSCC
T ss_pred HC-------cCHHHHhhCccccCCc
Confidence 65 9999999999997643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=293.63 Aligned_cols=222 Identities=18% Similarity=0.185 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||+++++++++.+.+|+||||+++|+|..++.+. ..+++..++.++.|++.||.|||++||
T Consensus 104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi 183 (412)
T 2vd5_A 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY 183 (412)
T ss_dssp GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3445788999999999999999999999999999999999999999988653 479999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccC------CccCCCccchhhHHHHHHHh
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVG------DTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~------~~~~~~~~DvwSlG~il~el 167 (303)
+||||||+|||++.++.+||+|||++........ ....+||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 184 iHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyel 263 (412)
T 2vd5_A 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263 (412)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHH
T ss_pred eecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHH
Confidence 9999999999999999999999999988654433 234689999999999873 23489999999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
++|..||.+....+....++.....+..+ ......++++.+++.+
T Consensus 264 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-----------------------------------~~~~~~s~~~~dli~~ 308 (412)
T 2vd5_A 264 FYGQTPFYADSTAETYGKIVHYKEHLSLP-----------------------------------LVDEGVPEEARDFIQR 308 (412)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCC---------------------------------------CCCHHHHHHHHT
T ss_pred HhCCCCCCCCCHHHHHHHHHhcccCcCCC-----------------------------------ccccCCCHHHHHHHHH
Confidence 99999999988777766655421111100 0012245677788888
Q ss_pred hhccccceeeccccccccccccceeeeeecC
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
||. .+..|- -+.++.+++.||||...
T Consensus 309 lL~-~p~~Rl----gr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 309 LLC-PPETRL----GRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp TSS-CGGGCT----TTTTHHHHHTSGGGTTC
T ss_pred HcC-ChhhcC----CCCCHHHHhcCCCcCCC
Confidence 876 443331 13578888888888653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=296.59 Aligned_cols=215 Identities=20% Similarity=0.251 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i 95 (303)
....+.+|+.+++.++||||+++++++...+.+|+||||+++|+|..++.....+++..+..++.|++.||.|||+ .||
T Consensus 191 ~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gi 270 (446)
T 4ejn_A 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270 (446)
T ss_dssp ----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence 3455678899999999999999999999999999999999999999988877889999999999999999999998 999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+|||++.++.+||+|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 271 iHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf 349 (446)
T 4ejn_A 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF 349 (446)
T ss_dssp CCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCC
Confidence 999999999999999999999999997643 233445678999999999998765 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.....+. ....++++.+++.+||..+|.
T Consensus 350 ~~~~~~~~~~~i~~~~~~~----------------------------------------p~~~~~~~~~li~~~L~~dP~ 389 (446)
T 4ejn_A 350 YNQDHEKLFELILMEEIRF----------------------------------------PRTLGPEAKSLLSGLLKKDPK 389 (446)
T ss_dssp CCSSHHHHHHHHHHCCCCC----------------------------------------CTTSCHHHHHHHHHHTCSSTT
T ss_pred CCCCHHHHHHHHHhCCCCC----------------------------------------CccCCHHHHHHHHHHcccCHH
Confidence 8887777666554432221 112346778889899886666
Q ss_pred eeeccccccc-----cccccceeeeeecCC
Q psy763 255 YIQSEKQDSI-----RGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~-----~~~~~l~~~~~~~~~ 279 (303)
.| + ++.++++||||...+
T Consensus 390 ~R-------~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 390 QR-------LGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp TS-------TTCSTTTHHHHHTSGGGTTCC
T ss_pred Hh-------CCCCCCCHHHHHhCccccCCC
Confidence 55 7 899999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=276.98 Aligned_cols=233 Identities=28% Similarity=0.409 Sum_probs=179.1
Q ss_pred HHHHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHHcCCCC--CCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 25 KKEKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 25 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.++.++||||+++++++.... ..++|+|+++ ++|.+++..... +++..++.++.|++.||+|||++||+|
T Consensus 65 l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 143 (308)
T 3g33_A 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVH 143 (308)
T ss_dssp HHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 33444556999999999998765 5899999998 588887766543 999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
|||||+||+++.++.+||+|||++.............+|+.|+|||++.+.. ++.++||||+||++|||++|..||.+.
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999998776555556678999999999998766 899999999999999999999999999
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
...+....+....+.++....+...... ...+.....++.... .+...+.+.+++.+||..+|..|
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R- 288 (308)
T 3g33_A 223 SEADQLGKIFDLIGLPPEDDWPRDVSLP------RGAFPPRGPRPVQSV-------VPEMEESGAQLLLEMLTFNPHKR- 288 (308)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSCSSCSSC------GGGSCCCCCCCHHHH-------SCSCCHHHHHHHHHHTCSSTTTS-
T ss_pred CHHHHHHHHHHHhCCCChhhccchhhcc------ccccCCCCCCcHHHh-------CccccHHHHHHHHHHhcCCCccC-
Confidence 9888888877764443311111110000 011111122222222 12456788999999999766666
Q ss_pred ccccccccccccceeeeeecCC
Q psy763 258 SEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+++.++++||||...+
T Consensus 289 ------~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 289 ------ISAFRALQHSYLHKDE 304 (308)
T ss_dssp ------CCHHHHHTSTTC----
T ss_pred ------CCHHHHhcCccccCCC
Confidence 9999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=286.66 Aligned_cols=218 Identities=23% Similarity=0.263 Sum_probs=184.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++||||+++++++...+.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||
T Consensus 129 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 208 (373)
T 2x4f_A 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI 208 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 345678999999999999999999999999999999999999999886643 4579999999999999999999999999
Q ss_pred eecccCCCcEEE--ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 96 IHRDIKPENILL--TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 96 vH~dlk~~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||||||+|||+ +.++.+||+|||++.............||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 209 vH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p 287 (373)
T 2x4f_A 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSP 287 (373)
T ss_dssp ECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCC
Confidence 999999999999 456789999999999877666556678999999999987655 79999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
|.+....+....++.....++ .+ .....++++.+++.+||..++
T Consensus 288 f~~~~~~~~~~~i~~~~~~~~---------~~---------------------------~~~~~~~~~~~li~~~L~~dp 331 (373)
T 2x4f_A 288 FLGDNDAETLNNILACRWDLE---------DE---------------------------EFQDISEEAKEFISKLLIKEK 331 (373)
T ss_dssp TCCSSHHHHHHHHHHTCCCSC---------SG---------------------------GGTTSCHHHHHHHHTTSCSSG
T ss_pred CCCCCHHHHHHHHHhccCCCC---------hh---------------------------hhccCCHHHHHHHHHHcCCCh
Confidence 999888877777665433211 00 001235678899999999766
Q ss_pred ceeeccccccccccccceeeeeecC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
..| +++.++++||||.+.
T Consensus 332 ~~R-------ps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 332 SWR-------ISASEALKHPWLSDH 349 (373)
T ss_dssp GGS-------CCHHHHHHSHHHHCH
T ss_pred hhC-------CCHHHHhcCcCcCCC
Confidence 666 999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.75 Aligned_cols=168 Identities=24% Similarity=0.298 Sum_probs=146.8
Q ss_pred HHHHHHH-HHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 21 EATNKKE-KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 21 ~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
+.+|... ++.++||||+++++++.+.+.+|+||||+++|+|..++.+.+.+++..++.++.||+.||.|||++||+|||
T Consensus 85 ~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrD 164 (373)
T 2r5t_A 85 IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 164 (373)
T ss_dssp ------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 3444444 678999999999999999999999999999999999988777899999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 100 IKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
|||+|||++.++.+||+|||++.... ........+||+.|+|||++.+.. ++.++|+|||||++|||++|..||.+..
T Consensus 165 lkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999998643 333445678999999999998766 8999999999999999999999999988
Q ss_pred hHHHHHHHhhc
Q psy763 179 GSHMARNLLKN 189 (303)
Q Consensus 179 ~~~~~~~~~~~ 189 (303)
..+....++..
T Consensus 244 ~~~~~~~i~~~ 254 (373)
T 2r5t_A 244 TAEMYDNILNK 254 (373)
T ss_dssp HHHHHHHHHHS
T ss_pred HHHHHHHHHhc
Confidence 88777766654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=288.36 Aligned_cols=252 Identities=15% Similarity=0.121 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 69 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 148 (389)
T 3gni_B 69 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG 148 (389)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4567888999999999999999999999999999999999999999987654 67999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCC--------CccccccCCCcccCcccccCC-ccCCCccchhhHHHHHH
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPG--------ENYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~ 165 (303)
|+||||||+|||++.++.+||+|||.+...... .......||+.|+|||++.+. ..++.++||||+||++|
T Consensus 149 ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 228 (389)
T 3gni_B 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228 (389)
T ss_dssp EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHH
Confidence 999999999999999999999999988654321 112334788999999999863 34899999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhh---------hhhhhhhcCCChhHHHHHHhHhCCCCCC
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWD---------LTWQEIFSKTSTTTIFKYLLIRGGNTDR 236 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 236 (303)
||++|..||.+....+.....+...... .......+.+... ............++..... ........
T Consensus 229 el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 305 (389)
T 3gni_B 229 ELANGHVPFKDMPATQMLLEKLNGTVPC--LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS-PSHPYHRT 305 (389)
T ss_dssp HHHHSSCTTTTCCSTTHHHHC-----------------------------------------------------------
T ss_pred HHHHCCCCCCCCCHHHHHHHHhcCCCCc--cccccccccccccccccccccccccccccccCccccccCCC-CCCccccc
Confidence 9999999998877766665544432211 1110000000000 0000000000001100000 01123344
Q ss_pred CchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 237 NSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 237 ~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.++++.+++.+||..+|..| +++.++++||||...
T Consensus 306 ~s~~~~~li~~~L~~dP~~R-------pta~ell~hp~f~~~ 340 (389)
T 3gni_B 306 FSPHFHHFVEQCLQRNPDAR-------PSASTLLNHSFFKQI 340 (389)
T ss_dssp CCHHHHHHHHHHTCSCTTTS-------CCHHHHTTSGGGGGC
T ss_pred cCHHHHHHHHHHhhcCcccC-------CCHHHHhcCHHHHHH
Confidence 57889999999999766666 999999999999763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=283.67 Aligned_cols=241 Identities=26% Similarity=0.406 Sum_probs=180.1
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
+.+|+.+++.++||||+++++++..++..++||||+++ ++..++ ..+..+++..+..++.|++.||.|||+.||+|||
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 125 (324)
T 3mtl_A 47 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125 (324)
T ss_dssp CCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred HHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence 45689999999999999999999999999999999995 555544 4456799999999999999999999999999999
Q ss_pred cCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 100 IKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 100 lk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
|||+||+++.++.+||+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+..
T Consensus 126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp CCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999865432 233445789999999999876668999999999999999999999999998
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhh-cCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIF-SKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
..+....+....+.+.....+..... ..+.... .......+... .+..++++.+++.+||..+|..|
T Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R- 273 (324)
T 3mtl_A 206 VEEQLHFIFRILGTPTEETWPGILSN----EEFKTYNYPKYRAEALLSH-------APRLDSDGADLLTKLLQFEGRNR- 273 (324)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGC----HHHHHTCCCCCCCCCHHHH-------CTTSCHHHHHHHHHHSCSSGGGS-
T ss_pred HHHHHHHHHHHhCCCChHhchhhhcc----hhhcccccccccchhhhhh-------cCCCCHHHHHHHHHHcCcCcccC-
Confidence 88888877776554321111110000 0010000 00111111111 12356788999999999766666
Q ss_pred ccccccccccccceeeeeecCCc
Q psy763 258 SEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+++.++++||||.....
T Consensus 274 ------~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 274 ------ISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp ------CCHHHHTTSGGGGGGCS
T ss_pred ------CCHHHHhcChhhhhccc
Confidence 99999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=280.69 Aligned_cols=219 Identities=21% Similarity=0.302 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH 138 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 45678899999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cccCCCcEEEecCC----cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 98 RDIKPENILLTANG----VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||||+||+++.++ .+||+|||++.............||+.|+|||.+.+.. ++.++|||||||++|+|++|..|
T Consensus 139 ~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCC
Confidence 99999999999887 79999999998876655556678999999999998765 79999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+.+....+....+.......+ .+ . ....++.+.+++.+|+..+|
T Consensus 218 f~~~~~~~~~~~i~~~~~~~~---------~~-----------------~----------~~~~~~~~~~li~~~l~~dp 261 (321)
T 2a2a_A 218 FLGDTKQETLANITSVSYDFD---------EE-----------------F----------FSHTSELAKDFIRKLLVKET 261 (321)
T ss_dssp SCCSSHHHHHHHHHTTCCCCC---------HH-----------------H----------HTTCCHHHHHHHHTTSCSST
T ss_pred CCCCCHHHHHHHHHhcccccC---------hh-----------------h----------hcccCHHHHHHHHHHcCCCh
Confidence 988877776665544322110 00 0 01234567889999998666
Q ss_pred ceeeccccccccccccceeeeeecCCc
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
..| +++.+++.|||+...+.
T Consensus 262 ~~R-------ps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 262 RKR-------LTIQEALRHPWITPVDN 281 (321)
T ss_dssp TTS-------CCHHHHHHSTTTSCSSH
T ss_pred hhC-------cCHHHHhcCccccCCCc
Confidence 666 99999999999976543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=296.01 Aligned_cols=215 Identities=21% Similarity=0.224 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.....+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|..++...+ .+++..++.++.||+.||.|||++
T Consensus 226 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~ 305 (576)
T 2acx_A 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305 (576)
T ss_dssp TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345667889999999999999999999999999999999999999999887644 499999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+.. ++.++||||+||++|||++|..|
T Consensus 306 gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~P 384 (576)
T 2acx_A 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSP 384 (576)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCS
T ss_pred CEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999998876655556678999999999998765 89999999999999999999999
Q ss_pred CCCCch---HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 174 GLGNMG---SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 174 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
|.+... ...+...+... ........++++.+++.+||.
T Consensus 385 F~~~~~~~~~~~i~~~i~~~---------------------------------------~~~~p~~~s~~~~dLI~~lL~ 425 (576)
T 2acx_A 385 FQQRKKKIKREEVERLVKEV---------------------------------------PEEYSERFSPQARSLCSQLLC 425 (576)
T ss_dssp SSCSSSCCCHHHHHHHHHHC---------------------------------------CCCCCTTSCHHHHHHHHHHTC
T ss_pred CcccccchhHHHHHHHhhcc---------------------------------------cccCCccCCHHHHHHHHHhcc
Confidence 876532 11111111100 111122345778899999988
Q ss_pred cccceeeccccccc-----cccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSI-----RGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~-----~~~~~l~~~~~~~ 277 (303)
.+|..| + ++.+++.||||..
T Consensus 426 ~dP~~R-------~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 426 KDPAER-------LGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp SSGGGS-------TTCSSSHHHHHHTSGGGTT
T ss_pred CCHHHc-------CCCCCCCHHHHHhChhhcc
Confidence 776666 6 7889999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=288.58 Aligned_cols=235 Identities=27% Similarity=0.405 Sum_probs=185.9
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELE---NHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.+|+.+++.++||||+++++++...+ .+++||||++++.+.... .....+++..++.++.|++.||.|||+
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36899999999999999999996543 388999999987655433 345689999999999999999999999
Q ss_pred CCceecccCCCcEEEe-cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLT-ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+||+||||||+||+++ .++.+||+|||++.............+|+.|+|||++.+...++.++||||+||++|||++|.
T Consensus 160 ~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 239 (394)
T 4e7w_A 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239 (394)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999 789999999999998766666667789999999999987766899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhh----hcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEI----FSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
.||.+....+.+..++...+.+.... +......+ +......++... ..+..++++.+++.+
T Consensus 240 ~pf~~~~~~~~l~~i~~~~g~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~ 304 (394)
T 4e7w_A 240 PLFPGESGIDQLVEIIKVLGTPSREQ---------IKTMNPNYMEHKFPQIRPHPFSKV------FRPRTPPDAIDLISR 304 (394)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHH---------HHHHCGGGSSSCCCCCCCCCHHHH------SCTTCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHH---------HHhhChhhhhhccccccCCcHHHh------ccccCCHHHHHHHHH
Confidence 99999998888888877655432110 00000000 011111222222 123356789999999
Q ss_pred hhccccceeeccccccccccccceeeeeecC
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
||..+|..| +++.+++.||||...
T Consensus 305 ~L~~dP~~R-------~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 305 LLEYTPSAR-------LTAIEALCHPFFDEL 328 (394)
T ss_dssp HCCSSGGGS-------CCHHHHHTSGGGSTT
T ss_pred HhCCChhhC-------CCHHHHhcChhhhhh
Confidence 999777666 999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=282.27 Aligned_cols=220 Identities=22% Similarity=0.284 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|
T Consensus 92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 171 (349)
T 2w4o_A 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171 (349)
T ss_dssp -------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 35677899999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cccCCCcEEEec---CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++. ++.+||+|||++.............||+.|+|||++.+.. ++.++|||||||++|||++|..|+
T Consensus 172 ~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf 250 (349)
T 2w4o_A 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPF 250 (349)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence 999999999975 7899999999998766544445678999999999998765 899999999999999999999998
Q ss_pred CCCchHHHH-HHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 175 LGNMGSHMA-RNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 175 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
.+....+.. ..+........ ....+..+.++.+++.+|+..+|
T Consensus 251 ~~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~L~~dP 294 (349)
T 2w4o_A 251 YDERGDQFMFRRILNCEYYFI------------------------------------SPWWDEVSLNAKDLVRKLIVLDP 294 (349)
T ss_dssp CCTTCHHHHHHHHHTTCCCCC------------------------------------TTTTTTSCHHHHHHHHTTSCSSG
T ss_pred CCCcccHHHHHHHHhCCCccC------------------------------------CchhhhCCHHHHHHHHHHccCCh
Confidence 877655433 33322211100 00112245677899999999777
Q ss_pred ceeeccccccccccccceeeeeecCCcc
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
..| +++.++++|||+......
T Consensus 295 ~~R-------pt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 295 KKR-------LTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp GGS-------CCHHHHHHSTTTTSTTCC
T ss_pred hhC-------cCHHHHhcCcccCCCccc
Confidence 666 999999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=277.79 Aligned_cols=247 Identities=40% Similarity=0.613 Sum_probs=183.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++..++..++||||++++++..+......+++..+..++.|++.||.|||+.|++
T Consensus 45 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iv 124 (311)
T 4agu_A 45 IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 35567789999999999999999999999999999999999999999988888899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||||+||+++.++.+||+|||++..... ........+|+.|+|||.+.+...++.++||||+||++|+|++|..|+.
T Consensus 125 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999987653 2333456789999999999876668999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc--CCC-hhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS--KTS-TTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
+....+....+....+........ ......+..... .+. ..++... .+..++.+.+++.+|+..+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~d 272 (311)
T 4agu_A 205 GKSDVDQLYLIRKTLGDLIPRHQQ-----VFSTNQYFSGVKIPDPEDMEPLELK-------FPNISYPALGLLKGCLHMD 272 (311)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHH-----HHHTCGGGTTCCCCCCSSCCCHHHH-------CTTCCHHHHHHHHHHCCSS
T ss_pred CCCHHHHHHHHHHHhccccccccc-----ccccccccccCcCCCccccchhhhh-------cccccHHHHHHHHHHccCC
Confidence 888877766655543322100000 000000000000 000 0000000 1235667889999999976
Q ss_pred cceeeccccccccccccceeeeeecCCcce
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
|..| +++.++++||||.......
T Consensus 273 P~~R-------pt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 273 PTER-------LTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TTTS-------CCHHHHHTSGGGTTCC---
T ss_pred hhhc-------CCHHHHhcChHHHhccCHH
Confidence 6666 9999999999998865443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=288.78 Aligned_cols=213 Identities=24% Similarity=0.298 Sum_probs=161.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.+|+..++.++||||+++++++.+.+.+++||||+++|+|..++...+.+++..++.++.|++.||+|||++||+||
T Consensus 61 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~ 140 (361)
T 3uc3_A 61 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHR 140 (361)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSC
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 44678999999999999999999999999999999999999999988777789999999999999999999999999999
Q ss_pred ccCCCcEEEecCCc--EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 99 DIKPENILLTANGV--VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 99 dlk~~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||+||+++.++. +||+|||++.............||+.|+|||++.+....+.++||||+||++|+|++|..||.+
T Consensus 141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp CCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred CCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 99999999987765 9999999998655444455678999999999998766334559999999999999999999876
Q ss_pred CchHHH----HHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 177 NMGSHM----ARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 177 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
...... ...+...... .......++++.+++.+||..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 221 PEEPRDYRKTIQRILSVKYS--------------------------------------IPDDIRISPECCHLISRIFVAD 262 (361)
T ss_dssp ---CCCHHHHHHHHHTTCCC--------------------------------------CCTTSCCCHHHHHHHHHHSCSC
T ss_pred CccHHHHHHHHHHHhcCCCC--------------------------------------CCCcCCCCHHHHHHHHHHccCC
Confidence 433221 1111111100 0111124567788999998866
Q ss_pred cceeeccccccccccccceeeeee
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
|..| +++.++++||||.
T Consensus 263 P~~R-------ps~~ell~hp~f~ 279 (361)
T 3uc3_A 263 PATR-------ISIPEIKTHSWFL 279 (361)
T ss_dssp TTTS-------CCHHHHHTSHHHH
T ss_pred hhHC-------cCHHHHHhCcchh
Confidence 6655 9999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=285.18 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++... ..+|+|+|++ +++|..++.. ..+++..+..++.|++.||.||
T Consensus 71 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~L 148 (367)
T 2fst_X 71 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 148 (367)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 445677899999999999999999999754 5689999999 5888888765 5799999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.||+||||||+||+++.++.+||+|||++..... ......+|+.|+|||++.+...++.++||||+||++|||++|
T Consensus 149 H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 226 (367)
T 2fst_X 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226 (367)
T ss_dssp HHTTCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHS
T ss_pred HHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999987543 234568899999999998755689999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+....+.+..++...+.+...... ....+........+ ......++... ....++.+.+++.+||.
T Consensus 227 ~~pf~~~~~~~~l~~i~~~~g~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~dLl~~mL~ 297 (367)
T 2fst_X 227 RTLFPGTDHIDQLKLILRLVGTPGAELLK-KISSESARNYIQSL-TQMPKMNFANV-------FIGANPLAVDLLEKMLV 297 (367)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHT-TCCCHHHHHHHHTS-CCCCCCCHHHH-------TTTCCHHHHHHHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHH-HhhhHHHHHHHhcc-CCCCCCCHHHH-------CCCCCHHHHHHHHHhCC
Confidence 99999999888888888765554321111 11111111001111 11111112111 12346789999999999
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|..| +++.+++.||||..
T Consensus 298 ~dP~~R-------~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 298 LDSDKR-------ITAAQALAHAYFAQ 317 (367)
T ss_dssp SSGGGS-------CCHHHHHTSGGGTT
T ss_pred CCcccC-------cCHHHHhcChhhhh
Confidence 777776 99999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=281.21 Aligned_cols=218 Identities=23% Similarity=0.248 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+|
T Consensus 49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH 128 (323)
T 3tki_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128 (323)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 35678899999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++.++.+||+|||++....... ......||+.|+|||++.+...++.++||||+||++|+|++|..||
T Consensus 129 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 208 (323)
T 3tki_A 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (323)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654222 2345689999999999987764578999999999999999999988
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+................ ........++.+.+++.+||..+|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~li~~~L~~dP~ 251 (323)
T 3tki_A 209 DQPSDSCQEYSDWKEKKT-------------------------------------YLNPWKKIDSAPLALLHKILVENPS 251 (323)
T ss_dssp SSSCTTSHHHHHHHTTCT-------------------------------------TSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CCCchHHHHHHHHhcccc-------------------------------------cCCccccCCHHHHHHHHHHccCChh
Confidence 765443222111111000 0000122456778899999986666
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.| +++.++++||||..+.
T Consensus 252 ~R-------~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 252 AR-------ITIPDIKKDRWYNKPL 269 (323)
T ss_dssp TS-------CCHHHHTTCTTTTCCC
T ss_pred hC-------cCHHHHhhChhhcccc
Confidence 66 9999999999997643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.83 Aligned_cols=219 Identities=24% Similarity=0.277 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++..++..++||||++++++...+.....+++..+..++.|++.||.|||+.|++|
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 128 (284)
T 3kk8_A 49 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128 (284)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCc
Confidence 45677899999999999999999999999999999999999999888777778999999999999999999999999999
Q ss_pred cccCCCcEEEecCCc---EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTANGV---VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++.++. +||+|||++.............+|+.|+|||.+.+.. ++.++||||+||++|+|++|..|+
T Consensus 129 ~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf 207 (284)
T 3kk8_A 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPF 207 (284)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCC
Confidence 999999999986654 9999999998876655556678999999999998765 799999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+. ......++++.+++.+|+..+|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~~l~~dp~ 251 (284)
T 3kk8_A 208 WDEDQHRLYAQIKAGAYDYPS------------------------------------PEWDTVTPEAKSLIDSMLTVNPK 251 (284)
T ss_dssp CCSSHHHHHHHHHHTCCCCCT------------------------------------TTTTTSCHHHHHHHHHHSCSSTT
T ss_pred CCCchhHHHHHHHhccccCCc------------------------------------hhhcccCHHHHHHHHHHcccChh
Confidence 888777766655443322110 00012346677899999986666
Q ss_pred eeeccccccccccccceeeeeecCCc
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
.| +++.++++|||+.....
T Consensus 252 ~R-------ps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 252 KR-------ITADQALKVPWICNRER 270 (284)
T ss_dssp TS-------CCHHHHTTSHHHHSCCC
T ss_pred hC-------CCHHHHhcCccccCChh
Confidence 66 99999999999977544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=267.79 Aligned_cols=215 Identities=25% Similarity=0.331 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.....+++..+..++.|++.||.|||++|++|
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 129 (277)
T 3f3z_A 50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129 (277)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 45678899999999999999999999999999999999999999998877778999999999999999999999999999
Q ss_pred cccCCCcEEE---ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILL---TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||+||++ +.++.++|+|||++.............+|+.|+|||.+.+. ++.++||||+||++|+|++|..|+
T Consensus 130 ~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~ 207 (277)
T 3f3z_A 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPF 207 (277)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCC
Confidence 9999999999 77889999999999887766666677899999999998754 799999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+ . ..+ ...++.+.+++.+|+..+|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~---------~-------~~~--------------------~~~~~~~~~li~~~l~~dp~ 251 (277)
T 3f3z_A 208 SAPTDSEVMLKIREGTFTFP---------E-------KDW--------------------LNVSPQAESLIRRLLTKSPK 251 (277)
T ss_dssp CCSSHHHHHHHHHHCCCCCC---------H-------HHH--------------------TTSCHHHHHHHHHHTCSSTT
T ss_pred CCCCHHHHHHHHHhCCCCCC---------c-------hhh--------------------hcCCHHHHHHHHHHccCChh
Confidence 88877777665554332221 0 000 01346778899999986666
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.++++||||..
T Consensus 252 ~R-------~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 252 QR-------ITSLQALEHEWFEK 267 (277)
T ss_dssp TS-------CCHHHHTTSHHHHH
T ss_pred hC-------cCHHHHhcCHHHhc
Confidence 66 99999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=278.76 Aligned_cols=243 Identities=37% Similarity=0.576 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++...+..++||||++++++..+......+++..+..++.|++.||.|||+.|++
T Consensus 67 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 146 (331)
T 4aaa_A 67 VKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146 (331)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 34567789999999999999999999999999999999999999999988778899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||||+||+++.++.+||+|||++..... ........+|+.|+|||.+.+...++.++||||+||++|+|++|..||.
T Consensus 147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999977543 2333456789999999999876568999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhh--hhhhhhh-cC-CChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWD--LTWQEIF-SK-TSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~-~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
+....+....+....+....... ..+. ..+.... .. ....+.... .+..++.+.+++.+|+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~L~~ 293 (331)
T 4aaa_A 227 GDSDIDQLYHIMMCLGNLIPRHQ------ELFNKNPVFAGVRLPEIKEREPLERR-------YPKLSEVVIDLAKKCLHI 293 (331)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHH------HHHHHCGGGTTCCCCCCSSCCCHHHH-------STTSCHHHHHHHHHHTCS
T ss_pred CCCcHHHHHHHHHHhCCCChhhh------hHhhhccccccccCccccccchhhhc-------ccchhHHHHHHHHHHhcc
Confidence 98888877777665443211000 0000 0000000 00 000111111 123467788999999997
Q ss_pred ccceeeccccccccccccceeeeeecCC
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+|..| +++.++++||||....
T Consensus 294 dP~~R-------pt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 294 DPDKR-------PFCAELLHHDFFQMDG 314 (331)
T ss_dssp SGGGS-------CCGGGGGGSHHHHGGG
T ss_pred CcccC-------CCHHHHhcCchhccCC
Confidence 77666 9999999999997654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=273.18 Aligned_cols=218 Identities=22% Similarity=0.299 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|
T Consensus 86 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 164 (321)
T 2c30_A 86 RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIH 164 (321)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 45577899999999999999999999999999999999999999998875 47999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+.+
T Consensus 165 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999876543 2335568999999999998665 89999999999999999999999988
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+....... .......++.+.+++.+|+..+|..|
T Consensus 244 ~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~R 286 (321)
T 2c30_A 244 DSPVQAMKRLRDSPPPK-------------------------------------LKNSHKVSPVLRDFLERMLVRDPQER 286 (321)
T ss_dssp SCHHHHHHHHHHSSCCC-------------------------------------CTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred CCHHHHHHHHhcCCCCC-------------------------------------cCccccCCHHHHHHHHHHccCChhhC
Confidence 77766655443321110 00001134567789999988666655
Q ss_pred eccccccccccccceeeeeecCCcc
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+++.+++.|||+.....+
T Consensus 287 -------ps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 287 -------ATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp -------CCHHHHHTSGGGGGCCCG
T ss_pred -------cCHHHHhcChhhccCCCc
Confidence 999999999999765543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.68 Aligned_cols=210 Identities=23% Similarity=0.235 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHH-HcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.++..+.+..+||||+++++++.+++.+++||||+.+ ++..+ ...+..+++..++.++.|++.||.|||+.||+
T Consensus 101 ~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 179 (311)
T 3p1a_A 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 34444555566667999999999999999999999999964 55554 44455799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+||+++.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|||++|..++++
T Consensus 180 H~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999988765555556679999999999876 389999999999999999999888776
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+.+. . +. ....+ ....++++.+++.+|+..+|..|
T Consensus 258 ~~~~~~~~---~-~~---------------------------~~~~~----------~~~~~~~l~~li~~~L~~dP~~R 296 (311)
T 3p1a_A 258 GEGWQQLR---Q-GY---------------------------LPPEF----------TAGLSSELRSVLVMMLEPDPKLR 296 (311)
T ss_dssp HHHHHHHT---T-TC---------------------------CCHHH----------HTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ccHHHHHh---c-cC---------------------------CCccc----------ccCCCHHHHHHHHHHcCCChhhC
Confidence 54433221 0 00 00000 01245678899999999766666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.++++||||..|
T Consensus 297 -------pt~~ell~hp~~~~p 311 (311)
T 3p1a_A 297 -------ATAEALLALPVLRQP 311 (311)
T ss_dssp -------CCHHHHHTSGGGSCC
T ss_pred -------cCHHHHHhCccccCC
Confidence 999999999999765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=279.93 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=186.0
Q ss_pred HHHHHHHHHHHhCC-CCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 19 ATEATNKKEKRSLK-HPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+|+.+++.++ ||||+++++++.+ ....++||||++++++..++. .+++..+..++.|++.||.|||++||
T Consensus 75 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i 151 (330)
T 3nsz_A 75 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGI 151 (330)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45778999999997 9999999999998 668999999999999999875 58999999999999999999999999
Q ss_pred eecccCCCcEEEecCC-cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANG-VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+||+++.++ .+||+|||++.............+++.|+|||.+.+...++.++||||+||++|+|++|..|+
T Consensus 152 vH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred eeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999999999776 899999999998776666666789999999999987566899999999999999999999887
Q ss_pred CCC-chHHHHHHHhhcCCceeEee---cC-CCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 175 LGN-MGSHMARNLLKNNGRVTVIL---KS-DSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 175 ~~~-~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
... ...+.+..+....+...... .. ....+ .+...........+..+ .........++++.+++.+||
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L 304 (330)
T 3nsz_A 232 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP-----RFNDILGRHSRKRWERF--VHSENQHLVSPEALDFLDKLL 304 (330)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT-----HHHHHHCCCCCCCGGGG--CCTTTGGGCCHHHHHHHHTTS
T ss_pred ccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc-----chhhhhhhccccchhhh--ccccccccCCHHHHHHHHHHh
Confidence 543 44444444433322211000 00 00000 11222222222233222 222333446788999999999
Q ss_pred ccccceeeccccccccccccceeeeeecCC
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
..+|..| +++.++++||||.+..
T Consensus 305 ~~dP~~R-------pta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 305 RYDHQSR-------LTAREAMEHPYFYTVV 327 (330)
T ss_dssp CSSGGGS-------CCHHHHHTSGGGTTCC
T ss_pred cCCcccC-------CCHHHHhcCccHhhhc
Confidence 9777666 9999999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=286.79 Aligned_cols=238 Identities=29% Similarity=0.483 Sum_probs=171.5
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHc---------CCCCCCHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELEN---------HPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~---------~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
.+.+|+.+++.++||||+++++++.. +..+++||||+++ ++..++. ....+++..++.++.||+.||.
T Consensus 64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~ 142 (405)
T 3rgf_A 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142 (405)
T ss_dssp HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999965 6789999999986 5554432 1225999999999999999999
Q ss_pred HHHHCCceecccCCCcEEE----ecCCcEEEccccceeeeCCC----CccccccCCCcccCcccccCCccCCCccchhhH
Q psy763 89 YCHRHACIHRDIKPENILL----TANGVVKLCDFGFARLINPG----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
|||+.||+||||||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+...++.++||||+
T Consensus 143 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 222 (405)
T 3rgf_A 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222 (405)
T ss_dssp HHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHH
T ss_pred HHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHH
Confidence 9999999999999999999 66789999999999876432 223456789999999999876668999999999
Q ss_pred HHHHHHhhccCccCCCCch---------HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChh----------
Q psy763 161 EWTSHSYSQIGFIGLGNMG---------SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTT---------- 221 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 221 (303)
||++|||++|..||.+... .+.+..++...+.+... . |..+..-+...
T Consensus 223 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~---------~----~~~~~~~~~~~~~~~~~~~~~ 289 (405)
T 3rgf_A 223 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK---------D----WEDIKKMPEHSTLMKDFRRNT 289 (405)
T ss_dssp HHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTT---------T----CGGGGGSTTHHHHHHHCCGGG
T ss_pred HHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChh---------h----cchhhcCcchhhhhhhccccC
Confidence 9999999999999976654 35555555544432210 0 11111111111
Q ss_pred ----HHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 222 ----TIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 222 ----~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.....+ ........+.+.+++.+||..+|..| +++.++++||||...+..
T Consensus 290 ~~~~~~~~~~---~~~~~~~~~~~~~Ll~~~L~~dP~~R-------~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 290 YTNCSLIKYM---EKHKVKPDSKAFHLLQKLLTMDPIKR-------ITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp GTTCCHHHHH---HTTTCCTTSHHHHHHHHHSCSSGGGS-------CCHHHHHTSGGGTSSSCC
T ss_pred CCcchhhhhH---hhcCCCCCHHHHHHHHHHccCCcccC-------CCHHHHhcChhhccCCCC
Confidence 111111 11222346788999999999777666 999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=275.10 Aligned_cols=215 Identities=23% Similarity=0.303 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.+.+.+|+.+++.++||||+++++++.+++.+|+||||+++++|...+.. +..+++..+..++.|++.||.|||++
T Consensus 70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 149 (351)
T 3c0i_A 70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149 (351)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678999999999999999999999999999999999999999876532 34689999999999999999999999
Q ss_pred CceecccCCCcEEEecCCc---EEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGV---VKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~---~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
||+||||||+||+++.++. +||+|||++........ .....||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus 150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~ 228 (351)
T 3c0i_A 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLS 228 (351)
T ss_dssp TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHH
Confidence 9999999999999986654 99999999988764332 34568999999999998765 8999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..||.+.. .+....+........ ...+ ...++++.+++.+||
T Consensus 229 g~~pf~~~~-~~~~~~i~~~~~~~~-------------------------~~~~-----------~~~s~~~~~li~~~L 271 (351)
T 3c0i_A 229 GCLPFYGTK-ERLFEGIIKGKYKMN-------------------------PRQW-----------SHISESAKDLVRRML 271 (351)
T ss_dssp SSCSSCSSH-HHHHHHHHHTCCCCC-------------------------HHHH-----------TTSCHHHHHHHHHHT
T ss_pred CCCCCCCcH-HHHHHHHHcCCCCCC-------------------------cccc-----------ccCCHHHHHHHHHHC
Confidence 999988753 333333333221110 0000 123567789999999
Q ss_pred ccccceeeccccccccccccceeeeeec
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..+|..| +++.++++|||+..
T Consensus 272 ~~dP~~R-------~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 272 MLDPAER-------ITVYEALNHPWLKE 292 (351)
T ss_dssp CSSTTTS-------CCHHHHHTSHHHHT
T ss_pred CCChhHC-------cCHHHHhcChhhcC
Confidence 8666666 99999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=284.15 Aligned_cols=236 Identities=24% Similarity=0.403 Sum_probs=183.1
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeC--------------------------------------CEEEEEEecCCCCcHHH
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRK--------------------------------------KKLHLVFEFCDHTVLNE 63 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~--------------------------------------~~~~lv~e~~~~~~l~~ 63 (303)
.+|+.+++.++||||+++++++... ..+++||||+++ +|..
T Consensus 48 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~ 126 (383)
T 3eb0_A 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126 (383)
T ss_dssp CHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHH
T ss_pred HHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHH
Confidence 3689999999999999999999543 348999999995 5444
Q ss_pred ----HHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEe-cCCcEEEccccceeeeCCCCccccccCCCc
Q psy763 64 ----LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLINPGENYTDYVATRW 138 (303)
Q Consensus 64 ----~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 138 (303)
+...+..+++..+..++.|++.||.|||+.||+||||||+||+++ .++.+||+|||++.............+|+.
T Consensus 127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~ 206 (383)
T 3eb0_A 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF 206 (383)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSS
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCC
Confidence 345567899999999999999999999999999999999999998 578999999999998776666667789999
Q ss_pred ccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhh-hhcC
Q psy763 139 YRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQE-IFSK 217 (303)
Q Consensus 139 y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 217 (303)
|+|||++.+...++.++||||+||++|||++|..||.+....+.+..++...+.+........ .+. +.. .+..
T Consensus 207 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~-~~~-----~~~~~~~~ 280 (383)
T 3eb0_A 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM-NPH-----YTEVRFPT 280 (383)
T ss_dssp CCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH-CTT-----C--CCCCC
T ss_pred ccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh-Ccc-----cccccCCc
Confidence 999999987666899999999999999999999999999998888888876555431100000 000 000 0000
Q ss_pred CChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 218 TSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 218 ~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.....+... .....++++.+++.+||..+|..| +++.++++||||..
T Consensus 281 ~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~R-------~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 281 LKAKDWRKI------LPEGTPSLAIDLLEQILRYEPDLR-------INPYEAMAHPFFDH 327 (383)
T ss_dssp CCCCCHHHH------SCTTCCHHHHHHHHHHCCSSGGGS-------CCHHHHHTSGGGHH
T ss_pred cCcccHHhh------CCCCCCHHHHHHHHHHccCChhhC-------CCHHHHhcCHHHHH
Confidence 111112111 112356778999999999776666 99999999999965
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=291.07 Aligned_cols=215 Identities=26% Similarity=0.355 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|.+.+.....+++..+..++.|++.||.|||++||+|
T Consensus 80 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 159 (494)
T 3lij_A 80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159 (494)
T ss_dssp THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 45678899999999999999999999999999999999999999988877778999999999999999999999999999
Q ss_pred cccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++.. +.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 160 ~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCC
Confidence 9999999999764 4599999999988776666667789999999999864 3899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+ ... | ...++++.+++.+||...|.
T Consensus 238 ~~~~~~~~~~~i~~~~~~~~---------~~~----~-----------------------~~~s~~~~~li~~~L~~dp~ 281 (494)
T 3lij_A 238 GGQTDQEILRKVEKGKYTFD---------SPE----W-----------------------KNVSEGAKDLIKQMLQFDSQ 281 (494)
T ss_dssp CCSSHHHHHHHHHHTCCCCC---------SGG----G-----------------------TTSCHHHHHHHHHHTCSSTT
T ss_pred CCCCHHHHHHHHHhCCCCCC---------chh----c-----------------------ccCCHHHHHHHHHHCCCChh
Confidence 98888777766655433221 000 1 12346778999999986666
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.++++|||+..
T Consensus 282 ~R-------~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 282 RR-------ISAQQALEHPWIKE 297 (494)
T ss_dssp TS-------CCHHHHHTCHHHHH
T ss_pred hC-------ccHHHHhcCccccc
Confidence 65 99999999999965
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=292.15 Aligned_cols=218 Identities=24% Similarity=0.339 Sum_probs=186.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+.+.+++|+||+.+|+|.+.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 70 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 149 (484)
T 3nyv_A 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 149 (484)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 45678899999999999999999999999999999999999999998888889999999999999999999999999999
Q ss_pred cccCCCcEEE---ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILL---TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||++ +.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 150 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 9999999999 4568999999999988766655566789999999999976 3899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+. . .| ...++++.+++.+||..+|.
T Consensus 228 ~~~~~~~~~~~i~~~~~~~~~---------~----~~-----------------------~~~s~~~~~li~~~L~~dp~ 271 (484)
T 3nyv_A 228 NGANEYDILKKVEKGKYTFEL---------P----QW-----------------------KKVSESAKDLIRKMLTYVPS 271 (484)
T ss_dssp CCSSHHHHHHHHHHCCCCCCS---------G----GG-----------------------GGSCHHHHHHHHHHTCSSGG
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------c----cc-----------------------ccCCHHHHHHHHHHCCCChh
Confidence 998888877766554332210 0 01 11346778999999997776
Q ss_pred eeeccccccccccccceeeeeecCCc
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
.| +++.+++.|||+.....
T Consensus 272 ~R-------~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 272 MR-------ISARDALDHEWIQTYTK 290 (484)
T ss_dssp GS-------CCHHHHHTSHHHHHHTC
T ss_pred HC-------cCHHHHhhChhhccccc
Confidence 66 99999999999976443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.77 Aligned_cols=214 Identities=19% Similarity=0.209 Sum_probs=181.4
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+..|..+++.+ +||||+++++++++.+.+|+||||+++|+|..++...+.+++..++.++.||+.||.|||++||
T Consensus 384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gI 463 (674)
T 3pfq_A 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463 (674)
T ss_dssp TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSE
T ss_pred HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 345566778888877 7999999999999999999999999999999998877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeC-CCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+|||++.++.+||+|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 464 iHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf 542 (674)
T 3pfq_A 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPF 542 (674)
T ss_dssp ECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCC
Confidence 999999999999999999999999998743 334456678999999999998766 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....++......+ +..++++.+++.+||..+|.
T Consensus 543 ~~~~~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~~li~~lL~~dP~ 582 (674)
T 3pfq_A 543 EGEDEDELFQSIMEHNVAYP----------------------------------------KSMSKEAVAICKGLMTKHPG 582 (674)
T ss_dssp CCSSHHHHHHHHHSSCCCCC----------------------------------------TTSCHHHHHHHHHHSCSSST
T ss_pred CCCCHHHHHHHHHhCCCCCC----------------------------------------ccCCHHHHHHHHHHccCCHH
Confidence 99888877776665432211 12346677888888886666
Q ss_pred eeeccccccccc-----cccceeeeeecC
Q psy763 255 YIQSEKQDSIRG-----KNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~-----~~~l~~~~~~~~ 278 (303)
.| +++ .+++.||||...
T Consensus 583 ~R-------~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 583 KR-------LGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp TC-------TTCSTTHHHHHHSSGGGSSC
T ss_pred HC-------CCCCCCcHHHHhcCccccCC
Confidence 66 665 788888888764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.48 Aligned_cols=216 Identities=24% Similarity=0.348 Sum_probs=181.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+.+.+|+|+||+.+|+|.+.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 65 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 144 (486)
T 3mwu_A 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144 (486)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 45678899999999999999999999999999999999999999988877778999999999999999999999999999
Q ss_pred cccCCCcEEEe---cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++ .++.+||+|||++.............||+.|+|||++.+. ++.++||||+||++|+|++|..||
T Consensus 145 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp SCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999995 4567999999999877665555667899999999999753 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+. . .| ...++++.+++.+||..+|.
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~---------~----~~-----------------------~~~s~~~~~li~~~L~~dp~ 266 (486)
T 3mwu_A 223 YGKNEYDILKRVETGKYAFDL---------P----QW-----------------------RTISDDAKDLIRKMLTFHPS 266 (486)
T ss_dssp CCSSHHHHHHHHHHTCCCSCS---------G----GG-----------------------GGSCHHHHHHHHHHTCSSTT
T ss_pred CCCCHHHHHHHHHhCCCCCCC---------c----cc-----------------------CCCCHHHHHHHHHHcCCChh
Confidence 998888777766554332210 0 01 11346778999999997666
Q ss_pred eeeccccccccccccceeeeeecC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.| +++.++++|||+...
T Consensus 267 ~R-------~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 267 LR-------ITATQCLEHPWIQKY 283 (486)
T ss_dssp TS-------CCHHHHHHCHHHHHT
T ss_pred hC-------cCHHHHhcCHhhccC
Confidence 66 999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=289.34 Aligned_cols=218 Identities=21% Similarity=0.202 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|..++... ..+++..+..++.||+.||.|||+
T Consensus 228 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~ 307 (543)
T 3c4z_A 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307 (543)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999987653 369999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+||+||||||+||+++.++.+||+|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 308 ~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~ 386 (543)
T 3c4z_A 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAAR 386 (543)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCC
Confidence 9999999999999999999999999999988764433 34458999999999998765 899999999999999999999
Q ss_pred ccCCCCch----HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 172 FIGLGNMG----SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 172 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
.||.+... .+....++... .......++.+.+++.+
T Consensus 387 ~PF~~~~~~~~~~~~~~~i~~~~----------------------------------------~~~p~~~s~~~~~li~~ 426 (543)
T 3c4z_A 387 GPFRARGEKVENKELKQRVLEQA----------------------------------------VTYPDKFSPASKDFCEA 426 (543)
T ss_dssp CSSCCTTCCCCHHHHHHHHHHCC----------------------------------------CCCCTTSCHHHHHHHHH
T ss_pred CCCCCCccchhHHHHHHHHhhcc----------------------------------------cCCCcccCHHHHHHHHH
Confidence 99876531 22222222111 01112345677788888
Q ss_pred hhccccceeeccccccccccccceeeeeec
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
||..+|..|-.- ...++.+++.||||..
T Consensus 427 lL~~dP~~R~~~--~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 427 LLQKDPEKRLGF--RDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HSCSSGGGSCCC--BTTBSHHHHTSGGGTT
T ss_pred hccCCHhHCCCC--cccCHHHHHcCccccC
Confidence 888777666111 1114578888998876
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=269.00 Aligned_cols=215 Identities=20% Similarity=0.264 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++++.+.+..++||||++++++..++.....+++..+..++.|++.||.|||+.|+
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 130 (279)
T 3fdn_A 51 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130 (279)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred hHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34567888999999999999999999999999999999999999999988877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+|+||+|+||+++.++.++|+|||++...... ......+++.|+|||.+.+.. ++.++||||+||++|+|++|..|+.
T Consensus 131 ~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 208 (279)
T 3fdn_A 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFE 208 (279)
T ss_dssp EECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ecccCChHhEEEcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999998654332 234467899999999998765 7999999999999999999999987
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+..... ......++++.+++.+|+..+|..
T Consensus 209 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~~p~~ 248 (279)
T 3fdn_A 209 ANTYQETYKRISRVEF----------------------------------------TFPDFVTEGARDLISRLLKHNPSQ 248 (279)
T ss_dssp CSSHHHHHHHHHHTCC----------------------------------------CCCTTSCHHHHHHHHHHCCSSGGG
T ss_pred CCcHHHHHHHHHhCCC----------------------------------------CCCCcCCHHHHHHHHHHhccChhh
Confidence 7666555443332211 111223456778999999866666
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
| +++.++++|||+....
T Consensus 249 R-------ps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 249 R-------PMLREVLEHPWITANS 265 (279)
T ss_dssp S-------CCHHHHHHCHHHHHHC
T ss_pred C-------CCHHHHhhCccccCCc
Confidence 6 9999999999997743
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=288.85 Aligned_cols=216 Identities=25% Similarity=0.333 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|.+.+.....+++..+..++.|++.||.|||+.||+|
T Consensus 90 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 169 (504)
T 3q5i_A 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVH 169 (504)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 45678899999999999999999999999999999999999999998877778999999999999999999999999999
Q ss_pred cccCCCcEEEecCC---cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTANG---VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++.++ .+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC
Confidence 99999999998775 699999999998776666667789999999999874 3899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+ ...| ...++++.+++.+||..+|.
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~----------------~~~~--------------------~~~s~~~~~li~~~L~~dp~ 291 (504)
T 3q5i_A 248 GGQNDQDIIKKVEKGKYYFD----------------FNDW--------------------KNISDEAKELIKLMLTYDYN 291 (504)
T ss_dssp CCSSHHHHHHHHHHCCCCCC----------------HHHH--------------------TTSCHHHHHHHHHHTCSSTT
T ss_pred CCCCHHHHHHHHHcCCCCCC----------------cccc--------------------CCCCHHHHHHHHHHcCCChh
Confidence 98888777766655432211 0000 12356788999999996666
Q ss_pred eeeccccccccccccceeeeeecC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.| +++.+++.|||+...
T Consensus 292 ~R-------~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 292 KR-------CTAEEALNSRWIKKY 308 (504)
T ss_dssp TS-------CCHHHHHTSHHHHHT
T ss_pred HC-------CCHHHHhcCHhhhhc
Confidence 66 999999999999654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=280.75 Aligned_cols=247 Identities=20% Similarity=0.265 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
....+.+|+.+++.++||||+++++++... ..+|+||||++++.+..+......+++..+..++.|++.||.|||
T Consensus 72 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 151 (362)
T 3pg1_A 72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151 (362)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999643 378999999996444445555558999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++||+|+||||+||+++.++.+||+|||++.............+|+.|+|||.+.+...++.++||||+||++|+|++|.
T Consensus 152 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 152 EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp HTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred HCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCC
Confidence 99999999999999999999999999999987655555556788999999999987555899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.||.+....+....+....+.+............ ................+... .+...+.+.+++.+||..
T Consensus 232 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~ 303 (362)
T 3pg1_A 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPS-ARDYLRNSLSNVPARAWTAV-------VPTADPVALDLIAKMLEF 303 (362)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHH-HHHHTTTCCCCCCCCCHHHH-------STTSCHHHHHHHHHHTCS
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChHHhhhccchh-hhHHHHhhcccCChhhHHhh-------CCCCCHHHHHHHHHHhcC
Confidence 9999999888888887765544311100000000 00000000111111111111 123467789999999997
Q ss_pred ccceeeccccccccccccceeeeeecC
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+|..| +++.++++||||...
T Consensus 304 dP~~R-------pt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 304 NPQRR-------ISTEQALRHPYFESL 323 (362)
T ss_dssp SGGGS-------CCHHHHHTSGGGTTT
T ss_pred ChhhC-------CCHHHHHcCchhhhc
Confidence 66666 999999999999763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.90 Aligned_cols=240 Identities=29% Similarity=0.445 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++||||+++++++...+..++||||+++ ++..++.. ...+++..+..++.|++.||.|||+.||+|
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 135 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Confidence 4567899999999999999999999999999999999996 66666554 347999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.++.+||+|||++..... ........+|+.|+|||++.+...++.++|||||||++|||++|..++.+
T Consensus 136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp CCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999987643 23344568899999999998766689999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+.+..++...+.+.....+...... + + .........++... ....++++.+++.+|+..+|..|
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~--~-~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R 283 (346)
T 1ua2_A 216 DSDLDQLTRIFETLGTPTEEQWPDMCSLP--D--Y-VTFKSFPGIPLHHI-------FSAAGDDLLDLIQGLFLFNPCAR 283 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSST--T--C-CCCCCCCCCCHHHH-------CTTCCHHHHHHHHHHHCSSTTTS
T ss_pred CCHHHHHHHHHHHcCCCChhhhhhhccCc--c--c-ccccccCCCChHHh-------hccCCHHHHHHHHHHhccChhhC
Confidence 88888888887765443311111110000 0 0 00000011111111 12346788999999999776666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.++++||||...
T Consensus 284 -------pt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 284 -------ITATQALKMKYFSNR 298 (346)
T ss_dssp -------CCHHHHHTSGGGTSS
T ss_pred -------CCHHHHhcChhhhcC
Confidence 999999999999763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=282.34 Aligned_cols=238 Identities=26% Similarity=0.380 Sum_probs=180.4
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHH---HcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~---~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.+|+.+++.++||||+++++++... ..+++||||++++.+..+ ......+++..++.++.||+.||.|||+
T Consensus 95 ~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 174 (420)
T 1j1b_A 95 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174 (420)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4689999999999999999998642 136799999996543332 2345689999999999999999999999
Q ss_pred CCceecccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
.||+||||||+|||++.+ +.+||+|||++.............+|+.|+|||++.+...++.++|||||||++|||++|.
T Consensus 175 ~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~ 254 (420)
T 1j1b_A 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254 (420)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence 999999999999999965 6789999999998766555566789999999999987656899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.||.+....+.+..+++..+.+........ .+..... -+......+|... ..+..++++.+++.+||..
T Consensus 255 ~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~-~~~~~~~----~~p~~~~~~~~~~------~~~~~~~~~~~Li~~~L~~ 323 (420)
T 1j1b_A 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF----KFPQIKAHPWTKV------FRPRTPPEAIALCSRLLEY 323 (420)
T ss_dssp CSSCCSSHHHHHHHHHHHHCSCCHHHHHHH-CSCCCCC----CCCCCCCCCHHHH------SCTTSCHHHHHHHHHHSCS
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-Chhhhhh----ccCccCCCCHHHh------cCCCCCHHHHHHHHHhccC
Confidence 999999888888887776444321000000 0000000 0011111222222 1223567899999999997
Q ss_pred ccceeeccccccccccccceeeeeec
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
++..| +++.+++.||||..
T Consensus 324 dP~~R-------~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 324 TPTAR-------LTPLEACAHSFFDE 342 (420)
T ss_dssp SGGGS-------CCHHHHHTSGGGGG
T ss_pred ChhHC-------CCHHHHhCCHhhcc
Confidence 77666 99999999999954
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=274.38 Aligned_cols=216 Identities=23% Similarity=0.293 Sum_probs=155.9
Q ss_pred HHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
....+|+..++.+. ||||+++++++.+++..|+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+|
T Consensus 50 ~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 129 (325)
T 3kn6_A 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129 (325)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Confidence 45567888999997 99999999999999999999999999999999888889999999999999999999999999999
Q ss_pred cccCCCcEEEecCC---cEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 98 RDIKPENILLTANG---VVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~---~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
|||||+||+++.++ .+||+|||++...... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|..|
T Consensus 130 ~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p 208 (325)
T 3kn6_A 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVP 208 (325)
T ss_dssp CCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCC
Confidence 99999999998765 8999999999876543 2334567899999999998765 89999999999999999999988
Q ss_pred CCCCch-------HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 174 GLGNMG-------SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 174 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
|.+... .+....+....... .. ..+ +..++++.+++.
T Consensus 209 f~~~~~~~~~~~~~~~~~~i~~~~~~~---------~~----------------~~~-----------~~~s~~~~~li~ 252 (325)
T 3kn6_A 209 FQSHDRSLTCTSAVEIMKKIKKGDFSF---------EG----------------EAW-----------KNVSQEAKDLIQ 252 (325)
T ss_dssp TC-------CCCHHHHHHHHTTTCCCC---------CS----------------HHH-----------HTSCHHHHHHHH
T ss_pred CCCCccccccccHHHHHHHHHcCCCCC---------Cc----------------ccc-----------cCCCHHHHHHHH
Confidence 876432 11222111111000 00 000 124567889999
Q ss_pred hhhccccceeeccccccccccccceeeeeecC
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+||..+|..| +++.+++.|||+.+.
T Consensus 253 ~~L~~dP~~R-------pt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 253 GLLTVDPNKR-------LKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHCCCTTTC-------CCTTTSTTCGGGCTT
T ss_pred HHCCCChhHC-------CCHHHHhcChhhccC
Confidence 9999666666 999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=267.36 Aligned_cols=224 Identities=22% Similarity=0.296 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+.+|+.+++.+. ||||+++++++..++..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 144 (298)
T 1phk_A 65 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34566788999999995 99999999999999999999999999999999887778999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCccccc-----CCccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV-----GDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~-----~~~~~~~~~DvwSlG~il~el~t 169 (303)
++|+||+|+||+++.++.+||+|||++.............+++.|+|||++. ....++.++|||||||++|+|++
T Consensus 145 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 224 (298)
T 1phk_A 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224 (298)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence 9999999999999999999999999998876655556678999999999985 23447899999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..|+.+.........+.......+ .. .....++.+.+++.+|+
T Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~---------~~---------------------------~~~~~~~~l~~li~~~l 268 (298)
T 1phk_A 225 GSPPFWHRKQMLMLRMIMSGNYQFG---------SP---------------------------EWDDYSDTVKDLVSRFL 268 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCC---------TT---------------------------TGGGSCHHHHHHHHHHC
T ss_pred CCCCCcCccHHHHHHHHhcCCcccC---------cc---------------------------cccccCHHHHHHHHHHc
Confidence 9999988777666655544322211 00 00113456778999999
Q ss_pred ccccceeeccccccccccccceeeeeecCCcce
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
..++..| +++.++++||||.......
T Consensus 269 ~~dp~~R-------ps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 269 VVQPQKR-------YTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp CSSGGGS-------CCHHHHTTSGGGCTTC---
T ss_pred cCCcccC-------CCHHHHHhChHhhhccchh
Confidence 8666666 9999999999998765443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=269.91 Aligned_cols=213 Identities=23% Similarity=0.301 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||+++++++.+ .+.+++||||+++++|..+.. ...+++..+..++.|++.||.|||++|+
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 158 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI 158 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3567899999999999999999999987 568999999999999988654 4589999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCcc--CCCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTL--YGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~--~~~~~DvwSlG~il~el~tg~~ 172 (303)
+||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+... ++.++|||||||++|+|++|..
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999999999999999999999998765432 2345679999999999976542 4778999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+.........+....... ...+..++++.+++.+|+..+
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~l~~li~~~l~~d 280 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEF--------------------------------------PDQPDIAEDLKDLITRMLDKN 280 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCC--------------------------------------CSSSCCCHHHHHHHHHHTCSC
T ss_pred CCCCccHHHHHHHHhcccCCC--------------------------------------CCccccCHHHHHHHHHHhhcC
Confidence 988776555444332221110 011224566789999999876
Q ss_pred cceeeccccccccccccceeeeee
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
|..| +++.++++||||.
T Consensus 281 p~~R-------~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 281 PESR-------IVVPEIKLHPWVT 297 (298)
T ss_dssp TTTS-------CCHHHHTTCHHHH
T ss_pred hhhC-------CCHHHHhcCcccc
Confidence 6666 9999999999973
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=276.52 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++...+ ..|+||||+++ ++...+. ..+++..+..++.|++.||.||
T Consensus 67 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~l 143 (371)
T 2xrw_A 67 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHL 143 (371)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHH
Confidence 3456778999999999999999999998664 78999999985 5666554 3689999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++||+||||||+||+++.++.+||+|||++.............+|+.|+|||++.+.. ++.++||||+||++|||++|
T Consensus 144 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g 222 (371)
T 2xrw_A 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKG 222 (371)
T ss_dssp HHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHS
T ss_pred HHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999998766544445678999999999998765 89999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhc-CCC--hhHHHHHHhHhCCCC-----CCCchhhH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFS-KTS--TTTIFKYLLIRGGNT-----DRNSHGVV 242 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~l~~~~~~~-----~~~~~~~~ 242 (303)
..||.+....+....++...+.+...... .... .+..+.. .+. ...+....-....+. ....+++.
T Consensus 223 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (371)
T 2xrw_A 223 GVLFPGTDHIDQWNKVIEQLGTPCPEFMK-KLQP-----TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 296 (371)
T ss_dssp SCSSCCSSHHHHHHHHHC-CCCCCHHHHT-TSCH-----HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHH-Hhhh-----HHHHHHhhCccccccchhhhcccccCcccccccccccHHHH
Confidence 99999998888888887765543211100 0000 0000000 000 000100000000000 01145788
Q ss_pred Hhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 243 KILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 243 dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.+||..+|..| +++.++++||||..
T Consensus 297 ~li~~mL~~dP~~R-------~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 297 DLLSKMLVIDASKR-------ISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHSCSSGGGS-------CCHHHHHHSHHHHT
T ss_pred HHHHHHCcCChhhC-------CCHHHHhCCcchhh
Confidence 99999999777666 99999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=275.33 Aligned_cols=217 Identities=24% Similarity=0.352 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.+ +||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|+
T Consensus 142 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi 221 (365)
T 2y7j_A 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221 (365)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 456678899999998 7999999999999999999999999999999998877789999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC-----CccCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG-----DTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~-----~~~~~~~~DvwSlG~il~el~tg 170 (303)
+|+||||+||+++.++.++|+|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|
T Consensus 222 ~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g 301 (365)
T 2y7j_A 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301 (365)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence 9999999999999999999999999988776665666789999999999863 23478999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+.........+........ ...+ ...++.+.+++.+|+.
T Consensus 302 ~~pf~~~~~~~~~~~i~~~~~~~~----------------~~~~--------------------~~~~~~~~~li~~~L~ 345 (365)
T 2y7j_A 302 SPPFWHRRQILMLRMIMEGQYQFS----------------SPEW--------------------DDRSSTVKDLISRLLQ 345 (365)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCC----------------HHHH--------------------SSSCHHHHHHHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCC----------------Cccc--------------------ccCCHHHHHHHHHHcC
Confidence 999988777666655544322110 0000 1234567899999998
Q ss_pred cccceeeccccccccccccceeeeee
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
.+|..| +++.+++.||||.
T Consensus 346 ~dP~~R-------ps~~ell~hp~f~ 364 (365)
T 2y7j_A 346 VDPEAR-------LTAEQALQHPFFE 364 (365)
T ss_dssp SSTTTS-------CCHHHHHHSGGGC
T ss_pred CChhHC-------cCHHHHhcCcccC
Confidence 666666 9999999999984
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=271.89 Aligned_cols=204 Identities=20% Similarity=0.259 Sum_probs=162.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++..++.+|+||||+++++|.+++...+++++..+..++.|++.||.|||++|++
T Consensus 54 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 133 (294)
T 4eqm_A 54 TLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133 (294)
T ss_dssp HHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45668899999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+.. ++.++||||+||++|+|++|..||
T Consensus 134 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf 212 (294)
T 4eqm_A 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPF 212 (294)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999997654322 223457899999999998766 799999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChh
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTT 221 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
.+..........+...........+...+..+.+.+..++..+|..|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 259 (294)
T 4eqm_A 213 NGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259 (294)
T ss_dssp CSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHc
Confidence 99888777666655433322122233444454555555554444433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.98 Aligned_cols=218 Identities=23% Similarity=0.317 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 131 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 45678899999999999999999999999999999999999999999877778999999999999999999999999999
Q ss_pred cccCCCcEEEecCC----cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 98 RDIKPENILLTANG----VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 98 ~dlk~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||+|+||+++.++ .+||+|||++.............+++.|+|||.+.+.. ++.++|||||||++|+|++|..|
T Consensus 132 ~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p 210 (283)
T 3bhy_A 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP 210 (283)
T ss_dssp SCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCC
Confidence 99999999998876 89999999998876555455567999999999998665 79999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+.+....+....+.......+ . .. ....++.+.+++.+|+..+|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~---------~-----------------~~----------~~~~~~~~~~li~~~l~~dp 254 (283)
T 3bhy_A 211 FLGETKQETLTNISAVNYDFD---------E-----------------EY----------FSNTSELAKDFIRRLLVKDP 254 (283)
T ss_dssp TCCSSHHHHHHHHHTTCCCCC---------H-----------------HH----------HTTCCHHHHHHHHTTSCSSG
T ss_pred CCCcchHHHHHHhHhcccCCc---------c-----------------hh----------cccCCHHHHHHHHHHccCCH
Confidence 988776666554433221110 0 00 01234567889999998666
Q ss_pred ceeeccccccccccccceeeeeecCC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
..| +++.+++.|||+....
T Consensus 255 ~~R-------ps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 255 KRR-------MTIAQSLEHSWIKAIR 273 (283)
T ss_dssp GGS-------CCHHHHHHCHHHHHHH
T ss_pred hHC-------cCHHHHHhCHHHHHHH
Confidence 666 9999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=266.65 Aligned_cols=214 Identities=20% Similarity=0.263 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++
T Consensus 57 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 136 (284)
T 2vgo_A 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 136 (284)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 34668889999999999999999999999999999999999999999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||++...... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|..|+.+
T Consensus 137 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999998765432 234567899999999998765 79999999999999999999999887
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+....+...... .....+.++.+++.+|+..+|..|
T Consensus 215 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~li~~~l~~~p~~R 254 (284)
T 2vgo_A 215 PSHTETHRRIVNVDLK----------------------------------------FPPFLSDGSKDLISKLLRYHPPQR 254 (284)
T ss_dssp SSHHHHHHHHHTTCCC----------------------------------------CCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCHhHHHHHHhccccC----------------------------------------CCCcCCHHHHHHHHHHhhcCHhhC
Confidence 7665554443322110 111234567789999998666666
Q ss_pred eccccccccccccceeeeeecCC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+++.+++.|||+....
T Consensus 255 -------ps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 255 -------LPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------CCHHHHHTCHHHHHHC
T ss_pred -------CCHHHHhhCHHHHhhc
Confidence 9999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=276.77 Aligned_cols=222 Identities=25% Similarity=0.309 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-----------------------------
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----------------------------- 67 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------------------- 67 (303)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 71 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (345)
T 3hko_A 71 DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150 (345)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccc
Confidence 456788999999999999999999999999999999999999999998742
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC--cEEEccccceeeeCCCC-----c
Q psy763 68 -----------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG--VVKLCDFGFARLINPGE-----N 129 (303)
Q Consensus 68 -----------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~--~~kl~dfg~~~~~~~~~-----~ 129 (303)
...+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++....... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 230 (345)
T 3hko_A 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230 (345)
T ss_dssp HSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----
T ss_pred ccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccccc
Confidence 11246778899999999999999999999999999999998766 89999999998754211 1
Q ss_pred cccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhh
Q psy763 130 YTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWD 208 (303)
Q Consensus 130 ~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (303)
.....+|+.|+|||.+.+. ..++.++|||||||++|||++|..||.+....+....++......+..
T Consensus 231 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 298 (345)
T 3hko_A 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP------------ 298 (345)
T ss_dssp ----CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG------------
T ss_pred ccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc------------
Confidence 2456789999999999752 448999999999999999999999999888887777666543322100
Q ss_pred hhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 209 LTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.....++.+.+++.+|+..+|..| +++.++++||||.....+
T Consensus 299 ------------------------~~~~~~~~~~~li~~~l~~~p~~R-------ps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 299 ------------------------NYNVLSPLARDLLSNLLNRNVDER-------FDAMRALQHPWISQFSDK 340 (345)
T ss_dssp ------------------------GGGGSCHHHHHHHHHHSCSCTTTS-------CCHHHHHHSHHHHTTSSC
T ss_pred ------------------------ccccCCHHHHHHHHHHcCCChhHC-------CCHHHHhcChhhccChHh
Confidence 001134667899999998666666 999999999999876544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=279.38 Aligned_cols=213 Identities=23% Similarity=0.263 Sum_probs=161.0
Q ss_pred HHHHHHHH-HhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 21 EATNKKEK-RSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 21 ~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+|+.++ +..+||||+++++++.. ...+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.
T Consensus 101 ~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 180 (400)
T 1nxk_A 101 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180 (400)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566554 66789999999999976 567899999999999999887643 599999999999999999999999
Q ss_pred CceecccCCCcEEEec---CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 ACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
||+||||||+|||++. ++.+||+|||++............+||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 181 ~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g 259 (400)
T 1nxk_A 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCG 259 (400)
T ss_dssp TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHS
T ss_pred CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhC
Confidence 9999999999999997 7889999999998876555556678999999999997655 89999999999999999999
Q ss_pred CccCCCCchHH----HHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhh
Q psy763 171 GFIGLGNMGSH----MARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILG 246 (303)
Q Consensus 171 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~ 246 (303)
..||.+..... ....+....... ........++++.+++.
T Consensus 260 ~~pf~~~~~~~~~~~~~~~i~~~~~~~------------------------------------~~~~~~~~s~~~~~li~ 303 (400)
T 1nxk_A 260 YPPFYSNHGLAISPGMKTRIRMGQYEF------------------------------------PNPEWSEVSEEVKMLIR 303 (400)
T ss_dssp SCSCCCCTTCSSCCSHHHHHHHTCCCC------------------------------------CTTTTTTSCHHHHHHHH
T ss_pred CCCCCCCccccccHHHHHHHHcCcccC------------------------------------CCcccccCCHHHHHHHH
Confidence 99987654211 111111100000 00001234567889999
Q ss_pred hhhccccceeeccccccccccccceeeeeec
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+||..++..| +++.+++.|||+..
T Consensus 304 ~~L~~dP~~R-------pt~~eil~hp~~~~ 327 (400)
T 1nxk_A 304 NLLKTEPTQR-------MTITEFMNHPWIMQ 327 (400)
T ss_dssp TTSCSSGGGS-------CCHHHHHHSHHHHT
T ss_pred HHCCCChhHC-------cCHHHHhcCccccC
Confidence 9998776666 99999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=275.67 Aligned_cols=211 Identities=19% Similarity=0.255 Sum_probs=169.3
Q ss_pred HHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Q psy763 23 TNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 101 (303)
Q Consensus 23 ~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 101 (303)
+|+..+..+ +||||+++++++.+++.+|+||||+++|+|.+.+...+.+++..+..++.|++.||.|||++||+|||||
T Consensus 64 ~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlk 143 (342)
T 2qr7_A 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLK 143 (342)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCC
Confidence 456666665 7999999999999999999999999999999998888889999999999999999999999999999999
Q ss_pred CCcEEEecC----CcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 102 PENILLTAN----GVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 102 ~~nil~~~~----~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||++... +.+||+|||++...... ......++|+.|+|||++.+.. ++.++||||+||++|||++|..||.+
T Consensus 144 p~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp GGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred HHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 999998543 35999999999876543 3345568899999999998655 78999999999999999999998876
Q ss_pred C---chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 177 N---MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 177 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
. ...+....+.......+ .......++++.+++.+||..+|
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~s~~~~~li~~~L~~dP 266 (342)
T 2qr7_A 223 GPDDTPEEILARIGSGKFSLS------------------------------------GGYWNSVSDTAKDLVSKMLHVDP 266 (342)
T ss_dssp STTSCHHHHHHHHHHCCCCCC------------------------------------STTTTTSCHHHHHHHHHHTCSST
T ss_pred CCcCCHHHHHHHHccCCcccC------------------------------------ccccccCCHHHHHHHHHHCCCCh
Confidence 3 23333333322211100 00112345678899999999777
Q ss_pred ceeeccccccccccccceeeeeec
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..| +++.++++|||+.+
T Consensus 267 ~~R-------~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 267 HQR-------LTAALVLRHPWIVH 283 (342)
T ss_dssp TTS-------CCHHHHTTSHHHHT
T ss_pred hHC-------cCHHHHhcCCeecC
Confidence 666 99999999999954
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=266.71 Aligned_cols=217 Identities=19% Similarity=0.230 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++.+.+..++|+||+++++|..++... ..+++..++.++.|++.||.|||+.|++
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 134 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL 134 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 466888999999999999999999999999999999999999999988764 5799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.+||+|||++...... .......+|+.|+|||.+.+.. ++.++||||+||++|+|++|..|+.
T Consensus 135 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp CSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999876532 2234467899999999998665 7999999999999999999998876
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+... ........++++.+++.+|+..+|..
T Consensus 214 ~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~ 253 (278)
T 3cok_A 214 TDTVKNTLNKVVLA----------------------------------------DYEMPSFLSIEAKDLIHQLLRRNPAD 253 (278)
T ss_dssp CCSCC-----CCSS----------------------------------------CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred ChhHHHHHHHHhhc----------------------------------------ccCCccccCHHHHHHHHHHcccCHhh
Confidence 54432222111000 00011224567789999999866666
Q ss_pred eeccccccccccccceeeeeecCCcce
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
| +++.+++.|||+.....+.
T Consensus 254 R-------ps~~~~l~h~~~~~~~~~~ 273 (278)
T 3cok_A 254 R-------LSLSSVLDHPFMSRNSSTK 273 (278)
T ss_dssp S-------CCHHHHTTSTTTC------
T ss_pred C-------CCHHHHhcCccccCCCCcc
Confidence 6 9999999999998766543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=273.58 Aligned_cols=206 Identities=21% Similarity=0.262 Sum_probs=174.3
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCC-cHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT-VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+.+|+.+++.++||||+++++++.+.+.+++||||+.+| ++..++.....+++..+..++.|++.||.|||++||+||
T Consensus 75 ~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~ 154 (335)
T 3dls_A 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR 154 (335)
T ss_dssp EEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEe
Confidence 4566899999999999999999999999999999999766 999999888899999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
||||+||+++.++.+||+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||.+..
T Consensus 155 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 155 DIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred ccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 99999999999999999999999987766656667899999999999877645889999999999999999998886421
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeec
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQS 258 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~ 258 (303)
.. ... ........++++.+++.+|+..+|..|
T Consensus 235 ~~------~~~----------------------------------------~~~~~~~~~~~l~~li~~~L~~dP~~R-- 266 (335)
T 3dls_A 235 ET------VEA----------------------------------------AIHPPYLVSKELMSLVSGLLQPVPERR-- 266 (335)
T ss_dssp GG------TTT----------------------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGS--
T ss_pred HH------Hhh----------------------------------------ccCCCcccCHHHHHHHHHHccCChhhC--
Confidence 10 000 000111235677889999998766666
Q ss_pred cccccccccccceeeeeecC
Q psy763 259 EKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 259 ~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.++++|||+..+
T Consensus 267 -----ps~~ell~hp~~~~~ 281 (335)
T 3dls_A 267 -----TTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----CCHHHHHHCTTTTCC
T ss_pred -----cCHHHHhcCccccCC
Confidence 999999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=264.52 Aligned_cols=215 Identities=22% Similarity=0.220 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++
T Consensus 58 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 137 (294)
T 2rku_A 58 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 137 (294)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45677889999999999999999999999999999999999999999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.+||+|||++...... .......+|+.|+|||.+.+.. ++.++||||+||++|+|++|..|+.
T Consensus 138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999876532 3334567899999999998765 7999999999999999999999887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+...... .....++.+.+++.+|+..++..
T Consensus 217 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~li~~~l~~~p~~ 256 (294)
T 2rku_A 217 TSCLKETYLRIKKNEYS----------------------------------------IPKHINPVAASLIQKMLQTDPTA 256 (294)
T ss_dssp CSSHHHHHHHHHTTCCC----------------------------------------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCCHHHHHHHHhhccCC----------------------------------------CccccCHHHHHHHHHHcccChhh
Confidence 77655554433221110 01123456778899998866655
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
| +++.+++.|+||....
T Consensus 257 R-------ps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 257 R-------PTINELLNDEFFTSGY 273 (294)
T ss_dssp S-------CCGGGGGGSHHHHTSC
T ss_pred C-------cCHHHHhhChheecCC
Confidence 5 9999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=265.80 Aligned_cols=215 Identities=21% Similarity=0.299 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.|||++|++
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 133 (276)
T 2h6d_A 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133 (276)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 34567889999999999999999999999999999999999999999987777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|+||+|+||+++.++.++|+|||++.............+++.|+|||.+.+....+.++||||+|+++|+|++|..|+.+
T Consensus 134 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998766554445567899999999998766446899999999999999999988877
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+...... .....++.+.+++.+|+..+|..|
T Consensus 214 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~l~~li~~~l~~~p~~R 253 (276)
T 2h6d_A 214 EHVPTLFKKIRGGVFY----------------------------------------IPEYLNRSVATLLMHMLQVDPLKR 253 (276)
T ss_dssp SSHHHHHHHHHHCCCC----------------------------------------CCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CcHHHHHHHhhcCccc----------------------------------------CchhcCHHHHHHHHHHccCChhhC
Confidence 6655544433221110 011234567789999998666666
Q ss_pred eccccccccccccceeeeeecC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+++.++++||||...
T Consensus 254 -------ps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 254 -------ATIKDIREHEWFKQD 268 (276)
T ss_dssp -------CCHHHHHHSHHHHTT
T ss_pred -------CCHHHHHhChhhccC
Confidence 999999999999654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=273.45 Aligned_cols=212 Identities=25% Similarity=0.349 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+++++.++||||+++++++..++..++||||+.| ++.+++ .....+++..+..++.|++.||.|||++||
T Consensus 97 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 175 (348)
T 1u5q_A 97 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175 (348)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 445678899999999999999999999999999999999985 555544 445689999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||||||+||+++.++.+||+|||++..... .....||+.|+|||++.+ ...++.++|||||||++|||++|..|
T Consensus 176 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 252 (348)
T 1u5q_A 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252 (348)
T ss_dssp BCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eeCCCCHHHEEECCCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976543 234679999999999853 34489999999999999999999999
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+.+.........+.....+.. .+ ...++.+.+++.+|+..+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~---~~-----------------------------------~~~~~~l~~li~~~l~~dP 294 (348)
T 1u5q_A 253 LFNMNAMSALYHIAQNESPAL---QS-----------------------------------GHWSEYFRNFVDSCLQKIP 294 (348)
T ss_dssp TTTSCHHHHHHHHHHSCCCCC---CC-----------------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred CCCCChHHHHHHHHhcCCCCC---CC-----------------------------------CCCCHHHHHHHHHHcccCh
Confidence 988877766655544322110 00 1123445577777777555
Q ss_pred ceeeccccccccccccceeeeeec
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..| +++.++++|||+..
T Consensus 295 ~~R-------ps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 295 QDR-------PTSEVLLKHRFVLR 311 (348)
T ss_dssp GGS-------CCHHHHTTCHHHHS
T ss_pred hhC-------cCHHHHhhChhhhc
Confidence 555 88888888888754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=273.61 Aligned_cols=244 Identities=18% Similarity=0.211 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHhCC-----CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLK-----HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~l 90 (303)
......|+.+++.+. ||||+++++++...+..++||||+ +++|.+++.... .+++..+..++.|++.||.||
T Consensus 75 ~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 153 (360)
T 3llt_A 75 TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153 (360)
T ss_dssp HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 344566888888886 999999999999999999999999 788888776543 599999999999999999999
Q ss_pred HHCCceecccCCCcEEEec-------------------------CCcEEEccccceeeeCCCCccccccCCCcccCcccc
Q psy763 91 HRHACIHRDIKPENILLTA-------------------------NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~-------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l 145 (303)
|+.||+||||||+|||++. ++.+||+|||++..... ......||+.|+|||++
T Consensus 154 H~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~ 231 (360)
T 3llt_A 154 RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVI 231 (360)
T ss_dssp HHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHH
T ss_pred HHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHH
Confidence 9999999999999999975 78899999999987443 33456789999999999
Q ss_pred cCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCC--------cchhhhhhhhhhcC
Q psy763 146 VGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLD--------SETWDLTWQEIFSK 217 (303)
Q Consensus 146 ~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 217 (303)
.+.. ++.++||||+||++|+|++|..||.+....+....+....+.++......... .......|. ..
T Consensus 232 ~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p---~~ 307 (360)
T 3llt_A 232 LNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWP---EN 307 (360)
T ss_dssp TTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTT---TT
T ss_pred cCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCc---cc
Confidence 8766 89999999999999999999999998888777776666544433111000000 000000111 11
Q ss_pred CChhHHHHHHhHhCC-CCCCCchhhHHhhhhhhccccceeeccccccccccccceeeee
Q psy763 218 TSTTTIFKYLLIRGG-NTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 218 ~~~~~~~~~l~~~~~-~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
............+.. ......+.+.+++.+||..+|..| +++.++++||||
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R-------pta~elL~hp~f 359 (360)
T 3llt_A 308 ASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR-------PSPAELLKHKFL 359 (360)
T ss_dssp CSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS-------CCHHHHTTSGGG
T ss_pred ccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC-------CCHHHHhcCccc
Confidence 111111111000000 011234677799999999777666 999999999997
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=265.64 Aligned_cols=213 Identities=21% Similarity=0.285 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
...+.+|+++++.++||||+++++++.+.+..++||||+++|+|.+.+.. +..+++..++.++.|++.||.|||+.
T Consensus 64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 143 (285)
T 3is5_A 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143 (285)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678899999999999999999999999999999999999999887632 36799999999999999999999999
Q ss_pred CceecccCCCcEEEe---cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 ACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 ~ivH~dlk~~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
||+||||||+||+++ .++.+||+|||++.............+|+.|+|||.+.+ .++.++||||+||++|||++|
T Consensus 144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHS
T ss_pred CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhC
Confidence 999999999999994 457899999999987665555566789999999999864 378999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+....+............. ......++++.+++.+|+.
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~li~~~L~ 264 (285)
T 3is5_A 222 CLPFTGTSLEEVQQKATYKEPNYA-------------------------------------VECRPLTPQAVDLLKQMLT 264 (285)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCC-------------------------------------C--CCCCHHHHHHHHHHTC
T ss_pred CCCCCCCCHHHHHhhhccCCcccc-------------------------------------cccCcCCHHHHHHHHHHcc
Confidence 999888766555443332211110 0011235677899999998
Q ss_pred cccceeeccccccccccccceeeeee
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
.+|..| +++.++++||||.
T Consensus 265 ~dP~~R-------ps~~e~l~hp~f~ 283 (285)
T 3is5_A 265 KDPERR-------PSAAQVLHHEWFK 283 (285)
T ss_dssp SCTTTS-------CCHHHHHTSGGGG
T ss_pred CChhhC-------cCHHHHhcCHHhh
Confidence 666666 9999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=270.04 Aligned_cols=214 Identities=23% Similarity=0.235 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.....+++..+..++.|++.||.|||++||+
T Consensus 84 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 163 (335)
T 2owb_A 84 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163 (335)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCE
Confidence 45667889999999999999999999999999999999999999999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|+||+|+||+++.++.+||+|||++..... ........+|+.|+|||.+.+.. ++.++|||||||++|+|++|..|+.
T Consensus 164 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCC
Confidence 999999999999999999999999987653 23334567899999999998765 7999999999999999999999887
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+....+....+...... ......+.+.+++.+|+..++..
T Consensus 243 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 243 TSCLKETYLRIKKNEYS----------------------------------------IPKHINPVAASLIQKMLQTDPTA 282 (335)
T ss_dssp CSSHHHHHHHHHHTCCC----------------------------------------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCCHHHHHHHHhcCCCC----------------------------------------CCccCCHHHHHHHHHHccCChhH
Confidence 76655554433322111 01123456678898998866655
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
| +++.+++.|+||...
T Consensus 283 R-------ps~~ell~~~~~~~~ 298 (335)
T 2owb_A 283 R-------PTINELLNDEFFTSG 298 (335)
T ss_dssp S-------CCGGGGGGSHHHHTS
T ss_pred C-------cCHHHHhcCccccCC
Confidence 5 999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=288.82 Aligned_cols=220 Identities=20% Similarity=0.253 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++. .+..++||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+|
T Consensus 184 ~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 262 (419)
T 3i6u_A 184 ALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262 (419)
T ss_dssp -CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 345788999999999999999999985 5568999999999999999888889999999999999999999999999999
Q ss_pred cccCCCcEEEecCC---cEEEccccceeeeCCCCccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhccCc
Q psy763 98 RDIKPENILLTANG---VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 98 ~dlk~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|||||+|||++.++ .+||+|||++.............||+.|+|||++.+ ...++.++||||+||++|+|++|..
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999997544 599999999988765555566789999999999864 3447889999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+..........+..+.... .+ .. ....++.+.+++.+||..+
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~--------~~--------------------~~-------~~~~~~~~~~li~~~L~~d 387 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNF--------IP--------------------EV-------WAEVSEKALDLVKKLLVVD 387 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCC--------CH--------------------HH-------HTTSCHHHHHHHHHHSCSS
T ss_pred CCCCCcchHHHHHHHhcCCCCC--------Cc--------------------hh-------hcccCHHHHHHHHHHccCC
Confidence 8876533322222222111100 00 00 0124567889999999866
Q ss_pred cceeeccccccccccccceeeeeecCCc
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
|..| +++.++++||||.+.+.
T Consensus 388 P~~R-------ps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 388 PKAR-------FTTEEALRHPWLQDEDM 408 (419)
T ss_dssp TTTS-------CCHHHHHHSGGGCCHHH
T ss_pred hhHC-------cCHHHHhCCcccCChhH
Confidence 6666 99999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=268.08 Aligned_cols=221 Identities=22% Similarity=0.267 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+.+++.+. ||||+++++++...+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++|
T Consensus 72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g 151 (327)
T 3lm5_A 72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151 (327)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345677888888885 69999999999999999999999999999998754 367999999999999999999999999
Q ss_pred ceecccCCCcEEEec---CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 95 CIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 95 ivH~dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
|+||||||+||+++. ++.+||+|||++.............+|+.|+|||.+.+.. ++.++|||||||++|+|++|.
T Consensus 152 ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~ 230 (327)
T 3lm5_A 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHT 230 (327)
T ss_dssp EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSS
T ss_pred eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCC
Confidence 999999999999987 7899999999998876555555678999999999998765 899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+.+....+....+.......+ .......++.+.+++.+|+..
T Consensus 231 ~pf~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~L~~ 274 (327)
T 3lm5_A 231 SPFVGEDNQETYLNISQVNVDYS------------------------------------EETFSSVSQLATDFIQSLLVK 274 (327)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCC------------------------------------TTTTTTSCHHHHHHHHHHSCS
T ss_pred CCCCCCCchHHHHHHHhcccccC------------------------------------chhhcccCHHHHHHHHHHcCC
Confidence 99988877776665544322211 000112345678999999987
Q ss_pred ccceeeccccccccccccceeeeeecCCcce
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPERKC 282 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 282 (303)
+|..| +++.++++|||+...+...
T Consensus 275 dP~~R-------pt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 275 NPEKR-------PTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp SGGGS-------CCHHHHTTCGGGCCCCTTC
T ss_pred ChhhC-------cCHHHHhCCHhhccccccc
Confidence 66666 9999999999997755443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=261.97 Aligned_cols=220 Identities=24% Similarity=0.259 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+++..++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 128 (276)
T 2yex_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128 (276)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 45678899999999999999999999999999999999999999999988788999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||+|+||+++.++.+||+|||.+....... ......+++.|+|||.+.+...++.++|||||||++|+|++|..|+
T Consensus 129 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 208 (276)
T 2yex_A 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (276)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654222 2345678999999999987664578999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+.............. ... .......++.+.+++.+|+..+|.
T Consensus 209 ~~~~~~~~~~~~~~~~---------------------------~~~----------~~~~~~~~~~~~~li~~~l~~~p~ 251 (276)
T 2yex_A 209 DQPSDSCQEYSDWKEK---------------------------KTY----------LNPWKKIDSAPLALLHKILVENPS 251 (276)
T ss_dssp SCSCTTSHHHHHHHTT---------------------------CTT----------STTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CCCchHHHHHHHhhhc---------------------------ccc----------cCchhhcCHHHHHHHHHHCCCCch
Confidence 7654322111111100 000 000112456778999999986666
Q ss_pred eeeccccccccccccceeeeeecCCcc
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.| +++.++++||||..+..+
T Consensus 252 ~R-------ps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 252 AR-------ITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp TS-------CCHHHHTTCTTTTCCCC-
T ss_pred hC-------CCHHHHhcCccccChhhc
Confidence 66 999999999999887554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=274.21 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=186.7
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCE-------EEEEEecCCCCcHHH---HHcCCCCCCHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKK-------LHLVFEFCDHTVLNE---LENHPHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------~~lv~e~~~~~~l~~---~~~~~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
.+.++++.++.++||||+++++++...+. +++||||++++.+.. .......+++..+..++.|++.||.|
T Consensus 65 ~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 144 (360)
T 3e3p_A 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144 (360)
T ss_dssp HHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 45567778888999999999999976433 889999999875443 34466789999999999999999999
Q ss_pred HH--HCCceecccCCCcEEEec-CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 90 CH--RHACIHRDIKPENILLTA-NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 90 lH--~~~ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
|| +.||+||||||+||+++. ++.+||+|||++.............+|+.|+|||++.+...++.++|||||||++||
T Consensus 145 lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~e 224 (360)
T 3e3p_A 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224 (360)
T ss_dssp HTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence 99 999999999999999997 899999999999887766655667889999999999876668999999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeec----CCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhH
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILK----SDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVV 242 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 242 (303)
|++|..||.+.........+....+.++.... +...... .......++... ........++++.
T Consensus 225 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~---~~~~~~~~~~~~~ 292 (360)
T 3e3p_A 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD---------LYNSKGIPWSNV---FSDHSLKDAKEAY 292 (360)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGG---------GGCCCCCCHHHH---TTTCCCTTHHHHH
T ss_pred HHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcc---------ccccccCCcccc---cchhhccccHHHH
Confidence 99999999999888888877775444321110 0000000 001111222222 1222334567889
Q ss_pred HhhhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 243 KILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 243 dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+++.+||..+|..| +++.++++||||.....
T Consensus 293 ~li~~~L~~dP~~R-------pt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 293 DLLSALLQYLPEER-------MKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHTCSSGGGS-------CCHHHHTTSGGGGGGGC
T ss_pred HHHHHHhccCcccc-------CCHHHHhcCccccccCC
Confidence 99999999777666 99999999999987443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=273.07 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
....+.+|+.+++.++||||+++++++... ...|+|+|+++ |+|..++.. +.+++..+..++.|++.||.|||
T Consensus 68 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH 145 (364)
T 3qyz_A 68 YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 145 (364)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999765 36899999998 477777764 47999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHh
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el 167 (303)
++||+||||||+||+++.++.+||+|||++........ .....||+.|+|||++.+...++.++||||+||++|+|
T Consensus 146 ~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 225 (364)
T 3qyz_A 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225 (364)
T ss_dssp HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHH
T ss_pred HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHH
Confidence 99999999999999999999999999999987653321 23458999999999987666689999999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
++|..||.+....+....+....+.+............ ...+..-.......++... .+..++++.+++.+
T Consensus 226 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~ 296 (364)
T 3qyz_A 226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK--ARNYLLSLPHKNKVPWNRL-------FPNADSKALDLLDK 296 (364)
T ss_dssp HHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH--HHHHHHTSCCCCCCCHHHH-------CTTSCHHHHHHHHH
T ss_pred HHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh--HHHHHHhcCCccCCCHHHh-------CCCCCHHHHHHHHH
Confidence 99999999988888877777654443211110000000 0000000111111122111 12346788999999
Q ss_pred hhccccceeeccccccccccccceeeeeec
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
||..+|..| +++.++++||||..
T Consensus 297 ~L~~dP~~R-------~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 297 MLTFNPHKR-------IEVEQALAHPYLEQ 319 (364)
T ss_dssp HTCSSTTTS-------CCHHHHHTSGGGTT
T ss_pred HcCCChhhC-------CCHHHHhcCcchhh
Confidence 999766666 99999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=274.27 Aligned_cols=240 Identities=23% Similarity=0.368 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE------EEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++...+.. ++||||++ +++..++. ..+++..+..++.|++.||.||
T Consensus 84 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~L 160 (371)
T 4exu_A 84 FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYI 160 (371)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999999877654 99999998 57777664 3599999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|+.||+||||||+||+++.++.+||+|||++..... ......+|+.|+|||++.+...++.++|||||||++|+|++|
T Consensus 161 H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 238 (371)
T 4exu_A 161 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238 (371)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred HHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999986543 234567899999999998755589999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+....+....++...+.++...... ........ +...........+... .+..++.+.+++.+||.
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~ 309 (371)
T 4exu_A 239 KTLFKGKDYLDQLTQILKVTGVPGTEFVQK-LNDKAAKS-YIQSLPQTPRKDFTQL-------FPRASPQAADLLEKMLE 309 (371)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHTT-CSCHHHHH-HHHHSCCCCCCCHHHH-------STTSCHHHHHHHHHHSC
T ss_pred CCCCCCCChHHHHHHHHHHhCCCcHHHHHH-hhhhhhhh-hhhccCCCcchhHHHh-------ccccChHHHHHHHHHCC
Confidence 999999998888888877655543211111 00000000 0000111111111111 12357889999999999
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|..| +++.++++||||..
T Consensus 310 ~dP~~R-------pt~~ell~hp~f~~ 329 (371)
T 4exu_A 310 LDVDKR-------LTAAQALTHPFFEP 329 (371)
T ss_dssp SCTTTS-------CCHHHHHTSGGGTT
T ss_pred CChhhc-------CCHHHHhcCccccc
Confidence 766666 99999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=266.45 Aligned_cols=216 Identities=20% Similarity=0.223 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 129 (304)
T 2jam_A 50 DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129 (304)
T ss_dssp --HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 35678899999999999999999999999999999999999999998877778999999999999999999999999999
Q ss_pred cccCCCcEEE---ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILL---TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||+|+||++ +.++.++|+|||++...... ......+|+.|+|||.+.+.. ++.++||||+||++|+|++|..|+
T Consensus 130 ~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999 67889999999998764332 234457899999999998765 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+ ....+..++.+.+++.+|+..+|.
T Consensus 208 ~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~dp~ 251 (304)
T 2jam_A 208 YEETESKLFEKIKEGYYEFE------------------------------------SPFWDDISESAKDFICHLLEKDPN 251 (304)
T ss_dssp TTSCHHHHHHHHHHCCCCCC------------------------------------TTTTTTSCHHHHHHHHHHHCSSTT
T ss_pred CCCCHHHHHHHHHcCCCCCC------------------------------------ccccccCCHHHHHHHHHHcCCChh
Confidence 88777666655544322110 000112346678899999986666
Q ss_pred eeeccccccccccccceeeeeecC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.| +++.++++|||+...
T Consensus 252 ~R-------ps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 252 ER-------YTCEKALSHPWIDGN 268 (304)
T ss_dssp TS-------CCHHHHHTSHHHHSS
T ss_pred HC-------cCHHHHhcCccccCC
Confidence 65 999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=274.15 Aligned_cols=253 Identities=17% Similarity=0.246 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-AC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i 95 (303)
....+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...+.+++..+..++.|++.||.|||+. ||
T Consensus 74 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i 153 (360)
T 3eqc_A 74 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 153 (360)
T ss_dssp HHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 44667889999999999999999999999999999999999999999988777899999999999999999999996 99
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+|+||||+||+++.++.+||+|||++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 154 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred EcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998654321 223457899999999998765 8999999999999999999999988
Q ss_pred CCchHHHHHHHhhcCC-ceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCC---CCCCCchhhHHhhhhhhcc
Q psy763 176 GNMGSHMARNLLKNNG-RVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGG---NTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~dll~~~l~~ 251 (303)
+....+.......... ......................................... .....+.++.+++.+|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 311 (360)
T 3eqc_A 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311 (360)
T ss_dssp CCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCS
T ss_pred CCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhc
Confidence 7766554332211111 00000000000000000000000001111122222211111 1122466789999999997
Q ss_pred ccceeeccccccccccccceeeeeecC
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+|..| +++.++++||||...
T Consensus 312 dP~~R-------pt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 312 NPAER-------ADLKQLMVHAFIKRS 331 (360)
T ss_dssp STTTS-------CCHHHHHTSHHHHHH
T ss_pred ChhhC-------CCHHHHhhChHhhcc
Confidence 66666 999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=263.56 Aligned_cols=215 Identities=20% Similarity=0.251 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+.+++.++||||+++++++.. ...+++||||+++++|.+++.....+++..++.++.|++.||.|||+
T Consensus 68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~ 147 (290)
T 1t4h_A 68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147 (290)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc
Confidence 45678899999999999999999999875 35689999999999999999877789999999999999999999999
Q ss_pred CC--ceecccCCCcEEEe-cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 93 HA--CIHRDIKPENILLT-ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 93 ~~--ivH~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
.| ++|+||||+||+++ .++.+||+|||++...... ......+|+.|+|||.+.+ .++.++||||+||++|+|++
T Consensus 148 ~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~ 224 (290)
T 1t4h_A 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHh
Confidence 99 99999999999998 7889999999999754432 3345678999999998874 37999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..|+.+..........+..+..+. .......+++.+++.+|+
T Consensus 225 g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~l~~li~~~l 267 (290)
T 1t4h_A 225 SEYPYSECQNAAQIYRRVTSGVKPA-------------------------------------SFDKVAIPEVKEIIEGCI 267 (290)
T ss_dssp SSCTTTTCSSHHHHHHHHTTTCCCG-------------------------------------GGGGCCCHHHHHHHHHHS
T ss_pred CCCCCCCcCcHHHHHHHHhccCCcc-------------------------------------ccCCCCCHHHHHHHHHHc
Confidence 9999887655555443333222110 000112356789999999
Q ss_pred ccccceeeccccccccccccceeeeeecC
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
..+|..| +++.++++||||.+.
T Consensus 268 ~~dp~~R-------ps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 268 RQNKDER-------YSIKDLLNHAFFQEE 289 (290)
T ss_dssp CSSGGGS-------CCHHHHHTSGGGC--
T ss_pred cCChhhC-------CCHHHHhhCcccccC
Confidence 8766666 999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=264.08 Aligned_cols=202 Identities=18% Similarity=0.232 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCC---CCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... +++..++.++.|++.||+|||+.|
T Consensus 78 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 157 (309)
T 3p86_A 78 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157 (309)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 45678899999999999999999999999999999999999999999876653 999999999999999999999999
Q ss_pred --ceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 95 --CIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 95 --ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
|+||||||+||+++.++.+||+|||++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|.
T Consensus 158 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~ 236 (309)
T 3p86_A 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQ 236 (309)
T ss_dssp SCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCC
T ss_pred CCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999765432 2234567899999999998766 799999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
.||.+....+....+.....+.. .+...++++.+++..|+..+|..||.
T Consensus 237 ~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps 285 (309)
T 3p86_A 237 QPWGNLNPAQVVAAVGFKCKRLE---IPRNLNPQVAAIIEGCWTNEPWKRPS 285 (309)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCHHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcC
Confidence 99988887777666554444332 23445566666666666666655554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=267.48 Aligned_cols=233 Identities=20% Similarity=0.268 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK--KLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+.+++.++||||+++++++.... ..++||||+++++|.+++.... .+++..++.++.|++.||.|||+
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 130 (319)
T 4euu_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130 (319)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999998765 7899999999999999887643 39999999999999999999999
Q ss_pred CCceecccCCCcEEE----ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC-------CccCCCccchhhHH
Q psy763 93 HACIHRDIKPENILL----TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG-------DTLYGPAVDVWAIE 161 (303)
Q Consensus 93 ~~ivH~dlk~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~-------~~~~~~~~DvwSlG 161 (303)
.||+||||||+||++ +.++.+||+|||++.............+|+.|+|||++.+ ...++.++||||||
T Consensus 131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG 210 (319)
T 4euu_A 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210 (319)
T ss_dssp TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHH
T ss_pred CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHH
Confidence 999999999999999 6777899999999998776666666789999999999862 24489999999999
Q ss_pred HHHHHhhccCccCCCC----chHHHHHHHhhcCCcee--EeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCC
Q psy763 162 WTSHSYSQIGFIGLGN----MGSHMARNLLKNNGRVT--VILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTD 235 (303)
Q Consensus 162 ~il~el~tg~~~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 235 (303)
|++|||++|..||.+. ...+....++....... ...... ... ..|...... ......
T Consensus 211 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~--~~~~~~~~~------------~~~~~~ 273 (319)
T 4euu_A 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE---NGP--IDWSGDMPV------------SCSLSR 273 (319)
T ss_dssp HHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECST---TCC--EEEESSCCT------------TCSSCH
T ss_pred HHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhccc---CCc--cccCccCCc------------ccccch
Confidence 9999999999888633 33445555554322111 010000 000 011111110 011112
Q ss_pred CCchhhHHhhhhhhccccceeeccccccccccccceeee
Q psy763 236 RNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFY 274 (303)
Q Consensus 236 ~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~ 274 (303)
...+.+.+++.+||..+|..| +++.++++||-
T Consensus 274 ~~~~~l~~ll~~~L~~dP~~R-------~s~~ell~h~~ 305 (319)
T 4euu_A 274 GLQVLLTPVLANILEADQEKC-------WGFDQFFAETS 305 (319)
T ss_dssp HHHHHHHHHHHHHSCCCTTTS-------CCHHHHHHHHH
T ss_pred hHHHHhHHHHHHhccCChhhh-------ccHHHhhhccH
Confidence 234466788999998666555 99999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=261.96 Aligned_cols=219 Identities=19% Similarity=0.271 Sum_probs=161.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH----cCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE----NHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.++...++.++||||+++++++.+++..++||||+++ ++..++ ..+..+++..++.++.|++.||.|||+
T Consensus 49 ~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (290)
T 3fme_A 49 QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127 (290)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345556666778999999999999999999999999999985 655543 356789999999999999999999999
Q ss_pred C-CceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCccccc---CCccCCCccchhhHHHHHHHhh
Q psy763 93 H-ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV---GDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 93 ~-~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~---~~~~~~~~~DvwSlG~il~el~ 168 (303)
+ |++||||||+||+++.++.+||+|||++.............+|+.|+|||.+. ....++.++||||+||++|+|+
T Consensus 128 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 207 (290)
T 3fme_A 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207 (290)
T ss_dssp HSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence 8 99999999999999999999999999998776555555568999999999973 3444799999999999999999
Q ss_pred ccCccCCCC-chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 169 QIGFIGLGN-MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 169 tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
+|..|+.+. ................ ......++++.+++.+
T Consensus 208 ~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~li~~ 249 (290)
T 3fme_A 208 ILRFPYDSWGTPFQQLKQVVEEPSPQ--------------------------------------LPADKFSAEFVDFTSQ 249 (290)
T ss_dssp HTSCSSCCCSCHHHHHHHHHHSCCCC--------------------------------------CCTTTSCHHHHHHHHH
T ss_pred HCCCCccccCchHHHHHHHhccCCCC--------------------------------------cccccCCHHHHHHHHH
Confidence 999888753 3333333322221110 0111234667899999
Q ss_pred hhccccceeeccccccccccccceeeeeecCCcc
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
|+..+|..| +++.++++||||.....+
T Consensus 250 ~l~~~p~~R-------pt~~e~l~hp~f~~~~~~ 276 (290)
T 3fme_A 250 CLKKNSKER-------PTYPELMQHPFFTLHESK 276 (290)
T ss_dssp HTCSSGGGS-------CCHHHHTTSHHHHHHHHS
T ss_pred HhhcChhhC-------cCHHHHHhCcccccCccc
Confidence 999766666 999999999999765443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=266.98 Aligned_cols=212 Identities=19% Similarity=0.287 Sum_probs=163.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-------------------------------------------------
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK------------------------------------------------- 47 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------------------------------------------------- 47 (303)
..+.+.+|+.+++.++||||+++++++.+..
T Consensus 47 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (332)
T 3qd2_B 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126 (332)
T ss_dssp HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------------------------
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccc
Confidence 3466789999999999999999999986543
Q ss_pred --------EEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEc
Q psy763 48 --------KLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 116 (303)
Q Consensus 48 --------~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~ 116 (303)
..++||||+++++|.+++.... ..++..++.++.|++.||.|||++||+||||||+||+++.++.+||+
T Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 206 (332)
T 3qd2_B 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 206 (332)
T ss_dssp -----CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEe
Confidence 3899999999999999987654 35566789999999999999999999999999999999999999999
Q ss_pred cccceeeeCCCC-------------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchHHHH
Q psy763 117 DFGFARLINPGE-------------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMA 183 (303)
Q Consensus 117 dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~ 183 (303)
|||++....... ......||+.|+|||.+.+.. ++.++||||+||++|||++|..++... ....
T Consensus 207 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~~--~~~~ 283 (332)
T 3qd2_B 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQMER--VRII 283 (332)
T ss_dssp CCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHH
T ss_pred ecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhHH--HHHH
Confidence 999998876432 223457999999999998765 899999999999999999865432111 1111
Q ss_pred HHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeecccccc
Q psy763 184 RNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDS 263 (303)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~ 263 (303)
.. .... ....... ...+++.+++.+|+..+|..|
T Consensus 284 ~~-~~~~---------------------------~~~~~~~-----------~~~~~~~~li~~~l~~~p~~R------- 317 (332)
T 3qd2_B 284 TD-VRNL---------------------------KFPLLFT-----------QKYPQEHMMVQDMLSPSPTER------- 317 (332)
T ss_dssp HH-HHTT---------------------------CCCHHHH-----------HHCHHHHHHHHHHHCSSGGGS-------
T ss_pred HH-hhcc---------------------------CCCcccc-----------cCChhHHHHHHHHccCCCCcC-------
Confidence 11 1000 0000000 123456789999998666666
Q ss_pred ccccccceeeeeec
Q psy763 264 IRGKNCKKTFYIPT 277 (303)
Q Consensus 264 ~~~~~~l~~~~~~~ 277 (303)
+++.++++||||.+
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=270.50 Aligned_cols=204 Identities=26% Similarity=0.363 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQI 79 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~ 79 (303)
..+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||+++|+|.+++... ..+++..+..+
T Consensus 129 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 208 (370)
T 2psq_A 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208 (370)
T ss_dssp HHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHH
Confidence 345688899999999 8999999999999999999999999999999987643 24889999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccc
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVD 156 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~D 156 (303)
+.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .....+|+.|+|||++.+.. ++.++|
T Consensus 209 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~D 287 (370)
T 2psq_A 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSD 287 (370)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHH
T ss_pred HHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHH
Confidence 99999999999999999999999999999999999999999987653322 23345678899999998765 899999
Q ss_pred hhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 157 VWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 157 vwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
||||||++|||++ |..|+.+....+... .+..+.++. .+..++.++.+++..|+..+|..||...
T Consensus 288 vwslG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 353 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFK 353 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999999999 667766655554443 444444322 2344556666666677766666555433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=264.65 Aligned_cols=233 Identities=17% Similarity=0.197 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRS-LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+..+++ .+||||+++++++.+++.+|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+
T Consensus 54 ~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 133 (316)
T 2ac3_A 54 RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133 (316)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 3456778888887 579999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCc---EEEccccceeeeCCCC--------ccccccCCCcccCcccccC----CccCCCccchhhHH
Q psy763 97 HRDIKPENILLTANGV---VKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIE 161 (303)
Q Consensus 97 H~dlk~~nil~~~~~~---~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG 161 (303)
||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+ ...++.++||||+|
T Consensus 134 H~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 213 (316)
T 2ac3_A 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213 (316)
T ss_dssp CCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHH
T ss_pred eCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHH
Confidence 9999999999987765 9999999987653211 1223468999999999874 13378999999999
Q ss_pred HHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhh
Q psy763 162 WTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGV 241 (303)
Q Consensus 162 ~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 241 (303)
|++|||++|..||.+....+.. ..............+..+.......+... ....++.+
T Consensus 214 ~il~~l~~g~~pf~~~~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--------~~~~~~~~ 272 (316)
T 2ac3_A 214 VILYILLSGYPPFVGRCGSDCG-------------WDRGEACPACQNMLFESIQEGKYEFPDKD--------WAHISCAA 272 (316)
T ss_dssp HHHHHHHHSSCSCCCCCCSCSC-------------C----CCHHHHHHHHHHHHHCCCCCCHHH--------HTTSCHHH
T ss_pred HHHHHHHHCCCCCccccccccc-------------ccccccchhHHHHHHHHHhccCcccCchh--------cccCCHHH
Confidence 9999999999988765321100 00000000000001111111000000000 01245678
Q ss_pred HHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 242 VKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 242 ~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.+++.+||..+|..| +++.++++||||...
T Consensus 273 ~~li~~~L~~dP~~R-------ps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 273 KDLISKLLVRDAKQR-------LSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHSCSSTTTS-------CCHHHHHHSTTCC--
T ss_pred HHHHHHHhhCChhhC-------CCHHHHhcChhhcCC
Confidence 899999999776666 999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=268.57 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
....+.+|+.+++.++||||+++++++... ...++|+||++ ++|..++.. +.+++..+..++.|++.||.|||
T Consensus 52 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH 129 (353)
T 2b9h_A 52 FALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLH 129 (353)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999998754 67899999998 578887764 47999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----------cccccCCCcccCcccccCCccCCCccchhhH
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----------YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
++|++||||||+||+++.++.+||+|||++........ .....||+.|+|||++.+...++.++|||||
T Consensus 130 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 99999999999999999999999999999987653211 1234789999999998765558999999999
Q ss_pred HHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchh
Q psy763 161 EWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHG 240 (303)
Q Consensus 161 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 240 (303)
||++|+|++|..||.+....+....+....+.+..................... ......++... .+..+++
T Consensus 210 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~ 281 (353)
T 2b9h_A 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSL-PMYPAAPLEKM-------FPRVNPK 281 (353)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTS-CCCCCCCHHHH-------STTSCHH
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcc-cCCCCcchhhh-------cccCCHH
Confidence 999999999999999988777776666554433211000000000000000000 00001111111 1235678
Q ss_pred hHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 241 VVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 241 ~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+.+++.+|+..+|..| +++.++++||||...
T Consensus 282 ~~~li~~~L~~dP~~R-------pt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 282 GIDLLQRMLVFDPAKR-------ITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHHHHHHSCSSGGGS-------CCHHHHHTSGGGTTT
T ss_pred HHHHHHHhcCcCcccC-------CCHHHHhcCcccccc
Confidence 8999999999777666 999999999999763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=259.38 Aligned_cols=211 Identities=18% Similarity=0.193 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+..+..+ +||||+++++++.+++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+
T Consensus 54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 133 (289)
T 1x8b_A 54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133 (289)
T ss_dssp HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34556777778887 9999999999999999999999999999999988653 579999999999999999999999
Q ss_pred CCceecccCCCcEEEecC-------------------CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCC
Q psy763 93 HACIHRDIKPENILLTAN-------------------GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGP 153 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~-------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~ 153 (303)
+||+||||||+||+++.+ ..+||+|||.+...... ....+|+.|+|||.+.+...++.
T Consensus 134 ~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~ 210 (289)
T 1x8b_A 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLP 210 (289)
T ss_dssp TTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHH
T ss_pred CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCc
Confidence 999999999999999844 47999999999876542 23468999999999987655678
Q ss_pred ccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCC
Q psy763 154 AVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGN 233 (303)
Q Consensus 154 ~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 233 (303)
++|||||||++|+|++|..++........+. . +.. ...
T Consensus 211 ~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~-~~~--------------------------------------~~~ 248 (289)
T 1x8b_A 211 KADIFALALTVVCAAGAEPLPRNGDQWHEIR---Q-GRL--------------------------------------PRI 248 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH---T-TCC--------------------------------------CCC
T ss_pred hhhHHHHHHHHHHHhcCCCCCcchhHHHHHH---c-CCC--------------------------------------CCC
Confidence 9999999999999999887765543322221 1 000 001
Q ss_pred CCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 234 TDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 234 ~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
....++++.+++.+|+..+|..| +++.++++||||.....
T Consensus 249 ~~~~~~~~~~li~~~l~~dp~~R-------ps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 249 PQVLSQEFTELLKVMIHPDPERR-------PSAMALVKHSVLLSASR 288 (289)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGS-------CCHHHHHTCTTC-----
T ss_pred CcccCHHHHHHHHHHhCCCcccC-------CCHHHHhhChHhhhhcc
Confidence 11235677899999998766666 99999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=270.48 Aligned_cols=219 Identities=21% Similarity=0.266 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++..+. .|+||||+++++|.+++.....+++..+..++.|++.||.|||++|++|
T Consensus 59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (322)
T 2ycf_A 59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137 (322)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 445788999999999999999999997665 8999999999999999888889999999999999999999999999999
Q ss_pred cccCCCcEEEecCCc---EEEccccceeeeCCCCccccccCCCcccCccccc--CCccCCCccchhhHHHHHHHhhccCc
Q psy763 98 RDIKPENILLTANGV---VKLCDFGFARLINPGENYTDYVATRWYRAPELLV--GDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 98 ~dlk~~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~--~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|||||+||+++.++. +||+|||++.............+|+.|+|||++. +...++.++|||||||++|+|++|..
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999987654 9999999998876544444567899999999974 23448999999999999999999998
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
|+.+......+...+..+... ..+ .. ....++.+.+++.+|+..+
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~--------~~~--------------------~~-------~~~~~~~~~~li~~~l~~d 262 (322)
T 2ycf_A 218 PFSEHRTQVSLKDQITSGKYN--------FIP--------------------EV-------WAEVSEKALDLVKKLLVVD 262 (322)
T ss_dssp SSCSTTCSSCHHHHHHHTCCC--------CCH--------------------HH-------HTTSCHHHHHHHHHHSCSS
T ss_pred CCcccchHHHHHHHHHhCccc--------cCc--------------------hh-------hhhcCHHHHHHHHHHcccC
Confidence 886643322222221111100 000 00 0123466788888888866
Q ss_pred cceeeccccccccccccceeeeeecCC
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
|..| +++.++++|||+.+.+
T Consensus 263 P~~R-------ps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 263 PKAR-------FTTEEALRHPWLQDED 282 (322)
T ss_dssp TTTS-------CCHHHHHTSGGGCCHH
T ss_pred HhhC-------CCHHHHhhCcCcCCHH
Confidence 6665 9999999999987643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=265.15 Aligned_cols=234 Identities=29% Similarity=0.423 Sum_probs=177.9
Q ss_pred HHHHhCCCCCcceeEEEEE-----eCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 26 KEKRSLKHPNLVNLLEVFR-----RKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 26 ~~l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
+.++.++||||+++++++. .....++|+||++ |+|.+++... ..+++..+..++.|++.||.|||+.|++|+
T Consensus 66 ~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~ 144 (326)
T 1blx_A 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR 144 (326)
T ss_dssp HHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 3444559999999999997 4567899999998 5888776543 359999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
||||+||+++.++.+||+|||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..
T Consensus 145 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 145 DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999998765444445678899999999998765 8999999999999999999999999988
Q ss_pred hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeec
Q psy763 179 GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQS 258 (303)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~ 258 (303)
..+....++...+.+.....+...... ...+......++. ......++.+.+++.+|+..+|..|
T Consensus 224 ~~~~~~~i~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~R-- 288 (326)
T 1blx_A 224 DVDQLGKILDVIGLPGEEDWPRDVALP------RQAFHSKSAQPIE-------KFVTDIDELGKDLLLKCLTFNPAKR-- 288 (326)
T ss_dssp HHHHHHHHHHHHCCCCGGGSCTTCSSC------GGGSCCCCCCCGG-------GTCCSCCHHHHHHHHHHSCSSTTTS--
T ss_pred HHHHHHHHHHHcCCCCcccCccccccc------hhhhcccCcchhh-------hccccCCHHHHHHHHHHcCCCcccC--
Confidence 888877777654433211111110000 0001111111111 1123356778899999999766666
Q ss_pred cccccccccccceeeeeecCCcc
Q psy763 259 EKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 259 ~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+++.+++.||||.+.+..
T Consensus 289 -----pt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 289 -----ISAYSALSHPYFQDLERC 306 (326)
T ss_dssp -----CCHHHHHTSGGGTTCCCC
T ss_pred -----CCHHHHhcCccccccchh
Confidence 999999999999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=267.98 Aligned_cols=234 Identities=18% Similarity=0.228 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHH------HcC--CCCCCHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL------ENH--PHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~------~~~--~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
..+.+|+.+++.++||||+++++++...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.||
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 6788899999999999999999999999999999999999999998 665 56899999999999999999999
Q ss_pred HH-CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCC-ccchhhHHHHHHHhh
Q psy763 91 HR-HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGP-AVDVWAIEWTSHSYS 168 (303)
Q Consensus 91 H~-~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~-~~DvwSlG~il~el~ 168 (303)
|+ .|++|+||+|+||+++.++.+||+|||++...... ......+++.|+|||.+.+...++. ++|||||||++|||+
T Consensus 168 H~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp HHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence 99 99999999999999999999999999999876543 3455678999999999987644555 999999999999999
Q ss_pred ccCccCCCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 169 QIGFIGLGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 169 tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
+|..|+.+... .+....+.......+. .... +........ ........++++.+++.+
T Consensus 247 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~--~~~~------------~~~~~~~~~-------~~~~~~~~~~~l~~li~~ 305 (348)
T 2pml_X 247 YNVVPFSLKISLVELFNNIRTKNIEYPL--DRNH------------FLYPLTNKK-------STCSNNFLSNEDIDFLKL 305 (348)
T ss_dssp HSSCSSCCSSCSHHHHHHHTSCCCCCCC--SSSS------------STTTTCC---------------CCCHHHHHHHHH
T ss_pred hCCCCCCCCCcHHHHHHHHhccCcCCcc--chhh------------hhccccccc-------cccchhhcCHHHHHHHHH
Confidence 99999988776 4444444333222110 0000 000000000 011123456788999999
Q ss_pred hhccccceeeccccccccccccceeeeeecCCcc
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
|+..+|..| +++.++++||||.+.+..
T Consensus 306 ~L~~dP~~R-------ps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 306 FLRKNPAER-------ITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HCCSSGGGS-------CCHHHHHTSGGGTTCCHH
T ss_pred HccCChhhC-------CCHHHHhcCccccCCCHH
Confidence 998766666 999999999999886643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.72 Aligned_cols=204 Identities=18% Similarity=0.264 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+..++.++||||+++++++.... ..|+||||+++++|.+++...+.+++..++.++.|++.||.|||+
T Consensus 55 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~ 134 (311)
T 3ork_A 55 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 134 (311)
T ss_dssp HHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999987654 359999999999999998877789999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
+||+||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+.. ++.++|||||||++|||+
T Consensus 135 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll 213 (311)
T 3ork_A 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVL 213 (311)
T ss_dssp TTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHH
T ss_pred CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHH
Confidence 999999999999999999999999999998754322 123356899999999998765 899999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
+|..||.+....+...........++ .......+.++.+++..|+..+|..|+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~R~ 266 (311)
T 3ork_A 214 TGEPPFTGDSPVSVAYQHVREDPIPP-SARHEGLSADLDAVVLKALAKNPENRY 266 (311)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCH-HHHSTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hCCCCCCCCChHHHHHHHhcCCCCCc-ccccCCCCHHHHHHHHHHHhcCHhhCh
Confidence 99999998888877777666554432 222334555566666666655555443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=264.71 Aligned_cols=202 Identities=17% Similarity=0.217 Sum_probs=162.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||
T Consensus 93 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 172 (325)
T 3kul_A 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172 (325)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3466788999999999999999999999999999999999999999988644 589999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
+||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++|||++ |
T Consensus 173 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g 251 (325)
T 3kul_A 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYG 251 (325)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred eCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987653321 12234577899999998665 7999999999999999998 7
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
..|+.+....+....+... .+++ .+...+.++.+++-.|+..+|..||.
T Consensus 252 ~~p~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 300 (325)
T 3kul_A 252 ERPYWNMTNRDVISSVEEG-YRLP---APMGCPHALHQLMLDCWHKDRAQRPR 300 (325)
T ss_dssp CCTTTTSCHHHHHHHHHTT-CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcccCCHHHHHHHHHcC-CCCC---CCCCcCHHHHHHHHHHccCChhhCcC
Confidence 7887777766666554443 3322 23455566666666666666665554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=268.17 Aligned_cols=213 Identities=22% Similarity=0.277 Sum_probs=169.7
Q ss_pred HHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+.+|+.+++.+ +||||+++++++...+.+++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||
T Consensus 104 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 183 (355)
T 1vzo_A 104 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183 (355)
T ss_dssp GCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 355678888888 6999999999999999999999999999999998877789999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhhccCccCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||+|||++.++.+||+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|||++|..|+.
T Consensus 184 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 999999999999999999999998754322 22345799999999999853 347899999999999999999998876
Q ss_pred CCch----HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 176 GNMG----SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 176 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
+... ......+... ........++.+.+++.+|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~L~~ 303 (355)
T 1vzo_A 264 VDGEKNSQAEISRRILKS----------------------------------------EPPYPQEMSALAKDLIQRLLMK 303 (355)
T ss_dssp CTTSCCCHHHHHHHHHHC----------------------------------------CCCCCTTSCHHHHHHHHHHTCS
T ss_pred cCCccchHHHHHHHHhcc----------------------------------------CCCCCcccCHHHHHHHHHHhhh
Confidence 4321 1111111110 1111223455677889999987
Q ss_pred ccceeeccccccc-----cccccceeeeeecCC
Q psy763 252 RFTYIQSEKQDSI-----RGKNCKKTFYIPTPE 279 (303)
Q Consensus 252 ~~~~~~~~~~~~~-----~~~~~l~~~~~~~~~ 279 (303)
+|..| + ++.++++||||...+
T Consensus 304 dP~~R-------~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 304 DPKKR-------LGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp SGGGS-------TTSSTTTHHHHHTSGGGTTCC
T ss_pred CHHHh-------cCCCCCCHHHHHcCcchhcCC
Confidence 76666 7 899999999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=257.50 Aligned_cols=215 Identities=21% Similarity=0.283 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.. +.+++..+..++.|++.||.|||+.|++|
T Consensus 64 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 142 (303)
T 3a7i_A 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIH 142 (303)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 45678899999999999999999999999999999999999999998875 57999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.+||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|..|+.+
T Consensus 143 ~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCC
Confidence 9999999999999999999999998765432 234567899999999998765 79999999999999999999988877
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+.... . .......+..+.+++.+|+..+|..|
T Consensus 222 ~~~~~~~~~~~~~~-~--------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~R 262 (303)
T 3a7i_A 222 LHPMKVLFLIPKNN-P--------------------------------------PTLEGNYSKPLKEFVEACLNKEPSFR 262 (303)
T ss_dssp SCHHHHHHHHHHSC-C--------------------------------------CCCCSSCCHHHHHHHHHHCCSSGGGS
T ss_pred cCHHHHHHHhhcCC-C--------------------------------------CCCccccCHHHHHHHHHHcCCChhhC
Confidence 66555443322211 0 00111234567788888888666666
Q ss_pred eccccccccccccceeeeeecCCc
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+++.++++|||+.....
T Consensus 263 -------ps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 263 -------PTAKELLKHKFILRNAK 279 (303)
T ss_dssp -------CCHHHHTTCHHHHHHCC
T ss_pred -------cCHHHHhhChhhhcCCC
Confidence 99999999999866443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=272.94 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHhCC--------CCCcceeEEEEE----eCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLK--------HPNLVNLLEVFR----RKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVL 84 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~--------h~niv~~~~~~~----~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~ 84 (303)
...+.+|+.+++.++ |+||+++++++. .+..+++||||+.++++..+.... ..+++..++.++.||+
T Consensus 77 ~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 156 (397)
T 1wak_A 77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156 (397)
T ss_dssp HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence 445677888888875 888999999998 456899999999777777666554 5799999999999999
Q ss_pred HHHHHHHHC-CceecccCCCcEEEecCC-------------------------------------------------cEE
Q psy763 85 RGVSYCHRH-ACIHRDIKPENILLTANG-------------------------------------------------VVK 114 (303)
Q Consensus 85 ~~l~~lH~~-~ivH~dlk~~nil~~~~~-------------------------------------------------~~k 114 (303)
.||.|||++ ||+||||||+|||++.++ .+|
T Consensus 157 ~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 236 (397)
T 1wak_A 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236 (397)
T ss_dssp HHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEE
T ss_pred HHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceE
Confidence 999999998 999999999999998765 799
Q ss_pred EccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCc------hHHHHHHHhh
Q psy763 115 LCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNM------GSHMARNLLK 188 (303)
Q Consensus 115 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~------~~~~~~~~~~ 188 (303)
|+|||++..... ......+|+.|+|||++.+.. ++.++|||||||++|||++|..||.+.. ....+..+..
T Consensus 237 l~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 313 (397)
T 1wak_A 237 IADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313 (397)
T ss_dssp ECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH
T ss_pred eccccccccccc--cCccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH
Confidence 999999987543 234567899999999998766 8999999999999999999999887654 3333444444
Q ss_pred cCCceeEeec-CCCCCcchhh--hhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeecccccccc
Q psy763 189 NNGRVTVILK-SDSLDSETWD--LTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIR 265 (303)
Q Consensus 189 ~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~ 265 (303)
..+.++.... ......+.+. ..+.. ..+.........+...........+.+.+++.+||..+|..| ++
T Consensus 314 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R-------pt 385 (397)
T 1wak_A 314 LLGKVPRKLIVAGKYSKEFFTKKGDLKH-ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR-------AT 385 (397)
T ss_dssp HHCSCCHHHHHHCTTGGGTBCTTSSBSS-CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGS-------CC
T ss_pred hcCCCChHHhhcccccccccCCcccccc-ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhc-------CC
Confidence 3332221100 0000000000 00000 001111122333333333444456678899999999777766 99
Q ss_pred ccccceeeeee
Q psy763 266 GKNCKKTFYIP 276 (303)
Q Consensus 266 ~~~~l~~~~~~ 276 (303)
+.++++||||.
T Consensus 386 ~~e~l~hp~~~ 396 (397)
T 1wak_A 386 AAECLRHPWLN 396 (397)
T ss_dssp HHHHHTSGGGG
T ss_pred HHHHhhCcccc
Confidence 99999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=258.60 Aligned_cols=216 Identities=19% Similarity=0.261 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++||||+++++++...+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.|++|
T Consensus 69 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 148 (314)
T 3com_A 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIH 148 (314)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 456789999999999999999999999999999999999999999875 4568999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
+||+|+||+++.++.+||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|..|+.+
T Consensus 149 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998765432 234567899999999998765 89999999999999999999998887
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
.........+........ ......++.+.+++.+|+..+|..|
T Consensus 228 ~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~l~~li~~~l~~dp~~R 270 (314)
T 3com_A 228 IHPMRAIFMIPTNPPPTF-------------------------------------RKPELWSDNFTDFVKQCLVKSPEQR 270 (314)
T ss_dssp SCHHHHHHHHHHSCCCCC-------------------------------------SSGGGSCHHHHHHHHHHTCSCTTTS
T ss_pred CChHHHHHHHhcCCCccc-------------------------------------CCcccCCHHHHHHHHHHccCChhhC
Confidence 665554433322111000 0001123556788888888666555
Q ss_pred eccccccccccccceeeeeecCC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+++.+++.|||+....
T Consensus 271 -------pt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 271 -------ATATQLLQHPFVRSAK 286 (314)
T ss_dssp -------CCHHHHTTSHHHHTCC
T ss_pred -------cCHHHHHhCHHHhcCC
Confidence 9999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=271.46 Aligned_cols=242 Identities=20% Similarity=0.285 Sum_probs=177.2
Q ss_pred HHHHHHHHHHhC------CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSL------KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 20 ~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
.+.+|+++++.+ +|+||+++++++...+.+++||||+. ++|.+++... ..+++..+..++.|++.||.|||
T Consensus 139 ~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH 217 (429)
T 3kvw_A 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217 (429)
T ss_dssp HHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 344455555544 68899999999999999999999997 4666655433 35999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCc--EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 92 RHACIHRDIKPENILLTANGV--VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
+.||+||||||+|||++.++. +||+|||++..... ......+|+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 218 ~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt 294 (429)
T 3kvw_A 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLT 294 (429)
T ss_dssp HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHH
T ss_pred HCCeecCCCCHHHeEEccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHh
Confidence 999999999999999999877 99999999976432 334568999999999998766 8999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCC-----------Ccch-----hh---------hhhhhhhcCCChhHHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSL-----------DSET-----WD---------LTWQEIFSKTSTTTIF 224 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~-----~~---------~~~~~~~~~~~~~~~~ 224 (303)
|..||.+....+.+..++...+.++........ +..+ .+ .........+..+.+.
T Consensus 295 G~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (429)
T 3kvw_A 295 GYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374 (429)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhH
Confidence 999999998888888777754443321100000 0000 00 0000000011111222
Q ss_pred HHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 225 KYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.. ......+.+.+++.+||..+|..| +++.++++||||...
T Consensus 375 ~~------l~~~~~~~~~dli~~~L~~dP~~R-------pta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 375 NA------LKGCDDPLFLDFLKQCLEWDPAVR-------MTPGQALRHPWLRRR 415 (429)
T ss_dssp HH------TTTCCCHHHHHHHHHHTCSSTTTS-------CCHHHHHTSTTTC--
T ss_pred hh------ccccchHHHHHHHHHHCCCChhhC-------CCHHHHhCChhhccC
Confidence 21 112246778999999999776666 999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=264.20 Aligned_cols=227 Identities=21% Similarity=0.266 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--------PHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
...+.+|+..++.++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|
T Consensus 57 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 136 (303)
T 2vwi_A 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136 (303)
T ss_dssp ---------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 45577899999999999999999999999999999999999999998752 4569999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC------ccccccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
||+.|++|+||+|+||+++.++.+||+|||++....... ......+|+.|+|||.+.+...++.++|||||||+
T Consensus 137 lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 216 (303)
T 2vwi_A 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216 (303)
T ss_dssp HHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHH
T ss_pred HHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHH
Confidence 999999999999999999999999999999987654321 12345789999999998764458999999999999
Q ss_pred HHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHH
Q psy763 164 SHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVK 243 (303)
Q Consensus 164 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~d 243 (303)
+|||++|..|+.+.................. .. . . .........++++.+
T Consensus 217 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~---------~--------~-----~~~~~~~~~~~~~~~ 266 (303)
T 2vwi_A 217 AIELATGAAPYHKYPPMKVLMLTLQNDPPSL--------ET---------G--------V-----QDKEMLKKYGKSFRK 266 (303)
T ss_dssp HHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT--------TC---------------------------CCCCCCCHHHHH
T ss_pred HHHHHhCCCCCccCchhhHHHHHhccCCCcc--------cc---------c--------c-----ccchhhhhhhHHHHH
Confidence 9999999999887766555443333211100 00 0 0 011112234567789
Q ss_pred hhhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 244 ILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 244 ll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
++.+|+..+|..| +++.++++||||.....+
T Consensus 267 li~~~l~~dp~~R-------ps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 267 MISLCLQKDPEKR-------PTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp HHHHHCCSSGGGS-------CCHHHHHTSTTC------
T ss_pred HHHHHccCChhhC-------cCHHHHhhChhhhcCCCC
Confidence 9999998666666 999999999999765443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=267.81 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE------EEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKK------LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+.+++.++||||+++++++...+. +|+||||++ ++|..++. ..+++..+..++.|++.||.||
T Consensus 66 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~L 142 (353)
T 3coi_A 66 FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYI 142 (353)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 44567789999999999999999999987653 599999998 57777664 3599999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++|++||||||+||+++.++.+||+|||++..... ......+|+.|+|||.+.+...++.++||||+||++|+|++|
T Consensus 143 H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 220 (353)
T 3coi_A 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220 (353)
T ss_dssp HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred HHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999876442 234457899999999998755589999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+....+.+..+....+.++...... ..... ...+.......+... -....+..++++.+++.+|+.
T Consensus 221 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~ 291 (353)
T 3coi_A 221 KTLFKGKDYLDQLTQILKVTGVPGTEFVQK-LNDKA----AKSYIQSLPQTPRKD----FTQLFPRASPQAADLLEKMLE 291 (353)
T ss_dssp SCSSBSSCHHHHHHHHHHHHCBCCHHHHTT-CSCHH----HHHHHHTSCBCSSCC----TTTTCTTSCHHHHHHHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHH-HhhHH----HHHHHHhCcCCCCcc----HHHhcCCcCHHHHHHHHHHcC
Confidence 999999888888777777554432111100 00000 000000000000000 011123457788999999999
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|..| +++.+++.||||..
T Consensus 292 ~dp~~R-------pt~~e~l~hp~f~~ 311 (353)
T 3coi_A 292 LDVDKR-------LTAAQALTHPFFEP 311 (353)
T ss_dssp SCTTTS-------CCHHHHHTSGGGTT
T ss_pred CCcccC-------CCHHHHhcCcchhh
Confidence 766666 99999999999965
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.37 Aligned_cols=159 Identities=26% Similarity=0.422 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.|+
T Consensus 50 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 129 (310)
T 3s95_A 50 TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129 (310)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 456788999999999999999999999999999999999999999998875 5689999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc---------------ccccCCCcccCcccccCCccCCCccchhhH
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY---------------TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~l~~~~~~~~~~DvwSl 160 (303)
+||||||+||+++.++.+||+|||++......... ....||+.|+|||.+.+.. ++.++|||||
T Consensus 130 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~sl 208 (310)
T 3s95_A 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSF 208 (310)
T ss_dssp ECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHH
T ss_pred cCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHH
Confidence 99999999999999999999999999876432211 1457999999999998765 8999999999
Q ss_pred HHHHHHhhccCccCCC
Q psy763 161 EWTSHSYSQIGFIGLG 176 (303)
Q Consensus 161 G~il~el~tg~~~~~~ 176 (303)
||++|||++|..++.+
T Consensus 209 G~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 209 GIVLCEIIGRVNADPD 224 (310)
T ss_dssp HHHHHHHHHTCCSSTT
T ss_pred HHHHHHHhcCCCCCcc
Confidence 9999999998877654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=258.35 Aligned_cols=216 Identities=23% Similarity=0.323 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+..++.++||||+++++++...+..++|+|++++++|.+.+.....+++..+..++.|++.||.|||+.|++|
T Consensus 65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 144 (287)
T 2wei_A 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144 (287)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 45677899999999999999999999999999999999999999888776678999999999999999999999999999
Q ss_pred cccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||+|+||+++.+ +.+||+|||++.............+++.|+|||.+.+. ++.++|||||||++|+|++|..|+
T Consensus 145 ~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~ 222 (287)
T 2wei_A 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPF 222 (287)
T ss_dssp SCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCC
Confidence 9999999999764 46999999999876654444555688999999998753 799999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+. . .....++++.+++.+|+..+|.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~----------------~--------------------~~~~~~~~~~~li~~~l~~dp~ 266 (287)
T 2wei_A 223 YGKNEYDILKRVETGKYAFDL----------------P--------------------QWRTISDDAKDLIRKMLTFHPS 266 (287)
T ss_dssp CCSSHHHHHHHHHHCCCCCCS----------------G--------------------GGTTSCHHHHHHHHHHTCSSGG
T ss_pred CCCCHHHHHHHHHcCCCCCCc----------------h--------------------hhhhcCHHHHHHHHHHcccChh
Confidence 888777666554443221100 0 0012345678999999997776
Q ss_pred eeeccccccccccccceeeeeecC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.| +++.++++||||...
T Consensus 267 ~R-------ps~~ell~hp~~~~~ 283 (287)
T 2wei_A 267 LR-------ITATQCLEHPWIQKY 283 (287)
T ss_dssp GS-------CCHHHHHHSHHHHHH
T ss_pred hC-------cCHHHHhcCHHHhcc
Confidence 66 999999999998653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=272.47 Aligned_cols=205 Identities=21% Similarity=0.264 Sum_probs=164.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+++++.++||||+++++++..++.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|+
T Consensus 155 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 234 (377)
T 3cbl_A 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234 (377)
T ss_dssp HHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3456788999999999999999999999999999999999999999987654 369999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
+||||||+|||++.++.+||+|||++......... ....+++.|+|||.+.+.. ++.++|||||||++|||++ |.
T Consensus 235 vHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp ECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSC
T ss_pred CCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875432211 1123467799999998655 7999999999999999998 55
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+.+... ......+..+.+++ .+..++.+..+++..||..+|..||.+..
T Consensus 314 ~p~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 364 (377)
T 3cbl_A 314 SPYPNLSN-QQTREFVEKGGRLP---CPELCPDAVFRLMEQCWAYEPGQRPSFST 364 (377)
T ss_dssp CSSTTSCH-HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCH-HHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 55555444 44455555555543 23455667777777777777776665444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=263.52 Aligned_cols=215 Identities=19% Similarity=0.214 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKH--PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++| |||+++++++..++.+++||| +.+++|.+++.....+++..+..++.|++.||.|||+.|
T Consensus 50 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 128 (343)
T 3dbq_A 50 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34667889999999987 999999999999999999999 567899998888889999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccC----------CccCCCccchhhHH
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVG----------DTLYGPAVDVWAIE 161 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~----------~~~~~~~~DvwSlG 161 (303)
|+||||||+|||++ ++.+||+|||++........ .....||+.|+|||++.+ ...++.++||||||
T Consensus 129 iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG 207 (343)
T 3dbq_A 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207 (343)
T ss_dssp CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHH
T ss_pred eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHH
Confidence 99999999999996 68899999999987653322 235679999999999864 23478899999999
Q ss_pred HHHHHhhccCccCCCCchH-HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchh
Q psy763 162 WTSHSYSQIGFIGLGNMGS-HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHG 240 (303)
Q Consensus 162 ~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 240 (303)
|++|||++|..||.+.... ......+..... ........++
T Consensus 208 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~ 249 (343)
T 3dbq_A 208 CILYYMTYGKTPFQQIINQISKLHAIIDPNHE--------------------------------------IEFPDIPEKD 249 (343)
T ss_dssp HHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--------------------------------------CCCCCCSCHH
T ss_pred HHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc--------------------------------------cCCcccCCHH
Confidence 9999999999888654322 222222211111 0111122356
Q ss_pred hHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 241 VVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 241 ~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+.+++.+|+..+|..| +++.++++|||+...
T Consensus 250 l~~li~~~L~~dp~~R-------pt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 250 LQDVLKCCLKRDPKQR-------ISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHHTCSSTTTS-------CCHHHHHTSHHHHSC
T ss_pred HHHHHHHHcCCChhHC-------CCHHHHHhCcccccc
Confidence 7788988888666655 999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=257.18 Aligned_cols=197 Identities=17% Similarity=0.132 Sum_probs=160.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 135 (289)
T 4fvq_A 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135 (289)
T ss_dssp HHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeE
Confidence 4567889999999999999999999999999999999999999999887654 499999999999999999999999999
Q ss_pred ecccCCCcEEEecCCc--------EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 97 HRDIKPENILLTANGV--------VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 97 H~dlk~~nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
||||||+||+++.++. +||+|||++..... .....+|+.|+|||.+.+...++.++|||||||++|||+
T Consensus 136 H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 212 (289)
T 4fvq_A 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212 (289)
T ss_dssp CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred CCCcCcceEEEecCCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence 9999999999998886 99999999865432 233457889999999987555899999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
+|+.+++..................+ ...+.+..+++..|+..+|..||
T Consensus 213 ~g~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rp 261 (289)
T 4fvq_A 213 SGGDKPLSALDSQRKLQFYEDRHQLP-----APKAAELANLINNCMDYEPDHRP 261 (289)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSC
T ss_pred cCCCCCccccchHHHHHHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCc
Confidence 98877777766666555555433322 22344555555555555554444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=267.34 Aligned_cols=216 Identities=19% Similarity=0.210 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLK--HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++ ||||+++++++..++.+|+||| +.+++|.+++.....+++..+..++.||+.||.|||+.|
T Consensus 97 ~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ 175 (390)
T 2zmd_A 97 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175 (390)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4566788999999997 5999999999999999999999 667899998887788999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCC----------ccCCCccchhhHH
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGD----------TLYGPAVDVWAIE 161 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~----------~~~~~~~DvwSlG 161 (303)
|+||||||+|||++ ++.+||+|||++....... ......||+.|+|||++.+. ..++.++||||||
T Consensus 176 ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG 254 (390)
T 2zmd_A 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254 (390)
T ss_dssp CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence 99999999999995 5889999999998765332 22456799999999998752 3478999999999
Q ss_pred HHHHHhhccCccCCCCchH-HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchh
Q psy763 162 WTSHSYSQIGFIGLGNMGS-HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHG 240 (303)
Q Consensus 162 ~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 240 (303)
|++|||++|..||.+.... ..+..++...... ........+
T Consensus 255 vil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~ 296 (390)
T 2zmd_A 255 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--------------------------------------EFPDIPEKD 296 (390)
T ss_dssp HHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--------------------------------------CCCCCSCHH
T ss_pred HHHHHHHHCCCcchhhhHHHHHHHHHhCccccC--------------------------------------CCCccchHH
Confidence 9999999999988765332 2333222211110 011112456
Q ss_pred hHHhhhhhhccccceeeccccccccccccceeeeeecCC
Q psy763 241 VVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 241 ~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+.+++.+|+..+|..| +++.+++.|||+....
T Consensus 297 ~~~li~~~L~~dP~~R-------ps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 297 LQDVLKCCLKRDPKQR-------ISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHTCSSTTTS-------CCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHcccChhhC-------CCHHHHhhCcCccccC
Confidence 7788988888666666 9999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=259.38 Aligned_cols=219 Identities=21% Similarity=0.285 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++..++..++|+||++++++..++.. ...+++..+..++.|++.||.|||+.|++
T Consensus 60 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 139 (302)
T 2j7t_A 60 LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139 (302)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 45677899999999999999999999999999999999999999997654 45799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCccccc----CCccCCCccchhhHHHHHHHhhccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLV----GDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~----~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
|+||+|+||+++.++.+||+|||++..... ........+|+.|+|||.+. ....++.++|||||||++|+|++|.
T Consensus 140 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 219 (302)
T 2j7t_A 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219 (302)
T ss_dssp CCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC
Confidence 999999999999999999999998754321 11223457899999999984 2344799999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+.+.........+........ ......+..+.+++.+|+..
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~l~~li~~~l~~ 262 (302)
T 2j7t_A 220 PPHHELNPMRVLLKIAKSDPPTL-------------------------------------LTPSKWSVEFRDFLKIALDK 262 (302)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCC-------------------------------------SSGGGSCHHHHHHHHHHSCS
T ss_pred CCCccCCHHHHHHHHhccCCccc-------------------------------------CCccccCHHHHHHHHHHccc
Confidence 99888776666554443321100 00011234567888888886
Q ss_pred ccceeeccccccccccccceeeeeecCCc
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+|..| +++.+++.|||+.....
T Consensus 263 dp~~R-------ps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 263 NPETR-------PSAAQLLEHPFVSSITS 284 (302)
T ss_dssp CTTTS-------CCHHHHTTSTTTTTCCC
T ss_pred ChhhC-------CCHHHHhcChHHhhhcc
Confidence 66555 99999999999877553
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=263.35 Aligned_cols=202 Identities=22% Similarity=0.225 Sum_probs=162.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC------------------------CCCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP------------------------HGLP 72 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------------------~~l~ 72 (303)
....+.+|+.+++.++||||+++++++..++..++||||+++|+|.+++... ..++
T Consensus 93 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 172 (343)
T 1luf_A 93 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172 (343)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCC
Confidence 4567889999999999999999999999999999999999999999987642 5799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCc
Q psy763 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDT 149 (303)
Q Consensus 73 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~ 149 (303)
+..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ......+|+.|+|||.+.+..
T Consensus 173 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 252 (343)
T 1luf_A 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 252 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC
Confidence 99999999999999999999999999999999999999999999999987654321 223456788999999998665
Q ss_pred cCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 150 LYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 150 ~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
++.++|||||||++|||++ |..|+.+....+....+... ... ..+...+.++.+++..|+..+|..||.
T Consensus 253 -~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 253 -YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NIL---ACPENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp -CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC-CcC---CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 8999999999999999999 77787777766665554443 221 123445556666666666665555543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=260.01 Aligned_cols=235 Identities=24% Similarity=0.362 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEE--------------eCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFR--------------RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~--------------~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~q 82 (303)
....+.+|+.+++.++||||+++++++. ..+..++||||++ |+|.+++.. +++++..++.++.|
T Consensus 51 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~q 128 (320)
T 2i6l_A 51 SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQ 128 (320)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHH
Confidence 3456778999999999999999999873 3468899999998 688888864 57999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEe-cCCcEEEccccceeeeCCC----CccccccCCCcccCcccccCCccCCCccch
Q psy763 83 VLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLINPG----ENYTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 83 i~~~l~~lH~~~ivH~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
++.||.|||++|++|+||||+||+++ .++.+||+|||++...... .......++..|+|||.+.+...++.++||
T Consensus 129 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 208 (320)
T 2i6l_A 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence 99999999999999999999999998 5679999999999875432 122345678999999998765558999999
Q ss_pred hhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcC----------CChhHHHHHH
Q psy763 158 WAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSK----------TSTTTIFKYL 227 (303)
Q Consensus 158 wSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l 227 (303)
|||||++|||++|..||.+....+....++...+... .+. +...... ....++...
T Consensus 209 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~- 274 (320)
T 2i6l_A 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH---------EED----RQELLSVIPVYIRNDMTEPHKPLTQL- 274 (320)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC---------HHH----HHHHHTTSCHHHHHHTTSCCCCHHHH-
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc---------hhh----hhhhhhcCcccccccccCCCCChhHh-
Confidence 9999999999999999999888887777766533321 000 1111110 000111111
Q ss_pred hHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 228 LIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 228 ~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
.+..++++.+++.+|+..+|..| +++.++++||||...+.
T Consensus 275 ------~~~~~~~~~~li~~~L~~dP~~R-------pt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 275 ------LPGISREAVDFLEQILTFSPMDR-------LTAEEALSHPYMSIYSF 314 (320)
T ss_dssp ------STTCCHHHHHHHHTTSCSSGGGS-------CCHHHHHTSHHHHTTCC
T ss_pred ------cchhhHHHHHHHHHHcCCCcccc-------CCHHHHhCCcccccccC
Confidence 12356788999999999776666 99999999999986544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=261.77 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHhCCCC------CcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHP------NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~ 89 (303)
...+.+|+.+++.++|+ +++++++++...+..++||||+ ++++.+++...+ ++++..+..++.|++.||.|
T Consensus 55 ~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~ 133 (339)
T 1z57_A 55 CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133 (339)
T ss_dssp HHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHH
Confidence 34566777777777655 5999999999999999999999 677777765443 68999999999999999999
Q ss_pred HHHCCceecccCCCcEEEec-------------------CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCcc
Q psy763 90 CHRHACIHRDIKPENILLTA-------------------NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTL 150 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~-------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~ 150 (303)
||++||+||||||+||+++. ++.+||+|||++..... ......+|+.|+|||++.+..
T Consensus 134 lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~- 210 (339)
T 1z57_A 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG- 210 (339)
T ss_dssp HHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-
T ss_pred HHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCC-
Confidence 99999999999999999987 66799999999987443 334567899999999998765
Q ss_pred CCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcch---hhhhhhhhhcCCChhHHHHHH
Q psy763 151 YGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSET---WDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 151 ~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 227 (303)
++.++|||||||++|||++|..|+.+....+....+....+.++............ ....|.. .. ......
T Consensus 211 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~ 284 (339)
T 1z57_A 211 WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDE---HS---SAGRYV 284 (339)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCT---TS---HHHHHH
T ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccc---cc---cccchh
Confidence 89999999999999999999999988877666555544333222110000000000 0000100 00 000000
Q ss_pred hH-------hCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 228 LI-------RGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 228 ~~-------~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.. .....+..++.+.+++.+|+..+|..| +++.++++||||...
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R-------pt~~ell~hp~f~~~ 335 (339)
T 1z57_A 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR-------ITLREALKHPFFDLL 335 (339)
T ss_dssp HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS-------CCHHHHTTSGGGGGG
T ss_pred hhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc-------cCHHHHhcCHHHHHH
Confidence 00 011222335667899999999777666 999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=265.35 Aligned_cols=203 Identities=25% Similarity=0.342 Sum_probs=163.1
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQI 79 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~ 79 (303)
....+.+|+++++.+ +||||+++++++..++..++||||+++|+|.+++... ..+++..++.+
T Consensus 117 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 196 (382)
T 3tt0_A 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196 (382)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHH
Confidence 345678899999999 8999999999999999999999999999999988643 25999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccc
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVD 156 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~D 156 (303)
+.|++.||.|||+.||+||||||+||+++.++.+||+|||++....... ......+|+.|+|||++.+.. ++.++|
T Consensus 197 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~D 275 (382)
T 3tt0_A 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSD 275 (382)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHH
T ss_pred HHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhH
Confidence 9999999999999999999999999999999999999999998765332 223346778899999998765 899999
Q ss_pred hhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 157 VWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 157 vwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
||||||++|||++ |..|+.+....+.. ..+..+.+.. .+...+.++.+++..|+..+|..||..
T Consensus 276 iwslG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~ 340 (382)
T 3tt0_A 276 VWSFGVLLWEIFTLGGSPYPGVPVEELF-KLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTF 340 (382)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999999999999 66776666555544 4444444332 234455666666666666666555543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=261.25 Aligned_cols=204 Identities=15% Similarity=0.127 Sum_probs=161.0
Q ss_pred HHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 20 TEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 20 ~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+|+.+++.+ +||||+++++++..++..++||||+ +++|.+++.. .+.+++..+..++.|++.||.|||+.||+|
T Consensus 50 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH 128 (330)
T 2izr_A 50 QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIY 128 (330)
T ss_dssp CHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 467889999999 9999999999999999999999999 8999998764 468999999999999999999999999999
Q ss_pred cccCCCcEEEecCCc-----EEEccccceeeeCCCCc--------cccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 98 RDIKPENILLTANGV-----VKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 98 ~dlk~~nil~~~~~~-----~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
|||||+||+++.++. +||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++
T Consensus 129 rDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il 207 (330)
T 2izr_A 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMF 207 (330)
T ss_dssp CCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred cCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHH
Confidence 999999999998877 99999999987653322 24568999999999998765 89999999999999
Q ss_pred HHhhccCccCCCCc---hHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 165 HSYSQIGFIGLGNM---GSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 165 ~el~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||++|..||.+.. ..+....+.......+........+ +..+++..|+..++..||....
T Consensus 208 ~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~ 271 (330)
T 2izr_A 208 MYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDY 271 (330)
T ss_dssp HHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHH
T ss_pred HHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHH
Confidence 99999999988743 2333333322221111111122233 6666666777766666664443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=266.50 Aligned_cols=204 Identities=17% Similarity=0.187 Sum_probs=161.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-------CCCCHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-------HGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~l 90 (303)
...+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++... ..+++..++.++.|++.||.||
T Consensus 118 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 197 (367)
T 3l9p_A 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197 (367)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH
Confidence 345778999999999999999999999999999999999999999987543 3599999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCC---cEEEccccceeeeCC---CCccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 91 HRHACIHRDIKPENILLTANG---VVKLCDFGFARLINP---GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~---~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
|++||+||||||+|||++.++ .+||+|||++..... ........+|+.|+|||++.+.. ++.++|||||||++
T Consensus 198 H~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il 276 (367)
T 3l9p_A 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLL 276 (367)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred HhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHH
Confidence 999999999999999999554 599999999975432 12223456789999999998665 89999999999999
Q ss_pred HHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 165 HSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 165 ~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||++ |..|+.+....+....+ ..+.++. .+...+.++.+++..|+..+|..||....
T Consensus 277 ~ellt~g~~pf~~~~~~~~~~~i-~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~e 335 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSNQEVLEFV-TSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAI 335 (367)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHH-HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHH-HcCCCCC---CCccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 99998 66666666655555444 4433322 23445566666667777666666654433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=251.92 Aligned_cols=200 Identities=20% Similarity=0.284 Sum_probs=158.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|
T Consensus 50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 129 (269)
T 4hcu_A 50 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 129 (269)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4578899999999999999999999999999999999999999998854 456999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
+||||+||+++.++.+||+|||++....... ......+|+.|+|||.+.+.. ++.++||||+||++|+|++ |..|+
T Consensus 130 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~ 208 (269)
T 4hcu_A 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPY 208 (269)
T ss_dssp SCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999997654322 223345677899999998655 8999999999999999999 67777
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
.+....+....+... .+. ..+...+.++.+++..|+..+|..||.
T Consensus 209 ~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps 253 (269)
T 4hcu_A 209 ENRSNSEVVEDISTG-FRL---YKPRLASTHVYQIMNHCWRERPEDRPA 253 (269)
T ss_dssp TTCCHHHHHHHHHTT-CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCHHHHHHHHhcC-ccC---CCCCcCCHHHHHHHHHHccCCcccCcC
Confidence 766666665554443 221 122333445555555555555544443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=264.41 Aligned_cols=204 Identities=16% Similarity=0.235 Sum_probs=155.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++||||+++++++..++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||
T Consensus 89 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (373)
T 2qol_A 89 QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4567889999999999999999999999999999999999999999988764 479999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
+||||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++|||++ |
T Consensus 169 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g 247 (373)
T 2qol_A 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYG 247 (373)
T ss_dssp CCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC
T ss_pred eCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987653221 11224567899999998655 8999999999999999998 7
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
..|+.+....+....+ ..+.+. ..+...+.++.+++..|+..+|..||...
T Consensus 248 ~~P~~~~~~~~~~~~i-~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 298 (373)
T 2qol_A 248 ERPYWEMSNQDVIKAV-DEGYRL---PPPMDCPAALYQLMLDCWQKDRNNRPKFE 298 (373)
T ss_dssp -CTTTTCCHHHHHHHH-HTTEEC---CCCTTCBHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCHHHHHHHH-HcCCCC---CCCccccHHHHHHHHHHhCcChhhCcCHH
Confidence 7777777666655444 333222 22345566677777777777776666443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=264.23 Aligned_cols=202 Identities=25% Similarity=0.327 Sum_probs=161.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCC-EEEEEEecCCCCcHHHHHcCCCC-------------------------
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKK-KLHLVFEFCDHTVLNELENHPHG------------------------- 70 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~------------------------- 70 (303)
.+.+.+|+.+++.+ +||||+++++++.+.+ .+++||||+++|+|.+++.....
T Consensus 69 ~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (359)
T 3vhe_A 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148 (359)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------
T ss_pred HHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchh
Confidence 45678899999999 7999999999998755 48999999999999998875432
Q ss_pred -----------------------------------------CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEec
Q psy763 71 -----------------------------------------LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA 109 (303)
Q Consensus 71 -----------------------------------------l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~ 109 (303)
+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~ 228 (359)
T 3vhe_A 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 228 (359)
T ss_dssp -----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred hhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC
Confidence 899999999999999999999999999999999999999
Q ss_pred CCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHH
Q psy763 110 NGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARN 185 (303)
Q Consensus 110 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~ 185 (303)
++.+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..|+.+....+....
T Consensus 229 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 307 (359)
T 3vhe_A 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307 (359)
T ss_dssp GGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence 9999999999998654322 223456788999999998655 8999999999999999998 8888887776666666
Q ss_pred HhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 186 LLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
.+..+.... .+...+++..+++..|+..+|..||.
T Consensus 308 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps 342 (359)
T 3vhe_A 308 RLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPT 342 (359)
T ss_dssp HHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCCC
Confidence 666555432 23344555666666666555554443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=257.74 Aligned_cols=201 Identities=20% Similarity=0.295 Sum_probs=160.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC------------------------CCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH------------------------GLP 72 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------------------~l~ 72 (303)
..+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .++
T Consensus 69 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (314)
T 2ivs_A 69 ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148 (314)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEEC
T ss_pred HHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcC
Confidence 34567889999999999999999999999999999999999999999886533 389
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCc
Q psy763 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDT 149 (303)
Q Consensus 73 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~ 149 (303)
+..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+..
T Consensus 149 ~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 999999999999999999999999999999999999999999999999987654322 23345678899999998655
Q ss_pred cCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 150 LYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 150 ~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
++.++||||+||++|||++ |..|+.+....+... .+..+.... .+...+.+..+++-.|+..+|..||
T Consensus 229 -~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp 297 (314)
T 2ivs_A 229 -YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN-LLKTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRP 297 (314)
T ss_dssp -ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HhhcCCcCC---CCccCCHHHHHHHHHHccCChhhCc
Confidence 7999999999999999999 777777666555443 334333221 2234455555555555555555444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=254.36 Aligned_cols=203 Identities=17% Similarity=0.149 Sum_probs=155.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++..++..++|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++
T Consensus 77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 156 (309)
T 2h34_A 77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT 156 (309)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCC
Confidence 45678889999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|+||+|+||+++.++.+||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|||++|..|+
T Consensus 157 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf 235 (309)
T 2h34_A 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPY 235 (309)
T ss_dssp CSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987755332 223457899999999998765 799999999999999999999888
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.+..... ....+......+ ...+...+.+..+++..|+..+|..|+
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 236 QGDQLSV-MGAHINQAIPRP-STVRPGIPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp CSCHHHH-HHHHHHSCCCCG-GGTSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred CCchHHH-HHHHhccCCCCc-cccCCCCCHHHHHHHHHhccCCHHHHH
Confidence 7766553 333444332221 122344555666666666665555544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=252.94 Aligned_cols=217 Identities=22% Similarity=0.284 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe-------------CCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR-------------KKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQ 82 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------------~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~q 82 (303)
....+.+|+.+++.++||||+++++++.+ .+..|+||||+++++|.+++.. +..+++..++.++.|
T Consensus 45 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q 124 (303)
T 1zy4_A 45 KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124 (303)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHH
Confidence 34567889999999999999999999865 3568999999999999998864 446888999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCC---------------CccccccCCCcccCcccccC
Q psy763 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG---------------ENYTDYVATRWYRAPELLVG 147 (303)
Q Consensus 83 i~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~l~~ 147 (303)
++.||.|||++|++|+||+|+||+++.++.+||+|||++...... .......+|+.|+|||.+.+
T Consensus 125 i~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred HHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 999999999999999999999999999999999999998765421 12234568999999999987
Q ss_pred CccCCCccchhhHHHHHHHhhccCccCCCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 148 DTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 148 ~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
...++.++||||+||++|+|++ ++..... .+....+.......
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~--------------------------------- 248 (303)
T 1zy4_A 205 TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEF--------------------------------- 248 (303)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCC---------------------------------
T ss_pred CCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccccccc---------------------------------
Confidence 6568999999999999999998 3332222 22222211111000
Q ss_pred HhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCC
Q psy763 227 LLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 227 l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.........+.+.+++.+|+..+|..| +++.+++.|||+....
T Consensus 249 ---~~~~~~~~~~~~~~li~~~l~~dp~~R-------ps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 249 ---PPDFDDNKMKVEKKIIRLLIDHDPNKR-------PGARTLLNSGWLPVKH 291 (303)
T ss_dssp ---CTTCCTTTSHHHHHHHHHHTCSSGGGS-------CCHHHHHHSSCSCCCC
T ss_pred ---CccccccchHHHHHHHHHHHhcCcccC-------cCHHHHhCCCCcCCCC
Confidence 001112234556789999998666666 9999999999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.09 Aligned_cols=217 Identities=23% Similarity=0.330 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhC-CCCCcceeEEEEEe------CCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSL-KHPNLVNLLEVFRR------KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 19 ~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~ 89 (303)
..+.+|+..++.+ +||||+++++++.. .+.+++||||+++++|.+++... ..+++..+..++.|++.||.|
T Consensus 65 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 144 (326)
T 2x7f_A 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144 (326)
T ss_dssp HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 4567788888888 79999999999987 46899999999999999988653 479999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccC----CccCCCccchhhHHHHH
Q psy763 90 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il 164 (303)
||+.|++|+||+|+||+++.++.+||+|||++...... .......+++.|+|||++.+ ...++.++|||||||++
T Consensus 145 lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 224 (326)
T 2x7f_A 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224 (326)
T ss_dssp HHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred HHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence 99999999999999999999999999999998775432 22344578999999999873 23478999999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
|+|++|..|+.+.........+....... ......++.+.++
T Consensus 225 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~l~~l 266 (326)
T 2x7f_A 225 IEMAEGAPPLCDMHPMRALFLIPRNPAPR--------------------------------------LKSKKWSKKFQSF 266 (326)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------------------------------CSCSCSCHHHHHH
T ss_pred HHHHhCCCCCCCCcHHHHHHHhhcCcccc--------------------------------------CCccccCHHHHHH
Confidence 99999999988776655544332221100 0011234566788
Q ss_pred hhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+.+|+..+|..| +++.++++||||.+.+.
T Consensus 267 i~~~l~~dp~~R-------ps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 267 IESCLVKNHSQR-------PATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHCCSSGGGS-------CCHHHHHTSHHHHCCTT
T ss_pred HHHHhccChhhC-------CCHHHHhhChHHhhCcc
Confidence 888888666655 99999999999887543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=261.24 Aligned_cols=203 Identities=23% Similarity=0.278 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-----------------------CCC
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-----------------------GLP 72 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------------------~l~ 72 (303)
..+.+.+|+.+++.+ +||||+++++++...+..++||||+++|+|.+++.... .++
T Consensus 91 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 170 (344)
T 1rjb_A 91 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170 (344)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CC
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCC
Confidence 446788899999999 89999999999999999999999999999999887543 379
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCc
Q psy763 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDT 149 (303)
Q Consensus 73 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~ 149 (303)
+..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+..
T Consensus 171 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 250 (344)
T 1rjb_A 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC
Confidence 999999999999999999999999999999999999999999999999987643322 23345678899999988655
Q ss_pred cCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 150 LYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 150 ~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
++.++|||||||++|||+| |..|+.+..........+..+.++. .+...+.+..+++..|+..+|..||.
T Consensus 251 -~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 321 (344)
T 1rjb_A 251 -YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPS 321 (344)
T ss_dssp -CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 8999999999999999998 7788877766666666666554432 23344556666666666665555554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=269.68 Aligned_cols=202 Identities=19% Similarity=0.231 Sum_probs=164.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK-KLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.+.+.+|+.+++.++||||+++++++.... .+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++|
T Consensus 230 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 309 (450)
T 1k9a_A 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309 (450)
T ss_dssp SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356788999999999999999999988765 7999999999999999886543 3799999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
++||||||+|||++.++.+||+|||++...... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..|
T Consensus 310 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P 386 (450)
T 1k9a_A 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVP 386 (450)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999999865432 22346788999999998765 8999999999999999998 7777
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+....+.... +..+.+++ .+..+++++.+++..||..+|..||.+..
T Consensus 387 ~~~~~~~~~~~~-i~~~~~~~---~p~~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 387 YPRIPLKDVVPR-VEKGYKMD---APDGCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp STTSCTTTHHHH-HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHH-HHcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 766655555444 44444432 34566777778888888877777765544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=250.05 Aligned_cols=169 Identities=21% Similarity=0.270 Sum_probs=145.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+..++.++||||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 127 (268)
T 3sxs_A 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127 (268)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 45788999999999999999999999999999999999999999987654 35999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
+||||+||+++.++.++|+|||++......... ....+|+.|+|||.+.+.. ++.++||||+||++|+|++ |..|+
T Consensus 128 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~ 206 (268)
T 3sxs_A 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPY 206 (268)
T ss_dssp SSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876543322 2345567899999998665 7999999999999999999 77777
Q ss_pred CCCchHHHHHHHhh
Q psy763 175 LGNMGSHMARNLLK 188 (303)
Q Consensus 175 ~~~~~~~~~~~~~~ 188 (303)
.+....+....+..
T Consensus 207 ~~~~~~~~~~~~~~ 220 (268)
T 3sxs_A 207 DLYTNSEVVLKVSQ 220 (268)
T ss_dssp TTSCHHHHHHHHHT
T ss_pred cccChHHHHHHHHc
Confidence 77666666555443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=260.88 Aligned_cols=250 Identities=18% Similarity=0.250 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHhCCCCC------cceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPN------LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~l 90 (303)
...+.+|+.+++.++|++ ++.+++++...+..++||||+.++++..+.... ..+++..+..++.|++.||.||
T Consensus 60 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l 139 (355)
T 2eu9_A 60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139 (355)
T ss_dssp HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 455667788888776655 999999999999999999999766666555543 4799999999999999999999
Q ss_pred HHCCceecccCCCcEEE-------------------ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccC
Q psy763 91 HRHACIHRDIKPENILL-------------------TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLY 151 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~-------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~ 151 (303)
|++||+||||||+||++ +.++.+||+|||++..... ......||+.|+|||++.+.. +
T Consensus 140 H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~ 216 (355)
T 2eu9_A 140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-W 216 (355)
T ss_dssp HTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-C
T ss_pred HHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-C
Confidence 99999999999999999 5678999999999987443 334567999999999998765 8
Q ss_pred CCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcc---hhhhhhhhhhcCCChhHHHHH--
Q psy763 152 GPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSE---TWDLTWQEIFSKTSTTTIFKY-- 226 (303)
Q Consensus 152 ~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-- 226 (303)
+.++|||||||++|||++|..||.+....+....+....+..+........... .....|.. ..........
T Consensus 217 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 293 (355)
T 2eu9_A 217 AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE---NSSDGRYVKENC 293 (355)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCT---TSHHHHHHHHHC
T ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccccc---ccchhccccccC
Confidence 999999999999999999999998887776665555543332211000000000 00000100 0000000000
Q ss_pred --HhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 227 --LLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 227 --l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+...........+++.+++.+|+..+|..| +++.++++||||...+.
T Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R-------pt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR-------ITLAEALLHPFFAGLTP 342 (355)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS-------CCHHHHTTSGGGGGCCH
T ss_pred CcccccccccchhHHHHHHHHHHHhcCChhhC-------cCHHHHhcChhhcCCCh
Confidence 000011122234577899999999766666 99999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=268.63 Aligned_cols=214 Identities=18% Similarity=0.169 Sum_probs=157.3
Q ss_pred HHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 21 EATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 21 ~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+|+.+++.+ +||||+++++++.+.+..|+||||++ |+|.+++... ..+++..+..++.|++.||.|||+.||+||
T Consensus 64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 142 (432)
T 3p23_A 64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142 (432)
T ss_dssp CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeC
Confidence 45788899998 79999999999999999999999997 5777776554 356666778999999999999999999999
Q ss_pred ccCCCcEEEec-----CCcEEEccccceeeeCCCC----ccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHh
Q psy763 99 DIKPENILLTA-----NGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 99 dlk~~nil~~~-----~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el 167 (303)
||||+||+++. ...+||+|||++....... ......||+.|+|||++.+ ...++.++||||+||++|||
T Consensus 143 DlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~el 222 (432)
T 3p23_A 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222 (432)
T ss_dssp CCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHH
Confidence 99999999953 2358899999998765332 2344679999999999974 23368899999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 168 SQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
++++.++++................ . . ..........+.+++.+
T Consensus 223 lt~g~~pf~~~~~~~~~~~~~~~~~-~------~-----------------------------~~~~~~~~~~~~~li~~ 266 (432)
T 3p23_A 223 ISEGSHPFGKSLQRQANILLGACSL-D------C-----------------------------LHPEKHEDVIARELIEK 266 (432)
T ss_dssp HTTSCBTTBSTTTHHHHHHTTCCCC-T------T-----------------------------SCTTCHHHHHHHHHHHH
T ss_pred HcCCCCCcchhhHHHHHHHhccCCc-c------c-----------------------------cCccccccHHHHHHHHH
Confidence 9955555554444433322221100 0 0 00000112346789999
Q ss_pred hhccccceeeccccccccccccceeeeeecC
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
|+..+|..| +++.++++||||...
T Consensus 267 ~L~~dP~~R-------ps~~evl~hp~f~~~ 290 (432)
T 3p23_A 267 MIAMDPQKR-------PSAKHVLKHPFFWSL 290 (432)
T ss_dssp HSCSSGGGS-------CCHHHHHTSTTTCCH
T ss_pred HHhCCHhhC-------CCHHHHHhCccccCh
Confidence 998766666 999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=257.41 Aligned_cols=202 Identities=25% Similarity=0.263 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC----------------CCCHHHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH----------------GLPWDLIKQI 79 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~l~~~~~~~~ 79 (303)
....+.+|+.+++.+ +||||+++++++.+.+..++||||+++++|.+++.... .+++..++.+
T Consensus 68 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 147 (327)
T 1fvr_A 68 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147 (327)
T ss_dssp --CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHH
Confidence 345678899999999 89999999999999999999999999999999887653 7999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhh
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwS 159 (303)
+.|++.||.|||++|++||||||+||+++.++.+||+|||++.............+++.|+|||.+.+.. ++.++||||
T Consensus 148 ~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s 226 (327)
T 1fvr_A 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWS 226 (327)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchH
Confidence 9999999999999999999999999999999999999999987543322334456788999999997655 799999999
Q ss_pred HHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 160 IEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 160 lG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|||++|||++ |..|+.+....+....+.. +.++. .+...+.+..+++..|+..+|..||.
T Consensus 227 lG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 287 (327)
T 1fvr_A 227 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLE---KPLNCDDEVYDLMRQCWREKPYERPS 287 (327)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-CCCCC---CCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999999998 8888877776666554433 32221 22344555566666666655555443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.83 Aligned_cols=201 Identities=18% Similarity=0.241 Sum_probs=149.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+..++.++||||+++++++. ++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 137 (281)
T 1mp8_A 59 VREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137 (281)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4566889999999999999999999984 56789999999999999987644 479999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+||||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 138 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~ 216 (281)
T 1mp8_A 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVK 216 (281)
T ss_dssp CCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987654322 22345678899999997655 7999999999999999997 777
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|+.+....+....+... .+.+ .+...+++..+++..|+..+|..||.
T Consensus 217 pf~~~~~~~~~~~i~~~-~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps 263 (281)
T 1mp8_A 217 PFQGVKNNDVIGRIENG-ERLP---MPPNCPPTLYSLMTKCWAYDPSRRPR 263 (281)
T ss_dssp TTTTCCGGGHHHHHHTT-CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcCCHHHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHHccCChhhCcC
Confidence 77776666655544433 2221 23345555556666666655555543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=256.76 Aligned_cols=202 Identities=23% Similarity=0.286 Sum_probs=162.4
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC------------------CCCHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH------------------GLPWDLIK 77 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------------~l~~~~~~ 77 (303)
..+.+.+|+..++.+ +||||+++++++..++..++||||+++|+|.+++.... .+++..++
T Consensus 69 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (313)
T 1t46_A 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148 (313)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHH
T ss_pred HHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHH
Confidence 346788999999999 89999999999999999999999999999999876443 48999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCc
Q psy763 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPA 154 (303)
Q Consensus 78 ~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~ 154 (303)
.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.+
T Consensus 149 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~ 227 (313)
T 1t46_A 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFE 227 (313)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHH
T ss_pred HHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChH
Confidence 9999999999999999999999999999999999999999999987654332 22345678899999988655 8999
Q ss_pred cchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 155 VDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 155 ~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
+|||||||++|||++ |..|+.+..........+..+.+.. .+...+.+..+++..|+..+|..||
T Consensus 228 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC---CcccCCHHHHHHHHHHcCCCchhCc
Confidence 999999999999998 7777777666566666655544322 2234445555555555555555444
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=252.64 Aligned_cols=205 Identities=14% Similarity=0.132 Sum_probs=163.6
Q ss_pred HHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 20 TEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 20 ~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+|+..++.+ +|+|++++++++..+...++||||+ +++|.+++... ..+++..+..++.|++.||.|||++||+|
T Consensus 51 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 129 (298)
T 1csn_A 51 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129 (298)
T ss_dssp CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 466788888988 7999999999999999999999999 89999987653 46999999999999999999999999999
Q ss_pred cccCCCcEEEecCCc-----EEEccccceeeeCCCCc--------cccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 98 RDIKPENILLTANGV-----VKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 98 ~dlk~~nil~~~~~~-----~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
|||||+||+++.++. +||+|||++........ .....||+.|+|||.+.+.. ++.++|||||||++
T Consensus 130 ~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il 208 (298)
T 1csn_A 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVF 208 (298)
T ss_dssp CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred CCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHH
Confidence 999999999987765 99999999987654322 24457899999999998766 79999999999999
Q ss_pred HHhhccCccCCCC---chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 165 HSYSQIGFIGLGN---MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 165 ~el~tg~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||++|..||.+. ...+....+.......+........+.+..+++..|+..+|..||....
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~ 273 (298)
T 1csn_A 209 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 273 (298)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred HHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHH
Confidence 9999999998874 3334444333332222222223456667777777777777776665443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=265.65 Aligned_cols=203 Identities=14% Similarity=0.097 Sum_probs=154.4
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeC----CEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRK----KKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...++..++.++||||+++++++... ...++||||+ +++|.+++... ..+++..++.++.|++.||.|||+.||
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 173 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEY 173 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44566778889999999999999864 4589999999 89999987654 689999999999999999999999999
Q ss_pred eecccCCCcEEEe--cCCcEEEccccceeeeCCCCc--------cccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 96 IHRDIKPENILLT--ANGVVKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 96 vH~dlk~~nil~~--~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
+||||||+|||++ .++.+||+|||++........ .....||+.|+|||.+.+.. ++.++|||||||++|
T Consensus 174 iHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~ 252 (364)
T 3op5_A 174 VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMI 252 (364)
T ss_dssp ECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHH
T ss_pred EEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHH
Confidence 9999999999999 889999999999987653221 13345999999999998766 899999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCce--eE----eecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRV--TV----ILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
||++|..||.+...............+. .. .+.....+.+..+++-.|+..++..||...
T Consensus 253 el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~ 318 (364)
T 3op5_A 253 QWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYE 318 (364)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHH
Confidence 9999999988654333322222211111 00 011134455556666666666555555433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=254.61 Aligned_cols=217 Identities=22% Similarity=0.317 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
..+.+.+|+..++.++||||+++++++.. .+..++||||+++++|.+++.. ...+++..++.++.|++.||.||
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 127 (279)
T 2w5a_A 48 EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127 (279)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999998864 5689999999999999998754 33599999999999999999999
Q ss_pred HHCC-----ceecccCCCcEEEecCCcEEEccccceeeeCCCCc-cccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 91 HRHA-----CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 91 H~~~-----ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
|+.| ++|+||+|+||+++.++.+||+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++
T Consensus 128 H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il 206 (279)
T 2w5a_A 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLL 206 (279)
T ss_dssp HHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHH
T ss_pred hcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHH
Confidence 9999 99999999999999999999999999877543322 23457899999999998765 79999999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
|+|++|..|+.+....+....+...... ......++++.++
T Consensus 207 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~---------------------------------------~~~~~~~~~l~~l 247 (279)
T 2w5a_A 207 YELCALMPPFTAFSQKELAGKIREGKFR---------------------------------------RIPYRYSDELNEI 247 (279)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHTCCC---------------------------------------CCCTTSCHHHHHH
T ss_pred HHHHHCCCCCcccCHHHHHHHHhhcccc---------------------------------------cCCcccCHHHHHH
Confidence 9999999888877665554433332110 0001234567788
Q ss_pred hhhhhccccceeeccccccccccccceeeeeecCCc
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
+.+|+..++..| +++.++++|+++..++-
T Consensus 248 i~~~l~~~p~~R-------ps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 248 ITRMLNLKDYHR-------PSVEEILENPLILEHHH 276 (279)
T ss_dssp HHHHTCSSGGGS-------CCHHHHHTSTTCCGGGS
T ss_pred HHHHcCCCcccC-------CCHHHHHhChhhhhhcc
Confidence 888888666665 99999999999887654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=249.69 Aligned_cols=199 Identities=25% Similarity=0.297 Sum_probs=153.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--- 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--- 94 (303)
.+.+.+|+.+++.++||||+++++++..++..++||||+++++|..++. ...+++..++.++.|++.||.|||++|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~ 128 (271)
T 3dtc_A 50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence 4567889999999999999999999999999999999999999999886 458999999999999999999999999
Q ss_pred ceecccCCCcEEEec--------CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 95 CIHRDIKPENILLTA--------NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 95 ivH~dlk~~nil~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
++||||||+||+++. ++.+||+|||++....... .....+|+.|+|||.+.+.. ++.++||||+||++|+
T Consensus 129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ 206 (271)
T 3dtc_A 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWE 206 (271)
T ss_dssp CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHH
T ss_pred eeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHH
Confidence 899999999999986 6789999999998655432 23457899999999998665 7999999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|++|..|+.+.................+ .+...+.+..+++..|+..+|..||
T Consensus 207 l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 259 (271)
T 3dtc_A 207 LLTGEVPFRGIDGLAVAYGVAMNKLALP---IPSTCPEPFAKLMEDCWNPDPHSRP 259 (271)
T ss_dssp HHHCCCTTTTSCHHHHHHHHHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCHHHHHHhhhcCCCCCC---CCcccCHHHHHHHHHHhcCCcccCc
Confidence 9999999988887777666555544332 2233444445555555554444443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=260.43 Aligned_cols=249 Identities=20% Similarity=0.296 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHhCC-CC-----CcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLK-HP-----NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 19 ~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~l 90 (303)
..+..|+.+++.++ |+ +|+++++++...+..|+||||+++ +|.+++... ..+++..+..++.|++.||.||
T Consensus 95 ~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l 173 (382)
T 2vx3_A 95 NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173 (382)
T ss_dssp HHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHh
Confidence 34455666666664 44 499999999999999999999975 777766543 4699999999999999999999
Q ss_pred H--HCCceecccCCCcEEEe--cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 91 H--RHACIHRDIKPENILLT--ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 91 H--~~~ivH~dlk~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
| +.||+||||||+|||++ .++.+||+|||++..... ......+|+.|+|||++.+.. ++.++|||||||++||
T Consensus 174 H~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~e 250 (382)
T 2vx3_A 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVE 250 (382)
T ss_dssp TSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred ccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHH
Confidence 9 57999999999999995 467899999999987643 334568899999999998766 8999999999999999
Q ss_pred hhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCC-----cchhhhhhhh--------hhcCCChhHHHHHHhHhCCC
Q psy763 167 YSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLD-----SETWDLTWQE--------IFSKTSTTTIFKYLLIRGGN 233 (303)
Q Consensus 167 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~~ 233 (303)
|++|..||.+....+.+..++...+.++......... ....+..|.. ....+..+.+...+-.....
T Consensus 251 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 330 (382)
T 2vx3_A 251 MHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330 (382)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccC
Confidence 9999999999988888888877654433221111000 0000000100 00111222222221111000
Q ss_pred C-----------CCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 234 T-----------DRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 234 ~-----------~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
. ....+++.+++.+||..+|..| +++.++++||||...
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R-------pta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR-------IQPYYALQHSFFKKT 379 (382)
T ss_dssp GGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS-------CCHHHHTTSGGGCC-
T ss_pred CCccccccccccchhhHHHHHHHHHhcCCChhhC-------CCHHHHhcCcccccC
Confidence 0 0012367899999999777666 999999999999653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=273.49 Aligned_cols=205 Identities=17% Similarity=0.118 Sum_probs=158.8
Q ss_pred HHHHHHHH---HHHHhCCCCCcceeE-------EEEEeCCE-----------------EEEEEecCCCCcHHHHHcCCCC
Q psy763 18 QATEATNK---KEKRSLKHPNLVNLL-------EVFRRKKK-----------------LHLVFEFCDHTVLNELENHPHG 70 (303)
Q Consensus 18 ~~~~~~e~---~~l~~l~h~niv~~~-------~~~~~~~~-----------------~~lv~e~~~~~~l~~~~~~~~~ 70 (303)
.+.+.+|+ +.++.++||||++++ +++...+. .|+||||+ +|+|.+++...+.
T Consensus 117 ~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~ 195 (377)
T 3byv_A 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS 195 (377)
T ss_dssp HHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc
Confidence 35577788 566667899999998 77776542 89999999 5799998875444
Q ss_pred CCH-------HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcc
Q psy763 71 LPW-------DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPE 143 (303)
Q Consensus 71 l~~-------~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 143 (303)
+++ ..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.... .......| +.|+|||
T Consensus 196 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE 272 (377)
T 3byv_A 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPE 272 (377)
T ss_dssp TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHH
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChh
Confidence 544 7888899999999999999999999999999999999999999999998633 23345567 9999999
Q ss_pred cccCC----------ccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhh
Q psy763 144 LLVGD----------TLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQE 213 (303)
Q Consensus 144 ~l~~~----------~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (303)
++.+. ..++.++|||||||++|||++|..||.+....... ..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~----------------------------~~ 324 (377)
T 3byv_A 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS----------------------------EW 324 (377)
T ss_dssp HHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS----------------------------GG
T ss_pred hhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch----------------------------hh
Confidence 99876 24899999999999999999998887543211110 00
Q ss_pred hhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 214 IFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 214 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
... .....++++.+++.+|+..+|..| +++.++++||||..
T Consensus 325 ~~~----------------~~~~~~~~~~~li~~~L~~dp~~R-------pt~~e~l~hp~f~~ 365 (377)
T 3byv_A 325 IFR----------------SCKNIPQPVRALLEGFLRYPKEDR-------LLPLQAMETPEYEQ 365 (377)
T ss_dssp GGS----------------SCCCCCHHHHHHHHHHTCSSGGGC-------CCHHHHHTSHHHHH
T ss_pred hhh----------------hccCCCHHHHHHHHHHcCCCchhC-------CCHHHHhhChHHHH
Confidence 000 002345678899999999766666 99999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=252.52 Aligned_cols=220 Identities=21% Similarity=0.230 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+|+.+++.++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|
T Consensus 63 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 142 (295)
T 2clq_A 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142 (295)
T ss_dssp -HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 456788999999999999999999999999999999999999999987643 25678999999999999999999999
Q ss_pred ceecccCCCcEEEec-CCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCC-ccCCCccchhhHHHHHHHhhccC
Q psy763 95 CIHRDIKPENILLTA-NGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGD-TLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 95 ivH~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~-~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++|+||+|+||+++. ++.+||+|||++....... ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.
T Consensus 143 i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (295)
T 2clq_A 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222 (295)
T ss_dssp EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTS
T ss_pred EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999997 8999999999998765322 23456789999999998754 23788999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcc
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIG 251 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~ 251 (303)
.|+.+............. .. .........++++.+++.+|+..
T Consensus 223 ~pf~~~~~~~~~~~~~~~-------------------------~~------------~~~~~~~~~~~~~~~li~~~l~~ 265 (295)
T 2clq_A 223 PPFYELGEPQAAMFKVGM-------------------------FK------------VHPEIPESMSAEAKAFILKCFEP 265 (295)
T ss_dssp CTTGGGSSHHHHHHHHHH-------------------------HC------------CCCCCCTTSCHHHHHHHHHTTCS
T ss_pred CCccCCCchhHHHHhhcc-------------------------cc------------ccccccccCCHHHHHHHHHHccC
Confidence 887654332221100000 00 00111123456777899999886
Q ss_pred ccceeeccccccccccccceeeeeecCCcc
Q psy763 252 RFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+|..| +++.+++.|+|+.....+
T Consensus 266 dp~~R-------ps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 266 DPDKR-------ACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp STTTS-------CCHHHHHTSGGGCC----
T ss_pred ChhhC-------CCHHHHhcChhhhhcccc
Confidence 66655 999999999999765543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=258.65 Aligned_cols=204 Identities=17% Similarity=0.235 Sum_probs=161.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||+++++++..++ .++|+|++.+|+|.+++.. ...+++..++.++.|++.||.|||++||
T Consensus 60 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 138 (327)
T 3poz_A 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138 (327)
T ss_dssp CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 4466888999999999999999999998765 7889999999999997764 4679999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
+||||||+||+++.++.+||+|||++......... ....+|+.|+|||.+.+.. ++.++|||||||++|||++ |.
T Consensus 139 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~ 217 (327)
T 3poz_A 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGS 217 (327)
T ss_dssp CCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred eCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCC
Confidence 99999999999999999999999999876543322 2345678899999998765 8999999999999999999 77
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+.+....+. ...+..+.+.+ .+...+.++.+++..|+..+|..||...-
T Consensus 218 ~p~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e 268 (327)
T 3poz_A 218 KPYDGIPASEI-SSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRE 268 (327)
T ss_dssp CTTTTCCGGGH-HHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred CCccCCCHHHH-HHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 77766655544 44444444332 23445556666667777766666654433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=251.24 Aligned_cols=201 Identities=20% Similarity=0.258 Sum_probs=161.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++||||+++++++ ..+..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++
T Consensus 61 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 139 (291)
T 1xbb_A 61 LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139 (291)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 356788999999999999999999999 5667899999999999999998877899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
|+||||+||+++.++.+||+|||++......... ....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.
T Consensus 140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~ 218 (291)
T 1xbb_A 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQ 218 (291)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999876543321 2234678899999998655 7899999999999999999 77
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
.|+.+....+... .+..+.++. .+...+.+..+++..|+..+|..||.
T Consensus 219 ~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 266 (291)
T 1xbb_A 219 KPYRGMKGSEVTA-MLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPG 266 (291)
T ss_dssp CSSTTCCHHHHHH-HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCCHHHHHH-HHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 7777766655544 444433322 23345556666666666666555543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=251.24 Aligned_cols=199 Identities=18% Similarity=0.281 Sum_probs=159.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
..+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|
T Consensus 64 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 143 (283)
T 3gen_A 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143 (283)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 4577899999999999999999999999999999999999999998876 457999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
+||||+||+++.++.+||+|||++....... ......+|+.|+|||.+.+.. ++.++||||+||++|+|++ |..|+
T Consensus 144 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~ 222 (283)
T 3gen_A 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPY 222 (283)
T ss_dssp SSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999997654322 122345678899999998665 7999999999999999998 77777
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.+....+....+... .+. ..+...+.++.+++..|+..+|..||
T Consensus 223 ~~~~~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 223 ERFTNSETAEHIAQG-LRL---YRPHLASEKVYTIMYSCWHEKADERP 266 (283)
T ss_dssp TTSCHHHHHHHHHTT-CCC---CCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred cccChhHHHHHHhcc-cCC---CCCCcCCHHHHHHHHHHccCChhHCc
Confidence 777766665555443 221 12233344444555555554444444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=257.58 Aligned_cols=201 Identities=21% Similarity=0.289 Sum_probs=149.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE------EEEEecCCCCcHHHHHcCC------CCCCHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHP------HGLPWDLIKQITWQVL 84 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~~~l~~~~~~~------~~l~~~~~~~~~~qi~ 84 (303)
..+.+.+|+.+++.++||||+++++++...... ++|+||+++|+|..++... ..+++..++.++.|++
T Consensus 68 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 147 (323)
T 3qup_A 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147 (323)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHH
Confidence 356788999999999999999999999877655 9999999999999987432 2699999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHH
Q psy763 85 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIE 161 (303)
Q Consensus 85 ~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG 161 (303)
.||.|||++|++||||||+||+++.++.+||+|||++......... ....+++.|+|||.+.+.. ++.++||||||
T Consensus 148 ~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG 226 (323)
T 3qup_A 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFG 226 (323)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHH
T ss_pred HHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHH
Confidence 9999999999999999999999999999999999999876543221 2345677899999998765 89999999999
Q ss_pred HHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 162 WTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 162 ~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|++|||++ |..|+.+....+....+.... +. ..+...+.++.+++..|+..+|..||
T Consensus 227 ~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rp 284 (323)
T 3qup_A 227 VTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RL---KQPPECMEEVYDLMYQCWSADPKQRP 284 (323)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CC---CCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred HHHHHHHhCCCCCccccChHHHHHHHhcCC-CC---CCCCccCHHHHHHHHHHccCChhhCc
Confidence 99999999 677777766666655544432 21 12233444555555555555444444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=258.44 Aligned_cols=158 Identities=26% Similarity=0.380 Sum_probs=137.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH- 93 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~- 93 (303)
.....|+..++.++||||+++++++.... .+++||||+++|+|.+++... .+++..+..++.|++.||.|||+.
T Consensus 63 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~ 141 (322)
T 3soc_A 63 WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDI 141 (322)
T ss_dssp HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCE
T ss_pred HHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhc
Confidence 34455888999999999999999998744 479999999999999998754 699999999999999999999999
Q ss_pred ---------CceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCC----ccCCCccch
Q psy763 94 ---------ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGD----TLYGPAVDV 157 (303)
Q Consensus 94 ---------~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~----~~~~~~~Dv 157 (303)
||+||||||+||+++.++.+||+|||++........ .....||+.|+|||++.+. ..++.++||
T Consensus 142 ~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 221 (322)
T 3soc_A 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221 (322)
T ss_dssp EEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred cccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh
Confidence 999999999999999999999999999987654332 2345789999999999863 335678999
Q ss_pred hhHHHHHHHhhccCccCCCC
Q psy763 158 WAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 158 wSlG~il~el~tg~~~~~~~ 177 (303)
|||||++|||++|..||.+.
T Consensus 222 wslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 222 YAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp HHHHHHHHHHHTTBTTSSSC
T ss_pred HHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999888764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=252.91 Aligned_cols=214 Identities=21% Similarity=0.319 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFR--RKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
....+.+|+..++.++||||+++++++. ..+..++||||++++....+.. ....+++..+..++.|++.||.|||++
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 128 (305)
T 2wtk_C 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128 (305)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567889999999999999999999984 4457899999999874333332 245799999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCC---CccccccCCCcccCcccccCCc-cCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPG---ENYTDYVATRWYRAPELLVGDT-LYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~-~~~~~~DvwSlG~il~el~t 169 (303)
|++|+||||+||+++.++.+||+|||++...... .......+|+.|+|||++.+.. .++.++|||||||++|||++
T Consensus 129 ~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (305)
T 2wtk_C 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208 (305)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999999876532 2224567899999999987643 24779999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..|+.+....+....+....... ....++.+.+++.+|+
T Consensus 209 g~~p~~~~~~~~~~~~i~~~~~~~----------------------------------------~~~~~~~l~~li~~~l 248 (305)
T 2wtk_C 209 GLYPFEGDNIYKLFENIGKGSYAI----------------------------------------PGDCGPPLSDLLKGML 248 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCC----------------------------------------CSSSCHHHHHHHHHHT
T ss_pred CCCCCCCchHHHHHHHHhcCCCCC----------------------------------------CCccCHHHHHHHHHHc
Confidence 999988876666555443321110 0112345567777777
Q ss_pred ccccceeeccccccccccccceeeeeec
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..++..| +++.++++|||+..
T Consensus 249 ~~dp~~R-------ps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 249 EYEPAKR-------FSIRQIRQHSWFRK 269 (305)
T ss_dssp CSSTTTS-------CCHHHHHHSHHHHS
T ss_pred cCChhhC-------CCHHHHhcCccccc
Confidence 7555544 77778888877754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=251.66 Aligned_cols=203 Identities=19% Similarity=0.235 Sum_probs=161.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE-EEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKL-HLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
..+.+.+|+.+++.++||||+++++++.+.+.. ++|+||+.+|+|.+++.. ...+++..+..++.|++.||.|||++|
T Consensus 65 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (298)
T 3pls_A 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144 (298)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456778899999999999999999999876655 999999999999998876 457999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCC-----CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPG-----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
++||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+.. ++.++||||+||++|+|++
T Consensus 145 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~ 223 (298)
T 3pls_A 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLT 223 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhh
Confidence 999999999999999999999999999765332 1223456788999999998765 7999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|+.+++...........+..+...+ .+...+.+..+++-.|+..+|..||.
T Consensus 224 g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps 274 (298)
T 3pls_A 224 RGAPPYRHIDPFDLTHFLAQGRRLP---QPEYCPDSLYQVMQQCWEADPAVRPT 274 (298)
T ss_dssp TSCCTTTTSCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCccCCHHHHHHHhhcCCCCC---CCccchHHHHHHHHHHccCChhhCcC
Confidence 8877776655555555555544332 23334445555555555555554443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=270.97 Aligned_cols=204 Identities=22% Similarity=0.258 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||+++++++...+.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||
T Consensus 260 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 339 (495)
T 1opk_A 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339 (495)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 45678899999999999999999999999999999999999999998864 3469999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+||||||+|||++.++.+||+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|||++ |..
T Consensus 340 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~ 418 (495)
T 1opk_A 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMS 418 (495)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987653321 12334577899999998655 8999999999999999999 666
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+. ...+..+.++. .+..++.++.+++..||..+|..||....
T Consensus 419 p~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~e 468 (495)
T 1opk_A 419 PYPGIDLSQV-YELLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAE 468 (495)
T ss_dssp SSTTCCGGGH-HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHH-HHHHHcCCCCC---CCCCCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 6666555444 44455544432 34556677777777888777777765544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=254.99 Aligned_cols=202 Identities=16% Similarity=0.217 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.|+
T Consensus 89 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (333)
T 1mqb_A 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168 (333)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 345678899999999999999999999999999999999999999998764 3679999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
+||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++|||++ |
T Consensus 169 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g 247 (333)
T 1mqb_A 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYG 247 (333)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred eCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987653221 12234577899999998665 7999999999999999998 7
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
..|+.+....+....+.. +.+++ .+...+.+..+++-.|+..+|..||.
T Consensus 248 ~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps 296 (333)
T 1mqb_A 248 ERPYWELSNHEVMKAIND-GFRLP---TPMDCPSAIYQLMMQCWQQERARRPK 296 (333)
T ss_dssp CCTTTTCCHHHHHHHHHT-TCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCcccCCHHHHHHHHHC-CCcCC---CcccCCHHHHHHHHHHcCCChhhCcC
Confidence 788777766665554433 33322 23345556666666666666665554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=247.41 Aligned_cols=201 Identities=19% Similarity=0.242 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++||||+++++++ ..+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|+
T Consensus 53 ~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 131 (287)
T 1u59_A 53 DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131 (287)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 455678899999999999999999999 45669999999999999998864 3569999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
+|+||+|+||+++.++.+||+|||++......... ....+|+.|+|||.+.+.. ++.++|||||||++|||++ |
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g 210 (287)
T 1u59_A 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYG 210 (287)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred eeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999887543321 2345678899999997655 7999999999999999998 8
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
..|+.+....+....+ ..+.++. .+...+.+..+++..|+..+|..||.
T Consensus 211 ~~p~~~~~~~~~~~~i-~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps 259 (287)
T 1u59_A 211 QKPYKKMKGPEVMAFI-EQGKRME---CPPECPPELYALMSDCWIYKWEDRPD 259 (287)
T ss_dssp CCTTTTCCTHHHHHHH-HTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred CCCcccCCHHHHHHHH-hcCCcCC---CCCCcCHHHHHHHHHHcCCChhhCcC
Confidence 8887776666555444 3333322 23445556666666666655555543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=266.88 Aligned_cols=219 Identities=11% Similarity=0.023 Sum_probs=150.2
Q ss_pred HHHHHHHH---HHHHHhCCCCCcceeE-------EEEEeC-----------------CEEEEEEecCCCCcHHHHHcCC-
Q psy763 17 RQATEATN---KKEKRSLKHPNLVNLL-------EVFRRK-----------------KKLHLVFEFCDHTVLNELENHP- 68 (303)
Q Consensus 17 ~~~~~~~e---~~~l~~l~h~niv~~~-------~~~~~~-----------------~~~~lv~e~~~~~~l~~~~~~~- 68 (303)
..+.+.+| +..++. +||||++++ +++... ..+|+||||++ |+|.+++...
T Consensus 105 ~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 182 (371)
T 3q60_A 105 ELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182 (371)
T ss_dssp HHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence 44455666 455556 799987755 566543 34899999999 8999987652
Q ss_pred CCCCHHHH------HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCc
Q psy763 69 HGLPWDLI------KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142 (303)
Q Consensus 69 ~~l~~~~~------~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP 142 (303)
..++...+ ..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ......+|+.|+||
T Consensus 183 ~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aP 260 (371)
T 3q60_A 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPR 260 (371)
T ss_dssp HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCH
T ss_pred cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcCh
Confidence 24444455 67779999999999999999999999999999999999999999987543 22245677999999
Q ss_pred ccccC-CccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChh
Q psy763 143 ELLVG-DTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTT 221 (303)
Q Consensus 143 E~l~~-~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
|++.+ ...++.++|||||||++|||++|..||.+....... ... ... . .......
T Consensus 261 E~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--------~~~---~~~----------~---~~~~~~~ 316 (371)
T 3q60_A 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG--------SWK---RPS----------L---RVPGTDS 316 (371)
T ss_dssp HHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT--------CCC---BCC----------T---TSCCCCS
T ss_pred hhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc--------chh---hhh----------h---hhccccc
Confidence 99975 234899999999999999999999888765321100 000 000 0 0000000
Q ss_pred HHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 222 TIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 222 ~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
......+..++.+.+++.+|+..+|..| +++.++++||||..
T Consensus 317 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R-------pt~~e~l~hp~f~~ 358 (371)
T 3q60_A 317 -------LAFGSCTPLPDFVKTLIGRFLNFDRRRR-------LLPLEAMETPEFLQ 358 (371)
T ss_dssp -------CCCTTSSCCCHHHHHHHHHHTCSSTTTC-------CCHHHHTTSHHHHH
T ss_pred -------cchhhccCCCHHHHHHHHHHcCCChhhC-------CCHHHHhcCHHHHH
Confidence 0011112456788899999999766666 99999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=249.35 Aligned_cols=155 Identities=27% Similarity=0.407 Sum_probs=138.5
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEe----------------CCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHH
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRR----------------KKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITW 81 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~ 81 (303)
.+.+|+..++.++||||+++++++.. ...+++||||+++++|.+++.. ...+++..++.++.
T Consensus 50 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 129 (284)
T 2a19_B 50 KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129 (284)
T ss_dssp GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHH
Confidence 45678999999999999999999864 3458999999999999998853 35799999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHH
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIE 161 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG 161 (303)
|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.............+++.|+|||.+.+.. ++.++||||||
T Consensus 130 qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG 208 (284)
T 2a19_B 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALG 208 (284)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHH
T ss_pred HHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHH
Confidence 99999999999999999999999999999999999999998876655556668999999999998765 79999999999
Q ss_pred HHHHHhhccCccCC
Q psy763 162 WTSHSYSQIGFIGL 175 (303)
Q Consensus 162 ~il~el~tg~~~~~ 175 (303)
|++|+|++|..++.
T Consensus 209 ~il~~l~~~~~~~~ 222 (284)
T 2a19_B 209 LILAELLHVCDTAF 222 (284)
T ss_dssp HHHHHHHSCCSSHH
T ss_pred HHHHHHHhcCCcch
Confidence 99999999887664
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=256.30 Aligned_cols=218 Identities=21% Similarity=0.245 Sum_probs=147.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-----CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-----HPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+.++..+++.++||||+++++++..++..++||||+++ ++..++. ....+++..+..++.|++.||.|||+.
T Consensus 66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 144 (327)
T 3aln_A 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144 (327)
T ss_dssp HHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc
Confidence 3444445588889999999999999999999999999996 6655543 256899999999999999999999999
Q ss_pred -CceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCccccc---CCccCCCccchhhHHHHHHHhhc
Q psy763 94 -ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV---GDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 -~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~---~~~~~~~~~DvwSlG~il~el~t 169 (303)
|++|+||||+||+++.++.+||+|||++.............||+.|+|||.+. ....++.++|||||||++|+|++
T Consensus 145 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~ 224 (327)
T 3aln_A 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224 (327)
T ss_dssp HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHH
T ss_pred CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999999999998765544444557999999999984 22347999999999999999999
Q ss_pred cCccCCCCchHHH-HHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhh
Q psy763 170 IGFIGLGNMGSHM-ARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKK 248 (303)
Q Consensus 170 g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~ 248 (303)
|..|+.+...... ...+.. +..+ . .........++.+.+++.+|
T Consensus 225 g~~pf~~~~~~~~~~~~~~~-~~~~-------~---------------------------~~~~~~~~~~~~l~~li~~~ 269 (327)
T 3aln_A 225 GRFPYPKWNSVFDQLTQVVK-GDPP-------Q---------------------------LSNSEEREFSPSFINFVNLC 269 (327)
T ss_dssp SCCCSSCC-------CCCCC-SCCC-------C---------------------------CCCCSSCCCCHHHHHHHHHH
T ss_pred CCCCCCCcchHHHHHHHHhc-CCCC-------C---------------------------CCCcccccCCHHHHHHHHHH
Confidence 9988865432111 100000 0000 0 00111123456788999999
Q ss_pred hccccceeeccccccccccccceeeeeecCC
Q psy763 249 LIGRFTYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+..+|..| +++.++++|||+...+
T Consensus 270 l~~dp~~R-------ps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 270 LTKDESKR-------PKYKELLKHPFILMYE 293 (327)
T ss_dssp TCSSGGGS-------CCHHHHTTSHHHHHHH
T ss_pred hhCChhhC-------cCHHHHHhChHHHHhH
Confidence 98766666 9999999999986543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=251.74 Aligned_cols=201 Identities=20% Similarity=0.263 Sum_probs=154.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFR-RKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++||||+++++++. .++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++|
T Consensus 69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ 148 (298)
T 3f66_A 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148 (298)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4456788999999999999999999865 45678999999999999998865 456899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCC-----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
++||||||+||+++.++.+||+|||++....... ......+|+.|+|||.+.+.. ++.++||||+||++|+|++
T Consensus 149 i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~ 227 (298)
T 3f66_A 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT 227 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998754322 123345678899999998665 7999999999999999999
Q ss_pred cCccCCCC-chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 170 IGFIGLGN-MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 170 g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|+.+++.. ...+....+.. +.+. ..+...+.+..+++..|+..+|..||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 228 RGAPPYPDVNTFDITVYLLQ-GRRL---LQPEYCPDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp TSCCSSTTSCTTTHHHHHHT-TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCccCCHHHHHHHHhc-CCCC---CCCccCCHHHHHHHHHHcCCChhhCc
Confidence 66655544 33344333333 2221 12333444555555555555544444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=252.06 Aligned_cols=204 Identities=22% Similarity=0.288 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+.+.+|+.+++.++||||+++++++... ..+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 54 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (295)
T 3ugc_A 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133 (295)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 345678999999999999999999998643 5689999999999999988654 3599999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|++||||||+||+++.++.+||+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 134 ~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~ 212 (295)
T 3ugc_A 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 212 (295)
T ss_dssp TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998765332 123345677899999998765 8999999999999999999
Q ss_pred cCccCCCCchH---------------HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 170 IGFIGLGNMGS---------------HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 170 g~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
|..++...... ......+..+.+.+ .+..++.+..+++..|+..+|..||..
T Consensus 213 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~ 279 (295)
T 3ugc_A 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSF 279 (295)
T ss_dssp TTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred cccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCH
Confidence 88776543221 11222223333322 234455566666666666555555443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=267.98 Aligned_cols=203 Identities=21% Similarity=0.315 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||+++++++. .+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||
T Consensus 227 ~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 305 (454)
T 1qcf_A 227 VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305 (454)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 456889999999999999999999986 66789999999999999998754 368999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+||||||+|||++.++.+||+|||++....... ......++..|+|||++.+.. ++.++|||||||++|||++ |..
T Consensus 306 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~ 384 (454)
T 1qcf_A 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRI 384 (454)
T ss_dssp CCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCC
Confidence 999999999999999999999999998754321 112334677899999998655 8999999999999999999 777
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+....+. .+.+++ .+..++.++.+++..||..+|..||.+..
T Consensus 385 P~~~~~~~~~~~~i~-~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~~ 434 (454)
T 1qcf_A 385 PYPGMSNPEVIRALE-RGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFEY 434 (454)
T ss_dssp SSTTCCHHHHHHHHH-HTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHH-cCCCCC---CCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 777776666655444 444432 34556677777777888777777665444
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=255.08 Aligned_cols=201 Identities=21% Similarity=0.270 Sum_probs=159.4
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+.+|+..++.++||||+++++++. ++..++|+||+.+|+|.+++... +.+++..+..++.|++.||.|||+.||+||
T Consensus 61 ~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 139 (325)
T 3kex_A 61 AVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHR 139 (325)
T ss_dssp SCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 4567888999999999999999986 45689999999999999987654 579999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
||||+||+++.++.+||+|||++....... ......+|..|+|||.+.+.. ++.++|||||||++|||++ |..|+
T Consensus 140 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp CCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCc
Confidence 999999999999999999999998765432 223456788999999998665 8999999999999999999 77777
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.+....+... .+..+.++. .+...+.+..+++..|+..+|..||....
T Consensus 219 ~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (325)
T 3kex_A 219 AGLRLAEVPD-LLEKGERLA---QPQICTIDVYMVMVKCWMIDENIRPTFKE 266 (325)
T ss_dssp TTSCTTHHHH-HHHTTCBCC---CCTTBCTTTTHHHHHHTCSCTTTSCCHHH
T ss_pred cccCHHHHHH-HHHcCCCCC---CCCcCcHHHHHHHHHHcCCChhhCcCHHH
Confidence 7766555544 344443322 33445566677777777777666654433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=257.29 Aligned_cols=203 Identities=21% Similarity=0.231 Sum_probs=162.2
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--------------CCCCCHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--------------PHGLPWDLIKQITW 81 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------~~~l~~~~~~~~~~ 81 (303)
....+.+|+.+++.+ +||||+++++++..++..++||||+++|+|.+++.. ...+++..++.++.
T Consensus 92 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (333)
T 2i1m_A 92 EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171 (333)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHH
Confidence 446688899999999 899999999999999999999999999999998753 34689999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchh
Q psy763 82 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVW 158 (303)
Q Consensus 82 qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~Dvw 158 (303)
|++.||.|||+.||+||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||
T Consensus 172 qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~ 250 (333)
T 2i1m_A 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVW 250 (333)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHH
Confidence 999999999999999999999999999999999999999986543222 12345678899999988655 89999999
Q ss_pred hHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 159 AIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 159 SlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
||||++|||++ |..|+.+.............+.+.. .+...+.+..+++..|+..+|..||.
T Consensus 251 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps 313 (333)
T 2i1m_A 251 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---QPAFAPKNIYSIMQACWALEPTHRPT 313 (333)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCcC
Confidence 99999999998 6677777666666666666554432 22334555555666666655555543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=254.29 Aligned_cols=202 Identities=25% Similarity=0.339 Sum_probs=161.5
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC----------------CCCHHHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH----------------GLPWDLIKQI 79 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~l~~~~~~~~ 79 (303)
....+.+|+.+++.+ +||||+++++++...+..++||||+++|+|.+++.... .+++..++.+
T Consensus 83 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 162 (334)
T 2pvf_A 83 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162 (334)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHH
Confidence 345678899999999 89999999999999999999999999999999887543 3899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccc
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVD 156 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~D 156 (303)
+.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|
T Consensus 163 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D 241 (334)
T 2pvf_A 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSD 241 (334)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHH
Confidence 99999999999999999999999999999999999999999987654322 23345678899999998655 799999
Q ss_pred hhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 157 VWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 157 vwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
||||||++|||++ |..|+.+....+....+ ..+.+.. .+...+.+..+++-.|+..+|..||.
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 305 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPT 305 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH-hcCCCCC---CCccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999 77777666655554443 3333322 23345556666666666665555543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=249.05 Aligned_cols=205 Identities=18% Similarity=0.210 Sum_probs=150.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++||||+++++++ ..+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|+
T Consensus 63 ~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 141 (289)
T 3og7_A 63 QLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141 (289)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 346688899999999999999999965 45668999999999999998854 4579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCC---CccccccCCCcccCcccccC--CccCCCccchhhHHHHHHHhhcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPG---ENYTDYVATRWYRAPELLVG--DTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~l~~--~~~~~~~~DvwSlG~il~el~tg 170 (303)
+|+||||+||+++.++.+||+|||++...... .......||+.|+|||.+.. ...++.++||||+||++|+|++|
T Consensus 142 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 221 (289)
T 3og7_A 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221 (289)
T ss_dssp CCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred ccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence 99999999999999999999999999765431 22244578999999999862 33478899999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEee-cCCCCCcchhhhhhhhhhcCCChhH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVIL-KSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
..|+.+....+.....+..+...+... .....+.++.+++-.|+..+|..||
T Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 274 (289)
T 3og7_A 222 QLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274 (289)
T ss_dssp SCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC
Confidence 999988777766666666544332111 1223344444444445444444443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=262.63 Aligned_cols=204 Identities=20% Similarity=0.250 Sum_probs=150.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
..+.+.+|+.+++.++||||+++++++.. ++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 133 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 212 (373)
T 3c1x_A 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212 (373)
T ss_dssp HHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45668889999999999999999998754 45789999999999999988754 46899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|+||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++|||++
T Consensus 213 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt 291 (373)
T 3c1x_A 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT 291 (373)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999986543221 12345678899999998655 8999999999999999999
Q ss_pred cCccCCCC-chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 170 IGFIGLGN-MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 170 g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
|+.+++.. ...+... .+..+.++ ..+..++.+..+++..||..+|..||...
T Consensus 292 ~~~~p~~~~~~~~~~~-~~~~~~~~---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ 344 (373)
T 3c1x_A 292 RGAPPYPDVNTFDITV-YLLQGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFS 344 (373)
T ss_dssp TSCCSCTTSCSSCHHH-HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCCCCCCCCHHHHHH-HHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 66555544 3333333 33333332 23345566666666677766666555433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=248.83 Aligned_cols=156 Identities=23% Similarity=0.351 Sum_probs=137.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.+.+.+|+.+++.++||||+++++++... +.+++||||+++++|.+++ .....+++..++.++.|++.||.|||++|
T Consensus 67 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 146 (302)
T 4e5w_A 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146 (302)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 45678899999999999999999999876 6789999999999999988 44457999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||||+||+++.++.+||+|||++........ .....+|..|+|||.+.+.. ++.++||||+||++|+|++|
T Consensus 147 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g 225 (302)
T 4e5w_A 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTY 225 (302)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999988654332 23456788899999998765 78999999999999999998
Q ss_pred CccC
Q psy763 171 GFIG 174 (303)
Q Consensus 171 ~~~~ 174 (303)
..|+
T Consensus 226 ~~p~ 229 (302)
T 4e5w_A 226 CDSD 229 (302)
T ss_dssp TCGG
T ss_pred cCCC
Confidence 8764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=257.42 Aligned_cols=157 Identities=17% Similarity=0.137 Sum_probs=140.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
..+.+|+..++.++||||+++++++.. ....|+||||+ +++|.+++...+.+++..++.++.|++.||+|||+.|
T Consensus 93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 171 (345)
T 2v62_A 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE 171 (345)
T ss_dssp HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346678899999999999999999988 77899999999 9999999987778999999999999999999999999
Q ss_pred ceecccCCCcEEEecCC--cEEEccccceeeeCCCC--------ccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 95 CIHRDIKPENILLTANG--VVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
|+||||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++
T Consensus 172 ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il 250 (345)
T 2v62_A 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCM 250 (345)
T ss_dssp EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHH
T ss_pred eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHH
Confidence 99999999999999887 99999999998764321 114457899999999998765 89999999999999
Q ss_pred HHhhccCccCCCC
Q psy763 165 HSYSQIGFIGLGN 177 (303)
Q Consensus 165 ~el~tg~~~~~~~ 177 (303)
|||++|..||.+.
T Consensus 251 ~ell~g~~pf~~~ 263 (345)
T 2v62_A 251 LRWLCGKLPWEQN 263 (345)
T ss_dssp HHHHHSSCTTGGG
T ss_pred HHHHhCCCCcccc
Confidence 9999999888653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=260.33 Aligned_cols=160 Identities=23% Similarity=0.312 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH----GLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.+.+.+|+..++.++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++
T Consensus 79 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 158 (321)
T 2qkw_B 79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158 (321)
T ss_dssp HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC
Confidence 4567889999999999999999999999999999999999999999886543 589999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|
T Consensus 159 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g 237 (321)
T 2qkw_B 159 AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCA 237 (321)
T ss_dssp TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHC
T ss_pred CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhC
Confidence 99999999999999999999999999998754321 223446899999999998665 89999999999999999999
Q ss_pred CccCCCCc
Q psy763 171 GFIGLGNM 178 (303)
Q Consensus 171 ~~~~~~~~ 178 (303)
..|+.+..
T Consensus 238 ~~p~~~~~ 245 (321)
T 2qkw_B 238 RSAIVQSL 245 (321)
T ss_dssp CTTCSCSS
T ss_pred CCcccccC
Confidence 98887653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=245.35 Aligned_cols=199 Identities=10% Similarity=0.078 Sum_probs=163.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.+.+.+|+..++.++||||+++++++.+. +..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (271)
T 3kmu_A 51 SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130 (271)
T ss_dssp HHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 45688999999999999999999999877 78899999999999999987665 589999999999999999999999
Q ss_pred C--ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCcc--CCCccchhhHHHHHHHhhc
Q psy763 94 A--CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTL--YGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~--ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~--~~~~~DvwSlG~il~el~t 169 (303)
| ++|+||||+||+++.++.++|+|||++.... .....+|+.|+|||.+.+... ++.++|||||||++|||++
T Consensus 131 ~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 206 (271)
T 3kmu_A 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206 (271)
T ss_dssp SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred CCceecCCCccceEEEcCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence 9 9999999999999999999999888865432 234578999999999986542 2337999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|..|+.+....+........+.++. .+...+.+..+++..|+..+|..||.
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps 257 (271)
T 3kmu_A 207 REVPFADLSNMEIGMKVALEGLRPT---IPPGISPHVSKLMKICMNEDPAKRPK 257 (271)
T ss_dssp CSCTTTTSCHHHHHHHHHHSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCccccChHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 9999998888887777776655543 23445556666666666665555543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=249.17 Aligned_cols=202 Identities=21% Similarity=0.268 Sum_probs=161.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+.+|+..++.++||||+++++++..+. .++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 141 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567889999999999999999999998765 88999999999999977643 57999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ- 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t- 169 (303)
++|+||||+||+++.++.+||+|||++........ .....+|..|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 142 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~ 220 (291)
T 1u46_A 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTY 220 (291)
T ss_dssp EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987654332 12345677899999998665 7899999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|..|+.+....+....+.....+++ .+...+.++.+++..|+..+|..||
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp 270 (291)
T 1u46_A 221 GQEPWIGLNGSQILHKIDKEGERLP---RPEDCPQDIYNVMVQCWAHKPEDRP 270 (291)
T ss_dssp SCCTTTTCCHHHHHHHHHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCcccCCHHHHHHHHHccCCCCC---CCcCcCHHHHHHHHHHccCCcccCc
Confidence 8888888877777776666544432 2334455555555555555554444
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=253.28 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=160.0
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCC-EEEEEEecCCCCcHHHHHcCCCC----------------CCHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKK-KLHLVFEFCDHTVLNELENHPHG----------------LPWDLIKQI 79 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~----------------l~~~~~~~~ 79 (303)
...+.+|+..++.+ +||||+++++++...+ .+++|+||+++++|.+++..... +++..+..+
T Consensus 74 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (316)
T 2xir_A 74 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153 (316)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHH
T ss_pred HHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHH
Confidence 45678899999999 6999999999998754 58999999999999999876543 899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccc
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVD 156 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~D 156 (303)
+.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|
T Consensus 154 ~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~D 232 (316)
T 2xir_A 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSD 232 (316)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHH
T ss_pred HHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhH
Confidence 99999999999999999999999999999999999999999987643322 23346788999999998655 799999
Q ss_pred hhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 157 VWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 157 vwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
||||||++|+|++ |..|+.+....+.....+..+.+.. .+...+++..+++..|+..+|..||
T Consensus 233 i~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp 296 (316)
T 2xir_A 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRP 296 (316)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999999998 7777777665555555555544332 2334455666666666655555444
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=266.26 Aligned_cols=203 Identities=22% Similarity=0.289 Sum_probs=159.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||+++++++.+ +..++||||+++|+|.+++.. +..+++..+..++.|++.||.|||++|+
T Consensus 223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 301 (452)
T 1fmk_A 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301 (452)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3567899999999999999999999876 678999999999999998864 2469999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+||||||+|||++.++.+||+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 302 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~ 380 (452)
T 1fmk_A 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRV 380 (452)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCC
Confidence 999999999999999999999999998764322 122345678899999998655 8999999999999999999 667
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+....+ ..+.+++ .+..++.++.+++..||..+|..||.+..
T Consensus 381 P~~~~~~~~~~~~i-~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 430 (452)
T 1fmk_A 381 PYPGMVNREVLDQV-ERGYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEY 430 (452)
T ss_dssp SSTTCCHHHHHHHH-HTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHH-HcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 77666666555444 4444432 23456667777777777777776665443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=259.97 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHhCC-----------CCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSLK-----------HPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENH--PHGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~ 80 (303)
...+.+|+.+++.++ ||||+++++++...+ .+++|+|++ +++|.+++.. ...+++..+..++
T Consensus 59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~ 137 (373)
T 1q8y_A 59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137 (373)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHH
Confidence 345667777777765 899999999998654 789999999 7888887754 3469999999999
Q ss_pred HHHHHHHHHHHHC-CceecccCCCcEEEecC------CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCC
Q psy763 81 WQVLRGVSYCHRH-ACIHRDIKPENILLTAN------GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGP 153 (303)
Q Consensus 81 ~qi~~~l~~lH~~-~ivH~dlk~~nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~ 153 (303)
.|++.||.|||++ ||+||||||+||+++.+ +.+||+|||++..... ......+|+.|+|||++.+.. ++.
T Consensus 138 ~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~ 214 (373)
T 1q8y_A 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGC 214 (373)
T ss_dssp HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCT
T ss_pred HHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCC-CCc
Confidence 9999999999998 99999999999999543 4799999999987543 234457899999999998766 899
Q ss_pred ccchhhHHHHHHHhhccCccCCCCc------hHHHHHHHhhcCCceeEeecCCCCCc-chh--hhhhhhhhcCCChhHHH
Q psy763 154 AVDVWAIEWTSHSYSQIGFIGLGNM------GSHMARNLLKNNGRVTVILKSDSLDS-ETW--DLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 154 ~~DvwSlG~il~el~tg~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~ 224 (303)
++|||||||++|||++|..||.+.. ....+..+....+.++.......... ... ...+..+ ......++.
T Consensus 215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 293 (373)
T 1q8y_A 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI-SKLKFWPLE 293 (373)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSC-CCCCBCCHH
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccc-ccccccchh
Confidence 9999999999999999998887654 23334444443332221100000000 000 0000000 011111222
Q ss_pred HHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 225 KYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
..+..........++++.+++.+||..+|..| +++.++++||||.+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R-------pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR-------ADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC-------BCHHHHHTCGGGTTC
T ss_pred hhhhhcccCCcchHHHHHHHHHHHhccCcccc-------CCHHHHhhChhhhcc
Confidence 22222223333445678899999999777666 999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=251.68 Aligned_cols=201 Identities=19% Similarity=0.258 Sum_probs=151.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEecCCCCcHHHHH------cCCCCCCHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELE------NHPHGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~------~~~~~l~~~~~~~~~~qi~~~ 86 (303)
.+.+.+|+..++.++||||+++++++...+ ..++|+||+++++|..++ .....+++..++.++.|++.|
T Consensus 80 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a 159 (313)
T 3brb_A 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159 (313)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHH
Confidence 456788999999999999999999998655 359999999999999987 334579999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
|.|||+.|++||||||+||+++.++.+||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||+
T Consensus 160 L~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i 238 (313)
T 3brb_A 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVT 238 (313)
T ss_dssp HHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHH
T ss_pred HHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHH
Confidence 999999999999999999999999999999999998764332 123345678899999998765 8999999999999
Q ss_pred HHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 164 SHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 164 l~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
+|+|++ |..|+.+....+....+... .++. .+...+.+..+++..|+..+|..||.
T Consensus 239 l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 295 (313)
T 3brb_A 239 MWEIATRGMTPYPGVQNHEMYDYLLHG-HRLK---QPEDCLDELYEIMYSCWRTDPLDRPT 295 (313)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCC---CBTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HHHHHhcCCCCCccCCHHHHHHHHHcC-CCCC---CCccccHHHHHHHHHHcCCChhhCcC
Confidence 999999 66666666655555544433 2221 22344555555555555555554443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=274.25 Aligned_cols=203 Identities=20% Similarity=0.250 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.. +..++||||+++|+|.+++.....+++..+..++.||+.||.|||++||+|
T Consensus 414 ~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiH 492 (635)
T 4fl3_A 414 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 492 (635)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeC
Confidence 4568899999999999999999999974 458999999999999999988888999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
|||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..
T Consensus 493 rDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~ 571 (635)
T 4fl3_A 493 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQK 571 (635)
T ss_dssp SCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987653322 22345678899999997655 8999999999999999998 777
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+... .+..+.++. .+..++.++.+++..||..+|..||....
T Consensus 572 Pf~~~~~~~~~~-~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 621 (635)
T 4fl3_A 572 PYRGMKGSEVTA-MLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAA 621 (635)
T ss_dssp SSTTCCHHHHHH-HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHH-HHHcCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 777766665544 444444432 33456667777777777777776665444
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=249.92 Aligned_cols=204 Identities=23% Similarity=0.315 Sum_probs=148.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+..++.++||||+++++++..++..++||||+++++|.+++. ....+++..++.++.|++.||.|||+
T Consensus 75 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 154 (310)
T 2wqm_A 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154 (310)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 45667889999999999999999999999999999999999999999775 35679999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
.|++|+||+|+||+++.++.+||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|.
T Consensus 155 ~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~ 233 (310)
T 2wqm_A 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQ 233 (310)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987755322 223457899999999998765 799999999999999999999
Q ss_pred ccCCCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 172 FIGLGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 172 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
.|+.+... .......+.....++ ......+.++.+++..|+..+|..||.
T Consensus 234 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps 284 (310)
T 2wqm_A 234 SPFYGDKMNLYSLCKKIEQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPD 284 (310)
T ss_dssp CTTC---CCHHHHHHHHHTTCSCC--CCTTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcccchhHHHHHHHhhcccCCC--CcccccCHHHHHHHHHHcCCChhhCCC
Confidence 98876532 222222233222211 112334445555555555555554443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=252.95 Aligned_cols=202 Identities=16% Similarity=0.197 Sum_probs=158.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------CCCCHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~l~~~~~~~~~~qi~~~ 86 (303)
....+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.|
T Consensus 71 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 150 (322)
T 1p4o_A 71 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150 (322)
T ss_dssp HHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999987542 357999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
|.|||++||+||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++||||+||+
T Consensus 151 l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i 229 (322)
T 1p4o_A 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVV 229 (322)
T ss_dssp HHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred HHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHH
Confidence 9999999999999999999999999999999999876543221 12345688899999988655 7999999999999
Q ss_pred HHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 164 SHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 164 l~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
+|+|++ |..|+.+....+....+... ... ..+...+.+..+++..|+..+|..||.
T Consensus 230 l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps 286 (322)
T 1p4o_A 230 LWEIATLAEQPYQGLSNEQVLRFVMEG-GLL---DKPDNCPDMLFELMRMCWQYNPKMRPS 286 (322)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHTT-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHhcCCCccccCCHHHHHHHHHcC-CcC---CCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 999999 56666666655555544433 221 123344555555555555555554443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=264.83 Aligned_cols=216 Identities=16% Similarity=0.173 Sum_probs=154.6
Q ss_pred HHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCC-------HHHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLP-------WDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 20 ~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~-------~~~~~~~~~qi~~~l~~lH 91 (303)
.+.+|+.+++.+ +||||+++++++.+++.+|+||||++ |+|.+++....... +..++.++.|++.||.|||
T Consensus 54 ~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 132 (434)
T 2rio_A 54 IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132 (434)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH
Confidence 456788888765 89999999999999999999999997 69999887654322 2345679999999999999
Q ss_pred HCCceecccCCCcEEEecC-------------CcEEEccccceeeeCCCCc-----cccccCCCcccCcccccC------
Q psy763 92 RHACIHRDIKPENILLTAN-------------GVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVG------ 147 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~-------------~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~------ 147 (303)
++||+||||||+||+++.+ +.+||+|||++........ .....||+.|+|||++.+
T Consensus 133 ~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 212 (434)
T 2rio_A 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQT 212 (434)
T ss_dssp HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSC
T ss_pred HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccc
Confidence 9999999999999999754 4899999999988654322 234579999999999975
Q ss_pred CccCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 148 DTLYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 148 ~~~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
...++.++|||||||++|||++ |..|+.+....+ ..++......+.. . ...
T Consensus 213 ~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~---~----------------~~~------- 264 (434)
T 2rio_A 213 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM---K----------------CLH------- 264 (434)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC---T----------------TCC-------
T ss_pred ccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc---c----------------ccc-------
Confidence 2348999999999999999999 555554433222 2222221111100 0 000
Q ss_pred HhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeecC
Q psy763 227 LLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 227 l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
....++++.+++.+|+..+|..| +++.++++||||...
T Consensus 265 -------~~~~~~~~~~li~~~L~~dP~~R-------ps~~eil~hp~f~~~ 302 (434)
T 2rio_A 265 -------DRSLIAEATDLISQMIDHDPLKR-------PTAMKVLRHPLFWPK 302 (434)
T ss_dssp -------CHHHHHHHHHHHHHHTCSSGGGS-------CCHHHHHTSGGGSCH
T ss_pred -------cccchHHHHHHHHHHhhCChhhC-------CCHHHHHhCCccCCc
Confidence 00112467789999998666666 999999999999643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=257.78 Aligned_cols=158 Identities=19% Similarity=0.215 Sum_probs=139.4
Q ss_pred HHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-----CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 20 TEATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-----HPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 20 ~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
.+..|+.+++.++ |+||+++++++..++..|+||||+++|+|.+++. ....+++..++.++.|++.||.|||
T Consensus 110 ~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH 189 (365)
T 3e7e_A 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189 (365)
T ss_dssp HHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 4556666667776 9999999999999999999999999999999886 3567999999999999999999999
Q ss_pred HCCceecccCCCcEEEec-----------CCcEEEccccceeeeC---CCCccccccCCCcccCcccccCCccCCCccch
Q psy763 92 RHACIHRDIKPENILLTA-----------NGVVKLCDFGFARLIN---PGENYTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~-----------~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
++||+||||||+|||++. ++.+||+|||+|.... .........||+.|+|||++.+.. ++.++||
T Consensus 190 ~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di 268 (365)
T 3e7e_A 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDY 268 (365)
T ss_dssp TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHH
T ss_pred hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccH
Confidence 999999999999999998 8999999999997653 233345578999999999998876 8999999
Q ss_pred hhHHHHHHHhhccCccCCCCc
Q psy763 158 WAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 158 wSlG~il~el~tg~~~~~~~~ 178 (303)
|||||++|||++|..||.+..
T Consensus 269 wslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 269 FGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp HHHHHHHHHHHHSSCCCEEEE
T ss_pred HHHHHHHHHHHhCCCccccCC
Confidence 999999999999998886543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=249.67 Aligned_cols=215 Identities=19% Similarity=0.266 Sum_probs=156.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRH-AC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~-~i 95 (303)
.+.+.++..+++.++||||+++++++..++..++||||+ ++++..+... ...+++..+..++.|++.||.|||++ |+
T Consensus 68 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 146 (318)
T 2dyl_A 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146 (318)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 345566667889999999999999999999999999999 4666665443 46899999999999999999999995 99
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhhccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+|+||+|+||+++.++.+||+|||++.............+++.|+|||.+.+ ...++.++|||||||++|||++|.
T Consensus 147 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (318)
T 2dyl_A 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226 (318)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS
T ss_pred EeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC
Confidence 9999999999999999999999999987655444455679999999999852 334789999999999999999999
Q ss_pred ccCCCC-chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 172 FIGLGN-MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 172 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
.|+.+. ...+....+....... . ......++++.+++.+|+.
T Consensus 227 ~pf~~~~~~~~~~~~~~~~~~~~--~-----------------------------------~~~~~~~~~l~~li~~~l~ 269 (318)
T 2dyl_A 227 FPYKNCKTDFEVLTKVLQEEPPL--L-----------------------------------PGHMGFSGDFQSFVKDCLT 269 (318)
T ss_dssp CTTTTCCSHHHHHHHHHHSCCCC--C-----------------------------------CSSSCCCHHHHHHHHHHTC
T ss_pred CCCCCCCccHHHHHHHhccCCCC--C-----------------------------------CccCCCCHHHHHHHHHHcc
Confidence 888764 3334444333321110 0 0001134556778888887
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|..| +++.++++|||+..
T Consensus 270 ~dp~~R-------ps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 270 KDHRKR-------PKYNKLLEHSFIKR 289 (318)
T ss_dssp SCTTTS-------CCHHHHTTSHHHHH
T ss_pred CChhHC-------cCHHHHhhCHHHHh
Confidence 555555 88888888888754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=272.03 Aligned_cols=203 Identities=19% Similarity=0.241 Sum_probs=162.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+.+|+++++.++||||+++++++.. +.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+
T Consensus 380 ~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ii 458 (613)
T 2ozo_A 380 TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458 (613)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 4567889999999999999999999976 5699999999999999988643 4699999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
||||||+|||++.++.+||+|||++......... ....+++.|+|||++.+.. ++.++|||||||++|||++ |.
T Consensus 459 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~ 537 (613)
T 2ozo_A 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQ 537 (613)
T ss_dssp CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999876432211 2234568899999998655 8999999999999999998 77
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.|+.+....+.... +..+.+++ .+..++.++.+++..||..++..||.+..
T Consensus 538 ~Pf~~~~~~~~~~~-i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 588 (613)
T 2ozo_A 538 KPYKKMKGPEVMAF-IEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLT 588 (613)
T ss_dssp CTTTTCCSHHHHHH-HHTTCCCC---CCTTCCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred CCCCCCCHHHHHHH-HHcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 77777666665544 44444432 34456777777777888777776665444
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=255.71 Aligned_cols=214 Identities=20% Similarity=0.253 Sum_probs=143.7
Q ss_pred HHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
+....++.++||||+++++++.. +..+++||||+++|+|.+++.... .+++..++.++.|++.||.|||++|++
T Consensus 71 e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~iv 150 (336)
T 3fhr_A 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIA 150 (336)
T ss_dssp HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34455778899999999999986 456899999999999999887653 699999999999999999999999999
Q ss_pred ecccCCCcEEEecC---CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 97 HRDIKPENILLTAN---GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 97 H~dlk~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
||||||+||+++.+ +.+||+|||++...... ......+|+.|+|||.+.+.. ++.++|||||||++|+|++|..|
T Consensus 151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p 228 (336)
T 3fhr_A 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPP 228 (336)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCC
T ss_pred cCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999864 55999999999875532 234567899999999987655 79999999999999999999998
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
+.+.................. .. .........++++.+++.+|+..+|
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~--------------------~~------------~~~~~~~~~~~~~~~li~~~L~~dP 276 (336)
T 3fhr_A 229 FYSNTGQAISPGMKRRIRLGQ--------------------YG------------FPNPEWSEVSEDAKQLIRLLLKTDP 276 (336)
T ss_dssp C-----------------------------------------C------------CCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred CCCccchhhhhhHHHhhhccc--------------------cc------------cCchhhccCCHHHHHHHHHHCCCCh
Confidence 876544332111100000000 00 0001112346678899999998666
Q ss_pred ceeeccccccccccccceeeeeec
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
..| +++.++++||||..
T Consensus 277 ~~R-------pt~~ell~hp~~~~ 293 (336)
T 3fhr_A 277 TER-------LTITQFMNHPWINQ 293 (336)
T ss_dssp GGS-------CCHHHHHHSHHHHT
T ss_pred hHC-------cCHHHHhcCccccc
Confidence 666 99999999999965
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=246.84 Aligned_cols=201 Identities=19% Similarity=0.225 Sum_probs=155.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++||||+++++++.++ ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 56 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 134 (281)
T 3cc6_A 56 NKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134 (281)
T ss_dssp HHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 346688899999999999999999998754 568999999999999987653 469999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 135 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp CCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987553321 23345678899999997655 7999999999999999998 888
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|+.+....+....+.. +.+++ .+...++...+++..|+..+|..||.
T Consensus 214 p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps 260 (281)
T 3cc6_A 214 PFFWLENKDVIGVLEK-GDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPR 260 (281)
T ss_dssp TTTTSCGGGHHHHHHH-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CcccCChHHHHHHHhc-CCCCC---CCCCCCHHHHHHHHHHccCCchhCcC
Confidence 8876666555444333 32221 23344455555555555555554443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=252.81 Aligned_cols=202 Identities=17% Similarity=0.247 Sum_probs=154.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++||||+++++++..+. .++|+|++.+|+|.+++.. ...+++..++.++.|++.||.|||++||+
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 139 (327)
T 3lzb_A 61 NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139 (327)
T ss_dssp HHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCc
Confidence 456778999999999999999999998765 7889999999999997754 45799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 140 H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~ 218 (327)
T 3lzb_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999987653322 22345677899999998765 8999999999999999999 777
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
|+.+....+.. ..+..+.+.+ .+...+.+..+++..|+..+|..||...
T Consensus 219 p~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ 267 (327)
T 3lzb_A 219 PYDGIPASEIS-SILEKGERLP---QPPICTIDVYMIMRKCWMIDADSRPKFR 267 (327)
T ss_dssp TTTTCCGGGHH-HHHHTTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCHHHHH-HHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 77666555544 4444444332 2344555666666666666666555433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=251.12 Aligned_cols=202 Identities=21% Similarity=0.279 Sum_probs=158.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+.+++.++||||+++++++.+. ..+++||||+++|+|.+++... .+++..++.++.|++.||.|||+.|
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ 154 (318)
T 3lxp_A 76 HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH 154 (318)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456688899999999999999999999984 6899999999999999998754 5999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
++|+||||+||+++.++.+||+|||++........ .....+|..|+|||.+.+.. ++.++|||||||++|+|++|
T Consensus 155 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g 233 (318)
T 3lxp_A 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTH 233 (318)
T ss_dssp EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999988764332 23456788899999998665 78999999999999999999
Q ss_pred CccCCCCchH--------------HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 171 GFIGLGNMGS--------------HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 171 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
..|+...... ......+..+.+.+ .+...+.++.+++..|+..+|..||.
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps 297 (318)
T 3lxp_A 234 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPT 297 (318)
T ss_dssp TCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcC
Confidence 8887654322 11222333333221 23344555555555665555554443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=245.17 Aligned_cols=199 Identities=20% Similarity=0.272 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+.+|+..++.++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|
T Consensus 48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 127 (267)
T 3t9t_A 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127 (267)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 46788999999999999999999999999999999999999999987654 57999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
+||+|+||+++.++.+||+|||++....... ......+++.|+|||.+.+.. ++.++||||+||++|+|++ |..|+
T Consensus 128 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp SSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCC
Confidence 9999999999999999999999987654321 112345678899999998655 7999999999999999999 67777
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.+....+....+... .+. ..+...+.+..+++-.|+..+|..||
T Consensus 207 ~~~~~~~~~~~i~~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 207 ENRSNSEVVEDISTG-FRL---YKPRLASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp TTCCHHHHHHHHHTT-CCC---CCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCHHHHHHHHhcC-CcC---CCCccCcHHHHHHHHHHccCChhhCc
Confidence 666666555544433 221 12223344444444555554444443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=257.03 Aligned_cols=210 Identities=22% Similarity=0.258 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHHHhC----CCCCcceeEEEEEeCCEEEEEEec-CCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSL----KHPNLVNLLEVFRRKKKLHLVFEF-CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~lv~e~-~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
....+.+|+..++.+ +||||+++++++...+..++|+|+ +.+++|.+++...+.+++..++.++.|++.||.|||
T Consensus 77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334456688888887 899999999999999999999999 789999999887778999999999999999999999
Q ss_pred HCCceecccCCCcEEEe-cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 92 RHACIHRDIKPENILLT-ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
+.|++|+||+|+||+++ .++.+||+|||++...... ......++..|+|||.+.+....+.++|||||||++|||++|
T Consensus 157 ~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 235 (312)
T 2iwi_A 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235 (312)
T ss_dssp HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHC
Confidence 99999999999999999 7899999999999876543 334567899999999988665445689999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..++.+... +.... .......++.+.+++.+|+.
T Consensus 236 ~~pf~~~~~------~~~~~----------------------------------------~~~~~~~~~~~~~li~~~l~ 269 (312)
T 2iwi_A 236 DIPFERDQE------ILEAE----------------------------------------LHFPAHVSPDCCALIRRCLA 269 (312)
T ss_dssp SCSCCSHHH------HHHTC----------------------------------------CCCCTTSCHHHHHHHHHHTC
T ss_pred CCCCCChHH------Hhhhc----------------------------------------cCCcccCCHHHHHHHHHHcc
Confidence 988764321 11100 00112234567788999988
Q ss_pred cccceeeccccccccccccceeeeeecCCc
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
.++..| +++.+++.|+|+..+..
T Consensus 270 ~~p~~R-------ps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 270 PKPSSR-------PSLEEILLDPWMQTPAE 292 (312)
T ss_dssp SSTTTS-------CCHHHHHHSTTTCC---
T ss_pred CChhhC-------cCHHHHhcChhhcCchh
Confidence 666555 99999999999887543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=247.82 Aligned_cols=201 Identities=22% Similarity=0.258 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|+
T Consensus 53 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 132 (288)
T 3kfa_A 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132 (288)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCc
Confidence 45678899999999999999999999999999999999999999998864 3469999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||||+||+++.++.++|+|||++........ .....+|+.|+|||.+.+.. ++.++||||+||++|+|++ |..
T Consensus 133 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~ 211 (288)
T 3kfa_A 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMS 211 (288)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987653322 23345678899999998665 7999999999999999999 666
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|+.+....+... .+....+.. .+...+.+..+++-.|+..+|..||.
T Consensus 212 p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 258 (288)
T 3kfa_A 212 PYPGIDLSQVYE-LLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPS 258 (288)
T ss_dssp SSTTCCGGGHHH-HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCHHHHHH-HHhccCCCC---CCCCCCHHHHHHHHHHhCCChhhCcC
Confidence 665555544433 334333322 22344555555555555555554443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=249.46 Aligned_cols=162 Identities=21% Similarity=0.313 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFR--RKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+.+.+|+.+++.++||||+++++++. ..+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.
T Consensus 67 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 146 (327)
T 3lxl_A 67 QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146 (327)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456889999999999999999999987 45679999999999999998865 34699999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|++|+||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 147 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~ 225 (327)
T 3lxl_A 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFT 225 (327)
T ss_dssp TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHh
Confidence 999999999999999999999999999987654332 23356788899999998765 7999999999999999999
Q ss_pred cCccCCCCch
Q psy763 170 IGFIGLGNMG 179 (303)
Q Consensus 170 g~~~~~~~~~ 179 (303)
|..|+.+...
T Consensus 226 g~~p~~~~~~ 235 (327)
T 3lxl_A 226 YCDKSCSPSA 235 (327)
T ss_dssp TTCGGGSHHH
T ss_pred CCCCCccccc
Confidence 9988766543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=275.52 Aligned_cols=237 Identities=22% Similarity=0.262 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe------CCEEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR------KKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGV 87 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l 87 (303)
....+.+|+.+++.++||||+++++++.. ++..++||||+++|+|.+++.... .+++..++.++.|++.||
T Consensus 55 ~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL 134 (676)
T 3qa8_A 55 NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134 (676)
T ss_dssp HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999765 667899999999999999887643 699999999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCc---EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 88 SYCHRHACIHRDIKPENILLTANGV---VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 88 ~~lH~~~ivH~dlk~~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
.|||+.||+||||+|+||+++.++. +||+|||++.............+|+.|+|||.+.+.. ++.++||||+||++
T Consensus 135 ~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviL 213 (676)
T 3qa8_A 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLA 213 (676)
T ss_dssp HHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHH
T ss_pred HHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHH
Confidence 9999999999999999999997654 9999999998876655556678999999999998765 89999999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHh
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKI 244 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dl 244 (303)
|+|++|..||.+.................... ...... ....|..... .........++.+.++
T Consensus 214 yeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~-~~~~l~---g~~~~~~~lp------------~p~~l~~~ls~~L~dL 277 (676)
T 3qa8_A 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIV-VYDDLT---GAVKFSSVLP------------TPNHLSGILAGKLERW 277 (676)
T ss_dssp HHHHSSCSSCCSSCHHHHSSTTCC------CC-SCCCCS---SSCCCCSSSC------------CSCCCCGGGHHHHHHH
T ss_pred HHHHHCCCCCCcccchhhhhhhhhcccchhhh-hhhhhc---cccccccccC------------CchhhchhhhHHHHHH
Confidence 99999999988765443221111111000000 000000 0000000000 0011122245677899
Q ss_pred hhhhhccccceeeccccccccccccceeeeeec
Q psy763 245 LGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 245 l~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+.+|+..+|..| +++.+++.||||..
T Consensus 278 I~~mL~~DP~kR-------PTa~elL~hp~F~~ 303 (676)
T 3qa8_A 278 LQCMLMWHQRQR-------GTDPQNPNVGCFQA 303 (676)
T ss_dssp HHHHSCSSCC----------CCTTCCCCTTHHH
T ss_pred HHHHccCCHhhC-------cCHHHHhcCHHHHH
Confidence 999999777666 99999999999866
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=244.12 Aligned_cols=200 Identities=21% Similarity=0.308 Sum_probs=158.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||+++++++. .+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|+
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 130 (279)
T 1qpc_A 52 PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130 (279)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 356788999999999999999999987 445899999999999999987543 69999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 131 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~ 209 (279)
T 1qpc_A 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRI 209 (279)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCC
T ss_pred eccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654322 22345678899999997655 7999999999999999999 677
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|+.+....+....+.. +.+. ..+...+.+..+++..|+..+|..||.
T Consensus 210 p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps 256 (279)
T 1qpc_A 210 PYPGMTNPEVIQNLER-GYRM---VRPDNCPEELYQLMRLCWKERPEDRPT 256 (279)
T ss_dssp SSTTCCHHHHHHHHHT-TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCcccCHHHHHHHHhc-ccCC---CCcccccHHHHHHHHHHhccChhhCCC
Confidence 7777666665554433 3222 123344556666666666655555543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=261.54 Aligned_cols=172 Identities=24% Similarity=0.389 Sum_probs=146.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK--KLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+.+++.++||||+++++++...+ ..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+
T Consensus 51 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 130 (396)
T 4eut_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130 (396)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345578999999999999999999998765 7899999999999999987643 39999999999999999999999
Q ss_pred CCceecccCCCcEEE----ecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCC-------ccCCCccchhhHH
Q psy763 93 HACIHRDIKPENILL----TANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD-------TLYGPAVDVWAIE 161 (303)
Q Consensus 93 ~~ivH~dlk~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-------~~~~~~~DvwSlG 161 (303)
.||+||||||+||++ +.++.+||+|||++.............||+.|+|||++.+. ..++.++||||||
T Consensus 131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG 210 (396)
T 4eut_A 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210 (396)
T ss_dssp TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHH
T ss_pred CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHH
Confidence 999999999999999 67778999999999887665555667899999999998641 3478899999999
Q ss_pred HHHHHhhccCccCCC----CchHHHHHHHhhc
Q psy763 162 WTSHSYSQIGFIGLG----NMGSHMARNLLKN 189 (303)
Q Consensus 162 ~il~el~tg~~~~~~----~~~~~~~~~~~~~ 189 (303)
|++|||++|..||.+ ....+.+..++..
T Consensus 211 ~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp HHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred HHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 999999999988864 2334555555544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=250.81 Aligned_cols=206 Identities=23% Similarity=0.289 Sum_probs=169.0
Q ss_pred HHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEecCCC-CcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 20 TEATNKKEKRSLK--HPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 20 ~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+|+.+++.++ ||||+++++++..++..++|+|++.+ ++|.+++...+.+++..++.++.|++.||.|||+.||+
T Consensus 92 ~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv 171 (320)
T 3a99_A 92 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 171 (320)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 3456788888886 59999999999999999999999986 89999888777899999999999999999999999999
Q ss_pred ecccCCCcEEEe-cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLT-ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+||+++ .++.+||+|||++...... ......+|+.|+|||.+.+...++.++|||||||++|||++|..|+.
T Consensus 172 H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 999999999999 6789999999999876543 33456799999999999876645789999999999999999988876
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+... ..... .......++++.+++.+|+..++..
T Consensus 251 ~~~~------~~~~~----------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~ 284 (320)
T 3a99_A 251 HDEE------IIRGQ----------------------------------------VFFRQRVSSECQHLIRWCLALRPSD 284 (320)
T ss_dssp SHHH------HHHCC----------------------------------------CCCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred Chhh------hhccc----------------------------------------ccccccCCHHHHHHHHHHccCChhh
Confidence 4321 11100 0011223566788999999866666
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
| +++.++++||||.+..
T Consensus 285 R-------ps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 285 R-------PTFEEIQNHPWMQDVL 301 (320)
T ss_dssp S-------CCHHHHHTSGGGSSCC
T ss_pred C-------cCHHHHhcCHhhcCcc
Confidence 6 9999999999997754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=241.87 Aligned_cols=199 Identities=16% Similarity=0.203 Sum_probs=154.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHA--C 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i 95 (303)
+.+.+|+.+++.++||||+++++++.+.. ++||||+++|+|.+.+. ....+++..+..++.|++.||.|||+.| +
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 56788999999999999999999987665 79999999999977654 4457999999999999999999999999 9
Q ss_pred eecccCCCcEEEecCCc-----EEEccccceeeeCCCCccccccCCCcccCcccccC-CccCCCccchhhHHHHHHHhhc
Q psy763 96 IHRDIKPENILLTANGV-----VKLCDFGFARLINPGENYTDYVATRWYRAPELLVG-DTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~DvwSlG~il~el~t 169 (303)
+|+||||+||+++.++. +||+|||++..... ......+|+.|+|||.+.+ ...++.++||||+||++|||++
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~ 223 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence 99999999999987776 99999999975432 3345679999999999853 3347899999999999999999
Q ss_pred cCccCCCCchHHH--HHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 170 IGFIGLGNMGSHM--ARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 170 g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
|..||.+...... .......+.++. .+...++++.+++..|+..+|..||..
T Consensus 224 g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~ 277 (287)
T 4f0f_A 224 GEGPFDEYSYGKIKFINMIREEGLRPT---IPEDCPPRLRNVIELCWSGDPKKRPHF 277 (287)
T ss_dssp SSCTTTTCCCCHHHHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCccccccHHHHHHHHhccCCCCC---CCcccCHHHHHHHHHHhcCChhhCcCH
Confidence 9998876654333 333333333321 223445555555555555555555433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=246.22 Aligned_cols=218 Identities=19% Similarity=0.215 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLK--HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
....+.+|+..++.++ ||||+++++++..++..++||| +.+++|.+++.....+++..+..++.|++.||.|||+.|
T Consensus 69 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 147 (313)
T 3cek_A 69 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147 (313)
T ss_dssp HHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999997 5999999999999999999999 667899998887788999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCC----------ccCCCccchhhHH
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGD----------TLYGPAVDVWAIE 161 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~----------~~~~~~~DvwSlG 161 (303)
++|+||||+||+++ ++.+||+|||++........ .....+++.|+|||.+.+. ..++.++||||||
T Consensus 148 ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG 226 (313)
T 3cek_A 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226 (313)
T ss_dssp CCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred ceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence 99999999999996 58999999999987653321 2345789999999998752 3478899999999
Q ss_pred HHHHHhhccCccCCCCchH-HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchh
Q psy763 162 WTSHSYSQIGFIGLGNMGS-HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHG 240 (303)
Q Consensus 162 ~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 240 (303)
|++|||++|..|+.+.... ............. ........+
T Consensus 227 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~ 268 (313)
T 3cek_A 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--------------------------------------EFPDIPEKD 268 (313)
T ss_dssp HHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC--------------------------------------CCCCCSCHH
T ss_pred HHHHHHHhCCCchhhHHHHHHHHHHHHhccccc--------------------------------------CCcccchHH
Confidence 9999999999888654322 2222221111110 111122456
Q ss_pred hHHhhhhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 241 VVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 241 ~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+.+++.+|+..+|..| +++.++++|||+......
T Consensus 269 l~~li~~~l~~dp~~R-------ps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 269 LQDVLKCCLKRDPKQR-------ISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp HHHHHHHHTCSSTTTS-------CCHHHHHTSHHHHCC---
T ss_pred HHHHHHHHccCCcccC-------cCHHHHhcCccccCCCCc
Confidence 7788999988666666 999999999999765443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=248.48 Aligned_cols=155 Identities=24% Similarity=0.230 Sum_probs=139.7
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHHHC--
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH----GLPWDLIKQITWQVLRGVSYCHRH-- 93 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~-- 93 (303)
.+.+|+.+++.++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.
T Consensus 73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 152 (326)
T 3uim_A 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152 (326)
T ss_dssp HHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57889999999999999999999999999999999999999999887543 499999999999999999999999
Q ss_pred -CceecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 -ACIHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 -~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+.. ++.++||||+||++|+|++|
T Consensus 153 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp SCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHC
T ss_pred CCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhC
Confidence 99999999999999999999999999998765332 234456999999999997665 79999999999999999999
Q ss_pred CccCC
Q psy763 171 GFIGL 175 (303)
Q Consensus 171 ~~~~~ 175 (303)
..|+.
T Consensus 232 ~~pf~ 236 (326)
T 3uim_A 232 QRAFD 236 (326)
T ss_dssp CCSBC
T ss_pred CCccc
Confidence 98875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=248.27 Aligned_cols=161 Identities=26% Similarity=0.301 Sum_probs=141.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
....+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.
T Consensus 73 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 152 (307)
T 2nru_A 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152 (307)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 355678899999999999999999999999999999999999999998763 34699999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++|+||||+||+++.++.+||+|||++........ .....||+.|+|||.+.+. ++.++|||||||++|+|++|
T Consensus 153 ~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHC
T ss_pred CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHC
Confidence 999999999999999999999999999987653221 2345789999999998753 69999999999999999999
Q ss_pred CccCCCCch
Q psy763 171 GFIGLGNMG 179 (303)
Q Consensus 171 ~~~~~~~~~ 179 (303)
..|+.+...
T Consensus 231 ~~p~~~~~~ 239 (307)
T 2nru_A 231 LPAVDEHRE 239 (307)
T ss_dssp CCSBCTTBS
T ss_pred CCCcccCcc
Confidence 988876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=243.48 Aligned_cols=202 Identities=14% Similarity=0.139 Sum_probs=154.4
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEE-EeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVF-RRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+|+.+++.++|++++..++.+ ..++..++||||+ +++|.+++. ....+++..+..++.|++.||.|||++|++|
T Consensus 50 ~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 128 (296)
T 3uzp_A 50 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128 (296)
T ss_dssp HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 467889999999988877666655 5677899999999 899999876 4568999999999999999999999999999
Q ss_pred cccCCCcEEE---ecCCcEEEccccceeeeCCCCc--------cccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 98 RDIKPENILL---TANGVVKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 98 ~dlk~~nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
|||||+||++ +.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++||
T Consensus 129 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMY 207 (296)
T ss_dssp SCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHH
Confidence 9999999999 4788999999999987654322 24467899999999998766 8999999999999999
Q ss_pred hhccCccCCCCch---HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 167 YSQIGFIGLGNMG---SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 167 l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|++|..||.+... .+....+.......+....+...+.+..+++..|+..+|..||.
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 267 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 267 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC
T ss_pred HHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCC
Confidence 9999999876422 22222222221111111122344556666666666666665554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=248.41 Aligned_cols=202 Identities=16% Similarity=0.175 Sum_probs=155.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-------CCCCHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-------HGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~ 89 (303)
....+.+|+.+++.++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.|
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 155 (327)
T 2yfx_A 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155 (327)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 3446778999999999999999999999999999999999999999988654 348999999999999999999
Q ss_pred HHHCCceecccCCCcEEEec---CCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 90 CHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 90 lH~~~ivH~dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
||+.|++||||||+||+++. +..+||+|||++....... ......+|+.|+|||.+.+.. ++.++|||||||+
T Consensus 156 LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i 234 (327)
T 2yfx_A 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVL 234 (327)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred HhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHH
Confidence 99999999999999999984 4569999999987543222 223356788999999997655 7999999999999
Q ss_pred HHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 164 SHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 164 l~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
+|+|++ |..|+.+....+.... +..+.++. .+...+.++.+++..|+..+|..||.
T Consensus 235 l~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 291 (327)
T 2yfx_A 235 LWEIFSLGYMPYPSKSNQEVLEF-VTSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPN 291 (327)
T ss_dssp HHHHHTTSCCSSTTCCHHHHHHH-HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHcCCCCCCCCcCHHHHHHH-HhcCCCCC---CCCCCCHHHHHHHHHHhcCChhhCcC
Confidence 999998 6666665555554443 33333322 22344455555555555555544443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=266.75 Aligned_cols=202 Identities=21% Similarity=0.278 Sum_probs=162.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++||||+++++++.+ +.+|+||||+++|+|.+++.. +..+++..+..++.||+.||.|||++||
T Consensus 306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 384 (535)
T 2h8h_A 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384 (535)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3567899999999999999999999876 678999999999999998864 2469999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+||||||+|||++.++.+||+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 385 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~ 463 (535)
T 2h8h_A 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRV 463 (535)
T ss_dssp CCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCC
T ss_pred eCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999997654321 112345678899999998655 8999999999999999999 667
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
|+.+....+.... +..+.+++ .+..++.++.+++..||..++..||.+.
T Consensus 464 P~~~~~~~~~~~~-i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ 512 (535)
T 2h8h_A 464 PYPGMVNREVLDQ-VERGYRMP---CPPECPESLHDLMCQCWRKEPEERPTFE 512 (535)
T ss_dssp SSTTCCHHHHHHH-HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCHHHHHHH-HHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 7666666555544 44444432 2345566777777777777776666543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=242.67 Aligned_cols=203 Identities=14% Similarity=0.148 Sum_probs=155.3
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEE-EeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVF-RRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+|+.+++.++|++++..++.+ ..++..++||||+ +++|.+++. ....+++..+..++.|++.||.|||+.||+|
T Consensus 50 ~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 128 (296)
T 4hgt_A 50 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128 (296)
T ss_dssp CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 467788999999988877766665 6778899999999 899998876 3567999999999999999999999999999
Q ss_pred cccCCCcEEE---ecCCcEEEccccceeeeCCCCc--------cccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 98 RDIKPENILL---TANGVVKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 98 ~dlk~~nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
|||||+||++ +.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++|+
T Consensus 129 ~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMY 207 (296)
T ss_dssp SCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHH
T ss_pred CCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHH
Confidence 9999999999 7889999999999987654322 23467899999999998766 8999999999999999
Q ss_pred hhccCccCCCCchH---HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 167 YSQIGFIGLGNMGS---HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 167 l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
|++|..||.+.... +....+.......+........+.+..+++..|+..+|..||..
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 268 (296)
T 4hgt_A 208 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 268 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred HhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCH
Confidence 99999998764321 22222222221111111223445566666666666666655543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=246.65 Aligned_cols=201 Identities=16% Similarity=0.212 Sum_probs=157.6
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+.+|+..++.++||||+++++++...+..++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++|+
T Consensus 75 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~ 154 (319)
T 2y4i_B 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154 (319)
T ss_dssp CCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 45678889999999999999999999999999999999999999987654 79999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCC------CCccccccCCCcccCcccccC--------CccCCCccchhhHHHHH
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINP------GENYTDYVATRWYRAPELLVG--------DTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~l~~--------~~~~~~~~DvwSlG~il 164 (303)
||||+||+++ ++.+||+|||++..... ........|++.|+|||.+.+ ...++.++|||||||++
T Consensus 155 dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp CCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred CCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 9999999998 67999999999766431 112233468899999999875 23378899999999999
Q ss_pred HHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHH
Q psy763 165 HSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIF 224 (303)
Q Consensus 165 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (303)
|||++|..|+.+.........+... ..+. ......+.++.+++..|+..+|..||..
T Consensus 234 ~el~~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 290 (319)
T 2y4i_B 234 YELHAREWPFKTQPAEAIIWQMGTG-MKPN--LSQIGMGKEISDILLFCWAFEQEERPTF 290 (319)
T ss_dssp HHHHHSSCSSSSCCHHHHHHHHHTT-CCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCH
T ss_pred HHHHhCCCCCCCCCHHHHHHHhccC-CCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999999998887776665554433 2221 1222445566666666666666655543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=244.95 Aligned_cols=148 Identities=24% Similarity=0.328 Sum_probs=126.1
Q ss_pred HHHHHHHHh--CCCCCcceeEEEEEeC----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----
Q psy763 22 ATNKKEKRS--LKHPNLVNLLEVFRRK----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH---- 91 (303)
Q Consensus 22 ~~e~~~l~~--l~h~niv~~~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---- 91 (303)
.+|.+++.. ++||||+++++++... ...++||||+++|+|.+++.. ..+++..+..++.|++.||.|||
T Consensus 48 ~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ 126 (301)
T 3q4u_A 48 FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIF 126 (301)
T ss_dssp HHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBC
T ss_pred HHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhh
Confidence 344455544 8999999999997643 468999999999999999864 57999999999999999999999
Q ss_pred ----HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCc-----cCCCccch
Q psy763 92 ----RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDT-----LYGPAVDV 157 (303)
Q Consensus 92 ----~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~-----~~~~~~Dv 157 (303)
+.||+||||||+||+++.++.+||+|||++........ .....||+.|+|||.+.+.. .++.++||
T Consensus 127 ~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv 206 (301)
T 3q4u_A 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206 (301)
T ss_dssp STTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred hccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence 99999999999999999999999999999987654332 23347999999999998653 24579999
Q ss_pred hhHHHHHHHhhcc
Q psy763 158 WAIEWTSHSYSQI 170 (303)
Q Consensus 158 wSlG~il~el~tg 170 (303)
|||||++|||++|
T Consensus 207 wslG~il~el~tg 219 (301)
T 3q4u_A 207 WAFGLVLWEVARR 219 (301)
T ss_dssp HHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhh
Confidence 9999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=244.21 Aligned_cols=198 Identities=17% Similarity=0.209 Sum_probs=148.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
.+.+.+|+..++.++||||+++++++... +..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 137 (278)
T 1byg_A 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137 (278)
T ss_dssp -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678899999999999999999997654 47899999999999999886543 3899999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCcc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFI 173 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~ 173 (303)
++|+||||+||+++.++.+||+|||++...... .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..|
T Consensus 138 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p 214 (278)
T 1byg_A 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVP 214 (278)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccCCCcceEEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999998765432 23346788999999997655 7999999999999999998 7777
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
+.+....+....+ ..+.++ ..+...+++..+++..|+..+|..||
T Consensus 215 ~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp 259 (278)
T 1byg_A 215 YPRIPLKDVVPRV-EKGYKM---DAPDGCPPAVYEVMKNCWHLDAAMRP 259 (278)
T ss_dssp CTTSCGGGHHHHH-TTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCHHHHHHHH-hcCCCC---CCcccCCHHHHHHHHHHhcCChhhCC
Confidence 6665555444433 333222 12234455555555555555555444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=251.35 Aligned_cols=158 Identities=16% Similarity=0.146 Sum_probs=138.4
Q ss_pred HHHHHHHHHHHhCCCCCcce---------------eEEEEEe-CCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVN---------------LLEVFRR-KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQIT 80 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~---------------~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~ 80 (303)
..+.+|+.+++.++||||++ +++++.. ++..++||||+ +++|.+++... ..+++..++.++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 35678899999999999887 6788876 67899999999 89999998765 689999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCC--cEEEccccceeeeCCCC--------ccccccCCCcccCcccccCCcc
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANG--VVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGDTL 150 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~ 150 (303)
.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ......||+.|+|||.+.+..
T Consensus 166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~- 244 (352)
T 2jii_A 166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG- 244 (352)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-
Confidence 9999999999999999999999999999988 89999999997754321 113357899999999998765
Q ss_pred CCCccchhhHHHHHHHhhccCccCCCCc
Q psy763 151 YGPAVDVWAIEWTSHSYSQIGFIGLGNM 178 (303)
Q Consensus 151 ~~~~~DvwSlG~il~el~tg~~~~~~~~ 178 (303)
++.++|||||||++|||++|..||.+..
T Consensus 245 ~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 245 PSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 8999999999999999999998887764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=243.69 Aligned_cols=198 Identities=24% Similarity=0.261 Sum_probs=147.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHH--
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHR-- 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~-- 92 (303)
...+.+|+..++.++||||+++++++.+ ..++||||+++|+|.+++.... .++...+..++.|++.||.|||+
T Consensus 45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 122 (307)
T 2eva_A 45 RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122 (307)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4567889999999999999999998763 4799999999999999987654 47899999999999999999999
Q ss_pred -CCceecccCCCcEEEecCCc-EEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 93 -HACIHRDIKPENILLTANGV-VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 93 -~~ivH~dlk~~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
+|++||||||+||+++.++. +||+|||++...... .....||+.|+|||.+.+.. ++.++|||||||++|||++|
T Consensus 123 ~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g 199 (307)
T 2eva_A 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITR 199 (307)
T ss_dssp SSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHT
T ss_pred CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHC
Confidence 89999999999999998876 799999998765432 23456899999999998765 89999999999999999999
Q ss_pred CccCCCCchHH-HHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHH
Q psy763 171 GFIGLGNMGSH-MARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTI 223 (303)
Q Consensus 171 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
..|+.+..... ........+.+++ .+...+.+..+++..|+..+|..||.
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps 250 (307)
T 2eva_A 200 RKPFDEIGGPAFRIMWAVHNGTRPP---LIKNLPKPIESLMTRCWSKDPSQRPS 250 (307)
T ss_dssp CCTTTTTCSSHHHHHHHHHTTCCCC---CBTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCchhhCccHHHHHHHHhcCCCCC---cccccCHHHHHHHHHHhcCChhhCcC
Confidence 98886543221 1222222222221 12344555566666666655555543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.53 Aligned_cols=203 Identities=19% Similarity=0.270 Sum_probs=160.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++||||+++++++. ++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||
T Consensus 434 ~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 512 (656)
T 2j0j_A 434 VREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512 (656)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4467889999999999999999999985 45689999999999999988644 479999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc--ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+||||||+|||++.++.+||+|||++......... ....+|+.|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 513 vHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~ 591 (656)
T 2j0j_A 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVK 591 (656)
T ss_dssp CCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876543221 2345678899999997655 8999999999999999997 677
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
||.+....+....+... .+++ .+..++++..+++..|+..+|..||...
T Consensus 592 Pf~~~~~~~~~~~i~~~-~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~ 640 (656)
T 2j0j_A 592 PFQGVKNNDVIGRIENG-ERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFT 640 (656)
T ss_dssp TTTTCCHHHHHHHHHHT-CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCHHHHHHHHHcC-CCCC---CCccccHHHHHHHHHHcCCChhHCcCHH
Confidence 77777666665555443 3322 2345566666666677766666555433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.68 Aligned_cols=159 Identities=22% Similarity=0.292 Sum_probs=137.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK--KLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+.+.+|+.+++.++||||+++++++...+ .+++||||+++++|.+++... ..+++..++.++.|++.||.|||+.
T Consensus 85 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 164 (326)
T 2w1i_A 85 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164 (326)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456789999999999999999999987544 689999999999999987654 4699999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|++|+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 165 ~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t 243 (326)
T 2w1i_A 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 243 (326)
T ss_dssp TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHH
T ss_pred CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999988654322 22345677899999998665 7999999999999999999
Q ss_pred cCccCCC
Q psy763 170 IGFIGLG 176 (303)
Q Consensus 170 g~~~~~~ 176 (303)
|..++..
T Consensus 244 g~~~~~~ 250 (326)
T 2w1i_A 244 YIEKSKS 250 (326)
T ss_dssp TTCGGGS
T ss_pred cCCCCCC
Confidence 9877654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=244.59 Aligned_cols=154 Identities=23% Similarity=0.298 Sum_probs=128.3
Q ss_pred HHHHHHHhCCCCCcceeEEEEEe-----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----
Q psy763 23 TNKKEKRSLKHPNLVNLLEVFRR-----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH---- 93 (303)
Q Consensus 23 ~e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---- 93 (303)
.++..++.++||||+++++.+.. ...+++||||+++|+|.+++... ..++..+..++.|++.||.|||+.
T Consensus 56 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 134 (336)
T 3g2f_A 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRG 134 (336)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCG
T ss_pred HHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccc
Confidence 44445566899999999987653 23679999999999999988654 568999999999999999999999
Q ss_pred -----CceecccCCCcEEEecCCcEEEccccceeeeCCCC---------ccccccCCCcccCcccccCC------ccCCC
Q psy763 94 -----ACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---------NYTDYVATRWYRAPELLVGD------TLYGP 153 (303)
Q Consensus 94 -----~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~l~~~------~~~~~ 153 (303)
||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+. ..++.
T Consensus 135 ~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp GGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred cccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence 99999999999999999999999999998764321 12245799999999999862 23678
Q ss_pred ccchhhHHHHHHHhhccCccCCCC
Q psy763 154 AVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 154 ~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
++|||||||++|||++|..+++..
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred ccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999999999998776643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-33 Score=243.98 Aligned_cols=160 Identities=24% Similarity=0.276 Sum_probs=136.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~ 88 (303)
....+.+|+.+++.++||||+++++++.. ....++|+||+++|+|.+++.. +..+++..++.++.|++.||.
T Consensus 69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~ 148 (317)
T 2buj_A 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148 (317)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999973 3478999999999999987753 568999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc----------cccccCCCcccCcccccCCc--cCCCccc
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----------YTDYVATRWYRAPELLVGDT--LYGPAVD 156 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~l~~~~--~~~~~~D 156 (303)
|||+.|++|+||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. .++.++|
T Consensus 149 ~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 228 (317)
T 2buj_A 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228 (317)
T ss_dssp HHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH
T ss_pred HHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhh
Confidence 99999999999999999999999999999999876432111 12345799999999987543 3689999
Q ss_pred hhhHHHHHHHhhccCccCCC
Q psy763 157 VWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 157 vwSlG~il~el~tg~~~~~~ 176 (303)
||||||++|||++|..|+.+
T Consensus 229 i~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 229 VWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp HHHHHHHHHHHHHSSCTTHH
T ss_pred HHHHHHHHHHHHhCCCChhh
Confidence 99999999999999988753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=241.53 Aligned_cols=144 Identities=20% Similarity=0.325 Sum_probs=123.2
Q ss_pred HHHHhCCCCCcceeEEEEEeC----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------
Q psy763 26 KEKRSLKHPNLVNLLEVFRRK----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-------- 93 (303)
Q Consensus 26 ~~l~~l~h~niv~~~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-------- 93 (303)
.....++||||+++++++... ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.
T Consensus 83 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 161 (337)
T 3mdy_A 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161 (337)
T ss_dssp HTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred HHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 333445999999999999987 7899999999999999998654 799999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCCcc-----ccccCCCcccCcccccCCccCCCc------cchhhHHH
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-----TDYVATRWYRAPELLVGDTLYGPA------VDVWAIEW 162 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~l~~~~~~~~~------~DvwSlG~ 162 (303)
||+||||||+||+++.++.+||+|||++......... ....||+.|+|||++.+.. ++.. +|||||||
T Consensus 162 ~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp CEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHH
T ss_pred CEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHH
Confidence 9999999999999999999999999999776433221 2457999999999998655 3443 99999999
Q ss_pred HHHHhhccC
Q psy763 163 TSHSYSQIG 171 (303)
Q Consensus 163 il~el~tg~ 171 (303)
++|||++|.
T Consensus 241 il~el~tg~ 249 (337)
T 3mdy_A 241 ILWEVARRC 249 (337)
T ss_dssp HHHHHHTTB
T ss_pred HHHHHHhcc
Confidence 999999993
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=240.00 Aligned_cols=150 Identities=22% Similarity=0.334 Sum_probs=130.5
Q ss_pred HHHHHHHHHHh--CCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--
Q psy763 20 TEATNKKEKRS--LKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-- 91 (303)
Q Consensus 20 ~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-- 91 (303)
.+.+|+++++. ++||||+++++++.... ..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||
T Consensus 80 ~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~ 158 (342)
T 1b6c_B 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHME 158 (342)
T ss_dssp HHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHH
Confidence 45566777776 79999999999999876 79999999999999999875 47999999999999999999999
Q ss_pred ------HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCcc-----CCCcc
Q psy763 92 ------RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTL-----YGPAV 155 (303)
Q Consensus 92 ------~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~-----~~~~~ 155 (303)
+.|++||||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+... ++.++
T Consensus 159 ~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 238 (342)
T 1b6c_B 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238 (342)
T ss_dssp BCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHH
T ss_pred HhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcc
Confidence 89999999999999999999999999999987654432 244578999999999986532 33689
Q ss_pred chhhHHHHHHHhhcc
Q psy763 156 DVWAIEWTSHSYSQI 170 (303)
Q Consensus 156 DvwSlG~il~el~tg 170 (303)
|||||||++|||++|
T Consensus 239 Di~slG~il~el~tg 253 (342)
T 1b6c_B 239 DIYAMGLVFWEIARR 253 (342)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhc
Confidence 999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=241.00 Aligned_cols=164 Identities=28% Similarity=0.397 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeEEEEEe--------CCEEEEEEecCCCCcHHHHHc---CCCCCCHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLK-HPNLVNLLEVFRR--------KKKLHLVFEFCDHTVLNELEN---HPHGLPWDLIKQITWQVL 84 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--------~~~~~lv~e~~~~~~l~~~~~---~~~~l~~~~~~~~~~qi~ 84 (303)
....+.+|+..++.+. ||||+++++++.. ...+++|+||++ |+|.+++. ..+.+++..++.++.|++
T Consensus 68 ~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~ 146 (337)
T 3ll6_A 68 KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTC 146 (337)
T ss_dssp HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHH
Confidence 3456778888999986 9999999999953 345899999997 66666553 355799999999999999
Q ss_pred HHHHHHHHCC--ceecccCCCcEEEecCCcEEEccccceeeeCCCCcc-------------ccccCCCcccCccccc--C
Q psy763 85 RGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-------------TDYVATRWYRAPELLV--G 147 (303)
Q Consensus 85 ~~l~~lH~~~--ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~l~--~ 147 (303)
.||.|||+.| ++|+||||+||+++.++.+||+|||++......... ....+|+.|+|||++. .
T Consensus 147 ~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 226 (337)
T 3ll6_A 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226 (337)
T ss_dssp HHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCT
T ss_pred HHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc
Confidence 9999999999 999999999999999999999999999876533221 1346899999999984 2
Q ss_pred CccCCCccchhhHHHHHHHhhccCccCCCCchHH
Q psy763 148 DTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSH 181 (303)
Q Consensus 148 ~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~ 181 (303)
...++.++|||||||++|+|++|..|+.+.....
T Consensus 227 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 227 NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp TSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 3337889999999999999999999987654433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.58 Aligned_cols=204 Identities=16% Similarity=0.150 Sum_probs=157.9
Q ss_pred HHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 20 TEATNKKEKRSLKH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 20 ~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+|+.+++.++| +++..+..++...+..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|
T Consensus 48 ~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 126 (483)
T 3sv0_A 48 QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126 (483)
T ss_dssp CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 35678889999987 55666666777888999999999 8899998763 568999999999999999999999999999
Q ss_pred cccCCCcEEE---ecCCcEEEccccceeeeCCCCc--------cccccCCCcccCcccccCCccCCCccchhhHHHHHHH
Q psy763 98 RDIKPENILL---TANGVVKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 98 ~dlk~~nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~e 166 (303)
|||||+|||+ +.++.+||+|||++........ .....||+.|+|||.+.+.. ++.++|||||||++||
T Consensus 127 rDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~e 205 (483)
T 3sv0_A 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMY 205 (483)
T ss_dssp CCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHH
T ss_pred cccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHH
Confidence 9999999999 5789999999999988654322 12567999999999998766 8999999999999999
Q ss_pred hhccCccCCCCch---HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 167 YSQIGFIGLGNMG---SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 167 l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
|++|..||.+... .+....+............+..++.++.+++..|+..++..||...
T Consensus 206 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~ 267 (483)
T 3sv0_A 206 FLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYS 267 (483)
T ss_dssp HHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHH
Confidence 9999999877533 2333333222111111112245566777777777777777666443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-33 Score=248.74 Aligned_cols=149 Identities=18% Similarity=0.148 Sum_probs=121.7
Q ss_pred HHHHHHHHHHhCC---------CCCcceeEEEEE------------------------------eCCEEEEEEecCCCCc
Q psy763 20 TEATNKKEKRSLK---------HPNLVNLLEVFR------------------------------RKKKLHLVFEFCDHTV 60 (303)
Q Consensus 20 ~~~~e~~~l~~l~---------h~niv~~~~~~~------------------------------~~~~~~lv~e~~~~~~ 60 (303)
.+.+|+.+++.++ ||||+++.+++. ..+.+|+||||+++|+
T Consensus 69 ~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ 148 (336)
T 2vuw_A 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGI 148 (336)
T ss_dssp HHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCE
T ss_pred HHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCc
Confidence 3455566655554 888888887754 2678999999999886
Q ss_pred HHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCCCcEEEecCC--------------------cEEEcccc
Q psy763 61 LNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLTANG--------------------VVKLCDFG 119 (303)
Q Consensus 61 l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlk~~nil~~~~~--------------------~~kl~dfg 119 (303)
+...+.+ +.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 149 ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG 227 (336)
T 2vuw_A 149 DLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227 (336)
T ss_dssp ETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCT
T ss_pred cHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecc
Confidence 5554433 57899999999999999999999 99999999999999999887 89999999
Q ss_pred ceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHH-HHHhhccCccCC
Q psy763 120 FARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT-SHSYSQIGFIGL 175 (303)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i-l~el~tg~~~~~ 175 (303)
+|...... ...||+.|+|||++.+.. +.++||||+|++ .+++++|..|+.
T Consensus 228 ~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 228 LSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccEecCCC----cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCc
Confidence 99876542 347999999999998765 889999998877 666777766653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=233.22 Aligned_cols=197 Identities=21% Similarity=0.240 Sum_probs=148.2
Q ss_pred HHHHHHHH-HhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 21 EATNKKEK-RSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 21 ~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+|+..+ +..+||||+++++++.. ...+++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.
T Consensus 57 ~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (299)
T 3m2w_A 57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136 (299)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 44566655 77799999999999987 67899999999999999988654 3699999999999999999999999
Q ss_pred CceecccCCCcEEEec---CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 ACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++||||||+||+++. ++.+||+|||++..... ..++.++||||+||++|||++|
T Consensus 137 ~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg 194 (299)
T 3m2w_A 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCG 194 (299)
T ss_dssp TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHS
T ss_pred CcccCCCCHHHEEEecCCCCCcEEEecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999998 78899999999865321 2368899999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+............. ........+.... ...++++.+++.+|+.
T Consensus 195 ~~pf~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~ 242 (299)
T 3m2w_A 195 YPPFYSNHGLAISPGMKTR------------------------IRMGQYEFPNPEW--------SEVSEEVKMLIRNLLK 242 (299)
T ss_dssp SCSCCC-------CCSCCS------------------------SCTTCCSSCHHHH--------TTSCHHHHHHHHHHTC
T ss_pred CCCCCCCcchhhhHHHHHH------------------------HhhccccCCchhc--------ccCCHHHHHHHHHHcc
Confidence 9988765433221100000 0000000000000 1245678899999998
Q ss_pred cccceeeccccccccccccceeeeeecC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.+|..| +++.++++|||+...
T Consensus 243 ~dP~~R-------ps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 243 TEPTQR-------MTITEFMNHPWIMQS 263 (299)
T ss_dssp SSTTTS-------CCHHHHHTSHHHHTG
T ss_pred cChhhC-------CCHHHHhcChhhccc
Confidence 666666 999999999999764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=257.79 Aligned_cols=152 Identities=15% Similarity=0.079 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 15 AIRQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 15 ~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
....+.+.+|+++|+++ .|+||+++++++++++.+||||||++|++|.+++.+++++++. .++.||+.||.|+|++
T Consensus 282 ~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~ 358 (569)
T 4azs_A 282 QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ 358 (569)
T ss_dssp HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC
Confidence 34566789999999999 6999999999999999999999999999999999998889875 4789999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
||+||||||+|||++.+|.+||+|||+|+..... ....+.+||+.|+|||++.+. +..++|+||+|++++++.++.
T Consensus 359 GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 359 GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence 9999999999999999999999999999876533 334557899999999999865 577899999999999886554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=256.55 Aligned_cols=152 Identities=24% Similarity=0.314 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-----EEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
....+.+|+.+++.++||||+++++++...+. .|+||||+++++|..++.. .+++..+..++.|++.||.|||
T Consensus 122 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH 199 (681)
T 2pzi_A 122 AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH 199 (681)
T ss_dssp HHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999987654 7999999999999987764 7999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++||+||||||+||+++.+ .+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.
T Consensus 200 ~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~ 273 (681)
T 2pzi_A 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDL 273 (681)
T ss_dssp HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCC
T ss_pred HCCCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCC
Confidence 9999999999999999875 8999999999876543 446799999999998754 488999999999999999987
Q ss_pred ccCCC
Q psy763 172 FIGLG 176 (303)
Q Consensus 172 ~~~~~ 176 (303)
.++.+
T Consensus 274 ~~~~~ 278 (681)
T 2pzi_A 274 PTRNG 278 (681)
T ss_dssp CEETT
T ss_pred CCCcc
Confidence 66654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=222.51 Aligned_cols=134 Identities=12% Similarity=0.023 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+..++.++||||+++++++..++..|+||||+++++|.+++..+ .....+..++.|++.||.|||++||+
T Consensus 74 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~giv 151 (286)
T 3uqc_A 74 VLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVA 151 (286)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCc
Confidence 4466788899999999999999999999999999999999999999998653 46677899999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+||+++.++.+||+++| |++ .++.++|||||||++|||++|..||.+
T Consensus 152 H~Dikp~NIll~~~g~~kl~~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 152 LSIDHPSRVRVSIDGDVVLAYPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp CCCCSGGGEEEETTSCEEECSCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred cCCCCcccEEEcCCCCEEEEecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99999999999999999998543 222 268999999999999999999999887
Q ss_pred Cch
Q psy763 177 NMG 179 (303)
Q Consensus 177 ~~~ 179 (303)
...
T Consensus 205 ~~~ 207 (286)
T 3uqc_A 205 AGV 207 (286)
T ss_dssp CSB
T ss_pred CCc
Confidence 654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=235.58 Aligned_cols=205 Identities=17% Similarity=0.107 Sum_probs=146.0
Q ss_pred HHHHHHHHHHHHhCCC-CCc---------ce------------eEEEEEe-----CCEEEEEEecCCCCcHHHHHc----
Q psy763 18 QATEATNKKEKRSLKH-PNL---------VN------------LLEVFRR-----KKKLHLVFEFCDHTVLNELEN---- 66 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h-~ni---------v~------------~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~---- 66 (303)
.+.+.+|+..++.++| +|. +. +..++.. ...++++++.+. ++|.+++.
T Consensus 122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~ 200 (413)
T 3dzo_A 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLS 200 (413)
T ss_dssp CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhc
Confidence 4557888999999987 221 11 1111111 123577777664 78888763
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcc
Q psy763 67 ---HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPE 143 (303)
Q Consensus 67 ---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 143 (303)
.+..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......| +.|+|||
T Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE 277 (413)
T 3dzo_A 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPE 277 (413)
T ss_dssp HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHH
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCC--ccccCCC-CceeCch
Confidence 133578889999999999999999999999999999999999999999999999877443 2445577 9999999
Q ss_pred ccc---------CCccCCCccchhhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhh
Q psy763 144 LLV---------GDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEI 214 (303)
Q Consensus 144 ~l~---------~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (303)
++. ....++.++|||||||++|||++|..||.+....+... ..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------------------~~ 329 (413)
T 3dzo_A 278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE----------------------------WI 329 (413)
T ss_dssp HHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------------------GG
T ss_pred hhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------------------HH
Confidence 993 33347889999999999999999998887654221110 00
Q ss_pred hcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 215 FSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 215 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+. .....++++.+++.+|+..+|..| +++.++++||||..
T Consensus 330 ~~----------------~~~~~~~~~~~li~~~l~~dP~~R-------pt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 330 FR----------------SCKNIPQPVRALLEGFLRYPKEDR-------LLPLQAMETPEYEQ 369 (413)
T ss_dssp GS----------------SCCCCCHHHHHHHHHHTCSSGGGS-------CCHHHHTTSHHHHH
T ss_pred Hh----------------hcccCCHHHHHHHHHHccCChhhC-------cCHHHHHhCHHHHH
Confidence 00 001234567788888887666555 88888888888754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.4e-25 Score=207.21 Aligned_cols=151 Identities=15% Similarity=0.230 Sum_probs=125.7
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHH
Q psy763 9 SSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88 (303)
Q Consensus 9 ~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~ 88 (303)
..........+.+.+|+++++.++||||+++..++...+..|+||||+++++|.+++.. +..++.|++.||.
T Consensus 374 ~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~ 445 (540)
T 3en9_A 374 DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVG 445 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHH
T ss_pred chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHH
Confidence 34445555677889999999999999999666666677778999999999999999875 5689999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc--------cccccCCCcccCcccccC--CccCCCccchh
Q psy763 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--------YTDYVATRWYRAPELLVG--DTLYGPAVDVW 158 (303)
Q Consensus 89 ~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~l~~--~~~~~~~~Dvw 158 (303)
|||++||+||||||+|||++. .+||+|||+++....... .....||+.|+|||++.+ .. |+..+|+|
T Consensus 446 ~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~-Y~~~~d~w 522 (540)
T 3en9_A 446 KLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEG-YKSVYDRW 522 (540)
T ss_dssp HHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHH-HHHHCTTH
T ss_pred HHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHH-HHHHHhHH
Confidence 999999999999999999998 999999999998754322 135689999999999975 33 78889999
Q ss_pred hHHHHHHHhhcc
Q psy763 159 AIEWTSHSYSQI 170 (303)
Q Consensus 159 SlG~il~el~tg 170 (303)
|.++-..+-..+
T Consensus 523 s~vl~~l~~v~~ 534 (540)
T 3en9_A 523 EIILELMKDVER 534 (540)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHh
Confidence 987777665443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=150.65 Aligned_cols=106 Identities=14% Similarity=0.155 Sum_probs=87.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++ | +++.+++.. +..|+||||++|++|.. +.. .....++.|++.||.|||+.||+
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~gii 215 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIV 215 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCE
Confidence 4567889999999999 4 666665544 44699999999999988 422 23457999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCccccc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLV 146 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~ 146 (303)
||||||+||+++ ++.+||+|||+|... ..+.|||.+.
T Consensus 216 HrDlkp~NILl~-~~~vkl~DFG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 216 HGDLSQYNVLVS-EEGIWIIDFPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp CSCCSTTSEEEE-TTEEEECCCTTCEET------------TSTTHHHHHH
T ss_pred eCCCCHHHEEEE-CCcEEEEECCCCeEC------------CCCCHHHHHH
Confidence 999999999999 999999999998642 3357888875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=8.7e-15 Score=125.20 Aligned_cols=99 Identities=20% Similarity=0.154 Sum_probs=78.2
Q ss_pred HHHHHHHHHHHHHhCCCCCc--ceeEEEEEeCCEEEEEEecCCC-C----cHHHHHcCCCCCCHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNL--VNLLEVFRRKKKLHLVFEFCDH-T----VLNELENHPHGLPWDLIKQITWQVLRGVSY 89 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~ 89 (303)
....+.+|+..++.+.|+++ +.+++. +..++||||+.+ | +|..+... .++..+..++.|++.||.+
T Consensus 113 ~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 113 VFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHH
Confidence 44567889999999988864 444442 245899999942 3 66665432 2345678899999999999
Q ss_pred HH-HCCceecccCCCcEEEecCCcEEEccccceeee
Q psy763 90 CH-RHACIHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 90 lH-~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
|| +.||+||||||+|||++. .++|+|||+|...
T Consensus 186 lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 186 LYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99 999999999999999988 9999999999763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.23 E-value=2.5e-11 Score=108.84 Aligned_cols=97 Identities=11% Similarity=0.099 Sum_probs=71.6
Q ss_pred HHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy763 20 TEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 99 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 99 (303)
...+|...+.++.+.++.-..-+.... .++||||++|+.+..+... .....++.|++.+|.+||+.||||||
T Consensus 159 ~A~kE~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrD 230 (397)
T 4gyi_A 159 AAIKEFAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGD 230 (397)
T ss_dssp HHHHHHHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 345677777777655543222122222 3799999999888765432 23456789999999999999999999
Q ss_pred cCCCcEEEecCC----------cEEEccccceeee
Q psy763 100 IKPENILLTANG----------VVKLCDFGFARLI 124 (303)
Q Consensus 100 lk~~nil~~~~~----------~~kl~dfg~~~~~ 124 (303)
|||.|||++.++ .+.|+||+-+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998776 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=1.5e-09 Score=92.44 Aligned_cols=99 Identities=16% Similarity=0.104 Sum_probs=80.1
Q ss_pred HHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH------
Q psy763 20 TEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR------ 92 (303)
Q Consensus 20 ~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~------ 92 (303)
.+.+|+..++.+. +..+.++++++...+..|+|||+++|.++..... +......++.+++.+++.||+
T Consensus 55 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~ 129 (263)
T 3tm0_A 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDC 129 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTC
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccC
Confidence 4677788888774 6778899999999999999999999999987632 112234788999999999998
Q ss_pred -----------------------------------------------------CCceecccCCCcEEEecCCcEEEcccc
Q psy763 93 -----------------------------------------------------HACIHRDIKPENILLTANGVVKLCDFG 119 (303)
Q Consensus 93 -----------------------------------------------------~~ivH~dlk~~nil~~~~~~~kl~dfg 119 (303)
.+++|+|++|.||+++.+..+.|+||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe 209 (263)
T 3tm0_A 130 PYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG 209 (263)
T ss_dssp SCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCT
T ss_pred CCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEch
Confidence 448999999999999876566799998
Q ss_pred ceee
Q psy763 120 FARL 123 (303)
Q Consensus 120 ~~~~ 123 (303)
.+..
T Consensus 210 ~a~~ 213 (263)
T 3tm0_A 210 RSGR 213 (263)
T ss_dssp TCEE
T ss_pred hccc
Confidence 7643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.81 E-value=1.3e-08 Score=86.08 Aligned_cols=96 Identities=14% Similarity=0.069 Sum_probs=73.5
Q ss_pred HHHHHHHHHHhCCCCC--cceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Q psy763 20 TEATNKKEKRSLKHPN--LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--- 94 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--- 94 (303)
.+.+|+..++.+.+.+ +.+++++...++..++|||+++|.++. .. ..+ ...++.+++..+..||+..
T Consensus 59 ~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~ 130 (264)
T 1nd4_A 59 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPAT 130 (264)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGG
T ss_pred hhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCC
Confidence 3566777777775444 567899888888899999999998884 22 122 2356778888888888753
Q ss_pred -------------------------------------------------------ceecccCCCcEEEecCCcEEEcccc
Q psy763 95 -------------------------------------------------------CIHRDIKPENILLTANGVVKLCDFG 119 (303)
Q Consensus 95 -------------------------------------------------------ivH~dlk~~nil~~~~~~~kl~dfg 119 (303)
++|+|++|.||+++.++.+.|+|||
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~ 210 (264)
T 1nd4_A 131 CPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCG 210 (264)
T ss_dssp CCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCT
T ss_pred CCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcch
Confidence 9999999999999877667799999
Q ss_pred ceee
Q psy763 120 FARL 123 (303)
Q Consensus 120 ~~~~ 123 (303)
.+..
T Consensus 211 ~a~~ 214 (264)
T 1nd4_A 211 RLGV 214 (264)
T ss_dssp TCEE
T ss_pred hccc
Confidence 8654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.6e-08 Score=90.14 Aligned_cols=104 Identities=14% Similarity=0.216 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHhCC--CCCcceeEEEEEeC---CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy763 19 ATEATNKKEKRSLK--HPNLVNLLEVFRRK---KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR- 92 (303)
Q Consensus 19 ~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~- 92 (303)
..+.+|..+++.+. +..++++++++.+. +..|+|||+++|..+.+.. ...++......++.+++.+|+.||+
T Consensus 81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~ 158 (359)
T 3dxp_A 81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTV 158 (359)
T ss_dssp -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCC
Confidence 45677888888887 45578999988776 3478999999998775421 1257788889999999999999997
Q ss_pred ---------------------------------------------------------CCceecccCCCcEEEecCC--cE
Q psy763 93 ---------------------------------------------------------HACIHRDIKPENILLTANG--VV 113 (303)
Q Consensus 93 ---------------------------------------------------------~~ivH~dlk~~nil~~~~~--~~ 113 (303)
.+++|+|+++.||+++.++ .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~ 238 (359)
T 3dxp_A 159 DYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVL 238 (359)
T ss_dssp CTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEE
T ss_pred CchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEE
Confidence 3589999999999998764 36
Q ss_pred EEccccceeee
Q psy763 114 KLCDFGFARLI 124 (303)
Q Consensus 114 kl~dfg~~~~~ 124 (303)
.|+||+.+...
T Consensus 239 ~viDwe~a~~g 249 (359)
T 3dxp_A 239 AVLDWELSTLG 249 (359)
T ss_dssp EECCCTTCEEE
T ss_pred EEECccccccC
Confidence 89999988763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.56 E-value=5.9e-08 Score=84.44 Aligned_cols=155 Identities=15% Similarity=0.117 Sum_probs=99.6
Q ss_pred HHHHHHHHHHHHhCC-CCC--cceeEEEEEeCC---EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLK-HPN--LVNLLEVFRRKK---KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
...+.+|...++.+. +.. +.+++.....++ ..|+|||+++|..+..... ..++......++.+++..++.||
T Consensus 54 ~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH 131 (304)
T 3sg8_A 54 STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELH 131 (304)
T ss_dssp HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHH
Confidence 455777888887763 333 445555543333 3488999999988875322 25778888889999999999998
Q ss_pred H----------------------------------------------------------CCceecccCCCcEEEec--CC
Q psy763 92 R----------------------------------------------------------HACIHRDIKPENILLTA--NG 111 (303)
Q Consensus 92 ~----------------------------------------------------------~~ivH~dlk~~nil~~~--~~ 111 (303)
+ ..++|+|++|.||+++. ..
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~ 211 (304)
T 3sg8_A 132 SINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNT 211 (304)
T ss_dssp HSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTE
T ss_pred cCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCC
Confidence 6 13699999999999998 45
Q ss_pred cEEEccccceeeeCCCCccccccCCCcccCccccc----CCcc---------CCCccchhhHHHHHHHhhccCccC
Q psy763 112 VVKLCDFGFARLINPGENYTDYVATRWYRAPELLV----GDTL---------YGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 112 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~----~~~~---------~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
.+.++||+.+....+............-.+|+... ..+. ...-.+.|++|.++|.+.+|..++
T Consensus 212 ~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 212 ICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp EEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred EEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 68899999987643321110000000001222211 1110 112258999999999998877554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=2.3e-05 Score=68.11 Aligned_cols=104 Identities=16% Similarity=0.142 Sum_probs=74.8
Q ss_pred HHHHHHHHHHHHhCCCC---CcceeEEEEE-eCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHP---NLVNLLEVFR-RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
...+.+|...++.+.+. .+.+++.+.. ..+..++|||+++|..+....-. .++......++.++...|+.||+.
T Consensus 53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~ 130 (306)
T 3tdw_A 53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAF 130 (306)
T ss_dssp HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcC
Confidence 45678888888888653 3567777765 34557899999999888763221 345566666666666666666642
Q ss_pred ------------------------------------------------------------CceecccCCCcEEEec---C
Q psy763 94 ------------------------------------------------------------ACIHRDIKPENILLTA---N 110 (303)
Q Consensus 94 ------------------------------------------------------------~ivH~dlk~~nil~~~---~ 110 (303)
.++|+|+++.||+++. +
T Consensus 131 ~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~ 210 (306)
T 3tdw_A 131 PVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQ 210 (306)
T ss_dssp CHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSS
T ss_pred CcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCC
Confidence 3489999999999987 3
Q ss_pred Cc-EEEccccceee
Q psy763 111 GV-VKLCDFGFARL 123 (303)
Q Consensus 111 ~~-~kl~dfg~~~~ 123 (303)
+. +.|+||+.+..
T Consensus 211 ~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 211 TPLTGIIDFGDAAI 224 (306)
T ss_dssp CCEEEECCCTTCEE
T ss_pred CceEEEEehhhcCC
Confidence 44 58999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.6e-05 Score=67.50 Aligned_cols=100 Identities=12% Similarity=0.051 Sum_probs=73.0
Q ss_pred HHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----
Q psy763 20 TEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH----- 93 (303)
Q Consensus 20 ~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----- 93 (303)
.+.+|...++.+. +--+.++++++.+++..++|||+++|.++....... ......+..+++..|..||+.
T Consensus 65 ~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~ 140 (272)
T 4gkh_A 65 DVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNC 140 (272)
T ss_dssp HHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGC
T ss_pred HHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccC
Confidence 4566777777664 333778999999999999999999998877754321 122334556666666666631
Q ss_pred -----------------------------------------------------CceecccCCCcEEEecCCcEEEccccc
Q psy763 94 -----------------------------------------------------ACIHRDIKPENILLTANGVVKLCDFGF 120 (303)
Q Consensus 94 -----------------------------------------------------~ivH~dlk~~nil~~~~~~~kl~dfg~ 120 (303)
.++|+|+.+.||+++.++.+-|+||+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~ 220 (272)
T 4gkh_A 141 PFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGR 220 (272)
T ss_dssp CBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTT
T ss_pred CcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcc
Confidence 268999999999999877778999998
Q ss_pred eee
Q psy763 121 ARL 123 (303)
Q Consensus 121 ~~~ 123 (303)
+..
T Consensus 221 a~~ 223 (272)
T 4gkh_A 221 VGI 223 (272)
T ss_dssp CEE
T ss_pred ccc
Confidence 754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=6.6e-05 Score=66.40 Aligned_cols=31 Identities=19% Similarity=0.248 Sum_probs=26.0
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
..++|+|+.+.||+++++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999999644578999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0081 Score=51.57 Aligned_cols=28 Identities=21% Similarity=0.324 Sum_probs=24.3
Q ss_pred ceecccCCCcEEEecCCcEEEccccceee
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 799999999999 5667789999988765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.017 Score=47.14 Aligned_cols=101 Identities=13% Similarity=0.011 Sum_probs=64.9
Q ss_pred cHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCC
Q psy763 60 VLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATR 137 (303)
Q Consensus 60 ~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 137 (303)
+|.+++. .+.++++.++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|...+ +.+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 5777654 45799999999999999999887632 1112333457888898888887663 1110 1223
Q ss_pred cccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 138 WYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 138 ~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
.+.|||... ...+.+.=|||||+++|..+-.+.+.
T Consensus 102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 356888764 22477889999999999998766554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0093 Score=51.79 Aligned_cols=31 Identities=23% Similarity=0.261 Sum_probs=27.6
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888899999997654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.025 Score=50.51 Aligned_cols=30 Identities=27% Similarity=0.363 Sum_probs=25.3
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
..++|||+.+.||+++.+ .++++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 568999999999999765 488999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.024 Score=49.10 Aligned_cols=44 Identities=9% Similarity=0.022 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEecCCCCcH
Q psy763 18 QATEATNKKEKRSLK---HPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~~l 61 (303)
...+..|...++.+. ...+++++++....+..++|||++++..+
T Consensus 72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 345666777776663 35688999988888899999999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.044 Score=47.51 Aligned_cols=33 Identities=30% Similarity=0.439 Sum_probs=28.0
Q ss_pred CCceecccCCCcEEEecC----CcEEEccccceeeeC
Q psy763 93 HACIHRDIKPENILLTAN----GVVKLCDFGFARLIN 125 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~----~~~kl~dfg~~~~~~ 125 (303)
..++|+|+.+.||+++.+ +.+.++||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 468999999999999874 678999999887643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.46 E-value=0.026 Score=50.26 Aligned_cols=30 Identities=33% Similarity=0.559 Sum_probs=26.4
Q ss_pred CceecccCCCcEEEecC----CcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTAN----GVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~----~~~kl~dfg~~~~ 123 (303)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 48999999999999876 6899999988765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.77 E-value=0.025 Score=50.98 Aligned_cols=78 Identities=13% Similarity=0.066 Sum_probs=46.1
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCcccccc--CCCcccCcccccCCc--cCCCccchhhHHHHHHH
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYV--ATRWYRAPELLVGDT--LYGPAVDVWAIEWTSHS 166 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~--~~~~y~aPE~l~~~~--~~~~~~DvwSlG~il~e 166 (303)
+...++|+|++|.||+++.++ ++++||+.+....+.-...... -...|.+|+...... .-....++.+.+..+|+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 456799999999999998776 9999999887643211111000 012345554432111 01123445577777777
Q ss_pred hhc
Q psy763 167 YSQ 169 (303)
Q Consensus 167 l~t 169 (303)
.++
T Consensus 309 ~y~ 311 (420)
T 2pyw_A 309 LFN 311 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.33 E-value=0.048 Score=46.92 Aligned_cols=31 Identities=29% Similarity=0.450 Sum_probs=26.0
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.+++|+|+.+.||+++.++.+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3689999999999998776668999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.58 E-value=0.18 Score=43.44 Aligned_cols=29 Identities=28% Similarity=0.244 Sum_probs=24.9
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999998 4 899999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.01 E-value=0.18 Score=43.92 Aligned_cols=32 Identities=22% Similarity=0.307 Sum_probs=27.8
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLI 124 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~ 124 (303)
.+++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35899999999999998788999999877653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.83 E-value=0.28 Score=43.09 Aligned_cols=29 Identities=28% Similarity=0.552 Sum_probs=24.1
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
+++|+|+.+.||+++.++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999997554 89999987754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.11 E-value=1.6 Score=35.43 Aligned_cols=82 Identities=9% Similarity=0.062 Sum_probs=58.9
Q ss_pred CCCCcceeEEEEEeCCEEEEEEecCCC-CcHHHHHcCCCCCCHHHHHHHHHHHHHHHH-HHHHCCceecccCCCcEEEec
Q psy763 32 KHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVS-YCHRHACIHRDIKPENILLTA 109 (303)
Q Consensus 32 ~h~niv~~~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~-~lH~~~ivH~dlk~~nil~~~ 109 (303)
.||++ -..+-.+++.+.+.++.-++ -++..+ + .++....+.++.+++.... ++ ..-+|--++|+|++++.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence 57777 33444666777777666533 344444 2 5788888999888887655 33 44578889999999999
Q ss_pred CCcEEEccccce
Q psy763 110 NGVVKLCDFGFA 121 (303)
Q Consensus 110 ~~~~kl~dfg~~ 121 (303)
++.+++.-.|.-
T Consensus 120 ~~~p~i~hRGi~ 131 (219)
T 4ano_A 120 ALEPFFLHVGVK 131 (219)
T ss_dssp TCCEEESCCEET
T ss_pred CCcEEEEEcCCc
Confidence 999999987753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.57 E-value=1.2 Score=35.91 Aligned_cols=114 Identities=10% Similarity=0.102 Sum_probs=75.6
Q ss_pred CCCCcceeEEEEEeCCEEEEEEecCC-CCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecC
Q psy763 32 KHPNLVNLLEVFRRKKKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 110 (303)
Q Consensus 32 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~ 110 (303)
.||+++.. .+-.+++.+.+.++.-+ +-++..+. ..+....+.++.+|+....++ ..=+|--++|+|++++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence 58888877 56666676666665544 33344432 577888999999998877444 334788899999999999
Q ss_pred CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 111 GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 111 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+.+++.--|+...+ +|. . .+...=+-.+=|++..++++...|
T Consensus 116 ~~p~i~~RGik~~l----------------~P~-----~-~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 116 GLPIAKTRGLQNVV----------------DPL-----P-VSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp SCEEESCCEETTTB----------------SCC-----C-CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred CCEEEEEccCccCC----------------CCC-----C-CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999877753221 221 1 122222335777788887765554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=86.63 E-value=0.27 Score=44.43 Aligned_cols=17 Identities=35% Similarity=0.548 Sum_probs=14.8
Q ss_pred CceecccCCCcEEEecC
Q psy763 94 ACIHRDIKPENILLTAN 110 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~ 110 (303)
.++|+|+.+.||+++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 48999999999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=85.99 E-value=0.37 Score=43.90 Aligned_cols=36 Identities=25% Similarity=0.262 Sum_probs=23.5
Q ss_pred HHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEecCCCCcH
Q psy763 22 ATNKKEKRSLKHPNL-VNLLEVFRRKKKLHLVFEFCDHTVL 61 (303)
Q Consensus 22 ~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~l 61 (303)
.+|...++.+...++ .++++++. + .+|+||++|..+
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 456777777764444 57777763 3 259999987443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.72 E-value=0.72 Score=41.10 Aligned_cols=29 Identities=31% Similarity=0.472 Sum_probs=24.7
Q ss_pred ceecccCCCcEEEe------cCCcEEEccccceee
Q psy763 95 CIHRDIKPENILLT------ANGVVKLCDFGFARL 123 (303)
Q Consensus 95 ivH~dlk~~nil~~------~~~~~kl~dfg~~~~ 123 (303)
++|+|+.+.||++. .+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 456799999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 303 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-35 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-29 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-28 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-28 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-24 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-22 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-14 | |
| d1i36a2 | 152 | c.2.1.6 (A:1-152) Conserved hypothetical protein M | 1e-09 | |
| d1pgja2 | 178 | c.2.1.6 (A:1-178) 6-phosphogluconate dehydrogenase | 6e-09 | |
| d3cuma2 | 162 | c.2.1.6 (A:1-162) Hydroxyisobutyrate dehydrogenase | 8e-09 | |
| d2pgda2 | 176 | c.2.1.6 (A:1-176) 6-phosphogluconate dehydrogenase | 9e-09 | |
| d1vpda2 | 161 | c.2.1.6 (A:3-163) Hydroxyisobutyrate dehydrogenase | 1e-08 | |
| d2cvza2 | 156 | c.2.1.6 (A:2-157) Hydroxyisobutyrate dehydrogenase | 4e-08 | |
| d2i76a2 | 153 | c.2.1.6 (A:2-154) Hypothetical protein TM1727 {The | 3e-06 | |
| d2f1ka2 | 165 | c.2.1.6 (A:1-165) Prephenate dehydrogenase TyrA {S | 5e-06 | |
| d1yqga2 | 152 | c.2.1.6 (A:1-152) Pyrroline-5-carboxylate reductas | 2e-05 | |
| d2ahra2 | 152 | c.2.1.6 (A:1-152) Pyrroline-5-carboxylate reductas | 2e-05 | |
| d1ks9a2 | 167 | c.2.1.6 (A:1-167) Ketopantoate reductase PanE {Esc | 0.002 | |
| d2pv7a2 | 152 | c.2.1.6 (A:92-243) Prephenate dehydrogenase TyrA { | 0.003 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-41
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 9/160 (5%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61
+ + K + + IR+ P +V F ++ + E D L
Sbjct: 38 LIHLEIKPAIRNQIIRELQVL------HECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91
Query: 62 NELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLTANGVVKLCDFGF 120
+++ +P ++ +++ V++G++Y +H +HRD+KP NIL+ + G +KLCDFG
Sbjct: 92 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151
Query: 121 ARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ + + +V TR Y +PE L G Y D+W++
Sbjct: 152 SGQLIDSMANS-FVGTRSYMSPERLQGTH-YSVQSDIWSM 189
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-41
Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 9/162 (5%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61
+ K+ + ++ + L H N+V R +L E+C L
Sbjct: 37 IVDMKRAVDCPENIKKEI------CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90
Query: 62 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 121
+ G+P ++ Q++ GV Y H HRDIKPEN+LL +K+ DFG A
Sbjct: 91 FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 150
Query: 122 RLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ T Y APELL + VDVW+
Sbjct: 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 8e-40
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 6/138 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGV 87
S HPN+V LL+ F + L ++ EFC ++ + L I+ + Q L +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLV 146
+Y H + IHRD+K NIL T +G +KL DFG + + ++ T ++ APE+++
Sbjct: 124 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 147 GDTL----YGPAVDVWAI 160
+T Y DVW++
Sbjct: 184 CETSKDRPYDYKADVWSL 201
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (347), Expect = 3e-39
Identities = 48/134 (35%), Positives = 74/134 (55%), Gaps = 5/134 (3%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+HPN + + R+ LV E+C + + LE H L I +T L+G++
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG- 147
Y H H IHRD+K NILL+ G+VKL DFG A ++ P +V T ++ APE+++
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM 186
Query: 148 -DTLYGPAVDVWAI 160
+ Y VDVW++
Sbjct: 187 DEGQYDGKVDVWSL 200
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 2/132 (1%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
L+HPN++ L F +++L+ E+ + ++ +S
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
YCH IHRDIKPEN+LL + G +K+ DFG++ P T T Y PE++ G
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGR 179
Query: 149 TLYGPAVDVWAI 160
+ VD+W++
Sbjct: 180 M-HDEKVDLWSL 190
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 135 bits (340), Expect = 6e-38
Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 4/138 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
L+HP LVNL + F ++ +++EF L E + + + + D + QV +G+
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 88 SYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
+ H + +H D+KPENI+ T + +KL DFG ++P ++ T + APE+
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197
Query: 146 VGDTLYGPAVDVWAIEWT 163
G G D+W++
Sbjct: 198 EGKP-VGYYTDMWSVGVL 214
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-37
Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 4/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
L HP V L F+ +KL+ + + L + + T +++ +
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELL 145
Y H IHRD+KPENILL + +++ DFG A++++P +V T Y +PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 146 VGDTLYGPAVDVWAI 160
+ + D+WA+
Sbjct: 183 TEKS-ACKSSDLWAL 196
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (327), Expect = 1e-36
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLK----HPNLVNLLEVFRRKKKLHLVFEFCD 57
+ S+ E +++ EAT KE L+ HPN++ L + + LVF+
Sbjct: 35 IIDVTGGGSFSAEEVQELREAT-LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 93
Query: 58 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCD 117
L + L ++I +L + H+ +HRD+KPENILL + +KL D
Sbjct: 94 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 153
Query: 118 FGFARLINPGENYTDYVATRWYRAPELLVGDTL-----YGPAVDVWAI 160
FGF+ ++PGE + T Y APE++ YG VD+W+
Sbjct: 154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 201
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-36
Identities = 42/144 (29%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 29 RSLKHPNLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQ 82
R LKHPN+V + R L++V E+C+ +V+ + L + + ++ Q
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 83 VLRGVSYCHRHAC-----IHRDIKPENILLTANGVVKLCDFGFARLINPGENY-TDYVAT 136
+ + CHR + +HRD+KP N+ L VKL DFG AR++N ++ +V T
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177
Query: 137 RWYRAPELLVGDTLYGPAVDVWAI 160
+Y +PE + + Y D+W++
Sbjct: 178 PYYMSPEQMNRMS-YNEKSDIWSL 200
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-35
Identities = 44/133 (33%), Positives = 70/133 (52%), Gaps = 3/133 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
R K+PN+VN L+ + +L +V E+ L ++ + I + + L+ +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALE 130
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+ H + IHRDIK +NILL +G VKL DFGF I + V T ++ APE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 148 DTLYGPAVDVWAI 160
YGP VD+W++
Sbjct: 191 KA-YGPKVDIWSL 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-35
Identities = 62/159 (38%), Positives = 89/159 (55%), Gaps = 4/159 (2%)
Query: 6 KKKSSYYKEAIRQATEATNKKEK---RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN 62
KK ++ + T +E + L HPN++ LL+ F K + LVF+F + +
Sbjct: 29 KKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV 88
Query: 63 ELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 122
++++ L IK L+G+ Y H+H +HRD+KP N+LL NGV+KL DFG A+
Sbjct: 89 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 148
Query: 123 LIN-PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
P YT V TRWYRAPELL G +YG VD+WA+
Sbjct: 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAV 187
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (322), Expect = 3e-35
Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 4/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
L HP L+NL + F K ++ L+ EF + + + + + + Q G+
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 88 SYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
+ H H+ +H DIKPENI+ VK+ DFG A +NP E AT + APE++
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 146 VGDTLYGPAVDVWAI 160
+ G D+WAI
Sbjct: 201 DREP-VGFYTDMWAI 214
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 5e-35
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 10/139 (7%)
Query: 29 RSLKHPNLVNLLEVF----RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 84
+ L+HPN+V + + + KK + LV E L + +++ Q+L
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 85 RGVSYCHRH--ACIHRDIKPENILLTA-NGVVKLCDFGFARLINPGENYTDYVATRWYRA 141
+G+ + H IHRD+K +NI +T G VK+ D G A L + T + A
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMA 181
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE+ Y +VDV+A
Sbjct: 182 PEMYEEK--YDESVDVYAF 198
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-33
Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 7/138 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
R +H N++ L + +L +V ++C+ + L L + I Q +G+
Sbjct: 59 RKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPEL 144
Y H + IHRD+K NI L + VK+ DFG A + + + + APE+
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 145 LVG--DTLYGPAVDVWAI 160
+ Y DV+A
Sbjct: 178 IRMQDKNPYSFQSDVYAF 195
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (304), Expect = 5e-33
Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 4/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+KHPN+V L +++ L+L+ + L + ++ +QVL V
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121
Query: 89 YCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
Y H +HRD+KPEN+L + + + DFG +++ +PG + T Y APE+L
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 146 VGDTLYGPAVDVWAI 160
Y AVD W+I
Sbjct: 182 AQKP-YSKAVDCWSI 195
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 121 bits (305), Expect = 1e-32
Identities = 33/156 (21%), Positives = 64/156 (41%), Gaps = 1/156 (0%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL 64
KK+ + E + P +V + F KL + + + L+
Sbjct: 38 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 97
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
+ ++ +++ G+ + H ++RD+KP NILL +G V++ D G A
Sbjct: 98 LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157
Query: 125 NPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ + + V T Y APE+L Y + D +++
Sbjct: 158 SKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSL 192
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-32
Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 27 EKRSLKHPNLVNLLEVFR----RKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQIT 80
R+ + P++V +++V+ +K L +V E D L + +I
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVATR 137
+ + Y H HRD+KPEN+L T+ N ++KL DFGFA+ + T T
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 138 WYRAPELLVGDTLYGPAVDVWA 159
+Y APE+L + Y + D+W+
Sbjct: 178 YYVAPEVLGPEK-YDKSCDMWS 198
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 4/135 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
+H N+++L E F ++L ++FEF + E + L I QV +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 88 SYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
+ H H H DI+PENI+ + +K+ +FG AR + PG+N+ Y APE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 146 VGDTLYGPAVDVWAI 160
D A D+W++
Sbjct: 176 QHDV-VSTATDMWSL 189
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-32
Identities = 59/144 (40%), Positives = 86/144 (59%), Gaps = 13/144 (9%)
Query: 29 RSLKHPNLVNLLEVF--------RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 80
+ LKH N+VNL+E+ R K ++LVF+FC+H + L N IK++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVA 135
+L G+ Y HR+ +HRD+K N+L+T +GV+KL DFG AR + +N YT+ V
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 136 TRWYRAPELLVGDTLYGPAVDVWA 159
T WYR PELL+G+ YGP +D+W
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWG 207
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-32
Identities = 52/142 (36%), Positives = 78/142 (54%), Gaps = 10/142 (7%)
Query: 29 RSLKHPNLVNLLEVF------RRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQI 79
R L H N+V L F + + L+LV ++ TV ++ LP +K
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLINPGENYTDYVATRW 138
+Q+ R ++Y H HRDIKP+N+LL + V+KLCDFG A+ + GE Y+ +R+
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 139 YRAPELLVGDTLYGPAVDVWAI 160
YRAPEL+ G T Y ++DVW+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSA 209
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-32
Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 8/163 (4%)
Query: 5 KKKKSSYYKEAIRQATEATNKKEK---RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61
K K K + R + ++E + ++HPN++ L EV+ K + L+ E L
Sbjct: 41 KFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL 100
Query: 62 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV----VKLCD 117
+ L + + Q+L GV Y H H D+KPENI+L V +K+ D
Sbjct: 101 FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 118 FGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
FG A I+ G + + T + APE++ + G D+W+I
Sbjct: 161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSI 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-31
Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 17/168 (10%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFR-----RKKKLHLVFEFC 56
+ + + +Y + +R+ +H N++ + ++ R + K ++LV
Sbjct: 40 KISPFEHQTYCQRTLREIKIL------LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93
Query: 57 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 116
+ L+ L D I +Q+LRG+ Y H +HRD+KP N+LL +K+C
Sbjct: 94 GADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151
Query: 117 DFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
DFG AR+ +P ++ T+YVATRWYRAPE+++ Y ++D+W++
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 199
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-31
Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 6/135 (4%)
Query: 29 RSLKHPNLVNLLEVF-RRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLR 85
L+H NLV LL V K L++V E+ L + L D + + + V
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 86 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELL 145
+ Y + +HRD+ N+L++ + V K+ DFG + + + APE L
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEAL 172
Query: 146 VGDTLYGPAVDVWAI 160
+ DVW+
Sbjct: 173 REKK-FSTKSDVWSF 186
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 7e-31
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 2/155 (1%)
Query: 7 KKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN 66
KK + + T + + +HP L ++ F+ K+ L V E+ + L
Sbjct: 36 KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ 95
Query: 67 HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LIN 125
H +++ G+ + H ++RD+K +NILL +G +K+ DFG + +
Sbjct: 96 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155
Query: 126 PGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ T Y APE+L+G Y +VD W+
Sbjct: 156 GDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSF 189
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-30
Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 4/162 (2%)
Query: 1 LRFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCD-HT 59
+ ++ R E K+ S ++ LL+ F R L+ E +
Sbjct: 37 VEKDRISDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQ 95
Query: 60 VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDF 118
L + L +L + WQVL V +CH +HRDIK ENIL+ N G +KL DF
Sbjct: 96 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 119 GFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
G L+ YTD+ TR Y PE + +G + VW++
Sbjct: 156 GSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (284), Expect = 2e-30
Identities = 53/133 (39%), Positives = 77/133 (57%), Gaps = 1/133 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L +V KK+L LVFE D + L+ GL K Q+L G++
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI-NPGENYTDYVATRWYRAPELLVG 147
YCH +HRD+KP+N+L+ G +K+ DFG AR P YT + T WYRAP++L+G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 148 DTLYGPAVDVWAI 160
Y +D+W++
Sbjct: 175 SKKYSTTIDIWSV 187
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 2e-30
Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 3/132 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ HP ++ + F+ +++ ++ ++ + L L P + K +V +
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
Y H I+RD+KPENILL NG +K+ DFGFA+ + + T Y APE++
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTK 176
Query: 149 TLYGPAVDVWAI 160
Y ++D W+
Sbjct: 177 P-YNKSIDWWSF 187
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-30
Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 32/185 (17%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61
+K SS + + + K + H N+VNLL ++L+FE+C + L
Sbjct: 74 MLKEKADSSEREALMSEL-----KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 62 NEL-----------------------ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98
E + L ++ + +QV +G+ + +C+HR
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188
Query: 99 DIKPENILLTANGVVKLCDFGFARLINPGENYT---DYVATRWYRAPELLVGDTLYGPAV 155
D+ N+L+T VVK+CDFG AR I NY + + APE L Y
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKS 247
Query: 156 DVWAI 160
DVW+
Sbjct: 248 DVWSY 252
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (282), Expect = 1e-29
Identities = 41/157 (26%), Positives = 84/157 (53%), Gaps = 10/157 (6%)
Query: 16 IRQATEATNKKEKRSLK----HPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPH 69
++ + K+E + L+ PN++ L ++ + + LVFE ++T + +
Sbjct: 68 LKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQ 124
Query: 70 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLINPGE 128
L I+ +++L+ + YCH +HRD+KP N+++ + ++L D+G A +PG+
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 129 NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165
Y VA+R+++ PELLV +Y ++D+W++
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-29
Identities = 58/161 (36%), Positives = 92/161 (57%), Gaps = 7/161 (4%)
Query: 6 KKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVF-----RRKKKLHLVFEFCDHTV 60
+ ++ + E + + +HPN+V L +V R+ KL LVFE D +
Sbjct: 42 RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 101
Query: 61 LNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 119
L+ P G+P + IK + +Q+LRG+ + H H +HRD+KP+NIL+T++G +KL DFG
Sbjct: 102 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161
Query: 120 FARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
AR+ + T V T WYRAPE+L+ + Y VD+W++
Sbjct: 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSV 201
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-29
Identities = 59/134 (44%), Positives = 86/134 (64%), Gaps = 2/134 (1%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGV 87
+ L HPN+V LL+V + KL+LVFEF + ++ + G+P LIK +Q+L+G+
Sbjct: 56 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLV 146
++CH H +HRD+KP+N+L+ G +KL DFG AR P YT V T WYRAPE+L+
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 147 GDTLYGPAVDVWAI 160
G Y AVD+W++
Sbjct: 176 GCKYYSTAVDIWSL 189
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-29
Identities = 53/132 (40%), Positives = 81/132 (61%), Gaps = 1/132 (0%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ LKH N+V L +V KKL LVFEFCD + ++ L +++K +Q+L+G+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN-PGENYTDYVATRWYRAPELLVG 147
+CH +HRD+KP+N+L+ NG +KL +FG AR P Y+ V T WYR P++L G
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 148 DTLYGPAVDVWA 159
LY ++D+W+
Sbjct: 176 AKLYSTSIDMWS 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 5e-29
Identities = 36/134 (26%), Positives = 57/134 (42%), Gaps = 4/134 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGV 87
L HP LV L V + + LVFEF +H L++ + + + V G+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY--VATRWYRAPELL 145
+Y IHRD+ N L+ N V+K+ DFG R + + + + +PE+
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 146 VGDTLYGPAVDVWA 159
Y DVW+
Sbjct: 175 SFSR-YSSKSDVWS 187
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-29
Identities = 33/135 (24%), Positives = 57/135 (42%), Gaps = 6/135 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L +P +V ++ + + LV E + LN+ + I ++ QV G+
Sbjct: 63 QQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPEL 144
Y +HRD+ N+LL K+ DFG ++ + ENY T + APE
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 145 LVGDTLYGPAVDVWA 159
+ + DVW+
Sbjct: 182 INYYK-FSSKSDVWS 195
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 8e-29
Identities = 33/136 (24%), Positives = 58/136 (42%), Gaps = 7/136 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 87
L +P +V L+ V + + L LV E L++ L +P + ++ QV G+
Sbjct: 64 HQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY----VATRWYRAPE 143
Y +HRD+ N+LL K+ DFG ++ + ++Y + APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 144 LLVGDTLYGPAVDVWA 159
+ + DVW+
Sbjct: 183 CINFRK-FSSRSDVWS 197
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 1e-28
Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 6/135 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRG 86
+ L+H LV L V ++ ++++ E+ ++ L + P G L + + + Q+ G
Sbjct: 63 KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPEL 144
+++ IHRD++ NIL++ K+ DFG ARLI E + APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 145 LVGDTLYGPAVDVWA 159
+ T + DVW+
Sbjct: 182 INYGT-FTIKSDVWS 195
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-28
Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 4/134 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGV 87
+L H LV L V +++ + ++ E+ + +LN L H + ++ V +
Sbjct: 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPELL 145
Y +HRD+ N L+ GVVK+ DFG +R + E + PE+L
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 146 VGDTLYGPAVDVWA 159
+ + D+WA
Sbjct: 174 MYSK-FSSKSDIWA 186
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 2e-28
Identities = 32/139 (23%), Positives = 58/139 (41%), Gaps = 8/139 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGV 87
HPN+++L V + + ++ EF ++ L+ G + + + G+
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDY------VATRWYRA 141
Y +HRD+ NIL+ +N V K+ DFG +R + + Y + A
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 142 PELLVGDTLYGPAVDVWAI 160
PE + + A DVW+
Sbjct: 202 PEAIQYRK-FTSASDVWSY 219
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-27
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 5/136 (3%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGV 87
SL H NL+ L V + +V E L + G + + QV G+
Sbjct: 66 HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPEL 144
Y IHRD+ N+LL +VK+ DFG R + +++ ++ +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 145 LVGDTLYGPAVDVWAI 160
+ + A D W
Sbjct: 185 SLKTRTFSHASDTWMF 200
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 4e-27
Identities = 28/134 (20%), Positives = 54/134 (40%), Gaps = 4/134 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
S+ +P++ LL + + +L+ + H + + Q+ +G++
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELL 145
Y +HRD+ N+L+ VK+ DFG A+L+ E + A E +
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 146 VGDTLYGPAVDVWA 159
+ Y DVW+
Sbjct: 186 LHRI-YTHQSDVWS 198
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-27
Identities = 37/136 (27%), Positives = 59/136 (43%), Gaps = 6/136 (4%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLP--WDLIKQITWQVLRG 86
+ L+H LV L V + +++V E+ L + G + + Q+ G
Sbjct: 67 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY--TDYVATRWYRAPEL 144
++Y R +HRD++ NIL+ N V K+ DFG ARLI E + APE
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 145 LVGDTLYGPAVDVWAI 160
+ + DVW+
Sbjct: 186 ALYGR-FTIKSDVWSF 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 104 bits (261), Expect = 5e-27
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 15/167 (8%)
Query: 1 LRFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKK----LHLVFEFC 56
LR + + S+Y R+A A +L HP +V + + + ++V E+
Sbjct: 40 LRADLARDPSFYLRFRREAQNA------AALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93
Query: 57 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 116
D L ++ + + ++ + +++ H++ IHRD+KP NI+++A VK+
Sbjct: 94 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 153
Query: 117 DFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
DFG AR I N + T Y +PE GD+ DV++
Sbjct: 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYS 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-26
Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 2/133 (1%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
++ +HP L L F+ +L V E+ + L + + + +++ +
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LINPGENYTDYVATRWYRAPELLVG 147
Y H ++RDIK EN++L +G +K+ DFG + I+ G + T Y APE+L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 148 DTLYGPAVDVWAI 160
+ YG AVD W +
Sbjct: 180 ND-YGRAVDWWGL 191
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-26
Identities = 46/138 (33%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ ++H N++ LL+VF + L +LV F + +++ L D I+ + +Q
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQ 129
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L+G+ Y H IHRD+KP N+ + + +K+ DFG AR T YV TRWYRAP
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAP 187
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++ Y VD+W++
Sbjct: 188 EVILNWMRYTQTVDIWSV 205
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (258), Expect = 2e-26
Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 5/136 (3%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRG 86
+ +KHPNLV LL V R+ +++ EF + L + E + + ++ + Q+
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPEL 144
+ Y + IHRD+ N L+ N +VK+ DFG +RL+ + + APE
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 145 LVGDTLYGPAVDVWAI 160
L + + DVWA
Sbjct: 188 LAYNK-FSIKSDVWAF 202
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-26
Identities = 38/180 (21%), Positives = 74/180 (41%), Gaps = 31/180 (17%)
Query: 2 RFNKKKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRK----KKLHLVFEFCD 57
F+ +++ S+++EA T L+H N++ + + +L LV ++ +
Sbjct: 33 IFSSREERSWFREAEIYQT--------VMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 58 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC--------IHRDIKPENILLTA 109
H L + N + + + + ++ G+++ H HRD+K +NIL+
Sbjct: 85 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 110 NGVVKLCDFGFARLINPGENYTD-----YVATRWYRAPELLVGDTL-----YGPAVDVWA 159
NG + D G A + + D V T+ Y APE+L D++A
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-26
Identities = 40/170 (23%), Positives = 63/170 (37%), Gaps = 17/170 (10%)
Query: 6 KKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL- 64
K+ Y + + + + HPN++NLL + L+L E+ H L +
Sbjct: 43 KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 102
Query: 65 ---------------ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA 109
+ L + V RG+ Y + IHRD+ NIL+
Sbjct: 103 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162
Query: 110 NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159
N V K+ DFG +R T + A E L ++Y DVW+
Sbjct: 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWS 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 3e-26
Identities = 34/169 (20%), Positives = 65/169 (38%), Gaps = 6/169 (3%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGV 87
H N++ L V + K + ++ E+ ++ L++ G + + + G+
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 88 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT----DYVATRWYRAPE 143
Y +HRD+ NIL+ +N V K+ DFG +R++ T + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 144 LLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGR 192
+ + A DVW+ G + +H + + R
Sbjct: 184 AISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (252), Expect = 1e-25
Identities = 42/158 (26%), Positives = 60/158 (37%), Gaps = 28/158 (17%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL------------------------ 64
+PN+V LL V K + L+FE+ + LNE
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 65 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 124
P L I QV G++Y +HRD+ N L+ N VVK+ DFG +R I
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 125 NPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
+ Y + + PE + + Y DVWA
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWA 227
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 5e-25
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 15/169 (8%)
Query: 4 NKKKKSSYYKEAIRQATEATNKKEK----------RSLKHPNLVNLLEVFRRKKKLHLVF 53
++ AI+ T+ + R HP++V L+ V + + ++
Sbjct: 28 YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86
Query: 54 EFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV 112
E C L + L + +Q+ ++Y +HRDI N+L+++N
Sbjct: 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 146
Query: 113 VKLCDFGFARLINPGENY--TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
VKL DFG +R + Y + + APE + + A DVW
Sbjct: 147 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWM 194
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 98.7 bits (245), Expect = 1e-24
Identities = 24/161 (14%), Positives = 51/161 (31%), Gaps = 14/161 (8%)
Query: 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLP 72
+ + + K + N+ + LV + ++ + L+
Sbjct: 40 RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS 99
Query: 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-----NGVVKLCDFGFARLINPG 127
+ Q+L V H + ++RDIKP+N L+ ++ + DFG +
Sbjct: 100 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159
Query: 128 EN--------YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ T Y + +G D+ A+
Sbjct: 160 VTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEAL 199
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 8e-24
Identities = 41/153 (26%), Positives = 62/153 (40%), Gaps = 22/153 (14%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL------------------ENHPH 69
H N+VNLL ++ E+C + L E+
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 70 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN 129
L + + ++QV +G+++ CIHRD+ NILLT + K+CDFG AR I N
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 130 Y---TDYVATRWYRAPELLVGDTLYGPAVDVWA 159
Y + + APE + Y DVW+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWS 232
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.2 bits (241), Expect = 8e-24
Identities = 34/130 (26%), Positives = 57/130 (43%), Gaps = 3/130 (2%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+++ P LV L F+ L++V E+ + + Q++
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD 148
Y H I+RD+KPEN+L+ G +++ DFGFA+ + T APE+++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSK 213
Query: 149 TLYGPAVDVW 158
Y AVD W
Sbjct: 214 G-YNKAVDWW 222
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 2e-23
Identities = 33/139 (23%), Positives = 53/139 (38%), Gaps = 8/139 (5%)
Query: 29 RSLKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRG 86
+ HPN+++LL + R + +V + H L H + QV +G
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY-----TDYVATRWYRA 141
+ + +HRD+ N +L VK+ DFG AR + E T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 142 PELLVGDTLYGPAVDVWAI 160
E L + DVW+
Sbjct: 203 LESLQTQK-FTTKSDVWSF 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.8 bits (232), Expect = 7e-23
Identities = 22/144 (15%), Positives = 49/144 (34%), Gaps = 13/144 (9%)
Query: 29 RSLKHPNLVNLLE-VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 87
+ ++ + + +V E ++ + + + Q++ +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 88 SYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLINPGENY--------TDYVAT 136
Y H IHRD+KP+N L+ +V + DFG A+ + + T
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 137 RWYRAPELLVGDTLYGPAVDVWAI 160
Y + +G D+ ++
Sbjct: 177 ARYASINTHLGIE-QSRRDDLESL 199
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 2e-22
Identities = 44/138 (31%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 29 RSLKHPNLVNLLEVFRRKKK------LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQ 82
+ + H N+++LL VF +K ++LV E D + ++ + + + +Q
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQ 127
Query: 83 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP 142
+L G+ + H IHRD+KP NI++ ++ +K+ DFG AR T YV TR+YRAP
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 143 ELLVGDTLYGPAVDVWAI 160
E+++G Y VD+W++
Sbjct: 188 EVILGMG-YKENVDIWSV 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 6e-22
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 3/158 (1%)
Query: 6 KKKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE 65
KK + K + T + + + P LV L F+ + KLHL+ ++ + L
Sbjct: 61 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 66 NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIN 125
+ ++ +++ + + H+ I+RDIK ENILL +NG V L DFG ++
Sbjct: 121 SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 126 PGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
E Y + + GD+ + AVD W++
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 6e-22
Identities = 47/137 (34%), Positives = 74/137 (54%), Gaps = 8/137 (5%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLH-----LVFEFCDHTVLNELENHPHGLPWDLIKQITWQV 83
+ +KH N++ LL+VF + L + LN + L D ++ + +Q+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 130
Query: 84 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPE 143
LRG+ Y H IHRD+KP N+ + + +K+ DFG AR + T YVATRWYRAPE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPE 188
Query: 144 LLVGDTLYGPAVDVWAI 160
+++ Y VD+W++
Sbjct: 189 IMLNWMHYNQTVDIWSV 205
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 8e-22
Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 20/152 (13%)
Query: 28 KRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL----------------ENHPHGL 71
K KH N++NLL + L+++ E+ L E N L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 72 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYT 131
+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR I+ + Y
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 132 ---DYVATRWYRAPELLVGDTLYGPAVDVWAI 160
+ + APE L D +Y DVW+
Sbjct: 193 KTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSF 223
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 8e-21
Identities = 27/148 (18%), Positives = 54/148 (36%), Gaps = 14/148 (9%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG----------LPWDLIKQ 78
+ ++V LL V + + ++ E L + Q
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 79 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVA 135
+ ++ G++Y + + +HRD+ N ++ + VK+ DFG R I + Y +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 136 TRWYRAPELLVGDTLYGPAVDVWAIEWT 163
+ +PE L + DVW+
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVV 224
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 2e-19
Identities = 47/174 (27%), Positives = 72/174 (41%), Gaps = 23/174 (13%)
Query: 7 KKSSYYKEAIRQATEATNKKEKRSLKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNEL- 64
K+ + + E +E K H N+VNLL + L ++ EFC L+
Sbjct: 52 KEGATHSEHRALMSEL--KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 109
Query: 65 ---------------ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA 109
+ + L + + ++QV +G+ + CIHRD+ NILL+
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169
Query: 110 NGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAI 160
VVK+CDFG AR I +Y D + APE + Y DVW+
Sbjct: 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSF 222
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.4 bits (169), Expect = 8e-15
Identities = 15/138 (10%), Positives = 45/138 (32%), Gaps = 27/138 (19%)
Query: 29 RSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 88
+ L+ + + ++ E D + + + ++ +L V+
Sbjct: 69 QKLQGLAVPKVYAWEGN----AVLMELIDA-------KELYRVRVENPDEVLDMILEEVA 117
Query: 89 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVA------TRWYRAP 142
+ +H D+ N+L++ G + + DF + + E + + + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGE-EGWREILERDVRNIITYFSRT 175
Query: 143 ELLVGDTLYGPAVDVWAI 160
Y D+ +
Sbjct: 176 --------YRTEKDINSA 185
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 70.8 bits (172), Expect = 2e-14
Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 16/178 (8%)
Query: 1 LRFNKKKKSSYYKEA-IRQATEATNKKEKRSLKHPNLVNLLEVF----RRKKKLHLVFEF 55
+R +K + E + Q + ++ S+ +++ LL+ F + +VFE
Sbjct: 46 VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV 105
Query: 56 CDHTVLNELENHPHGL-PWDLIKQITWQVLRGVSYCHRHACI-HRDIKPENILLTANGV- 112
+L ++ + H P +KQI+ Q+L G+ Y HR I H DIKPEN+L+
Sbjct: 106 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165
Query: 113 -----VKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165
+K+ D G A + E+YT+ + TR YR+PE+L+G +G D+W+
Sbjct: 166 ENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIF 220
|
| >d1i36a2 c.2.1.6 (A:1-152) Conserved hypothetical protein MTH1747 {Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]} Length = 152 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Conserved hypothetical protein MTH1747 species: Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]
Score = 53.7 bits (128), Expect = 1e-09
Identities = 11/44 (25%), Positives = 17/44 (38%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQ 212
++GFIG G + +A L V L+ S + T
Sbjct: 2 RVGFIGFGEVAQTLASRLRSRGVEVVTSLEGRSPSTIERARTVG 45
|
| >d1pgja2 c.2.1.6 (A:1-178) 6-phosphogluconate dehydrogenase {Trypanosoma brucei [TaxId: 5691]} Length = 178 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: 6-phosphogluconate dehydrogenase species: Trypanosoma brucei [TaxId: 5691]
Score = 52.3 bits (124), Expect = 6e-09
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
+G +GLG MG+++A N+ + +V V
Sbjct: 3 DVGVVGLGVMGANLALNIAEKGFKVAV 29
|
| >d3cuma2 c.2.1.6 (A:1-162) Hydroxyisobutyrate dehydrogenase {Pseudomonas aeruginosa [TaxId: 287]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Hydroxyisobutyrate dehydrogenase species: Pseudomonas aeruginosa [TaxId: 287]
Score = 51.8 bits (123), Expect = 8e-09
Identities = 16/28 (57%), Positives = 19/28 (67%)
Query: 168 SQIGFIGLGNMGSHMARNLLKNNGRVTV 195
QI FIGLG+MG+ MA NLLK + V
Sbjct: 2 KQIAFIGLGHMGAPMATNLLKAGYLLNV 29
|
| >d2pgda2 c.2.1.6 (A:1-176) 6-phosphogluconate dehydrogenase {Sheep (Ovis orientalis aries) [TaxId: 9940]} Length = 176 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: 6-phosphogluconate dehydrogenase species: Sheep (Ovis orientalis aries) [TaxId: 9940]
Score = 51.9 bits (123), Expect = 9e-09
Identities = 8/28 (28%), Positives = 13/28 (46%)
Query: 168 SQIGFIGLGNMGSHMARNLLKNNGRVTV 195
+ I IGL MG ++ N+ + V
Sbjct: 3 ADIALIGLAVMGQNLILNMNDHGFVVCA 30
|
| >d1vpda2 c.2.1.6 (A:3-163) Hydroxyisobutyrate dehydrogenase {Salmonella typhimurium [TaxId: 90371]} Length = 161 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Hydroxyisobutyrate dehydrogenase species: Salmonella typhimurium [TaxId: 90371]
Score = 51.3 bits (122), Expect = 1e-08
Identities = 14/27 (51%), Positives = 19/27 (70%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTV 195
++GFIGLG MG M++NLLK + V
Sbjct: 2 KVGFIGLGIMGKPMSKNLLKAGYSLVV 28
|
| >d2cvza2 c.2.1.6 (A:2-157) Hydroxyisobutyrate dehydrogenase {Thermus thermophilus [TaxId: 274]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Hydroxyisobutyrate dehydrogenase species: Thermus thermophilus [TaxId: 274]
Score = 49.5 bits (117), Expect = 4e-08
Identities = 10/26 (38%), Positives = 14/26 (53%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
+ FIGLG MG MA +L + +
Sbjct: 3 VAFIGLGAMGYPMAGHLARRFPTLVW 28
|
| >d2i76a2 c.2.1.6 (A:2-154) Hypothetical protein TM1727 {Thermotoga maritima [TaxId: 2336]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Hypothetical protein TM1727 species: Thermotoga maritima [TaxId: 2336]
Score = 44.2 bits (103), Expect = 3e-06
Identities = 5/39 (12%), Positives = 12/39 (30%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWD 208
+ F+G G + L ++ +S +
Sbjct: 2 LNFVGTGTLTRFFLECLKDRYEIGYILSRSIDRARNLAE 40
|
| >d2f1ka2 c.2.1.6 (A:1-165) Prephenate dehydrogenase TyrA {Synechocystis sp. pcc 6803 [TaxId: 1148]} Length = 165 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Prephenate dehydrogenase TyrA species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Score = 43.6 bits (101), Expect = 5e-06
Identities = 9/44 (20%), Positives = 21/44 (47%)
Query: 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQ 212
+IG +GLG +G+ +A +L + + + + S + +
Sbjct: 2 KIGVVGLGLIGASLAGDLRRRGHYLIGVSRQQSTCEKAVERQLV 45
|
| >d1yqga2 c.2.1.6 (A:1-152) Pyrroline-5-carboxylate reductase ProC {Neisseria meningitidis, serogroup B [TaxId: 487]} Length = 152 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Pyrroline-5-carboxylate reductase ProC species: Neisseria meningitidis, serogroup B [TaxId: 487]
Score = 41.5 bits (96), Expect = 2e-05
Identities = 11/48 (22%), Positives = 20/48 (41%), Gaps = 1/48 (2%)
Query: 170 IGFIGLGNMGSHMARNLLKNNG-RVTVILKSDSLDSETWDLTWQEIFS 216
+ F+G GNM + +A L+K G R+ + + E +
Sbjct: 3 VYFLGGGNMAAAVAGGLVKQGGYRIYIANRGAEKRERLEKELGVETSA 50
|
| >d2ahra2 c.2.1.6 (A:1-152) Pyrroline-5-carboxylate reductase ProC {Streptococcus pyogenes [TaxId: 1314]} Length = 152 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Pyrroline-5-carboxylate reductase ProC species: Streptococcus pyogenes [TaxId: 1314]
Score = 41.6 bits (96), Expect = 2e-05
Identities = 8/26 (30%), Positives = 14/26 (53%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTV 195
IG IG+G M S + + L + + +
Sbjct: 3 IGIIGVGKMASAIIKGLKQTPHELII 28
|
| >d1ks9a2 c.2.1.6 (A:1-167) Ketopantoate reductase PanE {Escherichia coli [TaxId: 562]} Length = 167 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Ketopantoate reductase PanE species: Escherichia coli [TaxId: 562]
Score = 36.4 bits (83), Expect = 0.002
Identities = 8/31 (25%), Positives = 11/31 (35%)
Query: 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSD 200
I +G G +G L K V L+
Sbjct: 3 ITVLGCGALGQLWLTALCKQGHEVQGWLRVP 33
|
| >d2pv7a2 c.2.1.6 (A:92-243) Prephenate dehydrogenase TyrA {Haemophilus influenzae [TaxId: 727]} Length = 152 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: NAD(P)-binding Rossmann-fold domains superfamily: NAD(P)-binding Rossmann-fold domains family: 6-phosphogluconate dehydrogenase-like, N-terminal domain domain: Prephenate dehydrogenase TyrA species: Haemophilus influenzae [TaxId: 727]
Score = 35.2 bits (80), Expect = 0.003
Identities = 11/94 (11%), Positives = 27/94 (28%), Gaps = 10/94 (10%)
Query: 170 IGFIG-LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLL 228
I +G G +G AR L + ++++ + D +E+ + + +
Sbjct: 12 IVIVGGYGKLGGLFARYLRASGYPISILDREDWAVAESILANADVVIVSVPINLTLETIE 71
Query: 229 IRGGNTDRNSHGV---------VKILGKKLIGRF 253
N + + + G
Sbjct: 72 RLKPYLTENMLLADLTSVKREPLAKMLEVHTGAV 105
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.71 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.89 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.22 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.8 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=329.17 Aligned_cols=218 Identities=20% Similarity=0.265 Sum_probs=186.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 11 YYKEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 11 ~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
...+......+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|..++.+.+.+++..+..++.||+.||+||
T Consensus 43 ~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~l 122 (263)
T d2j4za1 43 QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122 (263)
T ss_dssp HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 33334456678899999999999999999999999999999999999999999988778999999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++||+||||||+|||++.++.+||+|||+|...... ......||+.|+|||++.+.+ ++.++||||+||++|||++|
T Consensus 123 H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G 200 (263)
T d2j4za1 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVG 200 (263)
T ss_dssp HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHS
T ss_pred HHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcC
Confidence 9999999999999999999999999999999775533 334568999999999999866 89999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+.+..+....+....... .+..++++.+++.+||.
T Consensus 201 ~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------------p~~~s~~~~~li~~~L~ 240 (263)
T d2j4za1 201 KPPFEANTYQETYKRISRVEFTF----------------------------------------PDFVTEGARDLISRLLK 240 (263)
T ss_dssp SCTTCCSSHHHHHHHHHTTCCCC----------------------------------------CTTSCHHHHHHHHHHTC
T ss_pred CCCCCCCCHHHHHHHHHcCCCCC----------------------------------------CccCCHHHHHHHHHHcc
Confidence 99998887777666554322111 11235678899999999
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|..| +++.++++||||..
T Consensus 241 ~dp~~R-------~t~~eil~hp~~~~ 260 (263)
T d2j4za1 241 HNPSQR-------PMLREVLEHPWITA 260 (263)
T ss_dssp SSGGGS-------CCHHHHHTCHHHHH
T ss_pred CCHhHC-------cCHHHHHcCcCcCC
Confidence 777666 99999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=330.80 Aligned_cols=216 Identities=24% Similarity=0.256 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
+.+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||
T Consensus 48 ~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHr 127 (271)
T d1nvra_ 48 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127 (271)
T ss_dssp -CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccC
Confidence 45788999999999999999999999999999999999999999999888899999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||+|||++.++.+||+|||+|....... .....+||+.|+|||++.+.+.++.++||||+||++|||++|..||.
T Consensus 128 DiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 999999999999999999999998765332 23456899999999999877755788999999999999999999987
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+................. ....+..++++.+++.+||..+|..
T Consensus 208 ~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~ 250 (271)
T d1nvra_ 208 QPSDSCQEYSDWKEKKTY-------------------------------------LNPWKKIDSAPLALLHKILVENPSA 250 (271)
T ss_dssp SSSTTSHHHHHHHTTCTT-------------------------------------STTGGGSCHHHHHHHHHHSCSSTTT
T ss_pred CCChHHHHHHHHhcCCCC-------------------------------------CCccccCCHHHHHHHHHHcCCChhH
Confidence 654433322222211110 0001123567889999999876666
Q ss_pred eeccccccccccccceeeeeecC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
| +++.++++||||..+
T Consensus 251 R-------~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 251 R-------ITIPDIKKDRWYNKP 266 (271)
T ss_dssp S-------CCHHHHTTCTTTTCC
T ss_pred C-------cCHHHHhcCHhhCcC
Confidence 6 999999999999654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-47 Score=331.33 Aligned_cols=216 Identities=21% Similarity=0.274 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+|
T Consensus 51 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiH 130 (307)
T d1a06a_ 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130 (307)
T ss_dssp ----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeee
Confidence 35678899999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred cccCCCcEEEe---cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLT---ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||++. .++.+||+|||+|..........+.+||+.|+|||++.+.+ |+.++||||+||++|||++|..||
T Consensus 131 rDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCC
Confidence 99999999995 46899999999998876666666788999999999998765 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....++......+ ....+..++++.+++.+||..+|.
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~------------------------------------~~~~~~~s~~~~~li~~~L~~dP~ 253 (307)
T d1a06a_ 210 YDENDAKLFEQILKAEYEFD------------------------------------SPYWDDISDSAKDFIRHLMEKDPE 253 (307)
T ss_dssp CCSSHHHHHHHHHTTCCCCC------------------------------------TTTTTTSCHHHHHHHHHHSCSSGG
T ss_pred CCCCHHHHHHHHhccCCCCC------------------------------------CccccCCCHHHHHHHHHHccCCHh
Confidence 98888777776665433221 001122456788999999997776
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.++++||||..
T Consensus 254 ~R-------~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 254 KR-------FTCEQALQHPWIAG 269 (307)
T ss_dssp GS-------CCHHHHHHSTTTTS
T ss_pred HC-------cCHHHHhcCHhhCC
Confidence 66 99999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=325.12 Aligned_cols=214 Identities=24% Similarity=0.338 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+.+|+.+++.++||||+++++++.+++.+|+|||||++|+|..+..+ +.+++..+..++.||+.||.|||++||+|
T Consensus 61 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiH 139 (293)
T d1yhwa1 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIH 139 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 35678899999999999999999999999999999999999999998765 47999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+|||++.++.+||+|||+|...... ......+||+.|+|||++.+.+ ++.++||||+||++|||++|..||.+
T Consensus 140 rDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCC
Confidence 999999999999999999999999887543 3445678999999999998765 89999999999999999999999998
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+.+..+...+.... ...+..++++.+++.+||..+|..|
T Consensus 219 ~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R 261 (293)
T d1yhwa1 219 ENPLRALYLIATNGTPEL-------------------------------------QNPEKLSAIFRDFLNRCLDMDVEKR 261 (293)
T ss_dssp SCHHHHHHHHHHHCSCCC-------------------------------------SSGGGSCHHHHHHHHHHTCSSTTTS
T ss_pred CCHHHHHHHHHhCCCCCC-------------------------------------CCcccCCHHHHHHHHHHccCChhHC
Confidence 887777665554322100 0001134677899999999777776
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.++++||||..
T Consensus 262 -------~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 262 -------GSAKELLQHQFLKI 275 (293)
T ss_dssp -------CCHHHHTTCGGGGG
T ss_pred -------cCHHHHhcCHhhCC
Confidence 99999999999953
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=335.72 Aligned_cols=251 Identities=18% Similarity=0.266 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iv 96 (303)
...+.+|+.+++.++|||||+++++|.+++++|+||||+++|+|..++.+.+.+++..+..++.|++.||.|||+ +||+
T Consensus 48 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~Ii 127 (322)
T d1s9ja_ 48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127 (322)
T ss_dssp HHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 456788999999999999999999999999999999999999999999877889999999999999999999997 5999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
||||||+|||++.++.+||+|||+|...... ...+.+||+.|+|||++.+.. |+.++||||+||++|||++|..||.+
T Consensus 128 HRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999875432 234568999999999999866 89999999999999999999999988
Q ss_pred CchHHHHHHHhh-cCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCC---CCCCCchhhHHhhhhhhccc
Q psy763 177 NMGSHMARNLLK-NNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGG---NTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 177 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~dll~~~l~~~ 252 (303)
....+....... ..+......................................... +....++++.|++.+||..+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 285 (322)
T d1s9ja_ 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285 (322)
T ss_dssp CCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCC
Confidence 765433221111 11111100000000000000000000001111112222111111 11224678999999999977
Q ss_pred cceeeccccccccccccceeeeeec
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
|..| +++.++++||||..
T Consensus 286 P~~R-------~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 286 PAER-------ADLKQLMVHAFIKR 303 (322)
T ss_dssp TTTS-------CCHHHHHTSHHHHH
T ss_pred hhHC-------cCHHHHhhCHhhCc
Confidence 7666 99999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=325.12 Aligned_cols=216 Identities=20% Similarity=0.258 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.....+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||
T Consensus 50 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~i 129 (288)
T d1uu3a_ 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129 (288)
T ss_dssp TCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccE
Confidence 34567889999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
+||||||+||+++.++.+||+|||+|....... .....+||+.|+|||++.+.. ++.++||||+||++|||++|..
T Consensus 130 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~ 208 (288)
T d1uu3a_ 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLP 208 (288)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred EcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCC
Confidence 999999999999999999999999998875332 234568999999999998776 8999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+.+..+....+....... ....++++.+++.+||..+
T Consensus 209 Pf~~~~~~~~~~~i~~~~~~~----------------------------------------p~~~s~~~~~li~~~L~~d 248 (288)
T d1uu3a_ 209 PFRAGNEYLIFQKIIKLEYDF----------------------------------------PEKFFPKARDLVEKLLVLD 248 (288)
T ss_dssp SSCCSSHHHHHHHHHTTCCCC----------------------------------------CTTCCHHHHHHHHTTSCSS
T ss_pred CCCCcCHHHHHHHHHcCCCCC----------------------------------------CccCCHHHHHHHHHHccCC
Confidence 999888777766655432211 0123467789999999977
Q ss_pred cceeecccccccccccc------ceeeeeecCC
Q psy763 253 FTYIQSEKQDSIRGKNC------KKTFYIPTPE 279 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~------l~~~~~~~~~ 279 (303)
|..| +++.++ ++||||.+.+
T Consensus 249 P~~R-------~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 249 ATKR-------LGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp GGGS-------TTSGGGTCHHHHHTSGGGTTCC
T ss_pred HhHC-------cCHHHHcCCHHHHcCCccCCCC
Confidence 7777 888875 7788887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=328.12 Aligned_cols=218 Identities=20% Similarity=0.252 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++||||+++++++++++.+|+||||+++|+|..++.+.+.+++..++.++.|++.||.|||++||+
T Consensus 48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii 127 (337)
T d1o6la_ 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence 45667789999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+|||++.+|.+||+|||+|..... .......+||+.|+|||++.+.+ |+.++||||+||++|||++|..||.
T Consensus 128 HRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCC
Confidence 999999999999999999999999987543 34456678999999999998876 8999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.+..+....+.......+ +..++++.|++.+||..+|..
T Consensus 207 ~~~~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~dli~~~L~~dP~~ 246 (337)
T d1o6la_ 207 NQDHERLFELILMEEIRFP----------------------------------------RTLSPEAKSLLAGLLKKDPKQ 246 (337)
T ss_dssp CSSHHHHHHHHHHCCCCCC----------------------------------------TTSCHHHHHHHHHHTCSSTTT
T ss_pred CcCHHHHHHHHhcCCCCCC----------------------------------------ccCCHHHHHHHHhhccCCchh
Confidence 9888777766555322211 113456778888888866665
Q ss_pred eeccccccccccccceeeeeec
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
|-. ....++.++++||||..
T Consensus 247 R~~--~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 247 RLG--GGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp STT--CSTTTHHHHHTSGGGTT
T ss_pred hcc--cccccHHHHHcCccccc
Confidence 511 01114677888888755
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=328.24 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=195.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++|||||++++++..++.+|+||||+.++++..+...+..+++..+..++.||+.||+|||++||+|
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH 123 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence 34578899999999999999999999999999999999999999988887788999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+|||++.++.+||+|||+|...... ......+||+.|+|||++.+...|+.++||||+||++|||++|..||.+
T Consensus 124 rDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 999999999999999999999999776533 3334568999999999998766689999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+.+..+.+..+.+.....+..... ............++... ....++++.|++.+||..+|..|
T Consensus 204 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-------~~~~s~~~~dll~~~L~~dP~~R 271 (299)
T d1ua2a_ 204 DSDLDQLTRIFETLGTPTEEQWPDMCSL-----PDYVTFKSFPGIPLHHI-------FSAAGDDLLDLIQGLFLFNPCAR 271 (299)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSS-----TTCCCCCCCCCCCHHHH-------CTTCCHHHHHHHHHHHCSSTTTS
T ss_pred CCHHHHHHHHHHhcCCCChhhccchhcc-----chhhhhccCCCCChHHh-------cccCCHHHHHHHHHHccCChhhC
Confidence 9998888888776554332111111000 00000111111222222 12356789999999999777666
Q ss_pred eccccccccccccceeeeeecCCcc
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
+++.++++||||.+.+.+
T Consensus 272 -------~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 272 -------ITATQALKMKYFSNRPGP 289 (299)
T ss_dssp -------CCHHHHHTSGGGTSSSCC
T ss_pred -------cCHHHHhCCHhhCCCCCC
Confidence 999999999999875543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=327.38 Aligned_cols=220 Identities=21% Similarity=0.297 Sum_probs=188.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++|||||++++++.+++.+|+|||||++|+|.+++.+.+.+++..++.++.|++.||+|||+.||+
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~iv 135 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 135 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhccee
Confidence 35678899999999999999999999999999999999999999999988778999999999999999999999999999
Q ss_pred ecccCCCcEEEecCC----cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 97 HRDIKPENILLTANG----VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 97 H~dlk~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
||||||+||+++.++ .+|++|||+|.............+|+.|+|||++.+.. ++.++||||+||++|||++|..
T Consensus 136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCC
Confidence 999999999998776 59999999999887666667788999999999998765 8999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+.+..+....+.......+ .+. .+..++++.+++.+||..+
T Consensus 215 Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~----------~~~~s~~~~~li~~~L~~d 258 (293)
T d1jksa_ 215 PFLGDTKQETLANVSAVNYEFE--------------------------DEY----------FSNTSALAKDFIRRLLVKD 258 (293)
T ss_dssp SSCCSSHHHHHHHHHTTCCCCC--------------------------HHH----------HTTSCHHHHHHHHTTSCSS
T ss_pred CCCCCCHHHHHHHHHhcCCCCC--------------------------chh----------cCCCCHHHHHHHHHHccCC
Confidence 9999888887776655432211 000 0124567889999999977
Q ss_pred cceeeccccccccccccceeeeeecCCc
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
|..| +++.++++||||...+.
T Consensus 259 P~~R-------~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 259 PKKR-------MTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp GGGS-------CCHHHHHHSTTTCC---
T ss_pred hhHC-------cCHHHHhcCcccCCCCh
Confidence 7666 99999999999976443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-46 Score=324.20 Aligned_cols=213 Identities=25% Similarity=0.342 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|+.+++.++|||||++++++.+++.+|+|||||.+|++..+....+++++..++.++.||+.||.|||++||+
T Consensus 58 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~ii 137 (309)
T d1u5ra_ 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137 (309)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 44568889999999999999999999999999999999999999988877778999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCC--ccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGD--TLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+|||++.++.+||+|||+|..... .....||+.|+|||++.+. ..|+.++|||||||++|||++|..||
T Consensus 138 HrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCcceEEECCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 999999999999999999999999987543 3456899999999998753 34899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+.+..+........ .....++++.+++.+||..+|.
T Consensus 215 ~~~~~~~~~~~i~~~~~~~~--------------------------------------~~~~~s~~~~~li~~~L~~dP~ 256 (309)
T d1u5ra_ 215 FNMNAMSALYHIAQNESPAL--------------------------------------QSGHWSEYFRNFVDSCLQKIPQ 256 (309)
T ss_dssp TTSCHHHHHHHHHHSCCCCC--------------------------------------SCTTSCHHHHHHHHHHTCSSGG
T ss_pred CCCCHHHHHHHHHhCCCCCC--------------------------------------CCCCCCHHHHHHHHHHCcCChh
Confidence 98888777766655322110 0011245677889888886666
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.++++|||+..
T Consensus 257 ~R-------pt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 257 DR-------PTSEVLLKHRFVLR 272 (309)
T ss_dssp GS-------CCHHHHTTCHHHHS
T ss_pred HC-------cCHHHHHhCHHhcC
Confidence 66 99999999998854
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=323.20 Aligned_cols=218 Identities=23% Similarity=0.322 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+.+|+++++.++|||||++++++.+++.+|+|||||++|+|..++.+ .+++++..+..++.||+.||.|||++||+|
T Consensus 54 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivH 133 (288)
T d2jfla1 54 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133 (288)
T ss_dssp GGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 4577899999999999999999999999999999999999999998653 567999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC-CccccccCCCcccCcccccC----CccCCCccchhhHHHHHHHhhccCc
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG-ENYTDYVATRWYRAPELLVG----DTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~l~~----~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
|||||+|||++.++.+||+|||+|...... .......||+.|+|||++.+ ...|+.++||||+||++|||++|..
T Consensus 134 rDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred eecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCC
Confidence 999999999999999999999999775432 22345789999999999853 3348999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+....+.+..+........ ......++++.+++.+||..+
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~-------------------------------------~~~~~~s~~~~~li~~~L~~d 256 (288)
T d2jfla1 214 PHHELNPMRVLLKIAKSEPPTL-------------------------------------AQPSRWSSNFKDFLKKCLEKN 256 (288)
T ss_dssp TTTTSCGGGHHHHHHHSCCCCC-------------------------------------SSGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCCCHHHHHHHHHcCCCCCC-------------------------------------CccccCCHHHHHHHHHHccCC
Confidence 9988887777766655322100 000113467789999999977
Q ss_pred cceeeccccccccccccceeeeeecCCc
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTPER 280 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 280 (303)
|..| +++.++++||||.....
T Consensus 257 p~~R-------~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 257 VDAR-------WTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp TTTS-------CCHHHHTTSGGGCCCCC
T ss_pred hhHC-------cCHHHHhcCcccCCCCC
Confidence 7666 99999999999976544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-45 Score=322.80 Aligned_cols=221 Identities=19% Similarity=0.254 Sum_probs=187.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 13 KEAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 13 ~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.+....+.+.+|+.+++.++||||+++++++.+++.+|+||||++||++..++.....+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 122 (316)
T d1fota_ 43 VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122 (316)
T ss_dssp HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc
Confidence 33334567889999999999999999999999999999999999999999999888899999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
+||+||||||+|||++.++.+||+|||+|..... ...+.+||+.|+|||++.+.+ |+.++||||+||++|||++|..
T Consensus 123 ~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~ 199 (316)
T d1fota_ 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYT 199 (316)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSC
T ss_pred CcEEccccCchheeEcCCCCEEEecCccceEecc--ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCC
Confidence 9999999999999999999999999999988653 335678999999999998766 8999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+....+....++......+ +..++++.+++.+||..+
T Consensus 200 Pf~~~~~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 200 PFYDSNTMKTYEKILNAELRFP----------------------------------------PFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp TTCCSSHHHHHHHHHHCCCCCC----------------------------------------TTSCHHHHHHHHHHTCSC
T ss_pred CCCCcCHHHHHHHHHcCCCCCC----------------------------------------CCCCHHHHHHHHHHhhhC
Confidence 9999888877776665432211 113456778888888866
Q ss_pred cceeeccccccccccccceeeeeecC
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
+..| -+..+.++.++++||||.+.
T Consensus 240 p~~R--~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 240 LSQR--LGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp TTTC--TTSSTTTTHHHHTSGGGSSC
T ss_pred HHhc--cccchhhHHHHHcCcccccC
Confidence 6655 22344588889999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=317.16 Aligned_cols=211 Identities=20% Similarity=0.262 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
.+.+.+|++++++++|||||++++++.+ ++.+|+||||+++|+|.+++.+...+++..+..++.||+.||.|||++
T Consensus 52 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~ 131 (270)
T d1t4ha_ 52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131 (270)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 4568899999999999999999999975 356899999999999999998878999999999999999999999999
Q ss_pred C--ceecccCCCcEEEe-cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 A--CIHRDIKPENILLT-ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 ~--ivH~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
| |+||||||+|||++ .++.+||+|||+|..... ....+.+||+.|+|||++.+ + ++.++||||+||++|||++|
T Consensus 132 ~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g 208 (270)
T d1t4ha_ 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATS 208 (270)
T ss_dssp SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHS
T ss_pred CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHC
Confidence 9 99999999999997 478999999999976443 23356789999999999865 3 89999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+......+...+..+.++. . ......+++.+++.+|+.
T Consensus 209 ~~Pf~~~~~~~~~~~~i~~~~~~~---------------------------~----------~~~~~~~~~~~li~~~l~ 251 (270)
T d1t4ha_ 209 EYPYSECQNAAQIYRRVTSGVKPA---------------------------S----------FDKVAIPEVKEIIEGCIR 251 (270)
T ss_dssp SCTTTTCSSHHHHHHHHTTTCCCG---------------------------G----------GGGCCCHHHHHHHHHHSC
T ss_pred CCCCCCcccHHHHHHHHHcCCCCc---------------------------c----------cCccCCHHHHHHHHHHcc
Confidence 999987766555554444332211 0 001234667899999999
Q ss_pred cccceeeccccccccccccceeeee
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+|..| +++.++++||||
T Consensus 252 ~dp~~R-------~s~~ell~Hp~f 269 (270)
T d1t4ha_ 252 QNKDER-------YSIKDLLNHAFF 269 (270)
T ss_dssp SSGGGS-------CCHHHHHTSGGG
T ss_pred CCHhHC-------cCHHHHhCCccc
Confidence 777666 999999999997
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-45 Score=326.03 Aligned_cols=218 Identities=22% Similarity=0.269 Sum_probs=187.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+.+|+.+++.++|||||++++++.+++.+|+|||||++|+|.+++. ..+.+++..+..++.||+.||.|||++||+
T Consensus 67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii 146 (350)
T d1koaa2 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146 (350)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCe
Confidence 4567889999999999999999999999999999999999999999874 456799999999999999999999999999
Q ss_pred ecccCCCcEEEec--CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTA--NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+|||++. ++.+||+|||+|.............||+.|+|||++.+.+ ++.++||||+||++|||++|..||
T Consensus 147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf 225 (350)
T d1koaa2 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPF 225 (350)
T ss_dssp CCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCC
Confidence 9999999999964 5789999999999887766667789999999999998766 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+.......+... ....++++.+++.+||..+|.
T Consensus 226 ~~~~~~~~~~~i~~~~~~~~~~~------------------------------------~~~~s~~~~~li~~~L~~dP~ 269 (350)
T d1koaa2 226 GGENDDETLRNVKSCDWNMDDSA------------------------------------FSGISEDGKDFIRKLLLADPN 269 (350)
T ss_dssp CCSSHHHHHHHHHHTCCCSCCGG------------------------------------GGGCCHHHHHHHHHHCCSSGG
T ss_pred CCCCHHHHHHHHHhCCCCCCccc------------------------------------ccCCCHHHHHHHHHHccCChh
Confidence 99888888877766544321000 011346778999999997776
Q ss_pred eeeccccccccccccceeeeeecCC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
.| +++.++++||||....
T Consensus 270 ~R-------~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 270 TR-------MTIHQALEHPWLTPGN 287 (350)
T ss_dssp GS-------CCHHHHHHSTTTSCTT
T ss_pred HC-------cCHHHHhcCcccCCCC
Confidence 66 9999999999997644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-45 Score=324.98 Aligned_cols=217 Identities=22% Similarity=0.234 Sum_probs=187.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++|||||++++++.+++.+|+|||||+||+|.+.+.. +.++++..++.++.||+.||.|||++||+
T Consensus 70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii 149 (352)
T d1koba_ 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149 (352)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45677899999999999999999999999999999999999999886654 44799999999999999999999999999
Q ss_pred ecccCCCcEEEe--cCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLT--ANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+|||++ .++.+||+|||+|.............||+.|+|||++.+.. ++.++||||+||++|||++|..||
T Consensus 150 HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence 999999999998 56899999999999988777777789999999999998766 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+......++. ......++++.+++.+||..+|.
T Consensus 229 ~~~~~~~~~~~i~~~~~~~~~------------------------------------~~~~~~s~~~~~li~~~L~~dp~ 272 (352)
T d1koba_ 229 AGEDDLETLQNVKRCDWEFDE------------------------------------DAFSSVSPEAKDFIKNLLQKEPR 272 (352)
T ss_dssp CCSSHHHHHHHHHHCCCCCCS------------------------------------STTTTSCHHHHHHHHTTSCSSGG
T ss_pred CCCCHHHHHHHHHhCCCCCCc------------------------------------ccccCCCHHHHHHHHHHccCChh
Confidence 998888887777665433210 00112456788999999997777
Q ss_pred eeeccccccccccccceeeeeecC
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.| +++.++++||||...
T Consensus 273 ~R-------~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 273 KR-------LTVHDALEHPWLKGD 289 (352)
T ss_dssp GS-------CCHHHHHTSTTTSSC
T ss_pred HC-------cCHHHHhcCHhhCCC
Confidence 76 999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-44 Score=311.80 Aligned_cols=218 Identities=22% Similarity=0.307 Sum_probs=188.3
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 16 IRQATEATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
...+.+.+|+.+++.++ ||||+++++++.+++.+|+||||+++|+|.+++...+++++..++.++.||+.||+|||++|
T Consensus 51 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ 130 (277)
T d1phka_ 51 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 130 (277)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 34566788999999997 99999999999999999999999999999999988889999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccC-----CccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVG-----DTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~-----~~~~~~~~DvwSlG~il~el~t 169 (303)
|+||||||+||+++.++.+||+|||++.............||+.|+|||.+.+ ...++.++||||+||++|||++
T Consensus 131 ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~ 210 (277)
T d1phka_ 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210 (277)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred CcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc
Confidence 99999999999999999999999999998876666667789999999999863 3447889999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKL 249 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l 249 (303)
|..||.+.........++.....++. ......++++.+++.+||
T Consensus 211 g~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------------------~~~~~~s~~~~~li~~~L 254 (277)
T d1phka_ 211 GSPPFWHRKQMLMLRMIMSGNYQFGS------------------------------------PEWDDYSDTVKDLVSRFL 254 (277)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCT------------------------------------TTGGGSCHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCC------------------------------------cccccCCHHHHHHHHHHc
Confidence 99999998887777666654333210 000123467889999999
Q ss_pred ccccceeeccccccccccccceeeeee
Q psy763 250 IGRFTYIQSEKQDSIRGKNCKKTFYIP 276 (303)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~~~~~ 276 (303)
..+|..| +++.++++||||.
T Consensus 255 ~~~p~~R-------~s~~eil~h~~~~ 274 (277)
T d1phka_ 255 VVQPQKR-------YTAEEALAHPFFQ 274 (277)
T ss_dssp CSSGGGS-------CCHHHHTTSGGGC
T ss_pred cCChhHC-------cCHHHHHcCHHHH
Confidence 9777666 9999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-44 Score=321.62 Aligned_cols=219 Identities=20% Similarity=0.222 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 16 IRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 16 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
...+.+.+|+++++.++||||+++++++.+.+.+++|+||+.+|++..++.+.+.+++..++.++.||+.||.|||++||
T Consensus 83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~i 162 (350)
T d1rdqe_ 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34556789999999999999999999999999999999999999999988877899999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
+||||||+|||++.++.+||+|||+|..... ......||+.|+|||++.+.+ ++.++||||+||++|||++|..||.
T Consensus 163 iHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCcCCHHHcccCCCCCEEeeeceeeeeccc--ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCC
Confidence 9999999999999999999999999988653 234568999999999998766 8999999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.........+.......+ ...++++.+++.+||..+|..
T Consensus 240 ~~~~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~~li~~~L~~dP~k 279 (350)
T d1rdqe_ 240 ADQPIQIYEKIVSGKVRFP----------------------------------------SHFSSDLKDLLRNLLQVDLTK 279 (350)
T ss_dssp CSSHHHHHHHHHHCCCCCC----------------------------------------TTCCHHHHHHHHHHSCSCTTT
T ss_pred CcCHHHHHHHHhcCCCCCC----------------------------------------ccCCHHHHHHHHHHhhhCHHh
Confidence 9888777776655432211 113466778888888877766
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
| -...+.++.++++||||.+.+
T Consensus 280 R--~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 280 R--FGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp C--TTSSTTTTHHHHTSGGGTTCC
T ss_pred c--cccccccHHHHHcCccccCCC
Confidence 5 233446888999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=313.09 Aligned_cols=211 Identities=23% Similarity=0.321 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEecCCCCcHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
.+.+.+|+++++.++||||+++++++.+ ++.+|+|||||++|+|.+++.+ +..+++..++.++.|++.||.|||
T Consensus 47 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH 126 (269)
T d2java1 47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126 (269)
T ss_dssp HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4568899999999999999999999964 4568999999999999998743 457999999999999999999999
Q ss_pred HCC-----ceecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 92 RHA-----CIHRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 92 ~~~-----ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
++| |+||||||+|||++.++.+||+|||+|....... ......||+.|+|||++.+.. |+.++|||||||++|
T Consensus 127 ~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvily 205 (269)
T d2java1 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLY 205 (269)
T ss_dssp HHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHH
T ss_pred HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHH
Confidence 976 9999999999999999999999999998865433 335578999999999998765 899999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
||++|..||.+....+....+....... .....++++.+++
T Consensus 206 el~tg~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------------~~~~~s~~l~~li 246 (269)
T d2java1 206 ELCALMPPFTAFSQKELAGKIREGKFRR---------------------------------------IPYRYSDELNEII 246 (269)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHTCCCC---------------------------------------CCTTSCHHHHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHHcCCCCC---------------------------------------CCcccCHHHHHHH
Confidence 9999999998877776665544321110 0011345678999
Q ss_pred hhhhccccceeeccccccccccccceeeee
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYI 275 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 275 (303)
.+||..+|..| +++.++++|||+
T Consensus 247 ~~~L~~dp~~R-------ps~~ell~hp~i 269 (269)
T d2java1 247 TRMLNLKDYHR-------PSVEEILENPLI 269 (269)
T ss_dssp HHHTCSSGGGS-------CCHHHHHTSTTC
T ss_pred HHHcCCChhHC-------cCHHHHHhCCcC
Confidence 99999777666 999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-44 Score=322.67 Aligned_cols=213 Identities=17% Similarity=0.160 Sum_probs=174.5
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 100 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 100 (303)
+.+++.+++.++||||+++++++.+++.+|+||||+++|+|..++.+...+++..++.++.||+.||.|||++||+||||
T Consensus 54 e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDl 133 (364)
T d1omwa3 54 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 133 (364)
T ss_dssp HHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceee
Confidence 34557788888999999999999999999999999999999999988889999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCCchH
Q psy763 101 KPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGNMGS 180 (303)
Q Consensus 101 k~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~~~~ 180 (303)
||+|||++.++.+||+|||+|...... ......||+.|+|||++.+...|+.++||||+||++|||+||..||.+....
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999999876543 3345689999999999976555899999999999999999999998765433
Q ss_pred HHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceeeccc
Q psy763 181 HMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEK 260 (303)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~ 260 (303)
.... +....... .....+..++++.+++.+||..+|..|
T Consensus 213 ~~~~-~~~~~~~~------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R---- 251 (364)
T d1omwa3 213 DKHE-IDRMTLTM------------------------------------AVELPDSFSPELRSLLEGLLQRDVNRR---- 251 (364)
T ss_dssp CHHH-HHHHSSSC------------------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTS----
T ss_pred HHHH-HHHhcccC------------------------------------CCCCCCCCCHHHHHHHHHHcccCHHHh----
Confidence 2211 11110000 001112345678899999999777666
Q ss_pred ccccc-----ccccceeeeeecC
Q psy763 261 QDSIR-----GKNCKKTFYIPTP 278 (303)
Q Consensus 261 ~~~~~-----~~~~l~~~~~~~~ 278 (303)
++ +.++++||||.+.
T Consensus 252 ---~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 252 ---LGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp ---TTTSSSTHHHHHTSGGGTTC
T ss_pred ---CCCcccCHHHHHcCccccCC
Confidence 76 7899999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=312.58 Aligned_cols=212 Identities=19% Similarity=0.245 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
..+.++..+.+.++||||+++++++.+++.+|+||||+++|+|..++.....+++..++.++.||+.||.|||++||+||
T Consensus 48 ~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHr 127 (320)
T d1xjda_ 48 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127 (320)
T ss_dssp HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 33444444556899999999999999999999999999999999999888899999999999999999999999999999
Q ss_pred ccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 99 DIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 99 dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
||||+|||++.++.+||+|||++..... ........||+.|+|||++.+.+ ++.++||||+||++|||++|..||.+.
T Consensus 128 Dikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999987653 33345578999999999999766 899999999999999999999999998
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
+..+....+.......+ +..++++.+++++||..+|..|
T Consensus 207 ~~~~~~~~i~~~~~~~p----------------------------------------~~~s~~~~dli~~~L~~dP~~R- 245 (320)
T d1xjda_ 207 DEEELFHSIRMDNPFYP----------------------------------------RWLEKEAKDLLVKLFVREPEKR- 245 (320)
T ss_dssp SHHHHHHHHHHCCCCCC----------------------------------------TTSCHHHHHHHHHHSCSSGGGS-
T ss_pred CHHHHHHHHHcCCCCCC----------------------------------------ccCCHHHHHHHHHhcccCCCCC-
Confidence 88777766544321110 1235678899999998777666
Q ss_pred cccccccccc-ccceeeeeecC
Q psy763 258 SEKQDSIRGK-NCKKTFYIPTP 278 (303)
Q Consensus 258 ~~~~~~~~~~-~~l~~~~~~~~ 278 (303)
+++. +++.||||.+.
T Consensus 246 ------~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 246 ------LGVRGDIRQHPLFREI 261 (320)
T ss_dssp ------BTTBSCGGGSGGGTTC
T ss_pred ------cCHHHHHHhCchhccC
Confidence 8885 79999998653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=314.35 Aligned_cols=216 Identities=21% Similarity=0.285 Sum_probs=184.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+++++.++||||+++++++.+++.+|+|||||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+
T Consensus 45 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~ii 124 (321)
T d1tkia_ 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124 (321)
T ss_dssp HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3457789999999999999999999999999999999999999999887654 799999999999999999999999999
Q ss_pred ecccCCCcEEEecC--CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 97 HRDIKPENILLTAN--GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 97 H~dlk~~nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
||||||+|||++.+ +.+||+|||++.............+|+.|+|||.+.+.. ++.++||||+||++|+|++|..||
T Consensus 125 HrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf 203 (321)
T d1tkia_ 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCC
Confidence 99999999999854 589999999999877666666778999999999998766 899999999999999999999999
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....++.....++. +.. +..++++.+++.+||..+|.
T Consensus 204 ~~~~~~~~~~~i~~~~~~~~~--------------------------~~~----------~~~s~~~~~li~~~L~~dp~ 247 (321)
T d1tkia_ 204 LAETNQQIIENIMNAEYTFDE--------------------------EAF----------KEISIEAMDFVDRLLVKERK 247 (321)
T ss_dssp CCSSHHHHHHHHHHTCCCCCH--------------------------HHH----------TTSCHHHHHHHHTTSCSSGG
T ss_pred CCCCHHHHHHHHHhCCCCCCh--------------------------hhc----------cCCCHHHHHHHHHHccCChh
Confidence 998888887777664333210 000 11346778999999987776
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.+++.||||..
T Consensus 248 ~R-------~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 248 SR-------MTASEALQHPWLKQ 263 (321)
T ss_dssp GS-------CCHHHHHHSHHHHS
T ss_pred HC-------cCHHHHhcCHhhcc
Confidence 66 99999999999854
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=304.09 Aligned_cols=208 Identities=17% Similarity=0.188 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+.+|+.++++++||||+++++++.+ +.+++||||+++|+|.+++.. +..+++..+..++.||+.||+|||++||+
T Consensus 48 ~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iv 126 (276)
T d1uwha_ 48 LQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSII 126 (276)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEe
Confidence 4578899999999999999999998754 568999999999999998854 45799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCC--ccCCCccchhhHHHHHHHhhccC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGD--TLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~--~~~~~~~DvwSlG~il~el~tg~ 171 (303)
||||||+|||++.++.+||+|||+|....... ......||+.|+|||++.+. ..|+.++|||||||++|||+||.
T Consensus 127 HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence 99999999999999999999999998765322 23456899999999999753 34789999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEee-cCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVIL-KSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.||.+......+...+..+...+... .+..++.++.+++-.||..+|..||.+.-
T Consensus 207 ~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~ 262 (276)
T d1uwha_ 207 LPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ 262 (276)
T ss_dssp CTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 99988877777777776665544332 34456667777777888777777765444
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=308.56 Aligned_cols=244 Identities=28% Similarity=0.453 Sum_probs=190.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+++++.++||||+++++++.+++.+|+||||+.++++..... ....+++..+..++.|++.||.|||++||+
T Consensus 45 ~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~Ii 124 (298)
T d1gz8a_ 45 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124 (298)
T ss_dssp CHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEE
Confidence 4567889999999999999999999999999999999999877666544 356799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCC-CCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINP-GENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+|||++.++.+||+|||.|..... ........||+.|+|||++.....++.++|+||+||++|+|++|..||.
T Consensus 125 HrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp CSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 999999999999999999999999987653 3344556899999999998877767899999999999999999999999
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccce
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTY 255 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~ 255 (303)
+.+..+.+..+....+.+......... ....+..........+.... .+..++++.|++.+||..+|..
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~s~~~~dll~~mL~~dP~~ 273 (298)
T d1gz8a_ 205 GDSEIDQLFRIFRTLGTPDEVVWPGVT----SMPDYKPSFPKWARQDFSKV-------VPPLDEDGRSLLSQMLHYDPNK 273 (298)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGG----GSTTCCTTSCCCCCCCHHHH-------STTCCHHHHHHHHHHTCSSTTT
T ss_pred CCCHHHHHHHHHHhcCCCchhhccccc----cccccccccccccccchhhh-------ccCCCHHHHHHHHHHccCChhH
Confidence 998888887777654443211111000 00000001111111112111 1235678899999999976666
Q ss_pred eeccccccccccccceeeeeecCC
Q psy763 256 IQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 256 ~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
| +++.+++.||||.+..
T Consensus 274 R-------~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 274 R-------ISAKAALAHPFFQDVT 290 (298)
T ss_dssp S-------CCHHHHHTSGGGTTCC
T ss_pred C-------cCHHHHhCCHhhccCC
Confidence 6 9999999999997643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=302.50 Aligned_cols=204 Identities=21% Similarity=0.261 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
..+.+.+|++++++++|||||+++|+|.. +..++||||+++|+|.+++.+...+++..+..++.||+.||+|||++||+
T Consensus 51 ~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ii 129 (277)
T d1xbba_ 51 LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129 (277)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcc
Confidence 45678899999999999999999999965 45789999999999999998888999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc----ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY----TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IG 171 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~ 171 (303)
||||||+|||++.++.+||+|||+++........ ....||+.|+|||.+.+.. ++.++|||||||++|||+| |.
T Consensus 130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCC
Confidence 9999999999999999999999999886543322 2356899999999998665 8999999999999999998 66
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.||.+....+.. ..+..+.+++ .+..++.+..+++..||..+|..||.+.-
T Consensus 209 ~Pf~~~~~~~~~-~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dp~~RPs~~~ 259 (277)
T d1xbba_ 209 KPYRGMKGSEVT-AMLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAA 259 (277)
T ss_dssp CSSTTCCHHHHH-HHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCHHHHH-HHHHcCCCCC---CCcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 676666655544 4555555543 34567778888888888888888876544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-43 Score=305.99 Aligned_cols=203 Identities=17% Similarity=0.227 Sum_probs=158.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.+.+.+|+.+++.++|||||+++|++..++.+++|||||++|+|..++.. .+.+++..+..++.||+.||.|||++||+
T Consensus 71 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii 150 (299)
T d1jpaa_ 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 150 (299)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCc
Confidence 45688999999999999999999999999999999999999999997766 45799999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCcc------ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENY------TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ- 169 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t- 169 (303)
||||||+|||++.++.+||+|||+|+........ ....+|+.|+|||.+.+.. ++.++|||||||++|||+|
T Consensus 151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhC
Confidence 9999999999999999999999999876543221 1245788999999998765 8999999999999999998
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
|..||.+....+.... +..+.+++ .+..++.++.+++-.||..+|..||...
T Consensus 230 g~~Pf~~~~~~~~~~~-i~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ 281 (299)
T d1jpaa_ 230 GERPYWDMTNQDVINA-IEQDYRLP---PPMDCPSALHQLMLDCWQKDRNHRPKFG 281 (299)
T ss_dssp SCCTTTTCCHHHHHHH-HHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHH-HHcCCCCC---CCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 5666666666655544 44444443 3445677777777788877777666443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=302.32 Aligned_cols=204 Identities=19% Similarity=0.237 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|++++++++|||||+++|++.+ +.+|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||
T Consensus 52 ~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~i 130 (285)
T d1u59a_ 52 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130 (285)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34568899999999999999999999875 458999999999999998654 4679999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-c
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-I 170 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g 170 (303)
+||||||+||+++.++.+||+|||+|+....... .....||+.|+|||++.+.. ++.++|||||||++|||+| |
T Consensus 131 iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G 209 (285)
T d1u59a_ 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYG 209 (285)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred ecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCC
Confidence 9999999999999999999999999998764332 23456889999999998665 8999999999999999998 6
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..||.+....+.. ..+..+.+++ .+..++++..+++..||..+|..||.+.-
T Consensus 210 ~~Pf~~~~~~~~~-~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~p~~RPs~~~ 261 (285)
T d1u59a_ 210 QKPYKKMKGPEVM-AFIEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLT 261 (285)
T ss_dssp CCTTTTCCTHHHH-HHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHH-HHHHcCCCCC---CCCcCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 6776666655554 4455555543 34567778888888888888887775444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=298.87 Aligned_cols=204 Identities=21% Similarity=0.294 Sum_probs=159.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+.+|+++++.++||||++++|++..++.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+|
T Consensus 45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiH 124 (263)
T d1sm2a_ 45 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 124 (263)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceee
Confidence 4688999999999999999999999999999999999999999997654 457899999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
|||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||+|++.+++
T Consensus 125 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp TTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCC
Confidence 99999999999999999999999987654322 23457899999999998766 8999999999999999999776666
Q ss_pred CCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 176 GNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.......+...+..+.++. .+..++++..+++..||..+|..||..+-
T Consensus 204 ~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~p~~Rps~~~ 251 (263)
T d1sm2a_ 204 ENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWKERPEDRPAFSR 251 (263)
T ss_dssp CSCCHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHHHHHHHHHhcCCCC---CccccCHHHHHHHHHHccCCHhHCcCHHH
Confidence 6555544444555554432 34455667777777777777776665444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=302.99 Aligned_cols=235 Identities=29% Similarity=0.407 Sum_probs=182.9
Q ss_pred HHHHHHhCCCCCcceeEEEEEe-----CCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 24 NKKEKRSLKHPNLVNLLEVFRR-----KKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 24 e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+.++..+||||++++++|.. ...+++++|+++++++.... .....+++..++.++.|++.||+|||++||+|
T Consensus 60 ~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivH 139 (305)
T d1blxa_ 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH 139 (305)
T ss_dssp HHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence 3344555689999999999863 24789999999998876544 34567999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLGN 177 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~~ 177 (303)
|||||+|||++.++.+||+|||++.............||+.|+|||++.+.+ |+.++||||+||++|||++|..||.+.
T Consensus 140 rDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 140 RDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999998766555667789999999999998766 899999999999999999999999999
Q ss_pred chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccceee
Q psy763 178 MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYIQ 257 (303)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~~ 257 (303)
+..+.+..++...+.+.....+..... +..........+... .....++.+.||+.+||..+|..|
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~-------~~~~~s~~~~dli~~mL~~dP~~R- 284 (305)
T d1blxa_ 219 SDVDQLGKILDVIGLPGEEDWPRDVAL------PRQAFHSKSAQPIEK-------FVTDIDELGKDLLLKCLTFNPAKR- 284 (305)
T ss_dssp SHHHHHHHHHHHHCCCCGGGSCTTCSS------CGGGSCCCCCCCGGG-------TCCSCCHHHHHHHHHHSCSSTTTS-
T ss_pred CHHHHHHHHHHhhCCCchhcccccccc------hhhhhccccccchhh-------ccccCCHHHHHHHHHHCcCChhHC-
Confidence 998888888776554432221111100 011111111111111 123456788999999999666655
Q ss_pred ccccccccccccceeeeeecCC
Q psy763 258 SEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 258 ~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+++.+++.||||.+.+
T Consensus 285 ------~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 285 ------ISAYSALSHPYFQDLE 300 (305)
T ss_dssp ------CCHHHHHTSGGGTTCC
T ss_pred ------cCHHHHhcChhhcCch
Confidence 9999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=308.81 Aligned_cols=206 Identities=23% Similarity=0.283 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC-----------------------CCCC
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-----------------------HGLP 72 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----------------------~~l~ 72 (303)
....+.+|+.+++++ +|||||++++++.+.+.+|+|||||++|+|.+++... ..++
T Consensus 83 ~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 162 (325)
T d1rjba_ 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162 (325)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CC
T ss_pred HHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCC
Confidence 455678888888887 8999999999999999999999999999999988653 2489
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCc
Q psy763 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDT 149 (303)
Q Consensus 73 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~ 149 (303)
+..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+....... .....||+.|+|||++.+..
T Consensus 163 ~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 163 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC
Confidence 999999999999999999999999999999999999999999999999987654332 23456799999999998665
Q ss_pred cCCCccchhhHHHHHHHhhc-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 150 LYGPAVDVWAIEWTSHSYSQ-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 150 ~~~~~~DvwSlG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++.++|||||||++|||+| |..||.+....+.+..++..+.+++ .+..++.++.+++-.||..+|..||..+-
T Consensus 243 -~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 243 -YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp -CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 8999999999999999998 6778877777777788888776653 34456667777777777777776665443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-42 Score=300.90 Aligned_cols=205 Identities=21% Similarity=0.294 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+++++.++|||||+++++|.+++.+++||||+++|++..++.. ...+++..+..++.|++.||+|||++||
T Consensus 57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i 136 (287)
T d1opja_ 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136 (287)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34578999999999999999999999999999999999999999998753 3579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||||||+|||++.++.+||+|||+|+....... .....|++.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 137 iHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p 215 (287)
T d1opja_ 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMS 215 (287)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654322 22345788999999998765 89999999999999999999888
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+++......+...+..+.+++ .+..++.++.+++..||..+|..||...-
T Consensus 216 ~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e 265 (287)
T d1opja_ 216 PYPGIDLSQVYELLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAE 265 (287)
T ss_dssp SSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCcchHHHHHHHHhcCCCCC---CCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 887777777777777766543 34556777788888888887777765443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.3e-43 Score=302.31 Aligned_cols=242 Identities=26% Similarity=0.397 Sum_probs=188.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
...+.+|+.+++.++||||+++++++..++..++++|++.++++..+....+.+++..+..++.||+.||+|||+.||+|
T Consensus 44 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvH 123 (286)
T d1ob3a_ 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123 (286)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEe
Confidence 45678899999999999999999999999999999999999999998888889999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+|||++.++.+|++|||.|....... ......+++.|+|||.+.+...++.++||||+||++|||++|..||.+
T Consensus 124 rDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp SCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 9999999999999999999999998765432 334457899999999998877789999999999999999999999999
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
....+...++....+.+........ .... .+..........++ ....+..++.+.|++++||..+|..|
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~-------~~~~~~~s~~~~dli~~~L~~dP~~R 272 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNV--TELP--KYDPNFTVYEPLPW-------ESFLKGLDESGIDLLSKMLKLDPNQR 272 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTG--GGST--TCCTTCCCCCCCCG-------GGTCCSCCHHHHHHHHHHTCSSTTTS
T ss_pred CCHHHHHHHHHHhhCCCChhhccch--hhhh--hcccccccccCcch-------hhhcccCCHHHHHHHHHHccCChhHC
Confidence 8888887777665444321111100 0000 00000111111111 11223356788999999999777666
Q ss_pred eccccccccccccceeeeeec
Q psy763 257 QSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+++.++++||||.+
T Consensus 273 -------~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 273 -------ITAKQALEHAYFKE 286 (286)
T ss_dssp -------CCHHHHHTSGGGGC
T ss_pred -------cCHHHHhcCcccCc
Confidence 99999999999853
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=306.12 Aligned_cols=217 Identities=22% Similarity=0.267 Sum_probs=170.3
Q ss_pred HHHHHHHH-HhCCCCCcceeEEEEEe----CCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 21 EATNKKEK-RSLKHPNLVNLLEVFRR----KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 21 ~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
..+|+.++ +..+||||++++++|.+ .+.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++
T Consensus 51 ~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~ 130 (335)
T d2ozaa1 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130 (335)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc
Confidence 45677764 56689999999999976 35789999999999999988653 4799999999999999999999999
Q ss_pred CceecccCCCcEEEec---CCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 94 ACIHRDIKPENILLTA---NGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
||+||||||+|||++. .+.+||+|||+|.............||+.|+|||++.+.. |+.++||||+||++|+|+||
T Consensus 131 ~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg 209 (335)
T d2ozaa1 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCG 209 (335)
T ss_dssp TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTS
T ss_pred CCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhC
Confidence 9999999999999985 4679999999999887766667789999999999998766 89999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..||.+.........+........ ..-+ .+.. ...++++.+++.+||.
T Consensus 210 ~~Pf~~~~~~~~~~~~~~~i~~~~--------------------~~~~--~~~~----------~~~s~~~~~li~~~L~ 257 (335)
T d2ozaa1 210 YPPFYSNHGLAISPGMKTRIRMGQ--------------------YEFP--NPEW----------SEVSEEVKMLIRNLLK 257 (335)
T ss_dssp SCSCEETTCC--------CCCSCS--------------------SSCC--TTHH----------HHSCHHHHHHHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHHHHhcCC--------------------CCCC--Cccc----------ccCCHHHHHHHHHHcc
Confidence 999987654443332222111000 0000 0000 0135678899999999
Q ss_pred cccceeeccccccccccccceeeeeec
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.+|..| +++.+++.||||..
T Consensus 258 ~dP~~R-------~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 258 TEPTQR-------MTITEFMNHPWIMQ 277 (335)
T ss_dssp SSTTTS-------CCHHHHHHSHHHHT
T ss_pred CChhHC-------cCHHHHHcCHHhhC
Confidence 777666 99999999999854
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-42 Score=300.35 Aligned_cols=248 Identities=29% Similarity=0.418 Sum_probs=187.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEe--------CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRR--------KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
..+.+|+.+++.++||||+++++++.. .+.+|+|||+++++++.........+++..++.++.|++.||.||
T Consensus 54 ~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~l 133 (318)
T d3blha1 54 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 133 (318)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHh
Confidence 446789999999999999999999865 346899999999999888877778999999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCC-----CccccccCCCcccCcccccCCccCCCccchhhHHHHHH
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPG-----ENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSH 165 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~ 165 (303)
|++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||||+||++|
T Consensus 134 H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~ 213 (318)
T d3blha1 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213 (318)
T ss_dssp HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred ccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceee
Confidence 9999999999999999999999999999999876532 22344679999999999988767899999999999999
Q ss_pred HhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhh
Q psy763 166 SYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKIL 245 (303)
Q Consensus 166 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll 245 (303)
||++|..||.+.........+....+.+............................+.+.. ....++++||+
T Consensus 214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~dLl 285 (318)
T d3blha1 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA--------YVRDPYALDLI 285 (318)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHH--------HHCCHHHHHHH
T ss_pred eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhcc--------ccCCHHHHHHH
Confidence 9999999999888877777766654443321111111111110000000001111111111 11357889999
Q ss_pred hhhhccccceeeccccccccccccceeeeeecCCcc
Q psy763 246 GKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPTPERK 281 (303)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 281 (303)
.+||..+|..| +++.+++.||||.+.+.+
T Consensus 286 ~~mL~~dP~~R-------~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 286 DKLLVLDPAQR-------IDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp HHHSCSSTTTS-------CCHHHHHHSGGGSSSSCC
T ss_pred HHHCcCChhHC-------cCHHHHHcChhhccCCCC
Confidence 99999766665 999999999999875543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=295.75 Aligned_cols=204 Identities=18% Similarity=0.261 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
...+.+|+.+++.++|||||+++|++.+.+..++|+||+.+|++..+.. ....+++..+..++.|++.||.|||+.||+
T Consensus 53 ~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~ii 132 (283)
T d1mqba_ 53 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 132 (283)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccc
Confidence 4567899999999999999999999999999999999999999988654 446899999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||||++|||++++.
T Consensus 133 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~ 211 (283)
T d1mqba_ 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGE 211 (283)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCC
Confidence 999999999999999999999999987653321 22346799999999998765 8999999999999999999887
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
++++......+...+..+.+++ .+..++.++.+++..||..+|..||...
T Consensus 212 ~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ 261 (283)
T d1mqba_ 212 RPYWELSNHEVMKAINDGFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFA 261 (283)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CccccCCHHHHHHHHhccCCCC---CchhhHHHHHHHHHHHCcCCHhHCcCHH
Confidence 7777666666666677666654 3445667778888888888777776543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=295.09 Aligned_cols=204 Identities=22% Similarity=0.328 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.++++++|||||+++|++.+ +.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||
T Consensus 52 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~i 130 (272)
T d1qpca_ 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130 (272)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3468899999999999999999998764 56799999999999998765433 69999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||||||+|||++.++.+||+|||+|+....... .....+|+.|+|||++.+.. ++.++|||||||++|||+||+.+
T Consensus 131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCC
Confidence 9999999999999999999999999998764332 23457899999999998655 89999999999999999998877
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++.......+...+..+.++. .++.++.+..+++..||..+|..||....
T Consensus 210 ~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~e 259 (272)
T d1qpca_ 210 PYPGMTNPEVIQNLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDY 259 (272)
T ss_dssp SSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCC---CcccChHHHHHHHHHHcCCCHhHCcCHHH
Confidence 776666555555556555543 34566777777777888777777765443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=305.36 Aligned_cols=234 Identities=26% Similarity=0.360 Sum_probs=184.7
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEecCCCCcHHHH---HcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 22 ATNKKEKRSLKHPNLVNLLEVFRRK------KKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 22 ~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~l~~~---~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.+|+.+++.++||||++++++|... ..+|+||||++++++..+ ......+++..++.++.||+.||+|||+
T Consensus 61 ~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~ 140 (350)
T d1q5ka_ 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140 (350)
T ss_dssp CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4689999999999999999999643 358999999998765543 3456689999999999999999999999
Q ss_pred CCceecccCCCcEEEecCC-cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 93 HACIHRDIKPENILLTANG-VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
+||+||||||+|||++.++ .+||+|||++..........+..||+.|+|||.+.+...++.++||||+||++|||++|.
T Consensus 141 ~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~ 220 (350)
T d1q5ka_ 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220 (350)
T ss_dssp TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTS
T ss_pred cCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCC
Confidence 9999999999999999775 899999999998877666677889999999999987766899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhh----hhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQE----IFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
.||.+....+.+..+++..+.+.... +...... .+......++. ....+..++++.||+.+
T Consensus 221 ~pf~~~~~~~~l~~i~~~~g~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~s~~~~dLl~~ 285 (350)
T d1q5ka_ 221 PIFPGDSGVDQLVEIIKVLGTPTREQ---------IREMNPNYTEFKFPQIKAHPWT------KVFRPRTPPEAIALCSR 285 (350)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHH---------HHHHCC---CCCCCCCCCCCGG------GTSCTTSCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCChHHh---------hhhhccchhhccccccccCchh------hhcccCCCHHHHHHHHH
Confidence 99999988888887777544432110 0000000 00111111111 11233467889999999
Q ss_pred hhccccceeeccccccccccccceeeeeec
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
||..+|..| +++.++++||||.+
T Consensus 286 mL~~dP~~R-------~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 286 LLEYTPTAR-------LTPLEACAHSFFDE 308 (350)
T ss_dssp HSCSSGGGS-------CCHHHHHTSGGGGG
T ss_pred HccCChhHC-------cCHHHHhcCHhhcc
Confidence 999777666 99999999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-42 Score=303.27 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=182.8
Q ss_pred HHHHHHHHHHHhCC-CCCcceeEEEEEeC--CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 19 ATEATNKKEKRSLK-HPNLVNLLEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+|+.+++.++ ||||+++++++... ..+++||||+++++|..+. +.+++..++.++.||+.||.|||++||
T Consensus 74 ~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gI 150 (328)
T d3bqca1 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGI 150 (328)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhccc
Confidence 35678999999985 99999999999854 5699999999999998764 479999999999999999999999999
Q ss_pred eecccCCCcEEEecCC-cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccC
Q psy763 96 IHRDIKPENILLTANG-VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
+||||||+|||++.++ .+||+|||+|.............+|+.|+|||.+.+...++.++||||+||++|||++|..|+
T Consensus 151 vHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf 230 (328)
T d3bqca1 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230 (328)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCC
Confidence 9999999999999654 699999999998877666677889999999999988776899999999999999999999888
Q ss_pred CCCch-HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccc
Q psy763 175 LGNMG-SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRF 253 (303)
Q Consensus 175 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~ 253 (303)
..... ......+....+.+............ ....+...........+... .........++++.||+.+||..+|
T Consensus 231 ~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~mL~~dP 307 (328)
T d3bqca1 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDILGRHSRKRWERF--VHSENQHLVSPEALDFLDKLLRYDH 307 (328)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC-CCGGGGGTCCCCCCCCGGGG--CCTTTGGGCCHHHHHHHHHHSCSSG
T ss_pred CCCchhHHHHHHHHHHHCCchhhhhhhhcccc-cCcccchhcccccccchhhc--ccccccccCCHHHHHHHHHHccCCh
Confidence 76543 33333333222211100000000000 00001111111122222222 2223334567889999999999777
Q ss_pred ceeeccccccccccccceeeeeecCC
Q psy763 254 TYIQSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 254 ~~~~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
..| +++.++|+||||.+..
T Consensus 308 ~~R-------~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 308 QSR-------LTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGS-------CCHHHHHTSGGGTTSC
T ss_pred hHC-------cCHHHHhcCcccCCCC
Confidence 766 9999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=286.54 Aligned_cols=203 Identities=19% Similarity=0.284 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+.+|+.+++.++||||++++|++.+++.+++||||+++|++..++.. ...+++..+..++.|+++||+|||+.||+|
T Consensus 44 ~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH 123 (258)
T d1k2pa_ 44 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123 (258)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCC
T ss_pred HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccc
Confidence 4678999999999999999999999999999999999999999887544 457999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCCCc--cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPGEN--YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~~~ 174 (303)
|||||+||+++.++.+||+|||++........ .....+|+.|+|||.+.+.. ++.++|||||||++|||+| |..||
T Consensus 124 ~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf 202 (258)
T d1k2pa_ 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPY 202 (258)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCC
Confidence 99999999999999999999999987654332 23467899999999998765 8999999999999999998 56666
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.+.+..+....+ ..+.+++ .+...+++..+++-.||..+|..||.+..
T Consensus 203 ~~~~~~~~~~~i-~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~e 250 (258)
T d1k2pa_ 203 ERFTNSETAEHI-AQGLRLY---RPHLASEKVYTIMYSCWHEKADERPTFKI 250 (258)
T ss_dssp TTSCHHHHHHHH-HTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCCHHHHHHHH-HhCCCCC---CcccccHHHHHHHHHHccCCHhHCcCHHH
Confidence 666666655544 4444433 34556667777777777777777765544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=292.87 Aligned_cols=205 Identities=23% Similarity=0.297 Sum_probs=170.9
Q ss_pred HHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEecCCC-CcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 21 EATNKKEKRSLK--HPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 21 ~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+|+.+++.++ ||||+++++++.+++..++||||+.+ +++..++.+...+++..++.++.|++.||.|||++||+|
T Consensus 54 ~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiH 133 (273)
T d1xwsa_ 54 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 133 (273)
T ss_dssp EEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 457888999886 99999999999999999999999976 678888877789999999999999999999999999999
Q ss_pred cccCCCcEEEecC-CcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCCC
Q psy763 98 RDIKPENILLTAN-GVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGLG 176 (303)
Q Consensus 98 ~dlk~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~~ 176 (303)
|||||+||+++.+ +.+||+|||+|..... ....+..||+.|+|||++.+.+.++.++||||+||++|||++|..||.+
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccCcccceEEecCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 9999999999855 7999999999987543 3345678999999999998776567889999999999999999988865
Q ss_pred CchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhcccccee
Q psy763 177 NMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFTYI 256 (303)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~~~ 256 (303)
... +..... ......++++.+++.+||..+|..|
T Consensus 213 ~~~------i~~~~~----------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R 246 (273)
T d1xwsa_ 213 DEE------IIRGQV----------------------------------------FFRQRVSSECQHLIRWCLALRPSDR 246 (273)
T ss_dssp HHH------HHHCCC----------------------------------------CCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred chH------Hhhccc----------------------------------------CCCCCCCHHHHHHHHHHccCCHhHC
Confidence 321 111100 0112245778899999999777666
Q ss_pred eccccccccccccceeeeeecCC
Q psy763 257 QSEKQDSIRGKNCKKTFYIPTPE 279 (303)
Q Consensus 257 ~~~~~~~~~~~~~l~~~~~~~~~ 279 (303)
+++.++++||||.+..
T Consensus 247 -------~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 247 -------PTFEEIQNHPWMQDVL 262 (273)
T ss_dssp -------CCHHHHHTSGGGSSCC
T ss_pred -------cCHHHHhcCHhhCCCC
Confidence 9999999999997643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-41 Score=291.49 Aligned_cols=203 Identities=18% Similarity=0.269 Sum_probs=160.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
....+.+|+++++.++||||+++++++...+ .+|+||||++|++|..++...+.+++..++.++.||+.||.|||+
T Consensus 50 ~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 129 (277)
T d1o6ya_ 50 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129 (277)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4567889999999999999999999998654 489999999999999988888899999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
+||+||||||+||+++.++..+++|||.+....... ......||+.|+|||++.+.. ++.++||||+||++|||+
T Consensus 130 ~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHH
T ss_pred CCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHH
Confidence 999999999999999999999999999987654322 234567999999999998765 899999999999999999
Q ss_pred ccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChh
Q psy763 169 QIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTT 221 (303)
Q Consensus 169 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
||..||.+....+....++.....++ ....+..++++.+++-+++..+|..|
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~R 260 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPP-SARHEGLSADLDAVVLKALAKNPENR 260 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCG-GGTSSSCCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCC-chhccCCCHHHHHHHHHHccCCHhHC
Confidence 99999999988888888777655443 12223344444444444444444433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=295.58 Aligned_cols=242 Identities=24% Similarity=0.374 Sum_probs=186.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 90 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 90 (303)
....+.+|+++++.++|||||+++++|...+ .+|+||||+ ++++..+... +.+++..++.++.||+.||.||
T Consensus 60 ~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~L 137 (346)
T d1cm8a_ 60 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYI 137 (346)
T ss_dssp HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHH
Confidence 3456778999999999999999999998654 579999999 5677776653 5799999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc
Q psy763 91 HRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI 170 (303)
Q Consensus 91 H~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg 170 (303)
|++||+||||||+|||++.++.+|++|||+|..... ......+|+.|+|||++.+...++.++||||+||++|||++|
T Consensus 138 H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g 215 (346)
T d1cm8a_ 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215 (346)
T ss_dssp HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred HhCCCcccccCcchhhcccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC
Confidence 999999999999999999999999999999987543 345678999999999998776689999999999999999999
Q ss_pred CccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhc
Q psy763 171 GFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLI 250 (303)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~ 250 (303)
..|+.+.........+....+.++........... ...+..........++.. .....++++.||+.+||.
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~dli~~mL~ 286 (346)
T d1cm8a_ 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE--AKNYMKGLPELEKKDFAS-------ILTNASPLAVNLLEKMLV 286 (346)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH--HHHHHHHSCCCCCCCGGG-------TCTTCCHHHHHHHHHHSC
T ss_pred cCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh--hhhhhccCCcccccchHH-------hccCCCHHHHHHHHHHCc
Confidence 99999998888887777765544311110000000 000000011111111110 112356789999999999
Q ss_pred cccceeeccccccccccccceeeeeecC
Q psy763 251 GRFTYIQSEKQDSIRGKNCKKTFYIPTP 278 (303)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 278 (303)
.+|..| +++.+++.||||...
T Consensus 287 ~dP~~R-------~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 287 LDAEQR-------VTAGEALAHPYFESL 307 (346)
T ss_dssp SSTTTS-------CCHHHHHHSGGGTTT
T ss_pred CChhHC-------cCHHHHhcChhhCcC
Confidence 777666 999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-41 Score=287.95 Aligned_cols=208 Identities=22% Similarity=0.277 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 14 EAIRQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 14 ~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
.....+.+.+|+.+++.++||||++++|++.+ +..++|+||+++|++.+++. +.+.+++..+..++.|++.||.|||+
T Consensus 51 ~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 129 (273)
T d1u46a_ 51 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129 (273)
T ss_dssp -CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 33445678899999999999999999999975 46789999999999888554 34579999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCc----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhh
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYS 168 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~ 168 (303)
+||+||||||+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||+
T Consensus 130 ~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMF 208 (273)
T ss_dssp TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHH
T ss_pred CCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHH
Confidence 9999999999999999999999999999998754332 12346788999999998765 899999999999999999
Q ss_pred c-cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 169 Q-IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 169 t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
| |..||.+.+..+....+...+.+++ .+...++++.+++..||..+|..||.+.-
T Consensus 209 t~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~e 264 (273)
T d1u46a_ 209 TYGQEPWIGLNGSQILHKIDKEGERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264 (273)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hCCCCCCCCcCHHHHHHHHHhCCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 8 7788888888888888877776653 34566778888888888888887776544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=292.11 Aligned_cols=206 Identities=25% Similarity=0.266 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQI 79 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~ 79 (303)
..+.+.+|+++++.+ +||||++++|++.+++.+++||||+++|+|.+++... ..+++..+..+
T Consensus 53 ~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 132 (309)
T d1fvra_ 53 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132 (309)
T ss_dssp --CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHH
Confidence 345688999999998 7999999999999999999999999999999988643 57999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhh
Q psy763 80 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWA 159 (303)
Q Consensus 80 ~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwS 159 (303)
+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.............+|..|+|||.+.+.. ++.++||||
T Consensus 133 ~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwS 211 (309)
T d1fvra_ 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWS 211 (309)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHH
T ss_pred HHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeeh
Confidence 9999999999999999999999999999999999999999998765444444567899999999998665 899999999
Q ss_pred HHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 160 IEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 160 lG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|||++|||++|+.+|+.......+...+..+.+++ .+..++++..+++-.||..+|..||..+.
T Consensus 212 fGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~e 275 (309)
T d1fvra_ 212 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQ 275 (309)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999998765554444444444455555443 33456677778888888887777775544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-41 Score=287.65 Aligned_cols=204 Identities=19% Similarity=0.258 Sum_probs=155.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
....+.+|+.+++.++||||++++|++. ++.+|+||||+++|++..++. ....+++..++.++.||+.||.|||++|+
T Consensus 51 ~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~i 129 (273)
T d1mp8a_ 51 VREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129 (273)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCe
Confidence 4567889999999999999999999996 567899999999999998654 45579999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc-cCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ-IGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t-g~~ 172 (303)
+||||||+||+++.++.+||+|||+|....... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..
T Consensus 130 iHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~ 208 (273)
T d1mp8a_ 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVK 208 (273)
T ss_dssp CCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCC
T ss_pred eccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCC
Confidence 999999999999999999999999998765332 223456899999999998665 8999999999999999998 566
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.+....+....+. .+.+++ .+..++.+..+++-.||..+|..||...-
T Consensus 209 P~~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~e 258 (273)
T d1mp8a_ 209 PFQGVKNNDVIGRIE-NGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTE 258 (273)
T ss_dssp TTTTCCGGGHHHHHH-TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHH-cCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 666666666655544 444432 34456677777777777777766664443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=286.12 Aligned_cols=243 Identities=24% Similarity=0.386 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
....+.+|+.+++.++||||+++++++.+....++|+|++.++++..+....+.+++..++.++.|++.||+|||++||+
T Consensus 44 ~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~Iv 123 (292)
T d1unla_ 44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123 (292)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEe
Confidence 34567889999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCC-ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCccCC
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGE-NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~~~ 175 (303)
||||||+|||++.++.+||+|||.+....... ......+++.|+|||.+.+...++.++||||+||++|||++|+.||+
T Consensus 124 HrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred eecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 99999999999999999999999998876433 33445678889999999877767999999999999999999998866
Q ss_pred CC-chHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 176 GN-MGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 176 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.. ...+....+....+.+..... +.... +......+. .+... .........++.+.|++.+||..+|.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~-~~~~~---~~~~~~~~~s~~~~dll~~mL~~dP~ 272 (292)
T d1unla_ 204 PGNDVDDQLKRIFRLLGTPTEEQW-----PSMTK--LPDYKPYPM-YPATT---SLVNVVPKLNATGRDLLQNLLKCNPV 272 (292)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTC-----TTGGG--STTCCCCCC-CCTTC---CCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred CCCCHHHHHHHHHhhcCCCChhhh-----hhhhh--ccccccccc-ccccc---hhhhccccCCHHHHHHHHHHccCChh
Confidence 55 444444444443332211000 00000 000000000 00000 01112234567889999999987666
Q ss_pred eeeccccccccccccceeeeeec
Q psy763 255 YIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 255 ~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.| +++.++|+||||.+
T Consensus 273 ~R-------~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 273 QR-------ISAEEALQHPYFSD 288 (292)
T ss_dssp GS-------CCHHHHTTSGGGSS
T ss_pred HC-------cCHHHHhcChhhcC
Confidence 66 99999999999964
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=290.05 Aligned_cols=206 Identities=17% Similarity=0.268 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
..+.+.+|+.+++.++|||||+++|+|.+++ .++++|++.+|++.+.+ .....+++..++.++.||+.||.|||++||
T Consensus 54 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~i 132 (317)
T d1xkka_ 54 ANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132 (317)
T ss_dssp THHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 3456889999999999999999999998754 67788888888877754 445689999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCcc---ccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENY---TDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
+||||||+||+++.++.+||+|||+|......... ....||+.|+|||++.+.. ++.++|||||||++|||+|++.
T Consensus 133 iHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~ 211 (317)
T d1xkka_ 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGS 211 (317)
T ss_dssp CCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCC
Confidence 99999999999999999999999999886543322 2346899999999998765 8999999999999999999665
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHH
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (303)
+|+.......+...+..+.+++ .+..++.+..+++..||..+|..||...-+
T Consensus 212 ~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 263 (317)
T d1xkka_ 212 KPYDGIPASEISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFREL 263 (317)
T ss_dssp CTTTTSCGGGHHHHHHHTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 5555555555566666666653 345667788888888888888887765543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-40 Score=288.23 Aligned_cols=205 Identities=23% Similarity=0.274 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC------------------------CCCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP------------------------HGLP 72 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------------------~~l~ 72 (303)
....+.+|+.+++.++||||+++++++...+..++|+||+++|+|.+++... ..++
T Consensus 59 ~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 138 (301)
T d1lufa_ 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138 (301)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCC
Confidence 3567889999999999999999999999999999999999999999987532 2488
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCc
Q psy763 73 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDT 149 (303)
Q Consensus 73 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~ 149 (303)
+..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+|....... ...+..+++.|+|||.+.+..
T Consensus 139 ~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 99999999999999999999999999999999999999999999999998654322 223457889999999998765
Q ss_pred cCCCccchhhHHHHHHHhhccCcc-CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 150 LYGPAVDVWAIEWTSHSYSQIGFI-GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 150 ~~~~~~DvwSlG~il~el~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++.++|||||||++|||++|+.+ +.+....+... .+..+.+++ .+..++++..+++..||..+|..||.+.-
T Consensus 219 -~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~-~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 219 -YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY-YVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp -CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHH-HHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 89999999999999999999755 45555555544 445444432 34567788888888888888887775444
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=285.39 Aligned_cols=204 Identities=22% Similarity=0.300 Sum_probs=161.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
.+.+.+|+.+++.++|||||+++|++.+ +.+++||||+++|++..++.. ...+++..+..++.||+.||+|||++||
T Consensus 56 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~i 134 (285)
T d1fmka3 56 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134 (285)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhe
Confidence 3568899999999999999999999854 568899999999999987653 3479999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCC--ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCcc
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGE--NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGFI 173 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~~ 173 (303)
+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||.+.+.. ++.++|||||||++|||++|+.+
T Consensus 135 vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCC
Confidence 999999999999999999999999998765332 223467899999999998655 89999999999999999998777
Q ss_pred CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 174 GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++.......+...+..+.+++ .+..++.++.+++-.||..+|..||...-
T Consensus 214 ~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 263 (285)
T d1fmka3 214 PYPGMVNREVLDQVERGYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEY 263 (285)
T ss_dssp SSTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCC---CCcccCHHHHHHHHHHcccCHhHCcCHHH
Confidence 766666555555555555543 34556677777777777777777764443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=292.77 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 93 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 93 (303)
...+.+|+.+++.++||||+++++++.... ..+++++++.+|+|.+++.. +.+++..++.++.|++.||.|||++
T Consensus 50 ~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~ 128 (345)
T d1pmea_ 50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA 128 (345)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 445778999999999999999999997653 23344456678999998864 4799999999999999999999999
Q ss_pred CceecccCCCcEEEecCCcEEEccccceeeeCCCC----ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARLINPGE----NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
||+||||||+|||++.++.+||+|||+|....... ......||+.|+|||++.....++.++||||+||++|||++
T Consensus 129 ~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~ 208 (345)
T d1pmea_ 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208 (345)
T ss_dssp TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh
Confidence 99999999999999999999999999998765332 23446789999999999766668999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcC--CChhHHHHHHhHhCCCCCCCchhhHHhhhh
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSK--TSTTTIFKYLLIRGGNTDRNSHGVVKILGK 247 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~dll~~ 247 (303)
|..||.+................+............. +...... ....++... .+..++++.+++.+
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-------~~~~s~~~~~li~~ 277 (345)
T d1pmea_ 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA----RNYLLSLPHKNKVPWNRL-------FPNADSKALDLLDK 277 (345)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH----HHHHHTSCCCCCCCHHHH-------CTTSCHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh----hcccccCCccCCCCHHHh-------CCCCCHHHHHHHHH
Confidence 9999988887777666555433322111111111111 1111111 111112111 12345688999999
Q ss_pred hhccccceeeccccccccccccceeeeeec
Q psy763 248 KLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
||..+|..| +++.+++.||||..
T Consensus 278 ~L~~dP~~R-------~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 278 MLTFNPHKR-------IEVEQALAHPYLEQ 300 (345)
T ss_dssp HSCSSTTTS-------CCHHHHHTSGGGTT
T ss_pred HccCChhHC-------cCHHHHhcCHhhcc
Confidence 999777666 99999999999873
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=283.25 Aligned_cols=206 Identities=19% Similarity=0.237 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHA 94 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ 94 (303)
..+.+.+|++++++++||||++++|++.+ ++..++|||||++|++.+++... ..+++..+..++.|++.||.|||+.|
T Consensus 71 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~ 150 (311)
T d1r0pa_ 71 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150 (311)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC
Confidence 45678999999999999999999999876 46899999999999999977654 46888899999999999999999999
Q ss_pred ceecccCCCcEEEecCCcEEEccccceeeeCCCCc-----cccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhc
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARLINPGEN-----YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQ 169 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~t 169 (303)
|+||||||+|||+++++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||||++|||+|
T Consensus 151 iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t 229 (311)
T d1r0pa_ 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT 229 (311)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHH
Confidence 99999999999999999999999999987654322 12346889999999988655 8999999999999999999
Q ss_pred cCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 170 IGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|+.||........+...+..+.++. .+..++.+..+++..||..+|..||...-
T Consensus 230 ~~~p~~~~~~~~~~~~~i~~g~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 230 RGAPPYPDVNTFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp TSCCSCC------CHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCC---CcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 8888877665555555555555543 34566778888888888888887775544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=282.31 Aligned_cols=205 Identities=25% Similarity=0.345 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 18 QATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 18 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
...+.+|...++++ +|||||+++++|.+++.+++||||+++|++.+++... ..+++..++.++
T Consensus 62 ~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 141 (299)
T d1fgka_ 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141 (299)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHH
Confidence 34566666666666 8999999999999999999999999999999988643 358999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.||+.||+|||+.||+||||||+|||++.++.+||+|||++....... ......+|+.|+|||.+.+.. |+.++||
T Consensus 142 ~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~Di 220 (299)
T d1fgka_ 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDV 220 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHH
T ss_pred HHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhh
Confidence 999999999999999999999999999999999999999998765432 233467889999999998755 8999999
Q ss_pred hhHHHHHHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 158 WAIEWTSHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 158 wSlG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||||||+|||++++.+|+.....+.+...+..+.+++ .+...++++.+++-.||..+|..||...-
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~e 286 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999999996655555555556666666666654 23456667777777777777776664433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=281.14 Aligned_cols=201 Identities=18% Similarity=0.225 Sum_probs=156.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEecCCCCcHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy763 19 ATEATNKKEKRSLKHPNLVNLLEVFRR-KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHAC 95 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 95 (303)
+.+.+|++++++++||||++++|++.+ .+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+|
T Consensus 45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~i 124 (262)
T d1byga_ 45 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 124 (262)
T ss_dssp HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCce
Confidence 457889999999999999999999865 45689999999999999987543 358999999999999999999999999
Q ss_pred eecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhcc-CccC
Q psy763 96 IHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQI-GFIG 174 (303)
Q Consensus 96 vH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg-~~~~ 174 (303)
+||||||+||+++.++.+|++|||+++..... .....+|..|+|||.+.+.. ++.++|||||||++|||+|+ ..|+
T Consensus 125 vH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~ 201 (262)
T d1byga_ 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPY 201 (262)
T ss_dssp CCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred eccccchHhheecCCCCEeecccccceecCCC--CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999999875432 33456889999999998765 89999999999999999985 5555
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.+....+... .+..+.+++ .+...+++..+++..||..+|..||...-
T Consensus 202 ~~~~~~~~~~-~i~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 249 (262)
T d1byga_ 202 PRIPLKDVVP-RVEKGYKMD---APDGCPPAVYEVMKNCWHLDAAMRPSFLQ 249 (262)
T ss_dssp TTSCGGGHHH-HHTTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHHHHHH-HHHcCCCCC---CCccCCHHHHHHHHHHcccCHhHCcCHHH
Confidence 5544444444 444455543 34456677788888888877777765544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=282.48 Aligned_cols=203 Identities=26% Similarity=0.339 Sum_probs=155.2
Q ss_pred HHHHHHHHHH-HhCCCCCcceeEEEEEeC-CEEEEEEecCCCCcHHHHHcCC----------------CCCCHHHHHHHH
Q psy763 19 ATEATNKKEK-RSLKHPNLVNLLEVFRRK-KKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQIT 80 (303)
Q Consensus 19 ~~~~~e~~~l-~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~~~ 80 (303)
+.+.+|...+ +..+|+||+.+++++... +.+++|||||++|+|.+++... ..+++..+..++
T Consensus 61 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (299)
T d1ywna1 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140 (299)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHH
Confidence 3444455544 445799999999998765 4689999999999999987532 358999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCC---ccccccCCCcccCcccccCCccCCCccch
Q psy763 81 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGE---NYTDYVATRWYRAPELLVGDTLYGPAVDV 157 (303)
Q Consensus 81 ~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~Dv 157 (303)
.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ......||+.|+|||++.+.. ++.++||
T Consensus 141 ~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDi 219 (299)
T d1ywna1 141 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDV 219 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHH
T ss_pred HHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccce
Confidence 999999999999999999999999999999999999999998754332 223467999999999998765 8999999
Q ss_pred hhHHHHHHHhhccCc-cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 158 WAIEWTSHSYSQIGF-IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 158 wSlG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
|||||++|||+||+. |+.+....+.+...+..+.+++ .++..+++..+++..||..+|..||...
T Consensus 220 wS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 285 (299)
T d1ywna1 220 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFS 285 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 999999999999865 5555566666667777766653 3445666777777777777666665433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-39 Score=287.28 Aligned_cols=246 Identities=23% Similarity=0.309 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEe------CCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRR------KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 91 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 91 (303)
...+.+|+.+++.++||||++++++|.. .+++|+||||+.++++..+. ..+++..++.++.|++.||.|||
T Consensus 60 ~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH 136 (355)
T d2b1pa1 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH 136 (355)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhh
Confidence 3467899999999999999999999963 36899999999887776553 36899999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccC
Q psy763 92 RHACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIG 171 (303)
Q Consensus 92 ~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~ 171 (303)
++||+||||||+|||++.++.++++|||++.............+|+.|+|||++.+.. ++.++||||+||++|||++|.
T Consensus 137 ~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~ 215 (355)
T d2b1pa1 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_dssp HTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSS
T ss_pred hcccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCC
Confidence 9999999999999999999999999999988877666666778999999999998865 899999999999999999999
Q ss_pred ccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCC-----CCCCchhhHHhhh
Q psy763 172 FIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGN-----TDRNSHGVVKILG 246 (303)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~dll~ 246 (303)
.||.+.........++.....+...... ..........-... .....+........... ....++++.||+.
T Consensus 216 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~ 292 (355)
T d2b1pa1 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMK-KLQPTVRNYVENRP--KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292 (355)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHT-TSCHHHHHHHHTSC--CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhccCCCHHHHH-HhhhhHHHHhhcCc--cccccccccccccccccccccccccCCHHHHHHHH
Confidence 9999988887777776654332111000 00000000000000 00001111110000000 0112567899999
Q ss_pred hhhccccceeeccccccccccccceeeeeec
Q psy763 247 KKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
+||..+|..| ++++++|+||||-.
T Consensus 293 ~mL~~dP~~R-------~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 293 KMLVIDPAKR-------ISVDDALQHPYINV 316 (355)
T ss_dssp HHSCSSTTTS-------CCHHHHHTSTTTGG
T ss_pred HHCcCChhHC-------cCHHHHhcCcccCC
Confidence 9999777666 99999999999954
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=286.45 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy763 18 QATEATNKKEKRSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 92 (303)
Q Consensus 18 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 92 (303)
...+.+|+.+++.++||||+++++++... ...+++++++.+|+|.+++.. +++++..++.++.||+.||+|||+
T Consensus 61 ~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~ 139 (348)
T d2gfsa1 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS 139 (348)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHh
Confidence 34577899999999999999999999743 234666778889999998864 479999999999999999999999
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCccchhhHHHHHHHhhccCc
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSYSQIGF 172 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el~tg~~ 172 (303)
+||+||||||+|||++.++.+|++|||++.... ....+..|++.|+|||.+.+...++.++||||+||++|+|++|..
T Consensus 140 ~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp TTCCCCCCCGGGEEECTTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCCcccccCCccccccccccccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCC
Confidence 999999999999999999999999999987643 334556789999999998877767999999999999999999999
Q ss_pred cCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccc
Q psy763 173 IGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGR 252 (303)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~ 252 (303)
||.+.........++...+.+......... ...... +..........++... ....++++.||+.+||..+
T Consensus 218 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~-------~~~~s~~~~dli~~mL~~d 288 (348)
T d2gfsa1 218 LFPGTDHIDQLKLILRLVGTPGAELLKKIS-SESARN-YIQSLTQMPKMNFANV-------FIGANPLAVDLLEKMLVLD 288 (348)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHTTCC-CHHHHH-HHTTSCCCCCCCHHHH-------STTCCHHHHHHHHHHSCSS
T ss_pred CCCCCCHHHHHHHHHHhcCCCChHHhhhcc-chhhhh-hhhhcccCCCcchhhh-------cCCCCHHHHHHHHHHCcCC
Confidence 999998888888887765544321111110 000000 0001111111111111 1235678999999999977
Q ss_pred cceeeccccccccccccceeeeeec
Q psy763 253 FTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 253 ~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
|..| +++.++++||||..
T Consensus 289 P~~R-------~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 289 SDKR-------ITAAQALAHAYFAQ 306 (348)
T ss_dssp GGGS-------CCHHHHHTSGGGTT
T ss_pred hhhC-------cCHHHHhcCHhhCC
Confidence 7666 99999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=285.41 Aligned_cols=218 Identities=20% Similarity=0.253 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 19 ATEATNKKEKRSLKH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 19 ~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
+.+.+|+.++++++| |||+++++++.+...+++|+||+.+|+|..++...+.+++..+..++.|++.||.|||++||+|
T Consensus 73 ~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivH 152 (322)
T d1vzoa_ 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIY 152 (322)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEe
Confidence 456789999999977 8999999999999999999999999999999988889999999999999999999999999999
Q ss_pred cccCCCcEEEecCCcEEEccccceeeeCCC--CccccccCCCcccCcccccCCc-cCCCccchhhHHHHHHHhhccCccC
Q psy763 98 RDIKPENILLTANGVVKLCDFGFARLINPG--ENYTDYVATRWYRAPELLVGDT-LYGPAVDVWAIEWTSHSYSQIGFIG 174 (303)
Q Consensus 98 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~-~~~~~~DvwSlG~il~el~tg~~~~ 174 (303)
|||||+||+++.++.+||+|||++...... ....+..|++.|+|||.+.+.. .++.++||||+||++|||++|..||
T Consensus 153 rDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 153 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp CCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876432 2334568999999999997643 3688999999999999999999998
Q ss_pred CCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHHHhHhCCCCCCCchhhHHhhhhhhccccc
Q psy763 175 LGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKYLLIRGGNTDRNSHGVVKILGKKLIGRFT 254 (303)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~dll~~~l~~~~~ 254 (303)
.+....+....+... ... .........++++.+++.+|+..+|.
T Consensus 233 ~~~~~~~~~~~i~~~------------------------~~~------------~~~~~~~~~s~~~~~li~~~l~~dP~ 276 (322)
T d1vzoa_ 233 TVDGEKNSQAEISRR------------------------ILK------------SEPPYPQEMSALAKDLIQRLLMKDPK 276 (322)
T ss_dssp SCTTSCCCHHHHHHH------------------------HHH------------CCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CCCCHHHHHHHHHHh------------------------ccc------------CCCCCcccCCHHHHHHHHHHcccCHH
Confidence 766433222221111 000 00111233577899999999997776
Q ss_pred eeeccccccc-----cccccceeeeeecCC
Q psy763 255 YIQSEKQDSI-----RGKNCKKTFYIPTPE 279 (303)
Q Consensus 255 ~~~~~~~~~~-----~~~~~l~~~~~~~~~ 279 (303)
.| + ++.++++||||...+
T Consensus 277 ~R-------~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 277 KR-------LGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp GS-------TTSSTTTHHHHHTSGGGTTCC
T ss_pred Hc-------CCCCcccHHHHHcCHhhcCCC
Confidence 66 6 478999999997643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=278.44 Aligned_cols=206 Identities=15% Similarity=0.205 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC----------CCCCHHHHHHHHHHHHHH
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRG 86 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~l~~~~~~~~~~qi~~~ 86 (303)
....+.+|+.++++++||||++++|++..++..++||||+++|++..++... ..++...+..++.|+++|
T Consensus 66 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~g 145 (308)
T d1p4oa_ 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145 (308)
T ss_dssp HHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHH
Confidence 4457889999999999999999999999999999999999999999976421 357899999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCccchhhHHHH
Q psy763 87 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 87 l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~i 163 (303)
|.|||+++|+||||||+|||++.++.+||+|||+|........ .....+|+.|+|||.+.+.. ++.++|||||||+
T Consensus 146 l~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 146 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVV 224 (308)
T ss_dssp HHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred HHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHH
Confidence 9999999999999999999999999999999999987643222 23346899999999998765 7999999999999
Q ss_pred HHHhhccCccCCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 164 SHSYSQIGFIGLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 164 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+|||+||+.+|+...........+..+.+++ .++.+++++.+++..||..+|..||...-
T Consensus 225 l~El~t~~~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~ 284 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLE 284 (308)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999755554444444444444555433 34566778888888888888877775444
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-39 Score=280.35 Aligned_cols=206 Identities=24% Similarity=0.312 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCC------------------CCCCHHHHH
Q psy763 17 RQATEATNKKEKRSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHP------------------HGLPWDLIK 77 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------------~~l~~~~~~ 77 (303)
....+.+|+.+++.+ +|||||++++++.++..+++|||||++|++..++... ..+++..+.
T Consensus 69 ~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (311)
T d1t46a_ 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHH
Confidence 445678889999988 6999999999999999999999999999999987532 258999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCcEEEccccceeeeCCCCc---cccccCCCcccCcccccCCccCCCc
Q psy763 78 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLINPGEN---YTDYVATRWYRAPELLVGDTLYGPA 154 (303)
Q Consensus 78 ~~~~qi~~~l~~lH~~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~ 154 (303)
.++.||+.||+|||++|++||||||+||+++.++.+|++|||.+........ .....+|+.|+|||.+.+.. ++.+
T Consensus 149 ~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~ 227 (311)
T d1t46a_ 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFE 227 (311)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHH
T ss_pred HHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCc
Confidence 9999999999999999999999999999999999999999999987654322 23457899999999998655 8999
Q ss_pred cchhhHHHHHHHhhccCcc-CCCCchHHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHHH
Q psy763 155 VDVWAIEWTSHSYSQIGFI-GLGNMGSHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFKY 226 (303)
Q Consensus 155 ~DvwSlG~il~el~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+|||||||++|||+|++.+ +.+....+.+..++..+.++. .+...+.++.+++-.||..+|..||.+..
T Consensus 228 ~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~ 297 (311)
T d1t46a_ 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (311)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999999985544 555566677777777776653 33455667777777777777776665443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=268.00 Aligned_cols=154 Identities=23% Similarity=0.315 Sum_probs=130.6
Q ss_pred HHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH----
Q psy763 21 EATNKKEKRSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR---- 92 (303)
Q Consensus 21 ~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---- 92 (303)
.+.|+..++.++||||+++++++.+.+ .+|+||||+++|+|..++++. .+++..+..++.|++.||.|||+
T Consensus 44 ~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~ 122 (303)
T d1vjya_ 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 345666777899999999999998654 689999999999999999754 79999999999999999999996
Q ss_pred ----CCceecccCCCcEEEecCCcEEEccccceeeeCCCC-----ccccccCCCcccCcccccCCc-----cCCCccchh
Q psy763 93 ----HACIHRDIKPENILLTANGVVKLCDFGFARLINPGE-----NYTDYVATRWYRAPELLVGDT-----LYGPAVDVW 158 (303)
Q Consensus 93 ----~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~-----~~~~~~Dvw 158 (303)
+||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+.. .++.++|||
T Consensus 123 ~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~ 202 (303)
T d1vjya_ 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202 (303)
T ss_dssp TTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred hccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhh
Confidence 599999999999999999999999999998875433 223467999999999987532 257789999
Q ss_pred hHHHHHHHhhccCccCC
Q psy763 159 AIEWTSHSYSQIGFIGL 175 (303)
Q Consensus 159 SlG~il~el~tg~~~~~ 175 (303)
||||++|||+||..++.
T Consensus 203 S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 203 AMGLVFWEIARRCSIGG 219 (303)
T ss_dssp HHHHHHHHHHHTBCBTT
T ss_pred hhHHHHHHHhhCCCCCC
Confidence 99999999999876653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-35 Score=257.33 Aligned_cols=205 Identities=13% Similarity=0.111 Sum_probs=156.0
Q ss_pred HHHHHHHHHHhCCCCCcc-eeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy763 20 TEATNKKEKRSLKHPNLV-NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 98 (303)
Q Consensus 20 ~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 98 (303)
.+..|+++++.++|+|++ .+.+++.+++..++||||++++....+......+++..+..++.|++.||+|||++||+||
T Consensus 48 ~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHr 127 (299)
T d1ckia_ 48 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 127 (299)
T ss_dssp CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 466789999999877755 5556667888999999999877666666667789999999999999999999999999999
Q ss_pred ccCCCcEEEec---CCcEEEccccceeeeCCCC--------ccccccCCCcccCcccccCCccCCCccchhhHHHHHHHh
Q psy763 99 DIKPENILLTA---NGVVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTSHSY 167 (303)
Q Consensus 99 dlk~~nil~~~---~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il~el 167 (303)
||||+||+++. +..++|+|||+|....... ......||+.|+|||.+.+.+ ++.++|||||||++|||
T Consensus 128 DiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYF 206 (299)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHH
T ss_pred cCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHH
Confidence 99999999863 4579999999999875432 123457999999999998766 89999999999999999
Q ss_pred hccCccCCCCchHHHHHHHhhc---CCceeEeecCCCCCcchhhhhhhhhhcCCChhHHHH
Q psy763 168 SQIGFIGLGNMGSHMARNLLKN---NGRVTVILKSDSLDSETWDLTWQEIFSKTSTTTIFK 225 (303)
Q Consensus 168 ~tg~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
++|..||.+............. ....+....+..++++..+++-.|+..+|..||...
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~ 267 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred HhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999998776554433322221 111111222346677777777888887777776443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-35 Score=254.92 Aligned_cols=201 Identities=14% Similarity=0.130 Sum_probs=153.9
Q ss_pred HHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEecCCCCcHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy763 20 TEATNKKEKRSLKH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIH 97 (303)
Q Consensus 20 ~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 97 (303)
.+.+|++.++.++| +|++.+++++..+...++||||+. ++|..++. .+..++...+..++.|++.||.|||++||+|
T Consensus 46 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiH 124 (293)
T d1csna_ 46 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124 (293)
T ss_dssp CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCcee
Confidence 35677888888875 899999999999999999999995 66666654 4457999999999999999999999999999
Q ss_pred cccCCCcEEEec-----CCcEEEccccceeeeCCCC--------ccccccCCCcccCcccccCCccCCCccchhhHHHHH
Q psy763 98 RDIKPENILLTA-----NGVVKLCDFGFARLINPGE--------NYTDYVATRWYRAPELLVGDTLYGPAVDVWAIEWTS 164 (303)
Q Consensus 98 ~dlk~~nil~~~-----~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~DvwSlG~il 164 (303)
|||||+||+++. ++.+||+|||+|....... ......||+.|+|||.+.+.. ++.++|||||||++
T Consensus 125 rDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l 203 (293)
T d1csna_ 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVF 203 (293)
T ss_dssp CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred ccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHH
Confidence 999999999975 4689999999998865321 223467999999999998765 89999999999999
Q ss_pred HHhhccCccCCCCch---HHHHHHHhhcCCceeEeecCCCCCcchhhhhhhhhhcCCChhH
Q psy763 165 HSYSQIGFIGLGNMG---SHMARNLLKNNGRVTVILKSDSLDSETWDLTWQEIFSKTSTTT 222 (303)
Q Consensus 165 ~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
|||++|..||.+... .+....+.......+....+..++++..+++-.|+..++..||
T Consensus 204 ~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP 264 (293)
T d1csna_ 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264 (293)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred HHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 999999999876533 2222223222211111112344566666666666666555554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=2.5e-32 Score=243.71 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHhC-----------CCCCcceeEEEEEe--CCEEEEEEecCCCCcH-HH--HHcCCCCCCHHHHHHHHHH
Q psy763 19 ATEATNKKEKRSL-----------KHPNLVNLLEVFRR--KKKLHLVFEFCDHTVL-NE--LENHPHGLPWDLIKQITWQ 82 (303)
Q Consensus 19 ~~~~~e~~~l~~l-----------~h~niv~~~~~~~~--~~~~~lv~e~~~~~~l-~~--~~~~~~~l~~~~~~~~~~q 82 (303)
....+|+++++.+ .|+||+++++++.. ....+++++++..+.. .. .......+++..+..++.|
T Consensus 54 ~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~q 133 (362)
T d1q8ya_ 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133 (362)
T ss_dssp HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHH
Confidence 3445666666655 46889999999864 3566677766654432 22 2334468999999999999
Q ss_pred HHHHHHHHHH-CCceecccCCCcEEEecCC------cEEEccccceeeeCCCCccccccCCCcccCcccccCCccCCCcc
Q psy763 83 VLRGVSYCHR-HACIHRDIKPENILLTANG------VVKLCDFGFARLINPGENYTDYVATRWYRAPELLVGDTLYGPAV 155 (303)
Q Consensus 83 i~~~l~~lH~-~~ivH~dlk~~nil~~~~~------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~ 155 (303)
++.||.|||+ .||+||||||+|||++.++ .++++|||.+.... .......||+.|+|||++.+.. ++.++
T Consensus 134 il~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~ 210 (362)
T d1q8ya_ 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAP-WGCGA 210 (362)
T ss_dssp HHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCC-CCTHH
T ss_pred HHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc--cccccccccccccChhhccccC-CCccc
Confidence 9999999998 8999999999999998664 49999999988744 2335568999999999998765 89999
Q ss_pred chhhHHHHHHHhhccCccCCCCch------HHHHHHHhhcCCceeEeecCCCCCc-chhh-hhhhhhhcCCChhHHHHHH
Q psy763 156 DVWAIEWTSHSYSQIGFIGLGNMG------SHMARNLLKNNGRVTVILKSDSLDS-ETWD-LTWQEIFSKTSTTTIFKYL 227 (303)
Q Consensus 156 DvwSlG~il~el~tg~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~l 227 (303)
|+||+||++++|++|..||.+... .......+...+..+.......... .... .............++...+
T Consensus 211 DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (362)
T d1q8ya_ 211 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290 (362)
T ss_dssp HHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH
T ss_pred cccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhc
Confidence 999999999999999988765432 1222222222221110000000000 0000 0000011111222333333
Q ss_pred hHhCCCCCCCchhhHHhhhhhhccccceeeccccccccccccceeeeeec
Q psy763 228 LIRGGNTDRNSHGVVKILGKKLIGRFTYIQSEKQDSIRGKNCKKTFYIPT 277 (303)
Q Consensus 228 ~~~~~~~~~~~~~~~dll~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 277 (303)
.......+..++++.||+.+||..+|..| ++++++|+||||.+
T Consensus 291 ~~~~~~~~~~~~~~~dll~~mL~~dP~~R-------pta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKR-------ADAGGLVNHPWLKD 333 (362)
T ss_dssp HHTTCCCHHHHHHHHHHHGGGGCSSTTTC-------BCHHHHHTCGGGTT
T ss_pred ccccccCcccCHHHHHHHHHHCCCChhHC-------cCHHHHhcCcccCC
Confidence 33334445567789999999999777666 99999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.71 E-value=5.8e-18 Score=136.49 Aligned_cols=126 Identities=11% Similarity=0.070 Sum_probs=93.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy763 17 RQATEATNKKEKRSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 96 (303)
Q Consensus 17 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 96 (303)
.......|...+..+.|.+++..+++. . .+++||+++++.+.. ++...+..++.|++.|+.|||++||+
T Consensus 57 ~~~~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~gii 125 (191)
T d1zara2 57 AIRSARNEFRALQKLQGLAVPKVYAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIV 125 (191)
T ss_dssp HHHHHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHHccCCCcceEEEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEE
Confidence 344556788899999999999988653 2 279999999876644 33445678999999999999999999
Q ss_pred ecccCCCcEEEecCCcEEEccccceeeeCCCCccccccCCCcccCc------ccccCCccCCCccchhhHHHH
Q psy763 97 HRDIKPENILLTANGVVKLCDFGFARLINPGENYTDYVATRWYRAP------ELLVGDTLYGPAVDVWAIEWT 163 (303)
Q Consensus 97 H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP------E~l~~~~~~~~~~DvwSlG~i 163 (303)
||||||+|||++.+ .++|+|||.|......... .|... +.+ ...|+.++|+||+.--
T Consensus 126 HrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 126 HGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH--HHHHCCCCCHHHHHHH
T ss_pred EccCChhheeeeCC-CEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH--cCCCCCcccHHHHHHH
Confidence 99999999999854 5899999999775432211 11111 111 1337899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.89 E-value=2.5e-05 Score=63.82 Aligned_cols=98 Identities=16% Similarity=0.121 Sum_probs=67.0
Q ss_pred HHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC------
Q psy763 21 EATNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH------ 93 (303)
Q Consensus 21 ~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~------ 93 (303)
+.+|...++.+. +--+.+++++...++..++||++++|..+....... .. ...++.+++..++.||+.
T Consensus 56 ~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~ 130 (263)
T d1j7la_ 56 VEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCP 130 (263)
T ss_dssp HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCS
T ss_pred HHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccc
Confidence 455666665553 333678888888899999999999998886653221 11 222344445555555521
Q ss_pred -----------------------------------------------------CceecccCCCcEEEecCCcEEEccccc
Q psy763 94 -----------------------------------------------------ACIHRDIKPENILLTANGVVKLCDFGF 120 (303)
Q Consensus 94 -----------------------------------------------------~ivH~dlk~~nil~~~~~~~kl~dfg~ 120 (303)
.++|+|+.|.||+++.++.+.|+||+.
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~ 210 (263)
T d1j7la_ 131 YTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGR 210 (263)
T ss_dssp CBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTT
T ss_pred cCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechh
Confidence 278999999999998776667999997
Q ss_pred eee
Q psy763 121 ARL 123 (303)
Q Consensus 121 ~~~ 123 (303)
+..
T Consensus 211 a~~ 213 (263)
T d1j7la_ 211 SGR 213 (263)
T ss_dssp CEE
T ss_pred ccc
Confidence 654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.38 E-value=0.00016 Score=58.47 Aligned_cols=29 Identities=21% Similarity=0.231 Sum_probs=25.1
Q ss_pred ceecccCCCcEEEecCCcEEEccccceee
Q psy763 95 CIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 95 ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999998876678999987644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.37 E-value=0.0034 Score=54.14 Aligned_cols=29 Identities=28% Similarity=0.384 Sum_probs=25.1
Q ss_pred CceecccCCCcEEEecCCcEEEccccceee
Q psy763 94 ACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 94 ~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.++|||+.|.||+++.++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998664 89999988765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.38 E-value=0.019 Score=49.26 Aligned_cols=35 Identities=14% Similarity=0.021 Sum_probs=21.8
Q ss_pred HHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecCCCCcH
Q psy763 23 TNKKEKRSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVL 61 (303)
Q Consensus 23 ~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~l 61 (303)
+|..+++.+. +.-..++++++.. .+|+||++|..+
T Consensus 93 ~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 93 AESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 4555555553 3334678887642 578999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.22 E-value=0.0075 Score=49.97 Aligned_cols=31 Identities=29% Similarity=0.450 Sum_probs=27.2
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.|++|+|+.+.|++++.+...-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887789999998743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.80 E-value=0.15 Score=42.03 Aligned_cols=29 Identities=31% Similarity=0.329 Sum_probs=23.3
Q ss_pred CCceecccCCCcEEEecCCcEEEccccceee
Q psy763 93 HACIHRDIKPENILLTANGVVKLCDFGFARL 123 (303)
Q Consensus 93 ~~ivH~dlk~~nil~~~~~~~kl~dfg~~~~ 123 (303)
.+++|+|+.+.||++++ + ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999974 3 45899997754
|